data_2ndf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ndf _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.664 0.269 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.6 t -105.28 142.07 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.98 124.13 41.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.869 0.366 . . . . 0.0 110.454 -177.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.655 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -113.73 178.79 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.184 178.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 122' ' ' CYS . 16.2 tttp -145.51 135.8 23.98 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -176.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.94 151.95 39.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.676 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 41.7 tt0 -117.47 124.38 48.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.4 -176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.655 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -107.14 118.06 35.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.96 169.9 27.96 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.899 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -164.12 146.21 8.99 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.94 0.4 . . . . 0.0 110.43 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -117.48 134.96 54.27 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 173.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -122.94 117.17 24.91 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.933 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -110.54 150.5 28.84 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 32' ' ' THR . 1.8 p -103.62 161.6 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.1 mtp180 -110.33 146.86 35.0 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -76.12 -14.26 60.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 109.049 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -141.31 103.97 6.04 Favored Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.047 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.473 ' HG3' HG22 ' A' ' 32' ' ' THR . 82.0 Cg_exo -47.72 156.04 1.34 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.375 2.717 . . . . 0.0 113.049 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -77.7 -170.4 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.379 -173.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 m -61.68 -31.24 50.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.892 0.377 . . . . 0.0 111.297 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -86.43 3.38 44.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.742 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.97 29.38 69.15 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.391 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -89.56 133.93 34.37 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.6 p -90.07 -24.22 21.21 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.323 -171.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 79' ' ' SER . 63.3 m80 -118.7 150.04 40.41 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -170.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -129.6 119.54 23.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 42.9 p-90 -121.13 146.34 46.85 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.039 0.447 . . . . 0.0 110.676 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.561 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 24.2 ttp -122.85 109.82 14.65 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.482 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.8 m -94.52 150.05 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.463 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -151.8 156.03 39.4 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 7.8 m -122.05 124.95 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.632 168.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.463 ' HA ' ' NE ' ' A' ' 40' ' ' ARG . 3.1 mmp_? -126.63 178.12 6.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.098 -173.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.87 177.93 33.17 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.308 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.605 ' HD2' ' OG ' ' A' ' 45' ' ' SER . 13.0 Cg_exo -63.18 113.8 2.2 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.406 2.071 . . . . 0.0 111.27 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 61.3 46.04 8.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.253 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 65.37 16.4 10.51 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.605 ' OG ' ' HD2' ' A' ' 42' ' ' PRO . 60.6 p -67.87 139.88 56.52 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -68.89 125.29 26.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.533 HD11 HG23 ' A' ' 51' ' ' VAL . 3.4 pt -96.74 -0.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -172.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.68 -4.65 4.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -76.07 -34.9 59.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.554 0.216 . . . . 0.0 110.85 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.487 ' CE2' HG22 ' A' ' 47' ' ' ILE . 51.0 p90 -115.71 -17.65 11.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.297 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.533 HG23 HD11 ' A' ' 47' ' ' ILE . 86.8 t -91.92 122.7 43.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.213 0.53 . . . . 0.0 110.095 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 5.7 tp10 -89.21 -58.01 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.592 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.567 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 15.4 tttt -152.45 152.72 32.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.743 -175.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 95.4 t -130.82 156.9 43.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.3 p -140.67 138.04 35.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.179 0.514 . . . . 0.0 111.105 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.425 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 17.6 m-85 -120.41 110.7 16.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.5 94.35 7.45 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.86 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.54 ' CD2' HD13 ' A' ' 86' ' ' LEU . 9.0 mt -79.38 -177.15 5.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.759 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -80.27 145.38 32.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -56.88 -20.18 21.7 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.38 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 m -67.2 -21.73 65.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.117 0.484 . . . . 0.0 110.829 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -81.81 135.39 48.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.89 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.4 117.96 4.76 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.342 2.028 . . . . 0.0 110.812 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 60.5 80.87 0.25 Allowed Pre-proline 0 C--O 1.226 -0.182 0 O-C-N 123.665 0.603 . . . . 0.0 110.114 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.93 -22.71 64.37 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.615 2.21 . . . . 0.0 113.216 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.46 ' HE2' ' CG1' ' A' ' 68' ' ' VAL . 78.6 tttt -100.6 109.54 21.63 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.194 0.521 . . . . 0.0 110.855 -176.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 22.5 mmt85 -108.64 104.72 14.08 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.69 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 2.8 m -97.25 136.67 27.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.7 m -120.5 110.76 16.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.024 0.44 . . . . 0.0 110.09 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -99.69 -25.04 14.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.562 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.571 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 8.1 t70 -66.87 173.06 2.76 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.351 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.637 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 60.1 Cg_exo -30.22 -167.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.953 1 C-N-CA 125.322 4.014 . . . . 0.0 115.365 159.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.637 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.3 Cg_endo -32.19 121.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 123.408 2.739 . . . . 0.0 114.761 -154.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 31.8 m-85 -65.9 91.73 0.15 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.622 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 0.4 OUTLIER -148.73 148.16 29.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.541 0.686 . . . . 0.0 112.043 -178.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 36' ' ' MET . 94.2 t -118.92 129.23 75.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.239 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -117.18 101.6 8.59 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.42 170.55 15.32 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 -174.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 7.4 t -120.87 144.68 48.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.972 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.52 -161.98 12.9 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -138.32 -14.91 1.29 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.335 0.567 . . . . 0.0 112.341 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.25 146.46 35.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.91 0.386 . . . . 0.0 111.158 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.419 ' O ' ' HD2' ' B' ' 217' ' ' ARG . . . -86.08 170.15 42.95 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.52 -0.764 . . . . 0.0 113.045 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -170.58 159.71 6.89 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 122.566 0.346 . . . . 0.0 110.252 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.42 HG12 HH22 ' B' ' 217' ' ' ARG . 14.8 mm -68.24 119.48 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.54 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.8 tt -112.94 105.04 55.98 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.617 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.15 120.6 7.3 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 122.823 2.349 . . . . 0.0 112.299 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.5 mt -108.48 129.47 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.318 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.53 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.7 mt-10 -114.58 122.24 45.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.143 0.497 . . . . 0.0 110.086 176.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.459 HG13 ' CE1' ' A' ' 92' ' ' PHE . 71.6 t -102.69 123.22 55.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.804 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.567 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 93.9 m-85 -95.33 138.94 32.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.641 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.459 ' CE1' HG13 ' A' ' 90' ' ' VAL . 22.6 m-85 -113.13 161.04 17.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -108.09 91.6 3.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.467 0.651 . . . . 0.0 110.543 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.507 ' OD1' ' HB2' ' A' ' 96' ' ' GLU . 15.8 t-20 -159.57 167.7 27.9 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.842 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -113.58 9.07 17.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.507 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 3.1 mp0 -99.6 -152.95 0.43 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 14.3 mm-40 -32.43 152.37 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.192 0.997 . . . . 0.0 113.027 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.8 Cg_endo -44.21 117.74 1.43 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.136 3.224 . . . . 0.0 113.499 -168.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -87.45 20.76 2.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.133 -172.388 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.2 139.16 48.24 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.395 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.6 m -116.91 156.97 18.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.951 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -130.04 107.04 9.04 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.929 0.395 . . . . 0.0 110.32 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.655 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.5 m-85 -108.18 119.96 40.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.345 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -84.26 114.72 22.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.08 0.467 . . . . 0.0 109.81 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -126.31 133.8 51.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.661 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.3 115.98 26.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.802 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.48 HD21 HG12 ' A' ' 37' ' ' VAL . 2.5 mp -88.82 95.05 10.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.424 ' CE2' HG13 ' A' ' 117' ' ' VAL . 10.0 p90 -104.92 154.99 19.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.529 . . . . 0.0 111.57 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 mt -137.42 163.63 30.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.986 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.572 ' HD2' ' O ' ' A' ' 111' ' ' LEU . 17.9 p-80 -99.77 167.74 10.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.54 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.572 ' O ' ' HD2' ' A' ' 110' ' ' HIS . 1.0 OUTLIER -68.18 147.04 52.81 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 173.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.409 ' HA ' HG22 ' A' ' 22' ' ' VAL . 4.5 tt0 . . . . . 0 CA--C 1.533 0.307 0 C-N-CA 122.796 0.438 . . . . 0.0 110.349 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 58.0 t . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -138.0 96.71 3.26 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -122.12 125.78 46.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.852 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.1 mt -113.26 150.52 32.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.858 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.7 ttt180 -144.93 142.71 30.08 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.431 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 60.9 m -128.88 116.13 18.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.895 0.378 . . . . 0.0 111.193 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -111.64 135.12 52.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.311 -176.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -90.83 136.38 33.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.198 0.523 . . . . 0.0 111.562 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.655 ' HB2' HG21 ' A' ' 12' ' ' VAL . 9.0 mt -106.87 124.69 49.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 20.2 m -120.55 124.15 44.64 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.209 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -120.86 112.82 19.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.585 -176.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -85.57 127.9 34.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.007 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 56.75 58.16 8.47 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.493 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -84.51 166.13 12.17 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.455 2.104 . . . . 0.0 111.694 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.1 p -73.21 145.09 46.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.766 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -54.34 -42.37 70.14 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.507 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.514 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.1 p-10 -57.22 -33.04 67.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.638 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 11.0 t80 -75.73 -40.16 56.03 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.606 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 37.2 ttm180 -56.96 -45.29 82.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -56.43 -34.76 67.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.34 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 36.2 mtpt -75.2 -41.33 58.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.812 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.1 mt -69.33 -27.06 65.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 44.0 mt -83.99 -35.69 23.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.318 . . . . 0.0 110.937 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -70.59 -30.49 67.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.732 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.547 -0.74 . . . . 0.0 110.373 176.711 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.501 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . . . . . . 0 C--O 1.235 0.314 0 N-CA-C 111.121 0.045 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . 0.461 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 10.5 Cg_endo -53.7 165.59 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.562 2.175 . . . . 0.0 112.472 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . 0.42 HH22 HG12 ' A' ' 85' ' ' ILE . 6.2 tpt180 . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.86 -173.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 t -100.17 138.85 23.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 6.4 mp0 -125.7 119.86 29.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.936 0.398 . . . . 0.0 110.443 -174.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.626 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.56 -179.74 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.888 178.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -151.31 123.28 8.13 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.849 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.8 mt -106.66 145.57 31.81 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.313 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.609 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 3.5 tt0 -105.01 126.55 52.19 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.144 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.646 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -112.54 114.52 27.21 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.4 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -140.9 171.05 24.28 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.842 -1.171 . . . . 0.0 111.728 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -162.97 146.01 10.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.512 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -118.81 132.03 56.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.709 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -130.56 131.35 44.98 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.468 0.651 . . . . 0.0 111.271 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 3.8 tt0 -129.6 155.08 46.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.229 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 32' ' ' THR . 2.8 p -101.85 153.45 5.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 23' ' ' ARG . 1.1 mtp180 -102.57 135.48 44.12 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 24' ' ' LYS . 20.3 tptt -75.75 -5.54 46.25 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.613 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -133.87 99.78 13.68 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.079 168.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HG3' HG22 ' A' ' 32' ' ' THR . 83.1 Cg_exo -50.98 156.57 4.69 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.02 2.48 . . . . 0.0 111.868 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.475 HG21 ' HB2' ' A' ' 31' ' ' PHE . 10.2 t -78.79 -172.67 3.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.091 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 m -60.09 -31.66 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.928 0.394 . . . . 0.0 111.237 -174.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -86.73 4.29 41.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.11 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.42 32.5 68.13 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.253 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.475 ' HB2' HG21 ' A' ' 27' ' ' THR . 17.7 m-30 -90.72 127.19 36.23 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.51 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.1 p -87.52 -29.91 20.98 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -170.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 79' ' ' SER . 67.1 m80 -115.47 142.29 46.91 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -112.27 123.83 51.12 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.417 ' CZ2' ' HB3' ' A' ' 78' ' ' GLU . 54.2 p-90 -127.6 147.27 50.35 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.135 0.493 . . . . 0.0 110.889 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.625 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 51.7 ttp -123.6 122.64 38.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.459 174.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.2 m -102.5 152.21 5.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.587 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -153.27 152.04 30.71 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.951 -0.7 . . . . 0.0 112.812 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.0 m -122.76 125.99 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.703 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -134.65 -178.92 5.29 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.221 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.02 -173.84 39.22 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 1.4 Cg_endo -81.57 111.37 2.3 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.235 1.957 . . . . 0.0 112.693 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 58.7 70.18 0.67 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 71.74 -11.12 0.77 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.26 0.624 . . . . 0.0 112.344 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.502 ' HB3' ' OXT' ' A' ' 141' ' ' ALA . 19.9 m -66.92 120.67 13.98 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -69.86 127.16 31.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 120.881 0.372 . . . . 0.0 110.271 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.528 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.2 pt -90.5 -3.47 10.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.569 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -65.74 -0.87 2.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.891 0.377 . . . . 0.0 111.552 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -74.29 -39.87 62.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.221 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.476 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 53.5 p90 -113.61 -20.27 11.28 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.94 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.528 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 52.5 t -93.38 135.77 27.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.781 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' HB2' ' HG3' ' A' ' 93' ' ' LYS . 8.4 tp10 -111.91 -60.87 1.79 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.172 0.511 . . . . 0.0 110.711 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.675 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 6.7 tttm -138.24 146.92 43.16 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.253 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 98.1 t -127.01 159.21 37.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.552 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.8 p -141.85 136.2 30.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.299 0.571 . . . . 0.0 111.574 -174.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.43 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 22.0 m-85 -119.06 105.6 11.58 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -77.53 87.92 3.86 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.015 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.5 mt -71.38 -176.46 1.52 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.825 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -76.32 140.29 41.41 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -59.39 -19.55 47.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.021 -174.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -58.94 -27.27 65.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.743 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -85.47 131.64 47.24 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.084 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.95 121.5 10.12 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.668 2.246 . . . . 0.0 111.554 175.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.5 mtm180 55.79 67.24 3.06 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.512 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.36 -17.46 60.18 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.189 2.592 . . . . 0.0 113.52 -172.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -86.23 101.62 13.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.141 0.496 . . . . 0.0 110.228 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 22.0 mmt180 -98.42 107.83 20.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.68 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -99.05 136.19 31.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.1 m -120.6 113.56 20.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.295 0.569 . . . . 0.0 110.316 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -102.75 -24.55 13.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.614 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.543 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 13.8 t70 -68.0 170.12 8.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.623 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.629 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.2 Cg_exo -32.71 -178.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.568 1 C-N-CA 125.346 4.031 . . . . 0.0 114.865 164.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.629 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.7 Cg_endo -28.29 119.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 124.292 3.328 . . . . 0.0 113.942 -157.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 51.2 m-85 -60.1 98.66 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.59 -171.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.625 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 10.7 ptpt -140.18 150.42 44.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.438 0.637 . . . . 0.0 112.171 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 36' ' ' MET . 81.1 t -126.87 130.83 71.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.604 175.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.81 109.88 18.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.835 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.417 ' HB3' ' CZ2' ' A' ' 35' ' ' TRP . 1.9 tp10 -135.31 174.45 10.59 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -177.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.3 t -128.45 143.8 51.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.2 -170.62 26.09 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.884 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -130.36 -11.42 4.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.263 0.531 . . . . 0.0 112.066 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.84 139.3 22.55 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.434 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.498 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -75.5 176.45 50.37 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.355 -0.838 . . . . 0.0 113.361 -176.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -172.41 158.29 4.28 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.2 mm -65.44 126.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.329 . . . . 0.0 110.522 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.23 104.64 56.4 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.86 111.14 2.96 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.708 2.272 . . . . 0.0 111.826 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.412 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.9 mt -104.43 125.69 59.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.43 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.552 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 54.4 mt-10 -111.45 123.64 50.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.171 0.51 . . . . 0.0 110.039 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.606 HG13 ' CE1' ' A' ' 92' ' ' PHE . 72.4 t -103.79 122.42 56.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.112 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.675 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 75.7 m-85 -94.63 132.42 39.38 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 112.005 -176.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.606 ' CE1' HG13 ' A' ' 90' ' ' VAL . 18.9 m-85 -114.38 164.07 14.44 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.079 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -107.9 100.48 9.84 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 122.327 -0.233 . . . . 0.0 111.479 175.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -158.28 178.18 10.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.742 171.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.49 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.52 -1.11 15.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.756 -178.338 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -100.62 -153.12 0.44 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.092 -176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -29.56 152.74 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.395 1.078 . . . . 0.0 113.907 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -32.89 122.46 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 125.03 3.82 . . . . 0.0 114.2 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.9 19.5 2.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.697 -176.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -150.09 144.56 25.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.276 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.13 157.21 28.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 102' ' ' ARG . 11.6 ttt180 -129.08 108.69 10.58 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.8 m-85 -104.66 120.44 41.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.189 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.83 111.61 19.36 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -124.94 127.28 46.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.317 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -78.82 121.81 25.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.952 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 37' ' ' VAL . 1.5 mp -94.53 91.66 6.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.561 ' CE2' HG13 ' A' ' 117' ' ' VAL . 37.8 p90 -100.11 160.14 14.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.04 0.448 . . . . 0.0 110.845 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.9 mt -134.26 155.9 49.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -101.05 175.53 5.57 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 122.329 -0.232 . . . . 0.0 111.043 176.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.89 139.01 58.24 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.46 ' HA ' HG22 ' A' ' 22' ' ' VAL . 1.5 tm-20 . . . . . 0 N--CA 1.466 0.331 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.898 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 20' ' ' ALA . 4.7 t . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.665 0.269 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -141.93 97.98 3.24 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -122.45 130.75 53.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.04 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.8 mt -114.83 155.58 26.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.379 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 23.2 ttm180 -144.9 145.45 31.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 61.3 m -127.56 110.37 12.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.02 0.438 . . . . 0.0 110.768 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.433 ' HG3' HD23 ' A' ' 16' ' ' LEU . 2.5 mm-40 -107.21 125.84 51.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.27 -174.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -81.9 135.49 35.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.194 0.521 . . . . 0.0 111.431 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.626 ' HB2' HG21 ' A' ' 12' ' ' VAL . 9.2 mt -103.38 114.8 29.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.4 m -107.15 115.64 30.53 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.989 0.423 . . . . 0.0 110.902 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -115.39 106.22 13.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.036 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -81.6 118.52 22.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.82 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 62.43 67.51 1.17 Allowed Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.147 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -89.81 175.47 3.07 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.093 2.528 . . . . 0.0 111.881 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.3 p -84.31 147.05 27.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.41 -42.15 63.81 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.173 0.442 . . . . 0.0 112.147 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 6.4 p-10 -56.36 -32.02 64.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.796 0.332 . . . . 0.0 110.29 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.698 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.8 t80 -76.96 -42.74 37.86 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.66 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 38.0 ttm180 -54.74 -46.27 74.27 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -52.4 -42.8 64.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.381 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 36.1 mtpt -73.31 -38.98 65.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.853 0.358 . . . . 0.0 110.896 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 36.7 mt -70.02 -26.26 63.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.986 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.2 mt -83.58 -32.84 25.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 110.923 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -75.77 -26.38 57.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.308 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.502 ' OXT' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.466 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.463 ' HB2' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.236 0.351 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' B' ' 215' ' ' ALA . 5.0 Cg_endo -48.82 161.55 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.687 2.258 . . . . 0.0 112.551 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 5.1 tpp180 . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.05 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.28 138.23 31.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -124.96 127.4 46.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -176.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -115.17 164.65 11.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.273 178.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 37.8 mttp -129.23 131.51 47.08 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.4 mt -115.1 140.23 49.24 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.248 0.547 . . . . 0.0 109.786 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.5 tt0 -106.33 121.34 44.02 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.873 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.565 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -106.01 112.17 25.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -137.32 166.59 24.96 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.656 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -163.53 149.69 11.72 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.163 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.9 mtt180 -115.21 140.76 48.81 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.694 174.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.84 120.71 29.91 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.511 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -114.18 148.3 37.52 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 32' ' ' THR . 2.4 p -103.39 161.21 4.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 171.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 23' ' ' ARG . 3.0 mtp180 -116.15 134.67 54.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -68.92 -12.85 62.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.434 0.635 . . . . 0.0 109.679 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -134.89 102.17 11.27 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.162 171.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HG3' HG22 ' A' ' 32' ' ' THR . 98.4 Cg_exo -49.28 154.79 3.58 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.021 2.48 . . . . 0.0 112.054 175.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -78.23 -174.06 3.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.852 -170.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.485 HG22 ' OE1' ' A' ' 29' ' ' GLU . 1.9 m -66.31 -30.83 51.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.207 0.527 . . . . 0.0 110.48 -175.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.485 ' OE1' HG22 ' A' ' 28' ' ' VAL . 3.0 mp0 -76.24 -6.65 52.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.471 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.08 34.29 38.07 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.478 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -102.56 136.54 42.2 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.465 HG22 ' HG3' ' A' ' 26' ' ' PRO . 47.4 p -92.78 -24.12 18.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.422 -169.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.413 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.0 m80 -121.11 144.63 48.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -171.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -119.15 125.45 49.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.1 p-90 -126.49 147.32 49.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.036 0.446 . . . . 0.0 110.834 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.56 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.2 ttp -125.53 115.24 19.9 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.759 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 14.2 m -97.32 150.0 4.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.817 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.2 p90 -150.98 155.8 39.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.603 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.3 m -126.05 129.03 72.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.343 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -135.42 -176.9 4.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.332 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.38 -163.57 39.46 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.642 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 3.9 Cg_exo -71.91 109.85 2.77 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.17 1.913 . . . . 0.0 111.64 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 44' ' ' HIS . 28.9 mt-10 52.29 68.66 0.78 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.342 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.4 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 22.2 m170 75.51 -6.76 1.91 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.455 0.702 . . . . 0.0 112.764 172.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.529 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 72.5 m -61.2 136.05 57.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.467 0.175 . . . . 0.0 111.311 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -73.44 126.68 30.74 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.58 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.5 pt -97.27 -4.61 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -64.0 -0.43 1.13 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -77.66 -34.98 52.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.521 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.548 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 50.0 p90 -121.05 -16.88 7.94 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.727 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.58 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 77.8 t -94.26 126.02 46.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 9.5 tp10 -96.63 -57.88 2.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.444 0.64 . . . . 0.0 111.026 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 24.6 tttt -145.7 150.74 36.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.286 -175.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.464 HG11 HG23 ' A' ' 39' ' ' VAL . 88.9 t -131.28 158.1 43.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.435 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.582 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.2 p -141.71 138.42 31.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.266 0.555 . . . . 0.0 111.287 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.443 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 18.1 m-85 -120.95 110.35 16.18 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -82.53 95.88 7.87 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.957 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.4 mt -78.17 -178.8 5.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.815 0.34 . . . . 0.0 110.151 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.442 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 18.9 t60 -85.43 151.2 24.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -51.87 -28.33 15.7 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.797 -169.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 t -79.0 -6.2 55.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.867 0.365 . . . . 0.0 111.273 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -90.36 134.89 30.33 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.57 136.48 30.95 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.282 1.988 . . . . 0.0 109.727 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 61.64 73.8 0.55 Allowed Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -172.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.47 -18.73 60.41 Favored 'Trans proline' 0 C--O 1.223 -0.233 0 C-N-CA 121.887 1.725 . . . . 0.0 112.656 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -110.37 106.76 16.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.678 0.275 . . . . 0.0 110.598 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.3 mmt85 -104.41 100.0 9.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.769 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -89.54 137.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.557 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 36.0 t -128.1 116.81 20.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.096 0.474 . . . . 0.0 110.116 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -106.55 -27.26 10.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.124 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.667 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -71.42 -177.3 0.46 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.571 -175.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.667 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 13.5 Cg_exo -31.17 178.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 125.17 3.913 . . . . 0.0 114.862 163.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.621 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.8 Cg_exo -26.32 121.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 124.797 3.665 . . . . 0.0 114.972 -157.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.557 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 34.2 m-85 -62.21 91.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.958 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.39 151.64 39.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.611 0.719 . . . . 0.0 112.676 179.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 36' ' ' MET . 93.8 t -123.47 129.14 74.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.631 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -114.38 112.99 23.93 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.35 173.31 11.61 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.839 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 3.2 t -121.11 145.93 47.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.139 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.16 -157.96 9.48 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -144.51 -17.48 0.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.82 140.75 31.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.999 0.428 . . . . 0.0 111.116 -176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.89 169.81 55.03 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.773 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 59' ' ' HIS . 11.6 p90 -169.93 158.09 7.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.767 0.427 . . . . 0.0 110.059 -176.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.5 mm -67.18 126.14 26.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.609 0.243 . . . . 0.0 110.596 172.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.434 HD23 HG13 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -111.78 104.96 56.54 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.77 112.99 3.23 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.781 2.321 . . . . 0.0 112.088 171.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.434 HG13 HD23 ' A' ' 86' ' ' LEU . 6.3 mt -106.6 128.79 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.309 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.582 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 45.9 mt-10 -112.81 123.59 50.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.22 0.534 . . . . 0.0 109.964 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.5 t -104.84 118.88 52.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.747 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 89.3 m-85 -90.79 139.81 30.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.157 0.503 . . . . 0.0 111.245 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.418 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.0 m-85 -113.07 165.1 12.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.573 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -118.58 93.95 4.29 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.995 0.426 . . . . 0.0 112.001 -177.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.519 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 0.7 OUTLIER -160.48 -172.53 3.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.031 174.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 20.7 tptp -110.35 0.4 17.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.472 0.653 . . . . 0.0 111.23 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.462 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 6.5 mp0 -100.08 -155.71 0.52 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 -171.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.462 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 13.2 mm-40 -32.5 149.48 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.419 1.088 . . . . 0.0 113.536 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -30.22 125.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 125.205 3.936 . . . . 0.0 115.076 -164.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.519 ' HD3' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -82.01 18.96 1.21 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.83 -178.536 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -154.45 140.28 18.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.198 0.523 . . . . 0.0 110.941 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -120.31 157.35 22.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -128.25 107.64 9.94 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.657 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.565 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.6 m-85 -103.07 123.94 47.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.217 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -88.13 101.23 13.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.357 0.598 . . . . 0.0 110.147 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.427 ' HB3' HD12 ' A' ' 88' ' ' ILE . 40.8 t80 -110.18 132.27 54.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.769 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.16 118.37 21.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.06 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.482 HD21 HG12 ' A' ' 37' ' ' VAL . 1.2 mp -95.2 91.29 6.22 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 175.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -102.22 156.88 17.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.219 0.533 . . . . 0.0 111.278 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 mt -134.47 163.9 28.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.2 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -99.67 164.16 12.18 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.22 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.46 153.78 26.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.939 0.399 . . . . 0.0 111.145 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.451 ' HA ' HG22 ' A' ' 22' ' ' VAL . 8.7 tt0 . . . . . 0 CA--C 1.532 0.265 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.308 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 69.0 t . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 120.503 0.192 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.434 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.93 96.58 2.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -119.9 129.84 54.55 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.163 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.7 mt -108.11 149.34 28.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.547 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 15.6 ttt180 -140.73 137.93 33.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 85.8 m -120.09 116.58 25.97 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.157 0.504 . . . . 0.0 111.214 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 9.8 mm-40 -105.98 158.93 16.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.309 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -124.98 123.88 40.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.148 0.499 . . . . 0.0 111.387 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.643 ' HB2' HG21 ' A' ' 12' ' ' VAL . 5.9 mt -98.31 122.04 40.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.797 176.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.0 m -113.84 122.4 46.93 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.922 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -120.9 107.66 12.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.447 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -83.24 124.32 30.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.125 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 51.72 67.71 3.89 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.337 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -86.57 -179.27 2.97 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.947 2.431 . . . . 0.0 112.003 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 69.6 p -79.12 140.37 37.83 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -58.81 -33.19 70.09 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.446 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.2 p-10 -65.31 -30.97 71.88 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.621 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 18.7 t80 -74.3 -42.32 59.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.572 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.6 ttm180 -54.19 -45.51 72.17 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.929 173.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -55.23 -39.45 69.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.333 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 40.8 mtpt -69.95 -39.97 75.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.93 0.395 . . . . 0.0 110.421 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 41.7 mt -69.53 -31.77 70.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.72 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.6 mt -80.91 -31.39 35.13 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.188 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -76.99 -26.71 54.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.134 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.358 175.419 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.494 ' HB2' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.236 0.358 0 N-CA-C 110.888 -0.041 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' B' ' 215' ' ' ALA . 10.0 Cg_endo -51.9 176.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.974 2.449 . . . . 0.0 112.96 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.717 -172.582 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.943 0.402 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.3 t -109.7 140.32 29.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 172.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 4.5 mp0 -128.57 118.75 23.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.874 0.369 . . . . 0.0 110.168 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.633 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -107.03 170.21 2.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.174 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' A' ' 42' ' ' PRO . 54.9 mtmt -137.07 133.86 35.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.739 0.304 . . . . 0.0 110.467 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.3 mt -114.66 142.16 46.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.002 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.617 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.1 tt0 -103.48 123.48 46.98 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.712 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.641 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.1 mm? -110.56 113.32 25.85 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -142.19 175.52 22.7 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.896 -1.145 . . . . 0.0 111.981 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -167.1 151.67 7.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.06 0.457 . . . . 0.0 110.859 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 80.9 mtt180 -116.5 151.84 35.3 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.946 171.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -144.28 134.4 24.18 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.419 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -132.6 160.73 35.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.214 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 32' ' ' THR . 1.8 p -103.75 161.11 4.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 170.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.481 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 5.5 mtp85 -104.81 143.09 33.61 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -66.37 -19.05 65.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.59 0.709 . . . . 0.0 109.254 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -134.13 106.37 11.34 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.294 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.49 ' HG3' HG22 ' A' ' 32' ' ' THR . 99.0 Cg_exo -50.39 163.76 0.61 Allowed 'Trans proline' 0 N--CA 1.474 0.372 0 C-N-CA 123.109 2.539 . . . . 0.0 112.475 174.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.428 HG21 ' HB2' ' A' ' 31' ' ' PHE . 8.9 t -82.88 -175.7 5.94 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.468 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.05 -30.96 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.782 0.325 . . . . 0.0 111.309 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -82.78 -0.28 47.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.037 0.446 . . . . 0.0 110.701 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.81 33.96 49.7 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.476 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.428 ' HB2' HG21 ' A' ' 27' ' ' THR . 20.3 m-30 -95.57 130.71 42.34 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 176.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.587 ' O ' HG23 ' A' ' 22' ' ' VAL . 28.8 p -90.34 -30.98 17.1 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -170.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.426 ' O ' ' HA ' ' A' ' 79' ' ' SER . 62.7 m80 -112.19 146.21 38.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -170.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.481 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 6.1 m-20 -124.14 121.27 34.69 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.2 p-90 -122.52 150.22 42.85 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.639 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 46.0 ttp -125.59 118.06 24.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.612 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.9 m -100.02 150.15 5.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.263 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -151.13 154.69 37.43 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.6 m -124.15 127.97 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.833 170.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -132.08 -179.11 5.22 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.316 -174.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.11 -176.15 34.76 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.26 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.44 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 12.0 Cg_exo -68.8 111.7 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.768 2.312 . . . . 0.0 112.234 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 58.19 54.2 6.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.624 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 71.22 1.53 3.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.58 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.442 ' HB3' ' O ' ' A' ' 141' ' ' ALA . 49.7 m -63.11 128.23 34.89 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -68.96 128.22 35.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.042 0.449 . . . . 0.0 110.35 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.562 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.4 pt -94.66 -1.49 10.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.376 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -59.66 -3.69 0.53 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.515 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 93.2 m-70 -82.27 -31.98 29.82 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.143 -0.348 . . . . 0.0 111.471 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.549 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 54.2 p90 -119.66 -20.03 7.84 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.413 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.562 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 65.8 t -90.54 131.32 38.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 9.0 tp10 -102.62 -60.24 1.57 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.434 0.635 . . . . 0.0 110.262 -176.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.589 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 20.6 tttt -144.61 149.95 36.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.135 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.503 HG21 HG23 ' A' ' 39' ' ' VAL . 94.6 t -128.55 157.69 41.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.568 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 9.1 p -141.41 133.39 28.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.299 0.571 . . . . 0.0 111.054 -174.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.424 ' CD2' HG12 ' A' ' 88' ' ' ILE . 30.5 m-85 -117.02 109.04 16.48 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -80.62 91.93 5.9 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.915 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.535 ' CD2' HD13 ' A' ' 86' ' ' LEU . 11.0 mt -73.93 -176.96 2.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.999 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -77.34 147.53 36.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -56.14 -19.35 13.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.931 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.05 -24.99 65.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.108 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -81.65 137.56 47.67 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.645 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.73 118.03 5.14 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.462 2.108 . . . . 0.0 111.326 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 58.19 68.38 1.85 Allowed Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.521 0.513 . . . . 0.0 110.431 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.54 -18.48 63.73 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.845 2.363 . . . . 0.0 113.391 -174.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -88.94 101.25 13.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.185 0.517 . . . . 0.0 110.13 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 18.7 mmt180 -97.71 98.35 9.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.345 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -83.49 136.34 22.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.599 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.8 m -131.41 109.01 10.01 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -106.18 -24.24 12.38 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.63 0.728 . . . . 0.0 110.336 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.691 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 2.7 t70 -70.41 179.9 0.77 Allowed Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.319 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.691 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 16.6 Cg_exo -31.13 178.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 125.245 3.963 . . . . 0.0 114.489 163.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.597 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.3 Cg_endo -29.64 124.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 124.332 3.355 . . . . 0.0 114.442 -154.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 36.7 m-85 -61.87 93.94 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.901 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -146.14 145.53 30.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.264 0.554 . . . . 0.0 111.889 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.0 t -125.19 131.6 72.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.059 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -115.97 110.37 18.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.752 0.311 . . . . 0.0 110.196 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -130.18 165.44 22.34 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.933 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 2.1 m -116.12 129.65 56.43 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.979 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.42 -160.7 9.17 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -136.37 -20.04 1.42 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.291 0.546 . . . . 0.0 111.451 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.7 142.99 36.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.853 0.359 . . . . 0.0 110.974 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -78.88 174.55 55.25 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.58 -177.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -173.13 159.41 3.89 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.963 0.505 . . . . 0.0 110.131 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.42 HD11 ' HA ' ' A' ' 106' ' ' ASP . 14.3 mm -68.07 125.5 25.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 172.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.535 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.1 tt -117.72 105.55 47.59 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.994 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.99 114.07 3.25 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 123.227 2.618 . . . . 0.0 112.231 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.424 HG12 ' CD2' ' A' ' 56' ' ' PHE . 5.0 mt -104.6 126.37 59.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.09 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.568 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.2 mt-10 -112.53 124.34 52.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.238 0.542 . . . . 0.0 110.124 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.469 HG13 ' CE1' ' A' ' 92' ' ' PHE . 78.7 t -103.72 120.44 53.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.772 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.589 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 74.5 m-85 -90.06 139.1 30.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.967 0.413 . . . . 0.0 110.346 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.469 ' CE1' HG13 ' A' ' 90' ' ' VAL . 23.7 m-85 -111.36 146.32 37.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.8 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -84.2 93.93 8.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -155.98 159.33 39.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.372 0.606 . . . . 0.0 112.124 -171.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.76 -4.0 14.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.734 175.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.517 ' HG2' ' CG2' ' A' ' 131' ' ' THR . 0.4 OUTLIER -100.29 -153.92 0.46 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.42 -177.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.439 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 20.6 mm-40 -27.07 150.19 0.02 OUTLIER Pre-proline 0 N--CA 1.48 1.03 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 3.0 Cg_exo -32.5 126.43 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.189 1 C-N-CA 125.316 4.011 . . . . 0.0 114.465 -167.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -85.7 19.5 2.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.246 -176.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.52 143.45 22.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.286 0.565 . . . . 0.0 111.159 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -126.93 154.79 37.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -121.18 121.85 38.7 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.001 0.429 . . . . 0.0 111.073 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.641 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.9 m-85 -113.86 117.7 32.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.923 174.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.61 111.89 15.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.188 0.518 . . . . 0.0 109.761 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -121.4 136.17 54.99 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.553 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.42 ' HA ' HD11 ' A' ' 85' ' ' ILE . 11.7 t70 -89.35 110.6 21.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.62 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.468 HD21 HG12 ' A' ' 37' ' ' VAL . 1.5 mp -89.36 97.63 11.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.745 0.307 . . . . 0.0 110.199 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -104.33 155.65 18.58 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.014 0.435 . . . . 0.0 110.769 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.2 mt -130.76 152.46 50.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -101.82 168.82 9.19 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.875 -0.515 . . . . 0.0 111.191 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -53.61 134.81 41.25 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -172.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.428 ' HA ' HG22 ' A' ' 22' ' ' VAL . 35.5 tt0 . . . . . 0 C--O 1.232 0.168 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.221 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 20' ' ' ALA . 37.5 t . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.721 0.296 . . . . 0.0 111.719 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.483 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.2 OUTLIER -145.9 108.26 4.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.557 174.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.442 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.8 t-80 -127.22 135.25 50.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.657 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 119' ' ' HIS . 8.1 mt -118.03 147.36 43.31 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.497 0.498 . . . . 0.0 110.326 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.3 ttm180 -137.04 148.74 47.0 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.425 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 61.6 m -130.7 120.23 23.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.598 0.237 . . . . 0.0 110.39 175.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -118.47 143.63 46.57 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -100.94 136.54 40.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.259 0.552 . . . . 0.0 112.055 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.633 ' HB2' HG21 ' A' ' 12' ' ' VAL . 4.9 mt -104.42 115.2 29.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.814 174.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 34.4 m -105.13 116.77 32.52 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.062 0.458 . . . . 0.0 110.687 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -113.83 106.44 14.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.049 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -78.79 118.14 20.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.398 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.2 t30 52.14 63.03 9.69 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.397 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.25 -179.24 5.07 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.771 2.314 . . . . 0.0 112.395 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.517 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 3.5 p -72.75 139.74 47.32 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 173.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -56.95 -39.42 74.51 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.528 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 6.9 p-10 -63.33 -28.66 70.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.666 0.27 . . . . 0.0 110.343 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.621 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 14.8 t80 -75.57 -42.16 52.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.613 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 44.5 ttm105 -53.36 -45.97 69.39 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.099 0.476 . . . . 0.0 109.816 173.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -52.93 -41.12 64.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.381 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 38.8 mtpt -72.36 -39.6 67.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.618 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.9 mt -68.58 -30.59 69.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.909 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 36.1 mt -80.67 -35.68 33.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.163 -177.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -75.28 -30.09 60.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.78 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.749 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.458 ' HB2' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.235 0.34 0 CA-C-O 119.817 -0.135 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' B' ' 215' ' ' ALA . 9.4 Cg_endo -51.87 162.97 1.52 Allowed 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 122.407 2.071 . . . . 0.0 112.063 174.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 26.8 ttt180 . . . . . 0 C--N 1.319 -0.727 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.663 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.754 0.311 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.1 t -104.2 141.25 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 4.7 mp0 -128.76 130.26 46.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.899 0.38 . . . . 0.0 110.177 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.644 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -116.32 165.65 11.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.252 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 67.1 mttm -128.5 133.67 48.52 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.37 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.2 mt -115.6 141.19 48.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.722 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.9 tt0 -104.33 129.98 52.18 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.862 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.618 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -114.99 112.44 22.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -138.09 170.1 23.94 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.956 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -164.2 151.63 12.06 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.881 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 67.8 mtt180 -116.87 143.09 46.1 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.727 174.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -139.21 131.26 27.95 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.532 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -133.94 163.69 28.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.898 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 32' ' ' THR . 1.9 p -103.37 158.27 4.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 32' ' ' THR . 3.7 mtp180 -102.76 142.92 33.1 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -70.53 -13.36 62.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.663 0.744 . . . . 0.0 109.434 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -142.96 104.63 5.23 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.052 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.492 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.6 Cg_exo -47.81 152.91 2.71 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.059 2.506 . . . . 0.0 112.243 174.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 31' ' ' PHE . 8.8 t -76.42 -170.08 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -171.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 m -62.42 -32.86 56.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.762 0.315 . . . . 0.0 111.729 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -82.18 -4.1 56.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.254 0.55 . . . . 0.0 110.438 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.99 31.46 43.22 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.413 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.408 ' HB2' HG21 ' A' ' 27' ' ' THR . 19.0 m-30 -90.3 131.67 35.97 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 22' ' ' VAL . 75.7 p -90.27 -29.49 18.11 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -168.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.443 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.2 m80 -112.55 146.08 39.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -171.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -117.78 121.08 39.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -124.83 147.55 48.68 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.068 0.461 . . . . 0.0 110.788 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.619 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 47.3 ttp -124.24 116.91 23.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.662 176.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.4 m -98.43 150.68 4.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.443 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -151.1 151.16 31.58 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.294 0.569 . . . . 0.0 112.36 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -122.55 138.46 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.334 169.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -155.88 -176.97 6.23 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.41 -170.92 43.85 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.514 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 3.2 Cg_exo -74.46 110.1 3.03 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.103 1.869 . . . . 0.0 112.366 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 49.8 77.07 0.12 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.508 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 76.62 -11.7 1.14 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.791 0.436 . . . . 0.0 112.134 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.511 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 50.6 m -68.36 123.26 20.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.719 0.295 . . . . 0.0 110.452 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -76.5 129.18 36.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.029 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.539 HD11 HG23 ' A' ' 51' ' ' VAL . 4.8 pt -95.46 -1.68 10.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.404 ' HG2' ' OH ' ' A' ' 74' ' ' TYR . 96.2 mt-30 -69.85 -0.79 7.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.9 0.381 . . . . 0.0 111.384 -175.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -71.46 -39.53 70.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.22 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.508 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 55.5 p90 -113.57 -17.61 12.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.394 -0.523 . . . . 0.0 111.593 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.539 HG23 HD11 ' A' ' 47' ' ' ILE . 91.5 t -91.29 130.45 40.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.828 0.346 . . . . 0.0 110.215 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.46 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 8.0 tp10 -99.13 -55.99 2.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.182 0.515 . . . . 0.0 110.46 -175.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -148.79 156.88 42.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.473 HG21 HG23 ' A' ' 39' ' ' VAL . 90.2 t -131.92 156.93 42.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.8 p -142.55 133.99 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.318 0.58 . . . . 0.0 110.979 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.439 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 29.6 m-85 -116.06 104.32 11.45 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -78.33 92.43 4.54 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.981 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.5 mt -75.36 -177.79 3.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 151.78 22.9 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.56 -175.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.64 -21.95 20.34 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.727 -174.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.0 t -65.84 -24.58 66.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 110.614 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -82.62 135.22 46.46 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.332 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.45 120.36 7.87 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.233 1.955 . . . . 0.0 110.537 172.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 60.68 81.57 0.24 Allowed Pre-proline 0 N--CA 1.464 0.23 0 O-C-N 123.502 0.501 . . . . 0.0 110.379 -173.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -61.0 -25.31 81.32 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.584 2.189 . . . . 0.0 113.747 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HE3' ' CG1' ' A' ' 68' ' ' VAL . 23.5 ttpt -98.32 107.24 19.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.058 0.456 . . . . 0.0 111.1 -172.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -106.1 100.9 10.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.892 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.423 ' CG1' ' HE3' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -87.63 137.8 20.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.8 m -125.34 114.09 18.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -104.3 -28.21 11.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.43 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.506 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 26.7 t70 -73.58 171.06 11.68 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.135 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.563 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 72.7 Cg_exo -26.0 -174.1 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.676 1 C-N-CA 126.016 4.477 . . . . 0.0 116.062 164.127 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 6.5 Cg_endo -33.3 120.37 0.11 Allowed 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.375 2.717 . . . . 0.0 114.139 -149.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 38.8 m-85 -62.74 93.35 0.05 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.212 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -143.71 144.82 32.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.342 0.591 . . . . 0.0 112.039 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.5 t -120.35 131.8 71.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.595 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.18 105.99 13.21 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -131.51 173.2 11.34 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.508 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.0 t -125.03 144.74 50.25 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.724 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.84 -170.66 29.07 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -133.08 -12.26 2.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.411 0.606 . . . . 0.0 111.645 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.41 145.1 32.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.661 0.267 . . . . 0.0 110.589 -177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.554 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -83.63 178.03 52.48 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.782 -0.644 . . . . 0.0 113.266 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -178.15 157.81 1.13 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.064 0.546 . . . . 0.0 110.168 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.1 mm -62.67 125.47 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.661 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.438 HD23 HG13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -107.93 105.01 55.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -68.36 105.33 1.22 Allowed 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 123.013 2.475 . . . . 0.0 111.625 170.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.438 HG13 HD23 ' A' ' 86' ' ' LEU . 5.8 mt -100.87 123.73 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.237 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.9 mt-10 -109.67 123.62 49.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.286 0.565 . . . . 0.0 110.039 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -103.04 117.21 48.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.619 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.564 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 83.8 m-85 -87.89 141.23 28.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.086 0.469 . . . . 0.0 110.778 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.451 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.3 m-85 -114.12 153.82 28.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.884 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -95.77 94.13 7.49 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.504 HD22 ' HB2' ' A' ' 96' ' ' GLU . 58.3 t30 -155.37 158.46 38.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.933 -170.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.2 ptpp? -107.85 -6.95 16.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.718 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.504 ' HB2' HD22 ' A' ' 94' ' ' ASN . 23.7 mm-40 -101.29 -150.73 0.4 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.822 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.402 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 15.3 mm-40 -25.27 149.04 0.02 OUTLIER Pre-proline 0 N--CA 1.479 1.006 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -31.45 126.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 1 C-N-CA 125.41 4.074 . . . . 0.0 114.717 -170.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.58 19.52 1.97 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.823 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.73 142.12 20.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 110.537 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -124.63 155.63 32.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 174.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -124.19 119.11 28.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.144 0.497 . . . . 0.0 111.163 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.618 ' CD2' HD22 ' A' ' 16' ' ' LEU . 24.0 m-85 -111.58 115.77 29.72 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.906 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.79 101.82 7.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.37 0.605 . . . . 0.0 109.773 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -115.58 134.82 54.69 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.646 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.52 118.17 25.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.684 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.469 HD21 HG12 ' A' ' 37' ' ' VAL . 1.4 mp -93.96 91.45 6.9 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.593 ' CE1' HG13 ' A' ' 117' ' ' VAL . 50.4 p90 -99.32 157.03 16.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.043 0.449 . . . . 0.0 110.832 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.5 mt -133.68 158.57 42.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -102.13 174.48 5.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.244 -0.285 . . . . 0.0 110.364 172.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.24 160.98 31.18 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 . . . . . 0 N--CA 1.471 0.61 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.377 179.147 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.593 HG13 ' CE1' ' A' ' 108' ' ' PHE . 4.9 t . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.796 0.332 . . . . 0.0 111.59 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.453 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.16 97.13 3.0 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.442 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.9 t-80 -119.55 134.34 55.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.777 -176.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 119' ' ' HIS . 9.8 mt -117.91 145.76 44.42 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.681 0.613 . . . . 0.0 110.016 176.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.643 ' HD3' ' OE2' ' A' ' 123' ' ' GLU . 11.3 ttm180 -132.96 148.46 52.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.471 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 84.6 m -123.32 116.13 22.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.332 0.587 . . . . 0.0 111.059 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.643 ' OE2' ' HD3' ' A' ' 121' ' ' ARG . 64.3 mm-40 -98.43 162.45 13.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.383 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.547 ' HB3' ' HZ2' ' A' ' 124' ' ' LYS . 7.4 ttpm? -125.48 128.35 47.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.413 0.625 . . . . 0.0 111.115 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.644 ' HB2' HG21 ' A' ' 12' ' ' VAL . 8.3 mt -100.34 115.37 29.81 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.962 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 20.9 m -109.14 122.71 47.89 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.005 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -120.42 100.61 7.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.046 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -73.42 116.36 13.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.653 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.0 t30 58.26 74.76 0.59 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.452 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -97.48 -178.54 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.23 2.62 . . . . 0.0 112.817 -174.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.433 ' CG2' ' HG3' ' A' ' 96' ' ' GLU . 5.9 p -71.66 144.54 49.35 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -57.36 -45.97 83.84 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.92 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -57.93 -28.94 64.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.613 0.244 . . . . 0.0 110.918 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.652 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.2 t80 -73.12 -47.01 47.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.642 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.3 ttm105 -52.18 -48.3 65.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.264 0.554 . . . . 0.0 109.924 174.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -54.83 -34.52 62.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.778 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.5 mtmt -81.52 -37.68 27.46 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.514 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.8 mt -66.19 -28.9 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.7 mt -80.42 -37.98 31.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.434 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.435 ' NZ ' ' HB2' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -70.76 -30.39 66.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.877 -176.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.913 178.975 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.422 ' HB2' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.234 0.252 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' B' ' 215' ' ' ALA . 19.8 Cg_endo -58.49 170.01 2.74 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.434 2.089 . . . . 0.0 112.239 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 17.9 ttm180 . . . . . 0 C--N 1.321 -0.642 0 CA-C-O 120.979 0.418 . . . . 0.0 110.831 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.3 t -104.83 144.17 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -132.29 114.86 14.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.849 0.357 . . . . 0.0 110.292 -173.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -105.85 166.04 3.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.343 -179.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -129.23 126.01 38.18 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.148 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.0 mt -103.62 142.78 33.72 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.657 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 28.1 tt0 -107.94 125.5 51.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.302 -173.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.494 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -107.79 117.54 34.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 173.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -139.88 165.33 25.94 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.396 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -162.87 149.03 12.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.077 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 34.8 mtp180 -121.62 128.17 51.63 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.61 117.46 29.45 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.377 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -110.13 141.67 42.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.455 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 112' ' ' GLU . 5.7 p -102.95 146.08 11.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mtp85 -97.0 142.93 28.35 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -72.32 -13.92 61.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.489 0.661 . . . . 0.0 109.335 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 26' ' ' PRO . 13.7 tmtt? -138.8 100.49 8.12 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.89 176.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.491 ' HG3' HG22 ' A' ' 32' ' ' THR . 80.7 Cg_exo -50.78 160.31 1.88 Allowed 'Trans proline' 0 N--CA 1.478 0.577 0 C-N-CA 123.612 2.874 . . . . 0.0 113.359 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 31' ' ' PHE . 5.4 t -79.65 -174.41 4.3 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.836 -175.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.2 m -62.32 -32.59 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.849 0.357 . . . . 0.0 111.163 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -79.78 -6.45 57.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.11 0.481 . . . . 0.0 110.513 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.6 33.26 38.98 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.268 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.436 ' H ' HG23 ' A' ' 27' ' ' THR . 22.1 m-30 -93.46 130.88 39.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.491 HG22 ' HG3' ' A' ' 26' ' ' PRO . 45.9 p -92.04 -21.56 20.42 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.251 -170.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.474 ' HE1' ' OE1' ' A' ' 112' ' ' GLU . 54.9 m80 -118.84 147.24 44.15 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -171.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -123.3 117.28 24.9 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -121.3 147.93 45.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.105 0.479 . . . . 0.0 111.263 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.609 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 52.2 ttp -125.33 119.38 28.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.514 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.5 m -101.93 148.97 6.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.471 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 2.1 p90 -149.5 153.28 36.99 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.8 m -123.58 135.86 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.636 170.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.44 ' HD2' ' OE2' ' A' ' 15' ' ' GLU . 8.3 ptp85 -152.56 -176.74 5.85 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.75 -173.57 44.19 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.453 -175.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.509 ' HD2' ' OG ' ' A' ' 45' ' ' SER . 5.1 Cg_exo -74.21 125.7 9.93 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.169 2.579 . . . . 0.0 111.354 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 61.99 47.67 5.69 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.544 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 37.1 m80 64.23 18.36 11.24 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.509 ' OG ' ' HD2' ' A' ' 42' ' ' PRO . 22.9 p -71.05 153.64 42.42 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 122.131 -0.356 . . . . 0.0 110.137 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.35 125.5 30.45 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.538 HD11 HG23 ' A' ' 51' ' ' VAL . 4.6 pt -96.58 -1.52 10.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.575 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 32.8 tt0 -70.48 -4.52 23.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.575 0.702 . . . . 0.0 109.736 -174.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.41 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 93.8 m-70 -66.1 -39.41 89.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.304 173.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.485 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 55.3 p90 -116.07 -19.39 10.33 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.133 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.538 HG23 HD11 ' A' ' 47' ' ' ILE . 96.7 t -88.8 131.32 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.229 0.537 . . . . 0.0 109.939 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.96 -59.85 1.68 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.367 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 16.2 tttt -149.53 149.78 31.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.811 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 93.9 t -128.92 157.41 41.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -177.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.567 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 8.7 p -142.53 135.1 26.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.383 0.611 . . . . 0.0 111.169 -174.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.457 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 25.1 m-85 -117.78 108.3 15.2 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -81.31 93.58 6.58 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.123 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.581 ' CD2' HD13 ' A' ' 86' ' ' LEU . 9.9 mt -74.16 -177.82 3.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 73.2 t60 -80.93 137.48 36.13 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.5 -20.49 20.58 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.5 t -64.57 -18.14 64.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.866 0.365 . . . . 0.0 110.902 173.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 44.0 m-85 -83.27 144.14 46.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.13 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 62' ' ' PHE . 15.9 Cg_exo -68.71 118.69 5.82 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.425 2.083 . . . . 0.0 110.851 173.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 63.54 73.17 0.5 Allowed Pre-proline 0 N--CA 1.465 0.279 0 O-C-N 123.543 0.527 . . . . 0.0 110.007 -176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.24 -22.71 66.65 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.793 2.329 . . . . 0.0 113.406 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -97.35 103.29 15.21 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 120.974 0.416 . . . . 0.0 110.421 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.7 mmm-85 -105.15 102.23 11.73 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.321 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.6 m -95.26 138.27 21.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.5 m -125.13 119.63 29.11 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -106.74 -28.71 10.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.59 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.682 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 37.4 m-20 -72.13 -172.31 0.22 Allowed Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.531 1.132 . . . . 0.0 111.768 -174.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.682 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 72.4 Cg_exo -39.89 -172.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.858 0 C-N-CA 123.492 2.794 . . . . 0.0 114.084 165.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.7 Cg_endo -33.83 123.42 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 123.857 3.038 . . . . 0.0 114.442 -154.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 36.9 m-85 -63.21 92.07 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.187 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -142.79 145.41 33.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.183 0.516 . . . . 0.0 111.866 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 36' ' ' MET . 75.1 t -118.55 133.73 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.42 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.471 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 5.7 mm-40 -112.15 107.36 16.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.975 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.25 169.47 17.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.122 0.487 . . . . 0.0 111.039 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.2 t -126.94 143.24 51.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.888 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.76 -161.68 13.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.746 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -137.69 -14.86 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.292 0.546 . . . . 0.0 112.174 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.27 148.05 35.77 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.023 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.541 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -84.99 179.43 51.08 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.619 -0.719 . . . . 0.0 113.182 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -178.96 155.52 0.76 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.935 0.494 . . . . 0.0 109.911 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.403 HD11 ' HA ' ' A' ' 106' ' ' ASP . 23.0 mm -62.72 127.1 22.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.242 171.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.581 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.7 tt -120.09 104.82 43.27 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-O 121.129 0.49 . . . . 0.0 110.106 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.19 112.2 2.24 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.399 2.732 . . . . 0.0 112.721 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 mt -103.64 124.26 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.183 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.567 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 50.9 mt-10 -109.62 124.67 51.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.152 0.501 . . . . 0.0 109.903 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.42 HG13 ' CE1' ' A' ' 92' ' ' PHE . 59.1 t -105.26 119.2 54.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.841 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.599 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 88.9 m-85 -91.19 138.82 31.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.015 0.436 . . . . 0.0 110.863 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.5 m-85 -112.14 154.65 25.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.735 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.3 95.14 7.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.566 HD22 ' HB2' ' A' ' 96' ' ' GLU . 61.0 t30 -155.33 164.38 38.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.808 -172.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -112.86 -4.6 13.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.615 178.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.566 ' HB2' HD22 ' A' ' 94' ' ' ASN . 17.4 mm-40 -100.93 -153.47 0.45 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.067 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.477 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 20.3 mm-40 -29.89 153.23 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 124.621 1.168 . . . . 0.0 114.071 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 6.2 Cg_exo -32.72 124.86 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.125 1 C-N-CA 125.356 4.037 . . . . 0.0 114.876 -167.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.443 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -88.2 19.58 3.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.392 -177.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -152.37 140.41 20.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.235 0.54 . . . . 0.0 110.887 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.1 m -125.75 156.41 35.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.72 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -122.92 121.8 37.05 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.011 0.434 . . . . 0.0 111.201 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.494 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.6 m-85 -112.83 110.75 21.05 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.707 173.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -82.21 99.03 9.04 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -108.32 138.97 43.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.159 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.403 ' HA ' HD11 ' A' ' 85' ' ' ILE . 12.4 t70 -81.83 113.66 19.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.96 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.496 HD21 HG12 ' A' ' 37' ' ' VAL . 1.8 mp -90.01 104.99 17.51 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -116.01 154.95 28.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.91 0.386 . . . . 0.0 110.661 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.9 mt -135.48 162.59 32.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.647 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.411 ' CD2' ' H ' ' A' ' 110' ' ' HIS . 7.7 p80 -100.49 171.82 7.5 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.418 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' B' ' 215' ' ' ALA . 1.0 OUTLIER -74.42 168.85 18.89 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.834 0.349 . . . . 0.0 111.129 177.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.474 ' OE1' ' HE1' ' A' ' 33' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.468 0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.52 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 31.6 t . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -139.01 98.22 3.48 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -125.0 132.59 53.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.41 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.4 mt -111.43 156.45 21.62 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.866 0.729 . . . . 0.0 109.103 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 16.3 ttt180 -147.47 143.71 28.08 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.31 -0.244 . . . . 0.0 110.719 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 24.8 p -118.98 116.88 27.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.217 0.532 . . . . 0.0 111.064 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -111.92 132.84 54.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.951 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -97.81 131.56 44.2 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.164 0.506 . . . . 0.0 111.742 -172.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.664 ' HB2' HG21 ' A' ' 12' ' ' VAL . 7.4 mt -99.34 118.1 35.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.2 m -106.26 120.48 41.97 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.175 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -117.59 99.33 6.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.895 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -71.72 117.42 13.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.958 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 t30 55.94 78.35 0.38 Allowed Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.873 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -97.64 -178.22 0.31 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.003 2.469 . . . . 0.0 112.13 -177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.0 p -74.1 142.25 45.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 171.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.421 ' OE2' ' HD2' ' A' ' 135' ' ' ARG . 4.0 tp10 -56.51 -38.25 71.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.019 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.656 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 15.6 m-20 -59.98 -35.29 74.69 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.609 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.6 t80 -72.54 -40.66 66.55 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.671 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 30.9 ttm180 -55.85 -45.62 78.39 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -59.13 -34.69 72.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.955 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 40.4 mtpt -71.32 -43.56 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.2 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 37.3 mt -68.63 -34.33 75.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.767 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 43.4 mt -74.1 -33.81 63.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.928 0.394 . . . . 0.0 110.836 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.472 ' HZ1' ' CB ' ' A' ' 140' ' ' LYS . 2.4 ttpm? -76.57 -27.02 55.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.538 -175.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.84 178.32 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.451 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . . . . . . 0 C--O 1.235 0.331 0 N-CA-C 111.482 0.178 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.31 -177.3 0.12 Allowed 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.547 2.164 . . . . 0.0 113.23 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 18.4 ttm180 . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.71 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 t -99.97 139.8 20.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.0 mp0 -125.67 120.41 30.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.04 0.447 . . . . 0.0 110.046 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.68 161.85 5.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.974 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.447 ' CE ' ' HB3' ' A' ' 42' ' ' PRO . 47.5 mtmt -128.57 128.62 44.6 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.364 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.5 mt -111.79 140.64 46.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.103 0.478 . . . . 0.0 109.715 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.7 tt0 -104.68 122.35 45.49 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.929 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.645 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.4 mm? -108.67 117.92 35.43 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.23 -179.85 24.52 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.21 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -169.43 154.45 5.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -122.1 136.27 54.9 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.519 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -133.62 126.62 31.28 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.358 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 34' ' ' ASP . 0.6 OUTLIER -130.13 158.26 40.17 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.149 178.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 32' ' ' THR . 1.7 p -101.85 160.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.58 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 6.3 ptm180 -111.95 142.27 44.56 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -70.08 -8.85 52.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.532 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -144.55 100.89 4.71 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.584 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.06 155.04 4.76 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.144 2.563 . . . . 0.0 111.87 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.481 HG21 ' HB2' ' A' ' 31' ' ' PHE . 8.8 t -78.26 -175.47 4.19 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.062 -171.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 m -57.52 -33.09 43.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 122.634 0.373 . . . . 0.0 111.838 -175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -86.6 0.42 54.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.086 0.469 . . . . 0.0 110.73 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.04 33.18 41.78 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.899 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.481 ' HB2' HG21 ' A' ' 27' ' ' THR . 16.3 m-30 -92.07 133.17 35.99 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 22' ' ' VAL . 58.7 p -96.7 -27.76 14.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -168.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 79' ' ' SER . 66.9 m80 -118.42 140.77 49.35 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -172.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.58 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 17.3 m-20 -115.39 116.02 27.55 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -119.38 151.51 38.37 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.006 0.432 . . . . 0.0 110.893 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.611 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 57.0 ttp -127.43 120.9 29.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.43 174.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.8 m -100.84 152.16 5.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.212 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.589 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -153.08 154.14 34.26 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 10.2 m -120.82 126.15 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.671 168.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.437 ' HB2' ' HB3' ' A' ' 15' ' ' GLU . 14.1 mmm180 -128.62 176.52 7.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 -172.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.78 -177.4 33.76 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.571 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.447 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 8.1 Cg_exo -69.8 111.01 2.7 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.505 2.137 . . . . 0.0 112.323 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 53.56 61.66 3.01 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.525 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 76.55 -7.43 1.84 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.29 0.636 . . . . 0.0 112.366 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.4 m -69.44 128.6 37.12 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.29 -0.256 . . . . 0.0 111.046 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -65.22 129.59 40.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 110.653 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.535 HD11 HG23 ' A' ' 51' ' ' VAL . 4.2 pt -95.78 -1.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -61.22 -15.72 37.4 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.111 0.482 . . . . 0.0 110.906 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -63.64 -37.13 86.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.209 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.508 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 53.9 p90 -117.9 -16.63 9.9 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.408 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.535 HG23 HD11 ' A' ' 47' ' ' ILE . 95.4 t -89.56 129.71 40.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.131 0.491 . . . . 0.0 110.199 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -97.45 -66.0 0.93 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.417 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.643 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -144.45 151.18 38.83 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.461 HG21 HG23 ' A' ' 39' ' ' VAL . 95.1 t -124.2 159.52 29.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 O-C-N 122.104 -0.372 . . . . 0.0 110.198 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.546 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.4 p -143.18 137.53 26.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.073 0.464 . . . . 0.0 111.016 -174.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.465 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 17.1 m-85 -120.8 111.22 17.3 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -84.42 95.23 8.71 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.941 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.544 ' CD2' HD13 ' A' ' 86' ' ' LEU . 8.1 mt -73.48 -177.59 2.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -81.21 146.64 30.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -56.4 -19.26 14.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.413 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 m -69.59 -20.56 63.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.085 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -83.34 144.41 46.49 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.582 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.63 118.24 5.45 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.586 2.191 . . . . 0.0 110.65 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 61.06 78.5 0.31 Allowed Pre-proline 0 C--O 1.225 -0.192 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.181 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.65 -24.03 77.48 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.847 2.364 . . . . 0.0 113.732 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -97.44 109.14 21.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.969 -0.457 . . . . 0.0 110.881 -174.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -108.01 105.55 15.37 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.136 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.55 142.2 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 175.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 43.4 t -131.81 114.65 14.96 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -106.75 -24.82 11.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.242 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.556 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 24.7 t70 -68.97 171.63 6.16 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.564 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.576 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 82.6 Cg_exo -29.2 -170.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.557 1.652 1 C-N-CA 125.478 4.119 . . . . 0.0 115.466 164.032 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.613 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 Cg_endo -36.17 121.7 0.26 Allowed 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 122.808 2.339 . . . . 0.0 113.887 -151.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 39.5 m-85 -62.17 91.44 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.059 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 4.6 ptpt -139.16 146.92 41.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.261 0.553 . . . . 0.0 111.877 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.0 t -123.71 131.82 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.804 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.77 113.54 24.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.25 172.85 12.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.222 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.3 t -126.67 141.3 51.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.495 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.61 -171.44 23.59 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -131.47 -1.92 3.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.592 0.696 . . . . 0.0 112.195 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' B' ' 217' ' ' ARG . . . -152.68 129.92 11.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.902 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -72.31 175.29 43.16 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.348 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -175.96 158.95 2.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.669 0.388 . . . . 0.0 110.275 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.429 HD12 HG21 ' A' ' 85' ' ' ILE . 12.1 mm -65.58 124.86 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.409 171.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.544 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.9 tt -118.24 105.87 45.95 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.05 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.08 118.64 5.8 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.918 2.412 . . . . 0.0 112.212 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.0 mt -107.61 125.0 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.068 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.546 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 55.0 mt-10 -111.44 118.3 35.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.268 0.556 . . . . 0.0 109.924 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 64.6 t -100.42 119.18 48.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.825 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.643 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 82.5 m-85 -92.24 138.81 31.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.039 0.447 . . . . 0.0 110.815 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -112.53 150.84 30.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.19 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.67 95.13 10.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.543 HD22 ' HB2' ' A' ' 96' ' ' GLU . 62.6 t30 -154.2 155.34 35.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 0.0 112.152 -169.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.408 ' HB3' ' HZ1' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -111.87 -1.94 15.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.131 174.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.543 ' HB2' HD22 ' A' ' 94' ' ' ASN . 32.7 mm-40 -100.29 -152.22 0.42 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.792 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.402 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 14.7 mm-40 -31.36 154.06 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 4.6 Cg_exo -30.92 125.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.161 1 C-N-CA 125.37 4.047 . . . . 0.0 114.51 -169.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.66 17.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.899 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.62 149.08 26.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.142 0.496 . . . . 0.0 111.035 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.3 m -123.1 157.78 28.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.724 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -128.12 106.96 9.42 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.695 0.283 . . . . 0.0 110.35 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.4 m-85 -106.57 121.37 44.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.001 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.31 114.58 23.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -123.93 138.39 54.48 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.349 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.5 119.71 30.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.48 HD21 HG12 ' A' ' 37' ' ' VAL . 2.0 mp -93.11 91.7 7.44 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -100.28 153.51 19.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.963 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.5 mt -129.39 154.15 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.403 ' ND1' HG21 ' A' ' 117' ' ' VAL . 27.9 m170 -103.15 170.39 7.99 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.124 -0.36 . . . . 0.0 111.107 174.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.434 HD21 ' HA ' ' B' ' 215' ' ' ALA . 2.0 mm? -61.48 141.2 57.85 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 . . . . . 0 N--CA 1.474 0.765 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.896 175.74 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 20' ' ' ALA . 4.7 t . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 120.826 0.346 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -144.04 121.87 11.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -144.47 131.81 20.79 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.255 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.2 mt -116.28 147.4 41.55 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.707 0.629 . . . . 0.0 109.862 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 20.3 ttm180 -136.19 146.02 46.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 84.2 m -128.73 114.48 16.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.022 0.439 . . . . 0.0 110.703 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -109.79 142.7 40.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.006 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -102.74 129.29 49.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.494 0.664 . . . . 0.0 111.845 -172.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.647 ' HB2' HG21 ' A' ' 12' ' ' VAL . 6.5 mt -96.77 120.24 36.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.548 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.8 m -111.22 121.62 45.75 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.623 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -118.83 110.68 17.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.311 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -76.07 117.58 17.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.334 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.3 t30 48.03 64.66 8.21 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.92 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.41 176.28 10.17 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.367 2.044 . . . . 0.0 111.899 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.4 p -72.75 144.71 47.5 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.443 ' HG3' ' NH1' ' A' ' 135' ' ' ARG . 29.5 tt0 -56.01 -44.17 78.43 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.502 -0.479 . . . . 0.0 112.032 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -56.9 -32.37 65.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.651 0.262 . . . . 0.0 110.449 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.656 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.8 t80 -76.73 -41.28 45.65 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.611 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.9 ttm180 -54.93 -44.44 74.27 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -57.1 -40.14 76.4 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.311 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -71.19 -40.95 70.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.85 0.357 . . . . 0.0 110.858 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 45.9 mt -69.28 -33.77 73.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.3 mt -76.61 -31.24 57.3 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.826 0.346 . . . . 0.0 110.783 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -75.02 -27.51 60.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.167 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 119.151 -0.452 . . . . 0.0 110.119 175.093 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.434 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . . . . . . 0 C--O 1.233 0.228 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . 0.42 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 0.3 OUTLIER -36.18 145.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.622 2.882 . . . . 0.0 114.381 175.048 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 15.2 ttm180 . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.2 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 120.764 0.316 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 t -99.71 139.37 21.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.86 118.03 25.42 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.024 0.44 . . . . 0.0 110.101 -174.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.14 176.48 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.838 -178.217 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 57.6 mttt -143.67 138.72 29.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.097 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.8 mt -126.25 147.5 49.67 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.1 tt0 -105.01 127.95 53.09 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.225 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.665 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -112.98 120.7 42.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -145.65 175.93 24.92 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.926 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -167.91 150.41 5.65 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.152 0.501 . . . . 0.0 109.886 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.491 ' HG2' ' OD1' ' A' ' 118' ' ' ASN . 68.5 mtp180 -122.27 145.4 48.26 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.365 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.492 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -132.82 129.01 37.95 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.643 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.421 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 14.8 tt0 -126.09 147.95 49.47 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.223 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -103.05 156.3 5.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 170.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.677 ' NH2' ' HA ' ' A' ' 26' ' ' PRO . 17.6 mtm-85 -111.88 150.93 29.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -76.56 -6.26 51.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -136.95 106.14 8.85 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.677 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 71.5 Cg_exo -52.95 144.5 44.92 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.059 1.84 . . . . 0.0 112.272 175.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.43 ' N ' ' NH2' ' A' ' 23' ' ' ARG . 4.2 t -85.77 -175.28 5.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.745 -168.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.433 ' H ' HG11 ' A' ' 28' ' ' VAL . 1.4 m -57.2 -33.69 43.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -171.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -87.93 -0.26 56.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.718 0.294 . . . . 0.0 111.496 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.72 35.02 23.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.407 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -101.68 145.0 29.7 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 22' ' ' VAL . 30.3 p -104.36 -33.86 8.49 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.446 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.1 m80 -110.02 145.28 37.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -170.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.477 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -122.95 116.52 23.73 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.8 p-90 -118.16 155.1 31.05 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.702 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.634 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 48.3 ttp -130.86 121.07 24.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.574 175.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 9.2 m -100.82 152.03 5.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.05 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -153.72 151.73 29.96 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.597 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -121.88 124.78 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.246 168.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 40' ' ' ARG . 2.6 mmp_? -133.43 168.71 18.12 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.975 0.417 . . . . 0.0 110.985 -173.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.46 118.22 4.74 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.495 ' O ' ' HB2' ' A' ' 45' ' ' SER . 40.3 Cg_endo -74.64 151.69 41.75 Favored 'Trans proline' 0 C--N 1.326 -0.647 0 C-N-CA 122.854 2.369 . . . . 0.0 113.01 -176.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 61.86 54.47 2.85 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.994 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 66.2 1.06 1.85 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.297 0.639 . . . . 0.0 112.241 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 12.9 m -76.53 139.43 40.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.0 111.541 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -103.06 124.95 49.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD11 HG23 ' A' ' 51' ' ' VAL . 19.9 pt -95.7 -2.37 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -169.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -68.74 -11.5 60.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.472 0.653 . . . . 0.0 110.175 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.496 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 95.6 m-70 -68.87 -40.98 78.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.122 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.509 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 47.8 p90 -110.05 -14.54 14.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.753 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.516 HG23 HD11 ' A' ' 47' ' ' ILE . 96.4 t -92.59 129.37 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.995 0.426 . . . . 0.0 110.351 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -95.33 -58.43 2.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.377 0.608 . . . . 0.0 110.615 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -152.57 155.7 37.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.578 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 77.5 t -129.51 156.93 42.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.526 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 13.4 p -141.54 137.29 32.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.132 0.492 . . . . 0.0 111.042 -174.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.45 ' CE2' HG12 ' A' ' 88' ' ' ILE . 30.9 m-85 -119.07 108.3 14.55 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -79.63 95.59 5.95 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.05 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.574 ' CD2' HD13 ' A' ' 86' ' ' LEU . 10.6 mt -81.86 -178.07 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -87.85 152.08 22.37 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.67 -15.45 19.5 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.079 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -67.33 -18.89 65.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.348 0.594 . . . . 0.0 110.373 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.01 142.23 24.27 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.432 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.21 129.98 21.64 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.373 2.049 . . . . 0.0 110.384 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 61.01 76.62 0.4 Allowed Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 123.45 0.469 . . . . 0.0 109.864 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.95 -18.17 62.72 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.467 2.111 . . . . 0.0 113.312 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -110.42 107.22 16.83 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 122.06 -0.4 . . . . 0.0 110.653 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.6 mmt85 -105.74 108.0 19.29 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.415 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.8 m -97.74 138.85 21.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.3 m -123.2 113.19 18.61 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.995 0.426 . . . . 0.0 109.988 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -105.86 -25.54 12.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.625 0.726 . . . . 0.0 110.259 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.687 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 14.4 m-20 -75.05 -172.03 0.25 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.882 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.687 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 78.0 Cg_exo -38.42 -179.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.415 2.744 . . . . 0.0 114.027 166.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.613 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -30.48 125.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 124.622 3.548 . . . . 0.0 114.985 -153.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 31.5 m-85 -61.69 92.84 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.735 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.595 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 13.4 ptpt -147.71 144.7 28.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.235 0.541 . . . . 0.0 111.817 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.8 t -122.17 131.89 72.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.99 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -119.32 107.65 13.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.941 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.57 170.58 15.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.996 0.427 . . . . 0.0 110.828 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 5.8 t -117.92 143.88 45.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.371 -176.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.99 -162.43 11.97 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -137.38 -16.41 1.38 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.276 0.538 . . . . 0.0 111.38 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.94 143.51 32.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.671 0.272 . . . . 0.0 110.462 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.487 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -81.46 -177.86 52.03 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.128 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -176.8 157.6 1.53 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.087 0.555 . . . . 0.0 109.901 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.0 mm -63.41 120.17 9.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 172.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.574 HD13 ' CD2' ' A' ' 58' ' ' LEU . 5.9 tt -114.34 105.47 53.86 Favored Pre-proline 0 N--CA 1.444 -0.738 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.6 114.22 3.77 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.03 2.487 . . . . 0.0 112.231 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.45 HG12 ' CE2' ' A' ' 56' ' ' PHE . 3.7 mp -101.16 130.37 50.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.037 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.5 mt-10 -111.9 124.5 52.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.064 0.459 . . . . 0.0 110.149 174.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.51 HG13 ' CE1' ' A' ' 92' ' ' PHE . 68.8 t -103.29 117.84 49.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.71 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.546 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 89.5 m-85 -88.63 141.55 28.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.51 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.51 ' CE1' HG13 ' A' ' 90' ' ' VAL . 26.4 m-85 -115.43 154.39 29.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.702 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.453 ' HG3' ' HZ3' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -94.22 93.22 7.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.539 HD22 ' HB2' ' A' ' 96' ' ' GLU . 60.9 t30 -155.65 162.37 40.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.286 0.565 . . . . 0.0 112.076 -172.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -113.15 4.06 16.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.861 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.539 ' HB2' HD22 ' A' ' 94' ' ' ASN . 40.4 mm-40 -100.67 -155.57 0.52 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.153 -176.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.626 ' HB2' ' HD2' ' A' ' 98' ' ' PRO . 10.9 pt-20 -44.32 159.32 0.25 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.591 0.756 . . . . 0.0 111.853 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 97' ' ' GLU . 4.3 Cg_exo -31.36 128.33 0.08 OUTLIER 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 125.064 3.843 . . . . 0.0 115.189 -162.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.57 19.54 3.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.972 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.505 ' HE2' ' CE2' ' A' ' 91' ' ' TYR . 1.9 ptpt -149.04 143.86 26.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.939 0.399 . . . . 0.0 110.288 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -128.51 154.4 39.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.236 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -120.78 117.13 26.65 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.073 0.464 . . . . 0.0 110.836 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.665 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.1 m-85 -109.04 109.94 21.09 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.573 175.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.4 115.41 13.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.361 0.6 . . . . 0.0 109.699 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.447 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 66.4 t80 -129.93 127.72 40.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.542 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.88 111.46 18.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.847 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.481 HD21 ' CG1' ' A' ' 37' ' ' VAL . 2.0 mp -84.61 105.26 15.29 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -113.85 157.27 22.55 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.311 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.1 mt -131.0 154.81 47.77 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -101.64 169.72 8.65 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.394 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -55.98 134.64 52.46 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.455 173.964 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 20' ' ' ALA . 38.4 t . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 120.651 0.263 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.491 ' OD1' ' HG2' ' A' ' 19' ' ' ARG . 63.4 t30 -145.57 114.62 6.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.643 175.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.426 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.5 t-80 -137.4 134.46 35.93 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.241 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.3 mt -119.19 151.1 38.93 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.612 0.57 . . . . 0.0 110.326 177.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.489 ' HG2' ' N ' ' A' ' 122' ' ' CYS . 21.9 ttm180 -142.58 153.76 43.81 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 176.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.489 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 85.7 m -137.73 122.97 19.32 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 9.6 mt-10 -119.5 155.37 32.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.473 0.178 . . . . 0.0 110.644 -177.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -107.96 138.6 43.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.617 0.722 . . . . 0.0 112.412 -172.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.639 ' HB2' HG21 ' A' ' 12' ' ' VAL . 6.8 mt -109.52 123.44 49.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.683 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.6 m -114.1 122.15 45.99 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.185 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.474 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 28.6 m-85 -118.45 109.39 16.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.112 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.79 120.67 24.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.22 0.533 . . . . 0.0 111.433 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 53.36 60.78 11.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.116 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 127' ' ' PHE . 71.6 Cg_endo -76.11 167.7 25.48 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.143 1.895 . . . . 0.0 110.755 174.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 72.2 p -70.36 141.16 52.26 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.425 ' HG3' ' NH1' ' A' ' 135' ' ' ARG . 20.6 tt0 -52.43 -43.05 64.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -173.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.55 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 8.9 p-10 -59.21 -29.65 67.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.848 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.593 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 8.1 t80 -75.27 -39.64 59.56 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.604 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 36.2 ttm180 -54.66 -45.28 73.81 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -56.23 -35.08 66.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.591 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 38.5 mtpt -74.8 -42.25 58.43 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.256 -0.277 . . . . 0.0 110.423 176.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.0 mt -68.93 -32.92 72.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 -177.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 37.5 mt -78.37 -33.1 49.16 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.773 0.32 . . . . 0.0 110.785 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -73.27 -26.77 61.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.481 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.953 179.07 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.513 ' HB2' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.237 0.406 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' B' ' 215' ' ' ALA . 6.9 Cg_endo -49.42 167.22 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.701 2.267 . . . . 0.0 113.021 175.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . 0.487 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 6.5 tpp180 . . . . . 0 C--N 1.321 -0.67 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.448 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.381 0 CA-C-O 120.91 0.386 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.74 141.38 17.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.3 mp0 -124.08 135.16 53.37 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.029 0.442 . . . . 0.0 110.106 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.652 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -111.87 173.51 2.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.632 174.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -142.37 119.16 11.15 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -175.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.4 mt -107.35 142.31 37.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.203 0.525 . . . . 0.0 110.023 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.609 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.4 tm-20 -111.91 120.53 42.25 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.612 -176.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.511 ' O ' ' HB3' ' A' ' 121' ' ' ARG . 1.4 mm? -103.19 112.47 25.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -135.67 169.52 23.47 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.565 -1.303 . . . . 0.0 111.485 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -164.01 151.43 12.24 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.976 -0.689 . . . . 0.0 111.337 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 21.0 mtp180 -114.98 150.63 35.49 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.327 173.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.06 126.79 15.25 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.767 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -121.35 151.24 40.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 112' ' ' GLU . 4.5 p -101.77 153.92 5.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.563 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 3.0 mtp180 -107.38 140.02 40.96 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -68.46 -16.06 63.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.756 0.788 . . . . 0.0 109.623 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -136.23 105.55 9.43 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.969 172.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.455 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.0 Cg_exo -49.9 156.3 3.49 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.844 2.363 . . . . 0.0 112.004 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.429 HG21 ' HB2' ' A' ' 31' ' ' PHE . 10.1 t -75.85 -173.92 2.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.838 -174.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.42 -32.88 49.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.773 0.32 . . . . 0.0 111.45 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -84.39 -0.63 53.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.085 0.469 . . . . 0.0 110.742 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.41 32.14 52.4 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.638 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.429 ' HB2' HG21 ' A' ' 27' ' ' THR . 20.7 m-30 -92.03 130.91 37.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 22' ' ' VAL . 77.3 p -89.35 -29.97 18.73 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.445 -169.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -116.17 143.1 45.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -172.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.563 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -121.07 121.45 37.93 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -123.94 151.37 43.66 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.558 -174.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.652 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 56.0 ttp -127.33 116.59 20.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.705 175.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 8.7 m -98.2 151.98 4.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.38 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.563 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.0 OUTLIER -153.44 156.08 37.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 178.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.4 m -126.31 128.32 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.19 171.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -134.99 -177.07 4.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.023 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.53 -171.8 39.49 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.005 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 9.1 Cg_exo -67.41 111.76 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.562 2.175 . . . . 0.0 111.167 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 58.96 57.17 3.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.06 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 71.6 m80 67.83 9.36 7.06 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.47 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 71.5 m -67.47 138.04 56.3 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 122.432 -0.168 . . . . 0.0 110.902 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -70.3 126.15 28.82 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.922 0.391 . . . . 0.0 110.02 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.583 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.6 pt -97.32 -4.3 9.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -173.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.04 1.84 0.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -79.34 -33.39 43.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.505 0.193 . . . . 0.0 110.723 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.548 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 52.8 p90 -119.79 -20.78 7.48 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.211 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.583 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 91.7 t -89.36 130.29 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.449 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 10.3 tp10 -99.23 -63.07 1.16 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.204 0.526 . . . . 0.0 110.313 -176.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -144.06 152.84 41.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.045 178.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 97.5 t -127.04 159.06 37.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.208 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.56 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 13.0 p -141.74 137.33 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.131 0.491 . . . . 0.0 111.209 -176.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.451 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 23.6 m-85 -118.19 108.77 15.56 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -79.49 94.08 5.53 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.976 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.593 ' CD2' HD13 ' A' ' 86' ' ' LEU . 11.3 mt -78.67 -178.2 5.79 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 144.35 47.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.186 0.517 . . . . 0.0 109.811 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.23 -23.69 62.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.792 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.5 t -77.06 -13.35 59.97 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.751 0.31 . . . . 0.0 110.992 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -81.26 140.1 48.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.497 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.26 123.41 13.56 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.471 2.114 . . . . 0.0 110.798 172.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 57.87 77.58 0.4 Allowed Pre-proline 0 N--CA 1.454 -0.253 0 O-C-N 123.876 0.735 . . . . 0.0 110.733 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.12 -22.24 73.86 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.493 2.129 . . . . 0.0 113.094 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -106.29 105.84 16.07 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 120.858 0.361 . . . . 0.0 110.704 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.1 mmt85 -104.65 108.48 19.96 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.491 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 2.8 m -97.69 136.51 28.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.1 m -120.3 113.61 20.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.038 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -104.78 -23.04 13.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.041 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.563 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -70.39 -174.87 0.26 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.319 -175.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.637 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 48.4 Cg_exo -42.37 -179.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.542 2.828 . . . . 0.0 113.474 169.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.637 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 4.2 Cg_exo -28.4 122.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.451 3.434 . . . . 0.0 114.17 -159.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.563 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 40.7 m-85 -60.31 100.21 0.09 Allowed 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.276 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.652 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.2 ptpt -148.03 147.8 29.99 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.581 0.705 . . . . 0.0 112.501 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 36' ' ' MET . 83.8 t -122.91 132.28 71.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.428 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -117.45 106.6 13.36 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.445 ' CD ' HH22 ' A' ' 67' ' ' ARG . 1.8 tp10 -133.71 175.95 8.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.515 -175.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.2 t -128.04 145.87 50.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.201 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.21 -163.62 14.55 Favored Glycine 0 N--CA 1.453 -0.167 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.22 -12.57 2.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.693 0.746 . . . . 0.0 112.018 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' B' ' 216' ' ' PRO . . . -150.58 134.29 16.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.97 0.414 . . . . 0.0 111.119 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.47 167.16 44.59 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.201 -0.909 . . . . 0.0 114.144 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -166.53 154.84 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.017 -0.591 . . . . 0.0 109.964 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.91 124.51 16.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 110.375 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.593 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -118.34 104.92 47.27 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.671 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.31 119.53 6.43 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.058 2.505 . . . . 0.0 112.22 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.412 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.5 mt -109.13 129.31 64.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.179 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.56 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.8 mt-10 -110.39 126.31 54.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 0.0 110.044 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.57 HG13 ' CE1' ' A' ' 92' ' ' PHE . 80.2 t -106.08 121.65 58.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.564 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.6 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 96.6 m-85 -95.69 135.27 37.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.57 ' CE1' HG13 ' A' ' 90' ' ' VAL . 22.9 m-85 -109.55 156.44 20.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.342 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.449 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -98.48 93.08 5.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.004 0.43 . . . . 0.0 110.782 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.445 HD22 ' HB2' ' A' ' 96' ' ' GLU . 61.8 t30 -158.61 167.96 28.18 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.201 -0.312 . . . . 0.0 111.146 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.558 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -113.59 4.57 16.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.02 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.55 ' HG2' ' CG2' ' A' ' 131' ' ' THR . 0.0 OUTLIER -101.16 -153.16 0.45 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.479 -175.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.565 ' HB2' ' HD2' ' A' ' 98' ' ' PRO . 13.9 pt-20 -39.84 155.16 0.17 Allowed Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.781 0.832 . . . . 0.0 112.027 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 97' ' ' GLU . 2.2 Cg_endo -35.87 123.07 0.27 Allowed 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 124.896 3.73 . . . . 0.0 114.511 -165.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.439 ' N ' ' HD3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -93.63 21.02 6.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.067 -177.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.486 ' HB2' ' HZ1' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -143.05 138.93 30.28 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.093 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.2 m -128.38 155.83 40.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.674 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.98 120.03 26.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CD2' HD22 ' A' ' 16' ' ' LEU . 21.1 m-85 -110.48 132.72 53.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.659 0.266 . . . . 0.0 110.638 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -91.55 105.88 18.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.502 0.668 . . . . 0.0 109.573 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -116.66 135.78 53.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.573 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -87.8 114.51 24.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.993 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.481 HD21 HG12 ' A' ' 37' ' ' VAL . 1.7 mp -90.42 91.34 8.42 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -102.37 155.01 18.53 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.072 0.463 . . . . 0.0 110.977 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt -129.14 163.31 25.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -91.69 174.35 7.4 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.285 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.48 149.47 42.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.167 0.508 . . . . 0.0 111.554 177.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.512 ' HA ' HG22 ' A' ' 22' ' ' VAL . 18.7 tt0 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.107 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 22.3 t . . . . . 0 CA--C 1.521 -0.153 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.467 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.1 OUTLIER -145.35 97.85 3.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -126.23 131.56 51.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.545 -174.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.8 mt -107.39 146.54 31.51 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.698 0.623 . . . . 0.0 109.835 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -139.96 129.01 23.59 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.436 ' N ' ' HD3' ' A' ' 121' ' ' ARG . 67.2 m -120.07 123.91 44.56 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -172.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -122.43 145.49 48.24 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.727 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.484 ' HZ3' ' HB3' ' A' ' 124' ' ' LYS . 7.4 ttpm? -100.61 129.14 46.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.22 0.533 . . . . 0.0 111.797 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.652 ' HB2' HG21 ' A' ' 12' ' ' VAL . 9.5 mt -94.63 119.44 33.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.688 172.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.5 m -109.51 123.53 49.56 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.894 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.476 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 31.3 m-85 -120.07 108.3 14.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.894 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -78.73 118.2 20.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.508 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.7 t30 50.02 64.55 8.24 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.676 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 127' ' ' PHE . 74.3 Cg_endo -74.68 178.06 7.64 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.402 2.068 . . . . 0.0 111.673 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.55 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 10.8 p -72.19 142.94 49.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.58 -37.93 76.83 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.067 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -63.85 -29.37 70.57 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.637 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 9.6 t80 -73.85 -42.05 61.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.622 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.1 ttm180 -54.3 -46.05 72.69 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.766 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -54.61 -38.26 66.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.441 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 44.3 mtpt -73.93 -40.19 63.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.799 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.7 mt -67.87 -32.57 73.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 40.5 mt -79.71 -32.28 41.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.316 . . . . 0.0 111.099 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.498 ' HZ1' ' CB ' ' A' ' 140' ' ' LYS . 2.6 ttpm? -75.89 -25.74 56.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.306 -177.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.216 174.859 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.478 ' HB2' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.236 0.384 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 10.5 Cg_endo -54.54 157.97 11.14 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.038 1.825 . . . . 0.0 111.437 175.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 . . . . . 0 C--N 1.321 -0.641 0 CA-C-O 120.91 0.386 . . . . 0.0 110.387 179.647 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 121.095 0.474 . . . . 0.0 111.581 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 t -100.01 143.88 13.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.83 127.59 29.17 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.391 0.615 . . . . 0.0 110.955 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.619 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.02 176.81 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.942 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.543 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 95.3 mttt -138.64 137.63 37.09 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.8 mt -122.45 142.05 50.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.076 0.465 . . . . 0.0 109.812 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.2 tt0 -104.34 124.65 49.58 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.999 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.631 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -110.85 114.17 27.3 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -140.09 174.86 22.23 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.618 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -166.17 153.05 9.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.212 0.529 . . . . 0.0 110.195 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 38.4 mtp180 -120.8 134.59 55.28 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.438 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.89 119.87 23.99 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.492 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -117.89 145.84 44.34 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' A' ' 112' ' ' GLU . 5.0 p -99.07 154.79 4.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 32' ' ' THR . 2.4 mtp180 -107.61 147.89 30.04 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -76.54 -12.44 60.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.764 0.792 . . . . 0.0 109.502 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -142.5 104.97 5.45 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.032 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -47.25 157.86 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.489 2.793 . . . . 0.0 113.46 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -76.97 -173.04 2.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.898 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.428 HG22 ' OE1' ' A' ' 29' ' ' GLU . 2.1 m -66.52 -28.8 44.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.96 0.409 . . . . 0.0 110.898 -174.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.428 ' OE1' HG22 ' A' ' 28' ' ' VAL . 1.9 mp0 -78.49 -8.12 58.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 110.227 175.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.01 32.99 37.92 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.2 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -98.94 140.8 32.56 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 22' ' ' VAL . 38.0 p -89.25 -27.26 20.72 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -169.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -118.85 142.59 47.59 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -172.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -116.09 119.48 35.98 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 172.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.432 ' CZ2' ' HB3' ' A' ' 78' ' ' GLU . 48.8 p-90 -121.35 150.96 40.68 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.093 0.473 . . . . 0.0 111.13 -178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 53.4 ttp -126.34 120.6 30.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.679 175.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.4 m -101.19 150.1 6.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.225 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.631 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.2 p90 -151.46 152.41 32.99 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.5 m -124.03 127.24 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.001 170.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -136.8 -176.74 4.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . -91.82 169.63 32.67 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 175.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 15.0 Cg_endo -53.39 113.96 1.54 Allowed 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 123.776 2.984 . . . . 0.0 112.657 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 56.32 51.26 11.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.419 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 69.12 11.95 8.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.482 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.494 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 66.8 m -62.27 126.83 28.7 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 171.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.533 ' OD1' ' HB2' ' A' ' 48' ' ' GLN . 6.5 t-20 -68.7 125.49 26.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.095 -175.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.527 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.5 pt -96.78 -2.37 10.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -174.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.533 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 11.1 mt-30 -61.82 -3.95 1.34 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -77.56 -37.85 49.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.401 0.143 . . . . 0.0 110.871 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.523 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -115.23 -18.61 11.07 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.547 176.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 84.2 t -90.48 130.15 40.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -98.83 -58.58 1.91 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.315 0.579 . . . . 0.0 110.355 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.603 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -149.02 153.76 38.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.048 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.469 HG21 HG23 ' A' ' 39' ' ' VAL . 66.9 t -129.12 159.09 41.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.229 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.579 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.2 p -143.1 135.1 24.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.219 0.533 . . . . 0.0 111.363 -175.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.478 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 27.6 m-85 -116.7 111.66 20.11 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.16 93.15 7.0 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.414 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.61 ' CD2' HD13 ' A' ' 86' ' ' LEU . 12.6 mt -76.87 -176.91 4.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.426 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.494 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 36.8 t60 -66.86 138.69 57.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.063 0.459 . . . . 0.0 109.802 -177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -56.3 -25.68 49.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.4 t -75.52 -18.31 59.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.451 0.167 . . . . 0.0 111.438 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.494 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 3.3 m-85 -75.09 134.91 73.91 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -60.99 117.56 4.34 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.714 2.276 . . . . 0.0 111.437 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 59.02 70.51 1.13 Allowed Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.503 -171.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.73 -17.45 59.12 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.733 2.288 . . . . 0.0 111.866 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -91.88 102.33 14.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.165 -177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.0 mmt180 -97.91 104.68 16.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.781 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.05 136.14 24.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.218 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 79.6 m -126.12 115.42 19.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.953 0.406 . . . . 0.0 109.923 175.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -106.69 -24.77 12.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.605 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.665 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 6.0 p-10 -75.71 -174.71 0.41 Allowed Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.329 -175.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.665 ' HD2' ' HB2' ' A' ' 71' ' ' ASP . 71.7 Cg_exo -39.11 -172.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.01 3.14 . . . . 0.0 114.548 167.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.62 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 8.5 Cg_endo -35.55 122.92 0.24 Allowed 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.399 2.733 . . . . 0.0 113.662 -152.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 44.2 m-85 -61.93 91.2 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.21 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 5.4 ptpt -139.37 146.4 40.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 0.0 112.034 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.7 t -120.96 132.29 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.345 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.541 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 5.3 mm-40 -108.56 106.04 15.93 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.246 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.432 ' HB3' ' CZ2' ' A' ' 35' ' ' TRP . 1.5 tp10 -134.79 171.06 14.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.709 0.29 . . . . 0.0 110.412 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -131.91 144.4 50.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.856 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.5 -170.34 27.18 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -126.72 -11.63 6.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.289 0.544 . . . . 0.0 111.771 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' B' ' 216' ' ' PRO . . . -147.83 141.49 25.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.961 0.41 . . . . 0.0 111.565 -176.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.11 164.49 51.41 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.099 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -163.31 156.37 18.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 106' ' ' ASP . 21.9 mm -64.37 126.07 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 110.211 173.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.61 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.0 tt -120.39 104.46 42.99 Favored Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.232 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.9 116.56 4.2 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.296 2.664 . . . . 0.0 112.536 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.405 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.8 mt -107.76 127.45 63.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.175 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.579 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.5 mt-10 -110.11 126.88 54.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.1 0.476 . . . . 0.0 110.01 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.49 HG13 ' CE1' ' A' ' 92' ' ' PHE . 79.3 t -106.49 119.97 56.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.744 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.603 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 88.5 m-85 -92.53 135.84 33.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.822 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.49 ' CE1' HG13 ' A' ' 90' ' ' VAL . 24.1 m-85 -109.93 148.21 32.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.308 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.52 94.6 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.469 HD22 ' HB3' ' A' ' 96' ' ' GLU . 58.9 t30 -155.66 155.4 33.15 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.273 -172.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.52 -2.51 18.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.693 0.758 . . . . 0.0 109.466 171.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.469 ' HB3' HD22 ' A' ' 94' ' ' ASN . 2.1 tp10 -101.55 -152.01 0.43 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.218 -174.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.445 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 8.2 mm-40 -29.42 150.33 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.195 0.998 . . . . 0.0 113.548 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.0 Cg_exo -32.2 126.54 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.05 1 C-N-CA 125.415 4.077 . . . . 0.0 115.011 -168.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.443 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -89.64 19.03 4.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.304 -177.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.436 ' HZ2' ' HB2' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -155.9 140.07 16.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.361 0.6 . . . . 0.0 111.552 -177.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.2 m -130.47 155.36 41.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.008 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -123.44 120.33 32.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.978 0.418 . . . . 0.0 111.25 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.631 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.5 m-85 -112.44 116.6 30.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.446 174.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -85.93 105.98 16.79 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.455 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 61.8 t80 -112.34 137.2 50.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.911 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.449 ' HA ' HD11 ' A' ' 85' ' ' ILE . 38.2 t70 -86.36 103.52 15.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.308 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.468 HD21 ' CG1' ' A' ' 37' ' ' VAL . 2.5 mp -82.21 115.82 21.47 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -131.15 160.74 33.87 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.534 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.9 mt -136.18 163.26 30.78 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -175.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -100.84 172.81 6.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.99 152.25 24.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.846 0.355 . . . . 0.0 111.677 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.513 ' HA ' HG22 ' A' ' 22' ' ' VAL . 10.4 tt0 . . . . . 0 C--O 1.233 0.207 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.926 175.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 16.7 t . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.398 0.142 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -144.15 97.45 3.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.459 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.5 t-80 -120.82 137.68 54.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.764 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.0 mt -120.48 146.95 45.75 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.478 0.487 . . . . 0.0 110.436 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.3 ttm180 -138.93 149.99 45.41 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.436 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 71.6 m -133.7 121.13 21.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 175.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -116.62 133.79 55.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 110.358 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -84.7 141.44 30.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.544 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.619 ' HB2' HG21 ' A' ' 12' ' ' VAL . 5.3 mt -111.35 110.47 20.95 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.2 m -107.09 120.02 40.95 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.822 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.532 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 25.8 m-85 -116.78 109.98 17.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.787 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -79.0 116.91 19.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.976 0.417 . . . . 0.0 110.576 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.6 t30 56.7 61.67 6.79 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.211 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 127' ' ' PHE . 72.0 Cg_endo -75.74 169.86 21.38 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.306 2.004 . . . . 0.0 111.039 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.3 p -74.84 144.66 43.34 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -53.35 -43.09 67.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -172.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -55.73 -34.18 64.91 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.883 0.373 . . . . 0.0 110.421 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.665 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 7.8 t80 -75.95 -40.9 53.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.576 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.6 ttm180 -54.79 -43.92 73.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.564 0.697 . . . . 0.0 109.386 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.23 -36.49 75.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.216 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -73.97 -40.66 62.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.749 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.665 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.0 mt -66.81 -37.08 83.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.02 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.1 mt -75.33 -34.08 61.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.04 0.447 . . . . 0.0 110.577 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -72.32 -26.43 61.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.956 -175.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.352 -0.833 . . . . 0.0 110.541 175.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.526 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.234 0.282 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 29.2 Cg_endo -62.58 169.25 8.66 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 121.788 1.659 . . . . 0.0 111.49 176.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 121.159 0.504 . . . . 0.0 110.883 178.678 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.375 0 CA-C-O 120.725 0.298 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.56 138.52 41.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -114.39 138.77 50.13 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -132.71 125.77 53.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.441 177.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -99.81 130.23 45.99 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.639 -0.663 . . . . 0.0 111.279 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.3 mt -108.98 142.38 39.72 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.848 176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.683 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.0 tt0 -104.15 126.42 51.25 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.195 -174.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.602 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -114.55 122.64 47.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -152.1 172.74 31.37 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.239 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -165.7 152.38 9.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.044 0.449 . . . . 0.0 110.138 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -117.03 152.04 35.48 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.435 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -141.96 133.29 26.47 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.532 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -129.79 164.74 23.4 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.823 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 32' ' ' THR . 2.4 p -104.24 161.01 4.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 168.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.497 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 4.3 mtp85 -105.52 140.54 38.45 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -67.05 -17.87 65.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.73 0.776 . . . . 0.0 109.477 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -136.76 107.31 9.04 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.893 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.505 ' HG3' HG22 ' A' ' 32' ' ' THR . 64.7 Cg_exo -45.89 156.3 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.277 2.651 . . . . 0.0 113.176 177.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 31' ' ' PHE . 11.3 t -75.99 -169.92 1.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.634 -171.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.54 -27.4 42.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 122.874 0.47 . . . . 0.0 111.532 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -86.6 -12.06 49.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.408 0.623 . . . . 0.0 109.856 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.85 19.96 38.46 Favored Glycine 0 CA--C 1.503 -0.7 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.575 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.408 ' HB2' HG21 ' A' ' 27' ' ' THR . 20.4 m-30 -91.25 145.18 24.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.663 -0.768 . . . . 0.0 110.827 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.659 ' O ' HG23 ' A' ' 22' ' ' VAL . 44.6 p -94.0 -28.72 15.61 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.4 -164.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -108.64 153.69 23.06 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -169.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.497 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 1.1 m-20 -131.95 133.35 44.41 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -139.19 149.82 44.85 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.046 0.451 . . . . 0.0 111.488 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.645 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 47.7 ttp -125.85 120.91 31.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.887 174.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.5 m -99.92 152.73 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.315 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.3 p90 -150.94 153.16 34.72 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.4 m -127.09 128.54 70.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.244 170.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -135.28 -176.12 4.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.949 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.12 -169.06 42.11 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.269 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 4.9 Cg_exo -72.82 112.16 3.43 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.665 2.244 . . . . 0.0 111.617 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 59.55 60.68 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.536 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 67.0 m80 71.16 -3.0 2.18 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.453 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 66.6 m -60.06 134.15 56.78 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.479 0.181 . . . . 0.0 111.299 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -69.96 126.42 29.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.567 HG22 ' CZ ' ' A' ' 50' ' ' PHE . 1.5 pt -96.66 -4.84 9.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -174.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -68.89 6.21 0.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.851 0.357 . . . . 0.0 111.782 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -80.12 -33.57 38.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.546 172.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.567 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 54.4 p90 -119.39 -18.75 8.46 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.301 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.556 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 91.4 t -88.68 131.25 36.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -98.06 -52.01 3.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 0.0 110.366 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -156.97 158.56 36.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.67 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.477 HG11 HG23 ' A' ' 39' ' ' VAL . 93.9 t -132.29 158.11 43.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.576 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.6 p -141.92 135.39 29.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.225 0.535 . . . . 0.0 111.085 -175.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.485 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 29.3 m-85 -117.59 108.37 15.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.73 92.57 4.81 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.161 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.61 ' CD2' HD13 ' A' ' 86' ' ' LEU . 10.7 mt -76.9 -178.42 4.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -79.01 144.02 35.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.07 -19.76 21.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.832 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -66.58 -21.95 66.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.111 0.481 . . . . 0.0 110.997 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -84.14 132.89 46.54 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.528 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.82 122.43 10.98 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.41 2.074 . . . . 0.0 111.1 172.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 59.96 69.3 1.25 Allowed Pre-proline 0 CA--C 1.531 0.232 0 O-C-N 123.738 0.649 . . . . 0.0 110.476 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.81 -22.4 49.49 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.636 2.224 . . . . 0.0 113.157 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -93.33 98.47 11.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.247 0.546 . . . . 0.0 110.202 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 13.2 mmt180 -94.36 96.69 9.7 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.446 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -86.35 136.66 22.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 172.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.0 m -124.86 111.6 15.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.03 0.443 . . . . 0.0 109.925 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -100.73 -27.51 13.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.681 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.513 ' OD1' ' HD2' ' A' ' 72' ' ' PRO . 28.4 t70 -69.63 168.63 15.99 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.712 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.589 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 42.4 Cg_exo -26.35 -168.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.864 1 C-N-CA 126.12 4.547 . . . . 0.0 116.277 161.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.589 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 10.3 Cg_endo -37.18 120.2 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.981 2.454 . . . . 0.0 113.976 -151.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 35.3 m-85 -62.45 98.37 0.11 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.935 -177.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 11.9 ptpt -149.52 146.23 27.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.468 0.651 . . . . 0.0 112.103 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.9 t -126.5 131.22 71.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.011 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -117.0 111.34 19.43 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -132.7 171.54 13.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.33 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.0 t -116.4 146.41 42.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.18 172.06 28.52 Favored Glycine 0 CA--C 1.507 -0.434 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.802 -173.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -130.41 -4.17 4.3 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.962 0.41 . . . . 0.0 110.215 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -164.1 137.19 5.18 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.222 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.49 -174.47 28.72 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 116.187 -0.46 . . . . 0.0 114.19 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.0 p90 179.96 158.02 0.71 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.858 0.463 . . . . 0.0 110.462 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.411 HD12 HG21 ' A' ' 85' ' ' ILE . 22.6 mm -65.83 129.26 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 171.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.61 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.3 tt -120.85 104.76 41.48 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-O 121.109 0.48 . . . . 0.0 110.154 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.82 114.37 3.12 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 123.25 2.634 . . . . 0.0 112.196 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -104.43 124.58 59.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.065 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.576 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.0 mt-10 -108.52 127.09 53.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.164 0.507 . . . . 0.0 110.008 175.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.0 t -106.73 117.98 53.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.622 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.559 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 81.0 m-85 -90.32 139.33 30.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.809 -178.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.448 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.0 m-85 -114.94 151.66 33.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.197 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.5 95.48 9.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.567 HD22 ' HB2' ' A' ' 96' ' ' GLU . 56.6 t30 -155.5 160.9 40.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.222 0.534 . . . . 0.0 111.595 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.576 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.6 OUTLIER -112.37 -1.42 15.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.778 178.132 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.567 ' HB2' HD22 ' A' ' 94' ' ' ASN . 18.4 mm-40 -102.02 -154.19 0.48 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.787 -175.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 97' ' ' GLU . 2.4 mp0 -26.79 152.5 0.01 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.938 1.295 . . . . 0.0 114.082 172.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 3.2 Cg_exo -31.66 125.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.197 1 C-N-CA 125.399 4.066 . . . . 0.0 114.756 -169.206 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.26 19.72 3.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.998 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -153.49 146.47 24.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.188 0.518 . . . . 0.0 110.934 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -128.7 155.87 40.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.025 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -120.89 121.29 37.75 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.841 0.353 . . . . 0.0 111.064 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.602 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.4 m-85 -113.79 112.21 23.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.649 173.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.31 105.97 11.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -115.57 137.25 52.26 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.672 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -85.86 114.25 22.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.894 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.463 HD21 HG12 ' A' ' 37' ' ' VAL . 2.0 mp -92.89 103.86 16.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -115.59 158.9 21.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.064 0.459 . . . . 0.0 110.28 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.1 mt -130.75 158.11 41.0 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -101.82 173.86 6.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.297 0.498 . . . . 0.0 110.648 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -62.4 136.8 58.08 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -173.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 . . . . . 0 C--N 1.34 0.193 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.844 177.391 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 20' ' ' ALA . 39.5 t . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 111.619 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.458 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.2 OUTLIER -135.79 98.37 3.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -121.8 142.78 49.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.178 -176.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.405 HD12 ' H ' ' A' ' 121' ' ' ARG . 16.6 tp -136.99 159.38 42.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.163 0.506 . . . . 0.0 111.57 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.464 ' HD2' HD23 ' A' ' 16' ' ' LEU . 19.7 ttm180 -152.98 149.23 27.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.321 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.401 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 69.5 m -138.7 118.25 12.98 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 174.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -114.7 146.06 41.34 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -103.52 127.48 50.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.416 0.627 . . . . 0.0 112.398 -174.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.658 ' HB2' HG21 ' A' ' 12' ' ' VAL . 7.7 mt -86.43 149.53 24.93 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.3 m -140.97 121.89 14.5 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.144 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -115.93 114.85 25.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.232 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -84.76 120.85 26.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.315 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 50.5 65.49 6.73 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.766 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.35 -178.76 4.2 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.764 2.309 . . . . 0.0 112.074 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 74.4 p -74.97 137.15 41.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -61.19 -29.15 69.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -67.57 -28.3 67.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.63 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.8 t80 -75.07 -42.96 55.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.409 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.645 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.3 ttm180 -54.45 -43.69 71.85 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.755 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -55.87 -39.79 72.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.156 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 51.0 mtpt -71.09 -39.76 71.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.811 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 33.9 mt -69.61 -26.68 64.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.73 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 41.6 mt -86.19 -28.88 23.62 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.054 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -77.22 -31.15 55.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.261 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.828 178.487 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.419 ' HB2' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 110.715 -0.105 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' B' ' 215' ' ' ALA . 14.0 Cg_endo -58.97 172.27 1.73 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.221 1.947 . . . . 0.0 112.129 173.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.28 0.562 . . . . 0.0 111.577 178.484 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 121.054 0.454 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 t -101.72 140.72 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.1 mp0 -125.78 120.66 31.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.087 0.47 . . . . 0.0 110.224 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.629 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -108.52 177.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.686 179.007 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 98.7 mttt -142.58 136.42 29.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.579 0.228 . . . . 0.0 110.74 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.4 mt -119.68 142.56 48.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 109.945 174.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.8 tt0 -102.87 123.08 45.84 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.058 -176.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.635 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -109.78 113.68 26.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 174.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -142.67 173.8 23.8 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.849 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -164.01 151.93 12.7 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.007 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 70.6 mtt180 -116.82 140.92 48.87 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.748 171.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.0 125.51 29.87 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.282 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.45 ' HA ' ' HE2' ' A' ' 110' ' ' HIS . 2.8 pt20 -119.5 155.07 32.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 32' ' ' THR . 4.9 p -103.93 159.3 5.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.456 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 2.2 mtp180 -108.84 147.43 32.12 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -72.13 -18.39 61.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.651 0.738 . . . . 0.0 109.28 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -139.89 103.81 6.87 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.412 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.479 ' HG3' HG22 ' A' ' 32' ' ' THR . 70.2 Cg_exo -47.2 156.61 0.81 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.533 2.822 . . . . 0.0 112.736 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.467 HG21 ' HB2' ' A' ' 31' ' ' PHE . 10.2 t -77.23 -174.52 3.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.665 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.495 HG21 ' OE1' ' A' ' 29' ' ' GLU . 1.1 m -64.15 -27.81 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.106 0.479 . . . . 0.0 110.827 -175.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.495 ' OE1' HG21 ' A' ' 28' ' ' VAL . 2.3 mp0 -80.18 -2.06 43.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.382 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.26 31.22 63.92 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.365 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.467 ' HB2' HG21 ' A' ' 27' ' ' THR . 21.6 m-30 -93.64 131.55 38.84 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.479 HG22 ' HG3' ' A' ' 26' ' ' PRO . 62.1 p -89.69 -20.32 23.77 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.426 -168.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -124.07 148.33 47.18 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 7.4 m-20 -123.82 123.79 41.24 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 170.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -123.8 154.24 39.85 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.29 0.567 . . . . 0.0 111.192 -176.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.619 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 15.1 tmm? -128.96 136.71 50.73 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.062 174.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.3 m -121.67 149.43 24.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.387 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.669 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.6 OUTLIER -149.32 157.25 43.18 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.2 m -123.91 126.38 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.662 167.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -135.39 -176.28 4.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.734 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . -93.19 179.15 39.18 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.427 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -73.97 112.67 3.6 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.337 2.025 . . . . 0.0 111.879 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 61.71 47.86 5.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.079 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 67.88 6.97 5.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.715 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.487 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 48.6 m -63.26 122.53 16.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -60.83 125.01 22.14 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.93 0.395 . . . . 0.0 110.528 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.543 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.7 pt -95.3 -2.2 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.738 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -59.23 -12.85 5.99 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.306 0.574 . . . . 0.0 110.672 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -67.8 -45.0 76.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.959 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.499 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -111.83 -18.37 12.72 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.309 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.543 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 59.3 t -92.58 137.02 23.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.964 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.495 ' HB2' ' HG3' ' A' ' 93' ' ' LYS . 10.5 tp10 -113.98 -63.18 1.49 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.271 0.557 . . . . 0.0 110.915 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 24.9 tttt -136.73 149.55 47.92 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.129 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 99.0 t -131.13 156.94 43.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.588 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.9 p -140.62 134.9 34.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.374 0.606 . . . . 0.0 111.601 -175.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.458 ' CE2' HG12 ' A' ' 88' ' ' ILE . 16.1 m-85 -117.33 111.26 19.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -81.75 97.88 8.17 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.043 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.62 ' CD2' HD13 ' A' ' 86' ' ' LEU . 12.3 mt -80.77 -177.82 6.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.877 0.37 . . . . 0.0 110.631 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 143.2 45.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -60.04 -23.29 63.61 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.1 t -70.68 -22.15 62.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.998 0.427 . . . . 0.0 110.867 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -75.39 141.48 73.52 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.731 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.77 128.55 21.23 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.395 2.063 . . . . 0.0 110.318 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.492 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 52.9 mtm180 58.11 74.92 0.58 Allowed Pre-proline 0 C--N 1.331 -0.226 0 O-C-N 123.618 0.574 . . . . 0.0 110.246 -175.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.1 -24.38 52.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.509 2.139 . . . . 0.0 113.065 -178.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -101.52 104.62 15.53 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.14 0.495 . . . . 0.0 110.183 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 64' ' ' ARG . 9.4 mmm-85 -103.1 104.13 14.26 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.492 -177.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -98.59 137.63 25.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.8 m -118.1 120.22 37.12 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -103.16 -29.83 11.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.613 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.55 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 6.2 m-20 -81.03 -178.31 1.14 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.101 -175.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 0.9 OUTLIER -41.34 -166.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 124.277 3.318 . . . . 0.0 114.231 165.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 3.3 Cg_endo -29.82 118.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 123.291 2.661 . . . . 0.0 113.883 -147.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.669 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 54.2 m-85 -64.56 88.75 0.06 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.848 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 13.9 ptpt -136.92 142.9 42.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.409 0.623 . . . . 0.0 112.418 -174.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.6 t -119.56 136.56 56.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.618 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -124.21 107.01 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.35 172.84 12.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.402 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.4 t -123.15 146.03 48.11 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.674 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.38 23.72 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -130.27 -18.35 3.27 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.503 0.652 . . . . 0.0 111.903 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.75 145.09 32.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.001 0.429 . . . . 0.0 111.178 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.73 172.5 51.97 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.673 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -168.71 158.9 9.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 122.905 0.482 . . . . 0.0 110.064 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 mm -66.76 121.08 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.188 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.62 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.6 tt -116.46 108.25 45.67 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.406 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -79.9 121.26 4.47 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.799 2.333 . . . . 0.0 112.056 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.458 HG12 ' CE2' ' A' ' 56' ' ' PHE . 3.9 mp -105.53 133.59 49.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.323 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.9 mt-10 -113.37 121.32 43.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.202 0.525 . . . . 0.0 110.217 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.583 HG13 ' CE1' ' A' ' 92' ' ' PHE . 84.0 t -101.54 122.56 53.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.115 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.569 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 87.3 m-85 -91.12 138.57 31.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.548 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.583 ' CE1' HG13 ' A' ' 90' ' ' VAL . 21.3 m-85 -119.91 162.32 19.37 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.16 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.495 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -105.16 97.24 7.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 121.159 -0.217 . . . . 0.0 111.353 176.282 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -155.63 168.86 25.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.298 0.57 . . . . 0.0 112.272 173.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.539 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -103.97 9.28 36.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.484 174.596 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -101.01 -154.65 0.49 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.442 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 22.6 mm-40 -35.95 157.36 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.63 0 C-N-CA 124.24 1.016 . . . . 0.0 113.266 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 7.3 Cg_exo -31.88 125.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 124.713 3.609 . . . . 0.0 114.302 -172.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.45 20.06 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.841 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 98' ' ' PRO . 0.0 OUTLIER -152.13 140.76 20.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.919 178.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.2 m -115.91 156.79 16.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -128.39 107.88 10.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.873 0.368 . . . . 0.0 110.487 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.635 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.2 m-85 -105.67 120.96 43.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.202 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -82.59 117.15 22.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -126.6 136.18 52.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.242 0.544 . . . . 0.0 110.875 -176.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.38 112.79 21.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.951 -178.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.503 HD21 HG12 ' A' ' 37' ' ' VAL . 1.2 mp -91.04 94.64 9.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -104.03 155.85 18.34 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.087 0.47 . . . . 0.0 111.054 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.5 mt -129.36 162.5 27.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.247 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 21' ' ' GLN . 5.7 p80 -100.18 173.09 6.79 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.285 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.485 HD21 ' HA ' ' B' ' 215' ' ' ALA . 2.0 mm? -73.57 161.03 30.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.997 0.427 . . . . 0.0 111.635 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.437 ' HA ' HG22 ' A' ' 22' ' ' VAL . 14.7 mt-10 . . . . . 0 C--O 1.232 0.176 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.304 173.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 67.4 t . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.47 96.43 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -116.3 132.49 56.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.46 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.5 mt -117.04 141.82 47.76 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.51 0.506 . . . . 0.0 110.327 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 18.3 ttm180 -131.2 148.41 52.7 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.421 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 59.1 m -133.84 117.0 16.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 6.1 mt-10 -113.34 137.45 51.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.842 0.354 . . . . 0.0 111.085 -175.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -89.45 126.56 35.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.822 -175.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.629 ' HB2' HG21 ' A' ' 12' ' ' VAL . 9.2 mt -92.69 115.38 28.05 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 23.7 m -110.66 114.74 28.35 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.911 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -115.64 109.41 17.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.547 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -76.02 117.77 18.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.129 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 t30 54.46 67.32 3.45 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.267 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.96 -179.37 5.05 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.56 2.173 . . . . 0.0 111.359 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.2 p -77.52 145.7 36.82 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 173.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -54.42 -40.54 68.38 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.795 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.1 p-10 -59.81 -32.44 70.64 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.593 0.235 . . . . 0.0 110.662 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.663 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 4.7 t80 -73.78 -41.11 62.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.605 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 45.2 ttm105 -54.72 -43.61 72.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.609 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -57.33 -37.43 72.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.31 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 32.7 mtpt -73.94 -42.42 60.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.839 0.352 . . . . 0.0 110.3 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 33.0 mt -69.73 -30.99 68.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.219 -176.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 27.3 mt -79.64 -32.8 41.7 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.778 0.323 . . . . 0.0 110.684 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.62 -30.27 64.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.565 -176.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.757 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.562 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.237 0.441 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . 0.562 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 6.9 Cg_endo -51.09 168.62 0.23 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.12 1.88 . . . . 0.0 112.465 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' B' ' 217' ' ' ARG . 37.9 ttt85 . . . . . 0 C--N 1.321 -0.653 0 CA-C-O 120.923 0.392 . . . . 0.0 111.123 -174.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.117 0.484 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.21 142.38 21.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.08 124.99 38.38 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.262 -178.077 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.646 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -109.28 168.72 3.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.4 175.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.93 126.56 27.13 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.571 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.2 mt -105.99 142.2 36.1 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.991 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.5 tt0 -102.82 125.0 49.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.05 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.669 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -112.54 113.96 26.38 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -144.91 175.86 24.3 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.849 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -165.88 155.11 11.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.183 0.516 . . . . 0.0 111.164 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 26.7 mtp180 -116.55 152.18 34.66 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.745 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -147.56 125.82 12.25 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.839 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -125.48 141.99 51.75 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 112' ' ' GLU . 7.5 p -100.73 152.4 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.753 ' HD2' ' O ' ' A' ' 25' ' ' LYS . 5.9 ptt180 -116.7 138.65 51.3 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -68.02 -17.36 64.39 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.562 0.696 . . . . 0.0 109.473 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.753 ' O ' ' HD2' ' A' ' 23' ' ' ARG . 44.7 tttm -117.49 99.05 52.37 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.483 170.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.11 159.52 18.37 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.104 1.869 . . . . 0.0 110.915 171.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 t -81.68 -172.77 4.05 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.741 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.7 m -59.0 -29.82 42.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.208 0.528 . . . . 0.0 111.492 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -85.47 -0.22 54.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.32 30.53 62.49 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.162 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -89.45 125.55 35.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 22' ' ' VAL . 40.4 p -86.6 -27.51 23.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.471 -171.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 79' ' ' SER . 68.6 m80 -118.1 142.27 47.6 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -171.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -115.05 119.96 38.21 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 173.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -122.65 154.95 37.34 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.149 0.499 . . . . 0.0 111.32 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.633 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 52.4 ttp -133.21 119.92 20.48 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.571 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.0 m -100.53 152.31 4.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.285 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -152.46 155.5 37.62 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.539 -0.464 . . . . 0.0 112.234 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.6 m -128.11 127.17 67.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.132 170.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.45 HH11 ' HB3' ' A' ' 73' ' ' PRO . 9.9 mmm180 -132.49 -177.14 4.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.332 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.75 -167.55 42.49 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.649 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 2.9 Cg_exo -73.86 111.53 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.278 1.985 . . . . 0.0 111.697 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 60.78 61.28 1.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.662 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 72.91 -5.54 1.88 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.364 0.666 . . . . 0.0 112.527 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 58.7 m -59.31 133.07 55.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.551 0.215 . . . . 0.0 110.916 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -71.24 126.09 28.7 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.023 0.44 . . . . 0.0 110.318 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.585 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.4 pt -96.35 -2.73 10.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.485 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -57.86 -13.91 5.18 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.219 0.533 . . . . 0.0 111.285 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -69.88 -41.42 74.8 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.493 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.577 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 52.8 p90 -114.67 -14.39 12.04 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.883 -0.51 . . . . 0.0 111.543 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.585 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 90.0 t -94.31 125.86 46.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -92.44 -62.71 1.34 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.517 -176.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.683 ' HD2' ' CD1' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -145.86 151.1 37.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.478 HG11 HG23 ' A' ' 39' ' ' VAL . 98.1 t -125.28 160.93 30.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.582 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.6 p -142.32 137.81 29.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.192 0.52 . . . . 0.0 111.124 -176.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.476 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 26.7 m-85 -119.5 110.78 17.31 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -83.27 92.94 7.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.488 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.601 ' CD2' HD13 ' A' ' 86' ' ' LEU . 11.4 mt -78.54 177.73 8.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.986 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.89 144.32 49.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -58.87 -25.37 63.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.835 -170.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.8 t -72.75 -19.23 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.992 0.425 . . . . 0.0 110.592 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -75.23 135.31 73.13 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.23 118.65 5.49 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.436 2.091 . . . . 0.0 111.135 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 62.29 79.06 0.28 Allowed Pre-proline 0 CA--C 1.53 0.195 0 O-C-N 123.638 0.586 . . . . 0.0 110.203 -176.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.32 -21.16 66.02 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.803 2.336 . . . . 0.0 113.454 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -105.96 108.79 20.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.944 0.402 . . . . 0.0 110.694 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -106.64 98.37 8.05 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.035 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -84.29 136.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.391 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.9 m -125.7 112.04 15.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.862 0.363 . . . . 0.0 110.267 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -106.93 -21.65 12.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.31 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.681 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 3.1 t70 -65.37 -177.64 0.25 Allowed Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.537 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.681 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 16.7 Cg_exo -33.02 -175.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.542 0 C-N-CA 125.031 3.821 . . . . 0.0 114.285 160.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.636 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.6 Cg_endo -34.81 126.69 0.22 Allowed 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 123.657 2.905 . . . . 0.0 114.044 -160.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 33.0 m-85 -61.8 94.06 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.793 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 3.9 ptpt -144.15 146.29 32.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.225 0.536 . . . . 0.0 111.717 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 36' ' ' MET . 71.7 t -124.87 132.53 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.871 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.97 111.87 21.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.23 172.39 12.75 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.168 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 9.6 t -123.1 149.39 44.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.83 -175.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.82 -169.65 22.47 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -132.18 -10.93 3.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.146 0.473 . . . . 0.0 111.339 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -151.27 140.35 21.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.635 0.255 . . . . 0.0 110.47 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.61 179.22 49.35 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.771 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -173.94 156.28 2.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.677 0.275 . . . . 0.0 110.721 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 85' ' ' ILE . 14.2 mm -64.95 121.27 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.136 172.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.601 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -114.67 104.94 54.04 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.636 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.39 117.07 4.83 Favored 'Trans proline' 0 C--O 1.239 0.559 0 C-N-CA 123.05 2.5 . . . . 0.0 112.019 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 mt -106.81 126.17 62.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.21 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.582 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 46.3 mt-10 -110.57 122.64 48.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.367 0.603 . . . . 0.0 110.181 176.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.4 t -104.4 119.39 53.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.282 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.683 ' CD1' ' HD2' ' A' ' 53' ' ' LYS . 28.2 m-85 -94.8 156.14 16.51 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.424 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.7 m-85 -126.86 157.51 39.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.018 -177.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -105.76 93.65 4.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.252 0.548 . . . . 0.0 111.622 -178.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.559 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 62.0 t30 -160.24 -176.6 5.73 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 5.6 tmtt? -109.88 -5.04 15.63 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.245 0.545 . . . . 0.0 111.248 177.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 16.1 mm-40 -96.47 -155.41 0.48 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.852 -168.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.47 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 11.2 mm-40 -28.97 151.15 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 124.833 1.253 . . . . 0.0 113.902 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.5 Cg_exo -30.62 124.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 125.087 3.858 . . . . 0.0 114.713 -165.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.559 ' HD3' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -75.26 12.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.5 -177.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.538 ' HE2' ' CE2' ' A' ' 91' ' ' TYR . 2.5 ptpt -150.03 147.67 28.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.318 0.58 . . . . 0.0 111.342 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -123.55 155.24 29.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 174.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -128.53 106.82 9.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.76 0.314 . . . . 0.0 110.336 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.669 ' CD2' HD22 ' A' ' 16' ' ' LEU . 22.9 m-85 -103.09 121.19 42.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.304 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -84.31 112.64 20.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -124.79 138.34 54.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.377 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -90.86 120.15 31.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.919 0.39 . . . . 0.0 110.959 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.468 HD21 ' CG1' ' A' ' 37' ' ' VAL . 2.1 mp -93.76 91.75 7.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.009 175.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -101.03 157.74 16.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.207 0.527 . . . . 0.0 110.654 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.8 mt -129.76 163.78 25.46 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.466 ' O ' ' HB3' ' B' ' 215' ' ' ALA . 38.7 m170 -94.18 174.83 6.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 172.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.41 HD21 ' HA ' ' B' ' 215' ' ' ALA . 2.4 mm? -67.52 165.16 17.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.009 0.433 . . . . 0.0 111.634 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.56 ' HA ' HG22 ' A' ' 22' ' ' VAL . 16.9 tt0 . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.748 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 22.5 t . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.431 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.66 96.39 2.86 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -118.98 134.97 54.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.618 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.4 mt -116.58 152.59 33.84 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.514 0.509 . . . . 0.0 110.575 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 19.8 ttm180 -143.58 149.63 37.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 173.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.467 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 61.4 m -134.12 120.71 20.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -115.81 138.11 51.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.695 0.283 . . . . 0.0 110.437 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -90.48 129.91 36.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.474 0.654 . . . . 0.0 112.185 -174.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.646 ' HB2' HG21 ' A' ' 12' ' ' VAL . 11.1 mt -95.16 117.49 30.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.386 171.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.7 m -109.06 122.66 47.75 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.667 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -120.42 104.45 10.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.675 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -85.67 120.74 27.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.706 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.02 61.96 4.39 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.201 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -87.4 173.82 5.35 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.116 2.544 . . . . 0.0 112.013 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 134' ' ' PHE . 11.7 p -69.26 140.46 54.47 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -58.28 -37.08 74.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -63.36 -29.67 70.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.611 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.6 t80 -73.02 -43.4 62.15 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.671 ' O ' HD13 ' A' ' 139' ' ' LEU . 50.0 ttp180 -52.79 -52.58 56.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.809 175.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -55.09 -36.32 65.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.934 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.479 ' HZ3' ' HG2' ' A' ' 93' ' ' LYS . 20.2 mtmt -71.08 -39.2 72.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.624 -0.43 . . . . 0.0 109.84 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.6 mt -65.55 -19.11 65.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.706 0.765 . . . . 0.0 109.839 175.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.671 HD13 ' O ' ' A' ' 135' ' ' ARG . 6.4 mp -89.56 -26.36 20.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.962 -177.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -90.5 -19.14 24.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.203 0.525 . . . . 0.0 110.631 -174.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.18 174.384 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.86 175.22 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.676 1.584 . . . . 0.0 112.71 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.332 177.849 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 121.182 0.515 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.8 t -103.13 142.58 16.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -121.95 127.31 50.21 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.624 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -112.08 172.18 3.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.927 177.004 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 97.0 mttt -135.83 131.84 35.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.565 0.221 . . . . 0.0 110.611 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.5 mt -116.52 142.04 47.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.239 0.543 . . . . 0.0 109.954 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.621 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.5 tt0 -105.13 125.12 50.64 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.939 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.569 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.5 mm? -108.57 122.22 46.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.496 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -143.85 167.61 26.68 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.984 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -163.72 154.15 15.57 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.379 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 53.4 mtp180 -121.15 144.87 48.34 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.866 172.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.68 118.29 24.47 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.785 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.95 137.05 50.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 22' ' ' VAL . 3.3 p -103.5 137.87 30.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.4 mtp180 -92.81 139.96 30.0 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -175.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -68.14 -15.29 63.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.427 0.632 . . . . 0.0 109.729 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -139.03 102.35 7.55 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.427 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.512 ' HG3' HG22 ' A' ' 32' ' ' THR . 90.8 Cg_exo -50.19 158.0 2.68 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.076 2.517 . . . . 0.0 112.169 175.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.438 HG21 ' HB2' ' A' ' 31' ' ' PHE . 7.8 t -78.22 -175.67 4.27 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.407 -174.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.3 m -63.04 -31.05 51.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.092 0.472 . . . . 0.0 110.894 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -77.98 -6.7 55.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.447 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.37 33.41 39.52 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.401 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.438 ' HB2' HG21 ' A' ' 27' ' ' THR . 18.5 m-30 -94.7 129.7 41.49 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.512 HG22 ' HG3' ' A' ' 26' ' ' PRO . 38.9 p -91.9 -25.66 18.82 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.43 -168.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 79' ' ' SER . 56.5 m80 -117.28 140.53 49.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -113.86 112.15 22.88 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 54.7 p-90 -118.44 148.84 42.16 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.082 0.468 . . . . 0.0 111.127 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.639 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 57.8 ttp -129.37 122.64 29.88 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.802 175.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.7 m -102.59 151.29 6.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.369 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -152.15 152.87 32.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.2 m -124.02 127.14 73.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.271 171.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.513 ' CZ ' ' HA ' ' A' ' 73' ' ' PRO . 2.5 mmp_? -135.62 -176.58 4.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.705 -176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . -91.54 -171.73 42.57 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.661 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 30.7 Cg_endo -75.7 113.68 3.79 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.515 2.143 . . . . 0.0 112.173 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 58.98 52.45 6.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.384 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.6 t60 74.38 -3.82 2.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.825 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.463 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 63.9 m -59.04 128.74 38.75 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 176.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -72.25 127.06 31.38 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.779 0.324 . . . . 0.0 110.844 -174.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.54 HD11 HG23 ' A' ' 51' ' ' VAL . 5.9 pt -96.42 -1.96 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -61.31 -14.66 28.56 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.383 0.611 . . . . 0.0 110.928 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.517 ' ND1' ' HZ3' ' A' ' 140' ' ' LYS . 88.1 m-70 -65.7 -39.22 91.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.709 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.525 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 55.4 p90 -114.61 -16.01 11.91 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.464 176.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.54 HG23 HD11 ' A' ' 47' ' ' ILE . 99.3 t -91.79 129.09 43.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.084 0.469 . . . . 0.0 110.23 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -97.1 -63.92 1.09 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.335 0.588 . . . . 0.0 110.409 -175.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 6.6 ptmm? -141.1 157.54 45.16 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 91.7 t -130.04 158.33 42.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 67' ' ' ARG . 9.7 p -142.31 134.75 26.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.341 0.591 . . . . 0.0 111.214 -174.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.46 ' CD2' HG12 ' A' ' 88' ' ' ILE . 29.6 m-85 -117.78 105.5 12.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -77.05 90.86 3.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.872 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.579 ' CD2' HD13 ' A' ' 86' ' ' LEU . 12.9 mt -71.01 -177.77 1.75 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.825 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.79 139.77 43.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -176.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -56.53 -23.53 40.51 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -171.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.8 t -71.72 -16.31 62.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.069 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -79.51 141.01 56.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.13 116.84 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.097 1.865 . . . . 0.0 111.327 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 58.41 66.59 2.51 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.552 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.4 -18.74 66.01 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.223 2.615 . . . . 0.0 113.466 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -87.48 100.79 13.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.991 0.424 . . . . 0.0 110.534 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.581 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.0 mmt180 -100.13 110.81 23.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.826 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -100.64 136.01 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.7 m -114.37 118.24 33.32 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -105.09 -25.72 12.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.534 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.57 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 9.5 p-10 -76.5 -175.08 0.45 Allowed Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.382 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.58 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 1.5 Cg_exo -41.97 -166.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.231 3.288 . . . . 0.0 114.203 164.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.588 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 6.9 Cg_endo -34.89 120.02 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.005 2.47 . . . . 0.0 113.602 -151.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 47.5 m-85 -62.35 94.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.043 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 12.2 ptpt -142.28 145.9 34.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.279 0.561 . . . . 0.0 112.201 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 36' ' ' MET . 79.6 t -121.28 132.61 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.462 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.415 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 7.0 mm-40 -112.06 112.49 24.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.982 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -137.42 169.87 17.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.197 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 3.5 t -126.75 141.9 51.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.14 -169.27 24.17 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.281 -0.485 . . . . 0.0 111.953 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -132.84 -11.41 3.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.253 0.527 . . . . 0.0 111.973 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.41 136.99 20.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.18 -172.99 47.18 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.208 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -178.87 159.53 1.05 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.362 0.265 . . . . 0.0 110.485 -173.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.3 mm -63.9 123.43 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.579 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.1 tt -117.76 104.88 48.59 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-O 121.138 0.494 . . . . 0.0 109.995 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.54 112.98 3.0 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.336 2.691 . . . . 0.0 112.357 173.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.46 HG12 ' CD2' ' A' ' 56' ' ' PHE . 3.8 mt -102.33 123.52 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.283 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.8 mt-10 -109.48 124.46 51.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.179 0.514 . . . . 0.0 110.198 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.523 HG13 ' CE1' ' A' ' 92' ' ' PHE . 74.4 t -103.36 118.76 50.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.907 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 69.9 m-85 -91.05 134.75 34.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.512 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.523 ' CE1' HG13 ' A' ' 90' ' ' VAL . 25.6 m-85 -110.11 152.07 26.46 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.047 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.58 94.19 9.77 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.4 ' HB3' ' HG3' ' A' ' 99' ' ' ARG . 64.0 t30 -154.61 158.65 40.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.875 -172.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -111.42 -9.68 14.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.909 0.862 . . . . 0.0 110.006 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -99.05 -151.77 0.39 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.47 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.454 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 22.2 mm-40 -27.16 152.11 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.5 Cg_exo -31.1 126.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 1 C-N-CA 125.522 4.148 . . . . 0.0 115.262 -167.202 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.4 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -89.0 18.97 4.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.647 -179.182 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.65 143.01 20.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.247 0.546 . . . . 0.0 110.874 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -128.43 155.76 40.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.345 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -125.47 115.64 20.55 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.173 0.511 . . . . 0.0 111.118 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.569 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.8 m-85 -107.98 108.18 19.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.678 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -72.11 113.29 8.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.281 0.562 . . . . 0.0 109.659 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.474 ' CD1' ' HD2' ' A' ' 121' ' ' ARG . 31.8 t80 -124.47 129.22 50.25 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.707 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -85.15 106.85 16.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.605 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.473 HD21 HG12 ' A' ' 37' ' ' VAL . 1.6 mp -82.1 106.07 13.71 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.467 ' CE2' HG12 ' A' ' 117' ' ' VAL . 56.0 p90 -117.63 161.5 19.55 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.221 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.4 mt -135.05 162.98 30.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.636 -171.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.517 ' HD2' ' O ' ' A' ' 111' ' ' LEU . 6.9 p-80 -93.17 166.85 12.13 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 177.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.517 ' O ' ' HD2' ' A' ' 110' ' ' HIS . 2.1 mm? -68.01 146.83 53.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.701 0.286 . . . . 0.0 111.124 177.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.444 ' HA ' HG22 ' A' ' 22' ' ' VAL . 23.7 tt0 . . . . . 0 CA--C 1.531 0.226 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.888 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 26.7 t . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.431 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.2 OUTLIER -143.62 98.15 3.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.493 ' O ' HD23 ' A' ' 120' ' ' LEU . 55.0 t-80 -119.4 134.62 55.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.755 -176.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.3 mt -123.17 142.17 51.19 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 123.682 0.614 . . . . 0.0 110.558 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.561 ' HD3' ' HB2' ' A' ' 16' ' ' LEU . 17.9 mtp180 -119.41 146.76 45.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 22.0 p -117.46 101.43 8.38 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 165.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.9 mm-40 -97.56 154.52 17.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.461 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -108.66 135.68 49.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.223 0.535 . . . . 0.0 111.906 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.624 ' HB2' HG21 ' A' ' 12' ' ' VAL . 11.0 mt -106.64 120.77 42.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 171.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.4 m -115.36 123.1 47.83 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.964 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -120.26 104.85 10.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.036 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.24 124.87 30.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.063 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 63.25 61.25 1.88 Allowed Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.769 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.7 170.05 5.43 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.788 2.325 . . . . 0.0 111.574 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.3 p -71.43 144.86 49.6 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -56.71 -43.38 80.51 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.473 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.571 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 5.0 p-10 -59.68 -27.98 66.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.671 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.667 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 7.1 t80 -73.12 -41.72 63.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.646 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 34.8 ttm-85 -51.74 -47.35 64.08 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.569 0.699 . . . . 0.0 109.638 172.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.3 ttm180 -58.54 -37.43 75.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.543 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 39.0 mtpt -70.82 -41.32 71.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.838 0.352 . . . . 0.0 110.102 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 36.2 mt -69.12 -33.83 74.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.863 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 57.9 mt -75.22 -37.58 61.03 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.075 0.464 . . . . 0.0 110.606 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.517 ' HZ3' ' ND1' ' A' ' 49' ' ' HIS . 8.9 ttpp -70.22 -28.38 65.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.452 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.74 -0.648 . . . . 0.0 110.376 175.085 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.431 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . . . . . . 0 C--O 1.231 0.093 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.19 172.02 4.58 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 121.783 1.655 . . . . 0.0 112.429 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 120.918 0.39 . . . . 0.0 110.732 178.482 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 120.878 0.37 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 t -113.12 141.24 29.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.0 115.51 18.62 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.897 0.38 . . . . 0.0 110.287 -175.54 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -105.87 177.02 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.951 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.646 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 99.5 mttt -141.59 149.64 41.0 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.4 mt -129.02 143.37 50.85 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.703 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.3 tt0 -102.36 122.61 44.61 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.843 -175.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.666 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -110.84 116.25 30.92 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 175.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.77 179.87 25.24 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.293 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -169.73 150.37 3.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.932 0.396 . . . . 0.0 110.531 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.63 139.7 49.87 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.509 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -129.3 126.65 39.49 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.999 0.428 . . . . 0.0 111.085 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -129.66 151.36 50.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.692 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 32' ' ' THR . 1.3 p -101.7 158.02 4.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.515 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 mtp180 -105.91 142.94 34.76 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -70.51 -14.71 62.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.583 0.706 . . . . 0.0 109.209 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -138.23 103.45 8.02 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.043 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.49 ' HG3' HG22 ' A' ' 32' ' ' THR . 72.7 Cg_exo -47.47 160.1 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.335 2.69 . . . . 0.0 112.764 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.426 HG21 ' HB2' ' A' ' 31' ' ' PHE . 9.9 t -78.85 -177.88 5.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.605 -174.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -41.67 78.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.81 0.338 . . . . 0.0 111.271 -176.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -71.11 -7.95 50.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.9 0.381 . . . . 0.0 111.399 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.3 33.14 26.59 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.617 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.426 ' HB2' HG21 ' A' ' 27' ' ' THR . 15.7 m-30 -95.77 132.3 41.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 22' ' ' VAL . 69.4 p -90.83 -29.68 17.42 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -169.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 79' ' ' SER . 65.4 m80 -112.88 143.85 43.44 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -172.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.515 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -122.15 118.47 28.74 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 172.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.2 p-90 -121.87 151.5 40.6 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.791 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.587 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 50.0 ttp -127.21 119.81 27.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.777 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.521 ' CG2' ' HB ' ' A' ' 76' ' ' VAL . 9.9 m -98.84 154.8 3.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.148 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -155.3 156.14 34.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.703 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.1 m -125.07 127.58 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.784 169.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 mmm-85 -131.76 177.9 7.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.883 0.373 . . . . 0.0 110.912 -175.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.7 162.7 26.72 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.553 177.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 18.4 Cg_endo -57.25 114.11 1.79 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.229 2.619 . . . . 0.0 112.3 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 59.17 57.74 3.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.898 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 71.91 1.33 3.87 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.645 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 77.8 p -63.52 132.07 50.1 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.012 -0.43 . . . . 0.0 109.845 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -75.93 126.04 30.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.528 HG22 ' CZ ' ' A' ' 50' ' ' PHE . 6.1 pt -96.74 -1.22 10.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -171.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -63.24 -8.62 8.73 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -74.24 -36.87 63.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.072 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.528 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 52.3 p90 -114.07 -14.35 12.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.46 175.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.48 HG23 HD11 ' A' ' 47' ' ' ILE . 97.6 t -98.82 122.06 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 122.888 0.475 . . . . 0.0 110.145 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.602 ' CG ' ' HB3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -91.67 -44.31 9.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.194 0.521 . . . . 0.0 110.072 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -158.99 158.68 33.7 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.314 -174.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.522 HG21 HG23 ' A' ' 39' ' ' VAL . 96.6 t -137.21 157.05 34.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.953 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.601 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.8 p -142.18 136.52 29.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.344 0.592 . . . . 0.0 111.497 -175.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.448 ' CD2' HG12 ' A' ' 88' ' ' ILE . 19.8 m-85 -119.22 109.96 16.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -81.63 94.62 6.97 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.396 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.609 ' CD2' HD13 ' A' ' 86' ' ' LEU . 13.3 mt -77.16 -177.34 4.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.748 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.59 144.02 53.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.189 0.519 . . . . 0.0 109.697 -178.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -60.7 -24.24 65.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.004 -169.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.1 t -78.17 -8.67 58.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.614 0.245 . . . . 0.0 111.186 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -85.53 135.22 38.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -62.28 121.52 9.56 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.725 2.283 . . . . 0.0 110.901 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 61.36 72.1 0.71 Allowed Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.024 -173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.88 -20.58 58.12 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.496 2.13 . . . . 0.0 112.296 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.552 ' HE3' ' CG1' ' A' ' 68' ' ' VAL . 24.9 ttpt -93.23 104.46 16.63 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.929 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 7.3 mmm180 -103.79 102.32 12.15 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.259 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.552 ' CG1' ' HE3' ' A' ' 66' ' ' LYS . 2.2 m -99.03 138.29 23.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.8 m -125.06 119.54 28.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -107.13 -23.81 12.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.509 0.671 . . . . 0.0 110.547 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.665 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 3.8 p-10 -74.26 -172.62 0.26 Allowed Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.188 -175.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.665 ' HD2' ' HB2' ' A' ' 71' ' ' ASP . 75.1 Cg_exo -40.85 -170.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 124.181 3.254 . . . . 0.0 114.598 168.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.633 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 7.9 Cg_endo -36.32 122.41 0.29 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.509 2.806 . . . . 0.0 113.842 -155.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.497 ' CB ' HG22 ' A' ' 39' ' ' VAL . 41.0 m-85 -62.55 97.34 0.09 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.01 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 12.4 ptpt -146.37 144.36 29.7 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.461 0.648 . . . . 0.0 112.129 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.1 t -121.89 131.69 72.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.833 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -114.74 114.0 25.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.89 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.31 173.02 12.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.143 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 7.6 t -126.64 144.77 50.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.715 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.09 -171.76 29.73 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -130.06 -8.07 4.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.197 0.498 . . . . 0.0 111.331 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.87 144.32 28.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.927 0.394 . . . . 0.0 111.235 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -82.99 173.97 52.52 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.029 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -172.67 158.58 4.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.732 0.413 . . . . 0.0 110.041 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.431 HD12 HG21 ' A' ' 85' ' ' ILE . 16.1 mm -65.49 124.56 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.21 171.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.609 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -117.61 105.3 48.26 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.886 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.65 118.49 5.71 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 123.109 2.54 . . . . 0.0 112.652 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.448 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.2 mt -108.1 126.09 64.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.369 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.601 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 43.6 mt-10 -109.52 123.57 49.62 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.088 0.471 . . . . 0.0 110.081 176.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.499 HG13 ' CE1' ' A' ' 92' ' ' PHE . 75.6 t -103.33 125.22 57.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.715 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.548 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 76.8 m-85 -96.39 132.11 42.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.84 -177.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.499 ' CE1' HG13 ' A' ' 90' ' ' VAL . 19.9 m-85 -110.62 165.07 12.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.835 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.602 ' HB3' ' CG ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -116.05 95.31 5.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.208 0.528 . . . . 0.0 111.863 -178.068 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.61 ' OD1' ' HB2' ' A' ' 96' ' ' GLU . 9.1 t-20 -157.91 177.49 11.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.272 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.49 -0.83 15.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.917 0.865 . . . . 0.0 110.811 178.206 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.61 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -96.47 -152.93 0.39 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.508 -173.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.425 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 20.8 mm-40 -31.33 150.94 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -37.09 120.1 0.28 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 124.911 3.741 . . . . 0.0 114.013 -168.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.41 ' N ' ' HD3' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -87.72 20.31 3.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.889 -175.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.43 138.86 26.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.312 0.577 . . . . 0.0 110.574 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.3 m -122.38 155.25 27.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -129.24 106.07 8.58 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.192 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.666 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.3 m-85 -102.38 111.63 24.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.028 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -76.23 117.62 18.11 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -127.58 142.03 51.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.256 -175.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -92.05 118.48 30.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.064 -175.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.478 HD21 ' CG1' ' A' ' 37' ' ' VAL . 2.0 mp -97.09 96.22 8.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 175.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -105.08 156.44 18.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.984 0.421 . . . . 0.0 111.28 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 mt -132.44 152.86 51.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -101.53 174.21 6.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.382 0.537 . . . . 0.0 110.374 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.476 HD21 ' HA ' ' B' ' 215' ' ' ALA . 3.4 mm? -66.07 158.47 28.36 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -172.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 . . . . . 0 N--CA 1.477 0.899 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.093 -177.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 20' ' ' ALA . 43.5 t . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.694 0.283 . . . . 0.0 111.453 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -145.04 97.23 2.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.419 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.0 t-80 -123.65 134.14 53.81 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.104 -0.239 . . . . 0.0 111.23 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 119' ' ' HIS . 7.1 mt -117.03 153.74 32.17 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.757 0.661 . . . . 0.0 110.108 175.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 19.9 ttm180 -142.24 147.86 37.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 173.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 81.1 m -130.81 118.85 21.41 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 6.2 mt-10 -112.93 136.57 52.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.29 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -91.41 134.92 34.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.457 0.646 . . . . 0.0 111.639 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.654 ' HB2' HG21 ' A' ' 12' ' ' VAL . 5.5 mt -104.67 113.91 27.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.777 173.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.9 m -103.52 123.85 47.68 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.132 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -120.75 105.28 10.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.458 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.32 119.9 23.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.131 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 54.24 64.37 6.42 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.871 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.05 177.89 7.8 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.3 2.0 . . . . 0.0 111.297 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.406 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 5.6 p -76.86 141.99 40.39 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -56.49 -43.1 79.34 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.298 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 8.0 p-10 -59.65 -29.5 68.08 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.564 -0.161 . . . . 0.0 110.564 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.649 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 14.6 t80 -74.7 -40.84 61.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.591 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 43.8 ttm105 -56.02 -44.91 79.15 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.682 174.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -57.4 -37.0 72.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.019 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 44.3 mtpt -72.13 -38.96 69.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.702 0.287 . . . . 0.0 110.682 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.3 mt -69.84 -30.98 68.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.578 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 33.0 mt -82.84 -31.13 28.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.918 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -73.61 -31.13 63.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.02 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.198 176.909 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.476 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . . . . . . 0 C--O 1.236 0.372 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.87 165.53 3.67 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.528 1.485 . . . . 0.0 112.138 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 22.4 ttm180 . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 121.167 0.508 . . . . 0.0 111.41 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 121.037 0.446 . . . . 0.0 111.443 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.3 142.98 19.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -122.46 131.78 54.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.919 0.39 . . . . 0.0 110.203 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.663 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -114.79 165.77 9.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.622 176.385 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.592 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . 97.2 mttt -135.31 127.35 29.73 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.659 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.4 mt -113.19 142.66 45.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.196 0.522 . . . . 0.0 110.248 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.9 tt0 -104.49 126.08 51.25 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.758 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.645 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -112.43 113.71 26.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -145.64 176.64 24.52 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 119.699 -1.239 . . . . 0.0 111.756 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -166.29 156.03 11.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.993 0.425 . . . . 0.0 110.622 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 62.4 mtt180 -117.17 139.47 50.72 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 172.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.06 123.53 30.7 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.599 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -117.76 144.19 45.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.777 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' A' ' 112' ' ' GLU . 2.6 p -104.3 152.97 6.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 170.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.559 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -108.52 139.99 42.48 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -65.73 -20.51 66.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.606 0.717 . . . . 0.0 109.229 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -131.36 101.36 16.12 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.974 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.476 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.7 Cg_exo -48.63 158.7 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.52 2.813 . . . . 0.0 113.172 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.1 t -80.15 -173.04 3.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.211 -172.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -58.33 -36.98 60.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.0 0.52 . . . . 0.0 111.836 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -83.14 -1.34 52.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 110.704 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 34.09 37.87 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.962 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -98.16 134.95 40.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.476 HG22 ' HG3' ' A' ' 26' ' ' PRO . 25.6 p -88.4 -27.22 21.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.111 -171.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 109' ' ' LEU . 64.5 m80 -115.69 145.19 42.97 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -171.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.559 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 5.8 m-20 -123.23 125.63 45.44 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -128.28 149.85 50.31 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.097 0.475 . . . . 0.0 111.002 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.695 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 45.2 ttp -128.16 122.37 31.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.354 174.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 6.2 m -101.42 153.96 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.327 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -153.36 153.74 33.15 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.199 -0.6 . . . . 0.0 112.553 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 10.6 m -124.79 130.83 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.044 171.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.453 ' HB2' ' HB3' ' A' ' 15' ' ' GLU . 2.7 mmt85 -129.5 -177.09 4.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.958 0.408 . . . . 0.0 111.381 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.0 -164.17 36.37 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.229 174.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 2.7 Cg_exo -72.86 111.88 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.617 2.212 . . . . 0.0 111.369 177.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 57.18 56.52 5.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.578 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.1 m80 67.51 5.22 4.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.82 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.431 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 70.8 m -64.93 129.3 39.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.439 ' OD1' ' HB2' ' A' ' 48' ' ' GLN . 8.4 t-20 -59.96 127.08 30.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.595 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.603 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.5 pt -96.72 -3.89 10.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.439 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 1.5 mp0 -60.14 -6.27 1.36 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -73.0 -37.88 66.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.939 177.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.552 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -118.24 -21.09 8.31 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.353 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.603 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 96.6 t -87.06 130.52 36.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -99.64 -54.78 2.83 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.21 0.529 . . . . 0.0 110.526 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.89 142.14 16.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.177 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.499 HG11 HG23 ' A' ' 39' ' ' VAL . 90.2 t -117.55 160.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.937 -175.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.576 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.8 p -144.16 135.52 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.165 0.507 . . . . 0.0 111.145 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.493 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 30.9 m-85 -118.15 109.91 16.97 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -83.26 92.89 7.58 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.833 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.549 ' CD2' HD13 ' A' ' 86' ' ' LEU . 9.8 mt -71.51 -177.39 1.83 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.457 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 79.1 t60 -76.15 142.81 41.48 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.808 -0.757 . . . . 0.0 108.999 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.417 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 1.8 mp0 -54.52 -20.67 8.25 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.028 -171.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t -82.97 -5.87 59.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.672 0.272 . . . . 0.0 111.026 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 62.0 m-85 -82.35 148.46 59.28 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.88 117.91 5.23 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.613 2.209 . . . . 0.0 110.917 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 52.56 73.52 0.93 Allowed Pre-proline 0 C--O 1.226 -0.15 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.076 -174.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.46 -20.55 64.27 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.892 2.394 . . . . 0.0 113.56 -174.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -90.29 105.53 17.87 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.207 0.527 . . . . 0.0 110.457 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -106.73 89.26 2.96 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.281 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -71.6 139.64 19.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.149 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.4 m -126.91 114.26 17.63 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 175.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -107.35 -28.11 10.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.993 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.491 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 30.1 t70 -75.93 164.97 56.91 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.724 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.582 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 24.2 Cg_exo -28.72 178.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.534 1 C-N-CA 125.65 4.233 . . . . 0.0 115.111 168.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.582 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 4.5 Cg_exo -22.51 115.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 124.384 3.389 . . . . 0.0 115.036 -149.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.45 ' CB ' HG22 ' A' ' 39' ' ' VAL . 36.3 m-85 -60.89 107.86 0.77 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.603 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.695 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.4 ptpt -152.28 153.79 34.43 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.0 111.55 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 36' ' ' MET . 71.4 t -131.13 133.09 63.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.858 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -115.98 115.71 26.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.125 0.266 . . . . 0.0 110.407 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.77 172.09 13.16 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.274 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.6 t -120.89 146.87 46.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.78 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.41 -162.49 14.34 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.287 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -141.53 -18.34 0.78 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.8 134.7 37.29 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.567 -175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.484 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -75.54 169.27 54.75 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.378 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -168.48 154.97 7.22 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.403 HD11 ' HA ' ' A' ' 85' ' ' ILE . 23.4 mm -65.6 122.55 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.549 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.6 tt -113.6 104.95 55.27 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.548 -178.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.1 108.02 1.25 Allowed 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 123.197 2.598 . . . . 0.0 111.881 173.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -98.79 124.86 52.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.676 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.576 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 72.8 mt-10 -113.67 119.91 39.06 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.419 0.628 . . . . 0.0 110.075 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.458 HG13 ' CE1' ' A' ' 92' ' ' PHE . 60.7 t -102.98 123.34 56.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.432 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -99.25 155.45 17.49 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.86 0.838 . . . . 0.0 111.138 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.458 ' CE1' HG13 ' A' ' 90' ' ' VAL . 22.6 m-85 -125.67 156.9 38.55 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.998 -176.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.09 92.02 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.237 0.541 . . . . 0.0 111.346 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -158.42 -178.19 7.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.678 172.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.593 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -114.38 6.09 15.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.652 0.263 . . . . 0.0 111.383 -177.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -102.07 -152.76 0.45 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.851 -168.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.61 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 13.4 mm-40 -31.56 159.63 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.98 1.312 . . . . 0.0 113.317 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.61 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.4 Cg_exo -28.63 125.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 124.716 3.611 . . . . 0.0 114.19 -162.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -72.59 -1.76 17.31 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.226 -170.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -155.56 171.23 20.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.484 0.659 . . . . 0.0 111.012 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.5 m -133.11 154.55 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.207 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -123.03 117.02 24.5 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.019 0.438 . . . . 0.0 111.07 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.4 m-85 -108.76 116.99 33.03 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.741 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -81.58 109.99 16.54 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.435 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 68.5 t80 -122.35 137.17 54.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.725 -174.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 108' ' ' PHE . 30.6 t70 -86.95 110.64 20.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 37' ' ' VAL . 1.7 mp -83.61 91.41 7.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.479 ' CE2' HG12 ' A' ' 117' ' ' VAL . 15.6 p90 -98.59 154.72 17.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.105 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 22.8 mt -133.3 137.89 46.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -176.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.513 ' HD1' HG22 ' A' ' 117' ' ' VAL . 2.6 p-80 -67.86 172.12 5.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 173.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.1 155.56 32.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.565 0.698 . . . . 0.0 111.338 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.487 ' HA ' HG22 ' A' ' 22' ' ' VAL . 15.2 tt0 . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.22 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 48.6 t . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.91 96.69 3.01 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -115.67 136.0 53.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.731 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.5 mt -117.57 151.07 37.91 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.776 0.672 . . . . 0.0 110.295 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 18.0 ttm180 -140.36 148.01 40.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.592 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 42.4 t -132.51 125.86 31.58 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -121.61 134.01 55.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.715 -177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.71 129.43 35.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.198 0.523 . . . . 0.0 111.652 -175.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.663 ' HB2' HG21 ' A' ' 12' ' ' VAL . 6.4 mt -95.1 131.54 40.98 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.9 m -122.91 122.71 39.26 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.014 -0.674 . . . . 0.0 110.82 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -118.11 105.7 12.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.515 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.26 119.78 23.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.436 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.86 64.36 4.0 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.07 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -83.5 170.24 11.82 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.506 2.137 . . . . 0.0 111.155 172.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.7 p -70.24 142.81 52.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -57.0 -41.43 78.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.611 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -56.09 -33.03 64.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.79 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.688 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.8 t80 -75.41 -40.48 57.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.626 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.7 ttm180 -55.3 -45.89 76.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -53.05 -42.19 65.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.251 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 45.6 mtpt -71.68 -38.96 70.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 41.5 mt -68.11 -31.55 71.23 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.911 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 56.0 mt -80.52 -28.95 37.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.966 0.413 . . . . 0.0 110.917 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -78.72 -27.39 44.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.589 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.981 174.492 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.236 0.377 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 7.5 Cg_endo -50.94 168.71 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.285 2.657 . . . . 0.0 112.974 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . 0.484 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 8.7 tpp180 . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.8 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 120.998 0.428 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.1 t -99.92 139.06 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.556 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 1.7 mp0 -125.09 119.67 29.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.271 0.558 . . . . 0.0 110.366 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.633 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.45 164.4 4.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.767 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 42' ' ' PRO . 92.1 mttt -132.92 125.93 30.97 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.373 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.8 mt -115.48 142.38 46.78 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.276 0.56 . . . . 0.0 110.372 177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 7.0 tt0 -109.07 128.5 55.03 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.014 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.443 ' O ' ' HB3' ' A' ' 121' ' ' ARG . 1.6 mm? -109.14 122.19 46.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.474 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -143.5 170.59 25.53 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.649 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -165.42 152.53 10.5 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.745 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.673 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 62.6 mtp180 -117.48 140.7 49.26 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.979 171.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.407 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -135.98 123.83 22.62 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.572 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 14.3 tt0 -121.4 144.76 48.49 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.556 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.524 HG22 ' HA ' ' A' ' 112' ' ' GLU . 9.8 p -99.03 153.49 4.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -105.03 152.06 23.2 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.261 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.9 mmtm -68.2 -20.82 64.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.396 0.617 . . . . 0.0 109.737 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -140.79 111.09 6.75 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.646 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.495 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.2 Cg_exo -47.81 155.27 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.176 2.584 . . . . 0.0 112.423 173.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.487 HG21 ' HB2' ' A' ' 31' ' ' PHE . 9.1 t -75.11 -169.7 0.99 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.865 -172.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 m -61.81 -24.61 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -107.05 11.36 29.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.324 1.059 . . . . 0.0 109.327 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.74 33.1 47.9 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.538 172.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.487 ' HB2' HG21 ' A' ' 27' ' ' THR . 19.4 m-30 -90.38 127.93 36.33 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.495 HG22 ' HG3' ' A' ' 26' ' ' PRO . 60.3 p -85.48 -29.87 23.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.34 -169.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.427 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.8 m80 -118.87 144.43 46.39 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -172.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -115.41 119.94 37.92 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 171.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -122.78 150.86 42.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.212 0.529 . . . . 0.0 111.031 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.709 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 50.4 ttp -129.11 116.48 19.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.428 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.2 m -99.14 149.77 5.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.299 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.638 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.6 OUTLIER -151.61 156.26 40.09 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.263 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.1 m -123.73 135.22 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.899 169.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -134.95 175.78 9.26 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.002 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.14 -178.61 44.46 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.14 173.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HB3' ' HB2' ' A' ' 13' ' ' LYS . 37.4 Cg_endo -76.63 111.87 3.34 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.147 1.898 . . . . 0.0 112.458 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 57.7 67.12 1.0 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.882 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.6 m80 72.87 -7.27 1.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.0 m -67.49 126.71 30.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.373 0.13 . . . . 0.0 110.848 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -69.03 126.68 30.57 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.571 HG22 ' CZ ' ' A' ' 50' ' ' PHE . 1.1 pt -94.87 -3.74 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.763 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -63.36 -1.28 1.07 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.22 -0.446 . . . . 0.0 112.201 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -79.16 -33.6 43.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.571 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 54.0 p90 -117.65 -18.15 9.75 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.565 175.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 84.0 t -91.4 130.87 39.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.747 0.308 . . . . 0.0 110.369 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.443 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 7.8 tp10 -102.39 -63.36 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.144 0.497 . . . . 0.0 110.506 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -131.12 162.07 30.71 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 95.0 t -133.72 155.78 40.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 169.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.4 p -141.75 134.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.529 0.68 . . . . 0.0 111.402 -174.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.417 ' CD2' HG12 ' A' ' 88' ' ' ILE . 22.3 m-85 -115.88 107.27 14.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.131 -0.941 . . . . 0.0 108.646 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -79.44 90.74 5.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.229 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.408 HD12 HG12 ' A' ' 76' ' ' VAL . 19.9 mt -78.2 -176.85 4.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.888 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.79 143.96 43.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.15 -21.54 63.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.091 -175.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t -69.13 -17.04 63.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.888 0.375 . . . . 0.0 110.548 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -85.13 139.53 36.69 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.85 117.55 4.29 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.277 1.985 . . . . 0.0 111.271 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 57.37 80.19 0.3 Allowed Pre-proline 0 C--O 1.225 -0.231 0 O-C-N 123.672 0.607 . . . . 0.0 110.505 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.15 -20.79 48.12 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.884 2.389 . . . . 0.0 113.465 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -97.45 108.68 21.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.942 0.401 . . . . 0.0 110.915 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 19.7 mmt85 -111.38 104.87 13.36 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.017 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 5.4 m -90.63 135.92 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 169.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.0 m -112.87 116.46 30.06 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -101.38 -28.58 12.51 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.545 0.688 . . . . 0.0 110.245 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.558 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 3.1 m-20 -75.52 -177.17 0.66 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.927 -175.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.619 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 13.3 Cg_exo -45.0 -168.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.963 3.109 . . . . 0.0 113.936 165.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 2.6 Cg_endo -28.52 114.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.512 2.808 . . . . 0.0 114.563 -152.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.638 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 50.8 m-85 -62.17 96.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.287 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.709 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 17.3 ptpt -143.2 148.77 37.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.491 0.662 . . . . 0.0 112.727 -177.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 36' ' ' MET . 79.3 t -123.66 133.26 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.416 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -117.55 103.21 9.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -136.27 169.7 17.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.741 0.305 . . . . 0.0 110.765 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 8.3 t -123.69 144.91 49.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.173 -176.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.23 -174.13 27.54 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -130.38 2.14 4.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.298 0.549 . . . . 0.0 112.016 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -160.17 130.91 5.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.744 0.307 . . . . 0.0 110.77 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -71.33 173.96 42.28 Favored Glycine 0 C--O 1.237 0.326 0 CA-C-N 115.604 -0.726 . . . . 0.0 113.381 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -173.1 157.09 3.39 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.87 0.468 . . . . 0.0 110.218 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' A' ' 106' ' ' ASP . 12.9 mm -62.66 124.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.204 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.412 HD23 HG13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -108.66 106.2 58.3 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.98 112.7 3.47 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.807 2.338 . . . . 0.0 111.671 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.417 HG12 ' CD2' ' A' ' 56' ' ' PHE . 5.3 mt -108.15 125.74 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.633 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.585 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.2 mt-10 -107.93 122.12 46.17 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.388 0.613 . . . . 0.0 110.327 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.8 t -101.11 116.63 45.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.285 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -88.74 139.3 30.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.815 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.1 m-85 -113.21 146.24 39.63 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.923 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.443 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -89.75 94.4 9.82 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -156.32 156.35 33.82 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.754 -170.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -107.8 -7.78 16.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.345 1.069 . . . . 0.0 109.515 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.15 -151.22 0.4 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.516 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 8.0 mm-40 -27.07 154.52 0.01 OUTLIER Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 4.2 Cg_exo -31.29 126.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.214 1 C-N-CA 125.529 4.153 . . . . 0.0 115.133 -168.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.85 14.46 11.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.932 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -161.91 142.76 10.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.349 0.595 . . . . 0.0 111.224 -176.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -129.23 156.48 41.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -128.77 107.55 9.75 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.466 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.402 ' CD2' HD22 ' A' ' 16' ' ' LEU . 20.5 m-85 -100.27 137.89 38.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -94.73 122.51 37.41 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.377 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -133.26 130.76 39.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.324 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.459 ' HA ' HD11 ' A' ' 85' ' ' ILE . 17.4 t70 -84.47 107.0 16.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -175.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.47 HD21 HG12 ' A' ' 37' ' ' VAL . 1.5 mp -85.07 103.46 14.1 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.425 ' HB3' ' NH2' ' B' ' 217' ' ' ARG . 50.4 p90 -118.48 157.13 27.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.004 0.43 . . . . 0.0 110.352 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 mt -127.7 162.45 26.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.476 ' C ' ' HB3' ' B' ' 215' ' ' ALA . 36.0 m170 -94.62 164.07 13.12 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' B' ' 215' ' ' ALA . 1.3 mm? -51.99 147.07 7.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.958 0.409 . . . . 0.0 111.896 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.524 ' HA ' HG22 ' A' ' 22' ' ' VAL . 29.2 tt0 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.846 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 9.2 t . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 120.554 0.216 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.417 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.2 OUTLIER -118.23 100.99 7.87 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -127.47 127.67 44.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.215 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.4 mt -107.38 150.78 26.35 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.494 174.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.622 ' HD3' ' N ' ' A' ' 122' ' ' CYS . 0.0 OUTLIER -148.14 140.44 24.27 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -174.387 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.622 ' N ' ' HD3' ' A' ' 121' ' ' ARG . 49.7 t -131.57 130.23 41.97 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.829 -175.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -121.48 141.12 51.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.089 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -104.47 132.16 51.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.174 0.512 . . . . 0.0 111.37 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.633 ' HB2' HG21 ' A' ' 12' ' ' VAL . 6.9 mt -99.36 116.11 30.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.169 175.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 35.4 m -112.14 115.2 28.47 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.557 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -114.53 109.45 18.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.901 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.71 120.35 24.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.901 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 58.04 63.59 4.35 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.654 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -85.14 165.65 11.2 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.835 2.356 . . . . 0.0 111.496 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.4 p -67.47 145.08 55.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 175.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.12 -43.76 70.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.71 -30.77 69.03 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.746 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.686 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 11.0 t80 -76.01 -39.84 54.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.618 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 29.1 ttm180 -55.12 -46.03 75.56 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 121.236 0.541 . . . . 0.0 109.583 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -51.21 -44.01 61.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.495 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -71.75 -39.91 69.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.6 mt -69.3 -29.57 67.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.857 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 40.5 mt -80.31 -41.17 25.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.047 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -68.28 -30.19 69.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.337 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.583 176.964 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . 0.522 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.237 0.433 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . 0.522 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 0.1 OUTLIER -34.59 152.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.263 3.309 . . . . 0.0 114.749 168.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . 0.425 ' NH2' ' HB3' ' A' ' 108' ' ' PHE . 17.1 ttm180 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.024 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 120.923 0.392 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.9 t -101.87 137.25 30.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.442 ' HB3' ' HD3' ' A' ' 124' ' ' LYS . 3.5 mt-30 -117.2 120.53 38.54 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.037 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.49 167.84 3.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.711 175.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.628 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 43.7 mtpt -133.39 139.68 46.92 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.8 mt -126.99 151.9 47.95 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.683 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 41.1 tt0 -114.26 120.82 41.73 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.314 -174.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.626 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.1 mm? -108.67 115.32 29.87 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -144.88 169.64 26.6 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.011 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -163.11 155.78 18.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.164 0.507 . . . . 0.0 110.917 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 20.8 mtp180 -118.93 153.44 34.59 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.677 175.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.434 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -149.44 128.17 12.48 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.804 175.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -129.23 164.1 24.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 32' ' ' THR . 1.8 p -103.44 163.47 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.2 mtp180 -112.51 135.13 53.59 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.61 -11.38 58.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.495 0.664 . . . . 0.0 110.457 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -135.9 103.29 9.97 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.833 170.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.455 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.2 Cg_exo -47.06 155.29 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.183 2.589 . . . . 0.0 112.211 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 t -76.71 -172.32 2.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -171.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 m -61.97 -30.43 48.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.495 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.83 -7.3 59.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.181 0.515 . . . . 0.0 110.38 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.65 32.42 33.7 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.206 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -98.54 138.49 35.67 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.598 ' O ' HG23 ' A' ' 22' ' ' VAL . 26.5 p -86.77 -30.33 21.66 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -169.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.9 m80 -112.55 146.15 39.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -170.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -117.47 118.97 33.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -121.95 148.11 45.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.009 0.433 . . . . 0.0 111.111 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.639 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 41.1 ttp -125.75 122.04 35.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.526 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.9 m -103.23 153.05 5.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.072 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -154.26 154.52 33.57 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -126.71 129.5 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.844 169.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -134.91 -178.5 5.11 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.887 0.375 . . . . 0.0 111.067 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.37 166.85 29.68 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.628 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 41.0 Cg_endo -62.31 111.73 1.37 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 123.199 2.599 . . . . 0.0 112.727 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 58.02 67.84 0.91 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.784 172.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 75.47 -12.07 1.02 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.979 0.512 . . . . 0.0 112.353 172.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.1 m -62.37 122.94 16.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.799 0.333 . . . . 0.0 111.081 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.59 125.22 26.07 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.104 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.557 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 2.4 pt -96.07 -1.87 10.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.479 ' NE2' ' HH ' ' A' ' 74' ' ' TYR . 5.9 tp60 -56.35 -16.45 5.64 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.942 0.401 . . . . 0.0 111.394 -176.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -73.42 -43.85 59.56 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.617 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.497 ' CE2' HG22 ' A' ' 47' ' ' ILE . 49.5 p90 -106.07 -20.02 13.54 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.865 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.557 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 76.3 t -91.53 131.33 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.208 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.569 ' HA ' ' HZ3' ' A' ' 93' ' ' LYS . 26.2 tt0 -103.46 -62.72 1.26 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.693 0.759 . . . . 0.0 110.327 -173.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 45.2 mtpt -131.73 161.16 33.5 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.578 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 93.2 t -134.8 153.5 34.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.561 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.3 p -139.36 132.71 37.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.635 0.731 . . . . 0.0 111.157 -175.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.43 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 27.0 m-85 -113.28 105.45 13.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.51 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -79.04 94.26 5.27 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.468 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.568 ' CD2' HD13 ' A' ' 86' ' ' LEU . 11.3 mt -73.34 179.74 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.04 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.501 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 22.9 t60 -81.98 146.96 29.46 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -57.24 -21.68 35.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.669 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 t -64.71 -22.48 66.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.095 0.474 . . . . 0.0 110.581 174.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -90.48 129.12 46.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.567 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.65 138.31 44.99 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.152 1.901 . . . . 0.0 110.699 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 58.45 67.32 2.18 Favored Pre-proline 0 C--O 1.223 -0.302 0 O-C-N 123.447 0.467 . . . . 0.0 109.983 -174.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.91 -22.01 56.47 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.689 2.259 . . . . 0.0 113.79 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -93.92 109.97 21.66 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.061 0.458 . . . . 0.0 110.44 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 21.8 mmt85 -113.05 100.97 9.02 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.771 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.5 m -92.74 138.17 20.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 171.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.445 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 25.9 t -118.53 111.53 18.73 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -92.59 -26.93 17.65 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.926 0.869 . . . . 0.0 109.261 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.579 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -84.58 179.68 1.81 Allowed Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.946 -171.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 22.8 Cg_exo -28.28 -179.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.535 1 C-N-CA 126.125 4.55 . . . . 0.0 115.896 163.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.6 Cg_endo -29.24 115.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 124.318 3.345 . . . . 0.0 115.04 -153.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.503 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 42.3 m-85 -62.7 98.19 0.12 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.153 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.639 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.1 ptpt -145.27 151.26 38.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.275 0.559 . . . . 0.0 111.905 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 36' ' ' MET . 73.7 t -128.12 131.65 69.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.431 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.48 108.16 14.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.926 0.393 . . . . 0.0 110.009 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.34 174.01 10.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.424 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 8.1 t -122.99 146.89 47.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.217 -176.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.74 -168.24 27.61 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.221 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -138.31 -10.7 1.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.76 123.16 9.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.153 0.501 . . . . 0.0 110.938 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.71 175.03 13.17 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.001 -1.0 . . . . 0.0 114.471 -177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.501 ' CE2' ' HB2' ' A' ' 59' ' ' HIS . 21.8 p90 -174.24 155.59 2.43 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.218 -0.491 . . . . 0.0 110.288 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.8 mm -63.58 128.32 25.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.369 171.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.8 tt -120.03 105.84 41.99 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 121.025 0.44 . . . . 0.0 110.123 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.74 113.48 2.99 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 123.322 2.681 . . . . 0.0 112.327 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 mt -103.76 124.36 58.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.337 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.3 mt-10 -107.93 127.47 53.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.117 0.485 . . . . 0.0 110.289 175.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.0 t -107.3 120.8 59.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.741 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 86.7 m-85 -90.77 145.48 24.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.386 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.428 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 19.8 m-85 -126.04 161.42 27.61 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.933 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.569 ' HZ3' ' HA ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -101.6 94.22 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 117.986 0.357 . . . . 0.0 110.615 177.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -158.54 175.41 13.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.964 170.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.37 6.24 15.98 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 29.1 mm-40 -98.6 -153.08 0.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -176.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.418 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 41.9 mm-40 -30.85 150.17 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.963 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 175.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -37.57 120.8 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.677 3.585 . . . . 0.0 113.777 -169.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.443 ' N ' ' HD3' ' A' ' 99' ' ' ARG . 0.3 OUTLIER -89.77 20.34 4.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.871 -175.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -143.24 137.77 29.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.176 0.513 . . . . 0.0 110.16 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.32 155.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -125.41 117.35 23.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.118 0.485 . . . . 0.0 111.08 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.626 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.2 m-85 -108.1 119.6 39.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.966 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -80.91 105.82 12.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.35 0.595 . . . . 0.0 109.905 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -118.18 133.84 55.54 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.371 -175.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -87.55 111.82 21.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.039 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.478 HD21 HG12 ' A' ' 37' ' ' VAL . 1.9 mp -88.76 101.54 14.11 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -113.21 155.33 25.23 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.515 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.7 mt -128.52 155.09 45.42 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -100.23 162.13 13.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 118.36 0.527 . . . . 0.0 110.175 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -52.12 141.61 18.16 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 C--O 1.231 0.085 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.446 176.972 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 44.1 t . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.947 0.403 . . . . 0.0 111.97 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.4 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.88 96.51 2.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -122.27 134.09 54.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.215 -174.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 mt -117.78 153.9 32.66 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.452 0.47 . . . . 0.0 111.205 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.462 ' HG2' ' N ' ' A' ' 122' ' ' CYS . 20.8 ttm180 -145.17 151.14 37.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . 0.462 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 48.9 t -136.37 122.23 19.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -120.32 142.14 49.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.673 0.273 . . . . 0.0 111.089 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.442 ' HD3' ' HB3' ' A' ' 11' ' ' GLN . 22.1 ttmt -92.22 138.69 31.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.202 0.525 . . . . 0.0 111.641 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.654 ' HB2' HG21 ' A' ' 12' ' ' VAL . 5.9 mt -105.49 118.76 37.38 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.0 m -111.95 123.09 49.51 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.151 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -118.97 110.0 16.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.881 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -81.66 128.12 33.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.507 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 49.89 60.66 14.94 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.422 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.29 173.6 9.7 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.521 2.147 . . . . 0.0 111.626 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 p -67.58 136.92 55.23 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 174.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -56.5 -34.14 66.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.566 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.528 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 9.3 m-20 -62.76 -32.56 73.73 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.674 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.4 t80 -76.53 -40.45 49.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.555 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 50.3 ttp180 -55.75 -41.66 74.27 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -58.09 -36.3 72.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.06 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 37.8 mtpt -72.3 -40.38 67.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.89 0.376 . . . . 0.0 110.246 176.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 26.0 mt -71.15 -25.34 62.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.948 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 30.4 mt -89.8 -23.61 21.67 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.834 0.35 . . . . 0.0 110.783 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.413 ' HZ2' ' CB ' ' A' ' 140' ' ' LYS . 0.9 OUTLIER -81.02 -23.96 38.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.876 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.265 176.145 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.307 0 N-CA-C 110.727 -0.101 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.54 171.18 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.444 2.096 . . . . 0.0 112.602 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 30.6 mtp85 . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 177.652 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.065 0.46 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 t -101.7 139.75 22.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 5.2 mp0 -127.38 131.41 50.35 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -176.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.646 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -116.12 171.05 5.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.947 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -133.4 131.66 40.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.775 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.05 144.18 43.06 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.735 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 36.7 tt0 -109.68 123.26 49.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.036 -175.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.592 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.0 mm? -106.53 110.21 22.35 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -136.78 170.22 23.53 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.433 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -164.95 151.8 10.72 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.149 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.0 mtp180 -113.54 145.62 40.95 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.524 173.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.92 118.77 15.16 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.92 175.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -111.62 154.04 25.46 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 32' ' ' THR . 3.1 p -103.88 161.91 4.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.533 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 3.7 mtp180 -112.19 141.01 46.4 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -68.18 -20.26 64.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.571 0.7 . . . . 0.0 109.143 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -131.1 104.24 15.23 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.365 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.493 ' HG3' HG22 ' A' ' 32' ' ' THR . 88.3 Cg_exo -47.63 154.42 1.82 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.27 2.647 . . . . 0.0 112.988 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 31' ' ' PHE . 9.0 t -73.96 -170.65 0.95 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.077 -171.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 m -54.1 -33.48 24.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -104.24 5.96 35.14 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.162 0.982 . . . . 0.0 109.447 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.7 25.45 20.44 Favored Glycine 0 CA--C 1.503 -0.717 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.151 169.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.49 ' HB2' HG21 ' A' ' 27' ' ' THR . 21.9 m-30 -94.36 140.32 29.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.873 0.845 . . . . 0.0 111.11 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 22' ' ' VAL . 44.8 p -94.41 -23.85 17.59 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.857 -162.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.468 ' O ' ' HA ' ' A' ' 79' ' ' SER . 69.9 m80 -118.22 146.55 44.17 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -170.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.533 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 4.0 m-20 -126.98 123.73 37.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.483 170.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 54.1 p-90 -125.15 153.39 43.11 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.921 -175.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.672 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 44.8 ttp -129.61 120.65 25.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.273 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.9 m -100.46 151.19 5.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -151.69 152.74 33.19 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.735 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.5 m -124.35 127.65 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.19 171.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -127.18 -179.48 4.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.021 0.439 . . . . 0.0 111.22 -176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.68 -173.13 38.03 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.042 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -65.18 110.33 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.039 1.826 . . . . 0.0 111.753 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 51.09 65.31 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.325 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 75.4 t60 76.59 -10.39 1.33 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 171.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.6 m -60.24 127.09 30.07 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -66.04 126.6 29.12 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 120.863 0.363 . . . . 0.0 110.336 -178.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.612 HG22 ' CZ ' ' A' ' 50' ' ' PHE . 1.1 pt -94.97 -4.05 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.76 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -65.78 0.59 1.67 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.866 0.365 . . . . 0.0 111.866 -176.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -76.86 -36.01 57.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.467 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.612 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 55.3 p90 -116.91 -17.15 10.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.52 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 98.1 t -91.35 130.32 40.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.86 0.362 . . . . 0.0 110.259 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.428 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 9.6 tp10 -99.38 -62.49 1.23 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.263 0.554 . . . . 0.0 110.169 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 43.1 mtpt -132.26 163.69 28.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 39' ' ' VAL . 94.4 t -134.52 157.38 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 168.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.2 p -142.03 128.97 19.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.62 0.724 . . . . 0.0 111.166 -175.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.437 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 25.8 m-85 -110.86 104.57 13.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.581 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -78.31 92.5 4.53 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.815 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.617 ' CD2' HD13 ' A' ' 86' ' ' LEU . 12.5 mt -71.81 -178.67 2.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.89 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -76.18 142.08 41.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.17 -17.2 39.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -61.31 -28.54 69.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.36 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -82.09 131.82 55.41 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.088 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.93 124.74 15.05 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.183 1.922 . . . . 0.0 110.931 171.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 60.7 70.28 0.99 Allowed Pre-proline 0 N--CA 1.466 0.362 0 O-C-N 123.578 0.549 . . . . 0.0 110.406 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.75 -23.6 35.62 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.666 2.244 . . . . 0.0 113.781 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -90.45 105.25 17.69 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.309 0.576 . . . . 0.0 110.333 -174.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -105.54 86.92 2.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.078 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.3 m -69.27 138.22 22.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.211 0.529 . . . . 0.0 110.066 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.75 103.19 7.96 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -94.84 -23.73 17.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.054 0.931 . . . . 0.0 109.307 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.608 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 4.1 t70 -75.8 173.49 7.06 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.826 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.646 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.3 Cg_exo -32.91 -175.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.675 1 C-N-CA 125.457 4.105 . . . . 0.0 114.732 163.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.646 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.9 Cg_endo -28.01 115.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 124.299 3.332 . . . . 0.0 114.508 -158.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 42.7 m-85 -61.49 107.13 0.74 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.009 -175.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.672 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 17.3 ptpt -152.13 150.46 29.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.379 0.609 . . . . 0.0 112.066 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.5 t -128.57 132.55 67.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.629 177.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -121.11 106.31 11.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.455 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.29 169.14 18.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.035 0.445 . . . . 0.0 111.463 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 0.8 OUTLIER -114.91 137.05 52.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.861 -178.087 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -143.68 -178.1 19.16 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -129.76 -2.39 4.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.685 0.278 . . . . 0.0 110.97 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -163.55 142.27 7.98 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.398 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.46 179.72 39.63 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.425 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -178.11 157.03 1.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.605 0.362 . . . . 0.0 110.293 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.3 mm -63.02 128.49 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.057 171.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.617 HD13 ' CD2' ' A' ' 58' ' ' LEU . 5.7 tt -120.29 105.2 42.26 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-O 121.04 0.448 . . . . 0.0 110.224 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.34 110.66 2.3 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 123.312 2.675 . . . . 0.0 112.316 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.415 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.9 mt -102.3 123.75 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.29 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.6 mt-10 -109.27 126.62 53.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.042 0.449 . . . . 0.0 109.939 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.467 HG13 ' CE1' ' A' ' 92' ' ' PHE . 53.0 t -104.5 122.09 57.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.149 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 73.0 m-85 -89.64 136.82 32.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.018 -178.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.467 ' CE1' HG13 ' A' ' 90' ' ' VAL . 23.5 m-85 -114.77 156.36 25.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.077 178.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.428 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -104.47 91.67 3.99 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.26 0.552 . . . . 0.0 111.347 -178.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -158.51 179.75 8.84 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.909 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.531 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -113.19 4.19 16.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 110.915 176.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -99.34 -152.07 0.4 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.155 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -25.63 148.18 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -34.49 120.68 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 125.085 3.857 . . . . 0.0 113.873 -170.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.93 19.24 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.419 -174.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 11.8 ptpt -151.39 144.38 24.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.205 0.526 . . . . 0.0 110.432 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.94 154.71 30.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -120.81 118.96 31.35 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.939 0.399 . . . . 0.0 110.811 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.592 ' CD2' HD22 ' A' ' 16' ' ' LEU . 24.1 m-85 -112.54 117.08 31.35 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.712 174.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.98 105.93 14.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.626 0.727 . . . . 0.0 109.791 177.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -115.99 127.52 55.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.212 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -81.48 109.89 16.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.605 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.459 HD21 HG12 ' A' ' 37' ' ' VAL . 1.4 mp -83.87 91.16 7.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.442 . . . . 0.0 109.81 176.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -96.46 154.02 17.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.279 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.2 mt -127.91 162.3 27.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -96.52 166.97 11.43 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.792 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.11 150.59 47.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.954 0.407 . . . . 0.0 111.261 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.487 ' HA ' HG22 ' A' ' 22' ' ' VAL . 5.1 tt0 . . . . . 0 C--O 1.232 0.144 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.469 173.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 48.6 t . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.5 97.65 3.07 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -124.44 137.12 54.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.254 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.2 mt -115.74 153.48 31.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.74 0.65 . . . . 0.0 110.097 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 20.2 ttt180 -142.64 136.38 29.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 75.0 m -115.25 113.65 24.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.867 0.365 . . . . 0.0 111.052 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -110.73 134.89 52.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.878 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -96.48 125.9 41.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.261 0.553 . . . . 0.0 111.836 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.646 ' HB2' HG21 ' A' ' 12' ' ' VAL . 12.6 mt -90.21 120.42 31.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 171.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.2 m -112.84 119.9 39.59 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.694 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.481 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 30.6 m-85 -118.25 109.23 16.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.154 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.34 116.84 20.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.191 0.519 . . . . 0.0 111.153 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.4 t30 52.75 61.78 11.04 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.501 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 127' ' ' PHE . 96.5 Cg_endo -77.73 169.23 21.13 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.353 2.036 . . . . 0.0 111.489 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.42 ' OG1' ' HB2' ' A' ' 134' ' ' PHE . 6.6 p -59.62 141.25 55.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -57.82 -36.09 71.77 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.366 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.89 -34.5 74.75 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.668 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.0 t80 -73.94 -40.12 63.29 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.6 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 19.9 ttm180 -55.08 -44.62 75.02 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.591 173.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -55.49 -38.59 69.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.106 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -72.05 -39.74 68.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.984 0.421 . . . . 0.0 110.413 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 34.0 mt -72.62 -26.07 61.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.223 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.8 mt -85.6 -25.4 26.71 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.894 0.378 . . . . 0.0 110.689 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -80.74 -27.72 36.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.149 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.536 176.453 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.53 168.64 3.82 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.13 1.887 . . . . 0.0 111.674 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 . . . . . 0 C--N 1.323 -0.553 0 CA-C-O 121.372 0.606 . . . . 0.0 111.592 -178.432 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.822 0.344 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 t -104.93 143.34 16.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -127.35 127.67 44.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.743 0.306 . . . . 0.0 110.362 -176.09 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -112.13 171.92 3.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.224 178.278 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 99.6 mttt -137.41 138.06 39.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.695 0.284 . . . . 0.0 110.53 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.4 mt -121.4 142.02 50.41 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.53 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 121' ' ' ARG . 3.0 tm-20 -107.8 128.09 54.29 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.046 -175.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.601 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -111.24 107.64 17.01 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.81 168.4 23.95 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.612 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -162.88 152.17 15.21 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.485 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -122.46 121.06 35.72 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.61 117.4 30.2 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.283 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -111.09 158.9 18.33 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 112' ' ' GLU . 5.0 p -103.79 156.41 5.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 23' ' ' ARG . 3.0 mtp180 -104.66 140.74 37.6 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -63.39 -22.22 66.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.612 0.72 . . . . 0.0 109.342 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -140.93 107.91 6.35 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.483 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.454 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.8 Cg_exo -49.23 156.88 2.2 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.301 2.667 . . . . 0.0 112.816 174.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.41 HG21 ' HB2' ' A' ' 31' ' ' PHE . 9.0 t -79.36 -173.5 3.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.658 -175.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -42.43 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 122.625 0.37 . . . . 0.0 111.349 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -75.32 2.2 11.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.079 0.466 . . . . 0.0 111.144 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.61 29.33 65.81 Favored Glycine 0 CA--C 1.507 -0.466 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.64 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.41 ' HB2' HG21 ' A' ' 27' ' ' THR . 20.2 m-30 -86.8 129.43 34.88 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.9 p -91.51 -20.12 22.06 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.105 -168.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.0 m80 -122.12 145.85 47.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -172.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -121.81 123.81 42.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -126.22 143.31 51.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.196 0.522 . . . . 0.0 110.96 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.59 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 45.5 ttp -120.27 117.29 27.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.515 174.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 9.9 m -98.96 153.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.342 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.605 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.4 p90 -153.63 153.98 33.34 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -124.73 131.12 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.322 168.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.67 175.02 14.61 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.861 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . -81.88 -176.44 51.15 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.296 -168.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 11.8 Cg_exo -63.01 112.19 1.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.981 2.454 . . . . 0.0 111.702 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 52.02 52.58 14.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.671 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.0 t60 80.3 -3.47 1.91 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.701 171.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.49 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 49.9 m -58.58 123.42 16.22 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -58.11 127.12 30.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.652 0.263 . . . . 0.0 111.078 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.545 HG22 ' CZ ' ' A' ' 50' ' ' PHE . 5.6 pt -97.7 -1.98 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -66.51 -4.49 8.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.815 0.34 . . . . 0.0 111.003 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -71.35 -34.38 70.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.755 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.545 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 54.6 p90 -120.68 -17.5 7.99 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.555 175.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.541 HG23 HD11 ' A' ' 47' ' ' ILE . 91.4 t -89.75 128.48 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.921 0.391 . . . . 0.0 110.487 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.87 -62.38 1.27 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.366 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -145.66 153.56 41.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.462 HG11 HG23 ' A' ' 39' ' ' VAL . 91.5 t -128.0 158.16 39.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.914 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.626 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.7 p -142.11 134.13 26.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.14 0.495 . . . . 0.0 111.246 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.449 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 22.7 m-85 -115.86 107.29 14.83 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -77.94 94.33 4.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.925 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.589 ' CD2' HD13 ' A' ' 86' ' ' LEU . 12.4 mt -75.29 -177.7 3.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.845 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.492 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 68.7 t60 -73.97 138.89 44.46 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -54.97 -24.55 24.5 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.022 -170.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 t -69.3 -19.17 63.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.188 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 21.0 m-85 -77.95 139.6 61.71 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.7 0.286 . . . . 0.0 110.994 -176.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.35 119.9 6.81 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.066 2.51 . . . . 0.0 111.11 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 59.45 67.39 1.87 Allowed Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.45 -170.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.15 -20.25 50.06 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.591 2.194 . . . . 0.0 113.006 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -95.66 102.26 14.04 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.143 0.497 . . . . 0.0 110.488 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -98.75 94.23 6.51 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.516 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -79.52 135.21 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 172.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 m -127.95 114.56 17.3 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -106.66 -24.53 12.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.674 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.592 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 5.9 p-10 -68.51 -174.87 0.22 Allowed Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.397 1.079 . . . . 0.0 111.347 -175.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.612 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 4.2 Cg_exo -40.61 -167.63 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 124.231 3.287 . . . . 0.0 114.552 167.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.631 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 Cg_endo -39.68 124.49 1.33 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.626 2.217 . . . . 0.0 113.097 -155.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 46.7 m-85 -62.5 95.75 0.07 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.187 -175.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 4.8 ptpt -141.4 145.88 35.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.453 0.644 . . . . 0.0 112.251 -176.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 36' ' ' MET . 92.7 t -125.33 131.29 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.827 177.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -115.43 110.55 19.49 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -133.62 170.18 15.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.067 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.0 t -121.96 142.72 50.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.708 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.62 -168.5 21.71 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.125 -0.559 . . . . 0.0 111.892 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -135.8 -11.92 2.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.178 0.489 . . . . 0.0 111.651 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.63 132.73 20.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.914 0.388 . . . . 0.0 110.567 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.67 171.5 51.79 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.14 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -169.51 155.38 6.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.409 HD11 ' HA ' ' A' ' 106' ' ' ASP . 23.3 mm -63.21 126.45 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.982 172.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.589 HD13 ' CD2' ' A' ' 58' ' ' LEU . 5.6 tt -117.74 104.29 49.43 Favored Pre-proline 0 N--CA 1.444 -0.727 0 CA-C-O 121.22 0.533 . . . . 0.0 110.378 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.443 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 24.7 Cg_exo -65.47 108.48 1.21 Allowed 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 123.85 3.034 . . . . 0.0 112.384 172.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -101.49 124.47 55.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.26 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.626 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.5 mt-10 -108.17 127.49 53.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.095 0.474 . . . . 0.0 109.867 175.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.567 HG13 ' CE1' ' A' ' 92' ' ' PHE . 69.7 t -108.0 119.83 58.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.69 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.542 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 96.8 m-85 -93.24 138.55 31.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.583 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.567 ' CE1' HG13 ' A' ' 90' ' ' VAL . 24.9 m-85 -112.25 149.5 32.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.206 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.48 92.25 9.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.372 0.606 . . . . 0.0 109.946 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.5 ' HB3' ' HG3' ' A' ' 99' ' ' ARG . 50.9 t30 -158.13 156.69 31.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.668 -174.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -113.33 8.56 18.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.288 0.566 . . . . 0.0 111.013 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.485 ' HB2' HD22 ' A' ' 94' ' ' ASN . 0.4 OUTLIER -100.59 -152.29 0.42 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.236 -175.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.501 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 16.9 mm-40 -33.39 155.04 0.04 OUTLIER Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.133 0.973 . . . . 0.0 112.892 173.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 1.3 Cg_endo -37.88 122.44 0.51 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 124.566 3.511 . . . . 0.0 114.055 -168.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.5 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -95.62 20.18 10.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.412 -174.291 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.75 137.6 26.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.272 0.558 . . . . 0.0 111.01 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.0 OUTLIER -125.93 156.79 36.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.576 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.443 ' HE ' ' HB3' ' A' ' 87' ' ' PRO . 29.3 ttt180 -131.26 115.77 16.74 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.417 0.627 . . . . 0.0 110.8 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.601 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.8 m-85 -107.53 114.31 28.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.048 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.75 102.97 5.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.317 0.579 . . . . 0.0 109.636 176.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -114.08 127.29 55.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.287 0.565 . . . . 0.0 110.662 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.409 ' HA ' HD11 ' A' ' 85' ' ' ILE . 11.8 t70 -80.4 104.47 10.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.931 -177.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.483 HD21 HG12 ' A' ' 37' ' ' VAL . 1.8 mp -82.8 109.34 16.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 174.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.46 ' CE1' HG12 ' A' ' 117' ' ' VAL . 54.4 p90 -124.64 160.55 28.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.444 0.64 . . . . 0.0 111.054 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.3 mt -135.76 156.57 48.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -101.6 171.23 7.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.58 173.2 3.53 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.55 0.614 . . . . 0.0 112.262 -174.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.515 ' HA ' HG22 ' A' ' 22' ' ' VAL . 12.8 mt-10 . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 120.963 0.411 . . . . 0.0 110.888 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 30.1 t . . . . . 0 CA--C 1.513 -0.449 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -133.48 97.77 4.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.964 0.411 . . . . 0.0 110.12 -173.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -125.22 130.37 51.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.774 -173.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.3 mt -118.45 140.74 49.39 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.548 0.53 . . . . 0.0 110.397 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.662 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 22.2 ttm180 -131.37 132.34 44.35 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 120.519 0.199 . . . . 0.0 111.203 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 57.3 m -110.13 110.62 21.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.938 0.399 . . . . 0.0 110.708 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 22.5 mm-40 -97.65 159.52 14.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.578 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -120.28 133.59 55.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.213 0.53 . . . . 0.0 111.337 -177.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.647 ' HB2' HG21 ' A' ' 12' ' ' VAL . 9.8 mt -107.44 120.4 42.08 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.15 175.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.3 m -110.89 123.18 49.61 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.658 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -120.31 102.42 8.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.893 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -78.98 125.34 29.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.459 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 56.88 63.0 5.63 Favored Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.871 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.89 165.37 17.57 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.47 2.114 . . . . 0.0 111.675 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.444 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 13.4 p -68.1 143.21 55.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 174.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -57.79 -42.24 83.74 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.23 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -63.11 -25.93 68.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.622 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.6 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.3 t80 -73.43 -38.23 65.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.598 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 35.2 ttm180 -56.1 -45.57 79.41 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 173.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -55.06 -38.08 67.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.622 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 46.5 mtpt -72.35 -41.52 66.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.758 0.313 . . . . 0.0 110.763 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.0 mt -70.65 -32.87 70.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.065 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 50.8 mt -74.97 -33.89 61.95 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.482 ' HZ1' ' CB ' ' A' ' 140' ' ' LYS . 2.1 ttpm? -73.97 -28.66 61.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 -176.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.493 175.776 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.37 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.69 173.76 3.41 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.402 2.068 . . . . 0.0 112.453 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.961 -178.702 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.475 ' HA2' ' SD ' ' A' ' 4' ' ' MET . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -63.07 110.11 1.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.749 0.309 . . . . 0.0 111.024 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.1 t60 62.07 22.75 13.33 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.774 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.475 ' SD ' ' HA2' ' A' ' 1' ' ' GLY . 68.3 mtt -93.87 -23.82 17.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.008 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.35 156.09 17.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.626 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t -78.54 76.79 5.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.372 0.606 . . . . 0.0 109.751 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.6 m -126.06 133.63 51.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.907 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.9 m -96.12 113.51 25.12 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.12 139.2 48.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.664 0.269 . . . . 0.0 111.387 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.6 t -105.28 142.07 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.98 124.13 41.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.869 0.366 . . . . 0.0 110.454 -177.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.655 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -113.73 178.79 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.184 178.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 122' ' ' CYS . 16.2 tttp -145.51 135.8 23.98 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -176.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.94 151.95 39.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.676 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 41.7 tt0 -117.47 124.38 48.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.4 -176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.655 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -107.14 118.06 35.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.96 169.9 27.96 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.899 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -164.12 146.21 8.99 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.94 0.4 . . . . 0.0 110.43 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -117.48 134.96 54.27 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 173.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -122.94 117.17 24.91 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.933 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -110.54 150.5 28.84 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 32' ' ' THR . 1.8 p -103.62 161.6 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.1 mtp180 -110.33 146.86 35.0 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -76.12 -14.26 60.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 109.049 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -141.31 103.97 6.04 Favored Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.047 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.473 ' HG3' HG22 ' A' ' 32' ' ' THR . 82.0 Cg_exo -47.72 156.04 1.34 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.375 2.717 . . . . 0.0 113.049 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -77.7 -170.4 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.379 -173.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 m -61.68 -31.24 50.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.892 0.377 . . . . 0.0 111.297 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -86.43 3.38 44.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.742 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.97 29.38 69.15 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.391 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -89.56 133.93 34.37 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.6 p -90.07 -24.22 21.21 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.323 -171.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 79' ' ' SER . 63.3 m80 -118.7 150.04 40.41 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -170.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -129.6 119.54 23.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 42.9 p-90 -121.13 146.34 46.85 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.039 0.447 . . . . 0.0 110.676 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.561 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 24.2 ttp -122.85 109.82 14.65 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.482 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.8 m -94.52 150.05 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.463 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -151.8 156.03 39.4 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 7.8 m -122.05 124.95 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.632 168.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.463 ' HA ' ' NE ' ' A' ' 40' ' ' ARG . 3.1 mmp_? -126.63 178.12 6.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.098 -173.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.87 177.93 33.17 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.308 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.605 ' HD2' ' OG ' ' A' ' 45' ' ' SER . 13.0 Cg_exo -63.18 113.8 2.2 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.406 2.071 . . . . 0.0 111.27 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 61.3 46.04 8.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.253 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 65.37 16.4 10.51 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.605 ' OG ' ' HD2' ' A' ' 42' ' ' PRO . 60.6 p -67.87 139.88 56.52 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -68.89 125.29 26.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.533 HD11 HG23 ' A' ' 51' ' ' VAL . 3.4 pt -96.74 -0.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -172.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.68 -4.65 4.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -76.07 -34.9 59.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.554 0.216 . . . . 0.0 110.85 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.487 ' CE2' HG22 ' A' ' 47' ' ' ILE . 51.0 p90 -115.71 -17.65 11.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.297 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.533 HG23 HD11 ' A' ' 47' ' ' ILE . 86.8 t -91.92 122.7 43.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.213 0.53 . . . . 0.0 110.095 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 5.7 tp10 -89.21 -58.01 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.592 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.567 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 15.4 tttt -152.45 152.72 32.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.743 -175.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 95.4 t -130.82 156.9 43.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.3 p -140.67 138.04 35.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.179 0.514 . . . . 0.0 111.105 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.425 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 17.6 m-85 -120.41 110.7 16.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.5 94.35 7.45 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.86 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.54 ' CD2' HD13 ' A' ' 86' ' ' LEU . 9.0 mt -79.38 -177.15 5.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.759 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -80.27 145.38 32.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -56.88 -20.18 21.7 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.38 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 m -67.2 -21.73 65.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.117 0.484 . . . . 0.0 110.829 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -81.81 135.39 48.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.89 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.4 117.96 4.76 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.342 2.028 . . . . 0.0 110.812 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 60.5 80.87 0.25 Allowed Pre-proline 0 C--O 1.226 -0.182 0 O-C-N 123.665 0.603 . . . . 0.0 110.114 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.93 -22.71 64.37 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.615 2.21 . . . . 0.0 113.216 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.46 ' HE2' ' CG1' ' A' ' 68' ' ' VAL . 78.6 tttt -100.6 109.54 21.63 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.194 0.521 . . . . 0.0 110.855 -176.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 22.5 mmt85 -108.64 104.72 14.08 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.69 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 2.8 m -97.25 136.67 27.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.7 m -120.5 110.76 16.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.024 0.44 . . . . 0.0 110.09 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -99.69 -25.04 14.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.562 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.571 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 8.1 t70 -66.87 173.06 2.76 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.351 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.637 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 60.1 Cg_exo -30.22 -167.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.953 1 C-N-CA 125.322 4.014 . . . . 0.0 115.365 159.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.637 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.3 Cg_endo -32.19 121.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 123.408 2.739 . . . . 0.0 114.761 -154.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 31.8 m-85 -65.9 91.73 0.15 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.622 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 0.4 OUTLIER -148.73 148.16 29.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.541 0.686 . . . . 0.0 112.043 -178.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 36' ' ' MET . 94.2 t -118.92 129.23 75.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.239 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -117.18 101.6 8.59 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.42 170.55 15.32 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 -174.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 7.4 t -120.87 144.68 48.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.972 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.52 -161.98 12.9 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -138.32 -14.91 1.29 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.335 0.567 . . . . 0.0 112.341 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.488 ' HB1' ' HG2' ' B' ' 218' ' ' ALY . . . -142.25 146.46 35.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.91 0.386 . . . . 0.0 111.158 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.419 ' O ' ' HD2' ' B' ' 217' ' ' ARG . . . -86.08 170.15 42.95 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.52 -0.764 . . . . 0.0 113.045 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -170.58 159.71 6.89 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 122.566 0.346 . . . . 0.0 110.252 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.42 HG12 HH22 ' B' ' 217' ' ' ARG . 14.8 mm -68.24 119.48 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.54 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.8 tt -112.94 105.04 55.98 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.617 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.15 120.6 7.3 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 122.823 2.349 . . . . 0.0 112.299 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.5 mt -108.48 129.47 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.318 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.53 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.7 mt-10 -114.58 122.24 45.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.143 0.497 . . . . 0.0 110.086 176.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.459 HG13 ' CE1' ' A' ' 92' ' ' PHE . 71.6 t -102.69 123.22 55.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.804 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.567 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 93.9 m-85 -95.33 138.94 32.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.641 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.459 ' CE1' HG13 ' A' ' 90' ' ' VAL . 22.6 m-85 -113.13 161.04 17.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -108.09 91.6 3.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.467 0.651 . . . . 0.0 110.543 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.507 ' OD1' ' HB2' ' A' ' 96' ' ' GLU . 15.8 t-20 -159.57 167.7 27.9 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.842 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.51 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -113.58 9.07 17.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.507 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 3.1 mp0 -99.6 -152.95 0.43 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 14.3 mm-40 -32.43 152.37 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.192 0.997 . . . . 0.0 113.027 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.8 Cg_endo -44.21 117.74 1.43 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.136 3.224 . . . . 0.0 113.499 -168.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -87.45 20.76 2.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.133 -172.388 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.2 139.16 48.24 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.395 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.6 m -116.91 156.97 18.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.951 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -130.04 107.04 9.04 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.929 0.395 . . . . 0.0 110.32 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.655 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.5 m-85 -108.18 119.96 40.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.345 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -84.26 114.72 22.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.08 0.467 . . . . 0.0 109.81 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -126.31 133.8 51.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.661 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.3 115.98 26.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.802 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.48 HD21 HG12 ' A' ' 37' ' ' VAL . 2.5 mp -88.82 95.05 10.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.424 ' CE2' HG13 ' A' ' 117' ' ' VAL . 10.0 p90 -104.92 154.99 19.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.529 . . . . 0.0 111.57 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 mt -137.42 163.63 30.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.986 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.744 ' CE1' ' HA ' ' A' ' 116' ' ' PRO . 17.9 p-80 -99.77 167.74 10.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.54 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.572 ' O ' ' HD2' ' A' ' 110' ' ' HIS . 1.0 OUTLIER -68.18 147.04 52.81 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 173.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.409 ' HA ' HG22 ' A' ' 22' ' ' VAL . 4.5 tt0 -54.75 100.81 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.796 0.438 . . . . 0.0 110.349 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.63 30.4 4.34 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.838 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -135.63 153.14 77.32 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.057 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -27.64 127.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 124.155 3.237 . . . . 0.0 114.95 173.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.744 ' HA ' ' CE1' ' A' ' 110' ' ' HIS . 39.6 Cg_endo -66.98 -179.11 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.775 2.984 . . . . 0.0 112.489 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 58.0 t -122.03 126.92 75.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.488 -172.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -138.0 96.71 3.26 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -122.12 125.78 46.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.852 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.1 mt -113.26 150.52 32.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.858 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.7 ttt180 -144.93 142.71 30.08 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.431 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 60.9 m -128.88 116.13 18.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.895 0.378 . . . . 0.0 111.193 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -111.64 135.12 52.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.311 -176.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -90.83 136.38 33.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.198 0.523 . . . . 0.0 111.562 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.655 ' HB2' HG21 ' A' ' 12' ' ' VAL . 9.0 mt -106.87 124.69 49.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 20.2 m -120.55 124.15 44.64 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.209 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -120.86 112.82 19.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.585 -176.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -85.57 127.9 34.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.007 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 56.75 58.16 8.47 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.493 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -84.51 166.13 12.17 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.455 2.104 . . . . 0.0 111.694 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.1 p -73.21 145.09 46.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.766 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -54.34 -42.37 70.14 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.507 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.514 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.1 p-10 -57.22 -33.04 67.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.638 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 11.0 t80 -75.73 -40.16 56.03 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.606 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 37.2 ttm180 -56.96 -45.29 82.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -56.43 -34.76 67.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.34 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 36.2 mtpt -75.2 -41.33 58.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.812 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.1 mt -69.33 -27.06 65.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 44.0 mt -83.99 -35.69 23.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.318 . . . . 0.0 110.937 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -70.59 -30.49 67.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.732 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.547 -0.74 . . . . 0.0 110.373 176.711 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -149.74 80.71 0.2 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.082 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -149.77 -168.62 3.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.501 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -59.42 160.23 13.98 Favored Pre-proline 0 C--O 1.235 0.314 0 O-C-N 123.083 0.239 . . . . 0.0 111.121 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . 0.461 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 10.5 Cg_endo -53.7 165.59 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.562 2.175 . . . . 0.0 112.472 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.42 HH22 HG12 ' A' ' 85' ' ' ILE . 6.2 tpt180 -143.11 128.68 19.12 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.86 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . 0.488 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . 0.518 ' OE1' ' HA ' ' B' ' 222' ' ' THR . 8.6 pt20 -62.56 153.09 33.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.507 -176.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.412 HD22 ' N ' ' B' ' 220' ' ' LEU . 3.0 mm? -76.99 -29.02 55.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.398 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -139.17 116.24 11.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.931 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.518 ' HA ' ' OE1' ' B' ' 219' ' ' GLN . 25.6 m -71.6 106.38 4.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.442 -175.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt 58.6 43.26 19.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.687 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.978 -0.534 . . . . 0.0 110.222 177.827 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 m -80.6 124.7 29.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.898 0.38 . . . . 0.0 110.485 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -85.72 38.84 0.77 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.303 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.6 ttm -83.34 -24.56 32.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.965 0.412 . . . . 0.0 110.144 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.22 -53.19 11.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.199 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.6 p -86.22 76.76 9.68 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 t -107.26 110.02 21.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.307 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.6 t -158.16 117.17 3.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.87 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.66 128.19 56.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.852 0.358 . . . . 0.0 111.447 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 t -100.17 138.85 23.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 6.4 mp0 -125.7 119.86 29.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.936 0.398 . . . . 0.0 110.443 -174.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.626 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.56 -179.74 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.888 178.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -151.31 123.28 8.13 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.849 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.8 mt -106.66 145.57 31.81 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.313 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.609 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 3.5 tt0 -105.01 126.55 52.19 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.144 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.646 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -112.54 114.52 27.21 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.4 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -140.9 171.05 24.28 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.842 -1.171 . . . . 0.0 111.728 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -162.97 146.01 10.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.512 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -118.81 132.03 56.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.709 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -130.56 131.35 44.98 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.468 0.651 . . . . 0.0 111.271 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 3.8 tt0 -129.6 155.08 46.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.229 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.515 ' HB ' ' HG3' ' A' ' 115' ' ' PRO . 2.8 p -101.85 153.45 5.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 23' ' ' ARG . 1.1 mtp180 -102.57 135.48 44.12 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 24' ' ' LYS . 20.3 tptt -75.75 -5.54 46.25 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.613 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -133.87 99.78 13.68 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.079 168.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HG3' HG22 ' A' ' 32' ' ' THR . 83.1 Cg_exo -50.98 156.57 4.69 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.02 2.48 . . . . 0.0 111.868 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.475 HG21 ' HB2' ' A' ' 31' ' ' PHE . 10.2 t -78.79 -172.67 3.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.091 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 m -60.09 -31.66 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.928 0.394 . . . . 0.0 111.237 -174.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -86.73 4.29 41.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.11 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.42 32.5 68.13 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.253 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.475 ' HB2' HG21 ' A' ' 27' ' ' THR . 17.7 m-30 -90.72 127.19 36.23 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.51 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.1 p -87.52 -29.91 20.98 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -170.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 79' ' ' SER . 67.1 m80 -115.47 142.29 46.91 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -112.27 123.83 51.12 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.417 ' CZ2' ' HB3' ' A' ' 78' ' ' GLU . 54.2 p-90 -127.6 147.27 50.35 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.135 0.493 . . . . 0.0 110.889 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.625 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 51.7 ttp -123.6 122.64 38.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.459 174.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.2 m -102.5 152.21 5.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.587 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -153.27 152.04 30.71 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.951 -0.7 . . . . 0.0 112.812 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.0 m -122.76 125.99 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.703 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -134.65 -178.92 5.29 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.221 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.02 -173.84 39.22 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 1.4 Cg_endo -81.57 111.37 2.3 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.235 1.957 . . . . 0.0 112.693 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 58.7 70.18 0.67 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 71.74 -11.12 0.77 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.26 0.624 . . . . 0.0 112.344 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.502 ' HB3' ' OXT' ' A' ' 141' ' ' ALA . 19.9 m -66.92 120.67 13.98 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -69.86 127.16 31.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 120.881 0.372 . . . . 0.0 110.271 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.528 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.2 pt -90.5 -3.47 10.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.569 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -65.74 -0.87 2.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.891 0.377 . . . . 0.0 111.552 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -74.29 -39.87 62.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.221 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.476 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 53.5 p90 -113.61 -20.27 11.28 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.94 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.528 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 52.5 t -93.38 135.77 27.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.781 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.413 ' HB2' ' HG3' ' A' ' 93' ' ' LYS . 8.4 tp10 -111.91 -60.87 1.79 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.172 0.511 . . . . 0.0 110.711 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.675 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 6.7 tttm -138.24 146.92 43.16 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.253 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 98.1 t -127.01 159.21 37.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.552 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.8 p -141.85 136.2 30.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.299 0.571 . . . . 0.0 111.574 -174.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.43 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 22.0 m-85 -119.06 105.6 11.58 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -77.53 87.92 3.86 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.015 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.5 mt -71.38 -176.46 1.52 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.825 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -76.32 140.29 41.41 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -59.39 -19.55 47.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.021 -174.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -58.94 -27.27 65.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.743 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -85.47 131.64 47.24 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.084 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.95 121.5 10.12 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.668 2.246 . . . . 0.0 111.554 175.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.5 mtm180 55.79 67.24 3.06 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.512 -176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.36 -17.46 60.18 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.189 2.592 . . . . 0.0 113.52 -172.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -86.23 101.62 13.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.141 0.496 . . . . 0.0 110.228 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 22.0 mmt180 -98.42 107.83 20.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.68 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -99.05 136.19 31.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.1 m -120.6 113.56 20.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.295 0.569 . . . . 0.0 110.316 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -102.75 -24.55 13.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.614 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.543 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 13.8 t70 -68.0 170.12 8.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.623 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.629 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.2 Cg_exo -32.71 -178.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.568 1 C-N-CA 125.346 4.031 . . . . 0.0 114.865 164.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.629 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.7 Cg_endo -28.29 119.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 124.292 3.328 . . . . 0.0 113.942 -157.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 51.2 m-85 -60.1 98.66 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.59 -171.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.625 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 10.7 ptpt -140.18 150.42 44.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.438 0.637 . . . . 0.0 112.171 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 36' ' ' MET . 81.1 t -126.87 130.83 71.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.604 175.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.81 109.88 18.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.835 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.417 ' HB3' ' CZ2' ' A' ' 35' ' ' TRP . 1.9 tp10 -135.31 174.45 10.59 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -177.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.3 t -128.45 143.8 51.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.2 -170.62 26.09 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.884 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -130.36 -11.42 4.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.263 0.531 . . . . 0.0 112.066 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.497 ' HB1' ' HG2' ' B' ' 218' ' ' ALY . . . -148.84 139.3 22.55 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.434 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.498 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -75.5 176.45 50.37 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.355 -0.838 . . . . 0.0 113.361 -176.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -172.41 158.29 4.28 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.2 mm -65.44 126.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.329 . . . . 0.0 110.522 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.23 104.64 56.4 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.86 111.14 2.96 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.708 2.272 . . . . 0.0 111.826 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.412 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.9 mt -104.43 125.69 59.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.43 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.552 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 54.4 mt-10 -111.45 123.64 50.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.171 0.51 . . . . 0.0 110.039 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.606 HG13 ' CE1' ' A' ' 92' ' ' PHE . 72.4 t -103.79 122.42 56.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.112 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.675 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 75.7 m-85 -94.63 132.42 39.38 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 112.005 -176.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.606 ' CE1' HG13 ' A' ' 90' ' ' VAL . 18.9 m-85 -114.38 164.07 14.44 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.079 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.413 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -107.9 100.48 9.84 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 122.327 -0.233 . . . . 0.0 111.479 175.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -158.28 178.18 10.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.742 171.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.49 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.52 -1.11 15.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.756 -178.338 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -100.62 -153.12 0.44 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.092 -176.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -29.56 152.74 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.395 1.078 . . . . 0.0 113.907 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -32.89 122.46 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 125.03 3.82 . . . . 0.0 114.2 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.9 19.5 2.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.697 -176.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -150.09 144.56 25.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.276 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.13 157.21 28.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 102' ' ' ARG . 11.6 ttt180 -129.08 108.69 10.58 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.8 m-85 -104.66 120.44 41.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.189 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.83 111.61 19.36 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -124.94 127.28 46.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.317 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -78.82 121.81 25.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.952 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 37' ' ' VAL . 1.5 mp -94.53 91.66 6.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.561 ' CE2' HG13 ' A' ' 117' ' ' VAL . 37.8 p90 -100.11 160.14 14.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.04 0.448 . . . . 0.0 110.845 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.9 mt -134.26 155.9 49.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 115' ' ' PRO . 1.4 m-70 -101.05 175.53 5.57 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 122.329 -0.232 . . . . 0.0 111.043 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.89 139.01 58.24 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.46 ' HA ' HG22 ' A' ' 22' ' ' VAL . 1.5 tm-20 -50.74 117.9 2.77 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.898 173.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.466 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 122.68 -50.23 0.85 Allowed Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.633 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -144.22 75.43 15.4 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 117.293 0.546 . . . . 0.0 110.615 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.515 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 60.8 Cg_endo -108.35 109.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 123.185 2.59 . . . . 0.0 114.004 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -98.25 97.88 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.31 2.007 . . . . 0.0 111.016 166.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 20' ' ' ALA . 4.7 t -119.17 102.54 13.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.9 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -141.93 97.98 3.24 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -122.45 130.75 53.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.04 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.8 mt -114.83 155.58 26.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.379 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 23.2 ttm180 -144.9 145.45 31.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 61.3 m -127.56 110.37 12.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.02 0.438 . . . . 0.0 110.768 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.433 ' HG3' HD23 ' A' ' 16' ' ' LEU . 2.5 mm-40 -107.21 125.84 51.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.27 -174.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -81.9 135.49 35.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.194 0.521 . . . . 0.0 111.431 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.626 ' HB2' HG21 ' A' ' 12' ' ' VAL . 9.2 mt -103.38 114.8 29.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.4 m -107.15 115.64 30.53 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.989 0.423 . . . . 0.0 110.902 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -115.39 106.22 13.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.036 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -81.6 118.52 22.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.82 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 62.43 67.51 1.17 Allowed Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.147 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -89.81 175.47 3.07 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.093 2.528 . . . . 0.0 111.881 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.3 p -84.31 147.05 27.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.41 -42.15 63.81 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.173 0.442 . . . . 0.0 112.147 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 6.4 p-10 -56.36 -32.02 64.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.796 0.332 . . . . 0.0 110.29 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.698 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.8 t80 -76.96 -42.74 37.86 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.66 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 38.0 ttm180 -54.74 -46.27 74.27 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -52.4 -42.8 64.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.381 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 36.1 mtpt -73.31 -38.98 65.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.853 0.358 . . . . 0.0 110.896 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 36.7 mt -70.02 -26.26 63.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.986 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.2 mt -83.58 -32.84 25.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 110.923 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -75.77 -26.38 57.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.308 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.502 ' OXT' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.466 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 112.069 -0.413 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -109.74 -30.6 3.44 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.137 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -83.65 123.84 30.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.76 0.314 . . . . 0.0 110.645 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.463 ' HB2' ' HD2' ' B' ' 216' ' ' PRO . . . -67.5 164.33 39.3 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.296 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' B' ' 215' ' ' ALA . 5.0 Cg_endo -48.82 161.55 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.687 2.258 . . . . 0.0 112.551 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 5.1 tpp180 -142.04 129.87 21.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.05 -174.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . 0.497 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 71.51 -56.8 0.63 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.753 0.658 . . . . 0.0 111.048 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 6.4 mp -92.26 113.59 25.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.851 0.357 . . . . 0.0 110.435 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.84 -67.26 0.82 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.9 m 54.98 44.0 28.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.312 0.577 . . . . 0.0 111.26 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.41 -1.09 31.46 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.465 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.21 179.551 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.1 m -81.01 -23.14 38.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.967 0.413 . . . . 0.0 110.482 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -92.98 78.82 4.63 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.3 mtp -87.99 15.38 7.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.715 -175.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.61 -14.72 62.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.279 0.561 . . . . 0.0 109.962 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.3 m -97.87 136.09 38.68 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.926 176.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.7 m -66.38 110.23 3.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.566 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.1 p -86.67 112.57 21.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.18 0.514 . . . . 0.0 110.809 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.47 135.34 53.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.269 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 t -105.28 138.23 31.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -124.96 127.4 46.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -176.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -115.17 164.65 11.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.273 178.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 37.8 mttp -129.23 131.51 47.08 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.4 mt -115.1 140.23 49.24 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.248 0.547 . . . . 0.0 109.786 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.5 tt0 -106.33 121.34 44.02 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.873 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.565 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -106.01 112.17 25.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -137.32 166.59 24.96 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.656 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -163.53 149.69 11.72 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.163 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.9 mtt180 -115.21 140.76 48.81 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.694 174.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.84 120.71 29.91 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.511 176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -114.18 148.3 37.52 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 32' ' ' THR . 2.4 p -103.39 161.21 4.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 171.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 23' ' ' ARG . 3.0 mtp180 -116.15 134.67 54.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -68.92 -12.85 62.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.434 0.635 . . . . 0.0 109.679 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -134.89 102.17 11.27 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.162 171.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HG3' HG22 ' A' ' 32' ' ' THR . 98.4 Cg_exo -49.28 154.79 3.58 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.021 2.48 . . . . 0.0 112.054 175.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -78.23 -174.06 3.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.852 -170.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.485 HG22 ' OE1' ' A' ' 29' ' ' GLU . 1.9 m -66.31 -30.83 51.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.207 0.527 . . . . 0.0 110.48 -175.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.485 ' OE1' HG22 ' A' ' 28' ' ' VAL . 3.0 mp0 -76.24 -6.65 52.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.471 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.08 34.29 38.07 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.478 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -102.56 136.54 42.2 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.465 HG22 ' HG3' ' A' ' 26' ' ' PRO . 47.4 p -92.78 -24.12 18.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.422 -169.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.413 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.0 m80 -121.11 144.63 48.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -171.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -119.15 125.45 49.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.1 p-90 -126.49 147.32 49.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.036 0.446 . . . . 0.0 110.834 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.56 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.2 ttp -125.53 115.24 19.9 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.759 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 14.2 m -97.32 150.0 4.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.817 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.2 p90 -150.98 155.8 39.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.603 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.3 m -126.05 129.03 72.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.343 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -135.42 -176.9 4.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.332 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.38 -163.57 39.46 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.642 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 3.9 Cg_exo -71.91 109.85 2.77 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.17 1.913 . . . . 0.0 111.64 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 44' ' ' HIS . 28.9 mt-10 52.29 68.66 0.78 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.342 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.4 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 22.2 m170 75.51 -6.76 1.91 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.455 0.702 . . . . 0.0 112.764 172.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.529 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 72.5 m -61.2 136.05 57.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.467 0.175 . . . . 0.0 111.311 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -73.44 126.68 30.74 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.58 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.5 pt -97.27 -4.61 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -64.0 -0.43 1.13 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -77.66 -34.98 52.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.521 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.548 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 50.0 p90 -121.05 -16.88 7.94 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.727 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.58 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 77.8 t -94.26 126.02 46.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 9.5 tp10 -96.63 -57.88 2.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.444 0.64 . . . . 0.0 111.026 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 24.6 tttt -145.7 150.74 36.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.286 -175.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.464 HG11 HG23 ' A' ' 39' ' ' VAL . 88.9 t -131.28 158.1 43.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.435 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.582 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.2 p -141.71 138.42 31.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.266 0.555 . . . . 0.0 111.287 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.443 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 18.1 m-85 -120.95 110.35 16.18 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -82.53 95.88 7.87 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.957 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.4 mt -78.17 -178.8 5.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.815 0.34 . . . . 0.0 110.151 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.442 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 18.9 t60 -85.43 151.2 24.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -51.87 -28.33 15.7 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.797 -169.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 t -79.0 -6.2 55.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.867 0.365 . . . . 0.0 111.273 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -90.36 134.89 30.33 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.57 136.48 30.95 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.282 1.988 . . . . 0.0 109.727 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 61.64 73.8 0.55 Allowed Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -172.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.47 -18.73 60.41 Favored 'Trans proline' 0 C--O 1.223 -0.233 0 C-N-CA 121.887 1.725 . . . . 0.0 112.656 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -110.37 106.76 16.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.678 0.275 . . . . 0.0 110.598 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.3 mmt85 -104.41 100.0 9.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.769 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -89.54 137.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.557 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 36.0 t -128.1 116.81 20.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.096 0.474 . . . . 0.0 110.116 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -106.55 -27.26 10.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.124 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.667 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -71.42 -177.3 0.46 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.571 -175.166 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.667 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 13.5 Cg_exo -31.17 178.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 125.17 3.913 . . . . 0.0 114.862 163.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.621 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.8 Cg_exo -26.32 121.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 124.797 3.665 . . . . 0.0 114.972 -157.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.557 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 34.2 m-85 -62.21 91.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.958 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.39 151.64 39.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.611 0.719 . . . . 0.0 112.676 179.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 36' ' ' MET . 93.8 t -123.47 129.14 74.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.631 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -114.38 112.99 23.93 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.35 173.31 11.61 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.839 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 3.2 t -121.11 145.93 47.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.139 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.16 -157.96 9.48 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -144.51 -17.48 0.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.82 140.75 31.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.999 0.428 . . . . 0.0 111.116 -176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.89 169.81 55.03 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.773 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 59' ' ' HIS . 11.6 p90 -169.93 158.09 7.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.767 0.427 . . . . 0.0 110.059 -176.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.5 mm -67.18 126.14 26.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.609 0.243 . . . . 0.0 110.596 172.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.434 HD23 HG13 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -111.78 104.96 56.54 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.77 112.99 3.23 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.781 2.321 . . . . 0.0 112.088 171.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.434 HG13 HD23 ' A' ' 86' ' ' LEU . 6.3 mt -106.6 128.79 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.309 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.582 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 45.9 mt-10 -112.81 123.59 50.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.22 0.534 . . . . 0.0 109.964 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.5 t -104.84 118.88 52.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.747 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 89.3 m-85 -90.79 139.81 30.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.157 0.503 . . . . 0.0 111.245 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.418 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.0 m-85 -113.07 165.1 12.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.573 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -118.58 93.95 4.29 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.995 0.426 . . . . 0.0 112.001 -177.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.519 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 0.7 OUTLIER -160.48 -172.53 3.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.031 174.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.503 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 20.7 tptp -110.35 0.4 17.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.472 0.653 . . . . 0.0 111.23 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.462 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 6.5 mp0 -100.08 -155.71 0.52 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 -171.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.462 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 13.2 mm-40 -32.5 149.48 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.419 1.088 . . . . 0.0 113.536 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -30.22 125.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 125.205 3.936 . . . . 0.0 115.076 -164.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.519 ' HD3' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -82.01 18.96 1.21 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.83 -178.536 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -154.45 140.28 18.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.198 0.523 . . . . 0.0 110.941 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -120.31 157.35 22.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -128.25 107.64 9.94 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.657 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.565 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.6 m-85 -103.07 123.94 47.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.217 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -88.13 101.23 13.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.357 0.598 . . . . 0.0 110.147 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.427 ' HB3' HD12 ' A' ' 88' ' ' ILE . 40.8 t80 -110.18 132.27 54.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.769 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.16 118.37 21.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.06 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.482 HD21 HG12 ' A' ' 37' ' ' VAL . 1.2 mp -95.2 91.29 6.22 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 175.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -102.22 156.88 17.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.219 0.533 . . . . 0.0 111.278 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 mt -134.47 163.9 28.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.2 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.783 ' CD2' ' HA ' ' A' ' 116' ' ' PRO . 8.4 p80 -99.67 164.16 12.18 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.22 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.46 153.78 26.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.939 0.399 . . . . 0.0 111.145 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.451 ' HA ' HG22 ' A' ' 22' ' ' VAL . 8.7 tt0 -63.37 98.93 0.17 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.308 175.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.0 28.91 6.67 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.843 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.492 ' CG ' ' HD2' ' A' ' 115' ' ' PRO . 51.7 t-80 -136.23 148.72 65.56 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-O 118.348 -0.834 . . . . 0.0 108.788 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.492 ' HD2' ' CG ' ' A' ' 114' ' ' HIS . 1.1 Cg_exo -24.49 113.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 124.684 3.589 . . . . 0.0 115.194 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.783 ' HA ' ' CD2' ' A' ' 110' ' ' HIS . 50.3 Cg_exo -55.48 -179.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 124.047 3.164 . . . . 0.0 114.51 175.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 69.0 t -122.47 130.17 74.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.992 -172.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.434 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.93 96.58 2.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -119.9 129.84 54.55 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.163 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.7 mt -108.11 149.34 28.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.547 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 15.6 ttt180 -140.73 137.93 33.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 85.8 m -120.09 116.58 25.97 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.157 0.504 . . . . 0.0 111.214 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 9.8 mm-40 -105.98 158.93 16.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.309 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -124.98 123.88 40.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.148 0.499 . . . . 0.0 111.387 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.643 ' HB2' HG21 ' A' ' 12' ' ' VAL . 5.9 mt -98.31 122.04 40.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.797 176.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.0 m -113.84 122.4 46.93 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.922 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -120.9 107.66 12.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.447 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -83.24 124.32 30.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.125 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 51.72 67.71 3.89 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.337 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -86.57 -179.27 2.97 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.947 2.431 . . . . 0.0 112.003 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 69.6 p -79.12 140.37 37.83 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -58.81 -33.19 70.09 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.446 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.2 p-10 -65.31 -30.97 71.88 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.621 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 18.7 t80 -74.3 -42.32 59.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.572 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.6 ttm180 -54.19 -45.51 72.17 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.929 173.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -55.23 -39.45 69.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.333 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 40.8 mtpt -69.95 -39.97 75.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.93 0.395 . . . . 0.0 110.421 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 41.7 mt -69.53 -31.77 70.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.72 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.6 mt -80.91 -31.39 35.13 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.188 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -76.99 -26.71 54.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.134 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.358 175.419 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 112.101 -0.4 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.55 -86.2 1.52 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.047 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -74.79 127.25 32.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.041 0.448 . . . . 0.0 110.836 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.494 ' HB2' ' HD2' ' B' ' 216' ' ' PRO . . . -63.6 165.37 12.14 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.888 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' B' ' 215' ' ' ALA . 10.0 Cg_endo -51.9 176.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.974 2.449 . . . . 0.0 112.96 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -142.87 143.77 32.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.717 -172.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -137.25 -52.1 0.66 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.269 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 26.5 tp 58.77 62.43 1.91 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.62 0.724 . . . . 0.0 110.648 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -82.51 74.48 9.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.739 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 11.3 t -143.17 17.44 1.91 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.77 0.795 . . . . 0.0 109.711 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -109.99 38.74 2.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.439 -176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.147 179.335 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -85.4 112.9 21.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.879 0.371 . . . . 0.0 110.105 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -141.33 30.04 1.77 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.182 0.515 . . . . 0.0 110.639 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -76.48 -13.86 60.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.521 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.84 -9.55 51.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.58 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.4 t -92.06 92.43 8.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.186 0.517 . . . . 0.0 109.957 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 m -82.49 109.25 16.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.91 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 56.5 m -93.79 110.63 22.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.902 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.82 140.84 32.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.943 0.402 . . . . 0.0 111.861 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.3 t -109.7 140.32 29.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 172.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 4.5 mp0 -128.57 118.75 23.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.874 0.369 . . . . 0.0 110.168 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.633 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -107.03 170.21 2.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.174 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.44 ' HE3' ' HB3' ' A' ' 42' ' ' PRO . 54.9 mtmt -137.07 133.86 35.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.739 0.304 . . . . 0.0 110.467 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.3 mt -114.66 142.16 46.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.002 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.617 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.1 tt0 -103.48 123.48 46.98 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.712 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.641 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.1 mm? -110.56 113.32 25.85 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -142.19 175.52 22.7 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.896 -1.145 . . . . 0.0 111.981 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -167.1 151.67 7.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.06 0.457 . . . . 0.0 110.859 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 80.9 mtt180 -116.5 151.84 35.3 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.946 171.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -144.28 134.4 24.18 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.419 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -132.6 160.73 35.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.214 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 32' ' ' THR . 1.8 p -103.75 161.11 4.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 170.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.481 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 5.5 mtp85 -104.81 143.09 33.61 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -66.37 -19.05 65.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.59 0.709 . . . . 0.0 109.254 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -134.13 106.37 11.34 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.294 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.49 ' HG3' HG22 ' A' ' 32' ' ' THR . 99.0 Cg_exo -50.39 163.76 0.61 Allowed 'Trans proline' 0 N--CA 1.474 0.372 0 C-N-CA 123.109 2.539 . . . . 0.0 112.475 174.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.428 HG21 ' HB2' ' A' ' 31' ' ' PHE . 8.9 t -82.88 -175.7 5.94 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.468 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.05 -30.96 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.782 0.325 . . . . 0.0 111.309 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -82.78 -0.28 47.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.037 0.446 . . . . 0.0 110.701 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.81 33.96 49.7 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.476 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.428 ' HB2' HG21 ' A' ' 27' ' ' THR . 20.3 m-30 -95.57 130.71 42.34 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 176.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.587 ' O ' HG23 ' A' ' 22' ' ' VAL . 28.8 p -90.34 -30.98 17.1 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -170.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.426 ' O ' ' HA ' ' A' ' 79' ' ' SER . 62.7 m80 -112.19 146.21 38.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -170.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.481 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 6.1 m-20 -124.14 121.27 34.69 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.2 p-90 -122.52 150.22 42.85 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.639 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 46.0 ttp -125.59 118.06 24.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.612 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.9 m -100.02 150.15 5.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.263 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -151.13 154.69 37.43 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.6 m -124.15 127.97 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.833 170.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -132.08 -179.11 5.22 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.316 -174.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.11 -176.15 34.76 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.26 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.44 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 12.0 Cg_exo -68.8 111.7 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.768 2.312 . . . . 0.0 112.234 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 58.19 54.2 6.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.624 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 71.22 1.53 3.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.58 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.442 ' HB3' ' O ' ' A' ' 141' ' ' ALA . 49.7 m -63.11 128.23 34.89 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -68.96 128.22 35.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.042 0.449 . . . . 0.0 110.35 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.562 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.4 pt -94.66 -1.49 10.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.376 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -59.66 -3.69 0.53 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.515 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 93.2 m-70 -82.27 -31.98 29.82 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.143 -0.348 . . . . 0.0 111.471 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.549 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 54.2 p90 -119.66 -20.03 7.84 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.413 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.562 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 65.8 t -90.54 131.32 38.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 9.0 tp10 -102.62 -60.24 1.57 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.434 0.635 . . . . 0.0 110.262 -176.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.589 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 20.6 tttt -144.61 149.95 36.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.135 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.503 HG21 HG23 ' A' ' 39' ' ' VAL . 94.6 t -128.55 157.69 41.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.568 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 9.1 p -141.41 133.39 28.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.299 0.571 . . . . 0.0 111.054 -174.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.424 ' CD2' HG12 ' A' ' 88' ' ' ILE . 30.5 m-85 -117.02 109.04 16.48 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -80.62 91.93 5.9 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.915 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.535 ' CD2' HD13 ' A' ' 86' ' ' LEU . 11.0 mt -73.93 -176.96 2.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.999 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -77.34 147.53 36.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -56.14 -19.35 13.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.931 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.05 -24.99 65.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.108 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -81.65 137.56 47.67 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.645 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.73 118.03 5.14 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.462 2.108 . . . . 0.0 111.326 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 58.19 68.38 1.85 Allowed Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.521 0.513 . . . . 0.0 110.431 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.54 -18.48 63.73 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.845 2.363 . . . . 0.0 113.391 -174.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -88.94 101.25 13.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.185 0.517 . . . . 0.0 110.13 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 18.7 mmt180 -97.71 98.35 9.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.345 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -83.49 136.34 22.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.599 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.8 m -131.41 109.01 10.01 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -106.18 -24.24 12.38 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.63 0.728 . . . . 0.0 110.336 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.691 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 2.7 t70 -70.41 179.9 0.77 Allowed Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.319 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.691 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 16.6 Cg_exo -31.13 178.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 125.245 3.963 . . . . 0.0 114.489 163.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.597 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.3 Cg_endo -29.64 124.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 124.332 3.355 . . . . 0.0 114.442 -154.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 36.7 m-85 -61.87 93.94 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.901 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -146.14 145.53 30.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.264 0.554 . . . . 0.0 111.889 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.0 t -125.19 131.6 72.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.059 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -115.97 110.37 18.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.752 0.311 . . . . 0.0 110.196 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -130.18 165.44 22.34 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.933 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 2.1 m -116.12 129.65 56.43 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.979 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.42 -160.7 9.17 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -136.37 -20.04 1.42 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.291 0.546 . . . . 0.0 111.451 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.487 ' HB1' ' HG2' ' B' ' 218' ' ' ALY . . . -139.7 142.99 36.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.853 0.359 . . . . 0.0 110.974 -174.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -78.88 174.55 55.25 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.58 -177.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -173.13 159.41 3.89 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.963 0.505 . . . . 0.0 110.131 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.42 HD11 ' HA ' ' A' ' 106' ' ' ASP . 14.3 mm -68.07 125.5 25.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 172.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.535 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.1 tt -117.72 105.55 47.59 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.994 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.99 114.07 3.25 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 123.227 2.618 . . . . 0.0 112.231 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.424 HG12 ' CD2' ' A' ' 56' ' ' PHE . 5.0 mt -104.6 126.37 59.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.09 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.568 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.2 mt-10 -112.53 124.34 52.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.238 0.542 . . . . 0.0 110.124 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.469 HG13 ' CE1' ' A' ' 92' ' ' PHE . 78.7 t -103.72 120.44 53.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.772 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.589 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 74.5 m-85 -90.06 139.1 30.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.967 0.413 . . . . 0.0 110.346 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.469 ' CE1' HG13 ' A' ' 90' ' ' VAL . 23.7 m-85 -111.36 146.32 37.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.8 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -84.2 93.93 8.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -155.98 159.33 39.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.372 0.606 . . . . 0.0 112.124 -171.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.76 -4.0 14.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.734 175.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.517 ' HG2' ' CG2' ' A' ' 131' ' ' THR . 0.4 OUTLIER -100.29 -153.92 0.46 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.42 -177.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.439 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 20.6 mm-40 -27.07 150.19 0.02 OUTLIER Pre-proline 0 N--CA 1.48 1.03 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 3.0 Cg_exo -32.5 126.43 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.189 1 C-N-CA 125.316 4.011 . . . . 0.0 114.465 -167.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -85.7 19.5 2.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.246 -176.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.52 143.45 22.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.286 0.565 . . . . 0.0 111.159 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -126.93 154.79 37.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -121.18 121.85 38.7 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.001 0.429 . . . . 0.0 111.073 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.641 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.9 m-85 -113.86 117.7 32.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.923 174.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.61 111.89 15.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.188 0.518 . . . . 0.0 109.761 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -121.4 136.17 54.99 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.553 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.42 ' HA ' HD11 ' A' ' 85' ' ' ILE . 11.7 t70 -89.35 110.6 21.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.62 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.468 HD21 HG12 ' A' ' 37' ' ' VAL . 1.5 mp -89.36 97.63 11.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.745 0.307 . . . . 0.0 110.199 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -104.33 155.65 18.58 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.014 0.435 . . . . 0.0 110.769 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.2 mt -130.76 152.46 50.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -101.82 168.82 9.19 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.875 -0.515 . . . . 0.0 111.191 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -53.61 134.81 41.25 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -172.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.428 ' HA ' HG22 ' A' ' 22' ' ' VAL . 35.5 tt0 -49.48 118.43 2.75 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.221 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.585 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 123.75 -50.38 0.85 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.458 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -144.77 74.44 14.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 117.46 0.63 . . . . 0.0 111.791 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.448 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 58.1 Cg_endo -108.99 109.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.983 2.456 . . . . 0.0 113.864 176.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -98.17 97.54 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.967 2.445 . . . . 0.0 111.093 168.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 20' ' ' ALA . 37.5 t -117.14 112.19 38.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.719 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.483 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.2 OUTLIER -145.9 108.26 4.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.557 174.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.442 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.8 t-80 -127.22 135.25 50.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.657 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 119' ' ' HIS . 8.1 mt -118.03 147.36 43.31 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.497 0.498 . . . . 0.0 110.326 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.3 ttm180 -137.04 148.74 47.0 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.425 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 61.6 m -130.7 120.23 23.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.598 0.237 . . . . 0.0 110.39 175.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -118.47 143.63 46.57 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -100.94 136.54 40.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.259 0.552 . . . . 0.0 112.055 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.633 ' HB2' HG21 ' A' ' 12' ' ' VAL . 4.9 mt -104.42 115.2 29.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.814 174.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 34.4 m -105.13 116.77 32.52 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.062 0.458 . . . . 0.0 110.687 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -113.83 106.44 14.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.049 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -78.79 118.14 20.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.398 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.2 t30 52.14 63.03 9.69 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.397 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.25 -179.24 5.07 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.771 2.314 . . . . 0.0 112.395 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.517 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 3.5 p -72.75 139.74 47.32 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 173.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -56.95 -39.42 74.51 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.528 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 6.9 p-10 -63.33 -28.66 70.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.666 0.27 . . . . 0.0 110.343 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.621 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 14.8 t80 -75.57 -42.16 52.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.613 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 44.5 ttm105 -53.36 -45.97 69.39 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.099 0.476 . . . . 0.0 109.816 173.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -52.93 -41.12 64.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.381 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 38.8 mtpt -72.36 -39.6 67.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.618 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.9 mt -68.58 -30.59 69.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.909 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 36.1 mt -80.67 -35.68 33.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.163 -177.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -75.28 -30.09 60.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.78 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.749 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.42 0 N-CA-C 111.769 -0.532 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . 99.85 -50.48 1.12 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.908 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -85.83 129.15 34.91 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.775 0.321 . . . . 0.0 110.158 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.458 ' HB2' ' HD2' ' B' ' 216' ' ' PRO . . . -67.26 164.81 33.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.852 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' B' ' 215' ' ' ALA . 9.4 Cg_endo -51.87 162.97 1.52 Allowed 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 122.407 2.071 . . . . 0.0 112.063 174.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 26.8 ttt180 -142.03 144.02 33.42 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.663 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . 0.487 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -84.52 46.45 1.24 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.46 0.648 . . . . 0.0 110.182 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 54.4 tp -76.74 79.4 3.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.659 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -161.35 97.74 1.12 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.753 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 6.2 p -59.98 114.27 2.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.864 -177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . 0.447 ' HZ1' ' HB3' ' B' ' 223' ' ' LYS . 5.0 ttpm? -131.76 45.22 2.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.675 0.75 . . . . 0.0 109.058 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.887 -178.722 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -78.46 127.09 31.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -94.48 75.65 3.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.171 0.51 . . . . 0.0 110.147 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.9 tpt -99.04 -17.14 18.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.092 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.21 -32.61 66.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.696 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.1 p -91.76 76.81 5.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.158 0.504 . . . . 0.0 110.165 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.624 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 13.0 m -78.61 130.17 35.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.65 -176.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 40.6 t -153.53 125.38 7.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.282 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.68 130.45 51.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.754 0.311 . . . . 0.0 111.276 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.1 t -104.2 141.25 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 4.7 mp0 -128.76 130.26 46.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.899 0.38 . . . . 0.0 110.177 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.644 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -116.32 165.65 11.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.252 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 67.1 mttm -128.5 133.67 48.52 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.37 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.2 mt -115.6 141.19 48.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.722 175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.9 tt0 -104.33 129.98 52.18 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.862 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.618 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -114.99 112.44 22.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -138.09 170.1 23.94 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.956 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -164.2 151.63 12.06 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.881 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 67.8 mtt180 -116.87 143.09 46.1 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.727 174.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -139.21 131.26 27.95 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.532 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -133.94 163.69 28.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.898 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 32' ' ' THR . 1.9 p -103.37 158.27 4.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 32' ' ' THR . 3.7 mtp180 -102.76 142.92 33.1 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -70.53 -13.36 62.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.663 0.744 . . . . 0.0 109.434 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -142.96 104.63 5.23 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.052 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.492 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.6 Cg_exo -47.81 152.91 2.71 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.059 2.506 . . . . 0.0 112.243 174.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 31' ' ' PHE . 8.8 t -76.42 -170.08 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -171.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 m -62.42 -32.86 56.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.762 0.315 . . . . 0.0 111.729 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -82.18 -4.1 56.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.254 0.55 . . . . 0.0 110.438 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.99 31.46 43.22 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.413 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.408 ' HB2' HG21 ' A' ' 27' ' ' THR . 19.0 m-30 -90.3 131.67 35.97 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 22' ' ' VAL . 75.7 p -90.27 -29.49 18.11 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -168.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.443 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.2 m80 -112.55 146.08 39.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -171.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -117.78 121.08 39.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -124.83 147.55 48.68 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.068 0.461 . . . . 0.0 110.788 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.619 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 47.3 ttp -124.24 116.91 23.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.662 176.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.4 m -98.43 150.68 4.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.443 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -151.1 151.16 31.58 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.294 0.569 . . . . 0.0 112.36 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -122.55 138.46 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.334 169.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -155.88 -176.97 6.23 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.41 -170.92 43.85 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.514 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 3.2 Cg_exo -74.46 110.1 3.03 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.103 1.869 . . . . 0.0 112.366 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 49.8 77.07 0.12 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.508 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 76.62 -11.7 1.14 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.791 0.436 . . . . 0.0 112.134 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.511 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 50.6 m -68.36 123.26 20.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.719 0.295 . . . . 0.0 110.452 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -76.5 129.18 36.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.029 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.539 HD11 HG23 ' A' ' 51' ' ' VAL . 4.8 pt -95.46 -1.68 10.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.404 ' HG2' ' OH ' ' A' ' 74' ' ' TYR . 96.2 mt-30 -69.85 -0.79 7.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.9 0.381 . . . . 0.0 111.384 -175.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -71.46 -39.53 70.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.22 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.508 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 55.5 p90 -113.57 -17.61 12.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.394 -0.523 . . . . 0.0 111.593 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.539 HG23 HD11 ' A' ' 47' ' ' ILE . 91.5 t -91.29 130.45 40.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.828 0.346 . . . . 0.0 110.215 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.46 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 8.0 tp10 -99.13 -55.99 2.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.182 0.515 . . . . 0.0 110.46 -175.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -148.79 156.88 42.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.473 HG21 HG23 ' A' ' 39' ' ' VAL . 90.2 t -131.92 156.93 42.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.8 p -142.55 133.99 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.318 0.58 . . . . 0.0 110.979 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.439 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 29.6 m-85 -116.06 104.32 11.45 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -78.33 92.43 4.54 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.981 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.5 mt -75.36 -177.79 3.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 151.78 22.9 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.56 -175.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -55.64 -21.95 20.34 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.727 -174.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.0 t -65.84 -24.58 66.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 110.614 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -82.62 135.22 46.46 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.332 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.45 120.36 7.87 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.233 1.955 . . . . 0.0 110.537 172.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 60.68 81.57 0.24 Allowed Pre-proline 0 N--CA 1.464 0.23 0 O-C-N 123.502 0.501 . . . . 0.0 110.379 -173.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -61.0 -25.31 81.32 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.584 2.189 . . . . 0.0 113.747 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HE3' ' CG1' ' A' ' 68' ' ' VAL . 23.5 ttpt -98.32 107.24 19.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.058 0.456 . . . . 0.0 111.1 -172.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -106.1 100.9 10.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.892 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.423 ' CG1' ' HE3' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -87.63 137.8 20.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.8 m -125.34 114.09 18.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -104.3 -28.21 11.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.43 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.506 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 26.7 t70 -73.58 171.06 11.68 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.135 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.563 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 72.7 Cg_exo -26.0 -174.1 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.676 1 C-N-CA 126.016 4.477 . . . . 0.0 116.062 164.127 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.563 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 6.5 Cg_endo -33.3 120.37 0.11 Allowed 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.375 2.717 . . . . 0.0 114.139 -149.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 38.8 m-85 -62.74 93.35 0.05 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.212 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -143.71 144.82 32.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.342 0.591 . . . . 0.0 112.039 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.5 t -120.35 131.8 71.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.595 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.18 105.99 13.21 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -131.51 173.2 11.34 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.508 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.0 t -125.03 144.74 50.25 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.724 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.84 -170.66 29.07 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -133.08 -12.26 2.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.411 0.606 . . . . 0.0 111.645 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.449 ' HB1' ' HG2' ' B' ' 218' ' ' ALY . . . -143.41 145.1 32.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.661 0.267 . . . . 0.0 110.589 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.554 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -83.63 178.03 52.48 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.782 -0.644 . . . . 0.0 113.266 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -178.15 157.81 1.13 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.064 0.546 . . . . 0.0 110.168 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.1 mm -62.67 125.47 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.661 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.438 HD23 HG13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -107.93 105.01 55.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -68.36 105.33 1.22 Allowed 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 123.013 2.475 . . . . 0.0 111.625 170.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.438 HG13 HD23 ' A' ' 86' ' ' LEU . 5.8 mt -100.87 123.73 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.237 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.9 mt-10 -109.67 123.62 49.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.286 0.565 . . . . 0.0 110.039 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -103.04 117.21 48.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.619 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.564 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 83.8 m-85 -87.89 141.23 28.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.086 0.469 . . . . 0.0 110.778 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.451 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.3 m-85 -114.12 153.82 28.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.884 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.46 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -95.77 94.13 7.49 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.504 HD22 ' HB2' ' A' ' 96' ' ' GLU . 58.3 t30 -155.37 158.46 38.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.933 -170.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.2 ptpp? -107.85 -6.95 16.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.718 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.504 ' HB2' HD22 ' A' ' 94' ' ' ASN . 23.7 mm-40 -101.29 -150.73 0.4 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.822 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.402 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 15.3 mm-40 -25.27 149.04 0.02 OUTLIER Pre-proline 0 N--CA 1.479 1.006 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -31.45 126.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 1 C-N-CA 125.41 4.074 . . . . 0.0 114.717 -170.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.58 19.52 1.97 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.823 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.73 142.12 20.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 110.537 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -124.63 155.63 32.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 174.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -124.19 119.11 28.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.144 0.497 . . . . 0.0 111.163 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.618 ' CD2' HD22 ' A' ' 16' ' ' LEU . 24.0 m-85 -111.58 115.77 29.72 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.906 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.79 101.82 7.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.37 0.605 . . . . 0.0 109.773 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -115.58 134.82 54.69 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.646 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -86.52 118.17 25.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.684 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.469 HD21 HG12 ' A' ' 37' ' ' VAL . 1.4 mp -93.96 91.45 6.9 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.593 ' CE1' HG13 ' A' ' 117' ' ' VAL . 50.4 p90 -99.32 157.03 16.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.043 0.449 . . . . 0.0 110.832 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.5 mt -133.68 158.57 42.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 115' ' ' PRO . 2.7 m-70 -102.13 174.48 5.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.244 -0.285 . . . . 0.0 110.364 172.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.24 160.98 31.18 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -58.72 123.11 15.27 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.377 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.487 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 115.66 -45.04 1.35 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.843 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -140.98 74.58 25.5 Favored Pre-proline 0 N--CA 1.464 0.228 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.505 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.51 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 71.9 Cg_endo -113.0 107.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.789 2.326 . . . . 0.0 113.448 172.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -99.66 96.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 123.034 2.489 . . . . 0.0 110.922 165.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.593 HG13 ' CE1' ' A' ' 108' ' ' PHE . 4.9 t -123.09 109.41 23.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.59 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.453 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.16 97.13 3.0 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.442 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.9 t-80 -119.55 134.34 55.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.777 -176.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 119' ' ' HIS . 9.8 mt -117.91 145.76 44.42 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.681 0.613 . . . . 0.0 110.016 176.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.643 ' HD3' ' OE2' ' A' ' 123' ' ' GLU . 11.3 ttm180 -132.96 148.46 52.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.471 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 84.6 m -123.32 116.13 22.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.332 0.587 . . . . 0.0 111.059 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.643 ' OE2' ' HD3' ' A' ' 121' ' ' ARG . 64.3 mm-40 -98.43 162.45 13.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.383 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.547 ' HB3' ' HZ2' ' A' ' 124' ' ' LYS . 7.4 ttpm? -125.48 128.35 47.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.413 0.625 . . . . 0.0 111.115 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.644 ' HB2' HG21 ' A' ' 12' ' ' VAL . 8.3 mt -100.34 115.37 29.81 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.962 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 20.9 m -109.14 122.71 47.89 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.005 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -120.42 100.61 7.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.046 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -73.42 116.36 13.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.653 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.624 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 5.0 t30 58.26 74.76 0.59 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.452 175.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 8' ' ' CYS . 82.2 Cg_endo -97.48 -178.54 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.23 2.62 . . . . 0.0 112.817 -174.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.433 ' CG2' ' HG3' ' A' ' 96' ' ' GLU . 5.9 p -71.66 144.54 49.35 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -57.36 -45.97 83.84 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.92 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -57.93 -28.94 64.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.613 0.244 . . . . 0.0 110.918 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.652 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.2 t80 -73.12 -47.01 47.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.642 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.3 ttm105 -52.18 -48.3 65.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.264 0.554 . . . . 0.0 109.924 174.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -54.83 -34.52 62.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.778 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.5 mtmt -81.52 -37.68 27.46 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.514 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.8 mt -66.19 -28.9 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.7 mt -80.42 -37.98 31.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.434 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.435 ' NZ ' ' HB2' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -70.76 -30.39 66.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.877 -176.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.913 178.975 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.27 79.2 0.92 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.28 -0.486 . . . . 0.0 112.586 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -82.22 -42.6 18.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.958 0.409 . . . . 0.0 109.915 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.422 ' HB2' ' HD2' ' B' ' 216' ' ' PRO . . . -68.59 159.62 80.69 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.966 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' B' ' 215' ' ' ALA . 19.8 Cg_endo -58.49 170.01 2.74 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.434 2.089 . . . . 0.0 112.239 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 17.9 ttm180 -142.8 135.95 28.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.979 0.418 . . . . 0.0 110.831 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . 0.449 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -91.46 -31.39 16.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.854 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 18.4 tp -159.33 47.39 0.29 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.628 0.727 . . . . 0.0 109.814 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -70.38 -11.64 61.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.324 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 16.7 m -64.06 -25.91 68.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.909 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -96.01 19.64 11.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.579 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.093 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.173 179.85 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -67.75 -29.8 69.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.856 0.36 . . . . 0.0 111.51 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -76.49 -34.24 58.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.473 . . . . 0.0 110.034 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.5 tpp -71.39 -50.68 29.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.204 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.5 114.4 11.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.804 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.8 t -100.0 138.81 36.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.426 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 53.8 m -71.27 108.52 4.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.905 0.383 . . . . 0.0 110.156 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.561 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 61.8 m -97.95 116.24 29.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.713 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.8 134.06 43.26 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -171.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.3 t -104.83 144.17 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -132.29 114.86 14.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.849 0.357 . . . . 0.0 110.292 -173.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -105.85 166.04 3.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.343 -179.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -129.23 126.01 38.18 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.148 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.0 mt -103.62 142.78 33.72 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.657 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 28.1 tt0 -107.94 125.5 51.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.302 -173.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.494 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -107.79 117.54 34.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 173.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -139.88 165.33 25.94 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.396 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -162.87 149.03 12.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.077 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 34.8 mtp180 -121.62 128.17 51.63 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.61 117.46 29.45 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.377 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -110.13 141.67 42.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.455 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 112' ' ' GLU . 5.7 p -102.95 146.08 11.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mtp85 -97.0 142.93 28.35 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -72.32 -13.92 61.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.489 0.661 . . . . 0.0 109.335 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 26' ' ' PRO . 13.7 tmtt? -138.8 100.49 8.12 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.89 176.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.491 ' HG3' HG22 ' A' ' 32' ' ' THR . 80.7 Cg_exo -50.78 160.31 1.88 Allowed 'Trans proline' 0 N--CA 1.478 0.577 0 C-N-CA 123.612 2.874 . . . . 0.0 113.359 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 31' ' ' PHE . 5.4 t -79.65 -174.41 4.3 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.836 -175.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.2 m -62.32 -32.59 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.849 0.357 . . . . 0.0 111.163 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -79.78 -6.45 57.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.11 0.481 . . . . 0.0 110.513 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.6 33.26 38.98 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.268 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.436 ' H ' HG23 ' A' ' 27' ' ' THR . 22.1 m-30 -93.46 130.88 39.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.491 HG22 ' HG3' ' A' ' 26' ' ' PRO . 45.9 p -92.04 -21.56 20.42 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.251 -170.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.474 ' HE1' ' OE1' ' A' ' 112' ' ' GLU . 54.9 m80 -118.84 147.24 44.15 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -171.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -123.3 117.28 24.9 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -121.3 147.93 45.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.105 0.479 . . . . 0.0 111.263 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.609 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 52.2 ttp -125.33 119.38 28.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.514 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.5 m -101.93 148.97 6.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.471 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 2.1 p90 -149.5 153.28 36.99 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.8 m -123.58 135.86 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.636 170.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.44 ' HD2' ' OE2' ' A' ' 15' ' ' GLU . 8.3 ptp85 -152.56 -176.74 5.85 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.75 -173.57 44.19 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.453 -175.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.509 ' HD2' ' OG ' ' A' ' 45' ' ' SER . 5.1 Cg_exo -74.21 125.7 9.93 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.169 2.579 . . . . 0.0 111.354 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 61.99 47.67 5.69 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.544 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 37.1 m80 64.23 18.36 11.24 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.509 ' OG ' ' HD2' ' A' ' 42' ' ' PRO . 22.9 p -71.05 153.64 42.42 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 122.131 -0.356 . . . . 0.0 110.137 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.35 125.5 30.45 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.538 HD11 HG23 ' A' ' 51' ' ' VAL . 4.6 pt -96.58 -1.52 10.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.575 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 48' ' ' GLN . 32.8 tt0 -70.48 -4.52 23.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.575 0.702 . . . . 0.0 109.736 -174.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.41 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 93.8 m-70 -66.1 -39.41 89.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.304 173.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.485 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 55.3 p90 -116.07 -19.39 10.33 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.133 176.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.538 HG23 HD11 ' A' ' 47' ' ' ILE . 96.7 t -88.8 131.32 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.229 0.537 . . . . 0.0 109.939 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.96 -59.85 1.68 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.367 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 16.2 tttt -149.53 149.78 31.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.811 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 93.9 t -128.92 157.41 41.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -177.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.567 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 8.7 p -142.53 135.1 26.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.383 0.611 . . . . 0.0 111.169 -174.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.457 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 25.1 m-85 -117.78 108.3 15.2 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -81.31 93.58 6.58 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.123 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.581 ' CD2' HD13 ' A' ' 86' ' ' LEU . 9.9 mt -74.16 -177.82 3.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 73.2 t60 -80.93 137.48 36.13 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.5 -20.49 20.58 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.5 t -64.57 -18.14 64.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.866 0.365 . . . . 0.0 110.902 173.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 44.0 m-85 -83.27 144.14 46.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.13 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 62' ' ' PHE . 15.9 Cg_exo -68.71 118.69 5.82 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.425 2.083 . . . . 0.0 110.851 173.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 63.54 73.17 0.5 Allowed Pre-proline 0 N--CA 1.465 0.279 0 O-C-N 123.543 0.527 . . . . 0.0 110.007 -176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.24 -22.71 66.65 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.793 2.329 . . . . 0.0 113.406 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -97.35 103.29 15.21 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 120.974 0.416 . . . . 0.0 110.421 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.7 mmm-85 -105.15 102.23 11.73 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.321 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.6 m -95.26 138.27 21.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.5 m -125.13 119.63 29.11 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -106.74 -28.71 10.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.59 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.682 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 37.4 m-20 -72.13 -172.31 0.22 Allowed Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.531 1.132 . . . . 0.0 111.768 -174.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.682 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 72.4 Cg_exo -39.89 -172.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.858 0 C-N-CA 123.492 2.794 . . . . 0.0 114.084 165.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.7 Cg_endo -33.83 123.42 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 123.857 3.038 . . . . 0.0 114.442 -154.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 36.9 m-85 -63.21 92.07 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.187 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -142.79 145.41 33.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.183 0.516 . . . . 0.0 111.866 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 36' ' ' MET . 75.1 t -118.55 133.73 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.42 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.471 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 5.7 mm-40 -112.15 107.36 16.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.975 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.25 169.47 17.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.122 0.487 . . . . 0.0 111.039 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.2 t -126.94 143.24 51.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.888 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.76 -161.68 13.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.746 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -137.69 -14.86 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.292 0.546 . . . . 0.0 112.174 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.462 ' HB1' ' HG2' ' B' ' 218' ' ' ALY . . . -143.27 148.05 35.77 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.023 -176.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.541 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -84.99 179.43 51.08 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.619 -0.719 . . . . 0.0 113.182 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -178.96 155.52 0.76 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.935 0.494 . . . . 0.0 109.911 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.403 HD11 ' HA ' ' A' ' 106' ' ' ASP . 23.0 mm -62.72 127.1 22.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.242 171.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.581 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.7 tt -120.09 104.82 43.27 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-O 121.129 0.49 . . . . 0.0 110.106 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.19 112.2 2.24 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.399 2.732 . . . . 0.0 112.721 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 mt -103.64 124.26 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.183 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.567 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 50.9 mt-10 -109.62 124.67 51.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.152 0.501 . . . . 0.0 109.903 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.42 HG13 ' CE1' ' A' ' 92' ' ' PHE . 59.1 t -105.26 119.2 54.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.841 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.599 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 88.9 m-85 -91.19 138.82 31.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.015 0.436 . . . . 0.0 110.863 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.5 m-85 -112.14 154.65 25.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.735 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.3 95.14 7.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.566 HD22 ' HB2' ' A' ' 96' ' ' GLU . 61.0 t30 -155.33 164.38 38.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.808 -172.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -112.86 -4.6 13.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.615 178.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.566 ' HB2' HD22 ' A' ' 94' ' ' ASN . 17.4 mm-40 -100.93 -153.47 0.45 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.067 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.477 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 20.3 mm-40 -29.89 153.23 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 124.621 1.168 . . . . 0.0 114.071 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 6.2 Cg_exo -32.72 124.86 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.125 1 C-N-CA 125.356 4.037 . . . . 0.0 114.876 -167.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.443 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -88.2 19.58 3.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.392 -177.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -152.37 140.41 20.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.235 0.54 . . . . 0.0 110.887 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.1 m -125.75 156.41 35.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.72 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -122.92 121.8 37.05 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.011 0.434 . . . . 0.0 111.201 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.494 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.6 m-85 -112.83 110.75 21.05 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.707 173.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -82.21 99.03 9.04 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -108.32 138.97 43.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.159 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.403 ' HA ' HD11 ' A' ' 85' ' ' ILE . 12.4 t70 -81.83 113.66 19.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.96 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.496 HD21 HG12 ' A' ' 37' ' ' VAL . 1.8 mp -90.01 104.99 17.51 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -116.01 154.95 28.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.91 0.386 . . . . 0.0 110.661 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.9 mt -135.48 162.59 32.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.647 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.645 ' CD2' ' HA ' ' A' ' 116' ' ' PRO . 7.7 p80 -100.49 171.82 7.5 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.418 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.451 HD21 ' HA ' ' B' ' 215' ' ' ALA . 1.0 OUTLIER -74.42 168.85 18.89 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.834 0.349 . . . . 0.0 111.129 177.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.474 ' OE1' ' HE1' ' A' ' 33' ' ' HIS . 0.8 OUTLIER -67.23 120.3 13.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.52 178.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.73 16.89 62.77 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.925 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -115.76 152.4 47.33 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-O 118.709 -0.662 . . . . 0.0 110.024 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -28.28 124.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 124.288 3.325 . . . . 0.0 114.631 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.645 ' HA ' ' CD2' ' A' ' 110' ' ' HIS . 24.6 Cg_exo -62.98 -178.77 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.236 2.624 . . . . 0.0 112.936 174.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 31.6 t -122.42 130.73 74.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.064 -176.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -139.01 98.22 3.48 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -125.0 132.59 53.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.41 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.4 mt -111.43 156.45 21.62 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.866 0.729 . . . . 0.0 109.103 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 16.3 ttt180 -147.47 143.71 28.08 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.31 -0.244 . . . . 0.0 110.719 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 24.8 p -118.98 116.88 27.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.217 0.532 . . . . 0.0 111.064 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -111.92 132.84 54.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.951 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -97.81 131.56 44.2 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.164 0.506 . . . . 0.0 111.742 -172.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.664 ' HB2' HG21 ' A' ' 12' ' ' VAL . 7.4 mt -99.34 118.1 35.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.2 m -106.26 120.48 41.97 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.175 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -117.59 99.33 6.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.895 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -71.72 117.42 13.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.958 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.426 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 5.4 t30 55.94 78.35 0.38 Allowed Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.873 174.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 8' ' ' CYS . 95.6 Cg_endo -97.64 -178.22 0.31 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.003 2.469 . . . . 0.0 112.13 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.0 p -74.1 142.25 45.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 171.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.421 ' OE2' ' HD2' ' A' ' 135' ' ' ARG . 4.0 tp10 -56.51 -38.25 71.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.019 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.656 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 15.6 m-20 -59.98 -35.29 74.69 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.609 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.6 t80 -72.54 -40.66 66.55 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.671 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 30.9 ttm180 -55.85 -45.62 78.39 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -59.13 -34.69 72.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.955 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 40.4 mtpt -71.32 -43.56 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.2 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 37.3 mt -68.63 -34.33 75.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.767 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 43.4 mt -74.1 -33.81 63.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.928 0.394 . . . . 0.0 110.836 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.472 ' HZ1' ' CB ' ' A' ' 140' ' ' LYS . 2.4 ttpm? -76.57 -27.02 55.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.538 -175.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.84 178.32 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -77.99 68.68 2.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.606 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -80.04 -35.76 36.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.695 0.283 . . . . 0.0 110.791 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.451 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -71.78 161.31 79.36 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.482 -174.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.31 -177.3 0.12 Allowed 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.547 2.164 . . . . 0.0 113.23 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 18.4 ttm180 -150.18 138.92 20.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.71 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . 0.462 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -93.7 122.37 36.08 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 8.2 tt -74.91 100.15 4.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.079 0.466 . . . . 0.0 110.217 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -97.77 -59.49 1.76 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.54 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 16.5 m 51.38 55.29 9.67 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.725 0.774 . . . . 0.0 110.637 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -82.93 -34.21 26.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.353 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.018 175.554 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -87.61 141.51 28.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.875 0.369 . . . . 0.0 110.487 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -118.63 141.78 48.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -76.81 84.3 3.4 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 56.72 -90.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.898 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.6 t -118.67 145.68 45.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.3 m -59.02 110.1 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 129' ' ' ASN . 13.6 p -90.11 127.7 36.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.565 -171.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.5 129.36 46.44 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.992 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 t -99.97 139.8 20.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.0 mp0 -125.67 120.41 30.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.04 0.447 . . . . 0.0 110.046 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.68 161.85 5.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.974 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.447 ' CE ' ' HB3' ' A' ' 42' ' ' PRO . 47.5 mtmt -128.57 128.62 44.6 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.364 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.5 mt -111.79 140.64 46.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.103 0.478 . . . . 0.0 109.715 174.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.615 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.7 tt0 -104.68 122.35 45.49 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.929 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.645 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.4 mm? -108.67 117.92 35.43 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.23 -179.85 24.52 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.21 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -169.43 154.45 5.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -122.1 136.27 54.9 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.519 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -133.62 126.62 31.28 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.358 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 34' ' ' ASP . 0.6 OUTLIER -130.13 158.26 40.17 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.149 178.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 32' ' ' THR . 1.7 p -101.85 160.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.58 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 6.3 ptm180 -111.95 142.27 44.56 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -70.08 -8.85 52.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.532 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -144.55 100.89 4.71 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.584 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.06 155.04 4.76 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.144 2.563 . . . . 0.0 111.87 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.481 HG21 ' HB2' ' A' ' 31' ' ' PHE . 8.8 t -78.26 -175.47 4.19 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.062 -171.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 m -57.52 -33.09 43.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 122.634 0.373 . . . . 0.0 111.838 -175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -86.6 0.42 54.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.086 0.469 . . . . 0.0 110.73 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.04 33.18 41.78 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.899 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.481 ' HB2' HG21 ' A' ' 27' ' ' THR . 16.3 m-30 -92.07 133.17 35.99 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 22' ' ' VAL . 58.7 p -96.7 -27.76 14.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -168.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 79' ' ' SER . 66.9 m80 -118.42 140.77 49.35 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -172.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.58 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 17.3 m-20 -115.39 116.02 27.55 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -119.38 151.51 38.37 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.006 0.432 . . . . 0.0 110.893 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.611 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 57.0 ttp -127.43 120.9 29.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.43 174.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.8 m -100.84 152.16 5.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.212 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.589 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -153.08 154.14 34.26 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 10.2 m -120.82 126.15 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.671 168.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.437 ' HB2' ' HB3' ' A' ' 15' ' ' GLU . 14.1 mmm180 -128.62 176.52 7.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 -172.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.78 -177.4 33.76 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.571 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.447 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 8.1 Cg_exo -69.8 111.01 2.7 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.505 2.137 . . . . 0.0 112.323 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 53.56 61.66 3.01 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.525 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 76.55 -7.43 1.84 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.29 0.636 . . . . 0.0 112.366 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.4 m -69.44 128.6 37.12 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.29 -0.256 . . . . 0.0 111.046 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -65.22 129.59 40.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 110.653 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.535 HD11 HG23 ' A' ' 51' ' ' VAL . 4.2 pt -95.78 -1.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -61.22 -15.72 37.4 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.111 0.482 . . . . 0.0 110.906 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -63.64 -37.13 86.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.209 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.508 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 53.9 p90 -117.9 -16.63 9.9 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.408 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.535 HG23 HD11 ' A' ' 47' ' ' ILE . 95.4 t -89.56 129.71 40.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.131 0.491 . . . . 0.0 110.199 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -97.45 -66.0 0.93 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.417 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.643 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -144.45 151.18 38.83 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.461 HG21 HG23 ' A' ' 39' ' ' VAL . 95.1 t -124.2 159.52 29.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 O-C-N 122.104 -0.372 . . . . 0.0 110.198 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.546 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.4 p -143.18 137.53 26.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.073 0.464 . . . . 0.0 111.016 -174.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.465 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 17.1 m-85 -120.8 111.22 17.3 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -84.42 95.23 8.71 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.941 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.544 ' CD2' HD13 ' A' ' 86' ' ' LEU . 8.1 mt -73.48 -177.59 2.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -81.21 146.64 30.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -56.4 -19.26 14.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.413 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 m -69.59 -20.56 63.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.085 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -83.34 144.41 46.49 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.582 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.63 118.24 5.45 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.586 2.191 . . . . 0.0 110.65 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 61.06 78.5 0.31 Allowed Pre-proline 0 C--O 1.225 -0.192 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.181 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.65 -24.03 77.48 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.847 2.364 . . . . 0.0 113.732 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -97.44 109.14 21.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.969 -0.457 . . . . 0.0 110.881 -174.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -108.01 105.55 15.37 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.136 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.55 142.2 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 175.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.458 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 43.4 t -131.81 114.65 14.96 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -106.75 -24.82 11.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.242 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.556 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 24.7 t70 -68.97 171.63 6.16 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.564 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.576 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 82.6 Cg_exo -29.2 -170.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.557 1.652 1 C-N-CA 125.478 4.119 . . . . 0.0 115.466 164.032 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.613 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 Cg_endo -36.17 121.7 0.26 Allowed 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 122.808 2.339 . . . . 0.0 113.887 -151.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 39.5 m-85 -62.17 91.44 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.059 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 4.6 ptpt -139.16 146.92 41.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.261 0.553 . . . . 0.0 111.877 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.0 t -123.71 131.82 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.804 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.77 113.54 24.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.25 172.85 12.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.222 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.3 t -126.67 141.3 51.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.495 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.61 -171.44 23.59 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -131.47 -1.92 3.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.592 0.696 . . . . 0.0 112.195 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.505 ' HB1' ' HG2' ' B' ' 218' ' ' ALY . . . -152.68 129.92 11.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.902 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.507 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -72.31 175.29 43.16 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.348 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -175.96 158.95 2.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.669 0.388 . . . . 0.0 110.275 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.429 HD12 HG21 ' A' ' 85' ' ' ILE . 12.1 mm -65.58 124.86 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.409 171.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.544 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.9 tt -118.24 105.87 45.95 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.05 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.08 118.64 5.8 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.918 2.412 . . . . 0.0 112.212 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.0 mt -107.61 125.0 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.068 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.546 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 55.0 mt-10 -111.44 118.3 35.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.268 0.556 . . . . 0.0 109.924 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 64.6 t -100.42 119.18 48.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.825 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.643 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 82.5 m-85 -92.24 138.81 31.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.039 0.447 . . . . 0.0 110.815 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -112.53 150.84 30.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.19 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.67 95.13 10.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.543 HD22 ' HB2' ' A' ' 96' ' ' GLU . 62.6 t30 -154.2 155.34 35.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 0.0 112.152 -169.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.408 ' HB3' ' HZ1' ' A' ' 95' ' ' LYS . 0.1 OUTLIER -111.87 -1.94 15.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.131 174.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.543 ' HB2' HD22 ' A' ' 94' ' ' ASN . 32.7 mm-40 -100.29 -152.22 0.42 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.792 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.402 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 14.7 mm-40 -31.36 154.06 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 4.6 Cg_exo -30.92 125.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.161 1 C-N-CA 125.37 4.047 . . . . 0.0 114.51 -169.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.66 17.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.899 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.62 149.08 26.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.142 0.496 . . . . 0.0 111.035 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.3 m -123.1 157.78 28.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.724 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -128.12 106.96 9.42 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.695 0.283 . . . . 0.0 110.35 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.4 m-85 -106.57 121.37 44.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.001 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.31 114.58 23.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -123.93 138.39 54.48 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.349 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.5 119.71 30.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.48 HD21 HG12 ' A' ' 37' ' ' VAL . 2.0 mp -93.11 91.7 7.44 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -100.28 153.51 19.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.963 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.5 mt -129.39 154.15 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.403 ' ND1' HG21 ' A' ' 117' ' ' VAL . 27.9 m170 -103.15 170.39 7.99 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.124 -0.36 . . . . 0.0 111.107 174.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.434 HD21 ' HA ' ' B' ' 215' ' ' ALA . 2.0 mm? -61.48 141.2 57.85 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -50.77 123.06 8.25 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.896 175.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.521 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 119.47 -50.12 0.83 Allowed Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.845 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -144.48 74.26 15.39 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.629 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.424 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 72.1 Cg_endo -111.07 108.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 123.119 2.546 . . . . 0.0 113.368 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -97.91 97.95 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.927 2.418 . . . . 0.0 110.605 167.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 20' ' ' ALA . 4.7 t -116.34 109.58 28.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.075 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -144.04 121.87 11.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -144.47 131.81 20.79 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.255 -177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.2 mt -116.28 147.4 41.55 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.707 0.629 . . . . 0.0 109.862 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 20.3 ttm180 -136.19 146.02 46.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 84.2 m -128.73 114.48 16.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.022 0.439 . . . . 0.0 110.703 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -109.79 142.7 40.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.006 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -102.74 129.29 49.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.494 0.664 . . . . 0.0 111.845 -172.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.647 ' HB2' HG21 ' A' ' 12' ' ' VAL . 6.5 mt -96.77 120.24 36.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.548 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.8 m -111.22 121.62 45.75 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.623 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -118.83 110.68 17.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.311 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -76.07 117.58 17.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.334 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 5.3 t30 48.03 64.66 8.21 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.92 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.41 176.28 10.17 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.367 2.044 . . . . 0.0 111.899 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.4 p -72.75 144.71 47.5 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.443 ' HG3' ' NH1' ' A' ' 135' ' ' ARG . 29.5 tt0 -56.01 -44.17 78.43 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.502 -0.479 . . . . 0.0 112.032 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -56.9 -32.37 65.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.651 0.262 . . . . 0.0 110.449 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.656 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.8 t80 -76.73 -41.28 45.65 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.611 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.9 ttm180 -54.93 -44.44 74.27 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -57.1 -40.14 76.4 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.311 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -71.19 -40.95 70.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.85 0.357 . . . . 0.0 110.858 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 45.9 mt -69.28 -33.77 73.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.3 mt -76.61 -31.24 57.3 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.826 0.346 . . . . 0.0 110.783 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -75.02 -27.51 60.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.167 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 119.151 -0.452 . . . . 0.0 110.119 175.093 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 112.163 -0.375 . . . . 0.0 112.163 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -77.28 -49.69 7.25 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.87 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -86.46 128.93 35.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.7 0.286 . . . . 0.0 110.56 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.434 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -77.09 165.5 51.71 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.909 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . 0.42 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 0.3 OUTLIER -36.18 145.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.622 2.882 . . . . 0.0 114.381 175.048 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 15.2 ttm180 -151.63 127.94 10.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.2 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . 0.505 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -83.44 35.36 0.5 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.678 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' B' ' 218' ' ' ALY . 3.5 mm? -118.64 151.09 38.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.865 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -81.34 69.78 8.05 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.009 0.433 . . . . 0.0 110.872 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 6.0 t -70.82 133.78 46.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.641 178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -81.82 111.06 17.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.283 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.439 -0.791 . . . . 0.0 110.339 178.097 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 112.061 -0.416 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 38.8 m -131.32 62.34 1.62 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.834 0.349 . . . . 0.0 110.236 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.407 ' HB2' ' O ' ' A' ' 2' ' ' SER . 36.0 m-70 71.93 -55.3 0.67 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.67 0.788 . . . . 0.0 111.947 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.8 ptm -162.25 126.05 3.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.819 0.342 . . . . 0.0 110.345 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.27 -67.22 0.1 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.126 0.488 . . . . 0.0 110.338 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.0 p -88.82 163.55 15.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.858 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.571 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 67.3 m -73.73 108.4 6.54 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.144 0.497 . . . . 0.0 110.903 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 130' ' ' PRO . 51.2 t -104.99 104.87 14.7 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.325 176.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.93 126.58 50.15 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.009 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 t -99.71 139.37 21.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.86 118.03 25.42 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.024 0.44 . . . . 0.0 110.101 -174.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.14 176.48 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.838 -178.217 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 57.6 mttt -143.67 138.72 29.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.097 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.8 mt -126.25 147.5 49.67 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.1 tt0 -105.01 127.95 53.09 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.225 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.665 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -112.98 120.7 42.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -145.65 175.93 24.92 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.926 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -167.91 150.41 5.65 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.152 0.501 . . . . 0.0 109.886 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.491 ' HG2' ' OD1' ' A' ' 118' ' ' ASN . 68.5 mtp180 -122.27 145.4 48.26 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.365 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.492 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -132.82 129.01 37.95 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.643 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.421 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 14.8 tt0 -126.09 147.95 49.47 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.223 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.557 HG11 ' H ' ' A' ' 113' ' ' GLY . 1.0 OUTLIER -103.05 156.3 5.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 170.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.677 ' NH2' ' HA ' ' A' ' 26' ' ' PRO . 17.6 mtm-85 -111.88 150.93 29.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -76.56 -6.26 51.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -136.95 106.14 8.85 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.677 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 71.5 Cg_exo -52.95 144.5 44.92 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.059 1.84 . . . . 0.0 112.272 175.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.43 ' N ' ' NH2' ' A' ' 23' ' ' ARG . 4.2 t -85.77 -175.28 5.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.745 -168.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.433 ' H ' HG11 ' A' ' 28' ' ' VAL . 1.4 m -57.2 -33.69 43.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -171.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -87.93 -0.26 56.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.718 0.294 . . . . 0.0 111.496 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.72 35.02 23.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.407 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -101.68 145.0 29.7 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 22' ' ' VAL . 30.3 p -104.36 -33.86 8.49 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.446 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.1 m80 -110.02 145.28 37.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -170.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.477 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -122.95 116.52 23.73 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.8 p-90 -118.16 155.1 31.05 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.702 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.634 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 48.3 ttp -130.86 121.07 24.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.574 175.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 9.2 m -100.82 152.03 5.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.05 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -153.72 151.73 29.96 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.597 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -121.88 124.78 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.246 168.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 40' ' ' ARG . 2.6 mmp_? -133.43 168.71 18.12 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.975 0.417 . . . . 0.0 110.985 -173.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.46 118.22 4.74 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.495 ' O ' ' HB2' ' A' ' 45' ' ' SER . 40.3 Cg_endo -74.64 151.69 41.75 Favored 'Trans proline' 0 C--N 1.326 -0.647 0 C-N-CA 122.854 2.369 . . . . 0.0 113.01 -176.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 61.86 54.47 2.85 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.994 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 66.2 1.06 1.85 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.297 0.639 . . . . 0.0 112.241 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 12.9 m -76.53 139.43 40.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.0 111.541 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -103.06 124.95 49.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD11 HG23 ' A' ' 51' ' ' VAL . 19.9 pt -95.7 -2.37 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -169.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -68.74 -11.5 60.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.472 0.653 . . . . 0.0 110.175 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.496 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 95.6 m-70 -68.87 -40.98 78.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.122 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.509 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 47.8 p90 -110.05 -14.54 14.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.753 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.516 HG23 HD11 ' A' ' 47' ' ' ILE . 96.4 t -92.59 129.37 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.995 0.426 . . . . 0.0 110.351 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -95.33 -58.43 2.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.377 0.608 . . . . 0.0 110.615 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -152.57 155.7 37.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.578 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 77.5 t -129.51 156.93 42.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.526 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 13.4 p -141.54 137.29 32.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.132 0.492 . . . . 0.0 111.042 -174.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.45 ' CE2' HG12 ' A' ' 88' ' ' ILE . 30.9 m-85 -119.07 108.3 14.55 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -79.63 95.59 5.95 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.05 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.574 ' CD2' HD13 ' A' ' 86' ' ' LEU . 10.6 mt -81.86 -178.07 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -87.85 152.08 22.37 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.67 -15.45 19.5 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.079 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -67.33 -18.89 65.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.348 0.594 . . . . 0.0 110.373 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.01 142.23 24.27 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.432 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.21 129.98 21.64 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.373 2.049 . . . . 0.0 110.384 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 61.01 76.62 0.4 Allowed Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 123.45 0.469 . . . . 0.0 109.864 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.95 -18.17 62.72 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.467 2.111 . . . . 0.0 113.312 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -110.42 107.22 16.83 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 122.06 -0.4 . . . . 0.0 110.653 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.6 mmt85 -105.74 108.0 19.29 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.415 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.8 m -97.74 138.85 21.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.3 m -123.2 113.19 18.61 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.995 0.426 . . . . 0.0 109.988 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -105.86 -25.54 12.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.625 0.726 . . . . 0.0 110.259 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.687 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 14.4 m-20 -75.05 -172.03 0.25 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.882 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.687 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 78.0 Cg_exo -38.42 -179.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.415 2.744 . . . . 0.0 114.027 166.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.613 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -30.48 125.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 124.622 3.548 . . . . 0.0 114.985 -153.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 31.5 m-85 -61.69 92.84 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.735 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.595 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 13.4 ptpt -147.71 144.7 28.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.235 0.541 . . . . 0.0 111.817 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.8 t -122.17 131.89 72.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.99 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -119.32 107.65 13.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.941 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.57 170.58 15.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.996 0.427 . . . . 0.0 110.828 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 5.8 t -117.92 143.88 45.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.371 -176.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.99 -162.43 11.97 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -137.38 -16.41 1.38 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.276 0.538 . . . . 0.0 111.38 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.523 ' HB1' ' HG2' ' B' ' 218' ' ' ALY . . . -142.94 143.51 32.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.671 0.272 . . . . 0.0 110.462 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.487 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -81.46 -177.86 52.03 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.128 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -176.8 157.6 1.53 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.087 0.555 . . . . 0.0 109.901 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.0 mm -63.41 120.17 9.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 172.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.574 HD13 ' CD2' ' A' ' 58' ' ' LEU . 5.9 tt -114.34 105.47 53.86 Favored Pre-proline 0 N--CA 1.444 -0.738 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.6 114.22 3.77 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.03 2.487 . . . . 0.0 112.231 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.45 HG12 ' CE2' ' A' ' 56' ' ' PHE . 3.7 mp -101.16 130.37 50.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.037 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.5 mt-10 -111.9 124.5 52.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.064 0.459 . . . . 0.0 110.149 174.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.51 HG13 ' CE1' ' A' ' 92' ' ' PHE . 68.8 t -103.29 117.84 49.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.71 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.546 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 89.5 m-85 -88.63 141.55 28.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.51 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.51 ' CE1' HG13 ' A' ' 90' ' ' VAL . 26.4 m-85 -115.43 154.39 29.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.702 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.453 ' HG3' ' HZ3' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -94.22 93.22 7.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.539 HD22 ' HB2' ' A' ' 96' ' ' GLU . 60.9 t30 -155.65 162.37 40.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.286 0.565 . . . . 0.0 112.076 -172.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -113.15 4.06 16.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.861 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.539 ' HB2' HD22 ' A' ' 94' ' ' ASN . 40.4 mm-40 -100.67 -155.57 0.52 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.153 -176.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.626 ' HB2' ' HD2' ' A' ' 98' ' ' PRO . 10.9 pt-20 -44.32 159.32 0.25 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.591 0.756 . . . . 0.0 111.853 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 97' ' ' GLU . 4.3 Cg_exo -31.36 128.33 0.08 OUTLIER 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 125.064 3.843 . . . . 0.0 115.189 -162.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.57 19.54 3.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.972 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.505 ' HE2' ' CE2' ' A' ' 91' ' ' TYR . 1.9 ptpt -149.04 143.86 26.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.939 0.399 . . . . 0.0 110.288 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -128.51 154.4 39.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.236 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -120.78 117.13 26.65 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.073 0.464 . . . . 0.0 110.836 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.665 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.1 m-85 -109.04 109.94 21.09 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.573 175.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.4 115.41 13.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.361 0.6 . . . . 0.0 109.699 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.447 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 66.4 t80 -129.93 127.72 40.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.542 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.88 111.46 18.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.847 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.481 HD21 ' CG1' ' A' ' 37' ' ' VAL . 2.0 mp -84.61 105.26 15.29 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -113.85 157.27 22.55 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.311 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.1 mt -131.0 154.81 47.77 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -101.64 169.72 8.65 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.394 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -55.98 134.64 52.46 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -49.67 124.8 10.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.455 173.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.557 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 122.76 -52.19 0.77 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.127 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -146.58 73.59 12.69 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 117.501 0.65 . . . . 0.0 111.753 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.502 ' CG ' ' HB ' ' A' ' 22' ' ' VAL . 74.2 Cg_endo -107.46 108.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.857 2.371 . . . . 0.0 113.508 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -98.12 98.73 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.032 2.488 . . . . 0.0 111.033 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 20' ' ' ALA . 38.4 t -115.05 117.61 56.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.245 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.491 ' OD1' ' HG2' ' A' ' 19' ' ' ARG . 63.4 t30 -145.57 114.62 6.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.643 175.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.426 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.5 t-80 -137.4 134.46 35.93 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.241 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.3 mt -119.19 151.1 38.93 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.612 0.57 . . . . 0.0 110.326 177.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.489 ' HG2' ' N ' ' A' ' 122' ' ' CYS . 21.9 ttm180 -142.58 153.76 43.81 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 176.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.489 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 85.7 m -137.73 122.97 19.32 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.457 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 9.6 mt-10 -119.5 155.37 32.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.473 0.178 . . . . 0.0 110.644 -177.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -107.96 138.6 43.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.617 0.722 . . . . 0.0 112.412 -172.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.639 ' HB2' HG21 ' A' ' 12' ' ' VAL . 6.8 mt -109.52 123.44 49.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.683 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.6 m -114.1 122.15 45.99 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.185 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.474 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 28.6 m-85 -118.45 109.39 16.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.112 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.79 120.67 24.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.22 0.533 . . . . 0.0 111.433 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.571 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 65.1 m-80 53.36 60.78 11.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.116 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 71.6 Cg_endo -76.11 167.7 25.48 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.143 1.895 . . . . 0.0 110.755 174.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 72.2 p -70.36 141.16 52.26 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.425 ' HG3' ' NH1' ' A' ' 135' ' ' ARG . 20.6 tt0 -52.43 -43.05 64.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -173.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.55 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 8.9 p-10 -59.21 -29.65 67.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.848 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.593 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 8.1 t80 -75.27 -39.64 59.56 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.604 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 36.2 ttm180 -54.66 -45.28 73.81 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -56.23 -35.08 66.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.591 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 38.5 mtpt -74.8 -42.25 58.43 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.256 -0.277 . . . . 0.0 110.423 176.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.0 mt -68.93 -32.92 72.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 -177.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 37.5 mt -78.37 -33.1 49.16 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.773 0.32 . . . . 0.0 110.785 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -73.27 -26.77 61.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.481 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.953 179.07 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -104.82 -40.39 2.16 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.114 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -74.84 127.1 32.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.795 0.331 . . . . 0.0 110.795 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.513 ' HB2' ' HD2' ' B' ' 216' ' ' PRO . . . -69.17 166.31 30.21 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.208 177.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . 0.513 ' HD2' ' HB2' ' B' ' 215' ' ' ALA . 6.9 Cg_endo -49.42 167.22 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.701 2.267 . . . . 0.0 113.021 175.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.487 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 6.5 tpp180 -144.63 121.03 10.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.448 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . 0.523 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -82.75 67.69 8.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.61 0.719 . . . . 0.0 109.921 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 86.0 mt -94.88 106.36 18.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.101 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -110.01 84.15 1.88 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.218 0.532 . . . . 0.0 110.167 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 19.5 m -77.85 91.43 4.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.933 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -131.09 -63.96 0.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.149 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.417 -0.802 . . . . 0.0 110.443 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 112.074 -0.411 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -98.83 34.83 1.98 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.881 0.372 . . . . 0.0 111.235 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -145.28 76.57 1.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.294 0.569 . . . . 0.0 110.502 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.6 mtm -74.67 74.24 2.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.765 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.08 74.82 1.54 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.754 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 p -60.54 124.21 19.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.045 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.73 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 48.4 m -87.88 108.85 19.37 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.428 ' O ' ' HD2' ' A' ' 130' ' ' PRO . 58.8 m -116.33 126.21 53.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.988 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.64 123.73 41.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.91 0.386 . . . . 0.0 111.504 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.74 141.38 17.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.3 mp0 -124.08 135.16 53.37 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.029 0.442 . . . . 0.0 110.106 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.652 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -111.87 173.51 2.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.632 174.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -142.37 119.16 11.15 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -175.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.4 mt -107.35 142.31 37.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.203 0.525 . . . . 0.0 110.023 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.609 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.4 tm-20 -111.91 120.53 42.25 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.612 -176.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.511 ' O ' ' HB3' ' A' ' 121' ' ' ARG . 1.4 mm? -103.19 112.47 25.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -135.67 169.52 23.47 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.565 -1.303 . . . . 0.0 111.485 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -164.01 151.43 12.24 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.976 -0.689 . . . . 0.0 111.337 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 21.0 mtp180 -114.98 150.63 35.49 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.327 173.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.06 126.79 15.25 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.767 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -121.35 151.24 40.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 112' ' ' GLU . 4.5 p -101.77 153.92 5.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.563 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 3.0 mtp180 -107.38 140.02 40.96 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -68.46 -16.06 63.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.756 0.788 . . . . 0.0 109.623 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -136.23 105.55 9.43 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.969 172.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.455 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.0 Cg_exo -49.9 156.3 3.49 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.844 2.363 . . . . 0.0 112.004 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.429 HG21 ' HB2' ' A' ' 31' ' ' PHE . 10.1 t -75.85 -173.92 2.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.838 -174.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.42 -32.88 49.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.773 0.32 . . . . 0.0 111.45 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -84.39 -0.63 53.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.085 0.469 . . . . 0.0 110.742 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.41 32.14 52.4 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.638 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.429 ' HB2' HG21 ' A' ' 27' ' ' THR . 20.7 m-30 -92.03 130.91 37.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 22' ' ' VAL . 77.3 p -89.35 -29.97 18.73 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.445 -169.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -116.17 143.1 45.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -172.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.563 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -121.07 121.45 37.93 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -123.94 151.37 43.66 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.558 -174.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.652 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 56.0 ttp -127.33 116.59 20.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.705 175.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 8.7 m -98.2 151.98 4.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.38 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.563 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.0 OUTLIER -153.44 156.08 37.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 178.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.4 m -126.31 128.32 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.19 171.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -134.99 -177.07 4.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.023 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.53 -171.8 39.49 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.005 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 9.1 Cg_exo -67.41 111.76 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.562 2.175 . . . . 0.0 111.167 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 58.96 57.17 3.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.06 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 71.6 m80 67.83 9.36 7.06 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.47 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 71.5 m -67.47 138.04 56.3 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 122.432 -0.168 . . . . 0.0 110.902 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -70.3 126.15 28.82 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.922 0.391 . . . . 0.0 110.02 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.583 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.6 pt -97.32 -4.3 9.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -173.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.04 1.84 0.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -79.34 -33.39 43.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.505 0.193 . . . . 0.0 110.723 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.548 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 52.8 p90 -119.79 -20.78 7.48 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.211 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.583 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 91.7 t -89.36 130.29 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.449 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 10.3 tp10 -99.23 -63.07 1.16 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.204 0.526 . . . . 0.0 110.313 -176.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.6 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -144.06 152.84 41.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.045 178.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 97.5 t -127.04 159.06 37.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.208 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.56 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 13.0 p -141.74 137.33 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.131 0.491 . . . . 0.0 111.209 -176.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.451 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 23.6 m-85 -118.19 108.77 15.56 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -79.49 94.08 5.53 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.976 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.593 ' CD2' HD13 ' A' ' 86' ' ' LEU . 11.3 mt -78.67 -178.2 5.79 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 144.35 47.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.186 0.517 . . . . 0.0 109.811 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.23 -23.69 62.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.792 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.5 t -77.06 -13.35 59.97 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.751 0.31 . . . . 0.0 110.992 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -81.26 140.1 48.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.497 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.26 123.41 13.56 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.471 2.114 . . . . 0.0 110.798 172.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 57.87 77.58 0.4 Allowed Pre-proline 0 N--CA 1.454 -0.253 0 O-C-N 123.876 0.735 . . . . 0.0 110.733 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.12 -22.24 73.86 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.493 2.129 . . . . 0.0 113.094 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -106.29 105.84 16.07 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 120.858 0.361 . . . . 0.0 110.704 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.1 mmt85 -104.65 108.48 19.96 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.491 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 2.8 m -97.69 136.51 28.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.1 m -120.3 113.61 20.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.038 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -104.78 -23.04 13.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.041 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.563 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -70.39 -174.87 0.26 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.319 -175.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.637 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 48.4 Cg_exo -42.37 -179.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.542 2.828 . . . . 0.0 113.474 169.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.637 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 4.2 Cg_exo -28.4 122.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.451 3.434 . . . . 0.0 114.17 -159.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.563 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 40.7 m-85 -60.31 100.21 0.09 Allowed 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.276 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.652 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.2 ptpt -148.03 147.8 29.99 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.581 0.705 . . . . 0.0 112.501 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 36' ' ' MET . 83.8 t -122.91 132.28 71.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.428 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -117.45 106.6 13.36 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.445 ' CD ' HH22 ' A' ' 67' ' ' ARG . 1.8 tp10 -133.71 175.95 8.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.515 -175.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.2 t -128.04 145.87 50.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.201 -178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.21 -163.62 14.55 Favored Glycine 0 N--CA 1.453 -0.167 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.22 -12.57 2.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.693 0.746 . . . . 0.0 112.018 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.507 ' HB1' ' HG2' ' B' ' 218' ' ' ALY . . . -150.58 134.29 16.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.97 0.414 . . . . 0.0 111.119 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.47 167.16 44.59 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.201 -0.909 . . . . 0.0 114.144 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -166.53 154.84 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.017 -0.591 . . . . 0.0 109.964 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.91 124.51 16.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 110.375 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.593 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -118.34 104.92 47.27 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.671 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.31 119.53 6.43 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.058 2.505 . . . . 0.0 112.22 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.412 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.5 mt -109.13 129.31 64.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.179 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.56 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.8 mt-10 -110.39 126.31 54.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 0.0 110.044 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.57 HG13 ' CE1' ' A' ' 92' ' ' PHE . 80.2 t -106.08 121.65 58.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.564 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.6 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 96.6 m-85 -95.69 135.27 37.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.57 ' CE1' HG13 ' A' ' 90' ' ' VAL . 22.9 m-85 -109.55 156.44 20.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.342 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.449 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -98.48 93.08 5.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.004 0.43 . . . . 0.0 110.782 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.445 HD22 ' HB2' ' A' ' 96' ' ' GLU . 61.8 t30 -158.61 167.96 28.18 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.201 -0.312 . . . . 0.0 111.146 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.558 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -113.59 4.57 16.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.02 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.55 ' HG2' ' CG2' ' A' ' 131' ' ' THR . 0.0 OUTLIER -101.16 -153.16 0.45 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.479 -175.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.565 ' HB2' ' HD2' ' A' ' 98' ' ' PRO . 13.9 pt-20 -39.84 155.16 0.17 Allowed Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.781 0.832 . . . . 0.0 112.027 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 97' ' ' GLU . 2.2 Cg_endo -35.87 123.07 0.27 Allowed 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 124.896 3.73 . . . . 0.0 114.511 -165.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.439 ' N ' ' HD3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -93.63 21.02 6.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.067 -177.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.486 ' HB2' ' HZ1' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -143.05 138.93 30.28 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.093 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.2 m -128.38 155.83 40.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.674 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.98 120.03 26.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CD2' HD22 ' A' ' 16' ' ' LEU . 21.1 m-85 -110.48 132.72 53.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.659 0.266 . . . . 0.0 110.638 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -91.55 105.88 18.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.502 0.668 . . . . 0.0 109.573 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -116.66 135.78 53.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.573 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -87.8 114.51 24.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.993 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.481 HD21 HG12 ' A' ' 37' ' ' VAL . 1.7 mp -90.42 91.34 8.42 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -102.37 155.01 18.53 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.072 0.463 . . . . 0.0 110.977 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt -129.14 163.31 25.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -91.69 174.35 7.4 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.285 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.48 149.47 42.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.167 0.508 . . . . 0.0 111.554 177.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.512 ' HA ' HG22 ' A' ' 22' ' ' VAL . 18.7 tt0 -65.12 102.24 0.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.107 176.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.496 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 108.51 23.38 6.61 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.36 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.523 ' CG ' ' HD2' ' A' ' 115' ' ' PRO . 48.4 t60 -128.55 154.76 79.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 118.639 -0.695 . . . . 0.0 109.134 -176.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.523 ' HD2' ' CG ' ' A' ' 114' ' ' HIS . 7.0 Cg_exo -31.03 171.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.516 0 C-N-CA 125.042 3.828 . . . . 0.0 116.038 171.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -98.16 169.97 0.68 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 124.4 3.4 . . . . 0.0 112.41 -169.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 22.3 t -115.99 131.17 69.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.467 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.1 OUTLIER -145.35 97.85 3.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -126.23 131.56 51.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.545 -174.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.8 mt -107.39 146.54 31.51 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.698 0.623 . . . . 0.0 109.835 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -139.96 129.01 23.59 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.246 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.436 ' N ' ' HD3' ' A' ' 121' ' ' ARG . 67.2 m -120.07 123.91 44.56 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -172.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -122.43 145.49 48.24 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.727 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.484 ' HZ3' ' HB3' ' A' ' 124' ' ' LYS . 7.4 ttpm? -100.61 129.14 46.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.22 0.533 . . . . 0.0 111.797 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.652 ' HB2' HG21 ' A' ' 12' ' ' VAL . 9.5 mt -94.63 119.44 33.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.688 172.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.5 m -109.51 123.53 49.56 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.894 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.476 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 31.3 m-85 -120.07 108.3 14.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.894 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -78.73 118.2 20.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.508 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.73 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 6.7 t30 50.02 64.55 8.24 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.676 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 127' ' ' PHE . 74.3 Cg_endo -74.68 178.06 7.64 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.402 2.068 . . . . 0.0 111.673 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.55 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 10.8 p -72.19 142.94 49.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.58 -37.93 76.83 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.067 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -63.85 -29.37 70.57 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.637 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 9.6 t80 -73.85 -42.05 61.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.622 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.1 ttm180 -54.3 -46.05 72.69 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.766 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -54.61 -38.26 66.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.441 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 44.3 mtpt -73.93 -40.19 63.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.799 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.7 mt -67.87 -32.57 73.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 40.5 mt -79.71 -32.28 41.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.316 . . . . 0.0 111.099 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.498 ' HZ1' ' CB ' ' A' ' 140' ' ' LYS . 2.6 ttpm? -75.89 -25.74 56.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.306 -177.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.216 174.859 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.725 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -82.7 107.43 2.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.287 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm 62.92 -154.16 0.34 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 122.737 0.415 . . . . 0.0 110.198 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.478 ' HB2' ' HD2' ' B' ' 216' ' ' PRO . . . -63.56 164.72 14.3 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.109 173.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 10.5 Cg_endo -54.54 157.97 11.14 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.038 1.825 . . . . 0.0 111.437 175.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -128.41 160.77 31.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.91 0.386 . . . . 0.0 110.387 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . 0.507 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -77.94 -42.42 33.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.092 0.473 . . . . 0.0 109.858 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 90.3 mt -101.42 95.0 6.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.785 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 64.92 89.81 0.09 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.728 0.643 . . . . 0.0 111.731 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 32.8 m -64.7 110.61 2.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.589 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 61.48 27.63 17.13 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.458 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.518 -176.58 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m 58.0 42.79 22.13 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.258 0.552 . . . . 0.0 110.619 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -75.25 120.81 21.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.879 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -99.21 -24.46 14.85 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.385 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.35 -78.04 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.044 0.84 . . . . 0.0 111.78 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.6 t -140.04 124.97 18.44 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.476 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 16.9 m -103.01 108.91 20.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.84 0.352 . . . . 0.0 110.445 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.621 ' O ' ' HD2' ' A' ' 130' ' ' PRO . 42.7 t -92.24 111.63 23.26 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.96 118.37 35.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.095 0.474 . . . . 0.0 111.581 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 t -100.01 143.88 13.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.83 127.59 29.17 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.391 0.615 . . . . 0.0 110.955 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.619 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.02 176.81 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.942 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.543 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 95.3 mttt -138.64 137.63 37.09 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.8 mt -122.45 142.05 50.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.076 0.465 . . . . 0.0 109.812 173.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.2 tt0 -104.34 124.65 49.58 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.999 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.631 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -110.85 114.17 27.3 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -140.09 174.86 22.23 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.618 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -166.17 153.05 9.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.212 0.529 . . . . 0.0 110.195 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 38.4 mtp180 -120.8 134.59 55.28 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.438 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.89 119.87 23.99 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.492 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -117.89 145.84 44.34 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' A' ' 112' ' ' GLU . 5.0 p -99.07 154.79 4.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 32' ' ' THR . 2.4 mtp180 -107.61 147.89 30.04 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -76.54 -12.44 60.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.764 0.792 . . . . 0.0 109.502 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -142.5 104.97 5.45 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.032 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -47.25 157.86 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.489 2.793 . . . . 0.0 113.46 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -76.97 -173.04 2.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.898 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.428 HG22 ' OE1' ' A' ' 29' ' ' GLU . 2.1 m -66.52 -28.8 44.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.96 0.409 . . . . 0.0 110.898 -174.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.428 ' OE1' HG22 ' A' ' 28' ' ' VAL . 1.9 mp0 -78.49 -8.12 58.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 110.227 175.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.01 32.99 37.92 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.2 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -98.94 140.8 32.56 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 22' ' ' VAL . 38.0 p -89.25 -27.26 20.72 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -169.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -118.85 142.59 47.59 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -172.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -116.09 119.48 35.98 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 172.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.432 ' CZ2' ' HB3' ' A' ' 78' ' ' GLU . 48.8 p-90 -121.35 150.96 40.68 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.093 0.473 . . . . 0.0 111.13 -178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 53.4 ttp -126.34 120.6 30.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.679 175.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.4 m -101.19 150.1 6.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.225 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.631 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.2 p90 -151.46 152.41 32.99 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.5 m -124.03 127.24 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.001 170.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -136.8 -176.74 4.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . -91.82 169.63 32.67 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 175.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 15.0 Cg_endo -53.39 113.96 1.54 Allowed 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 123.776 2.984 . . . . 0.0 112.657 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 56.32 51.26 11.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.419 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 69.12 11.95 8.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.482 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.494 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 66.8 m -62.27 126.83 28.7 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 171.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.533 ' OD1' ' HB2' ' A' ' 48' ' ' GLN . 6.5 t-20 -68.7 125.49 26.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.095 -175.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.527 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.5 pt -96.78 -2.37 10.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -174.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.533 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 11.1 mt-30 -61.82 -3.95 1.34 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -77.56 -37.85 49.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.401 0.143 . . . . 0.0 110.871 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.523 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -115.23 -18.61 11.07 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.547 176.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 84.2 t -90.48 130.15 40.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -98.83 -58.58 1.91 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.315 0.579 . . . . 0.0 110.355 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.603 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -149.02 153.76 38.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.048 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.469 HG21 HG23 ' A' ' 39' ' ' VAL . 66.9 t -129.12 159.09 41.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.229 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.579 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.2 p -143.1 135.1 24.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.219 0.533 . . . . 0.0 111.363 -175.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.478 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 27.6 m-85 -116.7 111.66 20.11 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.16 93.15 7.0 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.414 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.61 ' CD2' HD13 ' A' ' 86' ' ' LEU . 12.6 mt -76.87 -176.91 4.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.426 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.494 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 36.8 t60 -66.86 138.69 57.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.063 0.459 . . . . 0.0 109.802 -177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -56.3 -25.68 49.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.4 t -75.52 -18.31 59.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.451 0.167 . . . . 0.0 111.438 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.494 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 3.3 m-85 -75.09 134.91 73.91 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -60.99 117.56 4.34 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.714 2.276 . . . . 0.0 111.437 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 59.02 70.51 1.13 Allowed Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.503 -171.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.73 -17.45 59.12 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.733 2.288 . . . . 0.0 111.866 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -91.88 102.33 14.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.165 -177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.0 mmt180 -97.91 104.68 16.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.781 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.05 136.14 24.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.218 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 79.6 m -126.12 115.42 19.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.953 0.406 . . . . 0.0 109.923 175.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -106.69 -24.77 12.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.605 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.665 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 6.0 p-10 -75.71 -174.71 0.41 Allowed Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.329 -175.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.665 ' HD2' ' HB2' ' A' ' 71' ' ' ASP . 71.7 Cg_exo -39.11 -172.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.01 3.14 . . . . 0.0 114.548 167.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.62 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 8.5 Cg_endo -35.55 122.92 0.24 Allowed 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.399 2.733 . . . . 0.0 113.662 -152.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 44.2 m-85 -61.93 91.2 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.21 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 5.4 ptpt -139.37 146.4 40.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 0.0 112.034 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.7 t -120.96 132.29 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.345 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.541 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 5.3 mm-40 -108.56 106.04 15.93 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.246 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.432 ' HB3' ' CZ2' ' A' ' 35' ' ' TRP . 1.5 tp10 -134.79 171.06 14.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.709 0.29 . . . . 0.0 110.412 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -131.91 144.4 50.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.856 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.5 -170.34 27.18 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -126.72 -11.63 6.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.289 0.544 . . . . 0.0 111.771 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' B' ' 216' ' ' PRO . . . -147.83 141.49 25.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.961 0.41 . . . . 0.0 111.565 -176.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.11 164.49 51.41 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.099 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -163.31 156.37 18.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 106' ' ' ASP . 21.9 mm -64.37 126.07 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 110.211 173.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.61 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.0 tt -120.39 104.46 42.99 Favored Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.232 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.9 116.56 4.2 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.296 2.664 . . . . 0.0 112.536 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.405 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.8 mt -107.76 127.45 63.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.175 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.579 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.5 mt-10 -110.11 126.88 54.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.1 0.476 . . . . 0.0 110.01 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.49 HG13 ' CE1' ' A' ' 92' ' ' PHE . 79.3 t -106.49 119.97 56.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.744 178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.603 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 88.5 m-85 -92.53 135.84 33.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.822 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.49 ' CE1' HG13 ' A' ' 90' ' ' VAL . 24.1 m-85 -109.93 148.21 32.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.308 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.52 94.6 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.469 HD22 ' HB3' ' A' ' 96' ' ' GLU . 58.9 t30 -155.66 155.4 33.15 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.273 -172.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.52 -2.51 18.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.693 0.758 . . . . 0.0 109.466 171.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.469 ' HB3' HD22 ' A' ' 94' ' ' ASN . 2.1 tp10 -101.55 -152.01 0.43 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.218 -174.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.445 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 8.2 mm-40 -29.42 150.33 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.195 0.998 . . . . 0.0 113.548 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.0 Cg_exo -32.2 126.54 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.05 1 C-N-CA 125.415 4.077 . . . . 0.0 115.011 -168.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.443 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -89.64 19.03 4.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.304 -177.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.436 ' HZ2' ' HB2' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -155.9 140.07 16.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.361 0.6 . . . . 0.0 111.552 -177.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.2 m -130.47 155.36 41.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.008 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -123.44 120.33 32.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.978 0.418 . . . . 0.0 111.25 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.631 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.5 m-85 -112.44 116.6 30.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.446 174.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -85.93 105.98 16.79 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.455 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 61.8 t80 -112.34 137.2 50.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.911 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.449 ' HA ' HD11 ' A' ' 85' ' ' ILE . 38.2 t70 -86.36 103.52 15.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.308 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.468 HD21 ' CG1' ' A' ' 37' ' ' VAL . 2.5 mp -82.21 115.82 21.47 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.465 ' HB2' ' HA3' ' B' ' 213' ' ' GLY . 50.0 p90 -131.15 160.74 33.87 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.534 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.9 mt -136.18 163.26 30.78 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -175.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -100.84 172.81 6.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.99 152.25 24.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.846 0.355 . . . . 0.0 111.677 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.513 ' HA ' HG22 ' A' ' 22' ' ' VAL . 10.4 tt0 -64.2 106.3 1.06 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.926 175.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.05 23.01 6.92 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 115' ' ' PRO . 21.9 m-70 -133.89 163.57 50.19 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 114' ' ' HIS . 1.3 Cg_endo -43.37 162.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.074 3.183 . . . . 0.0 114.392 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -89.53 -179.27 1.9 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.947 3.098 . . . . 0.0 111.288 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 16.7 t -126.82 134.15 66.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.671 -175.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -144.15 97.45 3.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.459 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.5 t-80 -120.82 137.68 54.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.764 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.0 mt -120.48 146.95 45.75 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.478 0.487 . . . . 0.0 110.436 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.3 ttm180 -138.93 149.99 45.41 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.436 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 71.6 m -133.7 121.13 21.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 175.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -116.62 133.79 55.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 110.358 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -84.7 141.44 30.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.544 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.619 ' HB2' HG21 ' A' ' 12' ' ' VAL . 5.3 mt -111.35 110.47 20.95 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.2 m -107.09 120.02 40.95 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.822 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.532 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 25.8 m-85 -116.78 109.98 17.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.787 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -79.0 116.91 19.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.976 0.417 . . . . 0.0 110.576 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.476 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 4.6 t30 56.7 61.67 6.79 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.211 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.621 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 72.0 Cg_endo -75.74 169.86 21.38 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.306 2.004 . . . . 0.0 111.039 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.3 p -74.84 144.66 43.34 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -53.35 -43.09 67.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -172.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -55.73 -34.18 64.91 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.883 0.373 . . . . 0.0 110.421 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.665 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 7.8 t80 -75.95 -40.9 53.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.576 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.6 ttm180 -54.79 -43.92 73.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.564 0.697 . . . . 0.0 109.386 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.23 -36.49 75.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.216 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -73.97 -40.66 62.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.749 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.665 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.0 mt -66.81 -37.08 83.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.02 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.1 mt -75.33 -34.08 61.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.04 0.447 . . . . 0.0 110.577 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -72.32 -26.43 61.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.956 -175.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.352 -0.833 . . . . 0.0 110.541 175.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . 0.429 ' H1 ' ' NH1' ' B' ' 217' ' ' ARG . . . . . . . . 0 N--CA 1.485 1.916 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 108' ' ' PHE . . . 109.21 176.54 21.42 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.856 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -128.43 36.88 4.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.826 0.346 . . . . 0.0 110.117 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.526 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -135.28 169.06 14.74 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 29.2 Cg_endo -62.58 169.25 8.66 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 121.788 1.659 . . . . 0.0 111.49 176.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.429 ' NH1' ' H1 ' ' B' ' 212' ' ' GLY . 33.1 mtp180 -138.66 157.3 46.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.159 0.504 . . . . 0.0 110.883 178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -82.87 154.53 24.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.858 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 35.6 tp -81.66 62.47 5.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.311 0.576 . . . . 0.0 109.501 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -79.85 -37.71 34.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.062 -176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 30.9 m 65.54 93.57 0.07 Allowed 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.532 0.52 . . . . 0.0 111.533 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -69.82 129.38 39.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.193 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 O-C-N 123.849 0.718 . . . . 0.0 111.221 179.01 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -80.48 -33.11 36.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.733 0.266 . . . . 0.0 111.178 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -88.12 -41.35 13.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.116 0.484 . . . . 0.0 109.911 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.3 mtt -118.26 98.42 6.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.948 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.36 143.4 26.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.42 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 p -76.12 91.72 3.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.434 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.417 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 15.6 t -80.85 109.69 15.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.184 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 60.1 m -131.44 141.35 49.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.537 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.11 151.01 31.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.56 138.52 41.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -114.39 138.77 50.13 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -132.71 125.77 53.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.441 177.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -99.81 130.23 45.99 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.639 -0.663 . . . . 0.0 111.279 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.3 mt -108.98 142.38 39.72 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.848 176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.683 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.0 tt0 -104.15 126.42 51.25 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.195 -174.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.602 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -114.55 122.64 47.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -152.1 172.74 31.37 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.239 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -165.7 152.38 9.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.044 0.449 . . . . 0.0 110.138 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -117.03 152.04 35.48 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.435 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -141.96 133.29 26.47 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.532 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -129.79 164.74 23.4 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.823 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 32' ' ' THR . 2.4 p -104.24 161.01 4.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 168.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.497 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 4.3 mtp85 -105.52 140.54 38.45 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -67.05 -17.87 65.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.73 0.776 . . . . 0.0 109.477 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -136.76 107.31 9.04 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.893 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.505 ' HG3' HG22 ' A' ' 32' ' ' THR . 64.7 Cg_exo -45.89 156.3 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.277 2.651 . . . . 0.0 113.176 177.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.408 HG21 ' HB2' ' A' ' 31' ' ' PHE . 11.3 t -75.99 -169.92 1.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.634 -171.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.54 -27.4 42.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 122.874 0.47 . . . . 0.0 111.532 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -86.6 -12.06 49.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.408 0.623 . . . . 0.0 109.856 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.85 19.96 38.46 Favored Glycine 0 CA--C 1.503 -0.7 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.575 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.408 ' HB2' HG21 ' A' ' 27' ' ' THR . 20.4 m-30 -91.25 145.18 24.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.663 -0.768 . . . . 0.0 110.827 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.659 ' O ' HG23 ' A' ' 22' ' ' VAL . 44.6 p -94.0 -28.72 15.61 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.4 -164.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -108.64 153.69 23.06 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -169.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.497 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 1.1 m-20 -131.95 133.35 44.41 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 56.7 p-90 -139.19 149.82 44.85 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.046 0.451 . . . . 0.0 111.488 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.645 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 47.7 ttp -125.85 120.91 31.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.887 174.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.5 m -99.92 152.73 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.315 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.3 p90 -150.94 153.16 34.72 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.4 m -127.09 128.54 70.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.244 170.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -135.28 -176.12 4.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.949 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.12 -169.06 42.11 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.269 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 4.9 Cg_exo -72.82 112.16 3.43 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.665 2.244 . . . . 0.0 111.617 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 59.55 60.68 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.536 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 67.0 m80 71.16 -3.0 2.18 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.453 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 66.6 m -60.06 134.15 56.78 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.479 0.181 . . . . 0.0 111.299 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -69.96 126.42 29.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.567 HG22 ' CZ ' ' A' ' 50' ' ' PHE . 1.5 pt -96.66 -4.84 9.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -174.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -68.89 6.21 0.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.851 0.357 . . . . 0.0 111.782 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -80.12 -33.57 38.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.546 172.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.567 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 54.4 p90 -119.39 -18.75 8.46 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.301 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.556 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 91.4 t -88.68 131.25 36.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -98.06 -52.01 3.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 0.0 110.366 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -156.97 158.56 36.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.67 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.477 HG11 HG23 ' A' ' 39' ' ' VAL . 93.9 t -132.29 158.11 43.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.576 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.6 p -141.92 135.39 29.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.225 0.535 . . . . 0.0 111.085 -175.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.485 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 29.3 m-85 -117.59 108.37 15.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.73 92.57 4.81 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.161 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.61 ' CD2' HD13 ' A' ' 86' ' ' LEU . 10.7 mt -76.9 -178.42 4.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -79.01 144.02 35.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.07 -19.76 21.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.832 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -66.58 -21.95 66.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.111 0.481 . . . . 0.0 110.997 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -84.14 132.89 46.54 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.528 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.82 122.43 10.98 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.41 2.074 . . . . 0.0 111.1 172.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 59.96 69.3 1.25 Allowed Pre-proline 0 CA--C 1.531 0.232 0 O-C-N 123.738 0.649 . . . . 0.0 110.476 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.81 -22.4 49.49 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.636 2.224 . . . . 0.0 113.157 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -93.33 98.47 11.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.247 0.546 . . . . 0.0 110.202 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 13.2 mmt180 -94.36 96.69 9.7 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.446 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -86.35 136.66 22.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 172.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.0 m -124.86 111.6 15.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.03 0.443 . . . . 0.0 109.925 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -100.73 -27.51 13.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.681 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.513 ' OD1' ' HD2' ' A' ' 72' ' ' PRO . 28.4 t70 -69.63 168.63 15.99 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.712 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.589 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 42.4 Cg_exo -26.35 -168.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.864 1 C-N-CA 126.12 4.547 . . . . 0.0 116.277 161.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.589 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 10.3 Cg_endo -37.18 120.2 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.981 2.454 . . . . 0.0 113.976 -151.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 35.3 m-85 -62.45 98.37 0.11 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.935 -177.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 11.9 ptpt -149.52 146.23 27.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.468 0.651 . . . . 0.0 112.103 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.9 t -126.5 131.22 71.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.011 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -117.0 111.34 19.43 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -132.7 171.54 13.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.33 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.0 t -116.4 146.41 42.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.18 172.06 28.52 Favored Glycine 0 CA--C 1.507 -0.434 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.802 -173.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -130.41 -4.17 4.3 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.962 0.41 . . . . 0.0 110.215 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -164.1 137.19 5.18 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.222 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.49 -174.47 28.72 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 116.187 -0.46 . . . . 0.0 114.19 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.0 p90 179.96 158.02 0.71 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.858 0.463 . . . . 0.0 110.462 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.411 HD12 HG21 ' A' ' 85' ' ' ILE . 22.6 mm -65.83 129.26 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 171.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.61 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.3 tt -120.85 104.76 41.48 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-O 121.109 0.48 . . . . 0.0 110.154 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.82 114.37 3.12 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 123.25 2.634 . . . . 0.0 112.196 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -104.43 124.58 59.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.065 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.576 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.0 mt-10 -108.52 127.09 53.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.164 0.507 . . . . 0.0 110.008 175.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.0 t -106.73 117.98 53.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.622 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.559 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 81.0 m-85 -90.32 139.33 30.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.809 -178.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.448 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.0 m-85 -114.94 151.66 33.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.197 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.5 95.48 9.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.567 HD22 ' HB2' ' A' ' 96' ' ' GLU . 56.6 t30 -155.5 160.9 40.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.222 0.534 . . . . 0.0 111.595 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.576 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.6 OUTLIER -112.37 -1.42 15.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.778 178.132 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.567 ' HB2' HD22 ' A' ' 94' ' ' ASN . 18.4 mm-40 -102.02 -154.19 0.48 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.787 -175.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 97' ' ' GLU . 2.4 mp0 -26.79 152.5 0.01 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.938 1.295 . . . . 0.0 114.082 172.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 3.2 Cg_exo -31.66 125.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.197 1 C-N-CA 125.399 4.066 . . . . 0.0 114.756 -169.206 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.26 19.72 3.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.998 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -153.49 146.47 24.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.188 0.518 . . . . 0.0 110.934 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -128.7 155.87 40.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.025 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -120.89 121.29 37.75 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.841 0.353 . . . . 0.0 111.064 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.602 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.4 m-85 -113.79 112.21 23.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.649 173.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.31 105.97 11.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -115.57 137.25 52.26 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.672 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -85.86 114.25 22.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.894 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.463 HD21 HG12 ' A' ' 37' ' ' VAL . 2.0 mp -92.89 103.86 16.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -115.59 158.9 21.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.064 0.459 . . . . 0.0 110.28 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.1 mt -130.75 158.11 41.0 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -101.82 173.86 6.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.297 0.498 . . . . 0.0 110.648 173.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -62.4 136.8 58.08 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -173.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -51.4 122.81 8.47 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.844 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.575 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 122.8 -50.66 0.83 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.963 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -145.19 74.7 14.17 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 117.183 0.491 . . . . 0.0 110.605 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.462 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 39.6 Cg_endo -107.06 108.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.131 2.554 . . . . 0.0 113.263 176.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -98.27 97.52 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 123.0 2.467 . . . . 0.0 111.068 170.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 20' ' ' ALA . 39.5 t -116.93 107.5 22.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.619 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.458 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.2 OUTLIER -135.79 98.37 3.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -121.8 142.78 49.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.178 -176.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.405 HD12 ' H ' ' A' ' 121' ' ' ARG . 16.6 tp -136.99 159.38 42.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.163 0.506 . . . . 0.0 111.57 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.464 ' HD2' HD23 ' A' ' 16' ' ' LEU . 19.7 ttm180 -152.98 149.23 27.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.321 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.401 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 69.5 m -138.7 118.25 12.98 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 174.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -114.7 146.06 41.34 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -103.52 127.48 50.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.416 0.627 . . . . 0.0 112.398 -174.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.658 ' HB2' HG21 ' A' ' 12' ' ' VAL . 7.7 mt -86.43 149.53 24.93 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.3 m -140.97 121.89 14.5 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.144 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -115.93 114.85 25.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.232 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -84.76 120.85 26.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.315 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.417 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 55.1 m-80 50.5 65.49 6.73 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.766 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.35 -178.76 4.2 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.764 2.309 . . . . 0.0 112.074 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 74.4 p -74.97 137.15 41.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -61.19 -29.15 69.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -67.57 -28.3 67.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.63 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.8 t80 -75.07 -42.96 55.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.409 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.645 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.3 ttm180 -54.45 -43.69 71.85 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.755 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -55.87 -39.79 72.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.156 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 51.0 mtpt -71.09 -39.76 71.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.811 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 33.9 mt -69.61 -26.68 64.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.73 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 41.6 mt -86.19 -28.88 23.62 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.054 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -77.22 -31.15 55.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.261 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.828 178.487 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.84 -93.0 1.72 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.844 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -80.63 141.33 35.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.015 0.436 . . . . 0.0 110.411 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.419 ' HB2' ' HD2' ' B' ' 216' ' ' PRO . . . -75.17 162.91 71.23 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.715 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' B' ' 215' ' ' ALA . 14.0 Cg_endo -58.97 172.27 1.73 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.221 1.947 . . . . 0.0 112.129 173.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 11.8 ptp180 -152.74 153.68 33.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.28 0.562 . . . . 0.0 111.577 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -136.66 26.7 3.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.747 -173.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 51.2 tp -106.96 89.28 2.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.316 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -94.16 16.19 15.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.83 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 30.0 m 75.29 -61.08 0.49 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.926 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 57.01 64.73 1.56 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.346 0.593 . . . . 0.0 110.728 -175.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.146 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.687 177.89 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t 59.23 76.16 0.37 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.37 0.605 . . . . 0.0 110.336 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -153.89 -172.13 4.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.977 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.5 tpp 61.86 80.05 0.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.804 0.69 . . . . 0.0 110.914 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.48 148.8 35.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.375 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.0 p -79.27 76.49 5.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.109 0.481 . . . . 0.0 110.559 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.2 t -73.87 109.41 7.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.379 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.9 m -105.33 114.89 29.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.692 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.9 131.21 43.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.054 0.454 . . . . 0.0 111.974 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 t -101.72 140.72 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.1 mp0 -125.78 120.66 31.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.087 0.47 . . . . 0.0 110.224 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.629 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -108.52 177.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.686 179.007 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 98.7 mttt -142.58 136.42 29.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.579 0.228 . . . . 0.0 110.74 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 79.4 mt -119.68 142.56 48.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 109.945 174.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.616 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.8 tt0 -102.87 123.08 45.84 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.058 -176.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.635 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -109.78 113.68 26.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 174.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -142.67 173.8 23.8 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.849 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -164.01 151.93 12.7 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.007 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 70.6 mtt180 -116.82 140.92 48.87 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.748 171.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.0 125.51 29.87 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.282 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.45 ' HA ' ' HE2' ' A' ' 110' ' ' HIS . 2.8 pt20 -119.5 155.07 32.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 32' ' ' THR . 4.9 p -103.93 159.3 5.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.456 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 2.2 mtp180 -108.84 147.43 32.12 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -72.13 -18.39 61.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.651 0.738 . . . . 0.0 109.28 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -139.89 103.81 6.87 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.412 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.479 ' HG3' HG22 ' A' ' 32' ' ' THR . 70.2 Cg_exo -47.2 156.61 0.81 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.533 2.822 . . . . 0.0 112.736 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.467 HG21 ' HB2' ' A' ' 31' ' ' PHE . 10.2 t -77.23 -174.52 3.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.665 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.495 HG21 ' OE1' ' A' ' 29' ' ' GLU . 1.1 m -64.15 -27.81 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.106 0.479 . . . . 0.0 110.827 -175.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.495 ' OE1' HG21 ' A' ' 28' ' ' VAL . 2.3 mp0 -80.18 -2.06 43.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.382 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.26 31.22 63.92 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.365 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.467 ' HB2' HG21 ' A' ' 27' ' ' THR . 21.6 m-30 -93.64 131.55 38.84 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.479 HG22 ' HG3' ' A' ' 26' ' ' PRO . 62.1 p -89.69 -20.32 23.77 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.426 -168.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -124.07 148.33 47.18 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 7.4 m-20 -123.82 123.79 41.24 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 170.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -123.8 154.24 39.85 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.29 0.567 . . . . 0.0 111.192 -176.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.619 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 15.1 tmm? -128.96 136.71 50.73 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.062 174.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.3 m -121.67 149.43 24.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.387 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.669 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.6 OUTLIER -149.32 157.25 43.18 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.2 m -123.91 126.38 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.662 167.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -135.39 -176.28 4.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.734 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . -93.19 179.15 39.18 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.427 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -73.97 112.67 3.6 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.337 2.025 . . . . 0.0 111.879 -178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 61.71 47.86 5.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.079 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 67.88 6.97 5.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.715 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.487 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 48.6 m -63.26 122.53 16.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -60.83 125.01 22.14 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.93 0.395 . . . . 0.0 110.528 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.543 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.7 pt -95.3 -2.2 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.738 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -59.23 -12.85 5.99 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.306 0.574 . . . . 0.0 110.672 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -67.8 -45.0 76.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.959 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.499 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -111.83 -18.37 12.72 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.309 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.543 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 59.3 t -92.58 137.02 23.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.964 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.495 ' HB2' ' HG3' ' A' ' 93' ' ' LYS . 10.5 tp10 -113.98 -63.18 1.49 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.271 0.557 . . . . 0.0 110.915 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.569 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 24.9 tttt -136.73 149.55 47.92 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.129 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 99.0 t -131.13 156.94 43.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.588 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.9 p -140.62 134.9 34.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.374 0.606 . . . . 0.0 111.601 -175.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.458 ' CE2' HG12 ' A' ' 88' ' ' ILE . 16.1 m-85 -117.33 111.26 19.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -81.75 97.88 8.17 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.043 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.62 ' CD2' HD13 ' A' ' 86' ' ' LEU . 12.3 mt -80.77 -177.82 6.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.877 0.37 . . . . 0.0 110.631 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 143.2 45.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -60.04 -23.29 63.61 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.1 t -70.68 -22.15 62.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.998 0.427 . . . . 0.0 110.867 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -75.39 141.48 73.52 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.731 -177.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.77 128.55 21.23 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.395 2.063 . . . . 0.0 110.318 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.492 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 52.9 mtm180 58.11 74.92 0.58 Allowed Pre-proline 0 C--N 1.331 -0.226 0 O-C-N 123.618 0.574 . . . . 0.0 110.246 -175.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.1 -24.38 52.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.509 2.139 . . . . 0.0 113.065 -178.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -101.52 104.62 15.53 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.14 0.495 . . . . 0.0 110.183 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 64' ' ' ARG . 9.4 mmm-85 -103.1 104.13 14.26 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.492 -177.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -98.59 137.63 25.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.8 m -118.1 120.22 37.12 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -103.16 -29.83 11.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.613 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.55 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 6.2 m-20 -81.03 -178.31 1.14 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.101 -175.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 0.9 OUTLIER -41.34 -166.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 124.277 3.318 . . . . 0.0 114.231 165.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 3.3 Cg_endo -29.82 118.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 123.291 2.661 . . . . 0.0 113.883 -147.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.669 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 54.2 m-85 -64.56 88.75 0.06 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.848 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 13.9 ptpt -136.92 142.9 42.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.409 0.623 . . . . 0.0 112.418 -174.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.6 t -119.56 136.56 56.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.618 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -124.21 107.01 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.35 172.84 12.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.402 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.4 t -123.15 146.03 48.11 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.674 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.38 23.72 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -130.27 -18.35 3.27 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.503 0.652 . . . . 0.0 111.903 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.463 ' HB1' ' HG2' ' B' ' 218' ' ' ALY . . . -142.75 145.09 32.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.001 0.429 . . . . 0.0 111.178 -174.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.73 172.5 51.97 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.673 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -168.71 158.9 9.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 122.905 0.482 . . . . 0.0 110.064 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 mm -66.76 121.08 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.188 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.62 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.6 tt -116.46 108.25 45.67 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.406 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -79.9 121.26 4.47 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.799 2.333 . . . . 0.0 112.056 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.458 HG12 ' CE2' ' A' ' 56' ' ' PHE . 3.9 mp -105.53 133.59 49.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.323 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.9 mt-10 -113.37 121.32 43.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.202 0.525 . . . . 0.0 110.217 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.583 HG13 ' CE1' ' A' ' 92' ' ' PHE . 84.0 t -101.54 122.56 53.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.115 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.569 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 87.3 m-85 -91.12 138.57 31.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.548 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.583 ' CE1' HG13 ' A' ' 90' ' ' VAL . 21.3 m-85 -119.91 162.32 19.37 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.16 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.495 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -105.16 97.24 7.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 121.159 -0.217 . . . . 0.0 111.353 176.282 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -155.63 168.86 25.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.298 0.57 . . . . 0.0 112.272 173.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.539 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -103.97 9.28 36.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.484 174.596 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -101.01 -154.65 0.49 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.442 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 22.6 mm-40 -35.95 157.36 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.63 0 C-N-CA 124.24 1.016 . . . . 0.0 113.266 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 7.3 Cg_exo -31.88 125.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 124.713 3.609 . . . . 0.0 114.302 -172.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.45 20.06 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.841 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 98' ' ' PRO . 0.0 OUTLIER -152.13 140.76 20.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.919 178.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.2 m -115.91 156.79 16.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -128.39 107.88 10.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.873 0.368 . . . . 0.0 110.487 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.635 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.2 m-85 -105.67 120.96 43.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.202 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -82.59 117.15 22.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -126.6 136.18 52.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.242 0.544 . . . . 0.0 110.875 -176.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.38 112.79 21.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.951 -178.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.503 HD21 HG12 ' A' ' 37' ' ' VAL . 1.2 mp -91.04 94.64 9.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -104.03 155.85 18.34 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.087 0.47 . . . . 0.0 111.054 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.5 mt -129.36 162.5 27.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.247 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.611 ' NE2' ' HA ' ' A' ' 116' ' ' PRO . 5.7 p80 -100.18 173.09 6.79 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.285 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.485 HD21 ' HA ' ' B' ' 215' ' ' ALA . 2.0 mm? -73.57 161.03 30.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.997 0.427 . . . . 0.0 111.635 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.437 ' HA ' HG22 ' A' ' 22' ' ' VAL . 14.7 mt-10 -64.99 125.53 25.17 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.304 173.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.08 21.29 59.29 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.432 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.461 ' CG ' ' HD2' ' A' ' 115' ' ' PRO . 57.4 t60 -121.31 147.58 47.52 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 114' ' ' HIS . 10.9 Cg_endo -55.28 136.58 74.12 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.278 1.985 . . . . 0.0 113.292 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.611 ' HA ' ' NE2' ' A' ' 110' ' ' HIS . 49.5 Cg_exo -44.73 177.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 124.932 3.755 . . . . 0.0 116.204 175.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 67.4 t -124.16 139.38 50.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.936 -173.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.47 96.43 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -116.3 132.49 56.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.46 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.5 mt -117.04 141.82 47.76 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.51 0.506 . . . . 0.0 110.327 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 18.3 ttm180 -131.2 148.41 52.7 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.421 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 59.1 m -133.84 117.0 16.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 6.1 mt-10 -113.34 137.45 51.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.842 0.354 . . . . 0.0 111.085 -175.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -89.45 126.56 35.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.822 -175.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.629 ' HB2' HG21 ' A' ' 12' ' ' VAL . 9.2 mt -92.69 115.38 28.05 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 23.7 m -110.66 114.74 28.35 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.911 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -115.64 109.41 17.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.547 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -76.02 117.77 18.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.129 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 t30 54.46 67.32 3.45 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.267 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.96 -179.37 5.05 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.56 2.173 . . . . 0.0 111.359 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.2 p -77.52 145.7 36.82 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 173.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -54.42 -40.54 68.38 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.795 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.1 p-10 -59.81 -32.44 70.64 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.593 0.235 . . . . 0.0 110.662 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.663 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 4.7 t80 -73.78 -41.11 62.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.605 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 45.2 ttm105 -54.72 -43.61 72.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.609 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -57.33 -37.43 72.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.31 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 32.7 mtpt -73.94 -42.42 60.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.839 0.352 . . . . 0.0 110.3 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 33.0 mt -69.73 -30.99 68.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.219 -176.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 27.3 mt -79.64 -32.8 41.7 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.778 0.323 . . . . 0.0 110.684 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.62 -30.27 64.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.565 -176.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.757 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' B' ' 214' ' ' LYS . . . -99.51 147.22 18.25 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.586 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' B' ' 213' ' ' GLY . 92.4 mttt 70.2 119.66 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.634 0.731 . . . . 0.0 112.091 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.562 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -72.27 171.05 10.54 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.612 172.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . 0.562 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 6.9 Cg_endo -51.09 168.62 0.23 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.12 1.88 . . . . 0.0 112.465 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' B' ' 217' ' ' ARG . 37.9 ttt85 -145.01 141.65 29.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.923 0.392 . . . . 0.0 111.123 -174.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . 0.463 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -59.41 151.61 23.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.446 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.591 HD21 ' H ' ' B' ' 220' ' ' LEU . 1.5 pt? -83.81 52.22 2.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.574 0.702 . . . . 0.0 110.217 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -140.18 149.67 43.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.148 -177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 15.1 t -107.6 149.57 27.89 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -135.24 147.64 49.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.299 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.858 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.417 172.208 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.522 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 t -122.69 -3.29 8.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.627 0.214 . . . . 0.0 110.807 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -70.96 -59.55 2.73 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.0 ttm -100.99 -34.74 9.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.706 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 53.83 56.59 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.544 0.528 . . . . 0.0 110.474 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.2 p -66.08 113.31 4.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.648 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.4 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 63.4 m -73.59 109.11 6.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.971 0.415 . . . . 0.0 110.081 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.5 p -88.53 111.96 22.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.514 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.27 132.27 55.04 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.117 0.484 . . . . 0.0 111.434 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.21 142.38 21.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.08 124.99 38.38 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.262 -178.077 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.646 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -109.28 168.72 3.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.4 175.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.93 126.56 27.13 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.571 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.2 mt -105.99 142.2 36.1 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.991 177.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.5 tt0 -102.82 125.0 49.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.05 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.669 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -112.54 113.96 26.38 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -144.91 175.86 24.3 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.849 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -165.88 155.11 11.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.183 0.516 . . . . 0.0 111.164 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 26.7 mtp180 -116.55 152.18 34.66 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.745 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -147.56 125.82 12.25 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.839 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -125.48 141.99 51.75 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 112' ' ' GLU . 7.5 p -100.73 152.4 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.753 ' HD2' ' O ' ' A' ' 25' ' ' LYS . 5.9 ptt180 -116.7 138.65 51.3 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -68.02 -17.36 64.39 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.562 0.696 . . . . 0.0 109.473 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.753 ' O ' ' HD2' ' A' ' 23' ' ' ARG . 44.7 tttm -117.49 99.05 52.37 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.483 170.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.11 159.52 18.37 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.104 1.869 . . . . 0.0 110.915 171.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 t -81.68 -172.77 4.05 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.741 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.7 m -59.0 -29.82 42.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.208 0.528 . . . . 0.0 111.492 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -85.47 -0.22 54.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.32 30.53 62.49 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.162 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -89.45 125.55 35.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 22' ' ' VAL . 40.4 p -86.6 -27.51 23.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.471 -171.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 79' ' ' SER . 68.6 m80 -118.1 142.27 47.6 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -171.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -115.05 119.96 38.21 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 173.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -122.65 154.95 37.34 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.149 0.499 . . . . 0.0 111.32 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.633 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 52.4 ttp -133.21 119.92 20.48 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.571 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.0 m -100.53 152.31 4.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.285 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.594 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -152.46 155.5 37.62 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.539 -0.464 . . . . 0.0 112.234 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.6 m -128.11 127.17 67.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.132 170.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.45 HH11 ' HB3' ' A' ' 73' ' ' PRO . 9.9 mmm180 -132.49 -177.14 4.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.332 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.75 -167.55 42.49 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.649 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 2.9 Cg_exo -73.86 111.53 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.278 1.985 . . . . 0.0 111.697 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 60.78 61.28 1.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.662 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 72.91 -5.54 1.88 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.364 0.666 . . . . 0.0 112.527 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 58.7 m -59.31 133.07 55.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.551 0.215 . . . . 0.0 110.916 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -71.24 126.09 28.7 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.023 0.44 . . . . 0.0 110.318 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.585 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.4 pt -96.35 -2.73 10.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.485 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -57.86 -13.91 5.18 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.219 0.533 . . . . 0.0 111.285 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -69.88 -41.42 74.8 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.493 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.577 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 52.8 p90 -114.67 -14.39 12.04 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.883 -0.51 . . . . 0.0 111.543 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.585 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 90.0 t -94.31 125.86 46.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -92.44 -62.71 1.34 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.517 -176.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.683 ' HD2' ' CD1' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -145.86 151.1 37.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.478 HG11 HG23 ' A' ' 39' ' ' VAL . 98.1 t -125.28 160.93 30.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.582 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.6 p -142.32 137.81 29.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.192 0.52 . . . . 0.0 111.124 -176.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.476 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 26.7 m-85 -119.5 110.78 17.31 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -83.27 92.94 7.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.488 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.601 ' CD2' HD13 ' A' ' 86' ' ' LEU . 11.4 mt -78.54 177.73 8.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.986 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.89 144.32 49.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -58.87 -25.37 63.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.835 -170.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.8 t -72.75 -19.23 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.992 0.425 . . . . 0.0 110.592 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -75.23 135.31 73.13 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.23 118.65 5.49 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.436 2.091 . . . . 0.0 111.135 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 62.29 79.06 0.28 Allowed Pre-proline 0 CA--C 1.53 0.195 0 O-C-N 123.638 0.586 . . . . 0.0 110.203 -176.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.32 -21.16 66.02 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.803 2.336 . . . . 0.0 113.454 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -105.96 108.79 20.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.944 0.402 . . . . 0.0 110.694 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 -106.64 98.37 8.05 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.035 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -84.29 136.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.391 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.9 m -125.7 112.04 15.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.862 0.363 . . . . 0.0 110.267 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -106.93 -21.65 12.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.31 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.681 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 3.1 t70 -65.37 -177.64 0.25 Allowed Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.537 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.681 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 16.7 Cg_exo -33.02 -175.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.542 0 C-N-CA 125.031 3.821 . . . . 0.0 114.285 160.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.636 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.6 Cg_endo -34.81 126.69 0.22 Allowed 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 123.657 2.905 . . . . 0.0 114.044 -160.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 33.0 m-85 -61.8 94.06 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.793 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 3.9 ptpt -144.15 146.29 32.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.225 0.536 . . . . 0.0 111.717 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 36' ' ' MET . 71.7 t -124.87 132.53 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.871 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.97 111.87 21.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.23 172.39 12.75 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.168 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 9.6 t -123.1 149.39 44.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.83 -175.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.82 -169.65 22.47 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -132.18 -10.93 3.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.146 0.473 . . . . 0.0 111.339 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -151.27 140.35 21.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.635 0.255 . . . . 0.0 110.47 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.61 179.22 49.35 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.771 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -173.94 156.28 2.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.677 0.275 . . . . 0.0 110.721 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 85' ' ' ILE . 14.2 mm -64.95 121.27 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.136 172.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.601 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -114.67 104.94 54.04 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.636 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.39 117.07 4.83 Favored 'Trans proline' 0 C--O 1.239 0.559 0 C-N-CA 123.05 2.5 . . . . 0.0 112.019 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 mt -106.81 126.17 62.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.21 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.582 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 46.3 mt-10 -110.57 122.64 48.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.367 0.603 . . . . 0.0 110.181 176.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.4 t -104.4 119.39 53.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.282 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.683 ' CD1' ' HD2' ' A' ' 53' ' ' LYS . 28.2 m-85 -94.8 156.14 16.51 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.424 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.7 m-85 -126.86 157.51 39.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.018 -177.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.536 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -105.76 93.65 4.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.252 0.548 . . . . 0.0 111.622 -178.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.559 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 62.0 t30 -160.24 -176.6 5.73 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 5.6 tmtt? -109.88 -5.04 15.63 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.245 0.545 . . . . 0.0 111.248 177.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 16.1 mm-40 -96.47 -155.41 0.48 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.852 -168.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.47 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 11.2 mm-40 -28.97 151.15 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 124.833 1.253 . . . . 0.0 113.902 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.5 Cg_exo -30.62 124.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 125.087 3.858 . . . . 0.0 114.713 -165.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.559 ' HD3' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -75.26 12.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.5 -177.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.538 ' HE2' ' CE2' ' A' ' 91' ' ' TYR . 2.5 ptpt -150.03 147.67 28.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.318 0.58 . . . . 0.0 111.342 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -123.55 155.24 29.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 174.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -128.53 106.82 9.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.76 0.314 . . . . 0.0 110.336 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.669 ' CD2' HD22 ' A' ' 16' ' ' LEU . 22.9 m-85 -103.09 121.19 42.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.304 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -84.31 112.64 20.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -124.79 138.34 54.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.377 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -90.86 120.15 31.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.919 0.39 . . . . 0.0 110.959 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.468 HD21 ' CG1' ' A' ' 37' ' ' VAL . 2.1 mp -93.76 91.75 7.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.009 175.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -101.03 157.74 16.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.207 0.527 . . . . 0.0 110.654 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.8 mt -129.76 163.78 25.46 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.466 ' O ' ' HB3' ' B' ' 215' ' ' ALA . 38.7 m170 -94.18 174.83 6.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 172.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.41 HD21 ' HA ' ' B' ' 215' ' ' ALA . 2.4 mm? -67.52 165.16 17.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.009 0.433 . . . . 0.0 111.634 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.56 ' HA ' HG22 ' A' ' 22' ' ' VAL . 16.9 tt0 -75.26 103.65 5.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.748 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.504 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 106.61 17.81 11.69 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -175.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.506 ' CD2' ' HD2' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -114.27 162.54 22.68 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.651 -177.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.506 ' HD2' ' CD2' ' A' ' 114' ' ' HIS . 1.6 Cg_endo -44.68 177.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 123.869 3.046 . . . . 0.0 114.005 174.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -97.04 166.83 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.83 3.02 . . . . 0.0 111.776 -171.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 22.5 t -113.61 126.45 71.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.431 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.66 96.39 2.86 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -118.98 134.97 54.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.618 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.4 mt -116.58 152.59 33.84 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.514 0.509 . . . . 0.0 110.575 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 19.8 ttm180 -143.58 149.63 37.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 173.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.467 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 61.4 m -134.12 120.71 20.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -115.81 138.11 51.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.695 0.283 . . . . 0.0 110.437 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -90.48 129.91 36.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.474 0.654 . . . . 0.0 112.185 -174.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.646 ' HB2' HG21 ' A' ' 12' ' ' VAL . 11.1 mt -95.16 117.49 30.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.386 171.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.7 m -109.06 122.66 47.75 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.667 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -120.42 104.45 10.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.675 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -85.67 120.74 27.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.706 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 83.6 m-20 59.02 61.96 4.39 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.201 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -87.4 173.82 5.35 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.116 2.544 . . . . 0.0 112.013 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 134' ' ' PHE . 11.7 p -69.26 140.46 54.47 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -58.28 -37.08 74.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -63.36 -29.67 70.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.611 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.6 t80 -73.02 -43.4 62.15 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.671 ' O ' HD13 ' A' ' 139' ' ' LEU . 50.0 ttp180 -52.79 -52.58 56.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.809 175.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -55.09 -36.32 65.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.934 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.479 ' HZ3' ' HG2' ' A' ' 93' ' ' LYS . 20.2 mtmt -71.08 -39.2 72.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.624 -0.43 . . . . 0.0 109.84 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.6 mt -65.55 -19.11 65.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.706 0.765 . . . . 0.0 109.839 175.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.671 HD13 ' O ' ' A' ' 135' ' ' ARG . 6.4 mp -89.56 -26.36 20.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.962 -177.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -90.5 -19.14 24.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.203 0.525 . . . . 0.0 110.631 -174.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.18 174.384 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -84.02 55.23 5.0 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.558 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -158.01 138.92 13.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.179 0.514 . . . . 0.0 110.7 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 110' ' ' HIS . . . -82.52 170.65 14.02 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.773 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.86 175.22 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.676 1.584 . . . . 0.0 112.71 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -150.03 158.59 44.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.332 177.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -107.09 74.99 1.01 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.85 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 10.1 mp -97.6 -15.64 20.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.772 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -144.81 83.78 1.71 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.665 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 32.5 m -87.62 111.66 21.49 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.005 -176.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -83.16 80.85 8.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.841 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.758 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.322 179.156 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.0 m -73.45 -11.03 60.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 111.458 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -73.99 -28.79 61.64 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.4 tpt -95.55 -42.03 8.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.171 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.7 97.41 7.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.605 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.6 t -71.55 138.85 49.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.002 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.41 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 8.5 t -79.97 138.57 37.1 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.516 -176.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.4 t -162.12 133.57 5.29 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.56 136.81 52.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.182 0.515 . . . . 0.0 112.302 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.8 t -103.13 142.58 16.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -121.95 127.31 50.21 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.624 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -112.08 172.18 3.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.927 177.004 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 97.0 mttt -135.83 131.84 35.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.565 0.221 . . . . 0.0 110.611 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.5 mt -116.52 142.04 47.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.239 0.543 . . . . 0.0 109.954 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.621 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.5 tt0 -105.13 125.12 50.64 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.939 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.569 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.5 mm? -108.57 122.22 46.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.496 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -143.85 167.61 26.68 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.984 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -163.72 154.15 15.57 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.379 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 53.4 mtp180 -121.15 144.87 48.34 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.866 172.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.68 118.29 24.47 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.785 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.95 137.05 50.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 22' ' ' VAL . 3.3 p -103.5 137.87 30.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.4 mtp180 -92.81 139.96 30.0 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -175.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -68.14 -15.29 63.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.427 0.632 . . . . 0.0 109.729 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -139.03 102.35 7.55 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.427 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.512 ' HG3' HG22 ' A' ' 32' ' ' THR . 90.8 Cg_exo -50.19 158.0 2.68 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.076 2.517 . . . . 0.0 112.169 175.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.438 HG21 ' HB2' ' A' ' 31' ' ' PHE . 7.8 t -78.22 -175.67 4.27 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.407 -174.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.3 m -63.04 -31.05 51.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.092 0.472 . . . . 0.0 110.894 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -77.98 -6.7 55.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.447 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.37 33.41 39.52 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.401 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.438 ' HB2' HG21 ' A' ' 27' ' ' THR . 18.5 m-30 -94.7 129.7 41.49 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.512 HG22 ' HG3' ' A' ' 26' ' ' PRO . 38.9 p -91.9 -25.66 18.82 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.43 -168.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 79' ' ' SER . 56.5 m80 -117.28 140.53 49.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -113.86 112.15 22.88 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 54.7 p-90 -118.44 148.84 42.16 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.082 0.468 . . . . 0.0 111.127 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.639 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 57.8 ttp -129.37 122.64 29.88 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.802 175.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.7 m -102.59 151.29 6.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.369 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -152.15 152.87 32.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.2 m -124.02 127.14 73.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.271 171.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.513 ' CZ ' ' HA ' ' A' ' 73' ' ' PRO . 2.5 mmp_? -135.62 -176.58 4.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.705 -176.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . -91.54 -171.73 42.57 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.661 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 30.7 Cg_endo -75.7 113.68 3.79 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.515 2.143 . . . . 0.0 112.173 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 58.98 52.45 6.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.384 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.6 t60 74.38 -3.82 2.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.825 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.463 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 63.9 m -59.04 128.74 38.75 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 176.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -72.25 127.06 31.38 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.779 0.324 . . . . 0.0 110.844 -174.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.54 HD11 HG23 ' A' ' 51' ' ' VAL . 5.9 pt -96.42 -1.96 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -61.31 -14.66 28.56 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.383 0.611 . . . . 0.0 110.928 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.517 ' ND1' ' HZ3' ' A' ' 140' ' ' LYS . 88.1 m-70 -65.7 -39.22 91.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.709 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.525 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 55.4 p90 -114.61 -16.01 11.91 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.464 176.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.54 HG23 HD11 ' A' ' 47' ' ' ILE . 99.3 t -91.79 129.09 43.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.084 0.469 . . . . 0.0 110.23 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -97.1 -63.92 1.09 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.335 0.588 . . . . 0.0 110.409 -175.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 6.6 ptmm? -141.1 157.54 45.16 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 91.7 t -130.04 158.33 42.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 67' ' ' ARG . 9.7 p -142.31 134.75 26.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.341 0.591 . . . . 0.0 111.214 -174.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.46 ' CD2' HG12 ' A' ' 88' ' ' ILE . 29.6 m-85 -117.78 105.5 12.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -77.05 90.86 3.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.872 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.579 ' CD2' HD13 ' A' ' 86' ' ' LEU . 12.9 mt -71.01 -177.77 1.75 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.825 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.79 139.77 43.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -176.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -56.53 -23.53 40.51 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -171.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.8 t -71.72 -16.31 62.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.069 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -79.51 141.01 56.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.13 116.84 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.097 1.865 . . . . 0.0 111.327 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 58.41 66.59 2.51 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.552 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.4 -18.74 66.01 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.223 2.615 . . . . 0.0 113.466 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -87.48 100.79 13.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.991 0.424 . . . . 0.0 110.534 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.581 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.0 mmt180 -100.13 110.81 23.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.826 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -100.64 136.01 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.7 m -114.37 118.24 33.32 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -105.09 -25.72 12.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.534 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.57 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 9.5 p-10 -76.5 -175.08 0.45 Allowed Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.382 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.58 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 1.5 Cg_exo -41.97 -166.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.231 3.288 . . . . 0.0 114.203 164.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.588 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 6.9 Cg_endo -34.89 120.02 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.005 2.47 . . . . 0.0 113.602 -151.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 47.5 m-85 -62.35 94.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.043 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 12.2 ptpt -142.28 145.9 34.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.279 0.561 . . . . 0.0 112.201 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 36' ' ' MET . 79.6 t -121.28 132.61 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.462 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.415 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 7.0 mm-40 -112.06 112.49 24.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.982 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -137.42 169.87 17.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.197 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 3.5 t -126.75 141.9 51.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.14 -169.27 24.17 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.281 -0.485 . . . . 0.0 111.953 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -132.84 -11.41 3.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.253 0.527 . . . . 0.0 111.973 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.41 136.99 20.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.18 -172.99 47.18 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.208 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -178.87 159.53 1.05 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.362 0.265 . . . . 0.0 110.485 -173.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.3 mm -63.9 123.43 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.579 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.1 tt -117.76 104.88 48.59 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-O 121.138 0.494 . . . . 0.0 109.995 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.54 112.98 3.0 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.336 2.691 . . . . 0.0 112.357 173.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.46 HG12 ' CD2' ' A' ' 56' ' ' PHE . 3.8 mt -102.33 123.52 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.283 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.8 mt-10 -109.48 124.46 51.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.179 0.514 . . . . 0.0 110.198 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.523 HG13 ' CE1' ' A' ' 92' ' ' PHE . 74.4 t -103.36 118.76 50.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.907 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 69.9 m-85 -91.05 134.75 34.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.512 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.523 ' CE1' HG13 ' A' ' 90' ' ' VAL . 25.6 m-85 -110.11 152.07 26.46 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.047 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.58 94.19 9.77 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.4 ' HB3' ' HG3' ' A' ' 99' ' ' ARG . 64.0 t30 -154.61 158.65 40.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.875 -172.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -111.42 -9.68 14.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.909 0.862 . . . . 0.0 110.006 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -99.05 -151.77 0.39 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.47 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.454 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 22.2 mm-40 -27.16 152.11 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.5 Cg_exo -31.1 126.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 1 C-N-CA 125.522 4.148 . . . . 0.0 115.262 -167.202 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.4 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -89.0 18.97 4.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.647 -179.182 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.65 143.01 20.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.247 0.546 . . . . 0.0 110.874 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -128.43 155.76 40.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.345 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -125.47 115.64 20.55 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.173 0.511 . . . . 0.0 111.118 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.569 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.8 m-85 -107.98 108.18 19.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.678 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -72.11 113.29 8.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.281 0.562 . . . . 0.0 109.659 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.474 ' CD1' ' HD2' ' A' ' 121' ' ' ARG . 31.8 t80 -124.47 129.22 50.25 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.707 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -85.15 106.85 16.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.605 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.473 HD21 HG12 ' A' ' 37' ' ' VAL . 1.6 mp -82.1 106.07 13.71 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.467 ' CE2' HG12 ' A' ' 117' ' ' VAL . 56.0 p90 -117.63 161.5 19.55 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.221 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.4 mt -135.05 162.98 30.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.636 -171.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.735 ' CE1' ' HA ' ' A' ' 116' ' ' PRO . 6.9 p-80 -93.17 166.85 12.13 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 177.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.517 ' O ' ' HD2' ' A' ' 110' ' ' HIS . 2.1 mm? -68.01 146.83 53.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.701 0.286 . . . . 0.0 111.124 177.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.444 ' HA ' HG22 ' A' ' 22' ' ' VAL . 23.7 tt0 -57.42 101.25 0.06 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.888 176.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.71 18.58 4.75 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.685 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.464 ' CG ' ' HD2' ' A' ' 115' ' ' PRO . 63.9 t60 -129.8 150.02 74.66 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.464 ' HD2' ' CG ' ' A' ' 114' ' ' HIS . 13.9 Cg_endo -56.63 166.06 4.05 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.253 1.969 . . . . 0.0 112.727 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.735 ' HA ' ' CE1' ' A' ' 110' ' ' HIS . 4.7 Cg_exo -77.4 -179.52 5.51 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 123.647 2.898 . . . . 0.0 114.142 -168.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 26.7 t -119.53 137.96 51.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.231 -1.349 . . . . 0.0 109.029 -177.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.431 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.2 OUTLIER -143.62 98.15 3.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.493 ' O ' HD23 ' A' ' 120' ' ' LEU . 55.0 t-80 -119.4 134.62 55.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.755 -176.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.3 mt -123.17 142.17 51.19 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 123.682 0.614 . . . . 0.0 110.558 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.561 ' HD3' ' HB2' ' A' ' 16' ' ' LEU . 17.9 mtp180 -119.41 146.76 45.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 22.0 p -117.46 101.43 8.38 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 165.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.9 mm-40 -97.56 154.52 17.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.461 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -108.66 135.68 49.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.223 0.535 . . . . 0.0 111.906 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.624 ' HB2' HG21 ' A' ' 12' ' ' VAL . 11.0 mt -106.64 120.77 42.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 171.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.4 m -115.36 123.1 47.83 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.964 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -120.26 104.85 10.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.036 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.24 124.87 30.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.063 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 78.7 m-20 63.25 61.25 1.88 Allowed Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.769 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.7 170.05 5.43 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.788 2.325 . . . . 0.0 111.574 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.3 p -71.43 144.86 49.6 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -56.71 -43.38 80.51 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.473 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.571 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 5.0 p-10 -59.68 -27.98 66.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.671 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.667 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 7.1 t80 -73.12 -41.72 63.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.646 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 34.8 ttm-85 -51.74 -47.35 64.08 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.569 0.699 . . . . 0.0 109.638 172.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.3 ttm180 -58.54 -37.43 75.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.543 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 39.0 mtpt -70.82 -41.32 71.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.838 0.352 . . . . 0.0 110.102 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 36.2 mt -69.12 -33.83 74.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.863 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 57.9 mt -75.22 -37.58 61.03 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.075 0.464 . . . . 0.0 110.606 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.517 ' HZ3' ' ND1' ' A' ' 49' ' ' HIS . 8.9 ttpp -70.22 -28.38 65.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.452 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.74 -0.648 . . . . 0.0 110.376 175.085 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -94.54 -0.39 64.82 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.447 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.83 -78.48 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.184 0.594 . . . . 0.0 111.619 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.431 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -75.9 162.98 69.8 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.19 172.02 4.58 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 121.783 1.655 . . . . 0.0 112.429 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -146.34 157.11 43.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.918 0.39 . . . . 0.0 110.732 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -137.55 118.65 14.43 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.647 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 53.39 66.46 1.23 Allowed 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.95 0.781 . . . . 0.0 110.013 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.77 144.49 28.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.583 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 2.6 m -80.06 64.36 4.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.33 0.586 . . . . 0.0 110.571 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -86.02 53.82 2.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.781 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.397 -179.298 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 p -76.26 -30.07 57.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.852 0.358 . . . . 0.0 111.07 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -86.05 123.05 30.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.004 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.8 ptp -131.48 50.48 2.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.506 0.669 . . . . 0.0 110.158 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.89 64.74 5.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.989 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.2 t -67.9 84.75 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.302 0.573 . . . . 0.0 109.823 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.4 m -72.6 109.15 6.04 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.318 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.3 m -110.89 110.94 21.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.09 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.31 146.01 33.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.878 0.37 . . . . 0.0 111.126 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 t -113.12 141.24 29.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.0 115.51 18.62 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.897 0.38 . . . . 0.0 110.287 -175.54 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -105.87 177.02 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.951 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.646 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 99.5 mttt -141.59 149.64 41.0 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.4 mt -129.02 143.37 50.85 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.703 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.3 tt0 -102.36 122.61 44.61 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.843 -175.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.666 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -110.84 116.25 30.92 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 175.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.77 179.87 25.24 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.293 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -169.73 150.37 3.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.932 0.396 . . . . 0.0 110.531 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.63 139.7 49.87 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.509 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -129.3 126.65 39.49 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.999 0.428 . . . . 0.0 111.085 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -129.66 151.36 50.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.692 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.588 HG11 ' H ' ' A' ' 113' ' ' GLY . 1.3 p -101.7 158.02 4.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.515 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 mtp180 -105.91 142.94 34.76 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -70.51 -14.71 62.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.583 0.706 . . . . 0.0 109.209 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -138.23 103.45 8.02 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.043 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.49 ' HG3' HG22 ' A' ' 32' ' ' THR . 72.7 Cg_exo -47.47 160.1 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.335 2.69 . . . . 0.0 112.764 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.426 HG21 ' HB2' ' A' ' 31' ' ' PHE . 9.9 t -78.85 -177.88 5.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.605 -174.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -41.67 78.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.81 0.338 . . . . 0.0 111.271 -176.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -71.11 -7.95 50.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.9 0.381 . . . . 0.0 111.399 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.3 33.14 26.59 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.617 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.426 ' HB2' HG21 ' A' ' 27' ' ' THR . 15.7 m-30 -95.77 132.3 41.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.52 ' O ' HG23 ' A' ' 22' ' ' VAL . 69.4 p -90.83 -29.68 17.42 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -169.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 79' ' ' SER . 65.4 m80 -112.88 143.85 43.44 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -172.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.515 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -122.15 118.47 28.74 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 172.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.2 p-90 -121.87 151.5 40.6 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.791 -175.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.587 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 50.0 ttp -127.21 119.81 27.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.777 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.521 ' CG2' ' HB ' ' A' ' 76' ' ' VAL . 9.9 m -98.84 154.8 3.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.148 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -155.3 156.14 34.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.703 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.1 m -125.07 127.58 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.784 169.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 mmm-85 -131.76 177.9 7.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.883 0.373 . . . . 0.0 110.912 -175.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.7 162.7 26.72 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.553 177.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 18.4 Cg_endo -57.25 114.11 1.79 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.229 2.619 . . . . 0.0 112.3 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 59.17 57.74 3.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.898 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 71.91 1.33 3.87 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.645 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 77.8 p -63.52 132.07 50.1 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.012 -0.43 . . . . 0.0 109.845 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -75.93 126.04 30.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.528 HG22 ' CZ ' ' A' ' 50' ' ' PHE . 6.1 pt -96.74 -1.22 10.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -171.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -63.24 -8.62 8.73 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -74.24 -36.87 63.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.072 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.528 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 52.3 p90 -114.07 -14.35 12.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.46 175.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.48 HG23 HD11 ' A' ' 47' ' ' ILE . 97.6 t -98.82 122.06 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 122.888 0.475 . . . . 0.0 110.145 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.602 ' CG ' ' HB3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -91.67 -44.31 9.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.194 0.521 . . . . 0.0 110.072 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -158.99 158.68 33.7 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.314 -174.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.522 HG21 HG23 ' A' ' 39' ' ' VAL . 96.6 t -137.21 157.05 34.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.953 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.601 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.8 p -142.18 136.52 29.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.344 0.592 . . . . 0.0 111.497 -175.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.448 ' CD2' HG12 ' A' ' 88' ' ' ILE . 19.8 m-85 -119.22 109.96 16.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -81.63 94.62 6.97 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.396 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.609 ' CD2' HD13 ' A' ' 86' ' ' LEU . 13.3 mt -77.16 -177.34 4.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.748 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.59 144.02 53.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.189 0.519 . . . . 0.0 109.697 -178.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -60.7 -24.24 65.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.004 -169.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.1 t -78.17 -8.67 58.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.614 0.245 . . . . 0.0 111.186 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -85.53 135.22 38.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -62.28 121.52 9.56 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.725 2.283 . . . . 0.0 110.901 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 61.36 72.1 0.71 Allowed Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.024 -173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.88 -20.58 58.12 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.496 2.13 . . . . 0.0 112.296 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.552 ' HE3' ' CG1' ' A' ' 68' ' ' VAL . 24.9 ttpt -93.23 104.46 16.63 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.929 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 7.3 mmm180 -103.79 102.32 12.15 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.259 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.552 ' CG1' ' HE3' ' A' ' 66' ' ' LYS . 2.2 m -99.03 138.29 23.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.8 m -125.06 119.54 28.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -107.13 -23.81 12.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.509 0.671 . . . . 0.0 110.547 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.665 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 3.8 p-10 -74.26 -172.62 0.26 Allowed Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.188 -175.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.665 ' HD2' ' HB2' ' A' ' 71' ' ' ASP . 75.1 Cg_exo -40.85 -170.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 124.181 3.254 . . . . 0.0 114.598 168.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.633 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 7.9 Cg_endo -36.32 122.41 0.29 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.509 2.806 . . . . 0.0 113.842 -155.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.497 ' CB ' HG22 ' A' ' 39' ' ' VAL . 41.0 m-85 -62.55 97.34 0.09 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.01 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 12.4 ptpt -146.37 144.36 29.7 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.461 0.648 . . . . 0.0 112.129 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.1 t -121.89 131.69 72.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.833 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -114.74 114.0 25.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.89 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.31 173.02 12.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.143 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 7.6 t -126.64 144.77 50.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.715 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.09 -171.76 29.73 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -130.06 -8.07 4.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.197 0.498 . . . . 0.0 111.331 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' B' ' 218' ' ' ALY . . . -147.87 144.32 28.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.927 0.394 . . . . 0.0 111.235 -176.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -82.99 173.97 52.52 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.029 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -172.67 158.58 4.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.732 0.413 . . . . 0.0 110.041 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.431 HD12 HG21 ' A' ' 85' ' ' ILE . 16.1 mm -65.49 124.56 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.21 171.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.609 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -117.61 105.3 48.26 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.886 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.65 118.49 5.71 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 123.109 2.54 . . . . 0.0 112.652 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.448 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.2 mt -108.1 126.09 64.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.369 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.601 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 43.6 mt-10 -109.52 123.57 49.62 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.088 0.471 . . . . 0.0 110.081 176.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.499 HG13 ' CE1' ' A' ' 92' ' ' PHE . 75.6 t -103.33 125.22 57.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.715 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.548 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 76.8 m-85 -96.39 132.11 42.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.84 -177.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.499 ' CE1' HG13 ' A' ' 90' ' ' VAL . 19.9 m-85 -110.62 165.07 12.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.835 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.602 ' HB3' ' CG ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -116.05 95.31 5.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.208 0.528 . . . . 0.0 111.863 -178.068 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.61 ' OD1' ' HB2' ' A' ' 96' ' ' GLU . 9.1 t-20 -157.91 177.49 11.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.272 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.49 -0.83 15.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.917 0.865 . . . . 0.0 110.811 178.206 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.61 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -96.47 -152.93 0.39 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.508 -173.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.425 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 20.8 mm-40 -31.33 150.94 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -37.09 120.1 0.28 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 124.911 3.741 . . . . 0.0 114.013 -168.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.41 ' N ' ' HD3' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -87.72 20.31 3.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.889 -175.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.43 138.86 26.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.312 0.577 . . . . 0.0 110.574 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.3 m -122.38 155.25 27.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -129.24 106.07 8.58 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.192 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.666 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.3 m-85 -102.38 111.63 24.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.028 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -76.23 117.62 18.11 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -127.58 142.03 51.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.256 -175.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -92.05 118.48 30.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.064 -175.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.478 HD21 ' CG1' ' A' ' 37' ' ' VAL . 2.0 mp -97.09 96.22 8.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 175.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -105.08 156.44 18.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.984 0.421 . . . . 0.0 111.28 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 mt -132.44 152.86 51.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 115' ' ' PRO . 7.7 m-70 -101.53 174.21 6.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.382 0.537 . . . . 0.0 110.374 173.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.476 HD21 ' HA ' ' B' ' 215' ' ' ALA . 3.4 mm? -66.07 158.47 28.36 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -172.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -54.93 154.25 5.48 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.093 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.588 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 85.12 -50.55 4.4 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.079 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -145.14 75.86 13.76 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-N 117.892 0.846 . . . . 0.0 112.356 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.578 ' CG ' ' HB ' ' A' ' 22' ' ' VAL . 57.6 Cg_endo -110.16 107.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.583 0 C-N-CA 122.836 2.357 . . . . 0.0 112.136 167.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -98.01 96.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.561 2.174 . . . . 0.0 111.053 171.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 20' ' ' ALA . 43.5 t -117.86 115.2 47.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.156 -0.617 . . . . 0.0 111.453 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -145.04 97.23 2.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.419 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.0 t-80 -123.65 134.14 53.81 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.104 -0.239 . . . . 0.0 111.23 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.419 HD23 ' O ' ' A' ' 119' ' ' HIS . 7.1 mt -117.03 153.74 32.17 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.757 0.661 . . . . 0.0 110.108 175.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 19.9 ttm180 -142.24 147.86 37.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 173.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 81.1 m -130.81 118.85 21.41 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 6.2 mt-10 -112.93 136.57 52.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.29 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -91.41 134.92 34.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.457 0.646 . . . . 0.0 111.639 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.654 ' HB2' HG21 ' A' ' 12' ' ' VAL . 5.5 mt -104.67 113.91 27.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.777 173.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.9 m -103.52 123.85 47.68 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.132 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -120.75 105.28 10.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.458 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.32 119.9 23.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.131 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 54.24 64.37 6.42 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.871 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.05 177.89 7.8 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.3 2.0 . . . . 0.0 111.297 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.406 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 5.6 p -76.86 141.99 40.39 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -56.49 -43.1 79.34 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.298 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 8.0 p-10 -59.65 -29.5 68.08 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.564 -0.161 . . . . 0.0 110.564 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.649 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 14.6 t80 -74.7 -40.84 61.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.591 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 43.8 ttm105 -56.02 -44.91 79.15 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.682 174.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -57.4 -37.0 72.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.019 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 44.3 mtpt -72.13 -38.96 69.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.702 0.287 . . . . 0.0 110.682 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.3 mt -69.84 -30.98 68.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.578 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 33.0 mt -82.84 -31.13 28.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.918 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -73.61 -31.13 63.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.02 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.198 176.909 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -96.5 -82.08 1.61 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.281 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -115.86 166.53 11.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.205 0.526 . . . . 0.0 111.367 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.476 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -71.09 170.79 10.2 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.655 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.87 165.53 3.67 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.528 1.485 . . . . 0.0 112.138 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 22.4 ttm180 -140.44 136.74 33.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.167 0.508 . . . . 0.0 111.41 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . 0.428 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -61.0 160.06 10.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.033 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 9.9 mp -77.46 80.96 3.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.837 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -68.46 104.54 1.94 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.576 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 20.0 p -100.73 139.67 36.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.741 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -113.04 5.0 16.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.738 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.564 -0.731 . . . . 0.0 110.229 177.136 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 112.336 -0.306 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 t 60.39 77.71 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.094 0.473 . . . . 0.0 110.603 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.9 m80 67.41 30.31 6.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.116 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.9 ttm -88.68 127.56 35.58 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 176.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.25 165.3 0.26 Allowed 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.825 0.703 . . . . 0.0 110.638 -175.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.8 t -140.28 140.17 35.66 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.7 m -68.96 108.28 3.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.925 0.393 . . . . 0.0 110.056 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.1 t -119.91 112.52 19.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.748 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.58 134.72 53.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.037 0.446 . . . . 0.0 111.443 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.3 142.98 19.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -122.46 131.78 54.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.919 0.39 . . . . 0.0 110.203 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.663 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -114.79 165.77 9.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.622 176.385 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.592 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . 97.2 mttt -135.31 127.35 29.73 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.659 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.4 mt -113.19 142.66 45.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.196 0.522 . . . . 0.0 110.248 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.9 tt0 -104.49 126.08 51.25 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.758 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.645 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -112.43 113.71 26.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -145.64 176.64 24.52 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 119.699 -1.239 . . . . 0.0 111.756 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -166.29 156.03 11.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.993 0.425 . . . . 0.0 110.622 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 62.4 mtt180 -117.17 139.47 50.72 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 172.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -130.06 123.53 30.7 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.599 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -117.76 144.19 45.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.777 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' A' ' 112' ' ' GLU . 2.6 p -104.3 152.97 6.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 170.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.559 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -108.52 139.99 42.48 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -65.73 -20.51 66.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.606 0.717 . . . . 0.0 109.229 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -131.36 101.36 16.12 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.974 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.476 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.7 Cg_exo -48.63 158.7 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.52 2.813 . . . . 0.0 113.172 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.1 t -80.15 -173.04 3.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.211 -172.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -58.33 -36.98 60.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.0 0.52 . . . . 0.0 111.836 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -83.14 -1.34 52.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 110.704 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 34.09 37.87 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.962 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -98.16 134.95 40.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.476 HG22 ' HG3' ' A' ' 26' ' ' PRO . 25.6 p -88.4 -27.22 21.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.111 -171.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 109' ' ' LEU . 64.5 m80 -115.69 145.19 42.97 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -171.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.559 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 5.8 m-20 -123.23 125.63 45.44 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -128.28 149.85 50.31 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.097 0.475 . . . . 0.0 111.002 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.695 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 45.2 ttp -128.16 122.37 31.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.354 174.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 6.2 m -101.42 153.96 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.327 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -153.36 153.74 33.15 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.199 -0.6 . . . . 0.0 112.553 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.674 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 10.6 m -124.79 130.83 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.044 171.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.453 ' HB2' ' HB3' ' A' ' 15' ' ' GLU . 2.7 mmt85 -129.5 -177.09 4.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.958 0.408 . . . . 0.0 111.381 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.0 -164.17 36.37 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.229 174.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 2.7 Cg_exo -72.86 111.88 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.617 2.212 . . . . 0.0 111.369 177.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 57.18 56.52 5.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.578 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.1 m80 67.51 5.22 4.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.82 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.431 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 70.8 m -64.93 129.3 39.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.439 ' OD1' ' HB2' ' A' ' 48' ' ' GLN . 8.4 t-20 -59.96 127.08 30.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.595 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.603 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.5 pt -96.72 -3.89 10.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.439 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 1.5 mp0 -60.14 -6.27 1.36 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -73.0 -37.88 66.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.939 177.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.552 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -118.24 -21.09 8.31 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.353 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.603 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 96.6 t -87.06 130.52 36.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -99.64 -54.78 2.83 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.21 0.529 . . . . 0.0 110.526 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.89 142.14 16.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.177 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.499 HG11 HG23 ' A' ' 39' ' ' VAL . 90.2 t -117.55 160.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.937 -175.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.576 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.8 p -144.16 135.52 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.165 0.507 . . . . 0.0 111.145 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.493 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 30.9 m-85 -118.15 109.91 16.97 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -83.26 92.89 7.58 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.833 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.549 ' CD2' HD13 ' A' ' 86' ' ' LEU . 9.8 mt -71.51 -177.39 1.83 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.457 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 79.1 t60 -76.15 142.81 41.48 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.808 -0.757 . . . . 0.0 108.999 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 1.8 mp0 -54.52 -20.67 8.25 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.028 -171.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t -82.97 -5.87 59.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.672 0.272 . . . . 0.0 111.026 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 62.0 m-85 -82.35 148.46 59.28 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.88 117.91 5.23 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.613 2.209 . . . . 0.0 110.917 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 52.56 73.52 0.93 Allowed Pre-proline 0 C--O 1.226 -0.15 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.076 -174.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.46 -20.55 64.27 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.892 2.394 . . . . 0.0 113.56 -174.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -90.29 105.53 17.87 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.207 0.527 . . . . 0.0 110.457 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -106.73 89.26 2.96 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.281 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -71.6 139.64 19.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.149 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.4 m -126.91 114.26 17.63 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 175.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -107.35 -28.11 10.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.993 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.491 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 30.1 t70 -75.93 164.97 56.91 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.724 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.582 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 24.2 Cg_exo -28.72 178.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.534 1 C-N-CA 125.65 4.233 . . . . 0.0 115.111 168.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.582 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 4.5 Cg_exo -22.51 115.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 124.384 3.389 . . . . 0.0 115.036 -149.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.45 ' CB ' HG22 ' A' ' 39' ' ' VAL . 36.3 m-85 -60.89 107.86 0.77 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.603 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.695 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.4 ptpt -152.28 153.79 34.43 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.0 111.55 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 36' ' ' MET . 71.4 t -131.13 133.09 63.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.858 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -115.98 115.71 26.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.125 0.266 . . . . 0.0 110.407 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.77 172.09 13.16 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.274 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.6 t -120.89 146.87 46.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.78 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.41 -162.49 14.34 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.287 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -141.53 -18.34 0.78 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.507 ' HB1' ' HG2' ' B' ' 218' ' ' ALY . . . -136.8 134.7 37.29 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.567 -175.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.484 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -75.54 169.27 54.75 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.378 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -168.48 154.97 7.22 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.403 HD11 ' HA ' ' A' ' 85' ' ' ILE . 23.4 mm -65.6 122.55 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.549 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.6 tt -113.6 104.95 55.27 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.548 -178.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.1 108.02 1.25 Allowed 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 123.197 2.598 . . . . 0.0 111.881 173.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -98.79 124.86 52.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.676 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.576 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 72.8 mt-10 -113.67 119.91 39.06 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.419 0.628 . . . . 0.0 110.075 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.458 HG13 ' CE1' ' A' ' 92' ' ' PHE . 60.7 t -102.98 123.34 56.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.432 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -99.25 155.45 17.49 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.86 0.838 . . . . 0.0 111.138 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.458 ' CE1' HG13 ' A' ' 90' ' ' VAL . 22.6 m-85 -125.67 156.9 38.55 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.998 -176.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.09 92.02 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.237 0.541 . . . . 0.0 111.346 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -158.42 -178.19 7.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.678 172.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.593 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -114.38 6.09 15.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.652 0.263 . . . . 0.0 111.383 -177.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -102.07 -152.76 0.45 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.851 -168.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.61 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 13.4 mm-40 -31.56 159.63 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.98 1.312 . . . . 0.0 113.317 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.61 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.4 Cg_exo -28.63 125.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 124.716 3.611 . . . . 0.0 114.19 -162.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -72.59 -1.76 17.31 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.226 -170.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -155.56 171.23 20.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.484 0.659 . . . . 0.0 111.012 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.5 m -133.11 154.55 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.207 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -123.03 117.02 24.5 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.019 0.438 . . . . 0.0 111.07 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.4 m-85 -108.76 116.99 33.03 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.741 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -81.58 109.99 16.54 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.435 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 68.5 t80 -122.35 137.17 54.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.725 -174.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 108' ' ' PHE . 30.6 t70 -86.95 110.64 20.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 37' ' ' VAL . 1.7 mp -83.61 91.41 7.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.49 ' HB2' ' HD2' ' B' ' 214' ' ' LYS . 15.6 p90 -98.59 154.72 17.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.105 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 22.8 mt -133.3 137.89 46.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -176.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.513 ' HD1' HG22 ' A' ' 117' ' ' VAL . 2.6 p-80 -67.86 172.12 5.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 173.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.1 155.56 32.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.565 0.698 . . . . 0.0 111.338 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.487 ' HA ' HG22 ' A' ' 22' ' ' VAL . 15.2 tt0 -56.22 101.17 0.05 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.22 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.432 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 120.89 2.44 11.31 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.913 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -109.47 140.23 21.9 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -56.84 152.46 42.62 Favored 'Trans proline' 0 C--N 1.363 1.306 0 C-N-CA 122.297 1.998 . . . . 0.0 114.367 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 17.6 Cg_exo -36.14 158.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.176 1 C-N-CA 126.064 4.509 . . . . 0.0 116.619 177.369 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 48.6 t -121.06 141.49 41.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.0 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.91 96.69 3.01 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -115.67 136.0 53.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.731 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.5 mt -117.57 151.07 37.91 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.776 0.672 . . . . 0.0 110.295 177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 18.0 ttm180 -140.36 148.01 40.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.592 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 42.4 t -132.51 125.86 31.58 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -121.61 134.01 55.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.715 -177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.71 129.43 35.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.198 0.523 . . . . 0.0 111.652 -175.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.663 ' HB2' HG21 ' A' ' 12' ' ' VAL . 6.4 mt -95.1 131.54 40.98 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.9 m -122.91 122.71 39.26 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.014 -0.674 . . . . 0.0 110.82 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -118.11 105.7 12.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.515 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.26 119.78 23.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.436 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.86 64.36 4.0 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.07 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -83.5 170.24 11.82 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.506 2.137 . . . . 0.0 111.155 172.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.7 p -70.24 142.81 52.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -57.0 -41.43 78.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.611 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -56.09 -33.03 64.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.79 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.688 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.8 t80 -75.41 -40.48 57.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.626 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.7 ttm180 -55.3 -45.89 76.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -53.05 -42.19 65.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.251 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 45.6 mtpt -71.68 -38.96 70.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.688 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 41.5 mt -68.11 -31.55 71.23 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.911 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 56.0 mt -80.52 -28.95 37.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.966 0.413 . . . . 0.0 110.917 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -78.72 -27.39 44.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.589 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.981 174.492 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 112.052 -0.419 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.96 36.71 12.66 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.013 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . 0.49 ' HD2' ' HB2' ' A' ' 108' ' ' PHE . 46.4 pttt -139.95 -175.8 4.36 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -58.49 158.29 15.51 Favored Pre-proline 0 C--O 1.236 0.377 0 O-C-N 123.36 0.412 . . . . 0.0 111.489 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 7.5 Cg_endo -50.94 168.71 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.285 2.657 . . . . 0.0 112.974 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.484 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 8.7 tpp180 -132.5 136.95 47.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.8 -177.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . 0.507 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -152.5 114.02 4.3 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 92.4 mt 60.57 29.45 19.02 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.684 0.615 . . . . 0.0 109.474 -171.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -68.24 110.1 3.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.142 -175.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.3 m -101.65 -31.87 10.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.552 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -94.03 -63.33 1.2 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.74 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.644 -0.693 . . . . 0.0 110.897 -178.267 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.4 t -84.27 132.18 34.66 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -110.68 62.17 0.61 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.904 0.383 . . . . 0.0 110.531 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 55.0 ttm -72.17 -33.24 67.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.287 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -107.2 152.07 24.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.424 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.6 m -78.83 93.89 5.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 176.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.518 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 67.9 m -59.29 109.24 0.83 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.209 0.528 . . . . 0.0 111.093 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.9 t -127.65 125.79 40.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.46 132.75 53.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.998 0.428 . . . . 0.0 111.268 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.1 t -99.92 139.06 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.556 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 1.7 mp0 -125.09 119.67 29.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.271 0.558 . . . . 0.0 110.366 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.633 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.45 164.4 4.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.767 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 42' ' ' PRO . 92.1 mttt -132.92 125.93 30.97 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.373 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.8 mt -115.48 142.38 46.78 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.276 0.56 . . . . 0.0 110.372 177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 7.0 tt0 -109.07 128.5 55.03 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.014 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.443 ' O ' ' HB3' ' A' ' 121' ' ' ARG . 1.6 mm? -109.14 122.19 46.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.474 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -143.5 170.59 25.53 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.649 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -165.42 152.53 10.5 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.745 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.673 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 62.6 mtp180 -117.48 140.7 49.26 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.979 171.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.407 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -135.98 123.83 22.62 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.572 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 14.3 tt0 -121.4 144.76 48.49 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.556 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.544 HG11 ' H ' ' A' ' 113' ' ' GLY . 9.8 p -99.03 153.49 4.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -105.03 152.06 23.2 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.261 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.9 mmtm -68.2 -20.82 64.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.396 0.617 . . . . 0.0 109.737 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -140.79 111.09 6.75 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.646 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.495 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.2 Cg_exo -47.81 155.27 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.176 2.584 . . . . 0.0 112.423 173.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.487 HG21 ' HB2' ' A' ' 31' ' ' PHE . 9.1 t -75.11 -169.7 0.99 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.865 -172.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 m -61.81 -24.61 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -107.05 11.36 29.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.324 1.059 . . . . 0.0 109.327 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.74 33.1 47.9 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.538 172.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.487 ' HB2' HG21 ' A' ' 27' ' ' THR . 19.4 m-30 -90.38 127.93 36.33 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.495 HG22 ' HG3' ' A' ' 26' ' ' PRO . 60.3 p -85.48 -29.87 23.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.34 -169.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.427 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.8 m80 -118.87 144.43 46.39 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -172.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -115.41 119.94 37.92 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 171.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -122.78 150.86 42.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.212 0.529 . . . . 0.0 111.031 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.709 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 50.4 ttp -129.11 116.48 19.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.428 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.2 m -99.14 149.77 5.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.299 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.638 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.6 OUTLIER -151.61 156.26 40.09 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.263 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.1 m -123.73 135.22 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.899 169.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -134.95 175.78 9.26 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.002 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.14 -178.61 44.46 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.14 173.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.409 ' HB3' ' HB2' ' A' ' 13' ' ' LYS . 37.4 Cg_endo -76.63 111.87 3.34 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.147 1.898 . . . . 0.0 112.458 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 57.7 67.12 1.0 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.882 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.6 m80 72.87 -7.27 1.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.0 m -67.49 126.71 30.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.373 0.13 . . . . 0.0 110.848 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -69.03 126.68 30.57 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.571 HG22 ' CZ ' ' A' ' 50' ' ' PHE . 1.1 pt -94.87 -3.74 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.763 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -63.36 -1.28 1.07 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.22 -0.446 . . . . 0.0 112.201 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -79.16 -33.6 43.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.571 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 54.0 p90 -117.65 -18.15 9.75 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.565 175.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 84.0 t -91.4 130.87 39.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.747 0.308 . . . . 0.0 110.369 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.443 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 7.8 tp10 -102.39 -63.36 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.144 0.497 . . . . 0.0 110.506 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -131.12 162.07 30.71 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 95.0 t -133.72 155.78 40.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 169.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.585 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.4 p -141.75 134.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.529 0.68 . . . . 0.0 111.402 -174.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.417 ' CD2' HG12 ' A' ' 88' ' ' ILE . 22.3 m-85 -115.88 107.27 14.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.131 -0.941 . . . . 0.0 108.646 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -79.44 90.74 5.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.229 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.408 HD12 HG12 ' A' ' 76' ' ' VAL . 19.9 mt -78.2 -176.85 4.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.888 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.79 143.96 43.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.15 -21.54 63.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.091 -175.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t -69.13 -17.04 63.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.888 0.375 . . . . 0.0 110.548 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -85.13 139.53 36.69 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.85 117.55 4.29 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.277 1.985 . . . . 0.0 111.271 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 57.37 80.19 0.3 Allowed Pre-proline 0 C--O 1.225 -0.231 0 O-C-N 123.672 0.607 . . . . 0.0 110.505 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.15 -20.79 48.12 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.884 2.389 . . . . 0.0 113.465 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -97.45 108.68 21.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.942 0.401 . . . . 0.0 110.915 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.557 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 19.7 mmt85 -111.38 104.87 13.36 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.017 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 5.4 m -90.63 135.92 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 169.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.0 m -112.87 116.46 30.06 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -101.38 -28.58 12.51 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.545 0.688 . . . . 0.0 110.245 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.558 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 3.1 m-20 -75.52 -177.17 0.66 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.927 -175.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.619 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 13.3 Cg_exo -45.0 -168.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.963 3.109 . . . . 0.0 113.936 165.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 2.6 Cg_endo -28.52 114.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.512 2.808 . . . . 0.0 114.563 -152.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.638 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 50.8 m-85 -62.17 96.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.287 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.709 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 17.3 ptpt -143.2 148.77 37.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.491 0.662 . . . . 0.0 112.727 -177.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 36' ' ' MET . 79.3 t -123.66 133.26 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.416 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -117.55 103.21 9.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -136.27 169.7 17.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.741 0.305 . . . . 0.0 110.765 -174.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 8.3 t -123.69 144.91 49.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.173 -176.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.23 -174.13 27.54 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -130.38 2.14 4.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.298 0.549 . . . . 0.0 112.016 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.518 ' HB1' ' HG2' ' B' ' 218' ' ' ALY . . . -160.17 130.91 5.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.744 0.307 . . . . 0.0 110.77 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -71.33 173.96 42.28 Favored Glycine 0 C--O 1.237 0.326 0 CA-C-N 115.604 -0.726 . . . . 0.0 113.381 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -173.1 157.09 3.39 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.87 0.468 . . . . 0.0 110.218 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' A' ' 106' ' ' ASP . 12.9 mm -62.66 124.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.204 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.412 HD23 HG13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -108.66 106.2 58.3 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.98 112.7 3.47 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.807 2.338 . . . . 0.0 111.671 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.417 HG12 ' CD2' ' A' ' 56' ' ' PHE . 5.3 mt -108.15 125.74 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.633 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.585 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.2 mt-10 -107.93 122.12 46.17 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.388 0.613 . . . . 0.0 110.327 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.8 t -101.11 116.63 45.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.285 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -88.74 139.3 30.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.815 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.1 m-85 -113.21 146.24 39.63 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.923 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.443 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -89.75 94.4 9.82 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -156.32 156.35 33.82 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.754 -170.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -107.8 -7.78 16.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.345 1.069 . . . . 0.0 109.515 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.15 -151.22 0.4 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.516 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.46 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 8.0 mm-40 -27.07 154.52 0.01 OUTLIER Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 4.2 Cg_exo -31.29 126.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.214 1 C-N-CA 125.529 4.153 . . . . 0.0 115.133 -168.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.85 14.46 11.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.932 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -161.91 142.76 10.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.349 0.595 . . . . 0.0 111.224 -176.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -129.23 156.48 41.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -128.77 107.55 9.75 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.466 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.402 ' CD2' HD22 ' A' ' 16' ' ' LEU . 20.5 m-85 -100.27 137.89 38.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -94.73 122.51 37.41 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.377 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -133.26 130.76 39.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.324 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.459 ' HA ' HD11 ' A' ' 85' ' ' ILE . 17.4 t70 -84.47 107.0 16.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -175.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.47 HD21 HG12 ' A' ' 37' ' ' VAL . 1.5 mp -85.07 103.46 14.1 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.425 ' HB3' ' NH2' ' B' ' 217' ' ' ARG . 50.4 p90 -118.48 157.13 27.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.004 0.43 . . . . 0.0 110.352 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 mt -127.7 162.45 26.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.476 ' C ' ' HB3' ' B' ' 215' ' ' ALA . 36.0 m170 -94.62 164.07 13.12 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' B' ' 215' ' ' ALA . 1.3 mm? -51.99 147.07 7.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.958 0.409 . . . . 0.0 111.896 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.524 ' HA ' HG22 ' A' ' 22' ' ' VAL . 29.2 tt0 -61.89 100.86 0.17 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.846 177.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.544 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 109.31 28.26 4.43 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.525 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.02 159.37 65.1 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 119.024 -0.513 . . . . 0.0 110.539 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -32.67 175.19 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 124.984 3.79 . . . . 0.0 115.879 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -97.35 165.07 0.91 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 124.022 3.148 . . . . 0.0 111.876 -172.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 9.2 t -113.99 102.29 13.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.624 -177.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.417 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.2 OUTLIER -118.23 100.99 7.87 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -127.47 127.67 44.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.215 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.4 mt -107.38 150.78 26.35 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.494 174.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.622 ' HD3' ' N ' ' A' ' 122' ' ' CYS . 0.0 OUTLIER -148.14 140.44 24.27 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -174.387 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.622 ' N ' ' HD3' ' A' ' 121' ' ' ARG . 49.7 t -131.57 130.23 41.97 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.829 -175.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -121.48 141.12 51.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.089 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -104.47 132.16 51.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.174 0.512 . . . . 0.0 111.37 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.633 ' HB2' HG21 ' A' ' 12' ' ' VAL . 6.9 mt -99.36 116.11 30.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.169 175.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 35.4 m -112.14 115.2 28.47 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.557 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -114.53 109.45 18.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.901 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.71 120.35 24.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.901 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.518 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 78.1 m-20 58.04 63.59 4.35 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.654 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -85.14 165.65 11.2 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.835 2.356 . . . . 0.0 111.496 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.4 p -67.47 145.08 55.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 175.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.12 -43.76 70.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.71 -30.77 69.03 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.746 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.686 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 11.0 t80 -76.01 -39.84 54.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.618 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 29.1 ttm180 -55.12 -46.03 75.56 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 121.236 0.541 . . . . 0.0 109.583 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -51.21 -44.01 61.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.495 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -71.75 -39.91 69.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.6 mt -69.3 -29.57 67.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.857 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 40.5 mt -80.31 -41.17 25.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.047 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -68.28 -30.19 69.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.337 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.583 176.964 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 110' ' ' HIS . . . 139.44 66.97 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.596 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -76.22 131.06 39.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.004 0.431 . . . . 0.0 110.533 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . 0.522 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -83.14 171.29 11.96 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.662 -176.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . 0.522 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 0.1 OUTLIER -34.59 152.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.263 3.309 . . . . 0.0 114.749 168.767 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.425 ' NH2' ' HB3' ' A' ' 108' ' ' PHE . 17.1 ttm180 -150.14 132.63 15.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.024 -178.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . 0.518 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -77.75 68.78 3.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.656 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 31.5 mt -116.75 135.14 54.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.111 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -153.75 -68.52 0.14 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.15 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.9 t -162.13 157.81 23.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.015 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 70.02 -62.52 0.42 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.887 0.742 . . . . 0.0 111.344 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.162 179.118 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.563 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.8 m 55.95 61.01 2.95 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.258 0.551 . . . . 0.0 111.042 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -78.85 -26.44 44.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.949 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.8 mmt -70.74 -52.41 20.98 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 52.07 69.97 0.61 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.99 175.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.4 m -65.22 131.58 46.89 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -50.13 109.16 0.27 Allowed 'General case' 0 C--O 1.232 0.166 0 O-C-N 123.759 0.662 . . . . 0.0 111.761 -171.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.2 t -154.89 101.42 2.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.709 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.87 129.32 55.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.923 0.392 . . . . 0.0 110.557 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.9 t -101.87 137.25 30.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.442 ' HB3' ' HD3' ' A' ' 124' ' ' LYS . 3.5 mt-30 -117.2 120.53 38.54 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.037 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.49 167.84 3.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.711 175.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.628 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 43.7 mtpt -133.39 139.68 46.92 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.8 mt -126.99 151.9 47.95 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 175.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.683 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 41.1 tt0 -114.26 120.82 41.73 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.314 -174.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.626 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.1 mm? -108.67 115.32 29.87 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -144.88 169.64 26.6 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.011 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -163.11 155.78 18.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.164 0.507 . . . . 0.0 110.917 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 20.8 mtp180 -118.93 153.44 34.59 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.677 175.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.434 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -149.44 128.17 12.48 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.804 175.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -129.23 164.1 24.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 32' ' ' THR . 1.8 p -103.44 163.47 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.2 mtp180 -112.51 135.13 53.59 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.61 -11.38 58.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.495 0.664 . . . . 0.0 110.457 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -135.9 103.29 9.97 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.833 170.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.455 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.2 Cg_exo -47.06 155.29 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.183 2.589 . . . . 0.0 112.211 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 t -76.71 -172.32 2.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -171.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 m -61.97 -30.43 48.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.495 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.83 -7.3 59.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.181 0.515 . . . . 0.0 110.38 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.65 32.42 33.7 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.206 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -98.54 138.49 35.67 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.598 ' O ' HG23 ' A' ' 22' ' ' VAL . 26.5 p -86.77 -30.33 21.66 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -169.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.9 m80 -112.55 146.15 39.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -170.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -117.47 118.97 33.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -121.95 148.11 45.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.009 0.433 . . . . 0.0 111.111 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.639 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 41.1 ttp -125.75 122.04 35.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.526 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.9 m -103.23 153.05 5.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.072 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -154.26 154.52 33.57 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -126.71 129.5 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.844 169.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -134.91 -178.5 5.11 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.887 0.375 . . . . 0.0 111.067 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.37 166.85 29.68 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 173.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.628 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 41.0 Cg_endo -62.31 111.73 1.37 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 123.199 2.599 . . . . 0.0 112.727 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 58.02 67.84 0.91 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.784 172.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 75.47 -12.07 1.02 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.979 0.512 . . . . 0.0 112.353 172.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.1 m -62.37 122.94 16.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.799 0.333 . . . . 0.0 111.081 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.59 125.22 26.07 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.104 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.557 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 2.4 pt -96.07 -1.87 10.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.479 ' NE2' ' HH ' ' A' ' 74' ' ' TYR . 5.9 tp60 -56.35 -16.45 5.64 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.942 0.401 . . . . 0.0 111.394 -176.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -73.42 -43.85 59.56 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.617 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.497 ' CE2' HG22 ' A' ' 47' ' ' ILE . 49.5 p90 -106.07 -20.02 13.54 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.865 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.557 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 76.3 t -91.53 131.33 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.208 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.569 ' HA ' ' HZ3' ' A' ' 93' ' ' LYS . 26.2 tt0 -103.46 -62.72 1.26 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.693 0.759 . . . . 0.0 110.327 -173.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 45.2 mtpt -131.73 161.16 33.5 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.578 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 93.2 t -134.8 153.5 34.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.561 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.3 p -139.36 132.71 37.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.635 0.731 . . . . 0.0 111.157 -175.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.43 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 27.0 m-85 -113.28 105.45 13.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.51 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -79.04 94.26 5.27 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.468 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.568 ' CD2' HD13 ' A' ' 86' ' ' LEU . 11.3 mt -73.34 179.74 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.04 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.501 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 22.9 t60 -81.98 146.96 29.46 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -57.24 -21.68 35.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.669 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 t -64.71 -22.48 66.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.095 0.474 . . . . 0.0 110.581 174.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -90.48 129.12 46.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.567 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.65 138.31 44.99 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.152 1.901 . . . . 0.0 110.699 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 58.45 67.32 2.18 Favored Pre-proline 0 C--O 1.223 -0.302 0 O-C-N 123.447 0.467 . . . . 0.0 109.983 -174.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.91 -22.01 56.47 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.689 2.259 . . . . 0.0 113.79 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -93.92 109.97 21.66 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.061 0.458 . . . . 0.0 110.44 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 21.8 mmt85 -113.05 100.97 9.02 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.771 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.5 m -92.74 138.17 20.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 171.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.445 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 25.9 t -118.53 111.53 18.73 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -92.59 -26.93 17.65 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.926 0.869 . . . . 0.0 109.261 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.579 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -84.58 179.68 1.81 Allowed Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.946 -171.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 22.8 Cg_exo -28.28 -179.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.535 1 C-N-CA 126.125 4.55 . . . . 0.0 115.896 163.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.6 Cg_endo -29.24 115.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 124.318 3.345 . . . . 0.0 115.04 -153.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.503 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 42.3 m-85 -62.7 98.19 0.12 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.153 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.639 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.1 ptpt -145.27 151.26 38.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.275 0.559 . . . . 0.0 111.905 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 36' ' ' MET . 73.7 t -128.12 131.65 69.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.431 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.48 108.16 14.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.926 0.393 . . . . 0.0 110.009 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.34 174.01 10.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.424 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 8.1 t -122.99 146.89 47.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.217 -176.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.74 -168.24 27.61 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.221 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -138.31 -10.7 1.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.76 123.16 9.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.153 0.501 . . . . 0.0 110.938 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.71 175.03 13.17 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.001 -1.0 . . . . 0.0 114.471 -177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.501 ' CE2' ' HB2' ' A' ' 59' ' ' HIS . 21.8 p90 -174.24 155.59 2.43 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.218 -0.491 . . . . 0.0 110.288 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.8 mm -63.58 128.32 25.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.369 171.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' A' ' 58' ' ' LEU . 6.8 tt -120.03 105.84 41.99 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 121.025 0.44 . . . . 0.0 110.123 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.74 113.48 2.99 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 123.322 2.681 . . . . 0.0 112.327 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 mt -103.76 124.36 58.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.337 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.3 mt-10 -107.93 127.47 53.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.117 0.485 . . . . 0.0 110.289 175.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.0 t -107.3 120.8 59.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.741 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 86.7 m-85 -90.77 145.48 24.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.386 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.428 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 19.8 m-85 -126.04 161.42 27.61 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.933 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.569 ' HZ3' ' HA ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -101.6 94.22 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 117.986 0.357 . . . . 0.0 110.615 177.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -158.54 175.41 13.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.964 170.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.37 6.24 15.98 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 29.1 mm-40 -98.6 -153.08 0.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -176.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.418 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 41.9 mm-40 -30.85 150.17 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.963 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 175.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -37.57 120.8 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.677 3.585 . . . . 0.0 113.777 -169.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.443 ' N ' ' HD3' ' A' ' 99' ' ' ARG . 0.3 OUTLIER -89.77 20.34 4.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.871 -175.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -143.24 137.77 29.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.176 0.513 . . . . 0.0 110.16 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.32 155.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -125.41 117.35 23.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.118 0.485 . . . . 0.0 111.08 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.626 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.2 m-85 -108.1 119.6 39.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.966 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -80.91 105.82 12.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.35 0.595 . . . . 0.0 109.905 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -118.18 133.84 55.54 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.371 -175.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -87.55 111.82 21.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.039 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.478 HD21 HG12 ' A' ' 37' ' ' VAL . 1.9 mp -88.76 101.54 14.11 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -113.21 155.33 25.23 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.515 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.7 mt -128.52 155.09 45.42 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.427 ' CB ' ' HA ' ' A' ' 115' ' ' PRO . 1.7 m-70 -100.23 162.13 13.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 118.36 0.527 . . . . 0.0 110.175 174.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -52.12 141.61 18.16 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -52.22 121.68 7.29 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.446 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.552 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 123.38 -49.74 0.88 Allowed Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.311 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -144.53 74.57 15.23 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 117.23 0.515 . . . . 0.0 112.119 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.466 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 35.7 Cg_endo -107.67 107.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 122.839 2.359 . . . . 0.0 113.506 174.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -99.39 98.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.353 2.702 . . . . 0.0 111.393 168.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 44.1 t -122.16 111.4 30.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.97 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.4 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.88 96.51 2.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -122.27 134.09 54.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.215 -174.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 mt -117.78 153.9 32.66 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.452 0.47 . . . . 0.0 111.205 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.462 ' HG2' ' N ' ' A' ' 122' ' ' CYS . 20.8 ttm180 -145.17 151.14 37.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.462 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 48.9 t -136.37 122.23 19.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -120.32 142.14 49.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.673 0.273 . . . . 0.0 111.089 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.442 ' HD3' ' HB3' ' A' ' 11' ' ' GLN . 22.1 ttmt -92.22 138.69 31.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.202 0.525 . . . . 0.0 111.641 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.654 ' HB2' HG21 ' A' ' 12' ' ' VAL . 5.9 mt -105.49 118.76 37.38 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.0 m -111.95 123.09 49.51 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.151 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -118.97 110.0 16.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.881 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -81.66 128.12 33.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.507 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 49.89 60.66 14.94 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.422 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.29 173.6 9.7 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.521 2.147 . . . . 0.0 111.626 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 p -67.58 136.92 55.23 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 174.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -56.5 -34.14 66.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.566 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.528 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 9.3 m-20 -62.76 -32.56 73.73 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.674 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.4 t80 -76.53 -40.45 49.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.555 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 50.3 ttp180 -55.75 -41.66 74.27 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -58.09 -36.3 72.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.06 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 37.8 mtpt -72.3 -40.38 67.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.89 0.376 . . . . 0.0 110.246 176.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 26.0 mt -71.15 -25.34 62.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.948 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 30.4 mt -89.8 -23.61 21.67 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.834 0.35 . . . . 0.0 110.783 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.413 ' HZ2' ' CB ' ' A' ' 140' ' ' LYS . 0.9 OUTLIER -81.02 -23.96 38.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.876 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.265 176.145 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -96.32 -48.33 2.22 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.006 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -84.7 142.57 29.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.95 0.405 . . . . 0.0 110.54 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.81 163.16 38.11 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.727 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.54 171.18 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.444 2.096 . . . . 0.0 112.602 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 30.6 mtp85 -133.4 139.31 46.69 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -141.64 -45.59 0.36 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.89 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.49 115.92 26.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.567 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -82.99 110.9 18.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.651 175.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 25.4 m -72.33 84.07 1.07 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.433 0.635 . . . . 0.0 111.067 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -131.66 0.15 3.95 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.827 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.615 -177.124 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 m -87.96 98.14 11.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.79 0.328 . . . . 0.0 110.458 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -140.2 8.42 2.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.821 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 96.6 mmm 61.59 -164.11 0.25 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.65 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.41 30.88 20.14 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.223 0.535 . . . . 0.0 110.907 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -139.87 86.02 2.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.288 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.1 m -59.48 111.01 1.24 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.537 -175.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.508 ' O ' ' HD2' ' A' ' 130' ' ' PRO . 3.4 p -88.47 108.39 19.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.955 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.75 124.88 39.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.065 0.46 . . . . 0.0 111.753 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 t -101.7 139.75 22.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 5.2 mp0 -127.38 131.41 50.35 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -176.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.646 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -116.12 171.05 5.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.947 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -133.4 131.66 40.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.775 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.05 144.18 43.06 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.735 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 36.7 tt0 -109.68 123.26 49.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.036 -175.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.592 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.0 mm? -106.53 110.21 22.35 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -136.78 170.22 23.53 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.433 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -164.95 151.8 10.72 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.149 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.0 mtp180 -113.54 145.62 40.95 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.524 173.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.92 118.77 15.16 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.92 175.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -111.62 154.04 25.46 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 32' ' ' THR . 3.1 p -103.88 161.91 4.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.533 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 3.7 mtp180 -112.19 141.01 46.4 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -68.18 -20.26 64.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.571 0.7 . . . . 0.0 109.143 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -131.1 104.24 15.23 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.365 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.493 ' HG3' HG22 ' A' ' 32' ' ' THR . 88.3 Cg_exo -47.63 154.42 1.82 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.27 2.647 . . . . 0.0 112.988 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 31' ' ' PHE . 9.0 t -73.96 -170.65 0.95 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.077 -171.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 m -54.1 -33.48 24.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -104.24 5.96 35.14 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.162 0.982 . . . . 0.0 109.447 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.7 25.45 20.44 Favored Glycine 0 CA--C 1.503 -0.717 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.151 169.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.49 ' HB2' HG21 ' A' ' 27' ' ' THR . 21.9 m-30 -94.36 140.32 29.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.873 0.845 . . . . 0.0 111.11 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 22' ' ' VAL . 44.8 p -94.41 -23.85 17.59 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.857 -162.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.468 ' O ' ' HA ' ' A' ' 79' ' ' SER . 69.9 m80 -118.22 146.55 44.17 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -170.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.533 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 4.0 m-20 -126.98 123.73 37.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.483 170.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 54.1 p-90 -125.15 153.39 43.11 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.921 -175.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.672 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 44.8 ttp -129.61 120.65 25.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.273 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.9 m -100.46 151.19 5.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -151.69 152.74 33.19 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.735 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.5 m -124.35 127.65 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.19 171.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -127.18 -179.48 4.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.021 0.439 . . . . 0.0 111.22 -176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.68 -173.13 38.03 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.042 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -65.18 110.33 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.039 1.826 . . . . 0.0 111.753 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 51.09 65.31 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.325 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 75.4 t60 76.59 -10.39 1.33 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 171.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.6 m -60.24 127.09 30.07 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -66.04 126.6 29.12 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 120.863 0.363 . . . . 0.0 110.336 -178.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.612 HG22 ' CZ ' ' A' ' 50' ' ' PHE . 1.1 pt -94.97 -4.05 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.76 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -65.78 0.59 1.67 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.866 0.365 . . . . 0.0 111.866 -176.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -76.86 -36.01 57.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.467 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.612 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 55.3 p90 -116.91 -17.15 10.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.52 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 98.1 t -91.35 130.32 40.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.86 0.362 . . . . 0.0 110.259 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.428 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 9.6 tp10 -99.38 -62.49 1.23 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.263 0.554 . . . . 0.0 110.169 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 43.1 mtpt -132.26 163.69 28.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 39' ' ' VAL . 94.4 t -134.52 157.38 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 168.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.2 p -142.03 128.97 19.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.62 0.724 . . . . 0.0 111.166 -175.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.437 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 25.8 m-85 -110.86 104.57 13.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.581 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -78.31 92.5 4.53 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.815 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.617 ' CD2' HD13 ' A' ' 86' ' ' LEU . 12.5 mt -71.81 -178.67 2.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.89 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -76.18 142.08 41.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.17 -17.2 39.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -61.31 -28.54 69.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.36 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -82.09 131.82 55.41 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.088 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.93 124.74 15.05 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.183 1.922 . . . . 0.0 110.931 171.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 60.7 70.28 0.99 Allowed Pre-proline 0 N--CA 1.466 0.362 0 O-C-N 123.578 0.549 . . . . 0.0 110.406 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.75 -23.6 35.62 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.666 2.244 . . . . 0.0 113.781 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -90.45 105.25 17.69 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.309 0.576 . . . . 0.0 110.333 -174.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -105.54 86.92 2.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.078 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.3 m -69.27 138.22 22.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.211 0.529 . . . . 0.0 110.066 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.75 103.19 7.96 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -94.84 -23.73 17.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.054 0.931 . . . . 0.0 109.307 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.608 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 4.1 t70 -75.8 173.49 7.06 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.826 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.646 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.3 Cg_exo -32.91 -175.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.675 1 C-N-CA 125.457 4.105 . . . . 0.0 114.732 163.202 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.646 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.9 Cg_endo -28.01 115.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 124.299 3.332 . . . . 0.0 114.508 -158.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 42.7 m-85 -61.49 107.13 0.74 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.009 -175.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.672 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 17.3 ptpt -152.13 150.46 29.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.379 0.609 . . . . 0.0 112.066 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.5 t -128.57 132.55 67.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.629 177.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -121.11 106.31 11.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.455 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.29 169.14 18.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.035 0.445 . . . . 0.0 111.463 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 0.8 OUTLIER -114.91 137.05 52.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.861 -178.087 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -143.68 -178.1 19.16 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -129.76 -2.39 4.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.685 0.278 . . . . 0.0 110.97 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -163.55 142.27 7.98 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.398 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.46 179.72 39.63 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.425 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -178.11 157.03 1.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.605 0.362 . . . . 0.0 110.293 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.3 mm -63.02 128.49 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.057 171.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.617 HD13 ' CD2' ' A' ' 58' ' ' LEU . 5.7 tt -120.29 105.2 42.26 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-O 121.04 0.448 . . . . 0.0 110.224 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.34 110.66 2.3 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 123.312 2.675 . . . . 0.0 112.316 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.415 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.9 mt -102.3 123.75 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.29 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.6 mt-10 -109.27 126.62 53.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.042 0.449 . . . . 0.0 109.939 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.467 HG13 ' CE1' ' A' ' 92' ' ' PHE . 53.0 t -104.5 122.09 57.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.149 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 73.0 m-85 -89.64 136.82 32.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.018 -178.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.467 ' CE1' HG13 ' A' ' 90' ' ' VAL . 23.5 m-85 -114.77 156.36 25.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.077 178.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.428 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -104.47 91.67 3.99 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.26 0.552 . . . . 0.0 111.347 -178.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -158.51 179.75 8.84 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.909 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.531 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -113.19 4.19 16.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 110.915 176.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -99.34 -152.07 0.4 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.155 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -25.63 148.18 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -34.49 120.68 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 125.085 3.857 . . . . 0.0 113.873 -170.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.93 19.24 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.419 -174.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 11.8 ptpt -151.39 144.38 24.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.205 0.526 . . . . 0.0 110.432 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.94 154.71 30.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -120.81 118.96 31.35 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.939 0.399 . . . . 0.0 110.811 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.592 ' CD2' HD22 ' A' ' 16' ' ' LEU . 24.1 m-85 -112.54 117.08 31.35 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.712 174.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.98 105.93 14.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.626 0.727 . . . . 0.0 109.791 177.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -115.99 127.52 55.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.212 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -81.48 109.89 16.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.605 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.459 HD21 HG12 ' A' ' 37' ' ' VAL . 1.4 mp -83.87 91.16 7.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.442 . . . . 0.0 109.81 176.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -96.46 154.02 17.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.279 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.2 mt -127.91 162.3 27.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.62 ' CD2' ' HA ' ' A' ' 116' ' ' PRO . 23.8 p80 -96.52 166.97 11.43 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.792 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.11 150.59 47.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.954 0.407 . . . . 0.0 111.261 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.487 ' HA ' HG22 ' A' ' 22' ' ' VAL . 5.1 tt0 -61.82 104.3 0.43 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.469 173.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.33 24.43 6.81 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.211 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -132.04 146.53 62.09 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -43.75 139.67 5.12 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 122.703 2.269 . . . . 0.0 114.112 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.62 ' HA ' ' CD2' ' A' ' 110' ' ' HIS . 22.0 Cg_endo -61.39 174.56 1.98 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.232 3.288 . . . . 0.0 114.176 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 48.6 t -116.42 133.12 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.398 -173.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.5 97.65 3.07 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -124.44 137.12 54.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.254 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.2 mt -115.74 153.48 31.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.74 0.65 . . . . 0.0 110.097 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 20.2 ttt180 -142.64 136.38 29.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 75.0 m -115.25 113.65 24.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.867 0.365 . . . . 0.0 111.052 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -110.73 134.89 52.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.878 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -96.48 125.9 41.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.261 0.553 . . . . 0.0 111.836 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.646 ' HB2' HG21 ' A' ' 12' ' ' VAL . 12.6 mt -90.21 120.42 31.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 171.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.2 m -112.84 119.9 39.59 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.694 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.481 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 30.6 m-85 -118.25 109.23 16.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.154 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.34 116.84 20.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.191 0.519 . . . . 0.0 111.153 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.4 t30 52.75 61.78 11.04 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.501 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 96.5 Cg_endo -77.73 169.23 21.13 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.353 2.036 . . . . 0.0 111.489 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.42 ' OG1' ' HB2' ' A' ' 134' ' ' PHE . 6.6 p -59.62 141.25 55.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -57.82 -36.09 71.77 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.366 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.89 -34.5 74.75 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.668 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.0 t80 -73.94 -40.12 63.29 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.6 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 19.9 ttm180 -55.08 -44.62 75.02 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.591 173.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -55.49 -38.59 69.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.106 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -72.05 -39.74 68.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.984 0.421 . . . . 0.0 110.413 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 34.0 mt -72.62 -26.07 61.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.223 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.8 mt -85.6 -25.4 26.71 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.894 0.378 . . . . 0.0 110.689 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -80.74 -27.72 36.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.149 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.536 176.453 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -126.97 158.07 20.82 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.2 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 66.7 mttm 66.27 94.93 0.06 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.107 0.563 . . . . 0.0 111.549 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.01 156.76 65.88 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.427 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.53 168.64 3.82 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.13 1.887 . . . . 0.0 111.674 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -149.27 152.26 35.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.372 0.606 . . . . 0.0 111.592 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -86.68 -40.03 15.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.161 0.505 . . . . 0.0 110.081 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 32.7 tp -145.25 52.05 1.2 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.485 -0.78 . . . . 0.0 108.929 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.26 106.41 18.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.82 -177.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 19.2 m -115.93 -37.46 3.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.295 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -120.88 41.28 3.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.182 0.515 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.134 178.231 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 t 55.87 48.35 18.23 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.357 0.599 . . . . 0.0 110.966 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -102.45 146.34 28.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.193 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.0 mtt 59.19 40.4 21.67 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.422 0.629 . . . . 0.0 110.027 -176.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.53 89.91 6.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.874 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 p -66.43 134.03 51.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.576 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.0 m -72.66 115.15 11.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.827 0.346 . . . . 0.0 110.202 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.5 p -129.45 116.89 19.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.368 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.87 138.72 49.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.657 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 t -104.93 143.34 16.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.426 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -127.35 127.67 44.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.743 0.306 . . . . 0.0 110.362 -176.09 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -112.13 171.92 3.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.224 178.278 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 99.6 mttt -137.41 138.06 39.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.695 0.284 . . . . 0.0 110.53 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.4 mt -121.4 142.02 50.41 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.53 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.662 ' HA ' ' O ' ' A' ' 121' ' ' ARG . 3.0 tm-20 -107.8 128.09 54.29 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.046 -175.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.601 HD22 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -111.24 107.64 17.01 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.81 168.4 23.95 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.612 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -162.88 152.17 15.21 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.485 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -122.46 121.06 35.72 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.412 ' O ' ' HE1' ' A' ' 114' ' ' HIS . . . -115.61 117.4 30.2 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.283 -176.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -111.09 158.9 18.33 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.552 HG11 ' H ' ' A' ' 113' ' ' GLY . 5.0 p -103.79 156.41 5.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 23' ' ' ARG . 3.0 mtp180 -104.66 140.74 37.6 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -63.39 -22.22 66.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.612 0.72 . . . . 0.0 109.342 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -140.93 107.91 6.35 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.483 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.454 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.8 Cg_exo -49.23 156.88 2.2 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.301 2.667 . . . . 0.0 112.816 174.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.41 HG21 ' HB2' ' A' ' 31' ' ' PHE . 9.0 t -79.36 -173.5 3.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.658 -175.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -42.43 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 122.625 0.37 . . . . 0.0 111.349 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -75.32 2.2 11.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.079 0.466 . . . . 0.0 111.144 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.61 29.33 65.81 Favored Glycine 0 CA--C 1.507 -0.466 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.64 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.41 ' HB2' HG21 ' A' ' 27' ' ' THR . 20.2 m-30 -86.8 129.43 34.88 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 22' ' ' VAL . 59.9 p -91.51 -20.12 22.06 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.105 -168.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.0 m80 -122.12 145.85 47.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -172.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -121.81 123.81 42.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -126.22 143.31 51.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.196 0.522 . . . . 0.0 110.96 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.59 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 45.5 ttp -120.27 117.29 27.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.515 174.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 9.9 m -98.96 153.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.342 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.605 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.4 p90 -153.63 153.98 33.34 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -124.73 131.12 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.322 168.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.67 175.02 14.61 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.861 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . -81.88 -176.44 51.15 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.296 -168.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 11.8 Cg_exo -63.01 112.19 1.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.981 2.454 . . . . 0.0 111.702 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 52.02 52.58 14.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.671 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.0 t60 80.3 -3.47 1.91 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.701 171.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.49 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 49.9 m -58.58 123.42 16.22 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -58.11 127.12 30.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.652 0.263 . . . . 0.0 111.078 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.545 HG22 ' CZ ' ' A' ' 50' ' ' PHE . 5.6 pt -97.7 -1.98 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -66.51 -4.49 8.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.815 0.34 . . . . 0.0 111.003 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -71.35 -34.38 70.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.755 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.545 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 54.6 p90 -120.68 -17.5 7.99 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.555 175.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.541 HG23 HD11 ' A' ' 47' ' ' ILE . 91.4 t -89.75 128.48 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.921 0.391 . . . . 0.0 110.487 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.87 -62.38 1.27 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.366 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -145.66 153.56 41.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.462 HG11 HG23 ' A' ' 39' ' ' VAL . 91.5 t -128.0 158.16 39.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.914 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.626 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.7 p -142.11 134.13 26.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.14 0.495 . . . . 0.0 111.246 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.449 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 22.7 m-85 -115.86 107.29 14.83 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -77.94 94.33 4.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.925 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.589 ' CD2' HD13 ' A' ' 86' ' ' LEU . 12.4 mt -75.29 -177.7 3.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.845 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.492 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 68.7 t60 -73.97 138.89 44.46 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -54.97 -24.55 24.5 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.022 -170.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 t -69.3 -19.17 63.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.188 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 21.0 m-85 -77.95 139.6 61.71 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.7 0.286 . . . . 0.0 110.994 -176.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.35 119.9 6.81 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.066 2.51 . . . . 0.0 111.11 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 59.45 67.39 1.87 Allowed Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.45 -170.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.15 -20.25 50.06 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.591 2.194 . . . . 0.0 113.006 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -95.66 102.26 14.04 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.143 0.497 . . . . 0.0 110.488 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -98.75 94.23 6.51 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.516 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -79.52 135.21 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 172.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 m -127.95 114.56 17.3 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -106.66 -24.53 12.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.674 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.592 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 5.9 p-10 -68.51 -174.87 0.22 Allowed Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.397 1.079 . . . . 0.0 111.347 -175.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.612 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 4.2 Cg_exo -40.61 -167.63 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 124.231 3.287 . . . . 0.0 114.552 167.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.631 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 Cg_endo -39.68 124.49 1.33 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.626 2.217 . . . . 0.0 113.097 -155.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 46.7 m-85 -62.5 95.75 0.07 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.187 -175.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 4.8 ptpt -141.4 145.88 35.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.453 0.644 . . . . 0.0 112.251 -176.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 36' ' ' MET . 92.7 t -125.33 131.29 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.827 177.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -115.43 110.55 19.49 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -133.62 170.18 15.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.067 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.0 t -121.96 142.72 50.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.708 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.62 -168.5 21.71 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.125 -0.559 . . . . 0.0 111.892 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -135.8 -11.92 2.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.178 0.489 . . . . 0.0 111.651 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.63 132.73 20.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.914 0.388 . . . . 0.0 110.567 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.67 171.5 51.79 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.14 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -169.51 155.38 6.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.409 HD11 ' HA ' ' A' ' 106' ' ' ASP . 23.3 mm -63.21 126.45 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.982 172.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.589 HD13 ' CD2' ' A' ' 58' ' ' LEU . 5.6 tt -117.74 104.29 49.43 Favored Pre-proline 0 N--CA 1.444 -0.727 0 CA-C-O 121.22 0.533 . . . . 0.0 110.378 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.443 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 24.7 Cg_exo -65.47 108.48 1.21 Allowed 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 123.85 3.034 . . . . 0.0 112.384 172.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -101.49 124.47 55.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.26 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.626 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.5 mt-10 -108.17 127.49 53.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.095 0.474 . . . . 0.0 109.867 175.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.567 HG13 ' CE1' ' A' ' 92' ' ' PHE . 69.7 t -108.0 119.83 58.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.69 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.542 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 96.8 m-85 -93.24 138.55 31.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.583 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.567 ' CE1' HG13 ' A' ' 90' ' ' VAL . 24.9 m-85 -112.25 149.5 32.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.206 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.48 92.25 9.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.372 0.606 . . . . 0.0 109.946 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.5 ' HB3' ' HG3' ' A' ' 99' ' ' ARG . 50.9 t30 -158.13 156.69 31.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.668 -174.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -113.33 8.56 18.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.288 0.566 . . . . 0.0 111.013 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.485 ' HB2' HD22 ' A' ' 94' ' ' ASN . 0.4 OUTLIER -100.59 -152.29 0.42 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.236 -175.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.501 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 16.9 mm-40 -33.39 155.04 0.04 OUTLIER Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.133 0.973 . . . . 0.0 112.892 173.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 1.3 Cg_endo -37.88 122.44 0.51 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 124.566 3.511 . . . . 0.0 114.055 -168.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.5 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -95.62 20.18 10.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.412 -174.291 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.75 137.6 26.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.272 0.558 . . . . 0.0 111.01 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.0 OUTLIER -125.93 156.79 36.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.576 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.443 ' HE ' ' HB3' ' A' ' 87' ' ' PRO . 29.3 ttt180 -131.26 115.77 16.74 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.417 0.627 . . . . 0.0 110.8 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.601 ' CD2' HD22 ' A' ' 16' ' ' LEU . 23.8 m-85 -107.53 114.31 28.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.048 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.75 102.97 5.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.317 0.579 . . . . 0.0 109.636 176.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -114.08 127.29 55.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.287 0.565 . . . . 0.0 110.662 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.409 ' HA ' HD11 ' A' ' 85' ' ' ILE . 11.8 t70 -80.4 104.47 10.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.931 -177.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.483 HD21 HG12 ' A' ' 37' ' ' VAL . 1.8 mp -82.8 109.34 16.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 174.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.46 ' CE1' HG12 ' A' ' 117' ' ' VAL . 54.4 p90 -124.64 160.55 28.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.444 0.64 . . . . 0.0 111.054 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.3 mt -135.76 156.57 48.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.585 ' HB2' ' CG ' ' A' ' 114' ' ' HIS . 55.3 m170 -101.6 171.23 7.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.58 173.2 3.53 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.55 0.614 . . . . 0.0 112.262 -174.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.515 ' HA ' HG22 ' A' ' 22' ' ' VAL . 12.8 mt-10 -61.3 131.62 50.92 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.963 0.411 . . . . 0.0 110.888 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.552 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 96.2 2.95 60.42 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.659 -177.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.585 ' CG ' ' HB2' ' A' ' 110' ' ' HIS . 10.3 p80 -78.77 149.57 74.43 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-O 119.832 -0.128 . . . . 0.0 110.896 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.06 137.46 37.56 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.335 1.357 . . . . 0.0 111.087 162.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -41.2 148.71 0.23 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.749 3.633 . . . . 0.0 114.905 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 30.1 t -100.22 125.25 54.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.668 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -133.48 97.77 4.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.964 0.411 . . . . 0.0 110.12 -173.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -125.22 130.37 51.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.774 -173.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.3 mt -118.45 140.74 49.39 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.548 0.53 . . . . 0.0 110.397 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.662 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 22.2 ttm180 -131.37 132.34 44.35 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 120.519 0.199 . . . . 0.0 111.203 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 57.3 m -110.13 110.62 21.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.938 0.399 . . . . 0.0 110.708 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 22.5 mm-40 -97.65 159.52 14.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.578 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -120.28 133.59 55.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.213 0.53 . . . . 0.0 111.337 -177.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.647 ' HB2' HG21 ' A' ' 12' ' ' VAL . 9.8 mt -107.44 120.4 42.08 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.15 175.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.3 m -110.89 123.18 49.61 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.658 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -120.31 102.42 8.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.893 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -78.98 125.34 29.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.459 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 56.88 63.0 5.63 Favored Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.871 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.89 165.37 17.57 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.47 2.114 . . . . 0.0 111.675 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.444 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 13.4 p -68.1 143.21 55.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 174.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -57.79 -42.24 83.74 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.23 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -63.11 -25.93 68.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.622 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.6 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.3 t80 -73.43 -38.23 65.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.598 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 35.2 ttm180 -56.1 -45.57 79.41 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 173.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -55.06 -38.08 67.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.622 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 46.5 mtpt -72.35 -41.52 66.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.758 0.313 . . . . 0.0 110.763 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.0 mt -70.65 -32.87 70.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.065 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 50.8 mt -74.97 -33.89 61.95 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.482 ' HZ1' ' CB ' ' A' ' 140' ' ' LYS . 2.1 ttpm? -73.97 -28.66 61.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 -176.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.493 175.776 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . 79.37 -113.16 3.6 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.322 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -164.08 137.91 5.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.97 150.28 97.84 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.69 173.76 3.41 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.402 2.068 . . . . 0.0 112.453 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -145.67 137.18 25.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.961 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -111.16 73.33 0.81 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.019 0.437 . . . . 0.0 110.698 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.36 77.25 3.4 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.346 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 58.07 67.51 0.94 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.56 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 5.8 t -84.24 -17.7 38.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.793 0.33 . . . . 0.0 110.734 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' LYS . . . . . 0.496 ' HB2' ' HZ1' ' B' ' 223' ' ' LYS . 0.1 OUTLIER -93.31 95.2 9.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.079 0.466 . . . . 0.0 110.112 -179.816 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.382 -0.818 . . . . 0.0 110.278 179.568 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.664 0.269 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.491 HG23 ' HG3' ' A' ' 130' ' ' PRO . 6.6 t -105.28 142.07 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -123.98 124.13 41.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.869 0.366 . . . . 0.0 110.454 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.834 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -113.73 178.79 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.184 178.067 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 122' ' ' CYS . 16.2 tttp -145.51 135.8 23.98 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.94 151.95 39.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 41.7 tt0 -117.47 124.38 48.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.4 -176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -107.14 118.06 35.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.96 169.9 27.96 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.899 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -164.12 146.21 8.99 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.94 0.4 . . . . 0.0 110.43 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -117.48 134.96 54.27 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 173.795 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -122.94 117.17 24.91 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.933 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -110.54 150.5 28.84 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.703 HG21 ' HA ' ' A' ' 112' ' ' GLU . 1.8 p -103.62 161.6 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.1 mtp180 -110.33 146.86 35.0 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -76.12 -14.26 60.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 109.049 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -141.31 103.97 6.04 Favored Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.047 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.564 ' HG3' HG22 ' A' ' 32' ' ' THR . 82.0 Cg_exo -47.72 156.04 1.34 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.375 2.717 . . . . 0.0 113.049 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -77.7 -170.4 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.379 -173.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 m -61.68 -31.24 50.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.892 0.377 . . . . 0.0 111.297 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -86.43 3.38 44.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.742 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.97 29.38 69.15 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.391 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -89.56 133.93 34.37 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.564 HG22 ' HG3' ' A' ' 26' ' ' PRO . 36.6 p -90.07 -24.22 21.21 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.323 -171.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.469 ' O ' ' HA ' ' A' ' 79' ' ' SER . 63.3 m80 -118.7 150.04 40.41 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -170.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -129.6 119.54 23.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.411 ' HH2' HD22 ' A' ' 58' ' ' LEU . 42.9 p-90 -121.13 146.34 46.85 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.039 0.447 . . . . 0.0 110.676 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.576 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 24.2 ttp -122.85 109.82 14.65 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.482 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.595 HG11 HD11 ' A' ' 107' ' ' LEU . 11.8 m -94.52 150.05 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.463 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.506 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 0.3 OUTLIER -151.8 156.03 39.4 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 7.8 m -122.05 124.95 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.632 168.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 40' ' ' ARG . 3.1 mmp_? -126.63 178.12 6.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.098 -173.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.55 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -96.87 177.93 33.17 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.308 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.605 ' HD2' ' OG ' ' A' ' 45' ' ' SER . 13.0 Cg_exo -63.18 113.8 2.2 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.406 2.071 . . . . 0.0 111.27 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 61.3 46.04 8.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.253 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 65.37 16.4 10.51 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.605 ' OG ' ' HD2' ' A' ' 42' ' ' PRO . 60.6 p -67.87 139.88 56.52 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -68.89 125.29 26.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.55 HG23 ' HA3' ' A' ' 41' ' ' GLY . 3.4 pt -96.74 -0.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -172.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.68 -4.65 4.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -76.07 -34.9 59.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.554 0.216 . . . . 0.0 110.85 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.422 ' CE2' HG22 ' A' ' 47' ' ' ILE . 51.0 p90 -115.71 -17.65 11.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.297 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.539 HG21 HD12 ' A' ' 47' ' ' ILE . 86.8 t -91.92 122.7 43.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.213 0.53 . . . . 0.0 110.095 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 5.7 tp10 -89.21 -58.01 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.592 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 15.4 tttt -152.45 152.72 32.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.743 -175.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 95.4 t -130.82 156.9 43.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.3 p -140.67 138.04 35.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.179 0.514 . . . . 0.0 111.105 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 17.6 m-85 -120.41 110.7 16.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.5 94.35 7.45 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.86 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.549 ' CD2' HD11 ' A' ' 86' ' ' LEU . 9.0 mt -79.38 -177.15 5.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.759 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -80.27 145.38 32.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -56.88 -20.18 21.7 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.38 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 m -67.2 -21.73 65.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.117 0.484 . . . . 0.0 110.829 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -81.81 135.39 48.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.89 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.4 117.96 4.76 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.342 2.028 . . . . 0.0 110.812 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 60.5 80.87 0.25 Allowed Pre-proline 0 C--O 1.226 -0.182 0 O-C-N 123.665 0.603 . . . . 0.0 110.114 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.93 -22.71 64.37 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.615 2.21 . . . . 0.0 113.216 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HE2' ' CG1' ' A' ' 68' ' ' VAL . 78.6 tttt -100.6 109.54 21.63 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.194 0.521 . . . . 0.0 110.855 -176.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 22.5 mmt85 -108.64 104.72 14.08 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.69 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 2.8 m -97.25 136.67 27.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.7 m -120.5 110.76 16.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.024 0.44 . . . . 0.0 110.09 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -99.69 -25.04 14.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.562 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.555 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 8.1 t70 -66.87 173.06 2.76 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.351 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.659 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 60.1 Cg_exo -30.22 -167.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.953 1 C-N-CA 125.322 4.014 . . . . 0.0 115.365 159.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.3 Cg_endo -32.19 121.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 123.408 2.739 . . . . 0.0 114.761 -154.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 31.8 m-85 -65.9 91.73 0.15 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.622 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 0.4 OUTLIER -148.73 148.16 29.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.541 0.686 . . . . 0.0 112.043 -178.451 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 36' ' ' MET . 94.2 t -118.92 129.23 75.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.239 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -117.18 101.6 8.59 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.42 170.55 15.32 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 -174.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 7.4 t -120.87 144.68 48.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.972 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.52 -161.98 12.9 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -138.32 -14.91 1.29 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.335 0.567 . . . . 0.0 112.341 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.25 146.46 35.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.91 0.386 . . . . 0.0 111.158 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.431 ' O ' ' HD2' ' B' ' 217' ' ' ARG . . . -86.08 170.15 42.95 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.52 -0.764 . . . . 0.0 113.045 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -170.58 159.71 6.89 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 122.566 0.346 . . . . 0.0 110.252 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.447 HG12 HH22 ' B' ' 217' ' ' ARG . 14.8 mm -68.24 119.48 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.549 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.8 tt -112.94 105.04 55.98 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.617 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.15 120.6 7.3 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 122.823 2.349 . . . . 0.0 112.299 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.5 mt -108.48 129.47 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.318 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.54 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.7 mt-10 -114.58 122.24 45.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.143 0.497 . . . . 0.0 110.086 176.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.6 t -102.69 123.22 55.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.804 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 93.9 m-85 -95.33 138.94 32.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.641 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -113.13 161.04 17.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -108.09 91.6 3.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.467 0.651 . . . . 0.0 110.543 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.515 ' OD1' ' HB2' ' A' ' 96' ' ' GLU . 15.8 t-20 -159.57 167.7 27.9 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.842 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.588 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -113.58 9.07 17.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.246 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.515 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 3.1 mp0 -99.6 -152.95 0.43 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 14.3 mm-40 -32.43 152.37 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.192 0.997 . . . . 0.0 113.027 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.8 Cg_endo -44.21 117.74 1.43 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.136 3.224 . . . . 0.0 113.499 -168.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -87.45 20.76 2.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.133 -172.388 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.2 139.16 48.24 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.395 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.531 HG21 ' CE2' ' A' ' 103' ' ' PHE . 1.6 m -116.91 156.97 18.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.951 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -130.04 107.04 9.04 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.929 0.395 . . . . 0.0 110.32 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.672 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.5 m-85 -108.18 119.96 40.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.345 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -84.26 114.72 22.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.08 0.467 . . . . 0.0 109.81 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -126.31 133.8 51.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.661 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.3 115.98 26.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.802 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.595 HD11 HG11 ' A' ' 37' ' ' VAL . 2.5 mp -88.82 95.05 10.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -104.92 154.99 19.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.529 . . . . 0.0 111.57 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 mt -137.42 163.63 30.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.986 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.564 ' CE1' ' HB ' ' A' ' 22' ' ' VAL . 31.0 p80 -99.77 167.74 10.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.54 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' B' ' 215' ' ' ALA . 1.0 OUTLIER -68.18 147.04 52.81 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 173.594 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.703 ' HA ' HG21 ' A' ' 22' ' ' VAL . 4.5 tt0 . . . . . 0 CA--C 1.533 0.307 0 C-N-CA 122.796 0.438 . . . . 0.0 110.349 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 58.0 t . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -138.0 96.71 3.26 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -122.12 125.78 46.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.852 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.1 mt -113.26 150.52 32.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.858 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.7 ttt180 -144.93 142.71 30.08 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 60.9 m -128.88 116.13 18.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.895 0.378 . . . . 0.0 111.193 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -111.64 135.12 52.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.311 -176.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -90.83 136.38 33.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.198 0.523 . . . . 0.0 111.562 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.834 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.0 mt -106.87 124.69 49.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 20.2 m -120.55 124.15 44.64 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.209 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -120.86 112.82 19.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.585 -176.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -85.57 127.9 34.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.007 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 56.75 58.16 8.47 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.493 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HG3' HG23 ' A' ' 10' ' ' VAL . 95.5 Cg_endo -84.51 166.13 12.17 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.455 2.104 . . . . 0.0 111.694 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.1 p -73.21 145.09 46.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.766 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -54.34 -42.37 70.14 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.507 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.511 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.1 p-10 -57.22 -33.04 67.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.651 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 11.0 t80 -75.73 -40.16 56.03 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.621 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 37.2 ttm180 -56.96 -45.29 82.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -56.43 -34.76 67.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.34 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 36.2 mtpt -75.2 -41.33 58.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.812 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.1 mt -69.33 -27.06 65.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 44.0 mt -83.99 -35.69 23.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.318 . . . . 0.0 110.937 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -70.59 -30.49 67.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.732 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.547 -0.74 . . . . 0.0 110.373 176.711 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.492 ' HA ' HD22 ' A' ' 111' ' ' LEU . . . . . . . . 0 C--O 1.235 0.314 0 N-CA-C 111.121 0.045 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 216' ' ' PRO . . . . . 0.44 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 10.5 Cg_endo -53.7 165.59 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.562 2.175 . . . . 0.0 112.472 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.447 HH22 HG12 ' A' ' 85' ' ' ILE . 6.2 tpt180 . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.86 -173.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.413 HG23 ' HG3' ' A' ' 130' ' ' PRO . 9.6 t -100.17 138.85 23.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 6.4 mp0 -125.7 119.86 29.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.936 0.398 . . . . 0.0 110.443 -174.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.808 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.56 -179.74 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.888 178.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 36.0 ttpt -151.31 123.28 8.13 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.849 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.443 ' HG ' HD11 ' A' ' 125' ' ' LEU . 84.8 mt -106.66 145.57 31.81 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.313 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 3.5 tt0 -105.01 126.55 52.19 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.144 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.657 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -112.54 114.52 27.21 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -140.9 171.05 24.28 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.842 -1.171 . . . . 0.0 111.728 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -162.97 146.01 10.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.512 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -118.81 132.03 56.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.709 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.631 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -130.56 131.35 44.98 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.468 0.651 . . . . 0.0 111.271 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 3.8 tt0 -129.6 155.08 46.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.229 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.665 HG21 ' HA ' ' A' ' 112' ' ' GLU . 2.8 p -101.85 153.45 5.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 23' ' ' ARG . 1.1 mtp180 -102.57 135.48 44.12 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 20.3 tptt -75.75 -5.54 46.25 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.613 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -133.87 99.78 13.68 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.079 168.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.483 ' HG3' HG22 ' A' ' 32' ' ' THR . 83.1 Cg_exo -50.98 156.57 4.69 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.02 2.48 . . . . 0.0 111.868 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 31' ' ' PHE . 10.2 t -78.79 -172.67 3.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.091 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 m -60.09 -31.66 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.928 0.394 . . . . 0.0 111.237 -174.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -86.73 4.29 41.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.11 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.42 32.5 68.13 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.253 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.459 ' HB2' HG22 ' A' ' 27' ' ' THR . 17.7 m-30 -90.72 127.19 36.23 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.483 HG22 ' HG3' ' A' ' 26' ' ' PRO . 36.1 p -87.52 -29.91 20.98 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -170.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 79' ' ' SER . 67.1 m80 -115.47 142.29 46.91 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -112.27 123.83 51.12 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.445 ' CZ2' ' HB3' ' A' ' 78' ' ' GLU . 54.2 p-90 -127.6 147.27 50.35 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.135 0.493 . . . . 0.0 110.889 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.638 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 51.7 ttp -123.6 122.64 38.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.459 174.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.57 ' CG2' ' HB ' ' A' ' 76' ' ' VAL . 10.2 m -102.5 152.21 5.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.588 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -153.27 152.04 30.71 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.951 -0.7 . . . . 0.0 112.812 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.0 m -122.76 125.99 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.703 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -134.65 -178.92 5.29 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.221 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.502 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -94.02 -173.84 39.22 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 175.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 1.4 Cg_endo -81.57 111.37 2.3 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.235 1.957 . . . . 0.0 112.693 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 58.7 70.18 0.67 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 71.74 -11.12 0.77 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.26 0.624 . . . . 0.0 112.344 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.5 ' HB3' ' OXT' ' A' ' 141' ' ' ALA . 19.9 m -66.92 120.67 13.98 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -69.86 127.16 31.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 120.881 0.372 . . . . 0.0 110.271 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.556 HD12 HG21 ' A' ' 51' ' ' VAL . 1.2 pt -90.5 -3.47 10.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.569 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -65.74 -0.87 2.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.891 0.377 . . . . 0.0 111.552 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -74.29 -39.87 62.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.221 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.407 ' CE2' HG22 ' A' ' 47' ' ' ILE . 53.5 p90 -113.61 -20.27 11.28 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.94 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.556 HG21 HD12 ' A' ' 47' ' ' ILE . 52.5 t -93.38 135.77 27.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.781 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 93' ' ' LYS . 8.4 tp10 -111.91 -60.87 1.79 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.172 0.511 . . . . 0.0 110.711 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.665 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 6.7 tttm -138.24 146.92 43.16 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.253 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 98.1 t -127.01 159.21 37.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.566 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.8 p -141.85 136.2 30.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.299 0.571 . . . . 0.0 111.574 -174.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.483 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 22.0 m-85 -119.06 105.6 11.58 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -77.53 87.92 3.86 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.015 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.5 mt -71.38 -176.46 1.52 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.825 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -76.32 140.29 41.41 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -59.39 -19.55 47.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.021 -174.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -58.94 -27.27 65.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.743 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -85.47 131.64 47.24 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.084 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.95 121.5 10.12 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.668 2.246 . . . . 0.0 111.554 175.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 64' ' ' ARG . 16.5 mtm180 55.79 67.24 3.06 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.512 -176.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.36 -17.46 60.18 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.189 2.592 . . . . 0.0 113.52 -172.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -86.23 101.62 13.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.141 0.496 . . . . 0.0 110.228 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 22.0 mmt180 -98.42 107.83 20.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.68 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -99.05 136.19 31.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.1 m -120.6 113.56 20.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.295 0.569 . . . . 0.0 110.316 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -102.75 -24.55 13.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.614 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.527 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 13.8 t70 -68.0 170.12 8.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.623 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.639 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.2 Cg_exo -32.71 -178.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.568 1 C-N-CA 125.346 4.031 . . . . 0.0 114.865 164.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.639 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.7 Cg_endo -28.29 119.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 124.292 3.328 . . . . 0.0 113.942 -157.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.588 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 51.2 m-85 -60.1 98.66 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.59 -171.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.638 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 10.7 ptpt -140.18 150.42 44.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.438 0.637 . . . . 0.0 112.171 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 36' ' ' MET . 81.1 t -126.87 130.83 71.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.604 175.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.81 109.88 18.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.835 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 35' ' ' TRP . 1.9 tp10 -135.31 174.45 10.59 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -177.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.3 t -128.45 143.8 51.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.2 -170.62 26.09 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.884 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -130.36 -11.42 4.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.263 0.531 . . . . 0.0 112.066 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.84 139.3 22.55 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.434 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.518 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -75.5 176.45 50.37 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.355 -0.838 . . . . 0.0 113.361 -176.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -172.41 158.29 4.28 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.2 mm -65.44 126.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.329 . . . . 0.0 110.522 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.512 HD22 HG13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -111.23 104.64 56.4 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.495 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.86 111.14 2.96 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.708 2.272 . . . . 0.0 111.826 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.512 HG13 HD22 ' A' ' 86' ' ' LEU . 4.9 mt -104.43 125.69 59.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.43 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.566 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 54.4 mt-10 -111.45 123.64 50.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.171 0.51 . . . . 0.0 110.039 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 72.4 t -103.79 122.42 56.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.112 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.665 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 75.7 m-85 -94.63 132.42 39.38 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 112.005 -176.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.499 ' HE1' HG22 ' A' ' 51' ' ' VAL . 18.9 m-85 -114.38 164.07 14.44 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.079 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.462 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -107.9 100.48 9.84 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 122.327 -0.233 . . . . 0.0 111.479 175.661 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -158.28 178.18 10.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.742 171.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.52 -1.11 15.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.756 -178.338 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -100.62 -153.12 0.44 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.092 -176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -29.56 152.74 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.395 1.078 . . . . 0.0 113.907 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -32.89 122.46 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 125.03 3.82 . . . . 0.0 114.2 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.9 19.5 2.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.697 -176.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -150.09 144.56 25.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.276 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.13 157.21 28.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 102' ' ' ARG . 11.6 ttt180 -129.08 108.69 10.58 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.8 m-85 -104.66 120.44 41.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.189 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.83 111.61 19.36 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -124.94 127.28 46.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.317 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -78.82 121.81 25.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.952 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.528 HD11 ' CG1' ' A' ' 37' ' ' VAL . 1.5 mp -94.53 91.66 6.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.538 ' CE2' HG13 ' A' ' 117' ' ' VAL . 37.8 p90 -100.11 160.14 14.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.04 0.448 . . . . 0.0 110.845 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.9 mt -134.26 155.9 49.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.406 ' O ' ' NE2' ' A' ' 33' ' ' HIS . 1.4 m-70 -101.05 175.53 5.57 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 122.329 -0.232 . . . . 0.0 111.043 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.89 139.01 58.24 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.665 ' HA ' HG21 ' A' ' 22' ' ' VAL . 1.5 tm-20 . . . . . 0 N--CA 1.466 0.331 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.898 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.631 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 4.7 t . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.665 0.269 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -141.93 97.98 3.24 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -122.45 130.75 53.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.04 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.8 mt -114.83 155.58 26.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.379 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 23.2 ttm180 -144.9 145.45 31.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 61.3 m -127.56 110.37 12.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.02 0.438 . . . . 0.0 110.768 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.438 ' HG3' HD23 ' A' ' 16' ' ' LEU . 2.5 mm-40 -107.21 125.84 51.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.27 -174.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -81.9 135.49 35.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.194 0.521 . . . . 0.0 111.431 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.808 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.2 mt -103.38 114.8 29.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.4 m -107.15 115.64 30.53 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.989 0.423 . . . . 0.0 110.902 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -115.39 106.22 13.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.036 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -81.6 118.52 22.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.82 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 62.43 67.51 1.17 Allowed Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.147 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.413 ' HG3' HG23 ' A' ' 10' ' ' VAL . 60.7 Cg_endo -89.81 175.47 3.07 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.093 2.528 . . . . 0.0 111.881 174.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.3 p -84.31 147.05 27.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.41 -42.15 63.81 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.173 0.442 . . . . 0.0 112.147 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 6.4 p-10 -56.36 -32.02 64.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.796 0.332 . . . . 0.0 110.29 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.708 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.8 t80 -76.96 -42.74 37.86 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.677 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 38.0 ttm180 -54.74 -46.27 74.27 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -52.4 -42.8 64.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.381 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 36.1 mtpt -73.31 -38.98 65.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.853 0.358 . . . . 0.0 110.896 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 36.7 mt -70.02 -26.26 63.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.986 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.2 mt -83.58 -32.84 25.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 110.923 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -75.77 -26.38 57.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.308 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.5 ' OXT' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.466 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.444 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.236 0.351 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 216' ' ' PRO . . . . . 0.444 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 5.0 Cg_endo -48.82 161.55 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.687 2.258 . . . . 0.0 112.551 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.518 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 5.1 tpp180 . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.05 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.475 HG23 ' HG3' ' A' ' 130' ' ' PRO . 3.2 t -105.28 138.23 31.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -124.96 127.4 46.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -176.412 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.826 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -115.17 164.65 11.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.273 178.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 37.8 mttp -129.23 131.51 47.08 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.411 HD13 HG11 ' A' ' 90' ' ' VAL . 90.4 mt -115.1 140.23 49.24 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.248 0.547 . . . . 0.0 109.786 174.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.5 tt0 -106.33 121.34 44.02 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.873 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.581 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -106.01 112.17 25.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -137.32 166.59 24.96 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.656 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -163.53 149.69 11.72 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.163 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.9 mtt180 -115.21 140.76 48.81 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.694 174.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.652 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -126.84 120.71 29.91 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.511 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -114.18 148.3 37.52 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 112' ' ' GLU . 2.4 p -103.39 161.21 4.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 171.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 23' ' ' ARG . 3.0 mtp180 -116.15 134.67 54.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -68.92 -12.85 62.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.434 0.635 . . . . 0.0 109.679 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -134.89 102.17 11.27 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.162 171.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.518 ' HG3' HG22 ' A' ' 32' ' ' THR . 98.4 Cg_exo -49.28 154.79 3.58 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.021 2.48 . . . . 0.0 112.054 175.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -78.23 -174.06 3.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.852 -170.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.523 HG22 ' OE1' ' A' ' 29' ' ' GLU . 1.9 m -66.31 -30.83 51.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.207 0.527 . . . . 0.0 110.48 -175.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.523 ' OE1' HG22 ' A' ' 28' ' ' VAL . 3.0 mp0 -76.24 -6.65 52.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.471 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.08 34.29 38.07 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.478 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -102.56 136.54 42.2 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.518 HG22 ' HG3' ' A' ' 26' ' ' PRO . 47.4 p -92.78 -24.12 18.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.422 -169.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.435 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.0 m80 -121.11 144.63 48.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -171.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -119.15 125.45 49.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.1 p-90 -126.49 147.32 49.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.036 0.446 . . . . 0.0 110.834 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.57 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.2 ttp -125.53 115.24 19.9 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.759 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.578 HG11 HD11 ' A' ' 107' ' ' LEU . 14.2 m -97.32 150.0 4.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.817 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.2 p90 -150.98 155.8 39.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.3 m -126.05 129.03 72.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.343 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 40' ' ' ARG . 10.1 mmm180 -135.42 -176.9 4.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.332 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.496 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -89.38 -163.57 39.46 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.642 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 3.9 Cg_exo -71.91 109.85 2.77 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.17 1.913 . . . . 0.0 111.64 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 44' ' ' HIS . 28.9 mt-10 52.29 68.66 0.78 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.342 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 22.2 m170 75.51 -6.76 1.91 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.455 0.702 . . . . 0.0 112.764 172.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.555 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 72.5 m -61.2 136.05 57.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.467 0.175 . . . . 0.0 111.311 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -73.44 126.68 30.74 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.598 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.5 pt -97.27 -4.61 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -64.0 -0.43 1.13 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -77.66 -34.98 52.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.521 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.479 ' CE2' HG22 ' A' ' 47' ' ' ILE . 50.0 p90 -121.05 -16.88 7.94 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.727 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.598 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 77.8 t -94.26 126.02 46.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 9.5 tp10 -96.63 -57.88 2.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.444 0.64 . . . . 0.0 111.026 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 24.6 tttt -145.7 150.74 36.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.286 -175.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 88.9 t -131.28 158.1 43.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.435 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.597 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.2 p -141.71 138.42 31.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.266 0.555 . . . . 0.0 111.287 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 18.1 m-85 -120.95 110.35 16.18 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -82.53 95.88 7.87 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.957 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.4 mt -78.17 -178.8 5.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.815 0.34 . . . . 0.0 110.151 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.45 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 18.9 t60 -85.43 151.2 24.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 1.6 mp0 -51.87 -28.33 15.7 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.797 -169.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 t -79.0 -6.2 55.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.867 0.365 . . . . 0.0 111.273 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -90.36 134.89 30.33 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.57 136.48 30.95 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.282 1.988 . . . . 0.0 109.727 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 61.64 73.8 0.55 Allowed Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -172.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.47 -18.73 60.41 Favored 'Trans proline' 0 C--O 1.223 -0.233 0 C-N-CA 121.887 1.725 . . . . 0.0 112.656 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -110.37 106.76 16.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.678 0.275 . . . . 0.0 110.598 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.3 mmt85 -104.41 100.0 9.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.769 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -89.54 137.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.578 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.564 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 36.0 t -128.1 116.81 20.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.096 0.474 . . . . 0.0 110.116 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -106.55 -27.26 10.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.124 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.665 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -71.42 -177.3 0.46 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.571 -175.166 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.665 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 13.5 Cg_exo -31.17 178.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 125.17 3.913 . . . . 0.0 114.862 163.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.63 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.8 Cg_exo -26.32 121.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 124.797 3.665 . . . . 0.0 114.972 -157.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.564 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 34.2 m-85 -62.21 91.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.958 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.39 151.64 39.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.611 0.719 . . . . 0.0 112.676 179.298 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 36' ' ' MET . 93.8 t -123.47 129.14 74.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.631 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -114.38 112.99 23.93 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.35 173.31 11.61 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.839 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 3.2 t -121.11 145.93 47.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.139 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.16 -157.96 9.48 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -144.51 -17.48 0.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.82 140.75 31.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.999 0.428 . . . . 0.0 111.116 -176.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.89 169.81 55.03 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.773 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 59' ' ' HIS . 11.6 p90 -169.93 158.09 7.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.767 0.427 . . . . 0.0 110.059 -176.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.5 mm -67.18 126.14 26.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.609 0.243 . . . . 0.0 110.596 172.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.532 HD22 HG13 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -111.78 104.96 56.54 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.521 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.77 112.99 3.23 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.781 2.321 . . . . 0.0 112.088 171.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.532 HG13 HD22 ' A' ' 86' ' ' LEU . 6.3 mt -106.6 128.79 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.309 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.597 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 45.9 mt-10 -112.81 123.59 50.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.22 0.534 . . . . 0.0 109.964 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.411 HG11 HD13 ' A' ' 14' ' ' LEU . 57.5 t -104.84 118.88 52.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.747 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.588 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 89.3 m-85 -90.79 139.81 30.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.157 0.503 . . . . 0.0 111.245 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.418 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.0 m-85 -113.07 165.1 12.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.573 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -118.58 93.95 4.29 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.995 0.426 . . . . 0.0 112.001 -177.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.524 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 0.7 OUTLIER -160.48 -172.53 3.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.031 174.247 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 20.7 tptp -110.35 0.4 17.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.472 0.653 . . . . 0.0 111.23 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.409 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 6.5 mp0 -100.08 -155.71 0.52 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 -171.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.409 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 13.2 mm-40 -32.5 149.48 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.419 1.088 . . . . 0.0 113.536 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -30.22 125.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 125.205 3.936 . . . . 0.0 115.076 -164.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.524 ' HD3' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -82.01 18.96 1.21 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.83 -178.536 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -154.45 140.28 18.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.198 0.523 . . . . 0.0 110.941 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -120.31 157.35 22.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.0 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -128.25 107.64 9.94 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.657 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.581 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.6 m-85 -103.07 123.94 47.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.217 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -88.13 101.23 13.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.357 0.598 . . . . 0.0 110.147 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -110.18 132.27 54.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.769 -175.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.16 118.37 21.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.06 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.578 HD11 HG11 ' A' ' 37' ' ' VAL . 1.2 mp -95.2 91.29 6.22 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 175.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -102.22 156.88 17.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.219 0.533 . . . . 0.0 111.278 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 mt -134.47 163.9 28.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.2 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.479 ' CD2' ' H ' ' A' ' 110' ' ' HIS . 8.4 p80 -99.67 164.16 12.18 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.22 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.46 153.78 26.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.939 0.399 . . . . 0.0 111.145 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.713 ' HA ' HG21 ' A' ' 22' ' ' VAL . 8.7 tt0 . . . . . 0 CA--C 1.532 0.265 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.308 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 69.0 t . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 120.503 0.192 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -144.93 96.58 2.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -119.9 129.84 54.55 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.163 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.7 mt -108.11 149.34 28.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.547 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 15.6 ttt180 -140.73 137.93 33.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 85.8 m -120.09 116.58 25.97 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.157 0.504 . . . . 0.0 111.214 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 9.8 mm-40 -105.98 158.93 16.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.309 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -124.98 123.88 40.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.148 0.499 . . . . 0.0 111.387 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.826 ' HB2' HG23 ' A' ' 12' ' ' VAL . 5.9 mt -98.31 122.04 40.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.797 176.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.0 m -113.84 122.4 46.93 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.922 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -120.9 107.66 12.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.447 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -83.24 124.32 30.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.125 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 51.72 67.71 3.89 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.337 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.475 ' HG3' HG23 ' A' ' 10' ' ' VAL . 83.4 Cg_endo -86.57 -179.27 2.97 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.947 2.431 . . . . 0.0 112.003 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 69.6 p -79.12 140.37 37.83 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -58.81 -33.19 70.09 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.2 p-10 -65.31 -30.97 71.88 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.631 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 18.7 t80 -74.3 -42.32 59.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.587 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.6 ttm180 -54.19 -45.51 72.17 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.929 173.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -55.23 -39.45 69.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.333 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 40.8 mtpt -69.95 -39.97 75.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.93 0.395 . . . . 0.0 110.421 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 41.7 mt -69.53 -31.77 70.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.72 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.6 mt -80.91 -31.39 35.13 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.188 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -76.99 -26.71 54.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.134 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.358 175.419 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.236 0.358 0 N-CA-C 110.888 -0.041 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 216' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 10.0 Cg_endo -51.9 176.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.974 2.449 . . . . 0.0 112.96 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.717 -172.582 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.943 0.402 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.421 HG23 ' HG3' ' A' ' 130' ' ' PRO . 4.3 t -109.7 140.32 29.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 172.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 4.5 mp0 -128.57 118.75 23.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.874 0.369 . . . . 0.0 110.168 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.874 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -107.03 170.21 2.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.174 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HE3' ' HB3' ' A' ' 42' ' ' PRO . 54.9 mtmt -137.07 133.86 35.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.739 0.304 . . . . 0.0 110.467 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.3 mt -114.66 142.16 46.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.002 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.1 tt0 -103.48 123.48 46.98 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.712 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.651 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.1 mm? -110.56 113.32 25.85 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -142.19 175.52 22.7 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.896 -1.145 . . . . 0.0 111.981 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -167.1 151.67 7.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.06 0.457 . . . . 0.0 110.859 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 80.9 mtt180 -116.5 151.84 35.3 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.946 171.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -144.28 134.4 24.18 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.419 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -132.6 160.73 35.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.214 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' A' ' 112' ' ' GLU . 1.8 p -103.75 161.11 4.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 170.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.476 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 5.5 mtp85 -104.81 143.09 33.61 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -66.37 -19.05 65.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.59 0.709 . . . . 0.0 109.254 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -134.13 106.37 11.34 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.294 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.562 ' HG3' HG22 ' A' ' 32' ' ' THR . 99.0 Cg_exo -50.39 163.76 0.61 Allowed 'Trans proline' 0 N--CA 1.474 0.372 0 C-N-CA 123.109 2.539 . . . . 0.0 112.475 174.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 31' ' ' PHE . 8.9 t -82.88 -175.7 5.94 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.468 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.05 -30.96 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.782 0.325 . . . . 0.0 111.309 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -82.78 -0.28 47.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.037 0.446 . . . . 0.0 110.701 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.81 33.96 49.7 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.476 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.404 ' HB2' HG22 ' A' ' 27' ' ' THR . 20.3 m-30 -95.57 130.71 42.34 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 176.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.562 HG22 ' HG3' ' A' ' 26' ' ' PRO . 28.8 p -90.34 -30.98 17.1 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -170.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.458 ' O ' ' HA ' ' A' ' 79' ' ' SER . 62.7 m80 -112.19 146.21 38.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -170.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.476 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 6.1 m-20 -124.14 121.27 34.69 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.481 ' HH2' HD22 ' A' ' 58' ' ' LEU . 49.2 p-90 -122.52 150.22 42.85 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.645 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 46.0 ttp -125.59 118.06 24.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.612 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.9 m -100.02 150.15 5.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.263 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -151.13 154.69 37.43 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.6 m -124.15 127.97 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.833 170.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -132.08 -179.11 5.22 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.316 -174.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.5 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -97.11 -176.15 34.76 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.26 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.468 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 12.0 Cg_exo -68.8 111.7 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.768 2.312 . . . . 0.0 112.234 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 58.19 54.2 6.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.624 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 71.22 1.53 3.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.58 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 141' ' ' ALA . 49.7 m -63.11 128.23 34.89 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -68.96 128.22 35.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.042 0.449 . . . . 0.0 110.35 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.581 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.4 pt -94.66 -1.49 10.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.376 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -59.66 -3.69 0.53 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.534 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 93.2 m-70 -82.27 -31.98 29.82 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.143 -0.348 . . . . 0.0 111.471 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.461 ' CE1' HG22 ' A' ' 47' ' ' ILE . 54.2 p90 -119.66 -20.03 7.84 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.413 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.581 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 65.8 t -90.54 131.32 38.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 9.0 tp10 -102.62 -60.24 1.57 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.434 0.635 . . . . 0.0 110.262 -176.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 20.6 tttt -144.61 149.95 36.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.135 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.452 HG21 HG21 ' A' ' 39' ' ' VAL . 94.6 t -128.55 157.69 41.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.58 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 9.1 p -141.41 133.39 28.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.299 0.571 . . . . 0.0 111.054 -174.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.474 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 30.5 m-85 -117.02 109.04 16.48 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -80.62 91.93 5.9 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.915 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.54 ' CD2' HD11 ' A' ' 86' ' ' LEU . 11.0 mt -73.93 -176.96 2.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.999 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -77.34 147.53 36.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -56.14 -19.35 13.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.931 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.05 -24.99 65.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.108 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -81.65 137.56 47.67 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.645 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.73 118.03 5.14 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.462 2.108 . . . . 0.0 111.326 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 58.19 68.38 1.85 Allowed Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.521 0.513 . . . . 0.0 110.431 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.54 -18.48 63.73 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.845 2.363 . . . . 0.0 113.391 -174.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -88.94 101.25 13.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.185 0.517 . . . . 0.0 110.13 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 18.7 mmt180 -97.71 98.35 9.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.345 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -83.49 136.34 22.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.599 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.8 m -131.41 109.01 10.01 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -106.18 -24.24 12.38 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.63 0.728 . . . . 0.0 110.336 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.678 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 2.7 t70 -70.41 179.9 0.77 Allowed Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.319 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.678 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 16.6 Cg_exo -31.13 178.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 125.245 3.963 . . . . 0.0 114.489 163.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.605 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.3 Cg_endo -29.64 124.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 124.332 3.355 . . . . 0.0 114.442 -154.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 36.7 m-85 -61.87 93.94 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.901 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -146.14 145.53 30.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.264 0.554 . . . . 0.0 111.889 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.0 t -125.19 131.6 72.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.059 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -115.97 110.37 18.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.752 0.311 . . . . 0.0 110.196 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -130.18 165.44 22.34 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.933 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 2.1 m -116.12 129.65 56.43 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.979 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.42 -160.7 9.17 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -136.37 -20.04 1.42 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.291 0.546 . . . . 0.0 111.451 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.7 142.99 36.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.853 0.359 . . . . 0.0 110.974 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -78.88 174.55 55.25 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.58 -177.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -173.13 159.41 3.89 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.963 0.505 . . . . 0.0 110.131 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 106' ' ' ASP . 14.3 mm -68.07 125.5 25.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 172.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.54 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.1 tt -117.72 105.55 47.59 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.994 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.99 114.07 3.25 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 123.227 2.618 . . . . 0.0 112.231 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.438 HG12 ' CD2' ' A' ' 56' ' ' PHE . 5.0 mt -104.6 126.37 59.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.09 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.58 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.2 mt-10 -112.53 124.34 52.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.238 0.542 . . . . 0.0 110.124 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.7 t -103.72 120.44 53.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.772 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.59 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 74.5 m-85 -90.06 139.1 30.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.967 0.413 . . . . 0.0 110.346 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.435 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.7 m-85 -111.36 146.32 37.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.8 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -84.2 93.93 8.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.428 ' CG ' ' H ' ' A' ' 96' ' ' GLU . 62.4 t30 -155.98 159.33 39.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.372 0.606 . . . . 0.0 112.124 -171.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.76 -4.0 14.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.734 175.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.527 ' HG2' ' CG2' ' A' ' 131' ' ' THR . 0.4 OUTLIER -100.29 -153.92 0.46 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.42 -177.393 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 20.6 mm-40 -27.07 150.19 0.02 OUTLIER Pre-proline 0 N--CA 1.48 1.03 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 3.0 Cg_exo -32.5 126.43 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.189 1 C-N-CA 125.316 4.011 . . . . 0.0 114.465 -167.139 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -85.7 19.5 2.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.246 -176.256 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.52 143.45 22.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.286 0.565 . . . . 0.0 111.159 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -126.93 154.79 37.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.506 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -121.18 121.85 38.7 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.001 0.429 . . . . 0.0 111.073 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.651 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.9 m-85 -113.86 117.7 32.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.923 174.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.61 111.89 15.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.188 0.518 . . . . 0.0 109.761 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -121.4 136.17 54.99 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.553 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.44 ' HA ' HD13 ' A' ' 85' ' ' ILE . 11.7 t70 -89.35 110.6 21.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.62 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.504 HD11 HG11 ' A' ' 37' ' ' VAL . 1.5 mp -89.36 97.63 11.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.745 0.307 . . . . 0.0 110.199 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -104.33 155.65 18.58 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.014 0.435 . . . . 0.0 110.769 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.2 mt -130.76 152.46 50.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -101.82 168.82 9.19 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.875 -0.515 . . . . 0.0 111.191 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -53.61 134.81 41.25 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -172.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.579 ' HA ' HG21 ' A' ' 22' ' ' VAL . 35.5 tt0 . . . . . 0 C--O 1.232 0.168 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.221 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 37.5 t . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.721 0.296 . . . . 0.0 111.719 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.491 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -145.9 108.26 4.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.557 174.099 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.478 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.8 t-80 -127.22 135.25 50.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.657 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 119' ' ' HIS . 8.1 mt -118.03 147.36 43.31 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.497 0.498 . . . . 0.0 110.326 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.3 ttm180 -137.04 148.74 47.0 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.437 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 61.6 m -130.7 120.23 23.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.598 0.237 . . . . 0.0 110.39 175.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -118.47 143.63 46.57 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -100.94 136.54 40.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.259 0.552 . . . . 0.0 112.055 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.874 ' HB2' HG23 ' A' ' 12' ' ' VAL . 4.9 mt -104.42 115.2 29.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.814 174.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 34.4 m -105.13 116.77 32.52 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.062 0.458 . . . . 0.0 110.687 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -113.83 106.44 14.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.049 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -78.79 118.14 20.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.398 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.2 t30 52.14 63.03 9.69 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.397 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.421 ' HG3' HG23 ' A' ' 10' ' ' VAL . 88.5 Cg_endo -80.25 -179.24 5.07 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.771 2.314 . . . . 0.0 112.395 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.527 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 3.5 p -72.75 139.74 47.32 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 173.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -56.95 -39.42 74.51 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.534 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 6.9 p-10 -63.33 -28.66 70.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.666 0.27 . . . . 0.0 110.343 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.635 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 14.8 t80 -75.57 -42.16 52.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.628 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 44.5 ttm105 -53.36 -45.97 69.39 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.099 0.476 . . . . 0.0 109.816 173.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -52.93 -41.12 64.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.381 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 38.8 mtpt -72.36 -39.6 67.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.618 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.9 mt -68.58 -30.59 69.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.909 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 36.1 mt -80.67 -35.68 33.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.163 -177.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -75.28 -30.09 60.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.78 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.749 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.235 0.34 0 CA-C-O 119.817 -0.135 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 216' ' ' PRO . . . . . 0.46 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 9.4 Cg_endo -51.87 162.97 1.52 Allowed 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 122.407 2.071 . . . . 0.0 112.063 174.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 26.8 ttt180 . . . . . 0 C--N 1.319 -0.727 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.663 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.754 0.311 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.44 HG23 ' HG3' ' A' ' 130' ' ' PRO . 5.1 t -104.2 141.25 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 4.7 mp0 -128.76 130.26 46.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.899 0.38 . . . . 0.0 110.177 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.832 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -116.32 165.65 11.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.252 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 67.1 mttm -128.5 133.67 48.52 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.37 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.451 HD22 HD13 ' A' ' 47' ' ' ILE . 82.2 mt -115.6 141.19 48.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.722 175.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.9 tt0 -104.33 129.98 52.18 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.862 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.628 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -114.99 112.44 22.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -138.09 170.1 23.94 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.956 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -164.2 151.63 12.06 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.881 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 67.8 mtt180 -116.87 143.09 46.1 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.727 174.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -139.21 131.26 27.95 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.532 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -133.94 163.69 28.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.898 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.609 HG21 ' HA ' ' A' ' 112' ' ' GLU . 1.9 p -103.37 158.27 4.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 32' ' ' THR . 3.7 mtp180 -102.76 142.92 33.1 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -70.53 -13.36 62.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.663 0.744 . . . . 0.0 109.434 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -142.96 104.63 5.23 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.052 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.6 Cg_exo -47.81 152.91 2.71 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.059 2.506 . . . . 0.0 112.243 174.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.405 HG22 ' HB2' ' A' ' 31' ' ' PHE . 8.8 t -76.42 -170.08 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -171.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 m -62.42 -32.86 56.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.762 0.315 . . . . 0.0 111.729 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -82.18 -4.1 56.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.254 0.55 . . . . 0.0 110.438 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.99 31.46 43.22 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.413 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.405 ' HB2' HG22 ' A' ' 27' ' ' THR . 19.0 m-30 -90.3 131.67 35.97 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.55 HG22 ' HG3' ' A' ' 26' ' ' PRO . 75.7 p -90.27 -29.49 18.11 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -168.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.2 m80 -112.55 146.08 39.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -171.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -117.78 121.08 39.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -124.83 147.55 48.68 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.068 0.461 . . . . 0.0 110.788 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.624 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 47.3 ttp -124.24 116.91 23.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.662 176.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.4 m -98.43 150.68 4.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.443 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -151.1 151.16 31.58 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.294 0.569 . . . . 0.0 112.36 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -122.55 138.46 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.334 169.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -155.88 -176.97 6.23 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.514 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -90.41 -170.92 43.85 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.514 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 3.2 Cg_exo -74.46 110.1 3.03 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.103 1.869 . . . . 0.0 112.366 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 49.8 77.07 0.12 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.508 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 76.62 -11.7 1.14 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.791 0.436 . . . . 0.0 112.134 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.538 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 50.6 m -68.36 123.26 20.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.719 0.295 . . . . 0.0 110.452 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -76.5 129.18 36.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.029 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.581 HD12 HG21 ' A' ' 51' ' ' VAL . 4.8 pt -95.46 -1.68 10.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.418 ' HG2' ' OH ' ' A' ' 74' ' ' TYR . 96.2 mt-30 -69.85 -0.79 7.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.9 0.381 . . . . 0.0 111.384 -175.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -71.46 -39.53 70.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.22 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -113.57 -17.61 12.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.394 -0.523 . . . . 0.0 111.593 176.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.581 HG21 HD12 ' A' ' 47' ' ' ILE . 91.5 t -91.29 130.45 40.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.828 0.346 . . . . 0.0 110.215 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.494 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 8.0 tp10 -99.13 -55.99 2.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.182 0.515 . . . . 0.0 110.46 -175.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.561 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -148.79 156.88 42.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 55' ' ' VAL . 90.2 t -131.92 156.93 42.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.8 p -142.55 133.99 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.318 0.58 . . . . 0.0 110.979 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 29.6 m-85 -116.06 104.32 11.45 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -78.33 92.43 4.54 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.981 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.5 mt -75.36 -177.79 3.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 151.78 22.9 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.56 -175.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 1.6 mp0 -55.64 -21.95 20.34 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.727 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.0 t -65.84 -24.58 66.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 110.614 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -82.62 135.22 46.46 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.332 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.45 120.36 7.87 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.233 1.955 . . . . 0.0 110.537 172.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 60.68 81.57 0.24 Allowed Pre-proline 0 N--CA 1.464 0.23 0 O-C-N 123.502 0.501 . . . . 0.0 110.379 -173.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -61.0 -25.31 81.32 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.584 2.189 . . . . 0.0 113.747 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HE3' ' CG1' ' A' ' 68' ' ' VAL . 23.5 ttpt -98.32 107.24 19.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.058 0.456 . . . . 0.0 111.1 -172.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -106.1 100.9 10.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.892 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.44 ' CG1' ' HE3' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -87.63 137.8 20.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.8 m -125.34 114.09 18.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -104.3 -28.21 11.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.43 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.483 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 26.7 t70 -73.58 171.06 11.68 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.135 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.583 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 72.7 Cg_exo -26.0 -174.1 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.676 1 C-N-CA 126.016 4.477 . . . . 0.0 116.062 164.127 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.583 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 6.5 Cg_endo -33.3 120.37 0.11 Allowed 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.375 2.717 . . . . 0.0 114.139 -149.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.556 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 38.8 m-85 -62.74 93.35 0.05 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.212 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -143.71 144.82 32.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.342 0.591 . . . . 0.0 112.039 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.5 t -120.35 131.8 71.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.595 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.18 105.99 13.21 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -131.51 173.2 11.34 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.508 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.0 t -125.03 144.74 50.25 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.724 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.84 -170.66 29.07 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -133.08 -12.26 2.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.411 0.606 . . . . 0.0 111.645 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.41 145.1 32.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.661 0.267 . . . . 0.0 110.589 -177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.552 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -83.63 178.03 52.48 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.782 -0.644 . . . . 0.0 113.266 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -178.15 157.81 1.13 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.064 0.546 . . . . 0.0 110.168 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 106' ' ' ASP . 21.1 mm -62.67 125.47 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.661 171.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.569 HD22 HG13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -107.93 105.01 55.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.359 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -68.36 105.33 1.22 Allowed 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 123.013 2.475 . . . . 0.0 111.625 170.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.569 HG13 HD22 ' A' ' 86' ' ' LEU . 5.8 mt -100.87 123.73 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.237 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.9 mt-10 -109.67 123.62 49.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.286 0.565 . . . . 0.0 110.039 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -103.04 117.21 48.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.619 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.561 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 83.8 m-85 -87.89 141.23 28.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.086 0.469 . . . . 0.0 110.778 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.451 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.3 m-85 -114.12 153.82 28.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.884 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.494 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -95.77 94.13 7.49 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.55 HD21 ' HB2' ' A' ' 96' ' ' GLU . 58.3 t30 -155.37 158.46 38.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.933 -170.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.2 ptpp? -107.85 -6.95 16.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.718 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.55 ' HB2' HD21 ' A' ' 94' ' ' ASN . 23.7 mm-40 -101.29 -150.73 0.4 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.822 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.462 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 15.3 mm-40 -25.27 149.04 0.02 OUTLIER Pre-proline 0 N--CA 1.479 1.006 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -31.45 126.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 1 C-N-CA 125.41 4.074 . . . . 0.0 114.717 -170.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.58 19.52 1.97 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.823 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.73 142.12 20.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 110.537 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -124.63 155.63 32.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 174.87 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -124.19 119.11 28.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.144 0.497 . . . . 0.0 111.163 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.628 ' CD2' HD21 ' A' ' 16' ' ' LEU . 24.0 m-85 -111.58 115.77 29.72 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.906 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.79 101.82 7.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.37 0.605 . . . . 0.0 109.773 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -115.58 134.82 54.69 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.646 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.411 ' HA ' HD13 ' A' ' 85' ' ' ILE . 12.6 t70 -86.52 118.17 25.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.684 -176.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.501 HD11 ' CG1' ' A' ' 37' ' ' VAL . 1.4 mp -93.96 91.45 6.9 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.512 ' CE1' HG13 ' A' ' 117' ' ' VAL . 50.4 p90 -99.32 157.03 16.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.043 0.449 . . . . 0.0 110.832 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.5 mt -133.68 158.57 42.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -102.13 174.48 5.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.244 -0.285 . . . . 0.0 110.364 172.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.24 160.98 31.18 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.609 ' HA ' HG21 ' A' ' 22' ' ' VAL . 5.4 mp0 . . . . . 0 N--CA 1.471 0.61 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.377 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 4.9 t . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.796 0.332 . . . . 0.0 111.59 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -144.16 97.13 3.0 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.465 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.9 t-80 -119.55 134.34 55.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.777 -176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 119' ' ' HIS . 9.8 mt -117.91 145.76 44.42 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.681 0.613 . . . . 0.0 110.016 176.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.653 ' HD3' ' OE2' ' A' ' 123' ' ' GLU . 11.3 ttm180 -132.96 148.46 52.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.482 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 84.6 m -123.32 116.13 22.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.332 0.587 . . . . 0.0 111.059 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.653 ' OE2' ' HD3' ' A' ' 121' ' ' ARG . 64.3 mm-40 -98.43 162.45 13.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.383 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -125.48 128.35 47.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.413 0.625 . . . . 0.0 111.115 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.832 ' HB2' HG23 ' A' ' 12' ' ' VAL . 8.3 mt -100.34 115.37 29.81 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.962 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 20.9 m -109.14 122.71 47.89 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.005 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -120.42 100.61 7.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.046 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -73.42 116.36 13.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.653 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.0 t30 58.26 74.76 0.59 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.452 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.44 ' HG3' HG23 ' A' ' 10' ' ' VAL . 82.2 Cg_endo -97.48 -178.54 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.23 2.62 . . . . 0.0 112.817 -174.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.456 ' CG2' ' HG3' ' A' ' 96' ' ' GLU . 5.9 p -71.66 144.54 49.35 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -57.36 -45.97 83.84 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.92 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -57.93 -28.94 64.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.613 0.244 . . . . 0.0 110.918 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.667 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.2 t80 -73.12 -47.01 47.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.656 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.3 ttm105 -52.18 -48.3 65.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.264 0.554 . . . . 0.0 109.924 174.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -54.83 -34.52 62.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.778 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.5 mtmt -81.52 -37.68 27.46 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.514 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.8 mt -66.19 -28.9 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.7 mt -80.42 -37.98 31.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.434 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.448 ' NZ ' ' HB2' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -70.76 -30.39 66.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.877 -176.488 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.913 178.975 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.432 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.234 0.252 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' PRO . . . . . 0.432 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 19.8 Cg_endo -58.49 170.01 2.74 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.434 2.089 . . . . 0.0 112.239 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 17.9 ttm180 . . . . . 0 C--N 1.321 -0.642 0 CA-C-O 120.979 0.418 . . . . 0.0 110.831 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.469 HG23 ' HG3' ' A' ' 130' ' ' PRO . 6.3 t -104.83 144.17 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 5.8 mp0 -132.29 114.86 14.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.849 0.357 . . . . 0.0 110.292 -173.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.903 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -105.85 166.04 3.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.343 -179.3 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -129.23 126.01 38.18 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.148 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.421 HD22 HD13 ' A' ' 47' ' ' ILE . 79.0 mt -103.62 142.78 33.72 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.662 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 28.1 tt0 -107.94 125.5 51.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.302 -173.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.529 ' CD1' HG12 ' A' ' 39' ' ' VAL . 2.2 mm? -107.79 117.54 34.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 173.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -139.88 165.33 25.94 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.396 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -162.87 149.03 12.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.077 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 34.8 mtp180 -121.62 128.17 51.63 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.47 ' O ' ' HE1' ' A' ' 110' ' ' HIS . . . -117.61 117.46 29.45 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.377 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -110.13 141.67 42.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.455 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' A' ' 112' ' ' GLU . 5.7 p -102.95 146.08 11.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mtp85 -97.0 142.93 28.35 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -72.32 -13.92 61.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.489 0.661 . . . . 0.0 109.335 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 26' ' ' PRO . 13.7 tmtt? -138.8 100.49 8.12 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.89 176.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HG3' HG22 ' A' ' 32' ' ' THR . 80.7 Cg_exo -50.78 160.31 1.88 Allowed 'Trans proline' 0 N--CA 1.478 0.577 0 C-N-CA 123.612 2.874 . . . . 0.0 113.359 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.4 t -79.65 -174.41 4.3 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.836 -175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.446 ' H ' HG13 ' A' ' 28' ' ' VAL . 1.2 m -62.32 -32.59 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.849 0.357 . . . . 0.0 111.163 -174.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -79.78 -6.45 57.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.11 0.481 . . . . 0.0 110.513 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.6 33.26 38.98 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.268 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -93.46 130.88 39.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.565 HG22 ' HG3' ' A' ' 26' ' ' PRO . 45.9 p -92.04 -21.56 20.42 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.251 -170.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.459 ' HE1' ' OE1' ' A' ' 112' ' ' GLU . 54.9 m80 -118.84 147.24 44.15 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -171.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -123.3 117.28 24.9 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.412 ' HH2' HD22 ' A' ' 58' ' ' LEU . 49.3 p-90 -121.3 147.93 45.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.105 0.479 . . . . 0.0 111.263 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.622 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 52.2 ttp -125.33 119.38 28.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.514 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.5 m -101.93 148.97 6.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.471 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 2.1 p90 -149.5 153.28 36.99 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.8 m -123.58 135.86 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.636 170.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HD2' ' OE2' ' A' ' 15' ' ' GLU . 8.3 ptp85 -152.56 -176.74 5.85 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.483 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -90.75 -173.57 44.19 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.453 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.525 ' HD2' ' OG ' ' A' ' 45' ' ' SER . 5.1 Cg_exo -74.21 125.7 9.93 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.169 2.579 . . . . 0.0 111.354 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 61.99 47.67 5.69 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.544 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 37.1 m80 64.23 18.36 11.24 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.525 ' OG ' ' HD2' ' A' ' 42' ' ' PRO . 22.9 p -71.05 153.64 42.42 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 122.131 -0.356 . . . . 0.0 110.137 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.35 125.5 30.45 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.585 HD12 HG21 ' A' ' 51' ' ' VAL . 4.6 pt -96.58 -1.52 10.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.575 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 32.8 tt0 -70.48 -4.52 23.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.575 0.702 . . . . 0.0 109.736 -174.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.427 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 93.8 m-70 -66.1 -39.41 89.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.304 173.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -116.07 -19.39 10.33 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.133 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.585 HG21 HD12 ' A' ' 47' ' ' ILE . 96.7 t -88.8 131.32 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.229 0.537 . . . . 0.0 109.939 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.96 -59.85 1.68 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.367 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 16.2 tttt -149.53 149.78 31.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.811 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 93.9 t -128.92 157.41 41.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -177.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.579 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 8.7 p -142.53 135.1 26.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.383 0.611 . . . . 0.0 111.169 -174.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 25.1 m-85 -117.78 108.3 15.2 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -81.31 93.58 6.58 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.123 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.584 ' CD2' HD11 ' A' ' 86' ' ' LEU . 9.9 mt -74.16 -177.82 3.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 73.2 t60 -80.93 137.48 36.13 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.5 -20.49 20.58 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.5 t -64.57 -18.14 64.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.866 0.365 . . . . 0.0 110.902 173.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 44.0 m-85 -83.27 144.14 46.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.13 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 62' ' ' PHE . 15.9 Cg_exo -68.71 118.69 5.82 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.425 2.083 . . . . 0.0 110.851 173.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.401 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 26.2 mmm180 63.54 73.17 0.5 Allowed Pre-proline 0 N--CA 1.465 0.279 0 O-C-N 123.543 0.527 . . . . 0.0 110.007 -176.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.24 -22.71 66.65 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.793 2.329 . . . . 0.0 113.406 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -97.35 103.29 15.21 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 120.974 0.416 . . . . 0.0 110.421 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.401 ' HD3' ' O ' ' A' ' 64' ' ' ARG . 15.7 mmm-85 -105.15 102.23 11.73 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.321 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.6 m -95.26 138.27 21.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.5 m -125.13 119.63 29.11 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -106.74 -28.71 10.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.59 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.727 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 37.4 m-20 -72.13 -172.31 0.22 Allowed Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.531 1.132 . . . . 0.0 111.768 -174.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.727 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 72.4 Cg_exo -39.89 -172.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.858 0 C-N-CA 123.492 2.794 . . . . 0.0 114.084 165.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.651 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.7 Cg_endo -33.83 123.42 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 123.857 3.038 . . . . 0.0 114.442 -154.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 36.9 m-85 -63.21 92.07 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.187 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -142.79 145.41 33.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.183 0.516 . . . . 0.0 111.866 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 36' ' ' MET . 75.1 t -118.55 133.73 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.42 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.469 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 5.7 mm-40 -112.15 107.36 16.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.975 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.25 169.47 17.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.122 0.487 . . . . 0.0 111.039 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.2 t -126.94 143.24 51.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.888 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.76 -161.68 13.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.746 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -137.69 -14.86 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.292 0.546 . . . . 0.0 112.174 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.27 148.05 35.77 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.023 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.541 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -84.99 179.43 51.08 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.619 -0.719 . . . . 0.0 113.182 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -178.96 155.52 0.76 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.935 0.494 . . . . 0.0 109.911 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 106' ' ' ASP . 23.0 mm -62.72 127.1 22.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.242 171.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.584 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.7 tt -120.09 104.82 43.27 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-O 121.129 0.49 . . . . 0.0 110.106 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.19 112.2 2.24 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.399 2.732 . . . . 0.0 112.721 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.406 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.9 mt -103.64 124.26 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.183 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.579 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 50.9 mt-10 -109.62 124.67 51.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.152 0.501 . . . . 0.0 109.903 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.1 t -105.26 119.2 54.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.841 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 88.9 m-85 -91.19 138.82 31.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.015 0.436 . . . . 0.0 110.863 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.5 m-85 -112.14 154.65 25.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.735 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.3 95.14 7.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.623 HD21 ' HB2' ' A' ' 96' ' ' GLU . 61.0 t30 -155.33 164.38 38.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.808 -172.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -112.86 -4.6 13.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.615 178.338 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.623 ' HB2' HD21 ' A' ' 94' ' ' ASN . 17.4 mm-40 -100.93 -153.47 0.45 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.067 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 20.3 mm-40 -29.89 153.23 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 124.621 1.168 . . . . 0.0 114.071 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 6.2 Cg_exo -32.72 124.86 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.125 1 C-N-CA 125.356 4.037 . . . . 0.0 114.876 -167.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.473 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -88.2 19.58 3.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.392 -177.495 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -152.37 140.41 20.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.235 0.54 . . . . 0.0 110.887 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.1 m -125.75 156.41 35.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.72 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -122.92 121.8 37.05 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.011 0.434 . . . . 0.0 111.201 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CZ ' HG21 ' A' ' 101' ' ' VAL . 23.6 m-85 -112.83 110.75 21.05 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.707 173.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -82.21 99.03 9.04 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -108.32 138.97 43.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.159 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.418 ' HA ' HD13 ' A' ' 85' ' ' ILE . 12.4 t70 -81.83 113.66 19.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.96 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.562 HD11 HG11 ' A' ' 37' ' ' VAL . 1.8 mp -90.01 104.99 17.51 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.402 ' CE2' HG11 ' A' ' 117' ' ' VAL . 12.4 p90 -116.01 154.95 28.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.91 0.386 . . . . 0.0 110.661 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.9 mt -135.48 162.59 32.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.647 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.47 ' HE1' ' O ' ' A' ' 20' ' ' ALA . 29.8 p-80 -100.49 171.82 7.5 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.418 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' B' ' 215' ' ' ALA . 1.0 OUTLIER -74.42 168.85 18.89 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.834 0.349 . . . . 0.0 111.129 177.629 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.71 ' HA ' HG21 ' A' ' 22' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.468 0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.52 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 31.6 t . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -139.01 98.22 3.48 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -125.0 132.59 53.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.41 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.4 mt -111.43 156.45 21.62 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.866 0.729 . . . . 0.0 109.103 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 16.3 ttt180 -147.47 143.71 28.08 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.31 -0.244 . . . . 0.0 110.719 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 24.8 p -118.98 116.88 27.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.217 0.532 . . . . 0.0 111.064 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -111.92 132.84 54.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.951 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -97.81 131.56 44.2 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.164 0.506 . . . . 0.0 111.742 -172.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.903 ' HB2' HG23 ' A' ' 12' ' ' VAL . 7.4 mt -99.34 118.1 35.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.2 m -106.26 120.48 41.97 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.175 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -117.59 99.33 6.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.895 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -71.72 117.42 13.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.958 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 t30 55.94 78.35 0.38 Allowed Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.873 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.469 ' HG3' HG23 ' A' ' 10' ' ' VAL . 95.6 Cg_endo -97.64 -178.22 0.31 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.003 2.469 . . . . 0.0 112.13 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.0 p -74.1 142.25 45.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 171.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.435 ' OE2' ' HD2' ' A' ' 135' ' ' ARG . 4.0 tp10 -56.51 -38.25 71.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.019 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.659 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 15.6 m-20 -59.98 -35.29 74.69 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.625 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.6 t80 -72.54 -40.66 66.55 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.685 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 30.9 ttm180 -55.85 -45.62 78.39 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -59.13 -34.69 72.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.955 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.659 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 40.4 mtpt -71.32 -43.56 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.2 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 37.3 mt -68.63 -34.33 75.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.767 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 43.4 mt -74.1 -33.81 63.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.928 0.394 . . . . 0.0 110.836 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -76.57 -27.02 55.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.538 -175.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.84 178.32 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.429 ' HA ' HD22 ' A' ' 111' ' ' LEU . . . . . . . . 0 C--O 1.235 0.331 0 N-CA-C 111.482 0.178 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.31 -177.3 0.12 Allowed 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.547 2.164 . . . . 0.0 113.23 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 18.4 ttm180 . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.71 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 t -99.97 139.8 20.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.0 mp0 -125.67 120.41 30.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.04 0.447 . . . . 0.0 110.046 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.867 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.68 161.85 5.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.974 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' CE ' ' HB3' ' A' ' 42' ' ' PRO . 47.5 mtmt -128.57 128.62 44.6 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.364 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.401 HD13 HG11 ' A' ' 90' ' ' VAL . 82.5 mt -111.79 140.64 46.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.103 0.478 . . . . 0.0 109.715 174.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.609 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.7 tt0 -104.68 122.35 45.49 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.929 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.657 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.4 mm? -108.67 117.92 35.43 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.23 -179.85 24.52 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.21 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -169.43 154.45 5.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -122.1 136.27 54.9 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -133.62 126.62 31.28 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.358 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.13 158.26 40.17 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.149 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.563 HG21 ' HA ' ' A' ' 112' ' ' GLU . 1.7 p -101.85 160.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.601 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 6.3 ptm180 -111.95 142.27 44.56 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -70.08 -8.85 52.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.532 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -144.55 100.89 4.71 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.584 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HG3' HG22 ' A' ' 32' ' ' THR . 86.7 Cg_exo -50.06 155.04 4.76 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.144 2.563 . . . . 0.0 111.87 175.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.435 HG22 ' HB2' ' A' ' 31' ' ' PHE . 8.8 t -78.26 -175.47 4.19 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.062 -171.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.419 ' H ' HG13 ' A' ' 28' ' ' VAL . 2.1 m -57.52 -33.09 43.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 122.634 0.373 . . . . 0.0 111.838 -175.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -86.6 0.42 54.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.086 0.469 . . . . 0.0 110.73 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.04 33.18 41.78 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.899 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.435 ' HB2' HG22 ' A' ' 27' ' ' THR . 16.3 m-30 -92.07 133.17 35.99 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.563 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 58.7 p -96.7 -27.76 14.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -168.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 79' ' ' SER . 66.9 m80 -118.42 140.77 49.35 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -172.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.601 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 17.3 m-20 -115.39 116.02 27.55 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -119.38 151.51 38.37 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.006 0.432 . . . . 0.0 110.893 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.626 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 57.0 ttp -127.43 120.9 29.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.43 174.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.8 m -100.84 152.16 5.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.212 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -153.08 154.14 34.26 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 10.2 m -120.82 126.15 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.671 168.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 15' ' ' GLU . 14.1 mmm180 -128.62 176.52 7.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 -172.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.553 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -97.78 -177.4 33.76 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.571 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 8.1 Cg_exo -69.8 111.01 2.7 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.505 2.137 . . . . 0.0 112.323 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 53.56 61.66 3.01 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.525 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 76.55 -7.43 1.84 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.29 0.636 . . . . 0.0 112.366 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.4 m -69.44 128.6 37.12 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.29 -0.256 . . . . 0.0 111.046 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -65.22 129.59 40.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 110.653 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.58 HD12 HG21 ' A' ' 51' ' ' VAL . 4.2 pt -95.78 -1.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -61.22 -15.72 37.4 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.111 0.482 . . . . 0.0 110.906 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -63.64 -37.13 86.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.209 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.415 ' CE2' HG22 ' A' ' 47' ' ' ILE . 53.9 p90 -117.9 -16.63 9.9 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.408 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.58 HG21 HD12 ' A' ' 47' ' ' ILE . 95.4 t -89.56 129.71 40.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.131 0.491 . . . . 0.0 110.199 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -97.45 -66.0 0.93 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.417 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.645 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -144.45 151.18 38.83 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 55' ' ' VAL . 95.1 t -124.2 159.52 29.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 O-C-N 122.104 -0.372 . . . . 0.0 110.198 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.561 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.4 p -143.18 137.53 26.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.073 0.464 . . . . 0.0 111.016 -174.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.525 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 17.1 m-85 -120.8 111.22 17.3 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -84.42 95.23 8.71 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.941 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.549 ' CD2' HD11 ' A' ' 86' ' ' LEU . 8.1 mt -73.48 -177.59 2.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 -81.21 146.64 30.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -56.4 -19.26 14.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.413 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 m -69.59 -20.56 63.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.085 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -83.34 144.41 46.49 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.582 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.63 118.24 5.45 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.586 2.191 . . . . 0.0 110.65 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 61.06 78.5 0.31 Allowed Pre-proline 0 C--O 1.225 -0.192 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.181 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.65 -24.03 77.48 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.847 2.364 . . . . 0.0 113.732 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -97.44 109.14 21.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.969 -0.457 . . . . 0.0 110.881 -174.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 21.6 mmt85 -108.01 105.55 15.37 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.136 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.55 142.2 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 175.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 43.4 t -131.81 114.65 14.96 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -106.75 -24.82 11.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.242 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.538 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 24.7 t70 -68.97 171.63 6.16 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.564 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 82.6 Cg_exo -29.2 -170.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.557 1.652 1 C-N-CA 125.478 4.119 . . . . 0.0 115.466 164.032 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.642 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 Cg_endo -36.17 121.7 0.26 Allowed 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 122.808 2.339 . . . . 0.0 113.887 -151.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 39.5 m-85 -62.17 91.44 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.059 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.642 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 4.6 ptpt -139.16 146.92 41.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.261 0.553 . . . . 0.0 111.877 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.0 t -123.71 131.82 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.804 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.77 113.54 24.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.25 172.85 12.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.222 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.3 t -126.67 141.3 51.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.495 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.61 -171.44 23.59 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.41 ' O ' ' HB2' ' B' ' 216' ' ' PRO . 45.5 p90 -131.47 -1.92 3.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.592 0.696 . . . . 0.0 112.195 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' B' ' 217' ' ' ARG . . . -152.68 129.92 11.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.902 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.517 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -72.31 175.29 43.16 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.348 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -175.96 158.95 2.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.669 0.388 . . . . 0.0 110.275 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 85' ' ' ILE . 12.1 mm -65.58 124.86 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.409 171.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.549 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.9 tt -118.24 105.87 45.95 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.05 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.08 118.64 5.8 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.918 2.412 . . . . 0.0 112.212 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.0 mt -107.61 125.0 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.068 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.561 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 55.0 mt-10 -111.44 118.3 35.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.268 0.556 . . . . 0.0 109.924 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.401 HG11 HD13 ' A' ' 14' ' ' LEU . 64.6 t -100.42 119.18 48.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.825 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.645 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 82.5 m-85 -92.24 138.81 31.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.039 0.447 . . . . 0.0 110.815 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -112.53 150.84 30.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.19 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.67 95.13 10.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.577 HD21 ' HB2' ' A' ' 96' ' ' GLU . 62.6 t30 -154.2 155.34 35.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 0.0 112.152 -169.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.87 -1.94 15.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.131 174.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.577 ' HB2' HD21 ' A' ' 94' ' ' ASN . 32.7 mm-40 -100.29 -152.22 0.42 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.792 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -31.36 154.06 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -30.92 125.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.161 1 C-N-CA 125.37 4.047 . . . . 0.0 114.51 -169.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.66 17.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.899 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.62 149.08 26.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.142 0.496 . . . . 0.0 111.035 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.511 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.3 m -123.1 157.78 28.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.724 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -128.12 106.96 9.42 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.695 0.283 . . . . 0.0 110.35 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.4 m-85 -106.57 121.37 44.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.001 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.31 114.58 23.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -123.93 138.39 54.48 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.349 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.5 119.71 30.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.555 HD11 HG11 ' A' ' 37' ' ' VAL . 2.0 mp -93.11 91.7 7.44 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CE2' HG13 ' A' ' 117' ' ' VAL . 27.0 p90 -100.28 153.51 19.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.963 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.5 mt -129.39 154.15 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.427 ' ND1' HG22 ' A' ' 117' ' ' VAL . 27.9 m170 -103.15 170.39 7.99 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.124 -0.36 . . . . 0.0 111.107 174.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.48 141.2 57.85 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.563 ' HA ' HG21 ' A' ' 22' ' ' VAL . 8.9 mt-10 . . . . . 0 N--CA 1.474 0.765 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.896 175.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 4.7 t . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 120.826 0.346 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -144.04 121.87 11.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.423 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.2 t-80 -144.47 131.81 20.79 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.255 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 119' ' ' HIS . 7.2 mt -116.28 147.4 41.55 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.707 0.629 . . . . 0.0 109.862 175.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 20.3 ttm180 -136.19 146.02 46.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 84.2 m -128.73 114.48 16.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.022 0.439 . . . . 0.0 110.703 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -109.79 142.7 40.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.006 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -102.74 129.29 49.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.494 0.664 . . . . 0.0 111.845 -172.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.867 ' HB2' HG23 ' A' ' 12' ' ' VAL . 6.5 mt -96.77 120.24 36.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.548 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.8 m -111.22 121.62 45.75 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.623 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -118.83 110.68 17.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.311 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -76.07 117.58 17.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.334 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.3 t30 48.03 64.66 8.21 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.92 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.41 176.28 10.17 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.367 2.044 . . . . 0.0 111.899 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.4 p -72.75 144.71 47.5 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.442 ' HG3' ' NH1' ' A' ' 135' ' ' ARG . 29.5 tt0 -56.01 -44.17 78.43 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.502 -0.479 . . . . 0.0 112.032 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -56.9 -32.37 65.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.651 0.262 . . . . 0.0 110.449 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.669 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.8 t80 -76.73 -41.28 45.65 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.628 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.9 ttm180 -54.93 -44.44 74.27 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -57.1 -40.14 76.4 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.311 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 50.2 mtpt -71.19 -40.95 70.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.85 0.357 . . . . 0.0 110.858 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 45.9 mt -69.28 -33.77 73.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.3 mt -76.61 -31.24 57.3 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.826 0.346 . . . . 0.0 110.783 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -75.02 -27.51 60.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.167 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 119.151 -0.452 . . . . 0.0 110.119 175.093 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.233 0.228 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 216' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 0.3 OUTLIER -36.18 145.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.622 2.882 . . . . 0.0 114.381 175.048 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 15.2 ttm180 . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.2 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 120.764 0.316 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 t -99.71 139.37 21.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -124.86 118.03 25.42 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.024 0.44 . . . . 0.0 110.101 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.839 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.14 176.48 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.838 -178.217 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 57.6 mttt -143.67 138.72 29.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.097 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.433 ' CD2' HG21 ' A' ' 47' ' ' ILE . 86.8 mt -126.25 147.5 49.67 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 175.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.1 tt0 -105.01 127.95 53.09 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.225 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.68 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -112.98 120.7 42.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -145.65 175.93 24.92 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.926 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -167.91 150.41 5.65 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.152 0.501 . . . . 0.0 109.886 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.506 ' HG2' ' OD1' ' A' ' 118' ' ' ASN . 68.5 mtp180 -122.27 145.4 48.26 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.365 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.738 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -132.82 129.01 37.95 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.643 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.428 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 14.8 tt0 -126.09 147.95 49.47 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.223 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 112' ' ' GLU . 1.0 OUTLIER -103.05 156.3 5.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 170.671 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.746 ' NH2' ' HA ' ' A' ' 26' ' ' PRO . 17.6 mtm-85 -111.88 150.93 29.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -76.56 -6.26 51.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -136.95 106.14 8.85 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.746 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 71.5 Cg_exo -52.95 144.5 44.92 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.059 1.84 . . . . 0.0 112.272 175.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.43 ' N ' ' NH2' ' A' ' 23' ' ' ARG . 4.2 t -85.77 -175.28 5.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.745 -168.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.4 m -57.2 -33.69 43.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -171.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -87.93 -0.26 56.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.718 0.294 . . . . 0.0 111.496 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.72 35.02 23.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.407 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -101.68 145.0 29.7 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.424 HG22 ' HG3' ' A' ' 26' ' ' PRO . 30.3 p -104.36 -33.86 8.49 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.1 m80 -110.02 145.28 37.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -170.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.464 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -122.95 116.52 23.73 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.417 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 50.8 p-90 -118.16 155.1 31.05 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.702 -175.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.644 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 48.3 ttp -130.86 121.07 24.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.574 175.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 9.2 m -100.82 152.03 5.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.05 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -153.72 151.73 29.96 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.597 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -121.88 124.78 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.246 168.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.442 ' HA ' ' NE ' ' A' ' 40' ' ' ARG . 2.6 mmp_? -133.43 168.71 18.12 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.975 0.417 . . . . 0.0 110.985 -173.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.449 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -85.46 118.22 4.74 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 173.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 45' ' ' SER . 40.3 Cg_endo -74.64 151.69 41.75 Favored 'Trans proline' 0 C--N 1.326 -0.647 0 C-N-CA 122.854 2.369 . . . . 0.0 113.01 -176.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 61.86 54.47 2.85 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.994 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 66.2 1.06 1.85 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.297 0.639 . . . . 0.0 112.241 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 12.9 m -76.53 139.43 40.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.0 111.541 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -103.06 124.95 49.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.574 HD12 HG21 ' A' ' 51' ' ' VAL . 19.9 pt -95.7 -2.37 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -169.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -68.74 -11.5 60.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.472 0.653 . . . . 0.0 110.175 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.51 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 95.6 m-70 -68.87 -40.98 78.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.122 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -110.05 -14.54 14.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.753 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.574 HG21 HD12 ' A' ' 47' ' ' ILE . 96.4 t -92.59 129.37 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.995 0.426 . . . . 0.0 110.351 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -95.33 -58.43 2.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.377 0.608 . . . . 0.0 110.615 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -152.57 155.7 37.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.578 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 77.5 t -129.51 156.93 42.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 13.4 p -141.54 137.29 32.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.132 0.492 . . . . 0.0 111.042 -174.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.468 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 30.9 m-85 -119.07 108.3 14.55 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -79.63 95.59 5.95 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.05 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.582 ' CD2' HD11 ' A' ' 86' ' ' LEU . 10.6 mt -81.86 -178.07 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -87.85 152.08 22.37 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 1.7 mp0 -59.67 -15.45 19.5 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.079 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -67.33 -18.89 65.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.348 0.594 . . . . 0.0 110.373 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.01 142.23 24.27 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.432 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.21 129.98 21.64 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.373 2.049 . . . . 0.0 110.384 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 61.01 76.62 0.4 Allowed Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 123.45 0.469 . . . . 0.0 109.864 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.95 -18.17 62.72 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.467 2.111 . . . . 0.0 113.312 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -110.42 107.22 16.83 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 122.06 -0.4 . . . . 0.0 110.653 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.6 mmt85 -105.74 108.0 19.29 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.415 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.8 m -97.74 138.85 21.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.3 m -123.2 113.19 18.61 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.995 0.426 . . . . 0.0 109.988 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -105.86 -25.54 12.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.625 0.726 . . . . 0.0 110.259 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.74 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 14.4 m-20 -75.05 -172.03 0.25 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.882 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.74 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 78.0 Cg_exo -38.42 -179.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.415 2.744 . . . . 0.0 114.027 166.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.63 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -30.48 125.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 124.622 3.548 . . . . 0.0 114.985 -153.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 31.5 m-85 -61.69 92.84 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.735 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.585 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 13.4 ptpt -147.71 144.7 28.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.235 0.541 . . . . 0.0 111.817 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.8 t -122.17 131.89 72.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.99 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -119.32 107.65 13.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.941 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.57 170.58 15.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.996 0.427 . . . . 0.0 110.828 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 5.8 t -117.92 143.88 45.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.371 -176.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.99 -162.43 11.97 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -137.38 -16.41 1.38 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.276 0.538 . . . . 0.0 111.38 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.94 143.51 32.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.671 0.272 . . . . 0.0 110.462 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -81.46 -177.86 52.03 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.128 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -176.8 157.6 1.53 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.087 0.555 . . . . 0.0 109.901 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.0 mm -63.41 120.17 9.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 172.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.582 HD11 ' CD2' ' A' ' 58' ' ' LEU . 5.9 tt -114.34 105.47 53.86 Favored Pre-proline 0 N--CA 1.444 -0.738 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.6 114.22 3.77 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.03 2.487 . . . . 0.0 112.231 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.468 HG12 ' CE2' ' A' ' 56' ' ' PHE . 3.7 mp -101.16 130.37 50.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.037 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.5 mt-10 -111.9 124.5 52.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.064 0.459 . . . . 0.0 110.149 174.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.8 t -103.29 117.84 49.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.71 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.537 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 89.5 m-85 -88.63 141.55 28.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.51 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.434 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 26.4 m-85 -115.43 154.39 29.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.702 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.22 93.22 7.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.578 HD21 ' HB2' ' A' ' 96' ' ' GLU . 60.9 t30 -155.65 162.37 40.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.286 0.565 . . . . 0.0 112.076 -172.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.721 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -113.15 4.06 16.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.861 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.578 ' HB2' HD21 ' A' ' 94' ' ' ASN . 40.4 mm-40 -100.67 -155.57 0.52 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.153 -176.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.656 ' HB2' ' HD2' ' A' ' 98' ' ' PRO . 10.9 pt-20 -44.32 159.32 0.25 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.591 0.756 . . . . 0.0 111.853 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 97' ' ' GLU . 4.3 Cg_exo -31.36 128.33 0.08 OUTLIER 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 125.064 3.843 . . . . 0.0 115.189 -162.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.57 19.54 3.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.972 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.515 ' HE2' ' CE2' ' A' ' 91' ' ' TYR . 1.9 ptpt -149.04 143.86 26.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.939 0.399 . . . . 0.0 110.288 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -128.51 154.4 39.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.236 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -120.78 117.13 26.65 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.073 0.464 . . . . 0.0 110.836 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.68 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.1 m-85 -109.04 109.94 21.09 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.573 175.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.4 115.41 13.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.361 0.6 . . . . 0.0 109.699 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.45 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 66.4 t80 -129.93 127.72 40.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.542 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.88 111.46 18.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.847 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.504 HD11 HG11 ' A' ' 37' ' ' VAL . 2.0 mp -84.61 105.26 15.29 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -113.85 157.27 22.55 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.311 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.1 mt -131.0 154.81 47.77 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -101.64 169.72 8.65 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.394 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -55.98 134.64 52.46 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.558 ' HA ' HG21 ' A' ' 22' ' ' VAL . 3.5 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.455 173.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.738 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 38.4 t . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 120.651 0.263 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.506 ' OD1' ' HG2' ' A' ' 19' ' ' ARG . 63.4 t30 -145.57 114.62 6.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.643 175.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.466 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.5 t-80 -137.4 134.46 35.93 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.241 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.3 mt -119.19 151.1 38.93 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.612 0.57 . . . . 0.0 110.326 177.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.504 ' HG2' ' N ' ' A' ' 122' ' ' CYS . 21.9 ttm180 -142.58 153.76 43.81 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 176.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.504 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 85.7 m -137.73 122.97 19.32 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 9.6 mt-10 -119.5 155.37 32.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.473 0.178 . . . . 0.0 110.644 -177.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -107.96 138.6 43.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.617 0.722 . . . . 0.0 112.412 -172.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.839 ' HB2' HG23 ' A' ' 12' ' ' VAL . 6.8 mt -109.52 123.44 49.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.683 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.6 m -114.1 122.15 45.99 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.185 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.483 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 28.6 m-85 -118.45 109.39 16.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.112 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.79 120.67 24.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.22 0.533 . . . . 0.0 111.433 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 53.36 60.78 11.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.116 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 127' ' ' PHE . 71.6 Cg_endo -76.11 167.7 25.48 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.143 1.895 . . . . 0.0 110.755 174.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 72.2 p -70.36 141.16 52.26 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.419 ' HG3' ' NH1' ' A' ' 135' ' ' ARG . 20.6 tt0 -52.43 -43.05 64.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -173.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.558 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 8.9 p-10 -59.21 -29.65 67.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.848 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.605 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 8.1 t80 -75.27 -39.64 59.56 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.621 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 36.2 ttm180 -54.66 -45.28 73.81 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -56.23 -35.08 66.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.591 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 38.5 mtpt -74.8 -42.25 58.43 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.256 -0.277 . . . . 0.0 110.423 176.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.0 mt -68.93 -32.92 72.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 -177.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 37.5 mt -78.37 -33.1 49.16 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.773 0.32 . . . . 0.0 110.785 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -73.27 -26.77 61.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.481 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.953 179.07 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.237 0.406 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 216' ' ' PRO . . . . . 0.513 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 6.9 Cg_endo -49.42 167.22 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.701 2.267 . . . . 0.0 113.021 175.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.496 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 6.5 tpp180 . . . . . 0 C--N 1.321 -0.67 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.448 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.381 0 CA-C-O 120.91 0.386 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.74 141.38 17.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.3 mp0 -124.08 135.16 53.37 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.029 0.442 . . . . 0.0 110.106 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.838 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -111.87 173.51 2.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.632 174.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 122' ' ' CYS . 47.3 tttt -142.37 119.16 11.15 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.4 mt -107.35 142.31 37.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.203 0.525 . . . . 0.0 110.023 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.6 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.4 tm-20 -111.91 120.53 42.25 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.612 -176.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.604 HD12 HG12 ' A' ' 39' ' ' VAL . 1.4 mm? -103.19 112.47 25.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -135.67 169.52 23.47 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.565 -1.303 . . . . 0.0 111.485 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -164.01 151.43 12.24 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.976 -0.689 . . . . 0.0 111.337 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 21.0 mtp180 -114.98 150.63 35.49 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.327 173.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -145.06 126.79 15.25 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.767 176.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -121.35 151.24 40.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.756 HG21 ' HA ' ' A' ' 112' ' ' GLU . 4.5 p -101.77 153.92 5.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.569 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 3.0 mtp180 -107.38 140.02 40.96 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -68.46 -16.06 63.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.756 0.788 . . . . 0.0 109.623 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -136.23 105.55 9.43 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.969 172.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.507 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.0 Cg_exo -49.9 156.3 3.49 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.844 2.363 . . . . 0.0 112.004 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -75.85 -173.92 2.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.838 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.42 -32.88 49.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.773 0.32 . . . . 0.0 111.45 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -84.39 -0.63 53.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.085 0.469 . . . . 0.0 110.742 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.41 32.14 52.4 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.638 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -92.03 130.91 37.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.507 HG22 ' HG3' ' A' ' 26' ' ' PRO . 77.3 p -89.35 -29.97 18.73 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.445 -169.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.404 ' O ' ' HA ' ' A' ' 79' ' ' SER . 69.6 m80 -116.17 143.1 45.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -172.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.569 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -121.07 121.45 37.93 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.88 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -123.94 151.37 43.66 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.558 -174.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.66 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 56.0 ttp -127.33 116.59 20.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.705 175.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 8.7 m -98.2 151.98 4.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.38 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.563 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.0 OUTLIER -153.44 156.08 37.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 178.869 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.604 HG12 HD12 ' A' ' 16' ' ' LEU . 4.4 m -126.31 128.32 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.19 171.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -134.99 -177.07 4.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.023 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.488 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -93.53 -171.8 39.49 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.005 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 9.1 Cg_exo -67.41 111.76 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.562 2.175 . . . . 0.0 111.167 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 58.96 57.17 3.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.06 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 71.6 m80 67.83 9.36 7.06 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.489 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 71.5 m -67.47 138.04 56.3 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 122.432 -0.168 . . . . 0.0 110.902 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -70.3 126.15 28.82 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.922 0.391 . . . . 0.0 110.02 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.603 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.6 pt -97.32 -4.3 9.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -173.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.04 1.84 0.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -79.34 -33.39 43.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.505 0.193 . . . . 0.0 110.723 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.478 ' CE1' HG22 ' A' ' 47' ' ' ILE . 52.8 p90 -119.79 -20.78 7.48 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.211 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.603 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 91.7 t -89.36 130.29 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.48 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 10.3 tp10 -99.23 -63.07 1.16 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.204 0.526 . . . . 0.0 110.313 -176.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -144.06 152.84 41.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.045 178.386 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 97.5 t -127.04 159.06 37.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.208 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.571 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 13.0 p -141.74 137.33 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.131 0.491 . . . . 0.0 111.209 -176.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 23.6 m-85 -118.19 108.77 15.56 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -79.49 94.08 5.53 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.976 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.607 ' CD2' HD11 ' A' ' 86' ' ' LEU . 11.3 mt -78.67 -178.2 5.79 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.11 144.35 47.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.186 0.517 . . . . 0.0 109.811 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.23 -23.69 62.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.792 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.5 t -77.06 -13.35 59.97 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.751 0.31 . . . . 0.0 110.992 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -81.26 140.1 48.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.497 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.26 123.41 13.56 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.471 2.114 . . . . 0.0 110.798 172.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 57.87 77.58 0.4 Allowed Pre-proline 0 N--CA 1.454 -0.253 0 O-C-N 123.876 0.735 . . . . 0.0 110.733 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.12 -22.24 73.86 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.493 2.129 . . . . 0.0 113.094 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -106.29 105.84 16.07 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 120.858 0.361 . . . . 0.0 110.704 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.1 mmt85 -104.65 108.48 19.96 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.491 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 2.8 m -97.69 136.51 28.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.1 m -120.3 113.61 20.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.038 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -104.78 -23.04 13.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.041 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.56 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -70.39 -174.87 0.26 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.319 -175.722 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.649 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 48.4 Cg_exo -42.37 -179.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.542 2.828 . . . . 0.0 113.474 169.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.649 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 4.2 Cg_exo -28.4 122.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.451 3.434 . . . . 0.0 114.17 -159.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.563 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 40.7 m-85 -60.31 100.21 0.09 Allowed 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.276 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.66 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.2 ptpt -148.03 147.8 29.99 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.581 0.705 . . . . 0.0 112.501 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 36' ' ' MET . 83.8 t -122.91 132.28 71.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.428 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -117.45 106.6 13.36 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.438 ' CD ' HH22 ' A' ' 67' ' ' ARG . 1.8 tp10 -133.71 175.95 8.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.515 -175.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 8.2 t -128.04 145.87 50.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.201 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.21 -163.62 14.55 Favored Glycine 0 N--CA 1.453 -0.167 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.22 -12.57 2.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.693 0.746 . . . . 0.0 112.018 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -150.58 134.29 16.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.97 0.414 . . . . 0.0 111.119 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.47 167.16 44.59 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.201 -0.909 . . . . 0.0 114.144 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -166.53 154.84 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.017 -0.591 . . . . 0.0 109.964 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.91 124.51 16.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 110.375 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.607 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -118.34 104.92 47.27 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.671 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.31 119.53 6.43 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.058 2.505 . . . . 0.0 112.22 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.423 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.5 mt -109.13 129.31 64.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.179 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.571 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.8 mt-10 -110.39 126.31 54.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 0.0 110.044 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 80.2 t -106.08 121.65 58.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.564 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 96.6 m-85 -95.69 135.27 37.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.438 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.9 m-85 -109.55 156.44 20.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.342 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.48 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -98.48 93.08 5.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.004 0.43 . . . . 0.0 110.782 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.48 HD21 ' HB2' ' A' ' 96' ' ' GLU . 61.8 t30 -158.61 167.96 28.18 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.201 -0.312 . . . . 0.0 111.146 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.591 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -113.59 4.57 16.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.02 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.554 ' HG2' ' CG2' ' A' ' 131' ' ' THR . 0.0 OUTLIER -101.16 -153.16 0.45 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.479 -175.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.583 ' HB2' ' HD2' ' A' ' 98' ' ' PRO . 13.9 pt-20 -39.84 155.16 0.17 Allowed Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.781 0.832 . . . . 0.0 112.027 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 97' ' ' GLU . 2.2 Cg_endo -35.87 123.07 0.27 Allowed 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 124.896 3.73 . . . . 0.0 114.511 -165.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.429 ' N ' ' HD3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -93.63 21.02 6.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.067 -177.246 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.05 138.93 30.28 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.093 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.507 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.2 m -128.38 155.83 40.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.674 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.98 120.03 26.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CZ ' HG21 ' A' ' 101' ' ' VAL . 21.1 m-85 -110.48 132.72 53.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.659 0.266 . . . . 0.0 110.638 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -91.55 105.88 18.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.502 0.668 . . . . 0.0 109.573 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -116.66 135.78 53.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.573 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -87.8 114.51 24.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.993 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.549 HD11 HG11 ' A' ' 37' ' ' VAL . 1.7 mp -90.42 91.34 8.42 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -102.37 155.01 18.53 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.072 0.463 . . . . 0.0 110.977 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt -129.14 163.31 25.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -91.69 174.35 7.4 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.285 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.48 149.47 42.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.167 0.508 . . . . 0.0 111.554 177.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.756 ' HA ' HG21 ' A' ' 22' ' ' VAL . 18.7 tt0 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.107 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 22.3 t . . . . . 0 CA--C 1.521 -0.153 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -145.35 97.85 3.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -126.23 131.56 51.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.545 -174.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.8 mt -107.39 146.54 31.51 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.698 0.623 . . . . 0.0 109.835 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -139.96 129.01 23.59 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.246 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.455 ' N ' ' HD3' ' A' ' 121' ' ' ARG . 67.2 m -120.07 123.91 44.56 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -172.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -122.43 145.49 48.24 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.727 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -100.61 129.14 46.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.22 0.533 . . . . 0.0 111.797 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.838 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.5 mt -94.63 119.44 33.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.688 172.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.5 m -109.51 123.53 49.56 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.894 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.485 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 31.3 m-85 -120.07 108.3 14.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.894 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -78.73 118.2 20.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.508 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.7 t30 50.02 64.55 8.24 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.676 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 127' ' ' PHE . 74.3 Cg_endo -74.68 178.06 7.64 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.402 2.068 . . . . 0.0 111.673 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.554 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 10.8 p -72.19 142.94 49.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.58 -37.93 76.83 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.067 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -63.85 -29.37 70.57 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.653 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 9.6 t80 -73.85 -42.05 61.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.639 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.1 ttm180 -54.3 -46.05 72.69 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.766 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -54.61 -38.26 66.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.441 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 44.3 mtpt -73.93 -40.19 63.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.799 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.7 mt -67.87 -32.57 73.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 40.5 mt -79.71 -32.28 41.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.316 . . . . 0.0 111.099 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -75.89 -25.74 56.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.306 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.216 174.859 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.484 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.236 0.384 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' PRO . . . . . 0.484 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 10.5 Cg_endo -54.54 157.97 11.14 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.038 1.825 . . . . 0.0 111.437 175.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 . . . . . 0 C--N 1.321 -0.641 0 CA-C-O 120.91 0.386 . . . . 0.0 110.387 179.647 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 121.095 0.474 . . . . 0.0 111.581 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 t -100.01 143.88 13.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.83 127.59 29.17 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.391 0.615 . . . . 0.0 110.955 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.794 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.02 176.81 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.942 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.582 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 95.3 mttt -138.64 137.63 37.09 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.408 ' HG ' HD11 ' A' ' 125' ' ' LEU . 88.8 mt -122.45 142.05 50.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.076 0.465 . . . . 0.0 109.812 173.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.2 tt0 -104.34 124.65 49.58 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.999 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.643 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -110.85 114.17 27.3 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -140.09 174.86 22.23 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.618 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 36' ' ' MET . 2.0 p-80 -166.17 153.05 9.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.212 0.529 . . . . 0.0 110.195 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 38.4 mtp180 -120.8 134.59 55.28 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.438 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -129.89 119.87 23.99 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.492 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -117.89 145.84 44.34 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.757 HG21 ' HA ' ' A' ' 112' ' ' GLU . 5.0 p -99.07 154.79 4.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 32' ' ' THR . 2.4 mtp180 -107.61 147.89 30.04 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -76.54 -12.44 60.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.764 0.792 . . . . 0.0 109.502 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -142.5 104.97 5.45 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.032 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.437 ' HG3' HG22 ' A' ' 32' ' ' THR . 78.7 Cg_exo -47.25 157.86 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.489 2.793 . . . . 0.0 113.46 177.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -76.97 -173.04 2.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.898 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.482 HG22 ' OE1' ' A' ' 29' ' ' GLU . 2.1 m -66.52 -28.8 44.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.96 0.409 . . . . 0.0 110.898 -174.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.482 ' OE1' HG22 ' A' ' 28' ' ' VAL . 1.9 mp0 -78.49 -8.12 58.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 110.227 175.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.01 32.99 37.92 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.2 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -98.94 140.8 32.56 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.437 HG22 ' HG3' ' A' ' 26' ' ' PRO . 38.0 p -89.25 -27.26 20.72 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -169.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -118.85 142.59 47.59 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -172.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -116.09 119.48 35.98 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 172.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 78' ' ' GLU . 48.8 p-90 -121.35 150.96 40.68 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.093 0.473 . . . . 0.0 111.13 -178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 53.4 ttp -126.34 120.6 30.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.679 175.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.4 m -101.19 150.1 6.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.225 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.635 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.2 p90 -151.46 152.41 32.99 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.5 m -124.03 127.24 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.001 170.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -136.8 -176.74 4.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . -91.82 169.63 32.67 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 175.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 15.0 Cg_endo -53.39 113.96 1.54 Allowed 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 123.776 2.984 . . . . 0.0 112.657 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 56.32 51.26 11.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.419 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 69.12 11.95 8.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.482 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.478 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 66.8 m -62.27 126.83 28.7 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 171.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.54 ' OD1' ' HB2' ' A' ' 48' ' ' GLN . 6.5 t-20 -68.7 125.49 26.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.095 -175.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.626 HD12 HG21 ' A' ' 51' ' ' VAL . 1.5 pt -96.78 -2.37 10.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -174.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.54 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 11.1 mt-30 -61.82 -3.95 1.34 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -77.56 -37.85 49.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.401 0.143 . . . . 0.0 110.871 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.443 ' CE2' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -115.23 -18.61 11.07 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.547 176.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.626 HG21 HD12 ' A' ' 47' ' ' ILE . 84.2 t -90.48 130.15 40.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 8.4 tp10 -98.83 -58.58 1.91 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.315 0.579 . . . . 0.0 110.355 -176.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -149.02 153.76 38.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.048 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 55' ' ' VAL . 66.9 t -129.12 159.09 41.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.229 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.592 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.2 p -143.1 135.1 24.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.219 0.533 . . . . 0.0 111.363 -175.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.527 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 27.6 m-85 -116.7 111.66 20.11 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.16 93.15 7.0 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.414 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.608 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.6 mt -76.87 -176.91 4.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.426 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.507 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 36.8 t60 -66.86 138.69 57.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.063 0.459 . . . . 0.0 109.802 -177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -56.3 -25.68 49.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.4 t -75.52 -18.31 59.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.451 0.167 . . . . 0.0 111.438 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 59' ' ' HIS . 3.3 m-85 -75.09 134.91 73.91 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -60.99 117.56 4.34 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.714 2.276 . . . . 0.0 111.437 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 59.02 70.51 1.13 Allowed Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.503 -171.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.73 -17.45 59.12 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.733 2.288 . . . . 0.0 111.866 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -91.88 102.33 14.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.165 -177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.0 mmt180 -97.91 104.68 16.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.781 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.05 136.14 24.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.218 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 79.6 m -126.12 115.42 19.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.953 0.406 . . . . 0.0 109.923 175.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -106.69 -24.77 12.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.605 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.726 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 6.0 p-10 -75.71 -174.71 0.41 Allowed Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.329 -175.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.726 ' HD2' ' HB2' ' A' ' 71' ' ' ASP . 71.7 Cg_exo -39.11 -172.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.01 3.14 . . . . 0.0 114.548 167.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.648 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 8.5 Cg_endo -35.55 122.92 0.24 Allowed 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.399 2.733 . . . . 0.0 113.662 -152.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 44.2 m-85 -61.93 91.2 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.21 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 5.4 ptpt -139.37 146.4 40.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 0.0 112.034 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.7 t -120.96 132.29 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.345 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.54 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 5.3 mm-40 -108.56 106.04 15.93 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.246 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 35' ' ' TRP . 1.5 tp10 -134.79 171.06 14.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.709 0.29 . . . . 0.0 110.412 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -131.91 144.4 50.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.856 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.5 -170.34 27.18 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -126.72 -11.63 6.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.289 0.544 . . . . 0.0 111.771 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' B' ' 217' ' ' ARG . . . -147.83 141.49 25.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.961 0.41 . . . . 0.0 111.565 -176.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.11 164.49 51.41 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.099 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -163.31 156.37 18.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.458 HD13 ' HA ' ' A' ' 106' ' ' ASP . 21.9 mm -64.37 126.07 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 110.211 173.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.608 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.0 tt -120.39 104.46 42.99 Favored Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.232 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.9 116.56 4.2 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.296 2.664 . . . . 0.0 112.536 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.417 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.8 mt -107.76 127.45 63.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.175 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.592 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.5 mt-10 -110.11 126.88 54.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.1 0.476 . . . . 0.0 110.01 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.3 t -106.49 119.97 56.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.744 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 88.5 m-85 -92.53 135.84 33.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.822 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.427 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.1 m-85 -109.93 148.21 32.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.308 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.413 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -87.52 94.6 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.476 ' HB3' ' HG3' ' A' ' 99' ' ' ARG . 1.4 t-20 -155.66 155.4 33.15 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.273 -172.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.52 -2.51 18.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.693 0.758 . . . . 0.0 109.466 171.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -101.55 -152.01 0.43 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.218 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.445 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 8.2 mm-40 -29.42 150.33 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.195 0.998 . . . . 0.0 113.548 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.0 Cg_exo -32.2 126.54 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.05 1 C-N-CA 125.415 4.077 . . . . 0.0 115.011 -168.32 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.476 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -89.64 19.03 4.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.304 -177.35 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.9 140.07 16.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.361 0.6 . . . . 0.0 111.552 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.2 m -130.47 155.36 41.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.008 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -123.44 120.33 32.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.978 0.418 . . . . 0.0 111.25 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.643 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.5 m-85 -112.44 116.6 30.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.446 174.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -85.93 105.98 16.79 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.457 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 61.8 t80 -112.34 137.2 50.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.911 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.458 ' HA ' HD13 ' A' ' 85' ' ' ILE . 38.2 t70 -86.36 103.52 15.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.308 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.499 HD11 HG11 ' A' ' 37' ' ' VAL . 2.5 mp -82.21 115.82 21.47 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -131.15 160.74 33.87 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.534 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.9 mt -136.18 163.26 30.78 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -175.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -100.84 172.81 6.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.99 152.25 24.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.846 0.355 . . . . 0.0 111.677 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.757 ' HA ' HG21 ' A' ' 22' ' ' VAL . 10.4 tt0 . . . . . 0 C--O 1.233 0.207 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.926 175.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 16.7 t . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.398 0.142 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -144.15 97.45 3.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.5 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.5 t-80 -120.82 137.68 54.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.764 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.5 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.0 mt -120.48 146.95 45.75 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.478 0.487 . . . . 0.0 110.436 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.3 ttm180 -138.93 149.99 45.41 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.448 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 71.6 m -133.7 121.13 21.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 175.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -116.62 133.79 55.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 110.358 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -84.7 141.44 30.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.544 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.794 ' HB2' HG23 ' A' ' 12' ' ' VAL . 5.3 mt -111.35 110.47 20.95 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.2 m -107.09 120.02 40.95 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.822 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.547 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 25.8 m-85 -116.78 109.98 17.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.787 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -79.0 116.91 19.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.976 0.417 . . . . 0.0 110.576 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.6 t30 56.7 61.67 6.79 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.211 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 127' ' ' PHE . 72.0 Cg_endo -75.74 169.86 21.38 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.306 2.004 . . . . 0.0 111.039 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.3 p -74.84 144.66 43.34 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -53.35 -43.09 67.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -172.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -55.73 -34.18 64.91 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.883 0.373 . . . . 0.0 110.421 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.682 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 7.8 t80 -75.95 -40.9 53.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.592 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.6 ttm180 -54.79 -43.92 73.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.564 0.697 . . . . 0.0 109.386 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.23 -36.49 75.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.216 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -73.97 -40.66 62.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.749 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.0 mt -66.81 -37.08 83.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.02 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.1 mt -75.33 -34.08 61.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.04 0.447 . . . . 0.0 110.577 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -72.32 -26.43 61.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.956 -175.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.352 -0.833 . . . . 0.0 110.541 175.986 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.583 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.234 0.282 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 216' ' ' PRO . . . . . 0.583 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 29.2 Cg_endo -62.58 169.25 8.66 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 121.788 1.659 . . . . 0.0 111.49 176.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.458 ' HA ' ' HB1' ' A' ' 82' ' ' ALA . 33.1 mtp180 . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 121.159 0.504 . . . . 0.0 110.883 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.375 0 CA-C-O 120.725 0.298 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.56 138.52 41.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.418 ' HB3' ' HD2' ' A' ' 124' ' ' LYS . 8.9 mt-30 -114.39 138.77 50.13 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.806 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -132.71 125.77 53.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.441 177.179 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -99.81 130.23 45.99 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.639 -0.663 . . . . 0.0 111.279 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD13 HG11 ' A' ' 90' ' ' VAL . 96.3 mt -108.98 142.38 39.72 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.848 176.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.68 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.0 tt0 -104.15 126.42 51.25 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.195 -174.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.612 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -114.55 122.64 47.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -152.1 172.74 31.37 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.239 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -165.7 152.38 9.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.044 0.449 . . . . 0.0 110.138 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -117.03 152.04 35.48 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -141.96 133.29 26.47 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.532 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -129.79 164.74 23.4 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.823 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' A' ' 112' ' ' GLU . 2.4 p -104.24 161.01 4.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 168.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.499 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 4.3 mtp85 -105.52 140.54 38.45 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -67.05 -17.87 65.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.73 0.776 . . . . 0.0 109.477 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -136.76 107.31 9.04 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.893 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.528 ' HG3' HG22 ' A' ' 32' ' ' THR . 64.7 Cg_exo -45.89 156.3 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.277 2.651 . . . . 0.0 113.176 177.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 29' ' ' GLU . 11.3 t -75.99 -169.92 1.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.634 -171.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.54 -27.4 42.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 122.874 0.47 . . . . 0.0 111.532 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.483 ' H ' HG23 ' A' ' 27' ' ' THR . 20.7 mm-40 -86.6 -12.06 49.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.408 0.623 . . . . 0.0 109.856 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.85 19.96 38.46 Favored Glycine 0 CA--C 1.503 -0.7 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.575 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -91.25 145.18 24.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.663 -0.768 . . . . 0.0 110.827 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.528 HG22 ' HG3' ' A' ' 26' ' ' PRO . 44.6 p -94.0 -28.72 15.61 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.4 -164.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.407 ' NE2' ' O ' ' A' ' 110' ' ' HIS . 59.9 m80 -108.64 153.69 23.06 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -169.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 1.1 m-20 -131.95 133.35 44.41 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.409 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 56.7 p-90 -139.19 149.82 44.85 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.046 0.451 . . . . 0.0 111.488 -177.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.654 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 47.7 ttp -125.85 120.91 31.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.887 174.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.5 m -99.92 152.73 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.315 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.3 p90 -150.94 153.16 34.72 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.4 m -127.09 128.54 70.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.244 170.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -135.28 -176.12 4.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.949 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.476 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -91.12 -169.06 42.11 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.269 177.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 4.9 Cg_exo -72.82 112.16 3.43 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.665 2.244 . . . . 0.0 111.617 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 59.55 60.68 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.536 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 67.0 m80 71.16 -3.0 2.18 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 66.6 m -60.06 134.15 56.78 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.479 0.181 . . . . 0.0 111.299 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -69.96 126.42 29.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.659 HD12 HG21 ' A' ' 51' ' ' VAL . 1.5 pt -96.66 -4.84 9.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -174.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -68.89 6.21 0.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.851 0.357 . . . . 0.0 111.782 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -80.12 -33.57 38.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.546 172.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.4 ' CE1' HG22 ' A' ' 47' ' ' ILE . 54.4 p90 -119.39 -18.75 8.46 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.301 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.659 HG21 HD12 ' A' ' 47' ' ' ILE . 91.4 t -88.68 131.25 36.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -98.06 -52.01 3.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 0.0 110.366 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -156.97 158.56 36.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.67 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 55' ' ' VAL . 93.9 t -132.29 158.11 43.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.586 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.6 p -141.92 135.39 29.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.225 0.535 . . . . 0.0 111.085 -175.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.512 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 29.3 m-85 -117.59 108.37 15.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.73 92.57 4.81 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.161 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.621 ' CD2' HD11 ' A' ' 86' ' ' LEU . 10.7 mt -76.9 -178.42 4.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -79.01 144.02 35.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.07 -19.76 21.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.832 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -66.58 -21.95 66.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.111 0.481 . . . . 0.0 110.997 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -84.14 132.89 46.54 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.528 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.82 122.43 10.98 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.41 2.074 . . . . 0.0 111.1 172.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 59.96 69.3 1.25 Allowed Pre-proline 0 CA--C 1.531 0.232 0 O-C-N 123.738 0.649 . . . . 0.0 110.476 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.81 -22.4 49.49 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.636 2.224 . . . . 0.0 113.157 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -93.33 98.47 11.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.247 0.546 . . . . 0.0 110.202 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 13.2 mmt180 -94.36 96.69 9.7 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.446 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -86.35 136.66 22.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 172.746 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.0 m -124.86 111.6 15.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.03 0.443 . . . . 0.0 109.925 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -100.73 -27.51 13.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.681 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.503 ' OD1' ' HD2' ' A' ' 72' ' ' PRO . 28.4 t70 -69.63 168.63 15.99 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.712 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.61 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 42.4 Cg_exo -26.35 -168.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.864 1 C-N-CA 126.12 4.547 . . . . 0.0 116.277 161.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.61 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 10.3 Cg_endo -37.18 120.2 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.981 2.454 . . . . 0.0 113.976 -151.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 35.3 m-85 -62.45 98.37 0.11 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.935 -177.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 11.9 ptpt -149.52 146.23 27.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.468 0.651 . . . . 0.0 112.103 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.9 t -126.5 131.22 71.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.011 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -117.0 111.34 19.43 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -132.7 171.54 13.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.33 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 5.0 t -116.4 146.41 42.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.18 172.06 28.52 Favored Glycine 0 CA--C 1.507 -0.434 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.802 -173.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -130.41 -4.17 4.3 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.962 0.41 . . . . 0.0 110.215 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' B' ' 217' ' ' ARG . . . -164.1 137.19 5.18 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.222 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.49 -174.47 28.72 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 116.187 -0.46 . . . . 0.0 114.19 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.0 p90 179.96 158.02 0.71 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.858 0.463 . . . . 0.0 110.462 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.83 129.26 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.621 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.3 tt -120.85 104.76 41.48 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-O 121.109 0.48 . . . . 0.0 110.154 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.82 114.37 3.12 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 123.25 2.634 . . . . 0.0 112.196 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -104.43 124.58 59.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.065 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.586 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.0 mt-10 -108.52 127.09 53.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.164 0.507 . . . . 0.0 110.008 175.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.452 HG11 HD13 ' A' ' 14' ' ' LEU . 57.0 t -106.73 117.98 53.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.622 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 81.0 m-85 -90.32 139.33 30.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.809 -178.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.448 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.0 m-85 -114.94 151.66 33.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.197 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.5 95.48 9.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.614 HD21 ' HB2' ' A' ' 96' ' ' GLU . 56.6 t30 -155.5 160.9 40.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.222 0.534 . . . . 0.0 111.595 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.66 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.6 OUTLIER -112.37 -1.42 15.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.778 178.132 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.614 ' HB2' HD21 ' A' ' 94' ' ' ASN . 18.4 mm-40 -102.02 -154.19 0.48 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.787 -175.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 97' ' ' GLU . 2.4 mp0 -26.79 152.5 0.01 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.938 1.295 . . . . 0.0 114.082 172.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 3.2 Cg_exo -31.66 125.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.197 1 C-N-CA 125.399 4.066 . . . . 0.0 114.756 -169.206 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.26 19.72 3.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.998 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -153.49 146.47 24.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.188 0.518 . . . . 0.0 110.934 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -128.7 155.87 40.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.025 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -120.89 121.29 37.75 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.841 0.353 . . . . 0.0 111.064 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.612 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.4 m-85 -113.79 112.21 23.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.649 173.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.31 105.97 11.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -115.57 137.25 52.26 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.672 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -85.86 114.25 22.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.894 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.532 HD11 HG11 ' A' ' 37' ' ' VAL . 2.0 mp -92.89 103.86 16.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -115.59 158.9 21.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.064 0.459 . . . . 0.0 110.28 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.1 mt -130.75 158.11 41.0 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.407 ' O ' ' NE2' ' A' ' 33' ' ' HIS . 2.8 m-70 -101.82 173.86 6.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.297 0.498 . . . . 0.0 110.648 173.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -62.4 136.8 58.08 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -173.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.487 ' HA ' HG21 ' A' ' 22' ' ' VAL . 6.5 tt0 . . . . . 0 C--N 1.34 0.193 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.844 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 39.5 t . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 111.619 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -135.79 98.37 3.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -121.8 142.78 49.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.178 -176.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.456 HD11 ' CG ' ' A' ' 15' ' ' GLU . 16.6 tp -136.99 159.38 42.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.163 0.506 . . . . 0.0 111.57 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.502 ' HD2' HD23 ' A' ' 16' ' ' LEU . 19.7 ttm180 -152.98 149.23 27.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.321 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.414 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 69.5 m -138.7 118.25 12.98 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 174.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -114.7 146.06 41.34 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 11' ' ' GLN . 38.6 ttpt -103.52 127.48 50.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.416 0.627 . . . . 0.0 112.398 -174.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.806 ' HB2' HG23 ' A' ' 12' ' ' VAL . 7.7 mt -86.43 149.53 24.93 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.3 m -140.97 121.89 14.5 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.144 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -115.93 114.85 25.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.232 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -84.76 120.85 26.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.315 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 50.5 65.49 6.73 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.766 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.35 -178.76 4.2 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.764 2.309 . . . . 0.0 112.074 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 74.4 p -74.97 137.15 41.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -61.19 -29.15 69.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -67.57 -28.3 67.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.646 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.8 t80 -75.07 -42.96 55.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.409 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.66 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.3 ttm180 -54.45 -43.69 71.85 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.755 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -55.87 -39.79 72.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.156 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 51.0 mtpt -71.09 -39.76 71.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.811 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 33.9 mt -69.61 -26.68 64.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.73 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 41.6 mt -86.19 -28.88 23.62 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.054 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -77.22 -31.15 55.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.261 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.828 178.487 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.409 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 110.715 -0.105 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 216' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 14.0 Cg_endo -58.97 172.27 1.73 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.221 1.947 . . . . 0.0 112.129 173.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.507 ' HA ' ' HB1' ' A' ' 82' ' ' ALA . 11.8 ptp180 . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.28 0.562 . . . . 0.0 111.577 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 121.054 0.454 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 t -101.72 140.72 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.1 mp0 -125.78 120.66 31.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.087 0.47 . . . . 0.0 110.224 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.857 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -108.52 177.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.686 179.007 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 98.7 mttt -142.58 136.42 29.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.579 0.228 . . . . 0.0 110.74 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.437 ' HG ' HD11 ' A' ' 125' ' ' LEU . 79.4 mt -119.68 142.56 48.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 109.945 174.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.609 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.8 tt0 -102.87 123.08 45.84 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.058 -176.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.645 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -109.78 113.68 26.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 174.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -142.67 173.8 23.8 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.849 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -164.01 151.93 12.7 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.007 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 70.6 mtt180 -116.82 140.92 48.87 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.748 171.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.0 125.51 29.87 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.282 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -119.5 155.07 32.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.718 HG21 ' HA ' ' A' ' 112' ' ' GLU . 4.9 p -103.93 159.3 5.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.452 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 2.2 mtp180 -108.84 147.43 32.12 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -72.13 -18.39 61.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.651 0.738 . . . . 0.0 109.28 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -139.89 103.81 6.87 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.412 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.533 ' HG3' HG22 ' A' ' 32' ' ' THR . 70.2 Cg_exo -47.2 156.61 0.81 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.533 2.822 . . . . 0.0 112.736 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.422 HG22 ' HB2' ' A' ' 31' ' ' PHE . 10.2 t -77.23 -174.52 3.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.665 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.49 HG22 ' OE1' ' A' ' 29' ' ' GLU . 1.1 m -64.15 -27.81 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.106 0.479 . . . . 0.0 110.827 -175.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.49 ' OE1' HG22 ' A' ' 28' ' ' VAL . 2.3 mp0 -80.18 -2.06 43.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.382 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.26 31.22 63.92 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.365 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.422 ' HB2' HG22 ' A' ' 27' ' ' THR . 21.6 m-30 -93.64 131.55 38.84 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.533 HG22 ' HG3' ' A' ' 26' ' ' PRO . 62.1 p -89.69 -20.32 23.77 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.426 -168.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.413 ' NE2' ' O ' ' A' ' 110' ' ' HIS . 66.0 m80 -124.07 148.33 47.18 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -172.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.452 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 7.4 m-20 -123.82 123.79 41.24 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 170.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -123.8 154.24 39.85 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.29 0.567 . . . . 0.0 111.192 -176.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.643 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 15.1 tmm? -128.96 136.71 50.73 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.062 174.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.3 m -121.67 149.43 24.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.387 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.663 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.6 OUTLIER -149.32 157.25 43.18 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.2 m -123.91 126.38 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.662 167.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -135.39 -176.28 4.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.734 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . -93.19 179.15 39.18 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.427 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.413 ' HB3' ' HB2' ' A' ' 13' ' ' LYS . 33.8 Cg_endo -73.97 112.67 3.6 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.337 2.025 . . . . 0.0 111.879 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 61.71 47.86 5.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.079 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 67.88 6.97 5.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.715 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.489 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 48.6 m -63.26 122.53 16.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -60.83 125.01 22.14 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.93 0.395 . . . . 0.0 110.528 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.584 HD12 HG21 ' A' ' 51' ' ' VAL . 1.7 pt -95.3 -2.2 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.738 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -59.23 -12.85 5.99 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.306 0.574 . . . . 0.0 110.672 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -67.8 -45.0 76.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.959 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.416 ' CE2' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -111.83 -18.37 12.72 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.309 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.584 HG21 HD12 ' A' ' 47' ' ' ILE . 59.3 t -92.58 137.02 23.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.964 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.555 ' HB2' ' HG3' ' A' ' 93' ' ' LYS . 10.5 tp10 -113.98 -63.18 1.49 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.271 0.557 . . . . 0.0 110.915 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 24.9 tttt -136.73 149.55 47.92 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.129 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 99.0 t -131.13 156.94 43.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.601 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.9 p -140.62 134.9 34.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.374 0.606 . . . . 0.0 111.601 -175.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.496 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 16.1 m-85 -117.33 111.26 19.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -81.75 97.88 8.17 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.043 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.625 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.3 mt -80.77 -177.82 6.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.877 0.37 . . . . 0.0 110.631 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 143.2 45.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -60.04 -23.29 63.61 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.1 t -70.68 -22.15 62.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.998 0.427 . . . . 0.0 110.867 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 17.8 m-85 -75.39 141.48 73.52 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.731 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 62' ' ' PHE . 23.4 Cg_exo -64.77 128.55 21.23 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.395 2.063 . . . . 0.0 110.318 171.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.519 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 52.9 mtm180 58.11 74.92 0.58 Allowed Pre-proline 0 C--N 1.331 -0.226 0 O-C-N 123.618 0.574 . . . . 0.0 110.246 -175.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.1 -24.38 52.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.509 2.139 . . . . 0.0 113.065 -178.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -101.52 104.62 15.53 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.14 0.495 . . . . 0.0 110.183 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.519 ' HD3' ' O ' ' A' ' 64' ' ' ARG . 9.4 mmm-85 -103.1 104.13 14.26 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.492 -177.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -98.59 137.63 25.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.8 m -118.1 120.22 37.12 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -103.16 -29.83 11.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.613 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.578 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 6.2 m-20 -81.03 -178.31 1.14 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.101 -175.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 0.9 OUTLIER -41.34 -166.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 124.277 3.318 . . . . 0.0 114.231 165.276 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.564 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 3.3 Cg_endo -29.82 118.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 123.291 2.661 . . . . 0.0 113.883 -147.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.663 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 54.2 m-85 -64.56 88.75 0.06 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.848 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 13.9 ptpt -136.92 142.9 42.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.409 0.623 . . . . 0.0 112.418 -174.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.6 t -119.56 136.56 56.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.618 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -124.21 107.01 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.35 172.84 12.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.402 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.4 t -123.15 146.03 48.11 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.674 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.38 23.72 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -130.27 -18.35 3.27 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.503 0.652 . . . . 0.0 111.903 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.75 145.09 32.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.001 0.429 . . . . 0.0 111.178 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.73 172.5 51.97 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.673 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -168.71 158.9 9.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 122.905 0.482 . . . . 0.0 110.064 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 mm -66.76 121.08 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.188 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.625 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.6 tt -116.46 108.25 45.67 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.406 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -79.9 121.26 4.47 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.799 2.333 . . . . 0.0 112.056 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.475 HG12 ' CE2' ' A' ' 56' ' ' PHE . 3.9 mp -105.53 133.59 49.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.323 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.9 mt-10 -113.37 121.32 43.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.202 0.525 . . . . 0.0 110.217 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.426 HG13 HG22 ' A' ' 54' ' ' VAL . 84.0 t -101.54 122.56 53.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.115 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.565 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 87.3 m-85 -91.12 138.57 31.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.548 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.461 ' HE1' HG22 ' A' ' 51' ' ' VAL . 21.3 m-85 -119.91 162.32 19.37 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.16 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.555 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -105.16 97.24 7.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 121.159 -0.217 . . . . 0.0 111.353 176.282 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -155.63 168.86 25.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.298 0.57 . . . . 0.0 112.272 173.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.591 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -103.97 9.28 36.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.484 174.596 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.4 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 35.9 mm-40 -101.01 -154.65 0.49 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.442 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.475 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 22.6 mm-40 -35.95 157.36 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.63 0 C-N-CA 124.24 1.016 . . . . 0.0 113.266 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 7.3 Cg_exo -31.88 125.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 124.713 3.609 . . . . 0.0 114.302 -172.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.45 20.06 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.841 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -152.13 140.76 20.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.919 178.58 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.2 m -115.91 156.79 16.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -128.39 107.88 10.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.873 0.368 . . . . 0.0 110.487 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.2 m-85 -105.67 120.96 43.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.202 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -82.59 117.15 22.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -126.6 136.18 52.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.242 0.544 . . . . 0.0 110.875 -176.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.38 112.79 21.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.951 -178.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.569 HD11 HG11 ' A' ' 37' ' ' VAL . 1.2 mp -91.04 94.64 9.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -104.03 155.85 18.34 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.087 0.47 . . . . 0.0 111.054 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.5 mt -129.36 162.5 27.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.247 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.524 ' CD2' ' H ' ' A' ' 110' ' ' HIS . 5.7 p80 -100.18 173.09 6.79 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.285 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -73.57 161.03 30.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.997 0.427 . . . . 0.0 111.635 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.718 ' HA ' HG21 ' A' ' 22' ' ' VAL . 14.7 mt-10 . . . . . 0 C--O 1.232 0.176 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.304 173.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 67.4 t . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -144.47 96.43 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.421 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.3 t-80 -116.3 132.49 56.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.46 -177.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 119' ' ' HIS . 9.5 mt -117.04 141.82 47.76 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.51 0.506 . . . . 0.0 110.327 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 18.3 ttm180 -131.2 148.41 52.7 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.434 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 59.1 m -133.84 117.0 16.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 6.1 mt-10 -113.34 137.45 51.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.842 0.354 . . . . 0.0 111.085 -175.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -89.45 126.56 35.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.822 -175.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.857 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.2 mt -92.69 115.38 28.05 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 23.7 m -110.66 114.74 28.35 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.911 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -115.64 109.41 17.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.547 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -76.02 117.77 18.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.129 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 t30 54.46 67.32 3.45 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.267 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.96 -179.37 5.05 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.56 2.173 . . . . 0.0 111.359 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.2 p -77.52 145.7 36.82 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 173.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -54.42 -40.54 68.38 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.795 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.1 p-10 -59.81 -32.44 70.64 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.593 0.235 . . . . 0.0 110.662 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.676 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 4.7 t80 -73.78 -41.11 62.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.621 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 45.2 ttm105 -54.72 -43.61 72.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.609 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -57.33 -37.43 72.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.31 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 32.7 mtpt -73.94 -42.42 60.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.839 0.352 . . . . 0.0 110.3 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 33.0 mt -69.73 -30.99 68.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.219 -176.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 27.3 mt -79.64 -32.8 41.7 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.778 0.323 . . . . 0.0 110.684 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.62 -30.27 64.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.565 -176.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.757 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.237 0.441 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 216' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 6.9 Cg_endo -51.09 168.62 0.23 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.12 1.88 . . . . 0.0 112.465 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 . . . . . 0 C--N 1.321 -0.653 0 CA-C-O 120.923 0.392 . . . . 0.0 111.123 -174.288 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.117 0.484 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.21 142.38 21.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.1 mp0 -128.08 124.99 38.38 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.262 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.885 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -109.28 168.72 3.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.4 175.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.93 126.56 27.13 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.571 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.412 HD13 HG11 ' A' ' 90' ' ' VAL . 82.2 mt -105.99 142.2 36.1 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.991 177.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.639 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.5 tt0 -102.82 125.0 49.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.05 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.681 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -112.54 113.96 26.38 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -144.91 175.86 24.3 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.849 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -165.88 155.11 11.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.183 0.516 . . . . 0.0 111.164 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 26.7 mtp180 -116.55 152.18 34.66 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.745 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.58 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -147.56 125.82 12.25 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.839 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -125.48 141.99 51.75 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.782 HG21 ' HA ' ' A' ' 112' ' ' GLU . 7.5 p -100.73 152.4 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.771 ' HD2' ' O ' ' A' ' 25' ' ' LYS . 5.9 ptt180 -116.7 138.65 51.3 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -68.02 -17.36 64.39 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.562 0.696 . . . . 0.0 109.473 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.771 ' O ' ' HD2' ' A' ' 23' ' ' ARG . 44.7 tttm -117.49 99.05 52.37 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.483 170.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HG3' HG22 ' A' ' 32' ' ' THR . 50.3 Cg_exo -58.11 159.52 18.37 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.104 1.869 . . . . 0.0 110.915 171.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 t -81.68 -172.77 4.05 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.741 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.413 ' H ' HG13 ' A' ' 28' ' ' VAL . 1.7 m -59.0 -29.82 42.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.208 0.528 . . . . 0.0 111.492 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -85.47 -0.22 54.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.32 30.53 62.49 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.162 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -89.45 125.55 35.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.445 HG22 ' HG3' ' A' ' 26' ' ' PRO . 40.4 p -86.6 -27.51 23.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.471 -171.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 79' ' ' SER . 68.6 m80 -118.1 142.27 47.6 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -171.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -115.05 119.96 38.21 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 173.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -122.65 154.95 37.34 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.149 0.499 . . . . 0.0 111.32 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.645 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 52.4 ttp -133.21 119.92 20.48 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.571 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.0 m -100.53 152.31 4.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.285 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.597 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -152.46 155.5 37.62 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.539 -0.464 . . . . 0.0 112.234 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.6 m -128.11 127.17 67.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.132 170.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.475 HH11 ' HB3' ' A' ' 73' ' ' PRO . 9.9 mmm180 -132.49 -177.14 4.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.332 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.456 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -89.75 -167.55 42.49 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.649 174.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 2.9 Cg_exo -73.86 111.53 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.278 1.985 . . . . 0.0 111.697 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 60.78 61.28 1.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.662 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 72.91 -5.54 1.88 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.364 0.666 . . . . 0.0 112.527 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 58.7 m -59.31 133.07 55.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.551 0.215 . . . . 0.0 110.916 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -71.24 126.09 28.7 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.023 0.44 . . . . 0.0 110.318 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.609 HD12 HG21 ' A' ' 51' ' ' VAL . 1.4 pt -96.35 -2.73 10.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.485 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -57.86 -13.91 5.18 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.219 0.533 . . . . 0.0 111.285 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -69.88 -41.42 74.8 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.493 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.469 ' CE2' HG22 ' A' ' 47' ' ' ILE . 52.8 p90 -114.67 -14.39 12.04 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.883 -0.51 . . . . 0.0 111.543 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.609 HG21 HD12 ' A' ' 47' ' ' ILE . 90.0 t -94.31 125.86 46.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -92.44 -62.71 1.34 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.517 -176.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.706 ' HD2' ' CD1' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -145.86 151.1 37.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 98.1 t -125.28 160.93 30.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.594 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.6 p -142.32 137.81 29.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.192 0.52 . . . . 0.0 111.124 -176.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.512 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 26.7 m-85 -119.5 110.78 17.31 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -83.27 92.94 7.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.488 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.606 ' CD2' HD11 ' A' ' 86' ' ' LEU . 11.4 mt -78.54 177.73 8.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.986 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.89 144.32 49.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -58.87 -25.37 63.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.835 -170.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.8 t -72.75 -19.23 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.992 0.425 . . . . 0.0 110.592 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -75.23 135.31 73.13 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.23 118.65 5.49 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.436 2.091 . . . . 0.0 111.135 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 62.29 79.06 0.28 Allowed Pre-proline 0 CA--C 1.53 0.195 0 O-C-N 123.638 0.586 . . . . 0.0 110.203 -176.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.32 -21.16 66.02 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.803 2.336 . . . . 0.0 113.454 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -105.96 108.79 20.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.944 0.402 . . . . 0.0 110.694 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 24.2 mmt85 -106.64 98.37 8.05 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.035 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -84.29 136.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.391 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.9 m -125.7 112.04 15.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.862 0.363 . . . . 0.0 110.267 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -106.93 -21.65 12.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.31 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.667 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 3.1 t70 -65.37 -177.64 0.25 Allowed Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.537 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.667 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 16.7 Cg_exo -33.02 -175.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.542 0 C-N-CA 125.031 3.821 . . . . 0.0 114.285 160.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.649 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.6 Cg_endo -34.81 126.69 0.22 Allowed 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 123.657 2.905 . . . . 0.0 114.044 -160.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 33.0 m-85 -61.8 94.06 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.793 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 3.9 ptpt -144.15 146.29 32.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.225 0.536 . . . . 0.0 111.717 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 36' ' ' MET . 71.7 t -124.87 132.53 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.871 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.97 111.87 21.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.23 172.39 12.75 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.168 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 9.6 t -123.1 149.39 44.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.83 -175.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.82 -169.65 22.47 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -132.18 -10.93 3.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.146 0.473 . . . . 0.0 111.339 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' B' ' 217' ' ' ARG . . . -151.27 140.35 21.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.635 0.255 . . . . 0.0 110.47 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.61 179.22 49.35 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.771 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -173.94 156.28 2.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.677 0.275 . . . . 0.0 110.721 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 85' ' ' ILE . 14.2 mm -64.95 121.27 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.136 172.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.606 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -114.67 104.94 54.04 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.636 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.39 117.07 4.83 Favored 'Trans proline' 0 C--O 1.239 0.559 0 C-N-CA 123.05 2.5 . . . . 0.0 112.019 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 mt -106.81 126.17 62.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.21 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.594 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 46.3 mt-10 -110.57 122.64 48.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.367 0.603 . . . . 0.0 110.181 176.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.412 HG11 HD13 ' A' ' 14' ' ' LEU . 54.4 t -104.4 119.39 53.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.282 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.706 ' CD1' ' HD2' ' A' ' 53' ' ' LYS . 28.2 m-85 -94.8 156.14 16.51 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.424 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.7 m-85 -126.86 157.51 39.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.018 -177.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -105.76 93.65 4.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.252 0.548 . . . . 0.0 111.622 -178.064 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.568 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 62.0 t30 -160.24 -176.6 5.73 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 5.6 tmtt? -109.88 -5.04 15.63 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.245 0.545 . . . . 0.0 111.248 177.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.436 ' HB2' ' ND2' ' A' ' 94' ' ' ASN . 16.1 mm-40 -96.47 -155.41 0.48 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.852 -168.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 11.2 mm-40 -28.97 151.15 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 124.833 1.253 . . . . 0.0 113.902 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -30.62 124.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 125.087 3.858 . . . . 0.0 114.713 -165.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -75.26 12.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.5 -177.835 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.546 ' HE2' ' CE2' ' A' ' 91' ' ' TYR . 2.5 ptpt -150.03 147.67 28.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.318 0.58 . . . . 0.0 111.342 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.52 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -123.55 155.24 29.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 174.312 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -128.53 106.82 9.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.76 0.314 . . . . 0.0 110.336 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.681 ' CD2' HD21 ' A' ' 16' ' ' LEU . 22.9 m-85 -103.09 121.19 42.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.304 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -84.31 112.64 20.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -124.79 138.34 54.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.377 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.401 ' HA ' HD13 ' A' ' 85' ' ' ILE . 24.6 t70 -90.86 120.15 31.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.919 0.39 . . . . 0.0 110.959 -177.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.516 HD11 HG11 ' A' ' 37' ' ' VAL . 2.1 mp -93.76 91.75 7.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.009 175.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -101.03 157.74 16.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.207 0.527 . . . . 0.0 110.654 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.8 mt -129.76 163.78 25.46 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' B' ' 215' ' ' ALA . 38.7 m170 -94.18 174.83 6.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 172.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -67.52 165.16 17.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.009 0.433 . . . . 0.0 111.634 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.782 ' HA ' HG21 ' A' ' 22' ' ' VAL . 16.9 tt0 . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.748 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 22.5 t . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -144.66 96.39 2.86 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.431 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.2 t-80 -118.98 134.97 54.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.618 -177.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 119' ' ' HIS . 8.4 mt -116.58 152.59 33.84 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.514 0.509 . . . . 0.0 110.575 177.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 19.8 ttm180 -143.58 149.63 37.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 173.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.482 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 61.4 m -134.12 120.71 20.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -115.81 138.11 51.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.695 0.283 . . . . 0.0 110.437 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -90.48 129.91 36.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.474 0.654 . . . . 0.0 112.185 -174.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.885 ' HB2' HG23 ' A' ' 12' ' ' VAL . 11.1 mt -95.16 117.49 30.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.386 171.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.7 m -109.06 122.66 47.75 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.667 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -120.42 104.45 10.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.675 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -85.67 120.74 27.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.706 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.02 61.96 4.39 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.201 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -87.4 173.82 5.35 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.116 2.544 . . . . 0.0 112.013 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 134' ' ' PHE . 11.7 p -69.26 140.46 54.47 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -58.28 -37.08 74.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -63.36 -29.67 70.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.62 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.6 t80 -73.02 -43.4 62.15 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.665 ' O ' HD13 ' A' ' 139' ' ' LEU . 50.0 ttp180 -52.79 -52.58 56.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.809 175.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -55.09 -36.32 65.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.934 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -71.08 -39.2 72.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.624 -0.43 . . . . 0.0 109.84 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.6 mt -65.55 -19.11 65.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.706 0.765 . . . . 0.0 109.839 175.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.665 HD13 ' O ' ' A' ' 135' ' ' ARG . 6.4 mp -89.56 -26.36 20.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.962 -177.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -90.5 -19.14 24.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.203 0.525 . . . . 0.0 110.631 -174.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.18 174.384 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 110' ' ' HIS . . . . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 216' ' ' PRO . . . . . 0.427 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 34.5 Cg_exo -59.86 175.22 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.676 1.584 . . . . 0.0 112.71 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.4 ' HA ' ' HB1' ' A' ' 82' ' ' ALA . 11.3 ptp180 . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.332 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 121.182 0.515 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.8 t -103.13 142.58 16.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 1.0 OUTLIER -121.95 127.31 50.21 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.365 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.806 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -112.08 172.18 3.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.927 177.004 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 97.0 mttt -135.83 131.84 35.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.565 0.221 . . . . 0.0 110.611 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.422 ' HG ' HD11 ' A' ' 125' ' ' LEU . 83.5 mt -116.52 142.04 47.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.239 0.543 . . . . 0.0 109.954 175.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.611 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.5 tt0 -105.13 125.12 50.64 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.939 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.582 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.5 mm? -108.57 122.22 46.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -143.85 167.61 26.68 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.984 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -163.72 154.15 15.57 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.379 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 53.4 mtp180 -121.15 144.87 48.34 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.866 172.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.68 118.29 24.47 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.785 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.95 137.05 50.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.678 HG21 ' HA ' ' A' ' 112' ' ' GLU . 3.3 p -103.5 137.87 30.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.4 mtp180 -92.81 139.96 30.0 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -175.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -68.14 -15.29 63.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.427 0.632 . . . . 0.0 109.729 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -139.03 102.35 7.55 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.427 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HG3' HG22 ' A' ' 32' ' ' THR . 90.8 Cg_exo -50.19 158.0 2.68 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.076 2.517 . . . . 0.0 112.169 175.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.8 t -78.22 -175.67 4.27 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.407 -174.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.423 ' H ' HG13 ' A' ' 28' ' ' VAL . 1.3 m -63.04 -31.05 51.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.092 0.472 . . . . 0.0 110.894 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -77.98 -6.7 55.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.447 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.37 33.41 39.52 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.401 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -94.7 129.7 41.49 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.557 HG22 ' HG3' ' A' ' 26' ' ' PRO . 38.9 p -91.9 -25.66 18.82 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.43 -168.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 79' ' ' SER . 56.5 m80 -117.28 140.53 49.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -113.86 112.15 22.88 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.406 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 54.7 p-90 -118.44 148.84 42.16 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.082 0.468 . . . . 0.0 111.127 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.648 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 57.8 ttp -129.37 122.64 29.88 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.802 175.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.7 m -102.59 151.29 6.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.369 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -152.15 152.87 32.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.2 m -124.02 127.14 73.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.271 171.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 73' ' ' PRO . 2.5 mmp_? -135.62 -176.58 4.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.705 -176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.489 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -91.54 -171.73 42.57 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.661 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 30.7 Cg_endo -75.7 113.68 3.79 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.515 2.143 . . . . 0.0 112.173 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 58.98 52.45 6.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.384 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.6 t60 74.38 -3.82 2.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.825 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 63.9 m -59.04 128.74 38.75 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 176.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -72.25 127.06 31.38 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.779 0.324 . . . . 0.0 110.844 -174.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.553 HD12 HG21 ' A' ' 51' ' ' VAL . 5.9 pt -96.42 -1.96 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -61.31 -14.66 28.56 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.383 0.611 . . . . 0.0 110.928 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.463 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 88.1 m-70 -65.7 -39.22 91.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.709 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -114.61 -16.01 11.91 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.464 176.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.553 HG21 HD12 ' A' ' 47' ' ' ILE . 99.3 t -91.79 129.09 43.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.084 0.469 . . . . 0.0 110.23 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -97.1 -63.92 1.09 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.335 0.588 . . . . 0.0 110.409 -175.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 6.6 ptmm? -141.1 157.54 45.16 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 91.7 t -130.04 158.33 42.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 67' ' ' ARG . 9.7 p -142.31 134.75 26.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.341 0.591 . . . . 0.0 111.214 -174.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 29.6 m-85 -117.78 105.5 12.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -77.05 90.86 3.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.872 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.581 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.9 mt -71.01 -177.77 1.75 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.825 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.79 139.77 43.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -176.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -56.53 -23.53 40.51 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -171.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.8 t -71.72 -16.31 62.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.069 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -79.51 141.01 56.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.13 116.84 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.097 1.865 . . . . 0.0 111.327 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 58.41 66.59 2.51 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.552 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.4 -18.74 66.01 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.223 2.615 . . . . 0.0 113.466 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -87.48 100.79 13.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.991 0.424 . . . . 0.0 110.534 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.0 mmt180 -100.13 110.81 23.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.826 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -100.64 136.01 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.7 m -114.37 118.24 33.32 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -105.09 -25.72 12.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.534 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.601 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 9.5 p-10 -76.5 -175.08 0.45 Allowed Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.382 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 1.5 Cg_exo -41.97 -166.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.231 3.288 . . . . 0.0 114.203 164.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.624 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 6.9 Cg_endo -34.89 120.02 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.005 2.47 . . . . 0.0 113.602 -151.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 47.5 m-85 -62.35 94.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.043 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 12.2 ptpt -142.28 145.9 34.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.279 0.561 . . . . 0.0 112.201 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 36' ' ' MET . 79.6 t -121.28 132.61 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.462 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.421 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 7.0 mm-40 -112.06 112.49 24.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.982 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -137.42 169.87 17.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.197 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 3.5 t -126.75 141.9 51.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.14 -169.27 24.17 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.281 -0.485 . . . . 0.0 111.953 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -132.84 -11.41 3.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.253 0.527 . . . . 0.0 111.973 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.41 136.99 20.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.18 -172.99 47.18 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.208 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -178.87 159.53 1.05 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.362 0.265 . . . . 0.0 110.485 -173.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.3 mm -63.9 123.43 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.581 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.1 tt -117.76 104.88 48.59 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-O 121.138 0.494 . . . . 0.0 109.995 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.54 112.98 3.0 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.336 2.691 . . . . 0.0 112.357 173.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 56' ' ' PHE . 3.8 mt -102.33 123.52 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.283 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.8 mt-10 -109.48 124.46 51.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.179 0.514 . . . . 0.0 110.198 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.4 t -103.36 118.76 50.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.907 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.587 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 69.9 m-85 -91.05 134.75 34.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.512 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.45 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 25.6 m-85 -110.11 152.07 26.46 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.047 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.58 94.19 9.77 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.418 ' HB3' ' HG3' ' A' ' 99' ' ' ARG . 64.0 t30 -154.61 158.65 40.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.875 -172.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -111.42 -9.68 14.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.909 0.862 . . . . 0.0 110.006 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 35.6 mm-40 -99.05 -151.77 0.39 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.47 -174.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 22.2 mm-40 -27.16 152.11 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.5 Cg_exo -31.1 126.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 1 C-N-CA 125.522 4.148 . . . . 0.0 115.262 -167.202 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.418 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -89.0 18.97 4.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.647 -179.182 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.422 ' HZ3' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -154.65 143.01 20.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.247 0.546 . . . . 0.0 110.874 -178.727 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -128.43 155.76 40.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.345 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -125.47 115.64 20.55 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.173 0.511 . . . . 0.0 111.118 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.582 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.8 m-85 -107.98 108.18 19.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.678 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -72.11 113.29 8.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.281 0.562 . . . . 0.0 109.659 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.5 ' CD1' ' HD2' ' A' ' 121' ' ' ARG . 31.8 t80 -124.47 129.22 50.25 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.707 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -85.15 106.85 16.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.605 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.529 HD11 HG11 ' A' ' 37' ' ' VAL . 1.6 mp -82.1 106.07 13.71 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.489 ' CE2' HG11 ' A' ' 117' ' ' VAL . 56.0 p90 -117.63 161.5 19.55 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.221 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.4 mt -135.05 162.98 30.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.636 -171.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.516 ' HD2' ' O ' ' A' ' 111' ' ' LEU . 6.9 p-80 -93.17 166.85 12.13 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 177.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.516 ' O ' ' HD2' ' A' ' 110' ' ' HIS . 2.1 mm? -68.01 146.83 53.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.701 0.286 . . . . 0.0 111.124 177.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.678 ' HA ' HG21 ' A' ' 22' ' ' VAL . 23.7 tt0 . . . . . 0 CA--C 1.531 0.226 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.888 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 26.7 t . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -143.62 98.15 3.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.525 ' O ' HD23 ' A' ' 120' ' ' LEU . 55.0 t-80 -119.4 134.62 55.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.755 -176.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.3 mt -123.17 142.17 51.19 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 123.682 0.614 . . . . 0.0 110.558 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.581 ' HD3' ' HB2' ' A' ' 16' ' ' LEU . 17.9 mtp180 -119.41 146.76 45.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 22.0 p -117.46 101.43 8.38 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 165.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.9 mm-40 -97.56 154.52 17.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.461 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -108.66 135.68 49.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.223 0.535 . . . . 0.0 111.906 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.806 ' HB2' HG23 ' A' ' 12' ' ' VAL . 11.0 mt -106.64 120.77 42.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 171.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.4 m -115.36 123.1 47.83 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.964 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -120.26 104.85 10.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.036 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.24 124.87 30.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.063 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 63.25 61.25 1.88 Allowed Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.769 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.7 170.05 5.43 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.788 2.325 . . . . 0.0 111.574 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 134' ' ' PHE . 12.3 p -71.43 144.86 49.6 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -56.71 -43.38 80.51 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.473 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.574 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 5.0 p-10 -59.68 -27.98 66.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.671 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.681 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 7.1 t80 -73.12 -41.72 63.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.659 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 34.8 ttm-85 -51.74 -47.35 64.08 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.569 0.699 . . . . 0.0 109.638 172.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.3 ttm180 -58.54 -37.43 75.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.543 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 39.0 mtpt -70.82 -41.32 71.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.838 0.352 . . . . 0.0 110.102 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 36.2 mt -69.12 -33.83 74.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.863 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 57.9 mt -75.22 -37.58 61.03 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.075 0.464 . . . . 0.0 110.606 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp -70.22 -28.38 65.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.452 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.74 -0.648 . . . . 0.0 110.376 175.085 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.093 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.19 172.02 4.58 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 121.783 1.655 . . . . 0.0 112.429 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 120.918 0.39 . . . . 0.0 110.732 178.482 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 120.878 0.37 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.433 HG23 ' HG3' ' A' ' 130' ' ' PRO . 4.6 t -113.12 141.24 29.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 4.6 mp0 -128.0 115.51 18.62 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.897 0.38 . . . . 0.0 110.287 -175.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.9 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -105.87 177.02 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.951 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.677 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 99.5 mttt -141.59 149.64 41.0 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.476 HD13 HG11 ' A' ' 90' ' ' VAL . 91.4 mt -129.02 143.37 50.85 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.71 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.3 tt0 -102.36 122.61 44.61 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.843 -175.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.679 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -110.84 116.25 30.92 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 175.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.77 179.87 25.24 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.293 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -169.73 150.37 3.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.932 0.396 . . . . 0.0 110.531 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.63 139.7 49.87 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -129.3 126.65 39.49 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.999 0.428 . . . . 0.0 111.085 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -129.66 151.36 50.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.692 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.591 HG21 ' HA ' ' A' ' 112' ' ' GLU . 1.3 p -101.7 158.02 4.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 mtp180 -105.91 142.94 34.76 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -70.51 -14.71 62.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.583 0.706 . . . . 0.0 109.209 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -138.23 103.45 8.02 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.043 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.532 ' HG3' HG22 ' A' ' 32' ' ' THR . 72.7 Cg_exo -47.47 160.1 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.335 2.69 . . . . 0.0 112.764 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.9 t -78.85 -177.88 5.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.605 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -41.67 78.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.81 0.338 . . . . 0.0 111.271 -176.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -71.11 -7.95 50.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.9 0.381 . . . . 0.0 111.399 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.3 33.14 26.59 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.617 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -95.77 132.3 41.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.532 HG22 ' HG3' ' A' ' 26' ' ' PRO . 69.4 p -90.83 -29.68 17.42 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -169.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 79' ' ' SER . 65.4 m80 -112.88 143.85 43.44 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -172.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.519 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -122.15 118.47 28.74 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 172.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.413 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 49.2 p-90 -121.87 151.5 40.6 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.791 -175.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.593 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 50.0 ttp -127.21 119.81 27.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.777 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 76' ' ' VAL . 9.9 m -98.84 154.8 3.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.148 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -155.3 156.14 34.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.1 m -125.07 127.58 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.784 169.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 mmm-85 -131.76 177.9 7.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.883 0.373 . . . . 0.0 110.912 -175.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.491 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -92.7 162.7 26.72 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.553 177.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.677 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 18.4 Cg_endo -57.25 114.11 1.79 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.229 2.619 . . . . 0.0 112.3 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 59.17 57.74 3.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.898 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 71.91 1.33 3.87 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.645 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 77.8 p -63.52 132.07 50.1 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.012 -0.43 . . . . 0.0 109.845 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -75.93 126.04 30.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.537 HD12 HG21 ' A' ' 51' ' ' VAL . 6.1 pt -96.74 -1.22 10.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -171.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -63.24 -8.62 8.73 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -74.24 -36.87 63.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.072 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.439 ' CE2' HG22 ' A' ' 47' ' ' ILE . 52.3 p90 -114.07 -14.35 12.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.46 175.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.537 HG21 HD12 ' A' ' 47' ' ' ILE . 97.6 t -98.82 122.06 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 122.888 0.475 . . . . 0.0 110.145 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.619 ' CG ' ' HB3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -91.67 -44.31 9.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.194 0.521 . . . . 0.0 110.072 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -158.99 158.68 33.7 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.314 -174.32 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 96.6 t -137.21 157.05 34.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.953 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.616 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.8 p -142.18 136.52 29.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.344 0.592 . . . . 0.0 111.497 -175.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 19.8 m-85 -119.22 109.96 16.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -81.63 94.62 6.97 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.396 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.611 ' CD2' HD11 ' A' ' 86' ' ' LEU . 13.3 mt -77.16 -177.34 4.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.748 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -69.59 144.02 53.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.189 0.519 . . . . 0.0 109.697 -178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -60.7 -24.24 65.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.004 -169.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.1 t -78.17 -8.67 58.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.614 0.245 . . . . 0.0 111.186 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -85.53 135.22 38.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -62.28 121.52 9.56 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.725 2.283 . . . . 0.0 110.901 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 61.36 72.1 0.71 Allowed Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.024 -173.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.88 -20.58 58.12 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.496 2.13 . . . . 0.0 112.296 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.564 ' HE3' ' CG1' ' A' ' 68' ' ' VAL . 24.9 ttpt -93.23 104.46 16.63 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.929 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 7.3 mmm180 -103.79 102.32 12.15 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.259 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.564 ' CG1' ' HE3' ' A' ' 66' ' ' LYS . 2.2 m -99.03 138.29 23.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.8 m -125.06 119.54 28.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -107.13 -23.81 12.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.509 0.671 . . . . 0.0 110.547 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.728 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 3.8 p-10 -74.26 -172.62 0.26 Allowed Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.188 -175.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.728 ' HD2' ' HB2' ' A' ' 71' ' ' ASP . 75.1 Cg_exo -40.85 -170.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 124.181 3.254 . . . . 0.0 114.598 168.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.651 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 7.9 Cg_endo -36.32 122.41 0.29 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.509 2.806 . . . . 0.0 113.842 -155.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.484 ' CB ' HG22 ' A' ' 39' ' ' VAL . 41.0 m-85 -62.55 97.34 0.09 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.01 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 12.4 ptpt -146.37 144.36 29.7 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.461 0.648 . . . . 0.0 112.129 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.1 t -121.89 131.69 72.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.833 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -114.74 114.0 25.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.89 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.31 173.02 12.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.143 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 7.6 t -126.64 144.77 50.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.715 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.09 -171.76 29.73 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -130.06 -8.07 4.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.197 0.498 . . . . 0.0 111.331 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.87 144.32 28.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.927 0.394 . . . . 0.0 111.235 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -82.99 173.97 52.52 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.029 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -172.67 158.58 4.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.732 0.413 . . . . 0.0 110.041 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 106' ' ' ASP . 16.1 mm -65.49 124.56 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.21 171.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.611 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -117.61 105.3 48.26 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.886 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.65 118.49 5.71 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 123.109 2.54 . . . . 0.0 112.652 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.464 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.2 mt -108.1 126.09 64.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.369 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.616 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 43.6 mt-10 -109.52 123.57 49.62 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.088 0.471 . . . . 0.0 110.081 176.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.476 HG11 HD13 ' A' ' 14' ' ' LEU . 75.6 t -103.33 125.22 57.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.715 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 76.8 m-85 -96.39 132.11 42.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.84 -177.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.406 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 19.9 m-85 -110.62 165.07 12.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.835 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.619 ' HB3' ' CG ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -116.05 95.31 5.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.208 0.528 . . . . 0.0 111.863 -178.068 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.611 ' OD1' ' HB2' ' A' ' 96' ' ' GLU . 9.1 t-20 -157.91 177.49 11.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.272 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.598 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.49 -0.83 15.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.917 0.865 . . . . 0.0 110.811 178.206 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.611 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -96.47 -152.93 0.39 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.508 -173.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -31.33 150.94 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -37.09 120.1 0.28 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 124.911 3.741 . . . . 0.0 114.013 -168.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.72 20.31 3.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.889 -175.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.43 138.86 26.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.312 0.577 . . . . 0.0 110.574 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.527 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.3 m -122.38 155.25 27.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -129.24 106.07 8.58 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.192 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.679 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.3 m-85 -102.38 111.63 24.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.028 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -76.23 117.62 18.11 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -127.58 142.03 51.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.256 -175.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.403 ' HA ' HD13 ' A' ' 85' ' ' ILE . 11.6 t70 -92.05 118.48 30.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.064 -175.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.478 HD11 HG11 ' A' ' 37' ' ' VAL . 2.0 mp -97.09 96.22 8.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 175.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -105.08 156.44 18.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.984 0.421 . . . . 0.0 111.28 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 mt -132.44 152.86 51.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -101.53 174.21 6.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.382 0.537 . . . . 0.0 110.374 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.07 158.47 28.36 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -172.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.591 ' HA ' HG21 ' A' ' 22' ' ' VAL . 6.2 mp0 . . . . . 0 N--CA 1.477 0.899 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.093 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.735 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 43.5 t . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.694 0.283 . . . . 0.0 111.453 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -145.04 97.23 2.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.455 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.0 t-80 -123.65 134.14 53.81 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.104 -0.239 . . . . 0.0 111.23 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 119' ' ' HIS . 7.1 mt -117.03 153.74 32.17 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.757 0.661 . . . . 0.0 110.108 175.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 19.9 ttm180 -142.24 147.86 37.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 173.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.411 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 81.1 m -130.81 118.85 21.41 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 6.2 mt-10 -112.93 136.57 52.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.29 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -91.41 134.92 34.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.457 0.646 . . . . 0.0 111.639 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.9 ' HB2' HG23 ' A' ' 12' ' ' VAL . 5.5 mt -104.67 113.91 27.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.777 173.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.9 m -103.52 123.85 47.68 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.132 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -120.75 105.28 10.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.458 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.32 119.9 23.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.131 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 54.24 64.37 6.42 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.871 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.433 ' HG3' HG23 ' A' ' 10' ' ' VAL . 91.9 Cg_endo -80.05 177.89 7.8 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.3 2.0 . . . . 0.0 111.297 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.408 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 5.6 p -76.86 141.99 40.39 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -56.49 -43.1 79.34 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.298 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 8.0 p-10 -59.65 -29.5 68.08 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.564 -0.161 . . . . 0.0 110.564 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.664 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 14.6 t80 -74.7 -40.84 61.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.606 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 43.8 ttm105 -56.02 -44.91 79.15 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.682 174.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -57.4 -37.0 72.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.019 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 44.3 mtpt -72.13 -38.96 69.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.702 0.287 . . . . 0.0 110.682 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.3 mt -69.84 -30.98 68.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.578 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 33.0 mt -82.84 -31.13 28.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.918 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -73.61 -31.13 63.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.02 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.198 176.909 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.236 0.372 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 216' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 49.5 Cg_exo -55.87 165.53 3.67 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.528 1.485 . . . . 0.0 112.138 177.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 22.4 ttm180 . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 121.167 0.508 . . . . 0.0 111.41 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 121.037 0.446 . . . . 0.0 111.443 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.3 142.98 19.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -122.46 131.78 54.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.919 0.39 . . . . 0.0 110.203 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.845 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -114.79 165.77 9.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.622 176.385 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.602 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . 97.2 mttt -135.31 127.35 29.73 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.659 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.414 HD13 HG11 ' A' ' 90' ' ' VAL . 89.4 mt -113.19 142.66 45.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.196 0.522 . . . . 0.0 110.248 177.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.668 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.9 tt0 -104.49 126.08 51.25 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.758 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.657 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -112.43 113.71 26.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -145.64 176.64 24.52 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 119.699 -1.239 . . . . 0.0 111.756 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -166.29 156.03 11.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.993 0.425 . . . . 0.0 110.622 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 62.4 mtt180 -117.17 139.47 50.72 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 172.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.06 123.53 30.7 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.599 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -117.76 144.19 45.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.777 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.782 HG21 ' HA ' ' A' ' 112' ' ' GLU . 2.6 p -104.3 152.97 6.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 170.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.558 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -108.52 139.99 42.48 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -65.73 -20.51 66.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.606 0.717 . . . . 0.0 109.229 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -131.36 101.36 16.12 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.974 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.553 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.7 Cg_exo -48.63 158.7 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.52 2.813 . . . . 0.0 113.172 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.1 t -80.15 -173.04 3.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.211 -172.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -58.33 -36.98 60.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.0 0.52 . . . . 0.0 111.836 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -83.14 -1.34 52.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 110.704 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 34.09 37.87 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.962 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -98.16 134.95 40.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.553 HG22 ' HG3' ' A' ' 26' ' ' PRO . 25.6 p -88.4 -27.22 21.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.111 -171.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.426 ' CD2' ' HB3' ' A' ' 109' ' ' LEU . 64.5 m80 -115.69 145.19 42.97 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -171.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.558 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 5.8 m-20 -123.23 125.63 45.44 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.417 ' HH2' HD22 ' A' ' 58' ' ' LEU . 55.7 p-90 -128.28 149.85 50.31 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.097 0.475 . . . . 0.0 111.002 -176.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.697 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 45.2 ttp -128.16 122.37 31.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.354 174.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 6.2 m -101.42 153.96 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.327 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -153.36 153.74 33.15 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.199 -0.6 . . . . 0.0 112.553 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 10.6 m -124.79 130.83 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.044 171.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.463 ' HB2' ' HB3' ' A' ' 15' ' ' GLU . 2.7 mmt85 -129.5 -177.09 4.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.958 0.408 . . . . 0.0 111.381 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.502 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -94.0 -164.17 36.37 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.229 174.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 2.7 Cg_exo -72.86 111.88 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.617 2.212 . . . . 0.0 111.369 177.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 57.18 56.52 5.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.578 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.1 m80 67.51 5.22 4.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.82 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 70.8 m -64.93 129.3 39.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.45 ' OD1' ' HB2' ' A' ' 48' ' ' GLN . 8.4 t-20 -59.96 127.08 30.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.595 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.621 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.5 pt -96.72 -3.89 10.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.45 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 1.5 mp0 -60.14 -6.27 1.36 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -73.0 -37.88 66.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.939 177.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.496 ' CE1' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -118.24 -21.09 8.31 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.353 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.621 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 96.6 t -87.06 130.52 36.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -99.64 -54.78 2.83 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.21 0.529 . . . . 0.0 110.526 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.89 142.14 16.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.177 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 55' ' ' VAL . 90.2 t -117.55 160.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.937 -175.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.59 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.8 p -144.16 135.52 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.165 0.507 . . . . 0.0 111.145 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.526 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 30.9 m-85 -118.15 109.91 16.97 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -83.26 92.89 7.58 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.833 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.561 ' CD2' HD11 ' A' ' 86' ' ' LEU . 9.8 mt -71.51 -177.39 1.83 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 79.1 t60 -76.15 142.81 41.48 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.808 -0.757 . . . . 0.0 108.999 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 1.8 mp0 -54.52 -20.67 8.25 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.028 -171.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t -82.97 -5.87 59.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.672 0.272 . . . . 0.0 111.026 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.475 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 62.0 m-85 -82.35 148.46 59.28 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.88 117.91 5.23 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.613 2.209 . . . . 0.0 110.917 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 52.56 73.52 0.93 Allowed Pre-proline 0 C--O 1.226 -0.15 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.076 -174.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.46 -20.55 64.27 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.892 2.394 . . . . 0.0 113.56 -174.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -90.29 105.53 17.87 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.207 0.527 . . . . 0.0 110.457 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -106.73 89.26 2.96 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.281 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -71.6 139.64 19.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.149 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.4 m -126.91 114.26 17.63 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 175.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -107.35 -28.11 10.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.993 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.464 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 30.1 t70 -75.93 164.97 56.91 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.724 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.593 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 24.2 Cg_exo -28.72 178.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.534 1 C-N-CA 125.65 4.233 . . . . 0.0 115.111 168.626 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.593 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 4.5 Cg_exo -22.51 115.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 124.384 3.389 . . . . 0.0 115.036 -149.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.43 ' CB ' HG22 ' A' ' 39' ' ' VAL . 36.3 m-85 -60.89 107.86 0.77 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.603 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.697 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.4 ptpt -152.28 153.79 34.43 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.0 111.55 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 36' ' ' MET . 71.4 t -131.13 133.09 63.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.858 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -115.98 115.71 26.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.125 0.266 . . . . 0.0 110.407 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.77 172.09 13.16 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.274 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.6 t -120.89 146.87 46.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.78 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.41 -162.49 14.34 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.287 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -141.53 -18.34 0.78 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.8 134.7 37.29 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.567 -175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.503 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -75.54 169.27 54.75 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.378 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -168.48 154.97 7.22 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.4 mm -65.6 122.55 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.561 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.6 tt -113.6 104.95 55.27 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.548 -178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.1 108.02 1.25 Allowed 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 123.197 2.598 . . . . 0.0 111.881 173.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -98.79 124.86 52.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.676 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.59 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 72.8 mt-10 -113.67 119.91 39.06 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.419 0.628 . . . . 0.0 110.075 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.414 HG11 HD13 ' A' ' 14' ' ' LEU . 60.7 t -102.98 123.34 56.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.432 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.441 ' CD2' ' HB3' ' A' ' 100' ' ' LYS . 25.7 m-85 -99.25 155.45 17.49 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.86 0.838 . . . . 0.0 111.138 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.445 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.6 m-85 -125.67 156.9 38.55 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.998 -176.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.09 92.02 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.237 0.541 . . . . 0.0 111.346 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -158.42 -178.19 7.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.678 172.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.677 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -114.38 6.09 15.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.652 0.263 . . . . 0.0 111.383 -177.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 6.3 mm-40 -102.07 -152.76 0.45 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.851 -168.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.618 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 13.4 mm-40 -31.56 159.63 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.98 1.312 . . . . 0.0 113.317 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.4 Cg_exo -28.63 125.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 124.716 3.611 . . . . 0.0 114.19 -162.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -72.59 -1.76 17.31 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.226 -170.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 91' ' ' TYR . 4.2 pttt -155.56 171.23 20.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.484 0.659 . . . . 0.0 111.012 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.572 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.5 m -133.11 154.55 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.207 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -123.03 117.02 24.5 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.019 0.438 . . . . 0.0 111.07 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.4 m-85 -108.76 116.99 33.03 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.741 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -81.58 109.99 16.54 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.437 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 68.5 t80 -122.35 137.17 54.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.725 -174.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.486 ' OD2' ' HB3' ' A' ' 108' ' ' PHE . 30.6 t70 -86.95 110.64 20.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.575 HD11 HG11 ' A' ' 37' ' ' VAL . 1.7 mp -83.61 91.41 7.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.502 ' CE2' HG11 ' A' ' 117' ' ' VAL . 15.6 p90 -98.59 154.72 17.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.105 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 22.8 mt -133.3 137.89 46.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -176.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.592 ' HD1' HG23 ' A' ' 117' ' ' VAL . 2.6 p-80 -67.86 172.12 5.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 173.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.1 155.56 32.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.565 0.698 . . . . 0.0 111.338 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.782 ' HA ' HG21 ' A' ' 22' ' ' VAL . 15.2 tt0 . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.22 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.592 HG23 ' HD1' ' A' ' 110' ' ' HIS . 48.6 t . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -141.91 96.69 3.01 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.443 ' O ' HD23 ' A' ' 120' ' ' LEU . 55.3 t-80 -115.67 136.0 53.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.731 -177.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 119' ' ' HIS . 7.5 mt -117.57 151.07 37.91 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.776 0.672 . . . . 0.0 110.295 177.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 18.0 ttm180 -140.36 148.01 40.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 42.4 t -132.51 125.86 31.58 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -121.61 134.01 55.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.715 -177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.71 129.43 35.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.198 0.523 . . . . 0.0 111.652 -175.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.845 ' HB2' HG23 ' A' ' 12' ' ' VAL . 6.4 mt -95.1 131.54 40.98 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.9 m -122.91 122.71 39.26 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.014 -0.674 . . . . 0.0 110.82 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -118.11 105.7 12.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.515 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.26 119.78 23.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.436 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.86 64.36 4.0 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.07 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -83.5 170.24 11.82 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.506 2.137 . . . . 0.0 111.155 172.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.7 p -70.24 142.81 52.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -57.0 -41.43 78.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.611 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -56.09 -33.03 64.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.79 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.705 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.8 t80 -75.41 -40.48 57.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.64 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.7 ttm180 -55.3 -45.89 76.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -53.05 -42.19 65.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.251 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 45.6 mtpt -71.68 -38.96 70.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 41.5 mt -68.11 -31.55 71.23 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.911 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 56.0 mt -80.52 -28.95 37.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.966 0.413 . . . . 0.0 110.917 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -78.72 -27.39 44.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.589 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.981 174.492 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.483 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.236 0.377 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 216' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 7.5 Cg_endo -50.94 168.71 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.285 2.657 . . . . 0.0 112.974 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 8.7 tpp180 . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.8 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 120.998 0.428 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.1 t -99.92 139.06 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 1.7 mp0 -125.09 119.67 29.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.271 0.558 . . . . 0.0 110.366 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.875 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.45 164.4 4.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.767 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 42' ' ' PRO . 92.1 mttt -132.92 125.93 30.97 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.373 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.48 HD13 HG11 ' A' ' 90' ' ' VAL . 90.8 mt -115.48 142.38 46.78 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.276 0.56 . . . . 0.0 110.372 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 7.0 tt0 -109.07 128.5 55.03 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.014 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.543 HD12 HG12 ' A' ' 39' ' ' VAL . 1.6 mm? -109.14 122.19 46.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -143.5 170.59 25.53 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.649 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -165.42 152.53 10.5 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.745 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.674 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 62.6 mtp180 -117.48 140.7 49.26 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.979 171.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -135.98 123.83 22.62 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.572 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 14.3 tt0 -121.4 144.76 48.49 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.556 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.77 HG21 ' HA ' ' A' ' 112' ' ' GLU . 9.8 p -99.03 153.49 4.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -105.03 152.06 23.2 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.261 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.9 mmtm -68.2 -20.82 64.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.396 0.617 . . . . 0.0 109.737 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -140.79 111.09 6.75 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.646 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.2 Cg_exo -47.81 155.27 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.176 2.584 . . . . 0.0 112.423 173.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.438 HG22 ' HB2' ' A' ' 31' ' ' PHE . 9.1 t -75.11 -169.7 0.99 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.865 -172.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 m -61.81 -24.61 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -107.05 11.36 29.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.324 1.059 . . . . 0.0 109.327 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.74 33.1 47.9 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.538 172.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.438 ' HB2' HG22 ' A' ' 27' ' ' THR . 19.4 m-30 -90.38 127.93 36.33 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.591 HG22 ' HG3' ' A' ' 26' ' ' PRO . 60.3 p -85.48 -29.87 23.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.34 -169.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.457 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.8 m80 -118.87 144.43 46.39 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -172.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -115.41 119.94 37.92 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 171.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -122.78 150.86 42.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.212 0.529 . . . . 0.0 111.031 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.72 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 50.4 ttp -129.11 116.48 19.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.428 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.2 m -99.14 149.77 5.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.299 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.643 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.6 OUTLIER -151.61 156.26 40.09 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.263 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.1 m -123.73 135.22 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.899 169.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -134.95 175.78 9.26 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.002 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.463 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -90.14 -178.61 44.46 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.14 173.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HB3' ' HB2' ' A' ' 13' ' ' LYS . 37.4 Cg_endo -76.63 111.87 3.34 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.147 1.898 . . . . 0.0 112.458 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 57.7 67.12 1.0 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.882 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.6 m80 72.87 -7.27 1.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.0 m -67.49 126.71 30.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.373 0.13 . . . . 0.0 110.848 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -69.03 126.68 30.57 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.637 HD12 HG21 ' A' ' 51' ' ' VAL . 1.1 pt -94.87 -3.74 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.763 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -63.36 -1.28 1.07 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.22 -0.446 . . . . 0.0 112.201 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -79.16 -33.6 43.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.416 ' CE2' HG22 ' A' ' 47' ' ' ILE . 54.0 p90 -117.65 -18.15 9.75 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.565 175.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.637 HG21 HD12 ' A' ' 47' ' ' ILE . 84.0 t -91.4 130.87 39.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.747 0.308 . . . . 0.0 110.369 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 7.8 tp10 -102.39 -63.36 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.144 0.497 . . . . 0.0 110.506 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -131.12 162.07 30.71 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 95.0 t -133.72 155.78 40.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 169.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.598 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.4 p -141.75 134.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.529 0.68 . . . . 0.0 111.402 -174.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.428 ' CD2' HG12 ' A' ' 88' ' ' ILE . 22.3 m-85 -115.88 107.27 14.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.131 -0.941 . . . . 0.0 108.646 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -79.44 90.74 5.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.229 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.449 HD11 HG11 ' A' ' 76' ' ' VAL . 19.9 mt -78.2 -176.85 4.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.888 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.79 143.96 43.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.15 -21.54 63.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.091 -175.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t -69.13 -17.04 63.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.888 0.375 . . . . 0.0 110.548 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -85.13 139.53 36.69 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.85 117.55 4.29 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.277 1.985 . . . . 0.0 111.271 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 57.37 80.19 0.3 Allowed Pre-proline 0 C--O 1.225 -0.231 0 O-C-N 123.672 0.607 . . . . 0.0 110.505 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.15 -20.79 48.12 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.884 2.389 . . . . 0.0 113.465 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -97.45 108.68 21.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.942 0.401 . . . . 0.0 110.915 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 19.7 mmt85 -111.38 104.87 13.36 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.017 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 5.4 m -90.63 135.92 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 169.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.0 m -112.87 116.46 30.06 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -101.38 -28.58 12.51 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.545 0.688 . . . . 0.0 110.245 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.571 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 3.1 m-20 -75.52 -177.17 0.66 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.927 -175.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.639 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 13.3 Cg_exo -45.0 -168.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.963 3.109 . . . . 0.0 113.936 165.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.639 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 2.6 Cg_endo -28.52 114.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.512 2.808 . . . . 0.0 114.563 -152.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 50.8 m-85 -62.17 96.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.287 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.72 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 17.3 ptpt -143.2 148.77 37.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.491 0.662 . . . . 0.0 112.727 -177.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 36' ' ' MET . 79.3 t -123.66 133.26 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.416 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -117.55 103.21 9.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' A' ' 67' ' ' ARG . 1.7 tp10 -136.27 169.7 17.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.741 0.305 . . . . 0.0 110.765 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 8.3 t -123.69 144.91 49.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.173 -176.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.23 -174.13 27.54 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -130.38 2.14 4.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.298 0.549 . . . . 0.0 112.016 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -160.17 130.91 5.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.744 0.307 . . . . 0.0 110.77 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -71.33 173.96 42.28 Favored Glycine 0 C--O 1.237 0.326 0 CA-C-N 115.604 -0.726 . . . . 0.0 113.381 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -173.1 157.09 3.39 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.87 0.468 . . . . 0.0 110.218 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 106' ' ' ASP . 12.9 mm -62.66 124.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.204 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.508 HD22 HG13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -108.66 106.2 58.3 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.98 112.7 3.47 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.807 2.338 . . . . 0.0 111.671 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.508 HG13 HD22 ' A' ' 86' ' ' LEU . 5.3 mt -108.15 125.74 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.633 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.598 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.2 mt-10 -107.93 122.12 46.17 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.388 0.613 . . . . 0.0 110.327 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 14' ' ' LEU . 75.8 t -101.11 116.63 45.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.285 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -88.74 139.3 30.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.815 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.1 m-85 -113.21 146.24 39.63 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.923 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -89.75 94.4 9.82 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.664 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -156.32 156.35 33.82 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.754 -170.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -107.8 -7.78 16.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.345 1.069 . . . . 0.0 109.515 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.15 -151.22 0.4 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.516 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.457 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 8.0 mm-40 -27.07 154.52 0.01 OUTLIER Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 4.2 Cg_exo -31.29 126.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.214 1 C-N-CA 125.529 4.153 . . . . 0.0 115.133 -168.238 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.85 14.46 11.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.932 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -161.91 142.76 10.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.349 0.595 . . . . 0.0 111.224 -176.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.513 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -129.23 156.48 41.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.761 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -128.77 107.55 9.75 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.466 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.513 ' CZ ' HG21 ' A' ' 101' ' ' VAL . 20.5 m-85 -100.27 137.89 38.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -94.73 122.51 37.41 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.377 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -133.26 130.76 39.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.324 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.465 ' HA ' HD13 ' A' ' 85' ' ' ILE . 17.4 t70 -84.47 107.0 16.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -175.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.467 HD11 ' CG1' ' A' ' 37' ' ' VAL . 1.5 mp -85.07 103.46 14.1 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.43 ' HB3' ' NH2' ' B' ' 217' ' ' ARG . 50.4 p90 -118.48 157.13 27.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.004 0.43 . . . . 0.0 110.352 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 mt -127.7 162.45 26.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.473 ' C ' ' HB2' ' B' ' 215' ' ' ALA . 36.0 m170 -94.62 164.07 13.12 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' B' ' 215' ' ' ALA . 1.3 mm? -51.99 147.07 7.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.958 0.409 . . . . 0.0 111.896 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.77 ' HA ' HG21 ' A' ' 22' ' ' VAL . 29.2 tt0 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.846 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 9.2 t . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 120.554 0.216 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -118.23 100.99 7.87 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -127.47 127.67 44.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.215 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.4 mt -107.38 150.78 26.35 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.494 174.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.638 ' HD3' ' N ' ' A' ' 122' ' ' CYS . 0.0 OUTLIER -148.14 140.44 24.27 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -174.387 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.638 ' N ' ' HD3' ' A' ' 121' ' ' ARG . 49.7 t -131.57 130.23 41.97 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.829 -175.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -121.48 141.12 51.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.089 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -104.47 132.16 51.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.174 0.512 . . . . 0.0 111.37 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.875 ' HB2' HG23 ' A' ' 12' ' ' VAL . 6.9 mt -99.36 116.11 30.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.169 175.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 35.4 m -112.14 115.2 28.47 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.557 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -114.53 109.45 18.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.901 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.71 120.35 24.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.901 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 58.04 63.59 4.35 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.654 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -85.14 165.65 11.2 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.835 2.356 . . . . 0.0 111.496 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.4 p -67.47 145.08 55.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 175.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.12 -43.76 70.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 136' ' ' ARG . 3.1 t70 -59.71 -30.77 69.03 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.746 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.698 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 11.0 t80 -76.01 -39.84 54.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.634 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 29.1 ttm180 -55.12 -46.03 75.56 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 121.236 0.541 . . . . 0.0 109.583 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 46.3 ttt180 -51.21 -44.01 61.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.495 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -71.75 -39.91 69.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.6 mt -69.3 -29.57 67.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.857 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 40.5 mt -80.31 -41.17 25.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.047 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -68.28 -30.19 69.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.337 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.583 176.964 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 215' ' ' ALA . . . . . 0.516 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.237 0.433 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 216' ' ' PRO . . . . . 0.516 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 0.1 OUTLIER -34.59 152.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.263 3.309 . . . . 0.0 114.749 168.767 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' A' ' 108' ' ' PHE . 17.1 ttm180 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.024 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 120.923 0.392 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.9 t -101.87 137.25 30.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.5 mt-30 -117.2 120.53 38.54 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.037 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.838 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.49 167.84 3.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.711 175.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.664 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 43.7 mtpt -133.39 139.68 46.92 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.46 HD13 HG11 ' A' ' 90' ' ' VAL . 96.8 mt -126.99 151.9 47.95 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 175.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.684 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 41.1 tt0 -114.26 120.82 41.73 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.314 -174.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.636 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.1 mm? -108.67 115.32 29.87 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -144.88 169.64 26.6 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.011 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -163.11 155.78 18.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.164 0.507 . . . . 0.0 110.917 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 20.8 mtp180 -118.93 153.44 34.59 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.677 175.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -149.44 128.17 12.48 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.804 175.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -129.23 164.1 24.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.524 HG21 ' HA ' ' A' ' 112' ' ' GLU . 1.8 p -103.44 163.47 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.2 mtp180 -112.51 135.13 53.59 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.61 -11.38 58.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.495 0.664 . . . . 0.0 110.457 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -135.9 103.29 9.97 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.833 170.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.531 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.2 Cg_exo -47.06 155.29 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.183 2.589 . . . . 0.0 112.211 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 t -76.71 -172.32 2.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -171.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 m -61.97 -30.43 48.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.495 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.83 -7.3 59.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.181 0.515 . . . . 0.0 110.38 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.65 32.42 33.7 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.206 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -98.54 138.49 35.67 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.531 HG22 ' HG3' ' A' ' 26' ' ' PRO . 26.5 p -86.77 -30.33 21.66 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -169.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.522 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.9 m80 -112.55 146.15 39.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -170.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -117.47 118.97 33.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -121.95 148.11 45.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.009 0.433 . . . . 0.0 111.111 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.645 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 41.1 ttp -125.75 122.04 35.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.526 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.9 m -103.23 153.05 5.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.072 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -154.26 154.52 33.57 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -126.71 129.5 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.844 169.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -134.91 -178.5 5.11 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.887 0.375 . . . . 0.0 111.067 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.44 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -92.37 166.85 29.68 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 173.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.664 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 41.0 Cg_endo -62.31 111.73 1.37 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 123.199 2.599 . . . . 0.0 112.727 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 58.02 67.84 0.91 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.784 172.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 75.47 -12.07 1.02 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.979 0.512 . . . . 0.0 112.353 172.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.1 m -62.37 122.94 16.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.799 0.333 . . . . 0.0 111.081 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -69.59 125.22 26.07 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.104 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.612 HD12 HG21 ' A' ' 51' ' ' VAL . 2.4 pt -96.07 -1.87 10.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -56.35 -16.45 5.64 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.942 0.401 . . . . 0.0 111.394 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -73.42 -43.85 59.56 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.617 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.475 ' CE2' HG22 ' A' ' 47' ' ' ILE . 49.5 p90 -106.07 -20.02 13.54 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.865 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.612 HG21 HD12 ' A' ' 47' ' ' ILE . 76.3 t -91.53 131.33 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.208 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.582 ' HB2' ' HG3' ' A' ' 93' ' ' LYS . 26.2 tt0 -103.46 -62.72 1.26 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.693 0.759 . . . . 0.0 110.327 -173.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 45.2 mtpt -131.73 161.16 33.5 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.578 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 93.2 t -134.8 153.5 34.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.573 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.3 p -139.36 132.71 37.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.635 0.731 . . . . 0.0 111.157 -175.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.48 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 27.0 m-85 -113.28 105.45 13.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.51 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -79.04 94.26 5.27 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.468 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.582 ' CD2' HD11 ' A' ' 86' ' ' LEU . 11.3 mt -73.34 179.74 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.04 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.51 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 22.9 t60 -81.98 146.96 29.46 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -57.24 -21.68 35.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.669 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 t -64.71 -22.48 66.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.095 0.474 . . . . 0.0 110.581 174.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -90.48 129.12 46.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.567 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.65 138.31 44.99 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.152 1.901 . . . . 0.0 110.699 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 58.45 67.32 2.18 Favored Pre-proline 0 C--O 1.223 -0.302 0 O-C-N 123.447 0.467 . . . . 0.0 109.983 -174.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.91 -22.01 56.47 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.689 2.259 . . . . 0.0 113.79 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -93.92 109.97 21.66 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.061 0.458 . . . . 0.0 110.44 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 21.8 mmt85 -113.05 100.97 9.02 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.771 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.5 m -92.74 138.17 20.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 171.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.45 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 25.9 t -118.53 111.53 18.73 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -92.59 -26.93 17.65 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.926 0.869 . . . . 0.0 109.261 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.576 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -84.58 179.68 1.81 Allowed Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.946 -171.535 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.62 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 22.8 Cg_exo -28.28 -179.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.535 1 C-N-CA 126.125 4.55 . . . . 0.0 115.896 163.058 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.62 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.6 Cg_endo -29.24 115.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 124.318 3.345 . . . . 0.0 115.04 -153.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 42.3 m-85 -62.7 98.19 0.12 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.153 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.645 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.1 ptpt -145.27 151.26 38.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.275 0.559 . . . . 0.0 111.905 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 36' ' ' MET . 73.7 t -128.12 131.65 69.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.431 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.48 108.16 14.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.926 0.393 . . . . 0.0 110.009 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.34 174.01 10.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.424 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 8.1 t -122.99 146.89 47.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.217 -176.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.74 -168.24 27.61 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.221 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -138.31 -10.7 1.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.76 123.16 9.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.153 0.501 . . . . 0.0 110.938 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.71 175.03 13.17 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.001 -1.0 . . . . 0.0 114.471 -177.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' A' ' 59' ' ' HIS . 21.8 p90 -174.24 155.59 2.43 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.218 -0.491 . . . . 0.0 110.288 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 106' ' ' ASP . 19.8 mm -63.58 128.32 25.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.369 171.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.582 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.8 tt -120.03 105.84 41.99 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 121.025 0.44 . . . . 0.0 110.123 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.74 113.48 2.99 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 123.322 2.681 . . . . 0.0 112.327 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 mt -103.76 124.36 58.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.337 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.3 mt-10 -107.93 127.47 53.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.117 0.485 . . . . 0.0 110.289 175.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.46 HG11 HD13 ' A' ' 14' ' ' LEU . 70.0 t -107.3 120.8 59.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.741 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 86.7 m-85 -90.77 145.48 24.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.386 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.428 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 19.8 m-85 -126.04 161.42 27.61 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.933 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.582 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -101.6 94.22 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 117.986 0.357 . . . . 0.0 110.615 177.887 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -158.54 175.41 13.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.964 170.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.463 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -114.37 6.24 15.98 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 177.241 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -98.6 -153.08 0.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -176.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -30.85 150.17 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.963 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -37.57 120.8 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.677 3.585 . . . . 0.0 113.777 -169.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.43 ' N ' ' HD3' ' A' ' 99' ' ' ARG . 0.3 OUTLIER -89.77 20.34 4.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.871 -175.35 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -143.24 137.77 29.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.176 0.513 . . . . 0.0 110.16 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.32 155.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.517 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -125.41 117.35 23.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.118 0.485 . . . . 0.0 111.08 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.636 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.2 m-85 -108.1 119.6 39.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.966 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -80.91 105.82 12.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.35 0.595 . . . . 0.0 109.905 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -118.18 133.84 55.54 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.371 -175.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.402 ' HA ' HD13 ' A' ' 85' ' ' ILE . 31.8 t70 -87.55 111.82 21.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.039 -175.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.522 HD11 HG11 ' A' ' 37' ' ' VAL . 1.9 mp -88.76 101.54 14.11 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -113.21 155.33 25.23 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.515 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.7 mt -128.52 155.09 45.42 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -100.23 162.13 13.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 118.36 0.527 . . . . 0.0 110.175 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -52.12 141.61 18.16 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.524 ' HA ' HG21 ' A' ' 22' ' ' VAL . 5.0 tt0 . . . . . 0 C--O 1.231 0.085 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.446 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 44.1 t . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.947 0.403 . . . . 0.0 111.97 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -144.88 96.51 2.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.427 ' O ' HD23 ' A' ' 120' ' ' LEU . 27.5 t-80 -122.27 134.09 54.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.215 -174.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 119' ' ' HIS . 8.3 mt -117.78 153.9 32.66 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.452 0.47 . . . . 0.0 111.205 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.478 ' HD2' HD23 ' A' ' 16' ' ' LEU . 20.8 ttm180 -145.17 151.14 37.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.474 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 48.9 t -136.37 122.23 19.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -120.32 142.14 49.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.673 0.273 . . . . 0.0 111.089 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.422 ' HD3' ' HB3' ' A' ' 11' ' ' GLN . 22.1 ttmt -92.22 138.69 31.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.202 0.525 . . . . 0.0 111.641 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.838 ' HB2' HG23 ' A' ' 12' ' ' VAL . 5.9 mt -105.49 118.76 37.38 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.0 m -111.95 123.09 49.51 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.151 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -118.97 110.0 16.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.881 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -81.66 128.12 33.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.507 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 49.89 60.66 14.94 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.422 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.29 173.6 9.7 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.521 2.147 . . . . 0.0 111.626 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 p -67.58 136.92 55.23 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 174.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -56.5 -34.14 66.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.566 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 9.3 m-20 -62.76 -32.56 73.73 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.686 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.4 t80 -76.53 -40.45 49.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.572 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 50.3 ttp180 -55.75 -41.66 74.27 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 43.7 ttm180 -58.09 -36.3 72.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.06 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 37.8 mtpt -72.3 -40.38 67.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.89 0.376 . . . . 0.0 110.246 176.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 26.0 mt -71.15 -25.34 62.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.948 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 30.4 mt -89.8 -23.61 21.67 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.834 0.35 . . . . 0.0 110.783 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.02 -23.96 38.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.876 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.265 176.145 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.307 0 N-CA-C 110.727 -0.101 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.54 171.18 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.444 2.096 . . . . 0.0 112.602 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 30.6 mtp85 . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 177.652 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.065 0.46 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 t -101.7 139.75 22.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 5.2 mp0 -127.38 131.41 50.35 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -176.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.829 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -116.12 171.05 5.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.947 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -133.4 131.66 40.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.775 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.05 144.18 43.06 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.744 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 36.7 tt0 -109.68 123.26 49.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.036 -175.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.611 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.0 mm? -106.53 110.21 22.35 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.426 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -136.78 170.22 23.53 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.433 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -164.95 151.8 10.72 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.149 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.0 mtp180 -113.54 145.62 40.95 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.524 173.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -136.92 118.77 15.16 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.92 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -111.62 154.04 25.46 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.733 HG21 ' HA ' ' A' ' 112' ' ' GLU . 3.1 p -103.88 161.91 4.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 3.7 mtp180 -112.19 141.01 46.4 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -68.18 -20.26 64.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.571 0.7 . . . . 0.0 109.143 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -131.1 104.24 15.23 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.365 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HG3' HG22 ' A' ' 32' ' ' THR . 88.3 Cg_exo -47.63 154.42 1.82 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.27 2.647 . . . . 0.0 112.988 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.432 HG22 ' HB2' ' A' ' 31' ' ' PHE . 9.0 t -73.96 -170.65 0.95 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.077 -171.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 m -54.1 -33.48 24.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -104.24 5.96 35.14 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.162 0.982 . . . . 0.0 109.447 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.7 25.45 20.44 Favored Glycine 0 CA--C 1.503 -0.717 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.151 169.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.432 ' HB2' HG22 ' A' ' 27' ' ' THR . 21.9 m-30 -94.36 140.32 29.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.873 0.845 . . . . 0.0 111.11 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.52 HG22 ' HG3' ' A' ' 26' ' ' PRO . 44.8 p -94.41 -23.85 17.59 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.857 -162.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.509 ' O ' ' HA ' ' A' ' 79' ' ' SER . 69.9 m80 -118.22 146.55 44.17 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -170.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.532 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 4.0 m-20 -126.98 123.73 37.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.483 170.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.412 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 54.1 p-90 -125.15 153.39 43.11 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.921 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.675 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 44.8 ttp -129.61 120.65 25.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.273 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.9 m -100.46 151.19 5.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -151.69 152.74 33.19 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.5 m -124.35 127.65 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.19 171.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -127.18 -179.48 4.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.021 0.439 . . . . 0.0 111.22 -176.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.539 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -94.68 -173.13 38.03 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.042 172.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -65.18 110.33 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.039 1.826 . . . . 0.0 111.753 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 15.4 mm-40 51.09 65.31 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.325 177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' A' ' 43' ' ' GLU . 75.4 t60 76.59 -10.39 1.33 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 171.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.6 m -60.24 127.09 30.07 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -66.04 126.6 29.12 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 120.863 0.363 . . . . 0.0 110.336 -178.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.666 HD12 HG21 ' A' ' 51' ' ' VAL . 1.1 pt -94.97 -4.05 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.76 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.78 0.59 1.67 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.866 0.365 . . . . 0.0 111.866 -176.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -76.86 -36.01 57.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.467 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 55.3 p90 -116.91 -17.15 10.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.52 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.666 HG21 HD12 ' A' ' 47' ' ' ILE . 98.1 t -91.35 130.32 40.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.86 0.362 . . . . 0.0 110.259 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.464 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 9.6 tp10 -99.38 -62.49 1.23 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.263 0.554 . . . . 0.0 110.169 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 43.1 mtpt -132.26 163.69 28.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.481 HG21 HG21 ' A' ' 39' ' ' VAL . 94.4 t -134.52 157.38 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 168.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.543 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.2 p -142.03 128.97 19.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.62 0.724 . . . . 0.0 111.166 -175.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.477 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 25.8 m-85 -110.86 104.57 13.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.581 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -78.31 92.5 4.53 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.815 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.635 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.5 mt -71.81 -178.67 2.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.89 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -76.18 142.08 41.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.17 -17.2 39.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -61.31 -28.54 69.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.36 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -82.09 131.82 55.41 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.088 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.93 124.74 15.05 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.183 1.922 . . . . 0.0 110.931 171.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 60.7 70.28 0.99 Allowed Pre-proline 0 N--CA 1.466 0.362 0 O-C-N 123.578 0.549 . . . . 0.0 110.406 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.75 -23.6 35.62 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.666 2.244 . . . . 0.0 113.781 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -90.45 105.25 17.69 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.309 0.576 . . . . 0.0 110.333 -174.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -105.54 86.92 2.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.078 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.3 m -69.27 138.22 22.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.211 0.529 . . . . 0.0 110.066 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.75 103.19 7.96 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -94.84 -23.73 17.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.054 0.931 . . . . 0.0 109.307 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.592 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 4.1 t70 -75.8 173.49 7.06 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.826 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.659 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.3 Cg_exo -32.91 -175.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.675 1 C-N-CA 125.457 4.105 . . . . 0.0 114.732 163.202 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.9 Cg_endo -28.01 115.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 124.299 3.332 . . . . 0.0 114.508 -158.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 42.7 m-85 -61.49 107.13 0.74 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.009 -175.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.675 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 17.3 ptpt -152.13 150.46 29.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.379 0.609 . . . . 0.0 112.066 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.5 t -128.57 132.55 67.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.629 177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -121.11 106.31 11.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.455 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.29 169.14 18.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.035 0.445 . . . . 0.0 111.463 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 0.8 OUTLIER -114.91 137.05 52.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.861 -178.087 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -143.68 -178.1 19.16 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -129.76 -2.39 4.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.685 0.278 . . . . 0.0 110.97 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -163.55 142.27 7.98 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.398 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.46 179.72 39.63 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.425 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -178.11 157.03 1.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.605 0.362 . . . . 0.0 110.293 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.3 mm -63.02 128.49 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.057 171.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.635 HD11 ' CD2' ' A' ' 58' ' ' LEU . 5.7 tt -120.29 105.2 42.26 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-O 121.04 0.448 . . . . 0.0 110.224 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.34 110.66 2.3 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 123.312 2.675 . . . . 0.0 112.316 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.427 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.9 mt -102.3 123.75 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.29 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.6 mt-10 -109.27 126.62 53.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.042 0.449 . . . . 0.0 109.939 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 53.0 t -104.5 122.09 57.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.149 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 73.0 m-85 -89.64 136.82 32.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.018 -178.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.444 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.5 m-85 -114.77 156.36 25.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.077 178.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.464 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -104.47 91.67 3.99 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.26 0.552 . . . . 0.0 111.347 -178.683 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -158.51 179.75 8.84 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.909 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.597 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -113.19 4.19 16.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 110.915 176.608 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 44.9 mm-40 -99.34 -152.07 0.4 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.155 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.439 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 51.3 mm-40 -25.63 148.18 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -34.49 120.68 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 125.085 3.857 . . . . 0.0 113.873 -170.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.93 19.24 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.419 -174.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 11.8 ptpt -151.39 144.38 24.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.205 0.526 . . . . 0.0 110.432 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.94 154.71 30.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.63 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -120.81 118.96 31.35 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.939 0.399 . . . . 0.0 110.811 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.611 ' CD2' HD21 ' A' ' 16' ' ' LEU . 24.1 m-85 -112.54 117.08 31.35 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.712 174.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.98 105.93 14.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.626 0.727 . . . . 0.0 109.791 177.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -115.99 127.52 55.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.212 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -81.48 109.89 16.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.605 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.523 HD11 HG11 ' A' ' 37' ' ' VAL . 1.4 mp -83.87 91.16 7.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.442 . . . . 0.0 109.81 176.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -96.46 154.02 17.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.279 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.2 mt -127.91 162.3 27.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.428 ' O ' ' NE2' ' A' ' 33' ' ' HIS . 23.8 p80 -96.52 166.97 11.43 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.792 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.11 150.59 47.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.954 0.407 . . . . 0.0 111.261 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.733 ' HA ' HG21 ' A' ' 22' ' ' VAL . 5.1 tt0 . . . . . 0 C--O 1.232 0.144 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.469 173.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 48.6 t . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -144.5 97.65 3.07 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -124.44 137.12 54.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.254 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.2 mt -115.74 153.48 31.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.74 0.65 . . . . 0.0 110.097 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 20.2 ttt180 -142.64 136.38 29.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 75.0 m -115.25 113.65 24.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.867 0.365 . . . . 0.0 111.052 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -110.73 134.89 52.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.878 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -96.48 125.9 41.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.261 0.553 . . . . 0.0 111.836 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.829 ' HB2' HG23 ' A' ' 12' ' ' VAL . 12.6 mt -90.21 120.42 31.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 171.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.2 m -112.84 119.9 39.59 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.694 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.49 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 30.6 m-85 -118.25 109.23 16.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.154 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.34 116.84 20.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.191 0.519 . . . . 0.0 111.153 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.4 t30 52.75 61.78 11.04 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.501 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 127' ' ' PHE . 96.5 Cg_endo -77.73 169.23 21.13 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.353 2.036 . . . . 0.0 111.489 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' A' ' 134' ' ' PHE . 6.6 p -59.62 141.25 55.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -57.82 -36.09 71.77 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.366 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.89 -34.5 74.75 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.676 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.0 t80 -73.94 -40.12 63.29 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.615 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 19.9 ttm180 -55.08 -44.62 75.02 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.591 173.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -55.49 -38.59 69.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.106 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -72.05 -39.74 68.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.984 0.421 . . . . 0.0 110.413 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 34.0 mt -72.62 -26.07 61.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.223 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.8 mt -85.6 -25.4 26.71 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.894 0.378 . . . . 0.0 110.689 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -80.74 -27.72 36.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.149 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.536 176.453 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.53 168.64 3.82 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.13 1.887 . . . . 0.0 111.674 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 . . . . . 0 C--N 1.323 -0.553 0 CA-C-O 121.372 0.606 . . . . 0.0 111.592 -178.432 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.822 0.344 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.496 HG23 ' HG3' ' A' ' 130' ' ' PRO . 10.2 t -104.93 143.34 16.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 2.8 mp0 -127.35 127.67 44.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.743 0.306 . . . . 0.0 110.362 -176.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.826 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -112.13 171.92 3.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.224 178.278 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 99.6 mttt -137.41 138.06 39.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.695 0.284 . . . . 0.0 110.53 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.404 HD22 HD13 ' A' ' 47' ' ' ILE . 85.4 mt -121.4 142.02 50.41 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.53 175.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 121' ' ' ARG . 3.0 tm-20 -107.8 128.09 54.29 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.046 -175.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.612 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -111.24 107.64 17.01 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.81 168.4 23.95 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.612 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -162.88 152.17 15.21 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.485 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.649 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -122.46 121.06 35.72 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.371 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.61 117.4 30.2 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.283 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -111.09 158.9 18.33 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.732 HG21 ' HA ' ' A' ' 112' ' ' GLU . 5.0 p -103.79 156.41 5.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 23' ' ' ARG . 3.0 mtp180 -104.66 140.74 37.6 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -63.39 -22.22 66.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.612 0.72 . . . . 0.0 109.342 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -140.93 107.91 6.35 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.483 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.523 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.8 Cg_exo -49.23 156.88 2.2 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.301 2.667 . . . . 0.0 112.816 174.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -79.36 -173.5 3.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.658 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -42.43 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 122.625 0.37 . . . . 0.0 111.349 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -75.32 2.2 11.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.079 0.466 . . . . 0.0 111.144 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.61 29.33 65.81 Favored Glycine 0 CA--C 1.507 -0.466 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.64 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -86.8 129.43 34.88 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.523 HG22 ' HG3' ' A' ' 26' ' ' PRO . 59.9 p -91.51 -20.12 22.06 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.105 -168.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.0 m80 -122.12 145.85 47.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -172.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -121.81 123.81 42.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -126.22 143.31 51.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.196 0.522 . . . . 0.0 110.96 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.595 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 45.5 ttp -120.27 117.29 27.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.515 174.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 9.9 m -98.96 153.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.342 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.4 p90 -153.63 153.98 33.34 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -124.73 131.12 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.322 168.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.67 175.02 14.61 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.861 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.509 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -81.88 -176.44 51.15 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.296 -168.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 11.8 Cg_exo -63.01 112.19 1.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.981 2.454 . . . . 0.0 111.702 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 52.02 52.58 14.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.671 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.0 t60 80.3 -3.47 1.91 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.701 171.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.481 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 49.9 m -58.58 123.42 16.22 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -58.11 127.12 30.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.652 0.263 . . . . 0.0 111.078 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.56 HD12 HG21 ' A' ' 51' ' ' VAL . 5.6 pt -97.7 -1.98 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -66.51 -4.49 8.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.815 0.34 . . . . 0.0 111.003 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -71.35 -34.38 70.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.755 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -120.68 -17.5 7.99 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.555 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 47' ' ' ILE . 91.4 t -89.75 128.48 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.921 0.391 . . . . 0.0 110.487 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.87 -62.38 1.27 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.366 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -145.66 153.56 41.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 55' ' ' VAL . 91.5 t -128.0 158.16 39.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.914 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.637 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.7 p -142.11 134.13 26.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.14 0.495 . . . . 0.0 111.246 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 22.7 m-85 -115.86 107.29 14.83 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -77.94 94.33 4.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.925 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.599 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.4 mt -75.29 -177.7 3.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.845 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.505 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 68.7 t60 -73.97 138.89 44.46 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -54.97 -24.55 24.5 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.022 -170.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 t -69.3 -19.17 63.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.188 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 21.0 m-85 -77.95 139.6 61.71 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.7 0.286 . . . . 0.0 110.994 -176.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.35 119.9 6.81 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.066 2.51 . . . . 0.0 111.11 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 59.45 67.39 1.87 Allowed Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.45 -170.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.15 -20.25 50.06 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.591 2.194 . . . . 0.0 113.006 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -95.66 102.26 14.04 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.143 0.497 . . . . 0.0 110.488 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -98.75 94.23 6.51 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.516 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -79.52 135.21 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 172.176 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 m -127.95 114.56 17.3 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -106.66 -24.53 12.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.674 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.626 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 5.9 p-10 -68.51 -174.87 0.22 Allowed Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.397 1.079 . . . . 0.0 111.347 -175.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.631 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 4.2 Cg_exo -40.61 -167.63 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 124.231 3.287 . . . . 0.0 114.552 167.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.657 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 Cg_endo -39.68 124.49 1.33 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.626 2.217 . . . . 0.0 113.097 -155.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 46.7 m-85 -62.5 95.75 0.07 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.187 -175.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.657 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 4.8 ptpt -141.4 145.88 35.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.453 0.644 . . . . 0.0 112.251 -176.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 36' ' ' MET . 92.7 t -125.33 131.29 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.827 177.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -115.43 110.55 19.49 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -133.62 170.18 15.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.067 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.0 t -121.96 142.72 50.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.708 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.62 -168.5 21.71 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.125 -0.559 . . . . 0.0 111.892 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -135.8 -11.92 2.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.178 0.489 . . . . 0.0 111.651 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.63 132.73 20.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.914 0.388 . . . . 0.0 110.567 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.67 171.5 51.79 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.14 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -169.51 155.38 6.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 106' ' ' ASP . 23.3 mm -63.21 126.45 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.982 172.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.599 HD11 ' CD2' ' A' ' 58' ' ' LEU . 5.6 tt -117.74 104.29 49.43 Favored Pre-proline 0 N--CA 1.444 -0.727 0 CA-C-O 121.22 0.533 . . . . 0.0 110.378 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.543 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 24.7 Cg_exo -65.47 108.48 1.21 Allowed 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 123.85 3.034 . . . . 0.0 112.384 172.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -101.49 124.47 55.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.26 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.637 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.5 mt-10 -108.17 127.49 53.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.095 0.474 . . . . 0.0 109.867 175.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.7 t -108.0 119.83 58.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.69 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.528 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 96.8 m-85 -93.24 138.55 31.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.583 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.416 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.9 m-85 -112.25 149.5 32.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.206 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.48 92.25 9.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.372 0.606 . . . . 0.0 109.946 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.539 ' HB3' ' HG3' ' A' ' 99' ' ' ARG . 50.9 t30 -158.13 156.69 31.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.668 -174.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -113.33 8.56 18.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.288 0.566 . . . . 0.0 111.013 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.515 ' HB2' HD21 ' A' ' 94' ' ' ASN . 0.4 OUTLIER -100.59 -152.29 0.42 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.236 -175.929 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.508 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 16.9 mm-40 -33.39 155.04 0.04 OUTLIER Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.133 0.973 . . . . 0.0 112.892 173.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 1.3 Cg_endo -37.88 122.44 0.51 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 124.566 3.511 . . . . 0.0 114.055 -168.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.539 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -95.62 20.18 10.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.412 -174.291 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.75 137.6 26.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.272 0.558 . . . . 0.0 111.01 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.0 OUTLIER -125.93 156.79 36.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.576 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.543 ' HE ' ' HB3' ' A' ' 87' ' ' PRO . 29.3 ttt180 -131.26 115.77 16.74 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.417 0.627 . . . . 0.0 110.8 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.612 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.8 m-85 -107.53 114.31 28.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.048 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.75 102.97 5.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.317 0.579 . . . . 0.0 109.636 176.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -114.08 127.29 55.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.287 0.565 . . . . 0.0 110.662 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.421 ' HA ' HD13 ' A' ' 85' ' ' ILE . 11.8 t70 -80.4 104.47 10.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.931 -177.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.529 HD11 HG11 ' A' ' 37' ' ' VAL . 1.8 mp -82.8 109.34 16.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 174.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.481 ' CE1' HG11 ' A' ' 117' ' ' VAL . 54.4 p90 -124.64 160.55 28.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.444 0.64 . . . . 0.0 111.054 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.3 mt -135.76 156.57 48.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.418 ' O ' ' NE2' ' A' ' 33' ' ' HIS . 55.3 m170 -101.6 171.23 7.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.58 173.2 3.53 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.55 0.614 . . . . 0.0 112.262 -174.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.732 ' HA ' HG21 ' A' ' 22' ' ' VAL . 12.8 mt-10 . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 120.963 0.411 . . . . 0.0 110.888 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 30.1 t . . . . . 0 CA--C 1.513 -0.449 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -133.48 97.77 4.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.964 0.411 . . . . 0.0 110.12 -173.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -125.22 130.37 51.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.774 -173.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.3 mt -118.45 140.74 49.39 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.548 0.53 . . . . 0.0 110.397 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 22.2 ttm180 -131.37 132.34 44.35 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 120.519 0.199 . . . . 0.0 111.203 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 57.3 m -110.13 110.62 21.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.938 0.399 . . . . 0.0 110.708 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 22.5 mm-40 -97.65 159.52 14.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.578 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -120.28 133.59 55.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.213 0.53 . . . . 0.0 111.337 -177.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.826 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.8 mt -107.44 120.4 42.08 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.15 175.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.3 m -110.89 123.18 49.61 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.658 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -120.31 102.42 8.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.893 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -78.98 125.34 29.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.459 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 56.88 63.0 5.63 Favored Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.871 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.496 ' HG3' HG23 ' A' ' 10' ' ' VAL . 71.6 Cg_endo -81.89 165.37 17.57 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.47 2.114 . . . . 0.0 111.675 177.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.45 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 13.4 p -68.1 143.21 55.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 174.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -57.79 -42.24 83.74 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.23 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -63.11 -25.93 68.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.622 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.612 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.3 t80 -73.43 -38.23 65.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.61 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 35.2 ttm180 -56.1 -45.57 79.41 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 173.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -55.06 -38.08 67.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.622 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.503 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 46.5 mtpt -72.35 -41.52 66.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.758 0.313 . . . . 0.0 110.763 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.0 mt -70.65 -32.87 70.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.065 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 50.8 mt -74.97 -33.89 61.95 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -73.97 -28.66 61.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.493 175.776 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.37 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.69 173.76 3.41 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.402 2.068 . . . . 0.0 112.453 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.961 -178.702 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' HA2' ' SD ' ' A' ' 4' ' ' MET . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -63.07 110.11 1.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.749 0.309 . . . . 0.0 111.024 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.1 t60 62.07 22.75 13.33 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.774 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.491 ' SD ' ' HA2' ' A' ' 1' ' ' GLY . 68.3 mtt -93.87 -23.82 17.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.008 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.35 156.09 17.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.626 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t -78.54 76.79 5.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.372 0.606 . . . . 0.0 109.751 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.6 m -126.06 133.63 51.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.907 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.9 m -96.12 113.51 25.12 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.12 139.2 48.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.664 0.269 . . . . 0.0 111.387 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.491 HG23 ' HG3' ' A' ' 130' ' ' PRO . 6.6 t -105.28 142.07 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -123.98 124.13 41.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.869 0.366 . . . . 0.0 110.454 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.834 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -113.73 178.79 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.184 178.067 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 122' ' ' CYS . 16.2 tttp -145.51 135.8 23.98 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.94 151.95 39.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 41.7 tt0 -117.47 124.38 48.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.4 -176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -107.14 118.06 35.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.96 169.9 27.96 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.899 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -164.12 146.21 8.99 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.94 0.4 . . . . 0.0 110.43 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -117.48 134.96 54.27 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 173.795 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -122.94 117.17 24.91 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.933 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -110.54 150.5 28.84 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.703 HG21 ' HA ' ' A' ' 112' ' ' GLU . 1.8 p -103.62 161.6 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.1 mtp180 -110.33 146.86 35.0 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -76.12 -14.26 60.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 109.049 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -141.31 103.97 6.04 Favored Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.047 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.564 ' HG3' HG22 ' A' ' 32' ' ' THR . 82.0 Cg_exo -47.72 156.04 1.34 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.375 2.717 . . . . 0.0 113.049 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -77.7 -170.4 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.379 -173.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 m -61.68 -31.24 50.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.892 0.377 . . . . 0.0 111.297 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -86.43 3.38 44.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.742 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.97 29.38 69.15 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.391 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -89.56 133.93 34.37 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.564 HG22 ' HG3' ' A' ' 26' ' ' PRO . 36.6 p -90.07 -24.22 21.21 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.323 -171.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.469 ' O ' ' HA ' ' A' ' 79' ' ' SER . 63.3 m80 -118.7 150.04 40.41 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -170.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -129.6 119.54 23.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.411 ' HH2' HD22 ' A' ' 58' ' ' LEU . 42.9 p-90 -121.13 146.34 46.85 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.039 0.447 . . . . 0.0 110.676 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.576 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 24.2 ttp -122.85 109.82 14.65 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.482 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.595 HG11 HD11 ' A' ' 107' ' ' LEU . 11.8 m -94.52 150.05 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.463 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.506 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 0.3 OUTLIER -151.8 156.03 39.4 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 7.8 m -122.05 124.95 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.632 168.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 40' ' ' ARG . 3.1 mmp_? -126.63 178.12 6.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.098 -173.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.55 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -96.87 177.93 33.17 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.308 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.605 ' HD2' ' OG ' ' A' ' 45' ' ' SER . 13.0 Cg_exo -63.18 113.8 2.2 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.406 2.071 . . . . 0.0 111.27 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 61.3 46.04 8.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.253 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 65.37 16.4 10.51 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.605 ' OG ' ' HD2' ' A' ' 42' ' ' PRO . 60.6 p -67.87 139.88 56.52 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -68.89 125.29 26.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.55 HG23 ' HA3' ' A' ' 41' ' ' GLY . 3.4 pt -96.74 -0.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -172.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.68 -4.65 4.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -76.07 -34.9 59.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.554 0.216 . . . . 0.0 110.85 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.422 ' CE2' HG22 ' A' ' 47' ' ' ILE . 51.0 p90 -115.71 -17.65 11.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.297 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.539 HG21 HD12 ' A' ' 47' ' ' ILE . 86.8 t -91.92 122.7 43.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.213 0.53 . . . . 0.0 110.095 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 5.7 tp10 -89.21 -58.01 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.592 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 15.4 tttt -152.45 152.72 32.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.743 -175.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 95.4 t -130.82 156.9 43.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.3 p -140.67 138.04 35.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.179 0.514 . . . . 0.0 111.105 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 17.6 m-85 -120.41 110.7 16.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.5 94.35 7.45 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.86 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.549 ' CD2' HD11 ' A' ' 86' ' ' LEU . 9.0 mt -79.38 -177.15 5.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.759 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -80.27 145.38 32.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -56.88 -20.18 21.7 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.38 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 m -67.2 -21.73 65.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.117 0.484 . . . . 0.0 110.829 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -81.81 135.39 48.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.89 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.4 117.96 4.76 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.342 2.028 . . . . 0.0 110.812 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 60.5 80.87 0.25 Allowed Pre-proline 0 C--O 1.226 -0.182 0 O-C-N 123.665 0.603 . . . . 0.0 110.114 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.93 -22.71 64.37 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.615 2.21 . . . . 0.0 113.216 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HE2' ' CG1' ' A' ' 68' ' ' VAL . 78.6 tttt -100.6 109.54 21.63 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.194 0.521 . . . . 0.0 110.855 -176.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 22.5 mmt85 -108.64 104.72 14.08 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.69 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 2.8 m -97.25 136.67 27.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.7 m -120.5 110.76 16.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.024 0.44 . . . . 0.0 110.09 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -99.69 -25.04 14.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.562 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.555 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 8.1 t70 -66.87 173.06 2.76 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.351 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.659 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 60.1 Cg_exo -30.22 -167.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.953 1 C-N-CA 125.322 4.014 . . . . 0.0 115.365 159.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.3 Cg_endo -32.19 121.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 123.408 2.739 . . . . 0.0 114.761 -154.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 31.8 m-85 -65.9 91.73 0.15 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.622 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 0.4 OUTLIER -148.73 148.16 29.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.541 0.686 . . . . 0.0 112.043 -178.451 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 36' ' ' MET . 94.2 t -118.92 129.23 75.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.239 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -117.18 101.6 8.59 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.42 170.55 15.32 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 -174.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 7.4 t -120.87 144.68 48.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.972 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.52 -161.98 12.9 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -138.32 -14.91 1.29 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.335 0.567 . . . . 0.0 112.341 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.446 ' HB3' ' HE3' ' B' ' 218' ' ' ALY . . . -142.25 146.46 35.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.91 0.386 . . . . 0.0 111.158 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.431 ' O ' ' HD2' ' B' ' 217' ' ' ARG . . . -86.08 170.15 42.95 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.52 -0.764 . . . . 0.0 113.045 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -170.58 159.71 6.89 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 122.566 0.346 . . . . 0.0 110.252 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.447 HG12 HH22 ' B' ' 217' ' ' ARG . 14.8 mm -68.24 119.48 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.549 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.8 tt -112.94 105.04 55.98 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.617 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.15 120.6 7.3 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 122.823 2.349 . . . . 0.0 112.299 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.5 mt -108.48 129.47 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.318 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.54 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.7 mt-10 -114.58 122.24 45.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.143 0.497 . . . . 0.0 110.086 176.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.6 t -102.69 123.22 55.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.804 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 93.9 m-85 -95.33 138.94 32.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.641 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -113.13 161.04 17.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -108.09 91.6 3.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.467 0.651 . . . . 0.0 110.543 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.515 ' OD1' ' HB2' ' A' ' 96' ' ' GLU . 15.8 t-20 -159.57 167.7 27.9 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.842 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.588 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -113.58 9.07 17.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.246 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.515 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 3.1 mp0 -99.6 -152.95 0.43 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 14.3 mm-40 -32.43 152.37 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.192 0.997 . . . . 0.0 113.027 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.8 Cg_endo -44.21 117.74 1.43 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.136 3.224 . . . . 0.0 113.499 -168.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -87.45 20.76 2.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.133 -172.388 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.2 139.16 48.24 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.395 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.531 HG21 ' CE2' ' A' ' 103' ' ' PHE . 1.6 m -116.91 156.97 18.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.951 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -130.04 107.04 9.04 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.929 0.395 . . . . 0.0 110.32 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.672 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.5 m-85 -108.18 119.96 40.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.345 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -84.26 114.72 22.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.08 0.467 . . . . 0.0 109.81 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -126.31 133.8 51.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.661 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.3 115.98 26.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.802 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.595 HD11 HG11 ' A' ' 37' ' ' VAL . 2.5 mp -88.82 95.05 10.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -104.92 154.99 19.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.529 . . . . 0.0 111.57 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 mt -137.42 163.63 30.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.986 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.906 ' CD2' ' HA ' ' A' ' 116' ' ' PRO . 31.0 p80 -99.77 167.74 10.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.54 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' B' ' 215' ' ' ALA . 1.0 OUTLIER -68.18 147.04 52.81 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 173.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.703 ' HA ' HG21 ' A' ' 22' ' ' VAL . 4.5 tt0 -54.75 100.81 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.796 0.438 . . . . 0.0 110.349 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.63 30.4 4.34 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.838 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -135.63 153.14 77.32 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.057 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -27.64 127.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 124.155 3.237 . . . . 0.0 114.95 173.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.906 ' HA ' ' CD2' ' A' ' 110' ' ' HIS . 39.6 Cg_endo -66.98 -179.11 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.775 2.984 . . . . 0.0 112.489 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 58.0 t -122.03 126.92 75.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.488 -172.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -138.0 96.71 3.26 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -122.12 125.78 46.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.852 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.1 mt -113.26 150.52 32.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.858 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.7 ttt180 -144.93 142.71 30.08 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 60.9 m -128.88 116.13 18.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.895 0.378 . . . . 0.0 111.193 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -111.64 135.12 52.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.311 -176.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -90.83 136.38 33.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.198 0.523 . . . . 0.0 111.562 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.834 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.0 mt -106.87 124.69 49.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 20.2 m -120.55 124.15 44.64 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.209 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -120.86 112.82 19.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.585 -176.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -85.57 127.9 34.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.007 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 56.75 58.16 8.47 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.493 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HG3' HG23 ' A' ' 10' ' ' VAL . 95.5 Cg_endo -84.51 166.13 12.17 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.455 2.104 . . . . 0.0 111.694 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.1 p -73.21 145.09 46.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.766 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -54.34 -42.37 70.14 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.507 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.511 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.1 p-10 -57.22 -33.04 67.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.651 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 11.0 t80 -75.73 -40.16 56.03 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.621 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 37.2 ttm180 -56.96 -45.29 82.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -56.43 -34.76 67.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.34 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 36.2 mtpt -75.2 -41.33 58.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.812 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.1 mt -69.33 -27.06 65.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 44.0 mt -83.99 -35.69 23.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.318 . . . . 0.0 110.937 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -70.59 -30.49 67.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.732 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.547 -0.74 . . . . 0.0 110.373 176.711 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -149.74 80.71 0.2 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.082 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -149.77 -168.62 3.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.492 ' HA ' HD22 ' A' ' 111' ' ' LEU . . . -59.42 160.23 13.98 Favored Pre-proline 0 C--O 1.235 0.314 0 O-C-N 123.083 0.239 . . . . 0.0 111.121 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.44 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 10.5 Cg_endo -53.7 165.59 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.562 2.175 . . . . 0.0 112.472 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.447 HH22 HG12 ' A' ' 85' ' ' ILE . 6.2 tpt180 -143.11 128.68 19.12 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.86 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 218' ' ' ALY . . . . . 0.446 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.533 ' OE1' ' HA ' ' B' ' 222' ' ' THR . 8.6 pt20 -62.56 153.09 33.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.507 -176.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.43 HD22 ' N ' ' B' ' 220' ' ' LEU . 3.0 mm? -76.99 -29.02 55.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.398 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.409 ' HB1' ' HB3' ' B' ' 224' ' ' ALA . . . -139.17 116.24 11.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.931 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.533 ' HA ' ' OE1' ' B' ' 219' ' ' GLN . 25.6 m -71.6 106.38 4.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.442 -175.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt 58.6 43.26 19.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.687 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' ALA . . . . . 0.409 ' HB3' ' HB1' ' B' ' 221' ' ' ALA . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.978 -0.534 . . . . 0.0 110.222 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 m -80.6 124.7 29.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.898 0.38 . . . . 0.0 110.485 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -85.72 38.84 0.77 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.303 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.6 ttm -83.34 -24.56 32.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.965 0.412 . . . . 0.0 110.144 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.22 -53.19 11.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.199 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.6 p -86.22 76.76 9.68 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 t -107.26 110.02 21.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.307 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.6 t -158.16 117.17 3.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.87 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.66 128.19 56.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.852 0.358 . . . . 0.0 111.447 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.413 HG23 ' HG3' ' A' ' 130' ' ' PRO . 9.6 t -100.17 138.85 23.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 6.4 mp0 -125.7 119.86 29.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.936 0.398 . . . . 0.0 110.443 -174.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.808 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.56 -179.74 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.888 178.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 36.0 ttpt -151.31 123.28 8.13 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.849 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.443 ' HG ' HD11 ' A' ' 125' ' ' LEU . 84.8 mt -106.66 145.57 31.81 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.313 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 3.5 tt0 -105.01 126.55 52.19 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.144 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.657 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -112.54 114.52 27.21 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -140.9 171.05 24.28 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.842 -1.171 . . . . 0.0 111.728 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -162.97 146.01 10.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.512 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -118.81 132.03 56.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.709 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.631 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -130.56 131.35 44.98 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.468 0.651 . . . . 0.0 111.271 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 3.8 tt0 -129.6 155.08 46.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.229 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.899 HG11 ' H ' ' A' ' 113' ' ' GLY . 2.8 p -101.85 153.45 5.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 23' ' ' ARG . 1.1 mtp180 -102.57 135.48 44.12 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 20.3 tptt -75.75 -5.54 46.25 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.613 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -133.87 99.78 13.68 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.079 168.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.483 ' HG3' HG22 ' A' ' 32' ' ' THR . 83.1 Cg_exo -50.98 156.57 4.69 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.02 2.48 . . . . 0.0 111.868 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 31' ' ' PHE . 10.2 t -78.79 -172.67 3.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.091 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 m -60.09 -31.66 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.928 0.394 . . . . 0.0 111.237 -174.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -86.73 4.29 41.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.11 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.42 32.5 68.13 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.253 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.459 ' HB2' HG22 ' A' ' 27' ' ' THR . 17.7 m-30 -90.72 127.19 36.23 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.483 HG22 ' HG3' ' A' ' 26' ' ' PRO . 36.1 p -87.52 -29.91 20.98 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -170.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 79' ' ' SER . 67.1 m80 -115.47 142.29 46.91 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -112.27 123.83 51.12 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.445 ' CZ2' ' HB3' ' A' ' 78' ' ' GLU . 54.2 p-90 -127.6 147.27 50.35 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.135 0.493 . . . . 0.0 110.889 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.638 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 51.7 ttp -123.6 122.64 38.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.459 174.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.57 ' CG2' ' HB ' ' A' ' 76' ' ' VAL . 10.2 m -102.5 152.21 5.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.588 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -153.27 152.04 30.71 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.951 -0.7 . . . . 0.0 112.812 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.0 m -122.76 125.99 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.703 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -134.65 -178.92 5.29 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.221 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.502 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -94.02 -173.84 39.22 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 175.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 1.4 Cg_endo -81.57 111.37 2.3 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.235 1.957 . . . . 0.0 112.693 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 58.7 70.18 0.67 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 71.74 -11.12 0.77 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.26 0.624 . . . . 0.0 112.344 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.5 ' HB3' ' OXT' ' A' ' 141' ' ' ALA . 19.9 m -66.92 120.67 13.98 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -69.86 127.16 31.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 120.881 0.372 . . . . 0.0 110.271 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.556 HD12 HG21 ' A' ' 51' ' ' VAL . 1.2 pt -90.5 -3.47 10.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.569 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -65.74 -0.87 2.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.891 0.377 . . . . 0.0 111.552 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -74.29 -39.87 62.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.221 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.407 ' CE2' HG22 ' A' ' 47' ' ' ILE . 53.5 p90 -113.61 -20.27 11.28 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.94 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.556 HG21 HD12 ' A' ' 47' ' ' ILE . 52.5 t -93.38 135.77 27.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.781 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 93' ' ' LYS . 8.4 tp10 -111.91 -60.87 1.79 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.172 0.511 . . . . 0.0 110.711 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.665 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 6.7 tttm -138.24 146.92 43.16 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.253 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 98.1 t -127.01 159.21 37.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.566 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.8 p -141.85 136.2 30.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.299 0.571 . . . . 0.0 111.574 -174.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.483 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 22.0 m-85 -119.06 105.6 11.58 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -77.53 87.92 3.86 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.015 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.5 mt -71.38 -176.46 1.52 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.825 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -76.32 140.29 41.41 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -59.39 -19.55 47.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.021 -174.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -58.94 -27.27 65.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.743 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -85.47 131.64 47.24 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.084 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.95 121.5 10.12 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.668 2.246 . . . . 0.0 111.554 175.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 64' ' ' ARG . 16.5 mtm180 55.79 67.24 3.06 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.512 -176.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.36 -17.46 60.18 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.189 2.592 . . . . 0.0 113.52 -172.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -86.23 101.62 13.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.141 0.496 . . . . 0.0 110.228 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 22.0 mmt180 -98.42 107.83 20.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.68 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -99.05 136.19 31.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.1 m -120.6 113.56 20.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.295 0.569 . . . . 0.0 110.316 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -102.75 -24.55 13.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.614 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.527 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 13.8 t70 -68.0 170.12 8.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.623 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.639 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.2 Cg_exo -32.71 -178.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.568 1 C-N-CA 125.346 4.031 . . . . 0.0 114.865 164.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.639 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.7 Cg_endo -28.29 119.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 124.292 3.328 . . . . 0.0 113.942 -157.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.588 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 51.2 m-85 -60.1 98.66 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.59 -171.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.638 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 10.7 ptpt -140.18 150.42 44.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.438 0.637 . . . . 0.0 112.171 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 36' ' ' MET . 81.1 t -126.87 130.83 71.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.604 175.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.81 109.88 18.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.835 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 35' ' ' TRP . 1.9 tp10 -135.31 174.45 10.59 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -177.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.3 t -128.45 143.8 51.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.2 -170.62 26.09 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.884 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -130.36 -11.42 4.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.263 0.531 . . . . 0.0 112.066 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.515 ' HB3' ' HE3' ' B' ' 218' ' ' ALY . . . -148.84 139.3 22.55 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.434 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.518 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -75.5 176.45 50.37 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.355 -0.838 . . . . 0.0 113.361 -176.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -172.41 158.29 4.28 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.44 HG12 HD21 ' B' ' 220' ' ' LEU . 23.2 mm -65.44 126.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.329 . . . . 0.0 110.522 173.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.512 HD22 HG13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -111.23 104.64 56.4 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.495 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.86 111.14 2.96 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.708 2.272 . . . . 0.0 111.826 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.512 HG13 HD22 ' A' ' 86' ' ' LEU . 4.9 mt -104.43 125.69 59.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.43 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.566 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 54.4 mt-10 -111.45 123.64 50.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.171 0.51 . . . . 0.0 110.039 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 72.4 t -103.79 122.42 56.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.112 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.665 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 75.7 m-85 -94.63 132.42 39.38 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 112.005 -176.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.499 ' HE1' HG22 ' A' ' 51' ' ' VAL . 18.9 m-85 -114.38 164.07 14.44 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.079 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.462 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -107.9 100.48 9.84 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 122.327 -0.233 . . . . 0.0 111.479 175.661 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -158.28 178.18 10.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.742 171.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.52 -1.11 15.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.756 -178.338 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -100.62 -153.12 0.44 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.092 -176.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -29.56 152.74 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.395 1.078 . . . . 0.0 113.907 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -32.89 122.46 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 125.03 3.82 . . . . 0.0 114.2 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.9 19.5 2.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.697 -176.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -150.09 144.56 25.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.276 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.13 157.21 28.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 102' ' ' ARG . 11.6 ttt180 -129.08 108.69 10.58 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.8 m-85 -104.66 120.44 41.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.189 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.83 111.61 19.36 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -124.94 127.28 46.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.317 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -78.82 121.81 25.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.952 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.528 HD11 ' CG1' ' A' ' 37' ' ' VAL . 1.5 mp -94.53 91.66 6.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.538 ' CE2' HG13 ' A' ' 117' ' ' VAL . 37.8 p90 -100.11 160.14 14.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.04 0.448 . . . . 0.0 110.845 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.9 mt -134.26 155.9 49.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.406 ' O ' ' NE2' ' A' ' 33' ' ' HIS . 1.4 m-70 -101.05 175.53 5.57 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 122.329 -0.232 . . . . 0.0 111.043 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.89 139.01 58.24 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.665 ' HA ' HG21 ' A' ' 22' ' ' VAL . 1.5 tm-20 -50.74 117.9 2.77 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.898 173.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.899 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 122.68 -50.23 0.85 Allowed Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.633 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -144.22 75.43 15.4 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 117.293 0.546 . . . . 0.0 110.615 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.563 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 60.8 Cg_endo -108.35 109.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 123.185 2.59 . . . . 0.0 114.004 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -98.25 97.88 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.31 2.007 . . . . 0.0 111.016 166.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.631 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 4.7 t -119.17 102.54 13.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.9 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -141.93 97.98 3.24 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -122.45 130.75 53.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.04 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.8 mt -114.83 155.58 26.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.379 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 23.2 ttm180 -144.9 145.45 31.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 61.3 m -127.56 110.37 12.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.02 0.438 . . . . 0.0 110.768 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.438 ' HG3' HD23 ' A' ' 16' ' ' LEU . 2.5 mm-40 -107.21 125.84 51.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.27 -174.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -81.9 135.49 35.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.194 0.521 . . . . 0.0 111.431 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.808 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.2 mt -103.38 114.8 29.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.4 m -107.15 115.64 30.53 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.989 0.423 . . . . 0.0 110.902 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -115.39 106.22 13.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.036 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -81.6 118.52 22.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.82 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 62.43 67.51 1.17 Allowed Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.147 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.413 ' HG3' HG23 ' A' ' 10' ' ' VAL . 60.7 Cg_endo -89.81 175.47 3.07 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.093 2.528 . . . . 0.0 111.881 174.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.3 p -84.31 147.05 27.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.41 -42.15 63.81 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.173 0.442 . . . . 0.0 112.147 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 6.4 p-10 -56.36 -32.02 64.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.796 0.332 . . . . 0.0 110.29 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.708 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.8 t80 -76.96 -42.74 37.86 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.677 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 38.0 ttm180 -54.74 -46.27 74.27 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -52.4 -42.8 64.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.381 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 36.1 mtpt -73.31 -38.98 65.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.853 0.358 . . . . 0.0 110.896 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 36.7 mt -70.02 -26.26 63.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.986 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.2 mt -83.58 -32.84 25.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 110.923 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -75.77 -26.38 57.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.308 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.5 ' OXT' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.466 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 112.069 -0.413 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -109.74 -30.6 3.44 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.137 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -83.65 123.84 30.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.76 0.314 . . . . 0.0 110.645 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.444 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -67.5 164.33 39.3 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.296 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.444 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 5.0 Cg_endo -48.82 161.55 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.687 2.258 . . . . 0.0 112.551 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.518 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 5.1 tpp180 -142.04 129.87 21.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.05 -174.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 218' ' ' ALY . . . . . 0.515 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' B' ' 218' ' ' ALY . 61.1 tt0 71.51 -56.8 0.63 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.753 0.658 . . . . 0.0 111.048 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.44 HD21 HG12 ' A' ' 85' ' ' ILE . 6.4 mp -92.26 113.59 25.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.851 0.357 . . . . 0.0 110.435 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.84 -67.26 0.82 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.9 m 54.98 44.0 28.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.312 0.577 . . . . 0.0 111.26 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.41 -1.09 31.46 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.465 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.21 179.551 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.1 m -81.01 -23.14 38.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.967 0.413 . . . . 0.0 110.482 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -92.98 78.82 4.63 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.3 mtp -87.99 15.38 7.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.715 -175.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.61 -14.72 62.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.279 0.561 . . . . 0.0 109.962 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.3 m -97.87 136.09 38.68 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.926 176.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.7 m -66.38 110.23 3.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.566 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.1 p -86.67 112.57 21.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.18 0.514 . . . . 0.0 110.809 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.47 135.34 53.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.269 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.475 HG23 ' HG3' ' A' ' 130' ' ' PRO . 3.2 t -105.28 138.23 31.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -124.96 127.4 46.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -176.412 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.826 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -115.17 164.65 11.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.273 178.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 37.8 mttp -129.23 131.51 47.08 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.411 HD13 HG11 ' A' ' 90' ' ' VAL . 90.4 mt -115.1 140.23 49.24 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.248 0.547 . . . . 0.0 109.786 174.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.5 tt0 -106.33 121.34 44.02 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.873 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.581 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -106.01 112.17 25.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -137.32 166.59 24.96 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.656 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -163.53 149.69 11.72 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.163 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.9 mtt180 -115.21 140.76 48.81 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.694 174.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.652 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -126.84 120.71 29.91 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.511 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -114.18 148.3 37.52 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 112' ' ' GLU . 2.4 p -103.39 161.21 4.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 171.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 23' ' ' ARG . 3.0 mtp180 -116.15 134.67 54.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -68.92 -12.85 62.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.434 0.635 . . . . 0.0 109.679 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -134.89 102.17 11.27 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.162 171.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.518 ' HG3' HG22 ' A' ' 32' ' ' THR . 98.4 Cg_exo -49.28 154.79 3.58 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.021 2.48 . . . . 0.0 112.054 175.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -78.23 -174.06 3.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.852 -170.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.523 HG22 ' OE1' ' A' ' 29' ' ' GLU . 1.9 m -66.31 -30.83 51.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.207 0.527 . . . . 0.0 110.48 -175.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.523 ' OE1' HG22 ' A' ' 28' ' ' VAL . 3.0 mp0 -76.24 -6.65 52.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.471 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.08 34.29 38.07 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.478 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -102.56 136.54 42.2 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.518 HG22 ' HG3' ' A' ' 26' ' ' PRO . 47.4 p -92.78 -24.12 18.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.422 -169.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.435 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.0 m80 -121.11 144.63 48.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -171.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -119.15 125.45 49.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.1 p-90 -126.49 147.32 49.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.036 0.446 . . . . 0.0 110.834 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.57 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.2 ttp -125.53 115.24 19.9 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.759 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.578 HG11 HD11 ' A' ' 107' ' ' LEU . 14.2 m -97.32 150.0 4.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.817 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.2 p90 -150.98 155.8 39.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.3 m -126.05 129.03 72.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.343 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 40' ' ' ARG . 10.1 mmm180 -135.42 -176.9 4.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.332 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.496 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -89.38 -163.57 39.46 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.642 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 3.9 Cg_exo -71.91 109.85 2.77 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.17 1.913 . . . . 0.0 111.64 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 44' ' ' HIS . 28.9 mt-10 52.29 68.66 0.78 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.342 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 22.2 m170 75.51 -6.76 1.91 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.455 0.702 . . . . 0.0 112.764 172.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.555 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 72.5 m -61.2 136.05 57.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.467 0.175 . . . . 0.0 111.311 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -73.44 126.68 30.74 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.598 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.5 pt -97.27 -4.61 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -64.0 -0.43 1.13 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -77.66 -34.98 52.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.521 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.479 ' CE2' HG22 ' A' ' 47' ' ' ILE . 50.0 p90 -121.05 -16.88 7.94 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.727 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.598 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 77.8 t -94.26 126.02 46.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 9.5 tp10 -96.63 -57.88 2.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.444 0.64 . . . . 0.0 111.026 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 24.6 tttt -145.7 150.74 36.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.286 -175.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 88.9 t -131.28 158.1 43.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.435 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.597 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.2 p -141.71 138.42 31.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.266 0.555 . . . . 0.0 111.287 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 18.1 m-85 -120.95 110.35 16.18 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -82.53 95.88 7.87 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.957 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.4 mt -78.17 -178.8 5.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.815 0.34 . . . . 0.0 110.151 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.45 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 18.9 t60 -85.43 151.2 24.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 1.6 mp0 -51.87 -28.33 15.7 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.797 -169.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 t -79.0 -6.2 55.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.867 0.365 . . . . 0.0 111.273 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -90.36 134.89 30.33 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.57 136.48 30.95 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.282 1.988 . . . . 0.0 109.727 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 61.64 73.8 0.55 Allowed Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -172.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.47 -18.73 60.41 Favored 'Trans proline' 0 C--O 1.223 -0.233 0 C-N-CA 121.887 1.725 . . . . 0.0 112.656 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -110.37 106.76 16.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.678 0.275 . . . . 0.0 110.598 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.3 mmt85 -104.41 100.0 9.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.769 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -89.54 137.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.578 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.564 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 36.0 t -128.1 116.81 20.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.096 0.474 . . . . 0.0 110.116 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -106.55 -27.26 10.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.124 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.665 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -71.42 -177.3 0.46 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.571 -175.166 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.665 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 13.5 Cg_exo -31.17 178.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 125.17 3.913 . . . . 0.0 114.862 163.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.63 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.8 Cg_exo -26.32 121.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 124.797 3.665 . . . . 0.0 114.972 -157.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.564 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 34.2 m-85 -62.21 91.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.958 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.39 151.64 39.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.611 0.719 . . . . 0.0 112.676 179.298 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 36' ' ' MET . 93.8 t -123.47 129.14 74.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.631 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -114.38 112.99 23.93 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.35 173.31 11.61 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.839 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 3.2 t -121.11 145.93 47.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.139 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.16 -157.96 9.48 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -144.51 -17.48 0.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.82 140.75 31.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.999 0.428 . . . . 0.0 111.116 -176.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.89 169.81 55.03 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.773 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 59' ' ' HIS . 11.6 p90 -169.93 158.09 7.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.767 0.427 . . . . 0.0 110.059 -176.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.5 mm -67.18 126.14 26.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.609 0.243 . . . . 0.0 110.596 172.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.532 HD22 HG13 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -111.78 104.96 56.54 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.521 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.77 112.99 3.23 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.781 2.321 . . . . 0.0 112.088 171.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.532 HG13 HD22 ' A' ' 86' ' ' LEU . 6.3 mt -106.6 128.79 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.309 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.597 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 45.9 mt-10 -112.81 123.59 50.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.22 0.534 . . . . 0.0 109.964 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.411 HG11 HD13 ' A' ' 14' ' ' LEU . 57.5 t -104.84 118.88 52.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.747 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.588 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 89.3 m-85 -90.79 139.81 30.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.157 0.503 . . . . 0.0 111.245 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.418 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.0 m-85 -113.07 165.1 12.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.573 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -118.58 93.95 4.29 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.995 0.426 . . . . 0.0 112.001 -177.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.524 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 0.7 OUTLIER -160.48 -172.53 3.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.031 174.247 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 20.7 tptp -110.35 0.4 17.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.472 0.653 . . . . 0.0 111.23 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.409 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 6.5 mp0 -100.08 -155.71 0.52 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 -171.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.409 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 13.2 mm-40 -32.5 149.48 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.419 1.088 . . . . 0.0 113.536 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -30.22 125.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 125.205 3.936 . . . . 0.0 115.076 -164.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.524 ' HD3' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -82.01 18.96 1.21 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.83 -178.536 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -154.45 140.28 18.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.198 0.523 . . . . 0.0 110.941 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -120.31 157.35 22.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -128.25 107.64 9.94 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.657 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.581 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.6 m-85 -103.07 123.94 47.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.217 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -88.13 101.23 13.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.357 0.598 . . . . 0.0 110.147 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -110.18 132.27 54.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.769 -175.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.16 118.37 21.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.06 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.578 HD11 HG11 ' A' ' 37' ' ' VAL . 1.2 mp -95.2 91.29 6.22 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 175.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -102.22 156.88 17.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.219 0.533 . . . . 0.0 111.278 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 mt -134.47 163.9 28.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.2 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.806 ' CD2' ' HA ' ' A' ' 116' ' ' PRO . 8.4 p80 -99.67 164.16 12.18 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.22 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.46 153.78 26.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.939 0.399 . . . . 0.0 111.145 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.713 ' HA ' HG21 ' A' ' 22' ' ' VAL . 8.7 tt0 -63.37 98.93 0.17 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.308 175.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.0 28.91 6.67 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.843 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.485 ' CG ' ' HD2' ' A' ' 115' ' ' PRO . 49.8 t60 -136.23 148.72 65.56 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-O 118.348 -0.834 . . . . 0.0 108.788 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 114' ' ' HIS . 1.1 Cg_exo -24.49 113.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 124.684 3.589 . . . . 0.0 115.194 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.806 ' HA ' ' CD2' ' A' ' 110' ' ' HIS . 50.3 Cg_exo -55.48 -179.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 124.047 3.164 . . . . 0.0 114.51 175.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 69.0 t -122.47 130.17 74.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.992 -172.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -144.93 96.58 2.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -119.9 129.84 54.55 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.163 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.7 mt -108.11 149.34 28.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.547 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 15.6 ttt180 -140.73 137.93 33.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 85.8 m -120.09 116.58 25.97 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.157 0.504 . . . . 0.0 111.214 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 9.8 mm-40 -105.98 158.93 16.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.309 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -124.98 123.88 40.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.148 0.499 . . . . 0.0 111.387 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.826 ' HB2' HG23 ' A' ' 12' ' ' VAL . 5.9 mt -98.31 122.04 40.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.797 176.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.0 m -113.84 122.4 46.93 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.922 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -120.9 107.66 12.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.447 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -83.24 124.32 30.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.125 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 51.72 67.71 3.89 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.337 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.475 ' HG3' HG23 ' A' ' 10' ' ' VAL . 83.4 Cg_endo -86.57 -179.27 2.97 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.947 2.431 . . . . 0.0 112.003 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 69.6 p -79.12 140.37 37.83 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -58.81 -33.19 70.09 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.2 p-10 -65.31 -30.97 71.88 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.631 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 18.7 t80 -74.3 -42.32 59.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.587 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.6 ttm180 -54.19 -45.51 72.17 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.929 173.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -55.23 -39.45 69.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.333 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 40.8 mtpt -69.95 -39.97 75.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.93 0.395 . . . . 0.0 110.421 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 41.7 mt -69.53 -31.77 70.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.72 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.6 mt -80.91 -31.39 35.13 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.188 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -76.99 -26.71 54.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.134 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.358 175.419 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 112.101 -0.4 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.55 -86.2 1.52 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.047 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -74.79 127.25 32.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.041 0.448 . . . . 0.0 110.836 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -63.6 165.37 12.14 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.888 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 10.0 Cg_endo -51.9 176.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.974 2.449 . . . . 0.0 112.96 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -142.87 143.77 32.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.717 -172.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -137.25 -52.1 0.66 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.269 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 26.5 tp 58.77 62.43 1.91 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.62 0.724 . . . . 0.0 110.648 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -82.51 74.48 9.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.739 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 11.3 t -143.17 17.44 1.91 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.77 0.795 . . . . 0.0 109.711 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -109.99 38.74 2.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.439 -176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.147 179.335 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -85.4 112.9 21.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.879 0.371 . . . . 0.0 110.105 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -141.33 30.04 1.77 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.182 0.515 . . . . 0.0 110.639 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -76.48 -13.86 60.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.521 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.84 -9.55 51.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.58 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.4 t -92.06 92.43 8.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.186 0.517 . . . . 0.0 109.957 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 m -82.49 109.25 16.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.91 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 56.5 m -93.79 110.63 22.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.902 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.82 140.84 32.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.943 0.402 . . . . 0.0 111.861 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.421 HG23 ' HG3' ' A' ' 130' ' ' PRO . 4.3 t -109.7 140.32 29.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 172.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 4.5 mp0 -128.57 118.75 23.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.874 0.369 . . . . 0.0 110.168 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.874 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -107.03 170.21 2.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.174 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HE3' ' HB3' ' A' ' 42' ' ' PRO . 54.9 mtmt -137.07 133.86 35.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.739 0.304 . . . . 0.0 110.467 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.3 mt -114.66 142.16 46.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.002 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.1 tt0 -103.48 123.48 46.98 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.712 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.651 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.1 mm? -110.56 113.32 25.85 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -142.19 175.52 22.7 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.896 -1.145 . . . . 0.0 111.981 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -167.1 151.67 7.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.06 0.457 . . . . 0.0 110.859 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 80.9 mtt180 -116.5 151.84 35.3 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.946 171.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -144.28 134.4 24.18 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.419 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -132.6 160.73 35.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.214 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.947 HG11 ' H ' ' A' ' 113' ' ' GLY . 1.8 p -103.75 161.11 4.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 170.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.476 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 5.5 mtp85 -104.81 143.09 33.61 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -66.37 -19.05 65.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.59 0.709 . . . . 0.0 109.254 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -134.13 106.37 11.34 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.294 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.562 ' HG3' HG22 ' A' ' 32' ' ' THR . 99.0 Cg_exo -50.39 163.76 0.61 Allowed 'Trans proline' 0 N--CA 1.474 0.372 0 C-N-CA 123.109 2.539 . . . . 0.0 112.475 174.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 31' ' ' PHE . 8.9 t -82.88 -175.7 5.94 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.468 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.05 -30.96 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.782 0.325 . . . . 0.0 111.309 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -82.78 -0.28 47.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.037 0.446 . . . . 0.0 110.701 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.81 33.96 49.7 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.476 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.404 ' HB2' HG22 ' A' ' 27' ' ' THR . 20.3 m-30 -95.57 130.71 42.34 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 176.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.562 HG22 ' HG3' ' A' ' 26' ' ' PRO . 28.8 p -90.34 -30.98 17.1 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -170.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.458 ' O ' ' HA ' ' A' ' 79' ' ' SER . 62.7 m80 -112.19 146.21 38.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -170.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.476 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 6.1 m-20 -124.14 121.27 34.69 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.481 ' HH2' HD22 ' A' ' 58' ' ' LEU . 49.2 p-90 -122.52 150.22 42.85 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.645 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 46.0 ttp -125.59 118.06 24.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.612 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.9 m -100.02 150.15 5.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.263 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -151.13 154.69 37.43 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.6 m -124.15 127.97 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.833 170.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -132.08 -179.11 5.22 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.316 -174.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.5 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -97.11 -176.15 34.76 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.26 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.468 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 12.0 Cg_exo -68.8 111.7 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.768 2.312 . . . . 0.0 112.234 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 58.19 54.2 6.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.624 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 71.22 1.53 3.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.58 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 141' ' ' ALA . 49.7 m -63.11 128.23 34.89 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -68.96 128.22 35.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.042 0.449 . . . . 0.0 110.35 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.581 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.4 pt -94.66 -1.49 10.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.376 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -59.66 -3.69 0.53 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.534 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 93.2 m-70 -82.27 -31.98 29.82 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.143 -0.348 . . . . 0.0 111.471 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.461 ' CE1' HG22 ' A' ' 47' ' ' ILE . 54.2 p90 -119.66 -20.03 7.84 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.413 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.581 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 65.8 t -90.54 131.32 38.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 9.0 tp10 -102.62 -60.24 1.57 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.434 0.635 . . . . 0.0 110.262 -176.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 20.6 tttt -144.61 149.95 36.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.135 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG21 HG21 ' A' ' 39' ' ' VAL . 94.6 t -128.55 157.69 41.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.58 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 9.1 p -141.41 133.39 28.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.299 0.571 . . . . 0.0 111.054 -174.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.474 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 30.5 m-85 -117.02 109.04 16.48 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -80.62 91.93 5.9 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.915 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.54 ' CD2' HD11 ' A' ' 86' ' ' LEU . 11.0 mt -73.93 -176.96 2.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.999 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -77.34 147.53 36.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -56.14 -19.35 13.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.931 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.05 -24.99 65.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.108 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -81.65 137.56 47.67 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.645 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.73 118.03 5.14 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.462 2.108 . . . . 0.0 111.326 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 58.19 68.38 1.85 Allowed Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.521 0.513 . . . . 0.0 110.431 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.54 -18.48 63.73 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.845 2.363 . . . . 0.0 113.391 -174.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -88.94 101.25 13.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.185 0.517 . . . . 0.0 110.13 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 18.7 mmt180 -97.71 98.35 9.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.345 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -83.49 136.34 22.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.599 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.8 m -131.41 109.01 10.01 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -106.18 -24.24 12.38 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.63 0.728 . . . . 0.0 110.336 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.678 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 2.7 t70 -70.41 179.9 0.77 Allowed Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.319 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.678 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 16.6 Cg_exo -31.13 178.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 125.245 3.963 . . . . 0.0 114.489 163.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.605 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.3 Cg_endo -29.64 124.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 124.332 3.355 . . . . 0.0 114.442 -154.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 36.7 m-85 -61.87 93.94 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.901 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -146.14 145.53 30.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.264 0.554 . . . . 0.0 111.889 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.0 t -125.19 131.6 72.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.059 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -115.97 110.37 18.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.752 0.311 . . . . 0.0 110.196 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -130.18 165.44 22.34 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.933 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 2.1 m -116.12 129.65 56.43 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.979 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.42 -160.7 9.17 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -136.37 -20.04 1.42 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.291 0.546 . . . . 0.0 111.451 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.481 ' HB3' ' HE3' ' B' ' 218' ' ' ALY . . . -139.7 142.99 36.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.853 0.359 . . . . 0.0 110.974 -174.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -78.88 174.55 55.25 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.58 -177.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -173.13 159.41 3.89 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.963 0.505 . . . . 0.0 110.131 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 106' ' ' ASP . 14.3 mm -68.07 125.5 25.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 172.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.54 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.1 tt -117.72 105.55 47.59 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.994 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.99 114.07 3.25 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 123.227 2.618 . . . . 0.0 112.231 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.438 HG12 ' CD2' ' A' ' 56' ' ' PHE . 5.0 mt -104.6 126.37 59.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.09 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.58 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.2 mt-10 -112.53 124.34 52.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.238 0.542 . . . . 0.0 110.124 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.7 t -103.72 120.44 53.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.772 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.59 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 74.5 m-85 -90.06 139.1 30.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.967 0.413 . . . . 0.0 110.346 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.435 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.7 m-85 -111.36 146.32 37.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.8 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -84.2 93.93 8.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.428 ' CG ' ' H ' ' A' ' 96' ' ' GLU . 62.4 t30 -155.98 159.33 39.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.372 0.606 . . . . 0.0 112.124 -171.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.76 -4.0 14.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.734 175.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.527 ' HG2' ' CG2' ' A' ' 131' ' ' THR . 0.4 OUTLIER -100.29 -153.92 0.46 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.42 -177.393 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 20.6 mm-40 -27.07 150.19 0.02 OUTLIER Pre-proline 0 N--CA 1.48 1.03 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 3.0 Cg_exo -32.5 126.43 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.189 1 C-N-CA 125.316 4.011 . . . . 0.0 114.465 -167.139 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -85.7 19.5 2.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.246 -176.256 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.52 143.45 22.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.286 0.565 . . . . 0.0 111.159 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -126.93 154.79 37.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.506 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -121.18 121.85 38.7 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.001 0.429 . . . . 0.0 111.073 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.651 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.9 m-85 -113.86 117.7 32.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.923 174.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.61 111.89 15.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.188 0.518 . . . . 0.0 109.761 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -121.4 136.17 54.99 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.553 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.44 ' HA ' HD13 ' A' ' 85' ' ' ILE . 11.7 t70 -89.35 110.6 21.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.62 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.504 HD11 HG11 ' A' ' 37' ' ' VAL . 1.5 mp -89.36 97.63 11.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.745 0.307 . . . . 0.0 110.199 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -104.33 155.65 18.58 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.014 0.435 . . . . 0.0 110.769 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.2 mt -130.76 152.46 50.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -101.82 168.82 9.19 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.875 -0.515 . . . . 0.0 111.191 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -53.61 134.81 41.25 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -172.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.579 ' HA ' HG21 ' A' ' 22' ' ' VAL . 35.5 tt0 -49.48 118.43 2.75 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.221 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.947 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 123.75 -50.38 0.85 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.458 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -144.77 74.44 14.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 117.46 0.63 . . . . 0.0 111.791 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.495 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 58.1 Cg_endo -108.99 109.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.983 2.456 . . . . 0.0 113.864 176.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -98.17 97.54 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.967 2.445 . . . . 0.0 111.093 168.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 37.5 t -117.14 112.19 38.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.719 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.491 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -145.9 108.26 4.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.557 174.099 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.478 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.8 t-80 -127.22 135.25 50.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.657 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 119' ' ' HIS . 8.1 mt -118.03 147.36 43.31 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.497 0.498 . . . . 0.0 110.326 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.3 ttm180 -137.04 148.74 47.0 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.437 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 61.6 m -130.7 120.23 23.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.598 0.237 . . . . 0.0 110.39 175.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -118.47 143.63 46.57 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -100.94 136.54 40.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.259 0.552 . . . . 0.0 112.055 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.874 ' HB2' HG23 ' A' ' 12' ' ' VAL . 4.9 mt -104.42 115.2 29.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.814 174.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 34.4 m -105.13 116.77 32.52 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.062 0.458 . . . . 0.0 110.687 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -113.83 106.44 14.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.049 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -78.79 118.14 20.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.398 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.2 t30 52.14 63.03 9.69 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.397 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.421 ' HG3' HG23 ' A' ' 10' ' ' VAL . 88.5 Cg_endo -80.25 -179.24 5.07 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.771 2.314 . . . . 0.0 112.395 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.527 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 3.5 p -72.75 139.74 47.32 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 173.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -56.95 -39.42 74.51 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.534 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 6.9 p-10 -63.33 -28.66 70.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.666 0.27 . . . . 0.0 110.343 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.635 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 14.8 t80 -75.57 -42.16 52.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.628 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 44.5 ttm105 -53.36 -45.97 69.39 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.099 0.476 . . . . 0.0 109.816 173.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -52.93 -41.12 64.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.381 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 38.8 mtpt -72.36 -39.6 67.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.618 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.9 mt -68.58 -30.59 69.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.909 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 36.1 mt -80.67 -35.68 33.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.163 -177.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -75.28 -30.09 60.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.78 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.749 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.42 0 N-CA-C 111.769 -0.532 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . 99.85 -50.48 1.12 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.908 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -85.83 129.15 34.91 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.775 0.321 . . . . 0.0 110.158 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -67.26 164.81 33.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.852 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.46 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 9.4 Cg_endo -51.87 162.97 1.52 Allowed 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 122.407 2.071 . . . . 0.0 112.063 174.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 26.8 ttt180 -142.03 144.02 33.42 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.663 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 218' ' ' ALY . . . . . 0.481 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -84.52 46.45 1.24 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.46 0.648 . . . . 0.0 110.182 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 54.4 tp -76.74 79.4 3.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.659 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -161.35 97.74 1.12 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.753 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 6.2 p -59.98 114.27 2.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.864 -177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -131.76 45.22 2.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.675 0.75 . . . . 0.0 109.058 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.887 -178.722 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -78.46 127.09 31.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -94.48 75.65 3.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.171 0.51 . . . . 0.0 110.147 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.9 tpt -99.04 -17.14 18.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.092 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.21 -32.61 66.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.696 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.1 p -91.76 76.81 5.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.158 0.504 . . . . 0.0 110.165 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.638 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 13.0 m -78.61 130.17 35.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.65 -176.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 40.6 t -153.53 125.38 7.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.282 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.68 130.45 51.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.754 0.311 . . . . 0.0 111.276 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.44 HG23 ' HG3' ' A' ' 130' ' ' PRO . 5.1 t -104.2 141.25 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 4.7 mp0 -128.76 130.26 46.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.899 0.38 . . . . 0.0 110.177 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.832 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -116.32 165.65 11.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.252 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 67.1 mttm -128.5 133.67 48.52 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.37 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.451 HD22 HD13 ' A' ' 47' ' ' ILE . 82.2 mt -115.6 141.19 48.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.722 175.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.9 tt0 -104.33 129.98 52.18 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.862 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.628 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -114.99 112.44 22.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -138.09 170.1 23.94 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.956 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -164.2 151.63 12.06 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.881 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 67.8 mtt180 -116.87 143.09 46.1 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.727 174.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -139.21 131.26 27.95 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.532 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -133.94 163.69 28.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.898 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.88 HG11 ' H ' ' A' ' 113' ' ' GLY . 1.9 p -103.37 158.27 4.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 32' ' ' THR . 3.7 mtp180 -102.76 142.92 33.1 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -70.53 -13.36 62.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.663 0.744 . . . . 0.0 109.434 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -142.96 104.63 5.23 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.052 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.6 Cg_exo -47.81 152.91 2.71 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.059 2.506 . . . . 0.0 112.243 174.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.405 HG22 ' HB2' ' A' ' 31' ' ' PHE . 8.8 t -76.42 -170.08 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -171.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 m -62.42 -32.86 56.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.762 0.315 . . . . 0.0 111.729 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -82.18 -4.1 56.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.254 0.55 . . . . 0.0 110.438 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.99 31.46 43.22 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.413 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.405 ' HB2' HG22 ' A' ' 27' ' ' THR . 19.0 m-30 -90.3 131.67 35.97 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.55 HG22 ' HG3' ' A' ' 26' ' ' PRO . 75.7 p -90.27 -29.49 18.11 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -168.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.2 m80 -112.55 146.08 39.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -171.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -117.78 121.08 39.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -124.83 147.55 48.68 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.068 0.461 . . . . 0.0 110.788 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.624 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 47.3 ttp -124.24 116.91 23.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.662 176.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.4 m -98.43 150.68 4.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.443 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -151.1 151.16 31.58 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.294 0.569 . . . . 0.0 112.36 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -122.55 138.46 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.334 169.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -155.88 -176.97 6.23 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.514 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -90.41 -170.92 43.85 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.514 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 3.2 Cg_exo -74.46 110.1 3.03 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.103 1.869 . . . . 0.0 112.366 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 49.8 77.07 0.12 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.508 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 76.62 -11.7 1.14 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.791 0.436 . . . . 0.0 112.134 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.538 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 50.6 m -68.36 123.26 20.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.719 0.295 . . . . 0.0 110.452 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -76.5 129.18 36.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.029 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.581 HD12 HG21 ' A' ' 51' ' ' VAL . 4.8 pt -95.46 -1.68 10.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.418 ' HG2' ' OH ' ' A' ' 74' ' ' TYR . 96.2 mt-30 -69.85 -0.79 7.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.9 0.381 . . . . 0.0 111.384 -175.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -71.46 -39.53 70.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.22 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -113.57 -17.61 12.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.394 -0.523 . . . . 0.0 111.593 176.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.581 HG21 HD12 ' A' ' 47' ' ' ILE . 91.5 t -91.29 130.45 40.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.828 0.346 . . . . 0.0 110.215 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.494 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 8.0 tp10 -99.13 -55.99 2.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.182 0.515 . . . . 0.0 110.46 -175.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.561 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -148.79 156.88 42.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 55' ' ' VAL . 90.2 t -131.92 156.93 42.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.8 p -142.55 133.99 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.318 0.58 . . . . 0.0 110.979 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 29.6 m-85 -116.06 104.32 11.45 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -78.33 92.43 4.54 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.981 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.5 mt -75.36 -177.79 3.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 151.78 22.9 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.56 -175.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 1.6 mp0 -55.64 -21.95 20.34 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.727 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.0 t -65.84 -24.58 66.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 110.614 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -82.62 135.22 46.46 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.332 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.45 120.36 7.87 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.233 1.955 . . . . 0.0 110.537 172.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 60.68 81.57 0.24 Allowed Pre-proline 0 N--CA 1.464 0.23 0 O-C-N 123.502 0.501 . . . . 0.0 110.379 -173.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -61.0 -25.31 81.32 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.584 2.189 . . . . 0.0 113.747 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HE3' ' CG1' ' A' ' 68' ' ' VAL . 23.5 ttpt -98.32 107.24 19.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.058 0.456 . . . . 0.0 111.1 -172.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -106.1 100.9 10.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.892 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.44 ' CG1' ' HE3' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -87.63 137.8 20.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.8 m -125.34 114.09 18.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -104.3 -28.21 11.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.43 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.483 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 26.7 t70 -73.58 171.06 11.68 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.135 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.583 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 72.7 Cg_exo -26.0 -174.1 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.676 1 C-N-CA 126.016 4.477 . . . . 0.0 116.062 164.127 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.583 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 6.5 Cg_endo -33.3 120.37 0.11 Allowed 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.375 2.717 . . . . 0.0 114.139 -149.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.556 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 38.8 m-85 -62.74 93.35 0.05 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.212 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -143.71 144.82 32.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.342 0.591 . . . . 0.0 112.039 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.5 t -120.35 131.8 71.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.595 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.18 105.99 13.21 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -131.51 173.2 11.34 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.508 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.0 t -125.03 144.74 50.25 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.724 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.84 -170.66 29.07 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -133.08 -12.26 2.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.411 0.606 . . . . 0.0 111.645 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.443 ' HB3' ' HG3' ' B' ' 218' ' ' ALY . . . -143.41 145.1 32.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.661 0.267 . . . . 0.0 110.589 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.552 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -83.63 178.03 52.48 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.782 -0.644 . . . . 0.0 113.266 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -178.15 157.81 1.13 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.064 0.546 . . . . 0.0 110.168 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 106' ' ' ASP . 21.1 mm -62.67 125.47 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.661 171.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.569 HD22 HG13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -107.93 105.01 55.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.359 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -68.36 105.33 1.22 Allowed 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 123.013 2.475 . . . . 0.0 111.625 170.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.569 HG13 HD22 ' A' ' 86' ' ' LEU . 5.8 mt -100.87 123.73 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.237 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.9 mt-10 -109.67 123.62 49.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.286 0.565 . . . . 0.0 110.039 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -103.04 117.21 48.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.619 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.561 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 83.8 m-85 -87.89 141.23 28.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.086 0.469 . . . . 0.0 110.778 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.451 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.3 m-85 -114.12 153.82 28.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.884 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.494 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -95.77 94.13 7.49 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.55 HD21 ' HB2' ' A' ' 96' ' ' GLU . 58.3 t30 -155.37 158.46 38.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.933 -170.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.2 ptpp? -107.85 -6.95 16.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.718 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.55 ' HB2' HD21 ' A' ' 94' ' ' ASN . 23.7 mm-40 -101.29 -150.73 0.4 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.822 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.462 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 15.3 mm-40 -25.27 149.04 0.02 OUTLIER Pre-proline 0 N--CA 1.479 1.006 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -31.45 126.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 1 C-N-CA 125.41 4.074 . . . . 0.0 114.717 -170.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.58 19.52 1.97 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.823 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.73 142.12 20.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 110.537 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -124.63 155.63 32.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 174.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -124.19 119.11 28.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.144 0.497 . . . . 0.0 111.163 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.628 ' CD2' HD21 ' A' ' 16' ' ' LEU . 24.0 m-85 -111.58 115.77 29.72 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.906 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.79 101.82 7.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.37 0.605 . . . . 0.0 109.773 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -115.58 134.82 54.69 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.646 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.411 ' HA ' HD13 ' A' ' 85' ' ' ILE . 12.6 t70 -86.52 118.17 25.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.684 -176.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.501 HD11 ' CG1' ' A' ' 37' ' ' VAL . 1.4 mp -93.96 91.45 6.9 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.512 ' CE1' HG13 ' A' ' 117' ' ' VAL . 50.4 p90 -99.32 157.03 16.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.043 0.449 . . . . 0.0 110.832 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.5 mt -133.68 158.57 42.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -102.13 174.48 5.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.244 -0.285 . . . . 0.0 110.364 172.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.661 HD23 ' HG3' ' B' ' 214' ' ' LYS . 3.0 mm? -70.24 160.98 31.18 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.609 ' HA ' HG21 ' A' ' 22' ' ' VAL . 5.4 mp0 -58.72 123.11 15.27 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.377 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.88 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 115.66 -45.04 1.35 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.843 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -140.98 74.58 25.5 Favored Pre-proline 0 N--CA 1.464 0.228 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.505 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.562 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 71.9 Cg_endo -113.0 107.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.789 2.326 . . . . 0.0 113.448 172.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -99.66 96.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 123.034 2.489 . . . . 0.0 110.922 165.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 4.9 t -123.09 109.41 23.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.59 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -144.16 97.13 3.0 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.465 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.9 t-80 -119.55 134.34 55.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.777 -176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 119' ' ' HIS . 9.8 mt -117.91 145.76 44.42 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.681 0.613 . . . . 0.0 110.016 176.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.653 ' HD3' ' OE2' ' A' ' 123' ' ' GLU . 11.3 ttm180 -132.96 148.46 52.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.482 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 84.6 m -123.32 116.13 22.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.332 0.587 . . . . 0.0 111.059 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.653 ' OE2' ' HD3' ' A' ' 121' ' ' ARG . 64.3 mm-40 -98.43 162.45 13.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.383 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -125.48 128.35 47.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.413 0.625 . . . . 0.0 111.115 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.832 ' HB2' HG23 ' A' ' 12' ' ' VAL . 8.3 mt -100.34 115.37 29.81 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.962 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 20.9 m -109.14 122.71 47.89 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.005 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -120.42 100.61 7.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.046 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -73.42 116.36 13.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.653 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.638 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 5.0 t30 58.26 74.76 0.59 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.452 175.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 8' ' ' CYS . 82.2 Cg_endo -97.48 -178.54 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.23 2.62 . . . . 0.0 112.817 -174.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.456 ' CG2' ' HG3' ' A' ' 96' ' ' GLU . 5.9 p -71.66 144.54 49.35 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -57.36 -45.97 83.84 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.92 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -57.93 -28.94 64.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.613 0.244 . . . . 0.0 110.918 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.667 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.2 t80 -73.12 -47.01 47.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.656 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.3 ttm105 -52.18 -48.3 65.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.264 0.554 . . . . 0.0 109.924 174.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -54.83 -34.52 62.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.778 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.5 mtmt -81.52 -37.68 27.46 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.514 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.8 mt -66.19 -28.9 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.7 mt -80.42 -37.98 31.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.434 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.448 ' NZ ' ' HB2' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -70.76 -30.39 66.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.877 -176.488 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.913 178.975 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.27 79.2 0.92 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.28 -0.486 . . . . 0.0 112.586 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' LYS . . . . . 0.661 ' HG3' HD23 ' A' ' 111' ' ' LEU . 23.2 tptm -82.22 -42.6 18.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.958 0.409 . . . . 0.0 109.915 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.432 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -68.59 159.62 80.69 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.966 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.432 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 19.8 Cg_endo -58.49 170.01 2.74 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.434 2.089 . . . . 0.0 112.239 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 17.9 ttm180 -142.8 135.95 28.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.979 0.418 . . . . 0.0 110.831 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 218' ' ' ALY . . . . . 0.443 ' HG3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -91.46 -31.39 16.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.854 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 18.4 tp -159.33 47.39 0.29 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.628 0.727 . . . . 0.0 109.814 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -70.38 -11.64 61.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.324 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 16.7 m -64.06 -25.91 68.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.909 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -96.01 19.64 11.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.579 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.093 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.173 179.85 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -67.75 -29.8 69.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.856 0.36 . . . . 0.0 111.51 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -76.49 -34.24 58.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.473 . . . . 0.0 110.034 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.5 tpp -71.39 -50.68 29.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.204 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.5 114.4 11.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.804 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.8 t -100.0 138.81 36.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.435 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 53.8 m -71.27 108.52 4.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.905 0.383 . . . . 0.0 110.156 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 61.8 m -97.95 116.24 29.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.713 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.8 134.06 43.26 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -171.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.469 HG23 ' HG3' ' A' ' 130' ' ' PRO . 6.3 t -104.83 144.17 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 5.8 mp0 -132.29 114.86 14.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.849 0.357 . . . . 0.0 110.292 -173.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.903 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -105.85 166.04 3.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.343 -179.3 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -129.23 126.01 38.18 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.148 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.421 HD22 HD13 ' A' ' 47' ' ' ILE . 79.0 mt -103.62 142.78 33.72 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.662 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 28.1 tt0 -107.94 125.5 51.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.302 -173.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.529 ' CD1' HG12 ' A' ' 39' ' ' VAL . 2.2 mm? -107.79 117.54 34.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 173.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -139.88 165.33 25.94 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.396 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -162.87 149.03 12.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.077 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 34.8 mtp180 -121.62 128.17 51.63 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.61 117.46 29.45 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.377 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -110.13 141.67 42.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.455 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' A' ' 112' ' ' GLU . 5.7 p -102.95 146.08 11.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mtp85 -97.0 142.93 28.35 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -72.32 -13.92 61.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.489 0.661 . . . . 0.0 109.335 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 26' ' ' PRO . 13.7 tmtt? -138.8 100.49 8.12 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.89 176.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HG3' HG22 ' A' ' 32' ' ' THR . 80.7 Cg_exo -50.78 160.31 1.88 Allowed 'Trans proline' 0 N--CA 1.478 0.577 0 C-N-CA 123.612 2.874 . . . . 0.0 113.359 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.4 t -79.65 -174.41 4.3 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.836 -175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.446 ' H ' HG13 ' A' ' 28' ' ' VAL . 1.2 m -62.32 -32.59 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.849 0.357 . . . . 0.0 111.163 -174.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -79.78 -6.45 57.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.11 0.481 . . . . 0.0 110.513 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.6 33.26 38.98 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.268 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -93.46 130.88 39.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.565 HG22 ' HG3' ' A' ' 26' ' ' PRO . 45.9 p -92.04 -21.56 20.42 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.251 -170.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.459 ' HE1' ' OE1' ' A' ' 112' ' ' GLU . 54.9 m80 -118.84 147.24 44.15 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -171.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -123.3 117.28 24.9 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.412 ' HH2' HD22 ' A' ' 58' ' ' LEU . 49.3 p-90 -121.3 147.93 45.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.105 0.479 . . . . 0.0 111.263 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.622 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 52.2 ttp -125.33 119.38 28.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.514 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.5 m -101.93 148.97 6.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.471 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 2.1 p90 -149.5 153.28 36.99 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.8 m -123.58 135.86 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.636 170.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HD2' ' OE2' ' A' ' 15' ' ' GLU . 8.3 ptp85 -152.56 -176.74 5.85 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.483 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -90.75 -173.57 44.19 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.453 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.525 ' HD2' ' OG ' ' A' ' 45' ' ' SER . 5.1 Cg_exo -74.21 125.7 9.93 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.169 2.579 . . . . 0.0 111.354 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 61.99 47.67 5.69 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.544 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 37.1 m80 64.23 18.36 11.24 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.525 ' OG ' ' HD2' ' A' ' 42' ' ' PRO . 22.9 p -71.05 153.64 42.42 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 122.131 -0.356 . . . . 0.0 110.137 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.35 125.5 30.45 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.585 HD12 HG21 ' A' ' 51' ' ' VAL . 4.6 pt -96.58 -1.52 10.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.575 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 32.8 tt0 -70.48 -4.52 23.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.575 0.702 . . . . 0.0 109.736 -174.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.427 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 93.8 m-70 -66.1 -39.41 89.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.304 173.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -116.07 -19.39 10.33 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.133 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.585 HG21 HD12 ' A' ' 47' ' ' ILE . 96.7 t -88.8 131.32 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.229 0.537 . . . . 0.0 109.939 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.96 -59.85 1.68 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.367 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 16.2 tttt -149.53 149.78 31.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.811 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 93.9 t -128.92 157.41 41.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -177.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.579 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 8.7 p -142.53 135.1 26.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.383 0.611 . . . . 0.0 111.169 -174.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 25.1 m-85 -117.78 108.3 15.2 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -81.31 93.58 6.58 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.123 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.584 ' CD2' HD11 ' A' ' 86' ' ' LEU . 9.9 mt -74.16 -177.82 3.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 73.2 t60 -80.93 137.48 36.13 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.5 -20.49 20.58 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.5 t -64.57 -18.14 64.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.866 0.365 . . . . 0.0 110.902 173.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 44.0 m-85 -83.27 144.14 46.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.13 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 62' ' ' PHE . 15.9 Cg_exo -68.71 118.69 5.82 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.425 2.083 . . . . 0.0 110.851 173.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.401 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 26.2 mmm180 63.54 73.17 0.5 Allowed Pre-proline 0 N--CA 1.465 0.279 0 O-C-N 123.543 0.527 . . . . 0.0 110.007 -176.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.24 -22.71 66.65 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.793 2.329 . . . . 0.0 113.406 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -97.35 103.29 15.21 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 120.974 0.416 . . . . 0.0 110.421 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.401 ' HD3' ' O ' ' A' ' 64' ' ' ARG . 15.7 mmm-85 -105.15 102.23 11.73 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.321 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.6 m -95.26 138.27 21.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.5 m -125.13 119.63 29.11 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -106.74 -28.71 10.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.59 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.727 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 37.4 m-20 -72.13 -172.31 0.22 Allowed Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.531 1.132 . . . . 0.0 111.768 -174.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.727 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 72.4 Cg_exo -39.89 -172.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.858 0 C-N-CA 123.492 2.794 . . . . 0.0 114.084 165.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.651 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.7 Cg_endo -33.83 123.42 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 123.857 3.038 . . . . 0.0 114.442 -154.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 36.9 m-85 -63.21 92.07 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.187 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -142.79 145.41 33.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.183 0.516 . . . . 0.0 111.866 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 36' ' ' MET . 75.1 t -118.55 133.73 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.42 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.469 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 5.7 mm-40 -112.15 107.36 16.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.975 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.25 169.47 17.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.122 0.487 . . . . 0.0 111.039 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.2 t -126.94 143.24 51.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.888 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.76 -161.68 13.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.746 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -137.69 -14.86 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.292 0.546 . . . . 0.0 112.174 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.444 ' HB3' ' HG3' ' B' ' 218' ' ' ALY . . . -143.27 148.05 35.77 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.023 -176.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.541 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -84.99 179.43 51.08 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.619 -0.719 . . . . 0.0 113.182 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -178.96 155.52 0.76 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.935 0.494 . . . . 0.0 109.911 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 106' ' ' ASP . 23.0 mm -62.72 127.1 22.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.242 171.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.584 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.7 tt -120.09 104.82 43.27 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-O 121.129 0.49 . . . . 0.0 110.106 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.19 112.2 2.24 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.399 2.732 . . . . 0.0 112.721 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.406 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.9 mt -103.64 124.26 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.183 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.579 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 50.9 mt-10 -109.62 124.67 51.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.152 0.501 . . . . 0.0 109.903 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.1 t -105.26 119.2 54.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.841 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 88.9 m-85 -91.19 138.82 31.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.015 0.436 . . . . 0.0 110.863 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.5 m-85 -112.14 154.65 25.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.735 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.3 95.14 7.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.623 HD21 ' HB2' ' A' ' 96' ' ' GLU . 61.0 t30 -155.33 164.38 38.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.808 -172.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -112.86 -4.6 13.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.615 178.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.623 ' HB2' HD21 ' A' ' 94' ' ' ASN . 17.4 mm-40 -100.93 -153.47 0.45 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.067 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 20.3 mm-40 -29.89 153.23 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 124.621 1.168 . . . . 0.0 114.071 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 6.2 Cg_exo -32.72 124.86 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.125 1 C-N-CA 125.356 4.037 . . . . 0.0 114.876 -167.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.473 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -88.2 19.58 3.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.392 -177.495 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -152.37 140.41 20.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.235 0.54 . . . . 0.0 110.887 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.1 m -125.75 156.41 35.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.72 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -122.92 121.8 37.05 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.011 0.434 . . . . 0.0 111.201 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CZ ' HG21 ' A' ' 101' ' ' VAL . 23.6 m-85 -112.83 110.75 21.05 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.707 173.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -82.21 99.03 9.04 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -108.32 138.97 43.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.159 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.418 ' HA ' HD13 ' A' ' 85' ' ' ILE . 12.4 t70 -81.83 113.66 19.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.96 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.562 HD11 HG11 ' A' ' 37' ' ' VAL . 1.8 mp -90.01 104.99 17.51 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.402 ' CE2' HG11 ' A' ' 117' ' ' VAL . 12.4 p90 -116.01 154.95 28.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.91 0.386 . . . . 0.0 110.661 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.9 mt -135.48 162.59 32.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.647 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.685 ' CD2' ' HA ' ' A' ' 116' ' ' PRO . 7.7 p80 -100.49 171.82 7.5 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.418 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' B' ' 215' ' ' ALA . 1.0 OUTLIER -74.42 168.85 18.89 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.834 0.349 . . . . 0.0 111.129 177.629 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.71 ' HA ' HG21 ' A' ' 22' ' ' VAL . 0.8 OUTLIER -67.23 120.3 13.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.52 178.384 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.682 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 85.73 16.89 62.77 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.925 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -115.76 152.4 47.33 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-O 118.709 -0.662 . . . . 0.0 110.024 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -28.28 124.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 124.288 3.325 . . . . 0.0 114.631 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.685 ' HA ' ' CD2' ' A' ' 110' ' ' HIS . 24.6 Cg_exo -62.98 -178.77 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.236 2.624 . . . . 0.0 112.936 174.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 31.6 t -122.42 130.73 74.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.064 -176.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -139.01 98.22 3.48 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -125.0 132.59 53.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.41 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.4 mt -111.43 156.45 21.62 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.866 0.729 . . . . 0.0 109.103 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 16.3 ttt180 -147.47 143.71 28.08 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.31 -0.244 . . . . 0.0 110.719 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 24.8 p -118.98 116.88 27.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.217 0.532 . . . . 0.0 111.064 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -111.92 132.84 54.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.951 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -97.81 131.56 44.2 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.164 0.506 . . . . 0.0 111.742 -172.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.903 ' HB2' HG23 ' A' ' 12' ' ' VAL . 7.4 mt -99.34 118.1 35.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.2 m -106.26 120.48 41.97 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.175 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -117.59 99.33 6.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.895 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -71.72 117.42 13.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.958 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.435 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 5.4 t30 55.94 78.35 0.38 Allowed Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.873 174.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.587 ' HD3' ' O ' ' A' ' 8' ' ' CYS . 95.6 Cg_endo -97.64 -178.22 0.31 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.003 2.469 . . . . 0.0 112.13 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.0 p -74.1 142.25 45.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 171.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.435 ' OE2' ' HD2' ' A' ' 135' ' ' ARG . 4.0 tp10 -56.51 -38.25 71.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.019 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.659 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 15.6 m-20 -59.98 -35.29 74.69 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.625 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.6 t80 -72.54 -40.66 66.55 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.685 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 30.9 ttm180 -55.85 -45.62 78.39 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -59.13 -34.69 72.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.955 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.659 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 40.4 mtpt -71.32 -43.56 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.2 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 37.3 mt -68.63 -34.33 75.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.767 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 43.4 mt -74.1 -33.81 63.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.928 0.394 . . . . 0.0 110.836 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -76.57 -27.02 55.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.538 -175.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.84 178.32 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -77.99 68.68 2.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.606 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -80.04 -35.76 36.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.695 0.283 . . . . 0.0 110.791 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.429 ' HA ' HD22 ' A' ' 111' ' ' LEU . . . -71.78 161.31 79.36 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.482 -174.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.31 -177.3 0.12 Allowed 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.547 2.164 . . . . 0.0 113.23 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 18.4 ttm180 -150.18 138.92 20.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.71 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 218' ' ' ALY . . . . . 0.444 ' HG3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -93.7 122.37 36.08 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 8.2 tt -74.91 100.15 4.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.079 0.466 . . . . 0.0 110.217 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -97.77 -59.49 1.76 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.54 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 16.5 m 51.38 55.29 9.67 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.725 0.774 . . . . 0.0 110.637 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -82.93 -34.21 26.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.353 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.018 175.554 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -87.61 141.51 28.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.875 0.369 . . . . 0.0 110.487 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -118.63 141.78 48.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -76.81 84.3 3.4 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 56.72 -90.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.898 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.6 t -118.67 145.68 45.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.3 m -59.02 110.1 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 129' ' ' ASN . 13.6 p -90.11 127.7 36.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.565 -171.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.5 129.36 46.44 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.992 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 t -99.97 139.8 20.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.0 mp0 -125.67 120.41 30.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.04 0.447 . . . . 0.0 110.046 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.867 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.68 161.85 5.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.974 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' CE ' ' HB3' ' A' ' 42' ' ' PRO . 47.5 mtmt -128.57 128.62 44.6 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.364 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.401 HD13 HG11 ' A' ' 90' ' ' VAL . 82.5 mt -111.79 140.64 46.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.103 0.478 . . . . 0.0 109.715 174.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.609 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.7 tt0 -104.68 122.35 45.49 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.929 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.657 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.4 mm? -108.67 117.92 35.43 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.23 -179.85 24.52 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.21 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -169.43 154.45 5.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -122.1 136.27 54.9 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -133.62 126.62 31.28 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.358 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.13 158.26 40.17 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.149 178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.83 HG11 ' H ' ' A' ' 113' ' ' GLY . 1.7 p -101.85 160.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.601 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 6.3 ptm180 -111.95 142.27 44.56 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -70.08 -8.85 52.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.532 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -144.55 100.89 4.71 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.584 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HG3' HG22 ' A' ' 32' ' ' THR . 86.7 Cg_exo -50.06 155.04 4.76 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.144 2.563 . . . . 0.0 111.87 175.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.435 HG22 ' HB2' ' A' ' 31' ' ' PHE . 8.8 t -78.26 -175.47 4.19 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.062 -171.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.419 ' H ' HG13 ' A' ' 28' ' ' VAL . 2.1 m -57.52 -33.09 43.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 122.634 0.373 . . . . 0.0 111.838 -175.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -86.6 0.42 54.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.086 0.469 . . . . 0.0 110.73 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.04 33.18 41.78 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.899 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.435 ' HB2' HG22 ' A' ' 27' ' ' THR . 16.3 m-30 -92.07 133.17 35.99 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.563 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 58.7 p -96.7 -27.76 14.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -168.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 79' ' ' SER . 66.9 m80 -118.42 140.77 49.35 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -172.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.601 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 17.3 m-20 -115.39 116.02 27.55 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -119.38 151.51 38.37 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.006 0.432 . . . . 0.0 110.893 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.626 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 57.0 ttp -127.43 120.9 29.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.43 174.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.8 m -100.84 152.16 5.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.212 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -153.08 154.14 34.26 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 10.2 m -120.82 126.15 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.671 168.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 15' ' ' GLU . 14.1 mmm180 -128.62 176.52 7.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 -172.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.553 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -97.78 -177.4 33.76 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.571 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 8.1 Cg_exo -69.8 111.01 2.7 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.505 2.137 . . . . 0.0 112.323 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 53.56 61.66 3.01 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.525 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 76.55 -7.43 1.84 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.29 0.636 . . . . 0.0 112.366 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.4 m -69.44 128.6 37.12 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.29 -0.256 . . . . 0.0 111.046 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -65.22 129.59 40.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 110.653 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.58 HD12 HG21 ' A' ' 51' ' ' VAL . 4.2 pt -95.78 -1.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -61.22 -15.72 37.4 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.111 0.482 . . . . 0.0 110.906 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -63.64 -37.13 86.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.209 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.415 ' CE2' HG22 ' A' ' 47' ' ' ILE . 53.9 p90 -117.9 -16.63 9.9 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.408 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.58 HG21 HD12 ' A' ' 47' ' ' ILE . 95.4 t -89.56 129.71 40.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.131 0.491 . . . . 0.0 110.199 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -97.45 -66.0 0.93 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.417 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.645 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -144.45 151.18 38.83 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 55' ' ' VAL . 95.1 t -124.2 159.52 29.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 O-C-N 122.104 -0.372 . . . . 0.0 110.198 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.561 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.4 p -143.18 137.53 26.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.073 0.464 . . . . 0.0 111.016 -174.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.525 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 17.1 m-85 -120.8 111.22 17.3 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -84.42 95.23 8.71 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.941 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.549 ' CD2' HD11 ' A' ' 86' ' ' LEU . 8.1 mt -73.48 -177.59 2.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 -81.21 146.64 30.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -56.4 -19.26 14.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.413 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 m -69.59 -20.56 63.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.085 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -83.34 144.41 46.49 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.582 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.63 118.24 5.45 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.586 2.191 . . . . 0.0 110.65 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 61.06 78.5 0.31 Allowed Pre-proline 0 C--O 1.225 -0.192 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.181 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.65 -24.03 77.48 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.847 2.364 . . . . 0.0 113.732 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -97.44 109.14 21.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.969 -0.457 . . . . 0.0 110.881 -174.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 21.6 mmt85 -108.01 105.55 15.37 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.136 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.55 142.2 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 175.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 43.4 t -131.81 114.65 14.96 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -106.75 -24.82 11.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.242 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.538 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 24.7 t70 -68.97 171.63 6.16 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.564 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 82.6 Cg_exo -29.2 -170.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.557 1.652 1 C-N-CA 125.478 4.119 . . . . 0.0 115.466 164.032 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.642 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 Cg_endo -36.17 121.7 0.26 Allowed 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 122.808 2.339 . . . . 0.0 113.887 -151.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 39.5 m-85 -62.17 91.44 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.059 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.642 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 4.6 ptpt -139.16 146.92 41.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.261 0.553 . . . . 0.0 111.877 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.0 t -123.71 131.82 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.804 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.77 113.54 24.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.25 172.85 12.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.222 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.3 t -126.67 141.3 51.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.495 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.61 -171.44 23.59 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.41 ' O ' ' HB2' ' B' ' 216' ' ' PRO . 45.5 p90 -131.47 -1.92 3.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.592 0.696 . . . . 0.0 112.195 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.582 ' HB3' ' HG3' ' B' ' 218' ' ' ALY . . . -152.68 129.92 11.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.902 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.517 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -72.31 175.29 43.16 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.348 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -175.96 158.95 2.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.669 0.388 . . . . 0.0 110.275 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 85' ' ' ILE . 12.1 mm -65.58 124.86 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.409 171.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.549 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.9 tt -118.24 105.87 45.95 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.05 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.08 118.64 5.8 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.918 2.412 . . . . 0.0 112.212 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.0 mt -107.61 125.0 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.068 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.561 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 55.0 mt-10 -111.44 118.3 35.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.268 0.556 . . . . 0.0 109.924 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.401 HG11 HD13 ' A' ' 14' ' ' LEU . 64.6 t -100.42 119.18 48.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.825 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.645 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 82.5 m-85 -92.24 138.81 31.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.039 0.447 . . . . 0.0 110.815 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -112.53 150.84 30.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.19 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.67 95.13 10.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.577 HD21 ' HB2' ' A' ' 96' ' ' GLU . 62.6 t30 -154.2 155.34 35.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 0.0 112.152 -169.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.87 -1.94 15.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.131 174.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.577 ' HB2' HD21 ' A' ' 94' ' ' ASN . 32.7 mm-40 -100.29 -152.22 0.42 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.792 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -31.36 154.06 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -30.92 125.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.161 1 C-N-CA 125.37 4.047 . . . . 0.0 114.51 -169.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.66 17.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.899 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.62 149.08 26.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.142 0.496 . . . . 0.0 111.035 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.511 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.3 m -123.1 157.78 28.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.724 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -128.12 106.96 9.42 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.695 0.283 . . . . 0.0 110.35 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.4 m-85 -106.57 121.37 44.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.001 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.31 114.58 23.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -123.93 138.39 54.48 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.349 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.5 119.71 30.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.555 HD11 HG11 ' A' ' 37' ' ' VAL . 2.0 mp -93.11 91.7 7.44 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CE2' HG13 ' A' ' 117' ' ' VAL . 27.0 p90 -100.28 153.51 19.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.963 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.5 mt -129.39 154.15 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.427 ' ND1' HG22 ' A' ' 117' ' ' VAL . 27.9 m170 -103.15 170.39 7.99 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.124 -0.36 . . . . 0.0 111.107 174.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.48 141.2 57.85 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.563 ' HA ' HG21 ' A' ' 22' ' ' VAL . 8.9 mt-10 -50.77 123.06 8.25 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.896 175.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.83 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 119.47 -50.12 0.83 Allowed Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.845 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -144.48 74.26 15.39 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.629 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.461 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 72.1 Cg_endo -111.07 108.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 123.119 2.546 . . . . 0.0 113.368 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -97.91 97.95 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.927 2.418 . . . . 0.0 110.605 167.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 4.7 t -116.34 109.58 28.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.075 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -144.04 121.87 11.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.423 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.2 t-80 -144.47 131.81 20.79 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.255 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 119' ' ' HIS . 7.2 mt -116.28 147.4 41.55 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.707 0.629 . . . . 0.0 109.862 175.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 20.3 ttm180 -136.19 146.02 46.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 84.2 m -128.73 114.48 16.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.022 0.439 . . . . 0.0 110.703 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -109.79 142.7 40.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.006 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -102.74 129.29 49.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.494 0.664 . . . . 0.0 111.845 -172.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.867 ' HB2' HG23 ' A' ' 12' ' ' VAL . 6.5 mt -96.77 120.24 36.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.548 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.8 m -111.22 121.62 45.75 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.623 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -118.83 110.68 17.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.311 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -76.07 117.58 17.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.334 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 5.3 t30 48.03 64.66 8.21 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.92 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.41 176.28 10.17 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.367 2.044 . . . . 0.0 111.899 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.4 p -72.75 144.71 47.5 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.442 ' HG3' ' NH1' ' A' ' 135' ' ' ARG . 29.5 tt0 -56.01 -44.17 78.43 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.502 -0.479 . . . . 0.0 112.032 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -56.9 -32.37 65.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.651 0.262 . . . . 0.0 110.449 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.669 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.8 t80 -76.73 -41.28 45.65 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.628 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.9 ttm180 -54.93 -44.44 74.27 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -57.1 -40.14 76.4 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.311 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 50.2 mtpt -71.19 -40.95 70.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.85 0.357 . . . . 0.0 110.858 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 45.9 mt -69.28 -33.77 73.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.3 mt -76.61 -31.24 57.3 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.826 0.346 . . . . 0.0 110.783 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -75.02 -27.51 60.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.167 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 119.151 -0.452 . . . . 0.0 110.119 175.093 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 112.163 -0.375 . . . . 0.0 112.163 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -77.28 -49.69 7.25 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.87 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -86.46 128.93 35.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.7 0.286 . . . . 0.0 110.56 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -77.09 165.5 51.71 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.909 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 0.3 OUTLIER -36.18 145.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.622 2.882 . . . . 0.0 114.381 175.048 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 15.2 ttm180 -151.63 127.94 10.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.2 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' ALY . . . . . 0.582 ' HG3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -83.44 35.36 0.5 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.678 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' B' ' 218' ' ' ALY . 3.5 mm? -118.64 151.09 38.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.865 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -81.34 69.78 8.05 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.009 0.433 . . . . 0.0 110.872 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 6.0 t -70.82 133.78 46.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.641 178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -81.82 111.06 17.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.283 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.439 -0.791 . . . . 0.0 110.339 178.097 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 112.061 -0.416 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 38.8 m -131.32 62.34 1.62 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.834 0.349 . . . . 0.0 110.236 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 2' ' ' SER . 36.0 m-70 71.93 -55.3 0.67 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.67 0.788 . . . . 0.0 111.947 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.8 ptm -162.25 126.05 3.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.819 0.342 . . . . 0.0 110.345 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.27 -67.22 0.1 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.126 0.488 . . . . 0.0 110.338 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.0 p -88.82 163.55 15.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.858 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.582 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 67.3 m -73.73 108.4 6.54 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.144 0.497 . . . . 0.0 110.903 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.529 ' O ' ' HD2' ' A' ' 130' ' ' PRO . 51.2 t -104.99 104.87 14.7 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.325 176.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.93 126.58 50.15 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.009 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 t -99.71 139.37 21.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -124.86 118.03 25.42 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.024 0.44 . . . . 0.0 110.101 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.839 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.14 176.48 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.838 -178.217 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 57.6 mttt -143.67 138.72 29.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.097 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.433 ' CD2' HG21 ' A' ' 47' ' ' ILE . 86.8 mt -126.25 147.5 49.67 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 175.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.1 tt0 -105.01 127.95 53.09 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.225 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.68 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -112.98 120.7 42.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -145.65 175.93 24.92 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.926 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -167.91 150.41 5.65 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.152 0.501 . . . . 0.0 109.886 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.506 ' HG2' ' OD1' ' A' ' 118' ' ' ASN . 68.5 mtp180 -122.27 145.4 48.26 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.365 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.738 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -132.82 129.01 37.95 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.643 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.428 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 14.8 tt0 -126.09 147.95 49.47 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.223 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.783 HG11 ' H ' ' A' ' 113' ' ' GLY . 1.0 OUTLIER -103.05 156.3 5.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 170.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.746 ' NH2' ' HA ' ' A' ' 26' ' ' PRO . 17.6 mtm-85 -111.88 150.93 29.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -76.56 -6.26 51.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -136.95 106.14 8.85 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.746 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 71.5 Cg_exo -52.95 144.5 44.92 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.059 1.84 . . . . 0.0 112.272 175.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.43 ' N ' ' NH2' ' A' ' 23' ' ' ARG . 4.2 t -85.77 -175.28 5.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.745 -168.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.4 m -57.2 -33.69 43.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -171.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -87.93 -0.26 56.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.718 0.294 . . . . 0.0 111.496 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.72 35.02 23.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.407 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -101.68 145.0 29.7 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.424 HG22 ' HG3' ' A' ' 26' ' ' PRO . 30.3 p -104.36 -33.86 8.49 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.1 m80 -110.02 145.28 37.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -170.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.464 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -122.95 116.52 23.73 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.417 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 50.8 p-90 -118.16 155.1 31.05 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.702 -175.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.644 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 48.3 ttp -130.86 121.07 24.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.574 175.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 9.2 m -100.82 152.03 5.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.05 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -153.72 151.73 29.96 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.597 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -121.88 124.78 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.246 168.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.442 ' HA ' ' NE ' ' A' ' 40' ' ' ARG . 2.6 mmp_? -133.43 168.71 18.12 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.975 0.417 . . . . 0.0 110.985 -173.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.449 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -85.46 118.22 4.74 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 173.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 45' ' ' SER . 40.3 Cg_endo -74.64 151.69 41.75 Favored 'Trans proline' 0 C--N 1.326 -0.647 0 C-N-CA 122.854 2.369 . . . . 0.0 113.01 -176.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 61.86 54.47 2.85 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.994 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 66.2 1.06 1.85 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.297 0.639 . . . . 0.0 112.241 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 12.9 m -76.53 139.43 40.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.0 111.541 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -103.06 124.95 49.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.574 HD12 HG21 ' A' ' 51' ' ' VAL . 19.9 pt -95.7 -2.37 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -169.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -68.74 -11.5 60.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.472 0.653 . . . . 0.0 110.175 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.51 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 95.6 m-70 -68.87 -40.98 78.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.122 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -110.05 -14.54 14.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.753 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.574 HG21 HD12 ' A' ' 47' ' ' ILE . 96.4 t -92.59 129.37 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.995 0.426 . . . . 0.0 110.351 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -95.33 -58.43 2.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.377 0.608 . . . . 0.0 110.615 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -152.57 155.7 37.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.578 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 77.5 t -129.51 156.93 42.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 13.4 p -141.54 137.29 32.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.132 0.492 . . . . 0.0 111.042 -174.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.468 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 30.9 m-85 -119.07 108.3 14.55 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -79.63 95.59 5.95 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.05 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.582 ' CD2' HD11 ' A' ' 86' ' ' LEU . 10.6 mt -81.86 -178.07 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -87.85 152.08 22.37 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 1.7 mp0 -59.67 -15.45 19.5 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.079 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -67.33 -18.89 65.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.348 0.594 . . . . 0.0 110.373 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.01 142.23 24.27 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.432 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.21 129.98 21.64 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.373 2.049 . . . . 0.0 110.384 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 61.01 76.62 0.4 Allowed Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 123.45 0.469 . . . . 0.0 109.864 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.95 -18.17 62.72 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.467 2.111 . . . . 0.0 113.312 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -110.42 107.22 16.83 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 122.06 -0.4 . . . . 0.0 110.653 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.6 mmt85 -105.74 108.0 19.29 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.415 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.8 m -97.74 138.85 21.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.3 m -123.2 113.19 18.61 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.995 0.426 . . . . 0.0 109.988 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -105.86 -25.54 12.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.625 0.726 . . . . 0.0 110.259 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.74 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 14.4 m-20 -75.05 -172.03 0.25 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.882 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.74 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 78.0 Cg_exo -38.42 -179.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.415 2.744 . . . . 0.0 114.027 166.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.63 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -30.48 125.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 124.622 3.548 . . . . 0.0 114.985 -153.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 31.5 m-85 -61.69 92.84 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.735 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.585 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 13.4 ptpt -147.71 144.7 28.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.235 0.541 . . . . 0.0 111.817 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.8 t -122.17 131.89 72.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.99 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -119.32 107.65 13.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.941 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.57 170.58 15.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.996 0.427 . . . . 0.0 110.828 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 5.8 t -117.92 143.88 45.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.371 -176.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.99 -162.43 11.97 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -137.38 -16.41 1.38 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.276 0.538 . . . . 0.0 111.38 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.431 ' HB3' ' HG3' ' B' ' 218' ' ' ALY . . . -142.94 143.51 32.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.671 0.272 . . . . 0.0 110.462 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -81.46 -177.86 52.03 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.128 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -176.8 157.6 1.53 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.087 0.555 . . . . 0.0 109.901 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.0 mm -63.41 120.17 9.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 172.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.582 HD11 ' CD2' ' A' ' 58' ' ' LEU . 5.9 tt -114.34 105.47 53.86 Favored Pre-proline 0 N--CA 1.444 -0.738 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.6 114.22 3.77 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.03 2.487 . . . . 0.0 112.231 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.468 HG12 ' CE2' ' A' ' 56' ' ' PHE . 3.7 mp -101.16 130.37 50.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.037 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.5 mt-10 -111.9 124.5 52.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.064 0.459 . . . . 0.0 110.149 174.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.8 t -103.29 117.84 49.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.71 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.537 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 89.5 m-85 -88.63 141.55 28.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.51 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.434 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 26.4 m-85 -115.43 154.39 29.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.702 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.22 93.22 7.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.578 HD21 ' HB2' ' A' ' 96' ' ' GLU . 60.9 t30 -155.65 162.37 40.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.286 0.565 . . . . 0.0 112.076 -172.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.721 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -113.15 4.06 16.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.861 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.578 ' HB2' HD21 ' A' ' 94' ' ' ASN . 40.4 mm-40 -100.67 -155.57 0.52 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.153 -176.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.656 ' HB2' ' HD2' ' A' ' 98' ' ' PRO . 10.9 pt-20 -44.32 159.32 0.25 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.591 0.756 . . . . 0.0 111.853 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 97' ' ' GLU . 4.3 Cg_exo -31.36 128.33 0.08 OUTLIER 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 125.064 3.843 . . . . 0.0 115.189 -162.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.57 19.54 3.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.972 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.515 ' HE2' ' CE2' ' A' ' 91' ' ' TYR . 1.9 ptpt -149.04 143.86 26.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.939 0.399 . . . . 0.0 110.288 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -128.51 154.4 39.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.236 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -120.78 117.13 26.65 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.073 0.464 . . . . 0.0 110.836 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.68 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.1 m-85 -109.04 109.94 21.09 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.573 175.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.4 115.41 13.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.361 0.6 . . . . 0.0 109.699 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.45 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 66.4 t80 -129.93 127.72 40.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.542 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.88 111.46 18.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.847 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.504 HD11 HG11 ' A' ' 37' ' ' VAL . 2.0 mp -84.61 105.26 15.29 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -113.85 157.27 22.55 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.311 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.1 mt -131.0 154.81 47.77 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.412 ' HB2' ' CB ' ' A' ' 115' ' ' PRO . 29.5 m170 -101.64 169.72 8.65 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.394 174.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -55.98 134.64 52.46 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.558 ' HA ' HG21 ' A' ' 22' ' ' VAL . 3.5 tt0 -49.67 124.8 10.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.455 173.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.783 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 122.76 -52.19 0.77 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.127 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -146.58 73.59 12.69 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 117.501 0.65 . . . . 0.0 111.753 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.516 ' CG ' ' HB ' ' A' ' 22' ' ' VAL . 74.2 Cg_endo -107.46 108.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.857 2.371 . . . . 0.0 113.508 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -98.12 98.73 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.032 2.488 . . . . 0.0 111.033 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.738 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 38.4 t -115.05 117.61 56.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.245 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.506 ' OD1' ' HG2' ' A' ' 19' ' ' ARG . 63.4 t30 -145.57 114.62 6.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.643 175.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.466 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.5 t-80 -137.4 134.46 35.93 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.241 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.3 mt -119.19 151.1 38.93 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.612 0.57 . . . . 0.0 110.326 177.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.504 ' HG2' ' N ' ' A' ' 122' ' ' CYS . 21.9 ttm180 -142.58 153.76 43.81 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 176.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.504 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 85.7 m -137.73 122.97 19.32 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 9.6 mt-10 -119.5 155.37 32.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.473 0.178 . . . . 0.0 110.644 -177.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -107.96 138.6 43.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.617 0.722 . . . . 0.0 112.412 -172.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.839 ' HB2' HG23 ' A' ' 12' ' ' VAL . 6.8 mt -109.52 123.44 49.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.683 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.6 m -114.1 122.15 45.99 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.185 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.483 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 28.6 m-85 -118.45 109.39 16.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.112 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.79 120.67 24.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.22 0.533 . . . . 0.0 111.433 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.582 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 65.1 m-80 53.36 60.78 11.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.116 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 71.6 Cg_endo -76.11 167.7 25.48 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.143 1.895 . . . . 0.0 110.755 174.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 72.2 p -70.36 141.16 52.26 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.419 ' HG3' ' NH1' ' A' ' 135' ' ' ARG . 20.6 tt0 -52.43 -43.05 64.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -173.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.558 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 8.9 p-10 -59.21 -29.65 67.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.848 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.605 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 8.1 t80 -75.27 -39.64 59.56 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.621 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 36.2 ttm180 -54.66 -45.28 73.81 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -56.23 -35.08 66.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.591 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 38.5 mtpt -74.8 -42.25 58.43 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.256 -0.277 . . . . 0.0 110.423 176.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.0 mt -68.93 -32.92 72.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 -177.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 37.5 mt -78.37 -33.1 49.16 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.773 0.32 . . . . 0.0 110.785 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -73.27 -26.77 61.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.481 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.953 179.07 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -104.82 -40.39 2.16 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.114 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -74.84 127.1 32.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.795 0.331 . . . . 0.0 110.795 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -69.17 166.31 30.21 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.208 177.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.513 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 6.9 Cg_endo -49.42 167.22 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.701 2.267 . . . . 0.0 113.021 175.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.496 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 6.5 tpp180 -144.63 121.03 10.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.448 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 218' ' ' ALY . . . . . 0.431 ' HG3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -82.75 67.69 8.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.61 0.719 . . . . 0.0 109.921 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 86.0 mt -94.88 106.36 18.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.101 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -110.01 84.15 1.88 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.218 0.532 . . . . 0.0 110.167 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 19.5 m -77.85 91.43 4.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.933 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -131.09 -63.96 0.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.149 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.417 -0.802 . . . . 0.0 110.443 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 112.074 -0.411 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -98.83 34.83 1.98 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.881 0.372 . . . . 0.0 111.235 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -145.28 76.57 1.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.294 0.569 . . . . 0.0 110.502 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.6 mtm -74.67 74.24 2.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.765 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.08 74.82 1.54 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.754 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 p -60.54 124.21 19.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.045 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.742 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 48.4 m -87.88 108.85 19.37 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.463 ' O ' ' HD2' ' A' ' 130' ' ' PRO . 58.8 m -116.33 126.21 53.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.988 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.64 123.73 41.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.91 0.386 . . . . 0.0 111.504 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.74 141.38 17.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.3 mp0 -124.08 135.16 53.37 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.029 0.442 . . . . 0.0 110.106 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.838 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -111.87 173.51 2.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.632 174.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 122' ' ' CYS . 47.3 tttt -142.37 119.16 11.15 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.4 mt -107.35 142.31 37.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.203 0.525 . . . . 0.0 110.023 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.6 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.4 tm-20 -111.91 120.53 42.25 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.612 -176.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.604 HD12 HG12 ' A' ' 39' ' ' VAL . 1.4 mm? -103.19 112.47 25.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -135.67 169.52 23.47 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.565 -1.303 . . . . 0.0 111.485 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -164.01 151.43 12.24 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.976 -0.689 . . . . 0.0 111.337 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 21.0 mtp180 -114.98 150.63 35.49 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.327 173.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -145.06 126.79 15.25 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.767 176.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -121.35 151.24 40.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.855 HG11 ' H ' ' A' ' 113' ' ' GLY . 4.5 p -101.77 153.92 5.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.569 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 3.0 mtp180 -107.38 140.02 40.96 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -68.46 -16.06 63.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.756 0.788 . . . . 0.0 109.623 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -136.23 105.55 9.43 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.969 172.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.507 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.0 Cg_exo -49.9 156.3 3.49 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.844 2.363 . . . . 0.0 112.004 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -75.85 -173.92 2.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.838 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.42 -32.88 49.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.773 0.32 . . . . 0.0 111.45 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -84.39 -0.63 53.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.085 0.469 . . . . 0.0 110.742 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.41 32.14 52.4 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.638 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -92.03 130.91 37.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.507 HG22 ' HG3' ' A' ' 26' ' ' PRO . 77.3 p -89.35 -29.97 18.73 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.445 -169.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.404 ' O ' ' HA ' ' A' ' 79' ' ' SER . 69.6 m80 -116.17 143.1 45.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -172.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.569 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -121.07 121.45 37.93 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.88 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -123.94 151.37 43.66 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.558 -174.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.66 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 56.0 ttp -127.33 116.59 20.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.705 175.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 8.7 m -98.2 151.98 4.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.38 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.563 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.0 OUTLIER -153.44 156.08 37.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 178.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.604 HG12 HD12 ' A' ' 16' ' ' LEU . 4.4 m -126.31 128.32 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.19 171.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -134.99 -177.07 4.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.023 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.488 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -93.53 -171.8 39.49 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.005 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 9.1 Cg_exo -67.41 111.76 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.562 2.175 . . . . 0.0 111.167 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 58.96 57.17 3.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.06 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 71.6 m80 67.83 9.36 7.06 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.489 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 71.5 m -67.47 138.04 56.3 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 122.432 -0.168 . . . . 0.0 110.902 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -70.3 126.15 28.82 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.922 0.391 . . . . 0.0 110.02 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.603 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.6 pt -97.32 -4.3 9.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -173.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.04 1.84 0.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -79.34 -33.39 43.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.505 0.193 . . . . 0.0 110.723 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.478 ' CE1' HG22 ' A' ' 47' ' ' ILE . 52.8 p90 -119.79 -20.78 7.48 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.211 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.603 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 91.7 t -89.36 130.29 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.48 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 10.3 tp10 -99.23 -63.07 1.16 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.204 0.526 . . . . 0.0 110.313 -176.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -144.06 152.84 41.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.045 178.386 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 97.5 t -127.04 159.06 37.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.208 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.571 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 13.0 p -141.74 137.33 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.131 0.491 . . . . 0.0 111.209 -176.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 23.6 m-85 -118.19 108.77 15.56 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -79.49 94.08 5.53 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.976 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.607 ' CD2' HD11 ' A' ' 86' ' ' LEU . 11.3 mt -78.67 -178.2 5.79 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 144.35 47.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.186 0.517 . . . . 0.0 109.811 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.23 -23.69 62.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.792 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.5 t -77.06 -13.35 59.97 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.751 0.31 . . . . 0.0 110.992 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -81.26 140.1 48.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.497 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.26 123.41 13.56 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.471 2.114 . . . . 0.0 110.798 172.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 57.87 77.58 0.4 Allowed Pre-proline 0 N--CA 1.454 -0.253 0 O-C-N 123.876 0.735 . . . . 0.0 110.733 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.12 -22.24 73.86 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.493 2.129 . . . . 0.0 113.094 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -106.29 105.84 16.07 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 120.858 0.361 . . . . 0.0 110.704 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.1 mmt85 -104.65 108.48 19.96 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.491 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 2.8 m -97.69 136.51 28.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.1 m -120.3 113.61 20.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.038 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -104.78 -23.04 13.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.041 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.56 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -70.39 -174.87 0.26 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.319 -175.722 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.649 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 48.4 Cg_exo -42.37 -179.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.542 2.828 . . . . 0.0 113.474 169.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.649 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 4.2 Cg_exo -28.4 122.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.451 3.434 . . . . 0.0 114.17 -159.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.563 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 40.7 m-85 -60.31 100.21 0.09 Allowed 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.276 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.66 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.2 ptpt -148.03 147.8 29.99 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.581 0.705 . . . . 0.0 112.501 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 36' ' ' MET . 83.8 t -122.91 132.28 71.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.428 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -117.45 106.6 13.36 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.438 ' CD ' HH22 ' A' ' 67' ' ' ARG . 1.8 tp10 -133.71 175.95 8.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.515 -175.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 8.2 t -128.04 145.87 50.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.201 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.21 -163.62 14.55 Favored Glycine 0 N--CA 1.453 -0.167 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.22 -12.57 2.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.693 0.746 . . . . 0.0 112.018 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.455 ' HB3' ' HE3' ' B' ' 218' ' ' ALY . . . -150.58 134.29 16.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.97 0.414 . . . . 0.0 111.119 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.47 167.16 44.59 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.201 -0.909 . . . . 0.0 114.144 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -166.53 154.84 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.017 -0.591 . . . . 0.0 109.964 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.91 124.51 16.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 110.375 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.607 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -118.34 104.92 47.27 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.671 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.31 119.53 6.43 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.058 2.505 . . . . 0.0 112.22 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.423 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.5 mt -109.13 129.31 64.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.179 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.571 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.8 mt-10 -110.39 126.31 54.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 0.0 110.044 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 80.2 t -106.08 121.65 58.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.564 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 96.6 m-85 -95.69 135.27 37.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.438 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.9 m-85 -109.55 156.44 20.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.342 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.48 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -98.48 93.08 5.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.004 0.43 . . . . 0.0 110.782 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.48 HD21 ' HB2' ' A' ' 96' ' ' GLU . 61.8 t30 -158.61 167.96 28.18 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.201 -0.312 . . . . 0.0 111.146 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.591 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -113.59 4.57 16.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.02 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.554 ' HG2' ' CG2' ' A' ' 131' ' ' THR . 0.0 OUTLIER -101.16 -153.16 0.45 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.479 -175.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.583 ' HB2' ' HD2' ' A' ' 98' ' ' PRO . 13.9 pt-20 -39.84 155.16 0.17 Allowed Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.781 0.832 . . . . 0.0 112.027 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 97' ' ' GLU . 2.2 Cg_endo -35.87 123.07 0.27 Allowed 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 124.896 3.73 . . . . 0.0 114.511 -165.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.429 ' N ' ' HD3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -93.63 21.02 6.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.067 -177.246 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.05 138.93 30.28 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.093 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.507 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.2 m -128.38 155.83 40.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.674 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.98 120.03 26.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CZ ' HG21 ' A' ' 101' ' ' VAL . 21.1 m-85 -110.48 132.72 53.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.659 0.266 . . . . 0.0 110.638 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -91.55 105.88 18.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.502 0.668 . . . . 0.0 109.573 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -116.66 135.78 53.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.573 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -87.8 114.51 24.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.993 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.549 HD11 HG11 ' A' ' 37' ' ' VAL . 1.7 mp -90.42 91.34 8.42 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -102.37 155.01 18.53 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.072 0.463 . . . . 0.0 110.977 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt -129.14 163.31 25.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -91.69 174.35 7.4 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.285 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.48 149.47 42.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.167 0.508 . . . . 0.0 111.554 177.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.756 ' HA ' HG21 ' A' ' 22' ' ' VAL . 18.7 tt0 -65.12 102.24 0.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.107 176.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.855 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 108.51 23.38 6.61 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.36 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.517 ' CG ' ' HD2' ' A' ' 115' ' ' PRO . 48.4 t60 -128.55 154.76 79.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 118.639 -0.695 . . . . 0.0 109.134 -176.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 114' ' ' HIS . 7.0 Cg_exo -31.03 171.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.516 0 C-N-CA 125.042 3.828 . . . . 0.0 116.038 171.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -98.16 169.97 0.68 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 124.4 3.4 . . . . 0.0 112.41 -169.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 22.3 t -115.99 131.17 69.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -145.35 97.85 3.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -126.23 131.56 51.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.545 -174.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.8 mt -107.39 146.54 31.51 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.698 0.623 . . . . 0.0 109.835 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -139.96 129.01 23.59 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.246 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.455 ' N ' ' HD3' ' A' ' 121' ' ' ARG . 67.2 m -120.07 123.91 44.56 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -172.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -122.43 145.49 48.24 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.727 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -100.61 129.14 46.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.22 0.533 . . . . 0.0 111.797 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.838 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.5 mt -94.63 119.44 33.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.688 172.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.5 m -109.51 123.53 49.56 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.894 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.485 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 31.3 m-85 -120.07 108.3 14.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.894 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -78.73 118.2 20.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.508 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.742 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 6.7 t30 50.02 64.55 8.24 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.676 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 127' ' ' PHE . 74.3 Cg_endo -74.68 178.06 7.64 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.402 2.068 . . . . 0.0 111.673 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.554 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 10.8 p -72.19 142.94 49.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.58 -37.93 76.83 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.067 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -63.85 -29.37 70.57 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.653 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 9.6 t80 -73.85 -42.05 61.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.639 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.1 ttm180 -54.3 -46.05 72.69 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.766 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -54.61 -38.26 66.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.441 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 44.3 mtpt -73.93 -40.19 63.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.799 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.7 mt -67.87 -32.57 73.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 40.5 mt -79.71 -32.28 41.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.316 . . . . 0.0 111.099 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -75.89 -25.74 56.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.306 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.216 174.859 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.725 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -82.7 107.43 2.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.287 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm 62.92 -154.16 0.34 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 122.737 0.415 . . . . 0.0 110.198 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.484 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -63.56 164.72 14.3 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.109 173.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.484 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 10.5 Cg_endo -54.54 157.97 11.14 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.038 1.825 . . . . 0.0 111.437 175.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -128.41 160.77 31.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.91 0.386 . . . . 0.0 110.387 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 218' ' ' ALY . . . . . 0.455 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -77.94 -42.42 33.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.092 0.473 . . . . 0.0 109.858 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 90.3 mt -101.42 95.0 6.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.785 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' B' ' 224' ' ' ALA . . . 64.92 89.81 0.09 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.728 0.643 . . . . 0.0 111.731 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 32.8 m -64.7 110.61 2.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.589 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 61.48 27.63 17.13 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.458 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' ALA . . . . . 0.415 ' HA ' ' HB1' ' B' ' 221' ' ' ALA . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.518 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m 58.0 42.79 22.13 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.258 0.552 . . . . 0.0 110.619 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -75.25 120.81 21.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.879 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -99.21 -24.46 14.85 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.385 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.35 -78.04 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.044 0.84 . . . . 0.0 111.78 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.6 t -140.04 124.97 18.44 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.489 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 16.9 m -103.01 108.91 20.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.84 0.352 . . . . 0.0 110.445 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.645 ' O ' ' HD2' ' A' ' 130' ' ' PRO . 42.7 t -92.24 111.63 23.26 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.96 118.37 35.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.095 0.474 . . . . 0.0 111.581 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 t -100.01 143.88 13.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.83 127.59 29.17 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.391 0.615 . . . . 0.0 110.955 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.794 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.02 176.81 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.942 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.582 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 95.3 mttt -138.64 137.63 37.09 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.408 ' HG ' HD11 ' A' ' 125' ' ' LEU . 88.8 mt -122.45 142.05 50.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.076 0.465 . . . . 0.0 109.812 173.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.2 tt0 -104.34 124.65 49.58 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.999 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.643 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -110.85 114.17 27.3 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -140.09 174.86 22.23 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.618 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 36' ' ' MET . 2.0 p-80 -166.17 153.05 9.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.212 0.529 . . . . 0.0 110.195 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 38.4 mtp180 -120.8 134.59 55.28 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.438 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -129.89 119.87 23.99 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.492 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -117.89 145.84 44.34 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.757 HG21 ' HA ' ' A' ' 112' ' ' GLU . 5.0 p -99.07 154.79 4.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 32' ' ' THR . 2.4 mtp180 -107.61 147.89 30.04 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -76.54 -12.44 60.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.764 0.792 . . . . 0.0 109.502 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -142.5 104.97 5.45 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.032 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.437 ' HG3' HG22 ' A' ' 32' ' ' THR . 78.7 Cg_exo -47.25 157.86 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.489 2.793 . . . . 0.0 113.46 177.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -76.97 -173.04 2.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.898 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.482 HG22 ' OE1' ' A' ' 29' ' ' GLU . 2.1 m -66.52 -28.8 44.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.96 0.409 . . . . 0.0 110.898 -174.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.482 ' OE1' HG22 ' A' ' 28' ' ' VAL . 1.9 mp0 -78.49 -8.12 58.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 110.227 175.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.01 32.99 37.92 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.2 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -98.94 140.8 32.56 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.437 HG22 ' HG3' ' A' ' 26' ' ' PRO . 38.0 p -89.25 -27.26 20.72 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -169.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -118.85 142.59 47.59 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -172.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -116.09 119.48 35.98 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 172.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 78' ' ' GLU . 48.8 p-90 -121.35 150.96 40.68 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.093 0.473 . . . . 0.0 111.13 -178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 53.4 ttp -126.34 120.6 30.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.679 175.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.4 m -101.19 150.1 6.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.225 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.635 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.2 p90 -151.46 152.41 32.99 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.5 m -124.03 127.24 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.001 170.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -136.8 -176.74 4.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . -91.82 169.63 32.67 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 175.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 15.0 Cg_endo -53.39 113.96 1.54 Allowed 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 123.776 2.984 . . . . 0.0 112.657 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 56.32 51.26 11.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.419 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 69.12 11.95 8.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.482 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.478 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 66.8 m -62.27 126.83 28.7 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 171.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.54 ' OD1' ' HB2' ' A' ' 48' ' ' GLN . 6.5 t-20 -68.7 125.49 26.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.095 -175.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.626 HD12 HG21 ' A' ' 51' ' ' VAL . 1.5 pt -96.78 -2.37 10.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -174.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.54 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 11.1 mt-30 -61.82 -3.95 1.34 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -77.56 -37.85 49.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.401 0.143 . . . . 0.0 110.871 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.443 ' CE2' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -115.23 -18.61 11.07 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.547 176.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.626 HG21 HD12 ' A' ' 47' ' ' ILE . 84.2 t -90.48 130.15 40.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.413 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 8.4 tp10 -98.83 -58.58 1.91 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.315 0.579 . . . . 0.0 110.355 -176.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -149.02 153.76 38.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.048 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 55' ' ' VAL . 66.9 t -129.12 159.09 41.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.229 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.592 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.2 p -143.1 135.1 24.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.219 0.533 . . . . 0.0 111.363 -175.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.527 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 27.6 m-85 -116.7 111.66 20.11 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.16 93.15 7.0 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.414 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.608 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.6 mt -76.87 -176.91 4.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.426 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.507 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 36.8 t60 -66.86 138.69 57.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.063 0.459 . . . . 0.0 109.802 -177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -56.3 -25.68 49.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.4 t -75.52 -18.31 59.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.451 0.167 . . . . 0.0 111.438 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 59' ' ' HIS . 3.3 m-85 -75.09 134.91 73.91 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -60.99 117.56 4.34 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.714 2.276 . . . . 0.0 111.437 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 59.02 70.51 1.13 Allowed Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.503 -171.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.73 -17.45 59.12 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.733 2.288 . . . . 0.0 111.866 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -91.88 102.33 14.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.165 -177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.0 mmt180 -97.91 104.68 16.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.781 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.05 136.14 24.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.218 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 79.6 m -126.12 115.42 19.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.953 0.406 . . . . 0.0 109.923 175.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -106.69 -24.77 12.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.605 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.726 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 6.0 p-10 -75.71 -174.71 0.41 Allowed Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.329 -175.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.726 ' HD2' ' HB2' ' A' ' 71' ' ' ASP . 71.7 Cg_exo -39.11 -172.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.01 3.14 . . . . 0.0 114.548 167.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.648 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 8.5 Cg_endo -35.55 122.92 0.24 Allowed 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.399 2.733 . . . . 0.0 113.662 -152.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 44.2 m-85 -61.93 91.2 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.21 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 5.4 ptpt -139.37 146.4 40.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 0.0 112.034 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.7 t -120.96 132.29 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.345 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.54 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 5.3 mm-40 -108.56 106.04 15.93 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.246 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 35' ' ' TRP . 1.5 tp10 -134.79 171.06 14.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.709 0.29 . . . . 0.0 110.412 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -131.91 144.4 50.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.856 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.5 -170.34 27.18 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -126.72 -11.63 6.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.289 0.544 . . . . 0.0 111.771 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' B' ' 217' ' ' ARG . . . -147.83 141.49 25.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.961 0.41 . . . . 0.0 111.565 -176.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.11 164.49 51.41 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.099 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -163.31 156.37 18.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.458 HD13 ' HA ' ' A' ' 106' ' ' ASP . 21.9 mm -64.37 126.07 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 110.211 173.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.608 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.0 tt -120.39 104.46 42.99 Favored Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.232 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.9 116.56 4.2 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.296 2.664 . . . . 0.0 112.536 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.417 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.8 mt -107.76 127.45 63.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.175 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.592 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.5 mt-10 -110.11 126.88 54.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.1 0.476 . . . . 0.0 110.01 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.3 t -106.49 119.97 56.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.744 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 88.5 m-85 -92.53 135.84 33.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.822 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.427 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.1 m-85 -109.93 148.21 32.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.308 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.413 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -87.52 94.6 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.476 ' HB3' ' HG3' ' A' ' 99' ' ' ARG . 1.4 t-20 -155.66 155.4 33.15 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.273 -172.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.52 -2.51 18.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.693 0.758 . . . . 0.0 109.466 171.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -101.55 -152.01 0.43 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.218 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.445 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 8.2 mm-40 -29.42 150.33 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.195 0.998 . . . . 0.0 113.548 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.0 Cg_exo -32.2 126.54 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.05 1 C-N-CA 125.415 4.077 . . . . 0.0 115.011 -168.32 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.476 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -89.64 19.03 4.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.304 -177.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.9 140.07 16.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.361 0.6 . . . . 0.0 111.552 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.2 m -130.47 155.36 41.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.008 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -123.44 120.33 32.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.978 0.418 . . . . 0.0 111.25 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.643 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.5 m-85 -112.44 116.6 30.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.446 174.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -85.93 105.98 16.79 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.457 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 61.8 t80 -112.34 137.2 50.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.911 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.458 ' HA ' HD13 ' A' ' 85' ' ' ILE . 38.2 t70 -86.36 103.52 15.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.308 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.499 HD11 HG11 ' A' ' 37' ' ' VAL . 2.5 mp -82.21 115.82 21.47 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.499 ' HB2' ' HA3' ' B' ' 213' ' ' GLY . 50.0 p90 -131.15 160.74 33.87 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.534 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.9 mt -136.18 163.26 30.78 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -175.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -100.84 172.81 6.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.99 152.25 24.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.846 0.355 . . . . 0.0 111.677 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.757 ' HA ' HG21 ' A' ' 22' ' ' VAL . 10.4 tt0 -64.2 106.3 1.06 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.926 175.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.51 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 108.05 23.01 6.92 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.449 ' HB3' ' HD2' ' A' ' 115' ' ' PRO . 21.9 m-70 -133.89 163.57 50.19 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 114' ' ' HIS . 1.3 Cg_endo -43.37 162.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.074 3.183 . . . . 0.0 114.392 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -89.53 -179.27 1.9 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.947 3.098 . . . . 0.0 111.288 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 16.7 t -126.82 134.15 66.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.671 -175.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -144.15 97.45 3.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.5 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.5 t-80 -120.82 137.68 54.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.764 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.5 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.0 mt -120.48 146.95 45.75 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.478 0.487 . . . . 0.0 110.436 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.3 ttm180 -138.93 149.99 45.41 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.448 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 71.6 m -133.7 121.13 21.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 175.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -116.62 133.79 55.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 110.358 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -84.7 141.44 30.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.544 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.794 ' HB2' HG23 ' A' ' 12' ' ' VAL . 5.3 mt -111.35 110.47 20.95 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.2 m -107.09 120.02 40.95 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.822 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.547 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 25.8 m-85 -116.78 109.98 17.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.787 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -79.0 116.91 19.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.976 0.417 . . . . 0.0 110.576 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 4.6 t30 56.7 61.67 6.79 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.211 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 72.0 Cg_endo -75.74 169.86 21.38 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.306 2.004 . . . . 0.0 111.039 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.3 p -74.84 144.66 43.34 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -53.35 -43.09 67.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -172.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -55.73 -34.18 64.91 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.883 0.373 . . . . 0.0 110.421 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.682 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 7.8 t80 -75.95 -40.9 53.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.592 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.6 ttm180 -54.79 -43.92 73.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.564 0.697 . . . . 0.0 109.386 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.23 -36.49 75.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.216 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -73.97 -40.66 62.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.749 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.0 mt -66.81 -37.08 83.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.02 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.1 mt -75.33 -34.08 61.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.04 0.447 . . . . 0.0 110.577 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -72.32 -26.43 61.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.956 -175.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.352 -0.833 . . . . 0.0 110.541 175.986 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.916 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 213' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 108' ' ' PHE . . . 109.21 176.54 21.42 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.856 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -128.43 36.88 4.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.826 0.346 . . . . 0.0 110.117 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.583 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -135.28 169.06 14.74 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.583 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 29.2 Cg_endo -62.58 169.25 8.66 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 121.788 1.659 . . . . 0.0 111.49 176.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.458 ' HA ' ' HB1' ' A' ' 82' ' ' ALA . 33.1 mtp180 -138.66 157.3 46.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.159 0.504 . . . . 0.0 110.883 178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -82.87 154.53 24.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.858 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 35.6 tp -81.66 62.47 5.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.311 0.576 . . . . 0.0 109.501 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -79.85 -37.71 34.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.062 -176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 30.9 m 65.54 93.57 0.07 Allowed 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.532 0.52 . . . . 0.0 111.533 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -69.82 129.38 39.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.193 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 O-C-N 123.849 0.718 . . . . 0.0 111.221 179.01 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -80.48 -33.11 36.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.733 0.266 . . . . 0.0 111.178 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -88.12 -41.35 13.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.116 0.484 . . . . 0.0 109.911 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.3 mtt -118.26 98.42 6.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.948 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.36 143.4 26.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.42 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 p -76.12 91.72 3.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.434 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.434 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 15.6 t -80.85 109.69 15.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.184 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 60.1 m -131.44 141.35 49.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.537 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.11 151.01 31.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.56 138.52 41.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.418 ' HB3' ' HD2' ' A' ' 124' ' ' LYS . 8.9 mt-30 -114.39 138.77 50.13 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.806 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -132.71 125.77 53.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.441 177.179 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -99.81 130.23 45.99 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.639 -0.663 . . . . 0.0 111.279 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD13 HG11 ' A' ' 90' ' ' VAL . 96.3 mt -108.98 142.38 39.72 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.848 176.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.68 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.0 tt0 -104.15 126.42 51.25 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.195 -174.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.612 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -114.55 122.64 47.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -152.1 172.74 31.37 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.239 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -165.7 152.38 9.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.044 0.449 . . . . 0.0 110.138 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -117.03 152.04 35.48 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -141.96 133.29 26.47 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.532 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -129.79 164.74 23.4 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.823 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.845 HG11 ' H ' ' A' ' 113' ' ' GLY . 2.4 p -104.24 161.01 4.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 168.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.499 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 4.3 mtp85 -105.52 140.54 38.45 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -67.05 -17.87 65.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.73 0.776 . . . . 0.0 109.477 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -136.76 107.31 9.04 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.893 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.528 ' HG3' HG22 ' A' ' 32' ' ' THR . 64.7 Cg_exo -45.89 156.3 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.277 2.651 . . . . 0.0 113.176 177.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 29' ' ' GLU . 11.3 t -75.99 -169.92 1.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.634 -171.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.54 -27.4 42.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 122.874 0.47 . . . . 0.0 111.532 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' H ' HG23 ' A' ' 27' ' ' THR . 20.7 mm-40 -86.6 -12.06 49.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.408 0.623 . . . . 0.0 109.856 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.85 19.96 38.46 Favored Glycine 0 CA--C 1.503 -0.7 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.575 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -91.25 145.18 24.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.663 -0.768 . . . . 0.0 110.827 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.528 HG22 ' HG3' ' A' ' 26' ' ' PRO . 44.6 p -94.0 -28.72 15.61 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.4 -164.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.407 ' NE2' ' O ' ' A' ' 110' ' ' HIS . 59.9 m80 -108.64 153.69 23.06 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -169.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 1.1 m-20 -131.95 133.35 44.41 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.409 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 56.7 p-90 -139.19 149.82 44.85 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.046 0.451 . . . . 0.0 111.488 -177.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.654 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 47.7 ttp -125.85 120.91 31.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.887 174.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.5 m -99.92 152.73 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.315 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.3 p90 -150.94 153.16 34.72 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.4 m -127.09 128.54 70.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.244 170.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -135.28 -176.12 4.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.949 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.476 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -91.12 -169.06 42.11 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.269 177.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 4.9 Cg_exo -72.82 112.16 3.43 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.665 2.244 . . . . 0.0 111.617 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 59.55 60.68 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.536 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 67.0 m80 71.16 -3.0 2.18 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 66.6 m -60.06 134.15 56.78 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.479 0.181 . . . . 0.0 111.299 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -69.96 126.42 29.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.659 HD12 HG21 ' A' ' 51' ' ' VAL . 1.5 pt -96.66 -4.84 9.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -174.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -68.89 6.21 0.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.851 0.357 . . . . 0.0 111.782 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -80.12 -33.57 38.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.546 172.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.4 ' CE1' HG22 ' A' ' 47' ' ' ILE . 54.4 p90 -119.39 -18.75 8.46 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.301 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.659 HG21 HD12 ' A' ' 47' ' ' ILE . 91.4 t -88.68 131.25 36.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -98.06 -52.01 3.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 0.0 110.366 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -156.97 158.56 36.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.67 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 55' ' ' VAL . 93.9 t -132.29 158.11 43.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.586 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.6 p -141.92 135.39 29.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.225 0.535 . . . . 0.0 111.085 -175.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.512 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 29.3 m-85 -117.59 108.37 15.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.73 92.57 4.81 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.161 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.621 ' CD2' HD11 ' A' ' 86' ' ' LEU . 10.7 mt -76.9 -178.42 4.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -79.01 144.02 35.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.07 -19.76 21.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.832 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -66.58 -21.95 66.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.111 0.481 . . . . 0.0 110.997 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -84.14 132.89 46.54 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.528 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.82 122.43 10.98 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.41 2.074 . . . . 0.0 111.1 172.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 59.96 69.3 1.25 Allowed Pre-proline 0 CA--C 1.531 0.232 0 O-C-N 123.738 0.649 . . . . 0.0 110.476 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.81 -22.4 49.49 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.636 2.224 . . . . 0.0 113.157 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -93.33 98.47 11.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.247 0.546 . . . . 0.0 110.202 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 13.2 mmt180 -94.36 96.69 9.7 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.446 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -86.35 136.66 22.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 172.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.0 m -124.86 111.6 15.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.03 0.443 . . . . 0.0 109.925 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -100.73 -27.51 13.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.681 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.503 ' OD1' ' HD2' ' A' ' 72' ' ' PRO . 28.4 t70 -69.63 168.63 15.99 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.712 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.61 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 42.4 Cg_exo -26.35 -168.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.864 1 C-N-CA 126.12 4.547 . . . . 0.0 116.277 161.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.61 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 10.3 Cg_endo -37.18 120.2 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.981 2.454 . . . . 0.0 113.976 -151.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 35.3 m-85 -62.45 98.37 0.11 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.935 -177.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 11.9 ptpt -149.52 146.23 27.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.468 0.651 . . . . 0.0 112.103 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.9 t -126.5 131.22 71.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.011 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -117.0 111.34 19.43 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -132.7 171.54 13.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.33 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 5.0 t -116.4 146.41 42.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.18 172.06 28.52 Favored Glycine 0 CA--C 1.507 -0.434 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.802 -173.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -130.41 -4.17 4.3 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.962 0.41 . . . . 0.0 110.215 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' B' ' 217' ' ' ARG . . . -164.1 137.19 5.18 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.222 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.49 -174.47 28.72 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 116.187 -0.46 . . . . 0.0 114.19 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.0 p90 179.96 158.02 0.71 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.858 0.463 . . . . 0.0 110.462 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.83 129.26 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.621 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.3 tt -120.85 104.76 41.48 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-O 121.109 0.48 . . . . 0.0 110.154 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.82 114.37 3.12 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 123.25 2.634 . . . . 0.0 112.196 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -104.43 124.58 59.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.065 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.586 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.0 mt-10 -108.52 127.09 53.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.164 0.507 . . . . 0.0 110.008 175.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.452 HG11 HD13 ' A' ' 14' ' ' LEU . 57.0 t -106.73 117.98 53.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.622 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 81.0 m-85 -90.32 139.33 30.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.809 -178.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.448 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.0 m-85 -114.94 151.66 33.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.197 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.5 95.48 9.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.614 HD21 ' HB2' ' A' ' 96' ' ' GLU . 56.6 t30 -155.5 160.9 40.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.222 0.534 . . . . 0.0 111.595 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.66 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.6 OUTLIER -112.37 -1.42 15.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.778 178.132 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.614 ' HB2' HD21 ' A' ' 94' ' ' ASN . 18.4 mm-40 -102.02 -154.19 0.48 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.787 -175.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 97' ' ' GLU . 2.4 mp0 -26.79 152.5 0.01 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.938 1.295 . . . . 0.0 114.082 172.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 3.2 Cg_exo -31.66 125.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.197 1 C-N-CA 125.399 4.066 . . . . 0.0 114.756 -169.206 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.26 19.72 3.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.998 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -153.49 146.47 24.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.188 0.518 . . . . 0.0 110.934 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -128.7 155.87 40.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.025 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -120.89 121.29 37.75 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.841 0.353 . . . . 0.0 111.064 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.612 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.4 m-85 -113.79 112.21 23.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.649 173.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.31 105.97 11.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -115.57 137.25 52.26 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.672 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -85.86 114.25 22.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.894 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.532 HD11 HG11 ' A' ' 37' ' ' VAL . 2.0 mp -92.89 103.86 16.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -115.59 158.9 21.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.064 0.459 . . . . 0.0 110.28 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.1 mt -130.75 158.11 41.0 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.407 ' O ' ' NE2' ' A' ' 33' ' ' HIS . 2.8 m-70 -101.82 173.86 6.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.297 0.498 . . . . 0.0 110.648 173.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -62.4 136.8 58.08 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -173.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.487 ' HA ' HG21 ' A' ' 22' ' ' VAL . 6.5 tt0 -51.4 122.81 8.47 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.844 177.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.845 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 122.8 -50.66 0.83 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.963 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -145.19 74.7 14.17 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 117.183 0.491 . . . . 0.0 110.605 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.514 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 39.6 Cg_endo -107.06 108.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.131 2.554 . . . . 0.0 113.263 176.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -98.27 97.52 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 123.0 2.467 . . . . 0.0 111.068 170.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 39.5 t -116.93 107.5 22.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.619 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -135.79 98.37 3.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -121.8 142.78 49.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.178 -176.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.456 HD11 ' CG ' ' A' ' 15' ' ' GLU . 16.6 tp -136.99 159.38 42.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.163 0.506 . . . . 0.0 111.57 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.502 ' HD2' HD23 ' A' ' 16' ' ' LEU . 19.7 ttm180 -152.98 149.23 27.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.321 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.414 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 69.5 m -138.7 118.25 12.98 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 174.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -114.7 146.06 41.34 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 11' ' ' GLN . 38.6 ttpt -103.52 127.48 50.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.416 0.627 . . . . 0.0 112.398 -174.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.806 ' HB2' HG23 ' A' ' 12' ' ' VAL . 7.7 mt -86.43 149.53 24.93 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.3 m -140.97 121.89 14.5 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.144 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -115.93 114.85 25.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.232 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -84.76 120.85 26.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.315 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 55.1 m-80 50.5 65.49 6.73 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.766 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.35 -178.76 4.2 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.764 2.309 . . . . 0.0 112.074 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 74.4 p -74.97 137.15 41.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -61.19 -29.15 69.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -67.57 -28.3 67.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.646 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.8 t80 -75.07 -42.96 55.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.409 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.66 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.3 ttm180 -54.45 -43.69 71.85 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.755 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -55.87 -39.79 72.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.156 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 51.0 mtpt -71.09 -39.76 71.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.811 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 33.9 mt -69.61 -26.68 64.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.73 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 41.6 mt -86.19 -28.88 23.62 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.054 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -77.22 -31.15 55.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.261 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.828 178.487 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.84 -93.0 1.72 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.844 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -80.63 141.33 35.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.015 0.436 . . . . 0.0 110.411 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.409 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -75.17 162.91 71.23 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.715 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 14.0 Cg_endo -58.97 172.27 1.73 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.221 1.947 . . . . 0.0 112.129 173.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.507 ' HA ' ' HB1' ' A' ' 82' ' ' ALA . 11.8 ptp180 -152.74 153.68 33.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.28 0.562 . . . . 0.0 111.577 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -136.66 26.7 3.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.747 -173.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 51.2 tp -106.96 89.28 2.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.316 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -94.16 16.19 15.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.83 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 30.0 m 75.29 -61.08 0.49 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.926 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 57.01 64.73 1.56 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.346 0.593 . . . . 0.0 110.728 -175.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.146 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.687 177.89 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t 59.23 76.16 0.37 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.37 0.605 . . . . 0.0 110.336 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -153.89 -172.13 4.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.977 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.5 tpp 61.86 80.05 0.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.804 0.69 . . . . 0.0 110.914 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.48 148.8 35.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.375 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.0 p -79.27 76.49 5.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.109 0.481 . . . . 0.0 110.559 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.404 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 25.2 t -73.87 109.41 7.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.379 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.9 m -105.33 114.89 29.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.692 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.9 131.21 43.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.054 0.454 . . . . 0.0 111.974 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 t -101.72 140.72 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.1 mp0 -125.78 120.66 31.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.087 0.47 . . . . 0.0 110.224 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.857 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -108.52 177.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.686 179.007 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 98.7 mttt -142.58 136.42 29.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.579 0.228 . . . . 0.0 110.74 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.437 ' HG ' HD11 ' A' ' 125' ' ' LEU . 79.4 mt -119.68 142.56 48.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 109.945 174.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.609 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.8 tt0 -102.87 123.08 45.84 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.058 -176.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.645 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -109.78 113.68 26.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 174.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -142.67 173.8 23.8 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.849 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -164.01 151.93 12.7 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.007 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 70.6 mtt180 -116.82 140.92 48.87 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.748 171.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.0 125.51 29.87 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.282 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -119.5 155.07 32.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.718 HG21 ' HA ' ' A' ' 112' ' ' GLU . 4.9 p -103.93 159.3 5.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.452 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 2.2 mtp180 -108.84 147.43 32.12 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -72.13 -18.39 61.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.651 0.738 . . . . 0.0 109.28 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -139.89 103.81 6.87 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.412 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.533 ' HG3' HG22 ' A' ' 32' ' ' THR . 70.2 Cg_exo -47.2 156.61 0.81 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.533 2.822 . . . . 0.0 112.736 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.422 HG22 ' HB2' ' A' ' 31' ' ' PHE . 10.2 t -77.23 -174.52 3.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.665 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.49 HG22 ' OE1' ' A' ' 29' ' ' GLU . 1.1 m -64.15 -27.81 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.106 0.479 . . . . 0.0 110.827 -175.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.49 ' OE1' HG22 ' A' ' 28' ' ' VAL . 2.3 mp0 -80.18 -2.06 43.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.382 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.26 31.22 63.92 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.365 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.422 ' HB2' HG22 ' A' ' 27' ' ' THR . 21.6 m-30 -93.64 131.55 38.84 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.533 HG22 ' HG3' ' A' ' 26' ' ' PRO . 62.1 p -89.69 -20.32 23.77 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.426 -168.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.413 ' NE2' ' O ' ' A' ' 110' ' ' HIS . 66.0 m80 -124.07 148.33 47.18 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -172.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.452 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 7.4 m-20 -123.82 123.79 41.24 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 170.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -123.8 154.24 39.85 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.29 0.567 . . . . 0.0 111.192 -176.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.643 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 15.1 tmm? -128.96 136.71 50.73 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.062 174.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.3 m -121.67 149.43 24.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.387 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.663 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.6 OUTLIER -149.32 157.25 43.18 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.2 m -123.91 126.38 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.662 167.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -135.39 -176.28 4.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.734 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . -93.19 179.15 39.18 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.427 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.413 ' HB3' ' HB2' ' A' ' 13' ' ' LYS . 33.8 Cg_endo -73.97 112.67 3.6 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.337 2.025 . . . . 0.0 111.879 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 61.71 47.86 5.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.079 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 67.88 6.97 5.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.715 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.489 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 48.6 m -63.26 122.53 16.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -60.83 125.01 22.14 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.93 0.395 . . . . 0.0 110.528 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.584 HD12 HG21 ' A' ' 51' ' ' VAL . 1.7 pt -95.3 -2.2 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.738 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -59.23 -12.85 5.99 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.306 0.574 . . . . 0.0 110.672 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -67.8 -45.0 76.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.959 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.416 ' CE2' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -111.83 -18.37 12.72 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.309 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.584 HG21 HD12 ' A' ' 47' ' ' ILE . 59.3 t -92.58 137.02 23.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.964 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.555 ' HB2' ' HG3' ' A' ' 93' ' ' LYS . 10.5 tp10 -113.98 -63.18 1.49 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.271 0.557 . . . . 0.0 110.915 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 24.9 tttt -136.73 149.55 47.92 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.129 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 99.0 t -131.13 156.94 43.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.601 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.9 p -140.62 134.9 34.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.374 0.606 . . . . 0.0 111.601 -175.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.496 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 16.1 m-85 -117.33 111.26 19.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -81.75 97.88 8.17 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.043 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.625 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.3 mt -80.77 -177.82 6.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.877 0.37 . . . . 0.0 110.631 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 143.2 45.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -60.04 -23.29 63.61 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.1 t -70.68 -22.15 62.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.998 0.427 . . . . 0.0 110.867 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 17.8 m-85 -75.39 141.48 73.52 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.731 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 62' ' ' PHE . 23.4 Cg_exo -64.77 128.55 21.23 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.395 2.063 . . . . 0.0 110.318 171.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.519 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 52.9 mtm180 58.11 74.92 0.58 Allowed Pre-proline 0 C--N 1.331 -0.226 0 O-C-N 123.618 0.574 . . . . 0.0 110.246 -175.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.1 -24.38 52.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.509 2.139 . . . . 0.0 113.065 -178.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -101.52 104.62 15.53 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.14 0.495 . . . . 0.0 110.183 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.519 ' HD3' ' O ' ' A' ' 64' ' ' ARG . 9.4 mmm-85 -103.1 104.13 14.26 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.492 -177.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -98.59 137.63 25.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.8 m -118.1 120.22 37.12 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -103.16 -29.83 11.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.613 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.578 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 6.2 m-20 -81.03 -178.31 1.14 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.101 -175.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 0.9 OUTLIER -41.34 -166.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 124.277 3.318 . . . . 0.0 114.231 165.276 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.564 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 3.3 Cg_endo -29.82 118.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 123.291 2.661 . . . . 0.0 113.883 -147.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.663 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 54.2 m-85 -64.56 88.75 0.06 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.848 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 13.9 ptpt -136.92 142.9 42.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.409 0.623 . . . . 0.0 112.418 -174.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.6 t -119.56 136.56 56.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.618 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -124.21 107.01 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.35 172.84 12.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.402 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.4 t -123.15 146.03 48.11 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.674 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.38 23.72 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -130.27 -18.35 3.27 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.503 0.652 . . . . 0.0 111.903 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.438 ' HB3' ' HG3' ' B' ' 218' ' ' ALY . . . -142.75 145.09 32.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.001 0.429 . . . . 0.0 111.178 -174.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.73 172.5 51.97 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.673 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -168.71 158.9 9.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 122.905 0.482 . . . . 0.0 110.064 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 mm -66.76 121.08 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.188 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.625 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.6 tt -116.46 108.25 45.67 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.406 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -79.9 121.26 4.47 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.799 2.333 . . . . 0.0 112.056 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.475 HG12 ' CE2' ' A' ' 56' ' ' PHE . 3.9 mp -105.53 133.59 49.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.323 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.9 mt-10 -113.37 121.32 43.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.202 0.525 . . . . 0.0 110.217 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.426 HG13 HG22 ' A' ' 54' ' ' VAL . 84.0 t -101.54 122.56 53.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.115 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.565 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 87.3 m-85 -91.12 138.57 31.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.548 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.461 ' HE1' HG22 ' A' ' 51' ' ' VAL . 21.3 m-85 -119.91 162.32 19.37 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.16 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.555 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -105.16 97.24 7.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 121.159 -0.217 . . . . 0.0 111.353 176.282 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -155.63 168.86 25.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.298 0.57 . . . . 0.0 112.272 173.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.591 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -103.97 9.28 36.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.484 174.596 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.4 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 35.9 mm-40 -101.01 -154.65 0.49 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.442 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.475 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 22.6 mm-40 -35.95 157.36 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.63 0 C-N-CA 124.24 1.016 . . . . 0.0 113.266 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 7.3 Cg_exo -31.88 125.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 124.713 3.609 . . . . 0.0 114.302 -172.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.45 20.06 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.841 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -152.13 140.76 20.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.919 178.58 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.2 m -115.91 156.79 16.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -128.39 107.88 10.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.873 0.368 . . . . 0.0 110.487 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.2 m-85 -105.67 120.96 43.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.202 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -82.59 117.15 22.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -126.6 136.18 52.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.242 0.544 . . . . 0.0 110.875 -176.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.38 112.79 21.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.951 -178.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.569 HD11 HG11 ' A' ' 37' ' ' VAL . 1.2 mp -91.04 94.64 9.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -104.03 155.85 18.34 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.087 0.47 . . . . 0.0 111.054 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.5 mt -129.36 162.5 27.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.247 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.6 ' NE2' ' HA ' ' A' ' 116' ' ' PRO . 5.7 p80 -100.18 173.09 6.79 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.285 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -73.57 161.03 30.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.997 0.427 . . . . 0.0 111.635 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.718 ' HA ' HG21 ' A' ' 22' ' ' VAL . 14.7 mt-10 -64.99 125.53 25.17 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.304 173.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.498 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 83.08 21.29 59.29 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.432 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.456 ' CG ' ' HD2' ' A' ' 115' ' ' PRO . 57.4 t60 -121.31 147.58 47.52 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 114' ' ' HIS . 10.9 Cg_endo -55.28 136.58 74.12 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.278 1.985 . . . . 0.0 113.292 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.6 ' HA ' ' NE2' ' A' ' 110' ' ' HIS . 49.5 Cg_exo -44.73 177.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 124.932 3.755 . . . . 0.0 116.204 175.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 67.4 t -124.16 139.38 50.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.936 -173.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -144.47 96.43 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.421 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.3 t-80 -116.3 132.49 56.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.46 -177.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 119' ' ' HIS . 9.5 mt -117.04 141.82 47.76 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.51 0.506 . . . . 0.0 110.327 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 18.3 ttm180 -131.2 148.41 52.7 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.434 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 59.1 m -133.84 117.0 16.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 6.1 mt-10 -113.34 137.45 51.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.842 0.354 . . . . 0.0 111.085 -175.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -89.45 126.56 35.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.822 -175.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.857 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.2 mt -92.69 115.38 28.05 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 23.7 m -110.66 114.74 28.35 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.911 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -115.64 109.41 17.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.547 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -76.02 117.77 18.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.129 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.404 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 5.5 t30 54.46 67.32 3.45 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.267 176.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.96 -179.37 5.05 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.56 2.173 . . . . 0.0 111.359 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.2 p -77.52 145.7 36.82 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 173.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -54.42 -40.54 68.38 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.795 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.1 p-10 -59.81 -32.44 70.64 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.593 0.235 . . . . 0.0 110.662 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.676 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 4.7 t80 -73.78 -41.11 62.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.621 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 45.2 ttm105 -54.72 -43.61 72.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.609 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -57.33 -37.43 72.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.31 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 32.7 mtpt -73.94 -42.42 60.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.839 0.352 . . . . 0.0 110.3 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 33.0 mt -69.73 -30.99 68.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.219 -176.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 27.3 mt -79.64 -32.8 41.7 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.778 0.323 . . . . 0.0 110.684 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.62 -30.27 64.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.565 -176.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.757 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 213' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' B' ' 214' ' ' LYS . . . -99.51 147.22 18.25 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.586 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 214' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' B' ' 213' ' ' GLY . 92.4 mttt 70.2 119.66 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.634 0.731 . . . . 0.0 112.091 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -72.27 171.05 10.54 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.612 172.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 6.9 Cg_endo -51.09 168.62 0.23 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.12 1.88 . . . . 0.0 112.465 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -145.01 141.65 29.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.923 0.392 . . . . 0.0 111.123 -174.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 218' ' ' ALY . . . . . 0.438 ' HG3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -59.41 151.61 23.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.446 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.758 ' H ' HD23 ' B' ' 220' ' ' LEU . 1.5 pt? -83.81 52.22 2.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.574 0.702 . . . . 0.0 110.217 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -140.18 149.67 43.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.148 -177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 15.1 t -107.6 149.57 27.89 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -135.24 147.64 49.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.299 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.858 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.417 172.208 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.522 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 t -122.69 -3.29 8.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.627 0.214 . . . . 0.0 110.807 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -70.96 -59.55 2.73 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.0 ttm -100.99 -34.74 9.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.706 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 53.83 56.59 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.544 0.528 . . . . 0.0 110.474 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.2 p -66.08 113.31 4.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.648 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.417 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 63.4 m -73.59 109.11 6.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.971 0.415 . . . . 0.0 110.081 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.5 p -88.53 111.96 22.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.514 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.27 132.27 55.04 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.117 0.484 . . . . 0.0 111.434 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.21 142.38 21.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.1 mp0 -128.08 124.99 38.38 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.262 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.885 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -109.28 168.72 3.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.4 175.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.93 126.56 27.13 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.571 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.412 HD13 HG11 ' A' ' 90' ' ' VAL . 82.2 mt -105.99 142.2 36.1 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.991 177.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.639 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.5 tt0 -102.82 125.0 49.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.05 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.681 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -112.54 113.96 26.38 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -144.91 175.86 24.3 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.849 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -165.88 155.11 11.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.183 0.516 . . . . 0.0 111.164 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 26.7 mtp180 -116.55 152.18 34.66 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.745 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.58 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -147.56 125.82 12.25 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.839 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -125.48 141.99 51.75 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.818 HG11 ' H ' ' A' ' 113' ' ' GLY . 7.5 p -100.73 152.4 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.771 ' HD2' ' O ' ' A' ' 25' ' ' LYS . 5.9 ptt180 -116.7 138.65 51.3 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -68.02 -17.36 64.39 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.562 0.696 . . . . 0.0 109.473 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.771 ' O ' ' HD2' ' A' ' 23' ' ' ARG . 44.7 tttm -117.49 99.05 52.37 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.483 170.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HG3' HG22 ' A' ' 32' ' ' THR . 50.3 Cg_exo -58.11 159.52 18.37 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.104 1.869 . . . . 0.0 110.915 171.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 t -81.68 -172.77 4.05 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.741 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.413 ' H ' HG13 ' A' ' 28' ' ' VAL . 1.7 m -59.0 -29.82 42.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.208 0.528 . . . . 0.0 111.492 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -85.47 -0.22 54.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.32 30.53 62.49 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.162 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -89.45 125.55 35.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.445 HG22 ' HG3' ' A' ' 26' ' ' PRO . 40.4 p -86.6 -27.51 23.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.471 -171.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 79' ' ' SER . 68.6 m80 -118.1 142.27 47.6 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -171.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -115.05 119.96 38.21 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 173.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -122.65 154.95 37.34 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.149 0.499 . . . . 0.0 111.32 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.645 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 52.4 ttp -133.21 119.92 20.48 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.571 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.0 m -100.53 152.31 4.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.285 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.597 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -152.46 155.5 37.62 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.539 -0.464 . . . . 0.0 112.234 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.6 m -128.11 127.17 67.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.132 170.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.475 HH11 ' HB3' ' A' ' 73' ' ' PRO . 9.9 mmm180 -132.49 -177.14 4.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.332 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.456 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -89.75 -167.55 42.49 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.649 174.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 2.9 Cg_exo -73.86 111.53 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.278 1.985 . . . . 0.0 111.697 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 60.78 61.28 1.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.662 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 72.91 -5.54 1.88 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.364 0.666 . . . . 0.0 112.527 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 58.7 m -59.31 133.07 55.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.551 0.215 . . . . 0.0 110.916 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -71.24 126.09 28.7 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.023 0.44 . . . . 0.0 110.318 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.609 HD12 HG21 ' A' ' 51' ' ' VAL . 1.4 pt -96.35 -2.73 10.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.485 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -57.86 -13.91 5.18 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.219 0.533 . . . . 0.0 111.285 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -69.88 -41.42 74.8 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.493 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.469 ' CE2' HG22 ' A' ' 47' ' ' ILE . 52.8 p90 -114.67 -14.39 12.04 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.883 -0.51 . . . . 0.0 111.543 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.609 HG21 HD12 ' A' ' 47' ' ' ILE . 90.0 t -94.31 125.86 46.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -92.44 -62.71 1.34 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.517 -176.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.706 ' HD2' ' CD1' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -145.86 151.1 37.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 98.1 t -125.28 160.93 30.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.594 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.6 p -142.32 137.81 29.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.192 0.52 . . . . 0.0 111.124 -176.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.512 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 26.7 m-85 -119.5 110.78 17.31 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -83.27 92.94 7.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.488 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.606 ' CD2' HD11 ' A' ' 86' ' ' LEU . 11.4 mt -78.54 177.73 8.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.986 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.89 144.32 49.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -58.87 -25.37 63.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.835 -170.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.8 t -72.75 -19.23 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.992 0.425 . . . . 0.0 110.592 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -75.23 135.31 73.13 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.23 118.65 5.49 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.436 2.091 . . . . 0.0 111.135 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 62.29 79.06 0.28 Allowed Pre-proline 0 CA--C 1.53 0.195 0 O-C-N 123.638 0.586 . . . . 0.0 110.203 -176.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.32 -21.16 66.02 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.803 2.336 . . . . 0.0 113.454 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -105.96 108.79 20.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.944 0.402 . . . . 0.0 110.694 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 24.2 mmt85 -106.64 98.37 8.05 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.035 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -84.29 136.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.391 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.9 m -125.7 112.04 15.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.862 0.363 . . . . 0.0 110.267 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -106.93 -21.65 12.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.31 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.667 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 3.1 t70 -65.37 -177.64 0.25 Allowed Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.537 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.667 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 16.7 Cg_exo -33.02 -175.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.542 0 C-N-CA 125.031 3.821 . . . . 0.0 114.285 160.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.649 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.6 Cg_endo -34.81 126.69 0.22 Allowed 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 123.657 2.905 . . . . 0.0 114.044 -160.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 33.0 m-85 -61.8 94.06 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.793 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 3.9 ptpt -144.15 146.29 32.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.225 0.536 . . . . 0.0 111.717 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 36' ' ' MET . 71.7 t -124.87 132.53 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.871 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.97 111.87 21.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.23 172.39 12.75 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.168 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 9.6 t -123.1 149.39 44.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.83 -175.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.82 -169.65 22.47 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -132.18 -10.93 3.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.146 0.473 . . . . 0.0 111.339 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' B' ' 217' ' ' ARG . . . -151.27 140.35 21.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.635 0.255 . . . . 0.0 110.47 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.61 179.22 49.35 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.771 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -173.94 156.28 2.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.677 0.275 . . . . 0.0 110.721 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 85' ' ' ILE . 14.2 mm -64.95 121.27 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.136 172.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.606 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -114.67 104.94 54.04 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.636 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.39 117.07 4.83 Favored 'Trans proline' 0 C--O 1.239 0.559 0 C-N-CA 123.05 2.5 . . . . 0.0 112.019 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 mt -106.81 126.17 62.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.21 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.594 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 46.3 mt-10 -110.57 122.64 48.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.367 0.603 . . . . 0.0 110.181 176.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.412 HG11 HD13 ' A' ' 14' ' ' LEU . 54.4 t -104.4 119.39 53.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.282 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.706 ' CD1' ' HD2' ' A' ' 53' ' ' LYS . 28.2 m-85 -94.8 156.14 16.51 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.424 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.7 m-85 -126.86 157.51 39.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.018 -177.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -105.76 93.65 4.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.252 0.548 . . . . 0.0 111.622 -178.064 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.568 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 62.0 t30 -160.24 -176.6 5.73 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 5.6 tmtt? -109.88 -5.04 15.63 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.245 0.545 . . . . 0.0 111.248 177.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.436 ' HB2' ' ND2' ' A' ' 94' ' ' ASN . 16.1 mm-40 -96.47 -155.41 0.48 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.852 -168.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 11.2 mm-40 -28.97 151.15 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 124.833 1.253 . . . . 0.0 113.902 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -30.62 124.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 125.087 3.858 . . . . 0.0 114.713 -165.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -75.26 12.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.5 -177.835 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.546 ' HE2' ' CE2' ' A' ' 91' ' ' TYR . 2.5 ptpt -150.03 147.67 28.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.318 0.58 . . . . 0.0 111.342 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.52 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -123.55 155.24 29.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 174.312 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -128.53 106.82 9.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.76 0.314 . . . . 0.0 110.336 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.681 ' CD2' HD21 ' A' ' 16' ' ' LEU . 22.9 m-85 -103.09 121.19 42.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.304 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -84.31 112.64 20.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -124.79 138.34 54.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.377 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.401 ' HA ' HD13 ' A' ' 85' ' ' ILE . 24.6 t70 -90.86 120.15 31.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.919 0.39 . . . . 0.0 110.959 -177.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.516 HD11 HG11 ' A' ' 37' ' ' VAL . 2.1 mp -93.76 91.75 7.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.009 175.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -101.03 157.74 16.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.207 0.527 . . . . 0.0 110.654 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.8 mt -129.76 163.78 25.46 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' B' ' 215' ' ' ALA . 38.7 m170 -94.18 174.83 6.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 172.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -67.52 165.16 17.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.009 0.433 . . . . 0.0 111.634 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.782 ' HA ' HG21 ' A' ' 22' ' ' VAL . 16.9 tt0 -75.26 103.65 5.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.748 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.818 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 106.61 17.81 11.69 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -175.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -114.27 162.54 22.68 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.651 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -44.68 177.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 123.869 3.046 . . . . 0.0 114.005 174.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -97.04 166.83 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.83 3.02 . . . . 0.0 111.776 -171.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 22.5 t -113.61 126.45 71.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -144.66 96.39 2.86 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.431 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.2 t-80 -118.98 134.97 54.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.618 -177.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 119' ' ' HIS . 8.4 mt -116.58 152.59 33.84 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.514 0.509 . . . . 0.0 110.575 177.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 19.8 ttm180 -143.58 149.63 37.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 173.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.482 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 61.4 m -134.12 120.71 20.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -115.81 138.11 51.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.695 0.283 . . . . 0.0 110.437 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -90.48 129.91 36.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.474 0.654 . . . . 0.0 112.185 -174.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.885 ' HB2' HG23 ' A' ' 12' ' ' VAL . 11.1 mt -95.16 117.49 30.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.386 171.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.7 m -109.06 122.66 47.75 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.667 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -120.42 104.45 10.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.675 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -85.67 120.74 27.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.706 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.417 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 83.6 m-20 59.02 61.96 4.39 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.201 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -87.4 173.82 5.35 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.116 2.544 . . . . 0.0 112.013 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 134' ' ' PHE . 11.7 p -69.26 140.46 54.47 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -58.28 -37.08 74.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -63.36 -29.67 70.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.62 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.6 t80 -73.02 -43.4 62.15 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.665 ' O ' HD13 ' A' ' 139' ' ' LEU . 50.0 ttp180 -52.79 -52.58 56.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.809 175.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -55.09 -36.32 65.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.934 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -71.08 -39.2 72.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.624 -0.43 . . . . 0.0 109.84 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.6 mt -65.55 -19.11 65.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.706 0.765 . . . . 0.0 109.839 175.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.665 HD13 ' O ' ' A' ' 135' ' ' ARG . 6.4 mp -89.56 -26.36 20.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.962 -177.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -90.5 -19.14 24.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.203 0.525 . . . . 0.0 110.631 -174.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.18 174.384 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -84.02 55.23 5.0 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.558 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -158.01 138.92 13.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.179 0.514 . . . . 0.0 110.7 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 110' ' ' HIS . . . -82.52 170.65 14.02 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.773 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.427 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 34.5 Cg_exo -59.86 175.22 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.676 1.584 . . . . 0.0 112.71 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.4 ' HA ' ' HB1' ' A' ' 82' ' ' ALA . 11.3 ptp180 -150.03 158.59 44.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.332 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -107.09 74.99 1.01 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.85 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 10.1 mp -97.6 -15.64 20.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.772 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -144.81 83.78 1.71 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.665 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 32.5 m -87.62 111.66 21.49 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.005 -176.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -83.16 80.85 8.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.841 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.758 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.322 179.156 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.0 m -73.45 -11.03 60.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 111.458 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -73.99 -28.79 61.64 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.4 tpt -95.55 -42.03 8.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.171 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.7 97.41 7.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.605 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.6 t -71.55 138.85 49.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.002 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.429 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 8.5 t -79.97 138.57 37.1 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.516 -176.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.4 t -162.12 133.57 5.29 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.56 136.81 52.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.182 0.515 . . . . 0.0 112.302 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.8 t -103.13 142.58 16.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 1.0 OUTLIER -121.95 127.31 50.21 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.365 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.806 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -112.08 172.18 3.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.927 177.004 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 97.0 mttt -135.83 131.84 35.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.565 0.221 . . . . 0.0 110.611 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.422 ' HG ' HD11 ' A' ' 125' ' ' LEU . 83.5 mt -116.52 142.04 47.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.239 0.543 . . . . 0.0 109.954 175.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.611 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.5 tt0 -105.13 125.12 50.64 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.939 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.582 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.5 mm? -108.57 122.22 46.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -143.85 167.61 26.68 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.984 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -163.72 154.15 15.57 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.379 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 53.4 mtp180 -121.15 144.87 48.34 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.866 172.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.68 118.29 24.47 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.785 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.95 137.05 50.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.678 HG21 ' HA ' ' A' ' 112' ' ' GLU . 3.3 p -103.5 137.87 30.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.4 mtp180 -92.81 139.96 30.0 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -175.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -68.14 -15.29 63.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.427 0.632 . . . . 0.0 109.729 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -139.03 102.35 7.55 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.427 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HG3' HG22 ' A' ' 32' ' ' THR . 90.8 Cg_exo -50.19 158.0 2.68 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.076 2.517 . . . . 0.0 112.169 175.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.8 t -78.22 -175.67 4.27 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.407 -174.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.423 ' H ' HG13 ' A' ' 28' ' ' VAL . 1.3 m -63.04 -31.05 51.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.092 0.472 . . . . 0.0 110.894 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -77.98 -6.7 55.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.447 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.37 33.41 39.52 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.401 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -94.7 129.7 41.49 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.557 HG22 ' HG3' ' A' ' 26' ' ' PRO . 38.9 p -91.9 -25.66 18.82 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.43 -168.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 79' ' ' SER . 56.5 m80 -117.28 140.53 49.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -113.86 112.15 22.88 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.406 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 54.7 p-90 -118.44 148.84 42.16 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.082 0.468 . . . . 0.0 111.127 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.648 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 57.8 ttp -129.37 122.64 29.88 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.802 175.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.7 m -102.59 151.29 6.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.369 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -152.15 152.87 32.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.2 m -124.02 127.14 73.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.271 171.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 73' ' ' PRO . 2.5 mmp_? -135.62 -176.58 4.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.705 -176.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.489 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -91.54 -171.73 42.57 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.661 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 30.7 Cg_endo -75.7 113.68 3.79 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.515 2.143 . . . . 0.0 112.173 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 58.98 52.45 6.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.384 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.6 t60 74.38 -3.82 2.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.825 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 63.9 m -59.04 128.74 38.75 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 176.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -72.25 127.06 31.38 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.779 0.324 . . . . 0.0 110.844 -174.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.553 HD12 HG21 ' A' ' 51' ' ' VAL . 5.9 pt -96.42 -1.96 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -61.31 -14.66 28.56 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.383 0.611 . . . . 0.0 110.928 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.463 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 88.1 m-70 -65.7 -39.22 91.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.709 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -114.61 -16.01 11.91 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.464 176.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.553 HG21 HD12 ' A' ' 47' ' ' ILE . 99.3 t -91.79 129.09 43.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.084 0.469 . . . . 0.0 110.23 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -97.1 -63.92 1.09 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.335 0.588 . . . . 0.0 110.409 -175.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 6.6 ptmm? -141.1 157.54 45.16 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 91.7 t -130.04 158.33 42.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 67' ' ' ARG . 9.7 p -142.31 134.75 26.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.341 0.591 . . . . 0.0 111.214 -174.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 29.6 m-85 -117.78 105.5 12.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -77.05 90.86 3.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.872 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.581 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.9 mt -71.01 -177.77 1.75 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.825 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.79 139.77 43.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -176.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -56.53 -23.53 40.51 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -171.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.8 t -71.72 -16.31 62.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.069 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -79.51 141.01 56.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.13 116.84 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.097 1.865 . . . . 0.0 111.327 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 58.41 66.59 2.51 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.552 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.4 -18.74 66.01 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.223 2.615 . . . . 0.0 113.466 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -87.48 100.79 13.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.991 0.424 . . . . 0.0 110.534 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.0 mmt180 -100.13 110.81 23.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.826 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -100.64 136.01 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.7 m -114.37 118.24 33.32 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -105.09 -25.72 12.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.534 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.601 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 9.5 p-10 -76.5 -175.08 0.45 Allowed Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.382 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 1.5 Cg_exo -41.97 -166.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.231 3.288 . . . . 0.0 114.203 164.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.624 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 6.9 Cg_endo -34.89 120.02 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.005 2.47 . . . . 0.0 113.602 -151.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 47.5 m-85 -62.35 94.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.043 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 12.2 ptpt -142.28 145.9 34.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.279 0.561 . . . . 0.0 112.201 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 36' ' ' MET . 79.6 t -121.28 132.61 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.462 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.421 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 7.0 mm-40 -112.06 112.49 24.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.982 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -137.42 169.87 17.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.197 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 3.5 t -126.75 141.9 51.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.14 -169.27 24.17 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.281 -0.485 . . . . 0.0 111.953 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -132.84 -11.41 3.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.253 0.527 . . . . 0.0 111.973 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.41 136.99 20.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.18 -172.99 47.18 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.208 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -178.87 159.53 1.05 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.362 0.265 . . . . 0.0 110.485 -173.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.3 mm -63.9 123.43 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.581 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.1 tt -117.76 104.88 48.59 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-O 121.138 0.494 . . . . 0.0 109.995 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.54 112.98 3.0 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.336 2.691 . . . . 0.0 112.357 173.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 56' ' ' PHE . 3.8 mt -102.33 123.52 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.283 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.8 mt-10 -109.48 124.46 51.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.179 0.514 . . . . 0.0 110.198 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.4 t -103.36 118.76 50.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.907 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.587 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 69.9 m-85 -91.05 134.75 34.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.512 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.45 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 25.6 m-85 -110.11 152.07 26.46 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.047 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.58 94.19 9.77 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.418 ' HB3' ' HG3' ' A' ' 99' ' ' ARG . 64.0 t30 -154.61 158.65 40.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.875 -172.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -111.42 -9.68 14.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.909 0.862 . . . . 0.0 110.006 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 35.6 mm-40 -99.05 -151.77 0.39 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.47 -174.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 22.2 mm-40 -27.16 152.11 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.5 Cg_exo -31.1 126.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 1 C-N-CA 125.522 4.148 . . . . 0.0 115.262 -167.202 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.418 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -89.0 18.97 4.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.647 -179.182 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.422 ' HZ3' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -154.65 143.01 20.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.247 0.546 . . . . 0.0 110.874 -178.727 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -128.43 155.76 40.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.345 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -125.47 115.64 20.55 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.173 0.511 . . . . 0.0 111.118 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.582 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.8 m-85 -107.98 108.18 19.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.678 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -72.11 113.29 8.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.281 0.562 . . . . 0.0 109.659 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.5 ' CD1' ' HD2' ' A' ' 121' ' ' ARG . 31.8 t80 -124.47 129.22 50.25 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.707 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -85.15 106.85 16.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.605 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.529 HD11 HG11 ' A' ' 37' ' ' VAL . 1.6 mp -82.1 106.07 13.71 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.489 ' CE2' HG11 ' A' ' 117' ' ' VAL . 56.0 p90 -117.63 161.5 19.55 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.221 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.4 mt -135.05 162.98 30.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.636 -171.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.735 ' CE1' ' HA ' ' A' ' 116' ' ' PRO . 6.9 p-80 -93.17 166.85 12.13 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 177.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.516 ' O ' ' HD2' ' A' ' 110' ' ' HIS . 2.1 mm? -68.01 146.83 53.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.701 0.286 . . . . 0.0 111.124 177.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.678 ' HA ' HG21 ' A' ' 22' ' ' VAL . 23.7 tt0 -57.42 101.25 0.06 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.888 176.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.504 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 118.71 18.58 4.75 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.685 -177.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.458 ' CG ' ' HD2' ' A' ' 115' ' ' PRO . 63.9 t60 -129.8 150.02 74.66 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.458 ' HD2' ' CG ' ' A' ' 114' ' ' HIS . 13.9 Cg_endo -56.63 166.06 4.05 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.253 1.969 . . . . 0.0 112.727 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.735 ' HA ' ' CE1' ' A' ' 110' ' ' HIS . 4.7 Cg_exo -77.4 -179.52 5.51 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 123.647 2.898 . . . . 0.0 114.142 -168.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 26.7 t -119.53 137.96 51.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.231 -1.349 . . . . 0.0 109.029 -177.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -143.62 98.15 3.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.525 ' O ' HD23 ' A' ' 120' ' ' LEU . 55.0 t-80 -119.4 134.62 55.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.755 -176.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.3 mt -123.17 142.17 51.19 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 123.682 0.614 . . . . 0.0 110.558 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.581 ' HD3' ' HB2' ' A' ' 16' ' ' LEU . 17.9 mtp180 -119.41 146.76 45.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 22.0 p -117.46 101.43 8.38 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 165.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.9 mm-40 -97.56 154.52 17.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.461 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -108.66 135.68 49.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.223 0.535 . . . . 0.0 111.906 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.806 ' HB2' HG23 ' A' ' 12' ' ' VAL . 11.0 mt -106.64 120.77 42.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 171.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.4 m -115.36 123.1 47.83 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.964 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -120.26 104.85 10.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.036 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.24 124.87 30.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.063 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 78.7 m-20 63.25 61.25 1.88 Allowed Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.769 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.7 170.05 5.43 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.788 2.325 . . . . 0.0 111.574 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 134' ' ' PHE . 12.3 p -71.43 144.86 49.6 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -56.71 -43.38 80.51 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.473 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.574 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 5.0 p-10 -59.68 -27.98 66.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.671 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.681 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 7.1 t80 -73.12 -41.72 63.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.659 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 34.8 ttm-85 -51.74 -47.35 64.08 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.569 0.699 . . . . 0.0 109.638 172.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.3 ttm180 -58.54 -37.43 75.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.543 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 39.0 mtpt -70.82 -41.32 71.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.838 0.352 . . . . 0.0 110.102 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 36.2 mt -69.12 -33.83 74.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.863 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 57.9 mt -75.22 -37.58 61.03 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.075 0.464 . . . . 0.0 110.606 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp -70.22 -28.38 65.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.452 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.74 -0.648 . . . . 0.0 110.376 175.085 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -94.54 -0.39 64.82 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.447 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.83 -78.48 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.184 0.594 . . . . 0.0 111.619 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -75.9 162.98 69.8 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.19 172.02 4.58 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 121.783 1.655 . . . . 0.0 112.429 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -146.34 157.11 43.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.918 0.39 . . . . 0.0 110.732 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -137.55 118.65 14.43 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.647 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' B' ' 220' ' ' LEU . 0.3 OUTLIER 53.39 66.46 1.23 Allowed 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.95 0.781 . . . . 0.0 110.013 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.77 144.49 28.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.583 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 2.6 m -80.06 64.36 4.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.33 0.586 . . . . 0.0 110.571 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -86.02 53.82 2.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.781 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.397 -179.298 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 p -76.26 -30.07 57.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.852 0.358 . . . . 0.0 111.07 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -86.05 123.05 30.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.004 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.8 ptp -131.48 50.48 2.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.506 0.669 . . . . 0.0 110.158 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.89 64.74 5.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.989 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.2 t -67.9 84.75 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.302 0.573 . . . . 0.0 109.823 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.4 m -72.6 109.15 6.04 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.318 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.3 m -110.89 110.94 21.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.09 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.31 146.01 33.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.878 0.37 . . . . 0.0 111.126 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.433 HG23 ' HG3' ' A' ' 130' ' ' PRO . 4.6 t -113.12 141.24 29.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 4.6 mp0 -128.0 115.51 18.62 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.897 0.38 . . . . 0.0 110.287 -175.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.9 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -105.87 177.02 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.951 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.677 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 99.5 mttt -141.59 149.64 41.0 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.476 HD13 HG11 ' A' ' 90' ' ' VAL . 91.4 mt -129.02 143.37 50.85 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.71 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.3 tt0 -102.36 122.61 44.61 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.843 -175.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.679 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -110.84 116.25 30.92 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 175.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.77 179.87 25.24 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.293 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -169.73 150.37 3.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.932 0.396 . . . . 0.0 110.531 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.63 139.7 49.87 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -129.3 126.65 39.49 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.999 0.428 . . . . 0.0 111.085 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -129.66 151.36 50.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.692 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.611 HG11 ' H ' ' A' ' 113' ' ' GLY . 1.3 p -101.7 158.02 4.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 mtp180 -105.91 142.94 34.76 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -70.51 -14.71 62.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.583 0.706 . . . . 0.0 109.209 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -138.23 103.45 8.02 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.043 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.532 ' HG3' HG22 ' A' ' 32' ' ' THR . 72.7 Cg_exo -47.47 160.1 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.335 2.69 . . . . 0.0 112.764 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.9 t -78.85 -177.88 5.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.605 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -41.67 78.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.81 0.338 . . . . 0.0 111.271 -176.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -71.11 -7.95 50.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.9 0.381 . . . . 0.0 111.399 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.3 33.14 26.59 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.617 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -95.77 132.3 41.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.532 HG22 ' HG3' ' A' ' 26' ' ' PRO . 69.4 p -90.83 -29.68 17.42 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -169.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 79' ' ' SER . 65.4 m80 -112.88 143.85 43.44 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -172.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.519 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -122.15 118.47 28.74 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 172.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.413 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 49.2 p-90 -121.87 151.5 40.6 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.791 -175.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.593 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 50.0 ttp -127.21 119.81 27.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.777 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 76' ' ' VAL . 9.9 m -98.84 154.8 3.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.148 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -155.3 156.14 34.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.1 m -125.07 127.58 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.784 169.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 mmm-85 -131.76 177.9 7.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.883 0.373 . . . . 0.0 110.912 -175.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.491 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -92.7 162.7 26.72 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.553 177.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.677 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 18.4 Cg_endo -57.25 114.11 1.79 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.229 2.619 . . . . 0.0 112.3 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 59.17 57.74 3.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.898 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 71.91 1.33 3.87 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.645 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 77.8 p -63.52 132.07 50.1 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.012 -0.43 . . . . 0.0 109.845 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -75.93 126.04 30.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.537 HD12 HG21 ' A' ' 51' ' ' VAL . 6.1 pt -96.74 -1.22 10.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -171.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -63.24 -8.62 8.73 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -74.24 -36.87 63.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.072 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.439 ' CE2' HG22 ' A' ' 47' ' ' ILE . 52.3 p90 -114.07 -14.35 12.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.46 175.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.537 HG21 HD12 ' A' ' 47' ' ' ILE . 97.6 t -98.82 122.06 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 122.888 0.475 . . . . 0.0 110.145 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.619 ' CG ' ' HB3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -91.67 -44.31 9.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.194 0.521 . . . . 0.0 110.072 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -158.99 158.68 33.7 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.314 -174.32 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 96.6 t -137.21 157.05 34.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.953 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.616 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.8 p -142.18 136.52 29.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.344 0.592 . . . . 0.0 111.497 -175.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 19.8 m-85 -119.22 109.96 16.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -81.63 94.62 6.97 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.396 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.611 ' CD2' HD11 ' A' ' 86' ' ' LEU . 13.3 mt -77.16 -177.34 4.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.748 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.59 144.02 53.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.189 0.519 . . . . 0.0 109.697 -178.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -60.7 -24.24 65.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.004 -169.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.1 t -78.17 -8.67 58.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.614 0.245 . . . . 0.0 111.186 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -85.53 135.22 38.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -62.28 121.52 9.56 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.725 2.283 . . . . 0.0 110.901 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 61.36 72.1 0.71 Allowed Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.024 -173.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.88 -20.58 58.12 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.496 2.13 . . . . 0.0 112.296 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.564 ' HE3' ' CG1' ' A' ' 68' ' ' VAL . 24.9 ttpt -93.23 104.46 16.63 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.929 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 7.3 mmm180 -103.79 102.32 12.15 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.259 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.564 ' CG1' ' HE3' ' A' ' 66' ' ' LYS . 2.2 m -99.03 138.29 23.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.8 m -125.06 119.54 28.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -107.13 -23.81 12.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.509 0.671 . . . . 0.0 110.547 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.728 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 3.8 p-10 -74.26 -172.62 0.26 Allowed Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.188 -175.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.728 ' HD2' ' HB2' ' A' ' 71' ' ' ASP . 75.1 Cg_exo -40.85 -170.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 124.181 3.254 . . . . 0.0 114.598 168.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.651 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 7.9 Cg_endo -36.32 122.41 0.29 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.509 2.806 . . . . 0.0 113.842 -155.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.484 ' CB ' HG22 ' A' ' 39' ' ' VAL . 41.0 m-85 -62.55 97.34 0.09 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.01 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 12.4 ptpt -146.37 144.36 29.7 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.461 0.648 . . . . 0.0 112.129 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.1 t -121.89 131.69 72.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.833 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -114.74 114.0 25.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.89 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.31 173.02 12.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.143 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 7.6 t -126.64 144.77 50.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.715 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.09 -171.76 29.73 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -130.06 -8.07 4.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.197 0.498 . . . . 0.0 111.331 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.532 ' HB3' ' HE3' ' B' ' 218' ' ' ALY . . . -147.87 144.32 28.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.927 0.394 . . . . 0.0 111.235 -176.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -82.99 173.97 52.52 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.029 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -172.67 158.58 4.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.732 0.413 . . . . 0.0 110.041 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 106' ' ' ASP . 16.1 mm -65.49 124.56 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.21 171.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.611 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -117.61 105.3 48.26 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.886 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.65 118.49 5.71 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 123.109 2.54 . . . . 0.0 112.652 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.464 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.2 mt -108.1 126.09 64.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.369 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.616 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 43.6 mt-10 -109.52 123.57 49.62 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.088 0.471 . . . . 0.0 110.081 176.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.476 HG11 HD13 ' A' ' 14' ' ' LEU . 75.6 t -103.33 125.22 57.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.715 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 76.8 m-85 -96.39 132.11 42.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.84 -177.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.406 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 19.9 m-85 -110.62 165.07 12.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.835 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.619 ' HB3' ' CG ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -116.05 95.31 5.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.208 0.528 . . . . 0.0 111.863 -178.068 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.611 ' OD1' ' HB2' ' A' ' 96' ' ' GLU . 9.1 t-20 -157.91 177.49 11.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.272 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.598 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.49 -0.83 15.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.917 0.865 . . . . 0.0 110.811 178.206 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.611 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -96.47 -152.93 0.39 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.508 -173.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -31.33 150.94 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -37.09 120.1 0.28 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 124.911 3.741 . . . . 0.0 114.013 -168.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.72 20.31 3.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.889 -175.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.43 138.86 26.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.312 0.577 . . . . 0.0 110.574 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.527 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.3 m -122.38 155.25 27.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -129.24 106.07 8.58 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.192 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.679 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.3 m-85 -102.38 111.63 24.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.028 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -76.23 117.62 18.11 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -127.58 142.03 51.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.256 -175.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.403 ' HA ' HD13 ' A' ' 85' ' ' ILE . 11.6 t70 -92.05 118.48 30.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.064 -175.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.478 HD11 HG11 ' A' ' 37' ' ' VAL . 2.0 mp -97.09 96.22 8.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 175.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -105.08 156.44 18.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.984 0.421 . . . . 0.0 111.28 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 mt -132.44 152.86 51.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 115' ' ' PRO . 7.7 m-70 -101.53 174.21 6.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.382 0.537 . . . . 0.0 110.374 173.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.07 158.47 28.36 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -172.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.591 ' HA ' HG21 ' A' ' 22' ' ' VAL . 6.2 mp0 -54.93 154.25 5.48 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.093 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.611 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 85.12 -50.55 4.4 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.079 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -145.14 75.86 13.76 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-N 117.892 0.846 . . . . 0.0 112.356 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.592 ' CG ' ' HB ' ' A' ' 22' ' ' VAL . 57.6 Cg_endo -110.16 107.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.583 0 C-N-CA 122.836 2.357 . . . . 0.0 112.136 167.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -98.01 96.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.561 2.174 . . . . 0.0 111.053 171.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.735 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 43.5 t -117.86 115.2 47.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.156 -0.617 . . . . 0.0 111.453 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -145.04 97.23 2.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.455 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.0 t-80 -123.65 134.14 53.81 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.104 -0.239 . . . . 0.0 111.23 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 119' ' ' HIS . 7.1 mt -117.03 153.74 32.17 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.757 0.661 . . . . 0.0 110.108 175.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 19.9 ttm180 -142.24 147.86 37.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 173.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.411 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 81.1 m -130.81 118.85 21.41 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 6.2 mt-10 -112.93 136.57 52.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.29 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -91.41 134.92 34.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.457 0.646 . . . . 0.0 111.639 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.9 ' HB2' HG23 ' A' ' 12' ' ' VAL . 5.5 mt -104.67 113.91 27.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.777 173.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.9 m -103.52 123.85 47.68 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.132 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -120.75 105.28 10.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.458 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.32 119.9 23.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.131 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 54.24 64.37 6.42 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.871 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.433 ' HG3' HG23 ' A' ' 10' ' ' VAL . 91.9 Cg_endo -80.05 177.89 7.8 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.3 2.0 . . . . 0.0 111.297 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.408 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 5.6 p -76.86 141.99 40.39 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -56.49 -43.1 79.34 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.298 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 8.0 p-10 -59.65 -29.5 68.08 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.564 -0.161 . . . . 0.0 110.564 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.664 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 14.6 t80 -74.7 -40.84 61.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.606 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 43.8 ttm105 -56.02 -44.91 79.15 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.682 174.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -57.4 -37.0 72.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.019 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 44.3 mtpt -72.13 -38.96 69.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.702 0.287 . . . . 0.0 110.682 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.3 mt -69.84 -30.98 68.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.578 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 33.0 mt -82.84 -31.13 28.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.918 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -73.61 -31.13 63.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.02 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.198 176.909 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -96.5 -82.08 1.61 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.281 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -115.86 166.53 11.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.205 0.526 . . . . 0.0 111.367 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -71.09 170.79 10.2 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.655 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 49.5 Cg_exo -55.87 165.53 3.67 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.528 1.485 . . . . 0.0 112.138 177.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 22.4 ttm180 -140.44 136.74 33.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.167 0.508 . . . . 0.0 111.41 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 218' ' ' ALY . . . . . 0.532 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -61.0 160.06 10.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.033 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 9.9 mp -77.46 80.96 3.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.837 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -68.46 104.54 1.94 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.576 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 20.0 p -100.73 139.67 36.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.741 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -113.04 5.0 16.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.738 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.564 -0.731 . . . . 0.0 110.229 177.136 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 112.336 -0.306 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 t 60.39 77.71 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.094 0.473 . . . . 0.0 110.603 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.9 m80 67.41 30.31 6.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.116 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.9 ttm -88.68 127.56 35.58 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 176.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.25 165.3 0.26 Allowed 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.825 0.703 . . . . 0.0 110.638 -175.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.8 t -140.28 140.17 35.66 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.7 m -68.96 108.28 3.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.925 0.393 . . . . 0.0 110.056 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.1 t -119.91 112.52 19.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.748 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.58 134.72 53.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.037 0.446 . . . . 0.0 111.443 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.3 142.98 19.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -122.46 131.78 54.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.919 0.39 . . . . 0.0 110.203 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.845 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -114.79 165.77 9.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.622 176.385 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.602 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . 97.2 mttt -135.31 127.35 29.73 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.659 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.414 HD13 HG11 ' A' ' 90' ' ' VAL . 89.4 mt -113.19 142.66 45.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.196 0.522 . . . . 0.0 110.248 177.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.668 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.9 tt0 -104.49 126.08 51.25 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.758 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.657 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -112.43 113.71 26.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -145.64 176.64 24.52 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 119.699 -1.239 . . . . 0.0 111.756 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -166.29 156.03 11.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.993 0.425 . . . . 0.0 110.622 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 62.4 mtt180 -117.17 139.47 50.72 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 172.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -130.06 123.53 30.7 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.599 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -117.76 144.19 45.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.777 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.814 HG11 ' H ' ' A' ' 113' ' ' GLY . 2.6 p -104.3 152.97 6.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 170.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.558 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -108.52 139.99 42.48 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -65.73 -20.51 66.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.606 0.717 . . . . 0.0 109.229 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -131.36 101.36 16.12 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.974 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.553 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.7 Cg_exo -48.63 158.7 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.52 2.813 . . . . 0.0 113.172 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.1 t -80.15 -173.04 3.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.211 -172.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -58.33 -36.98 60.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.0 0.52 . . . . 0.0 111.836 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -83.14 -1.34 52.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 110.704 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 34.09 37.87 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.962 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -98.16 134.95 40.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.553 HG22 ' HG3' ' A' ' 26' ' ' PRO . 25.6 p -88.4 -27.22 21.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.111 -171.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.426 ' CD2' ' HB3' ' A' ' 109' ' ' LEU . 64.5 m80 -115.69 145.19 42.97 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -171.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.558 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 5.8 m-20 -123.23 125.63 45.44 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.417 ' HH2' HD22 ' A' ' 58' ' ' LEU . 55.7 p-90 -128.28 149.85 50.31 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.097 0.475 . . . . 0.0 111.002 -176.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.697 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 45.2 ttp -128.16 122.37 31.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.354 174.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 6.2 m -101.42 153.96 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.327 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -153.36 153.74 33.15 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.199 -0.6 . . . . 0.0 112.553 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 10.6 m -124.79 130.83 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.044 171.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.463 ' HB2' ' HB3' ' A' ' 15' ' ' GLU . 2.7 mmt85 -129.5 -177.09 4.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.958 0.408 . . . . 0.0 111.381 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.502 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -94.0 -164.17 36.37 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.229 174.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 2.7 Cg_exo -72.86 111.88 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.617 2.212 . . . . 0.0 111.369 177.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 57.18 56.52 5.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.578 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.1 m80 67.51 5.22 4.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.82 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 70.8 m -64.93 129.3 39.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.45 ' OD1' ' HB2' ' A' ' 48' ' ' GLN . 8.4 t-20 -59.96 127.08 30.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.595 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.621 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.5 pt -96.72 -3.89 10.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.45 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 1.5 mp0 -60.14 -6.27 1.36 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -73.0 -37.88 66.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.939 177.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.496 ' CE1' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -118.24 -21.09 8.31 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.353 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.621 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 96.6 t -87.06 130.52 36.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -99.64 -54.78 2.83 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.21 0.529 . . . . 0.0 110.526 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.89 142.14 16.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.177 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 55' ' ' VAL . 90.2 t -117.55 160.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.937 -175.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.59 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.8 p -144.16 135.52 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.165 0.507 . . . . 0.0 111.145 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.526 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 30.9 m-85 -118.15 109.91 16.97 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -83.26 92.89 7.58 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.833 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.561 ' CD2' HD11 ' A' ' 86' ' ' LEU . 9.8 mt -71.51 -177.39 1.83 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 79.1 t60 -76.15 142.81 41.48 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.808 -0.757 . . . . 0.0 108.999 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 1.8 mp0 -54.52 -20.67 8.25 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.028 -171.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t -82.97 -5.87 59.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.672 0.272 . . . . 0.0 111.026 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.475 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 62.0 m-85 -82.35 148.46 59.28 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.88 117.91 5.23 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.613 2.209 . . . . 0.0 110.917 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 52.56 73.52 0.93 Allowed Pre-proline 0 C--O 1.226 -0.15 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.076 -174.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.46 -20.55 64.27 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.892 2.394 . . . . 0.0 113.56 -174.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -90.29 105.53 17.87 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.207 0.527 . . . . 0.0 110.457 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -106.73 89.26 2.96 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.281 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -71.6 139.64 19.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.149 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.4 m -126.91 114.26 17.63 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 175.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -107.35 -28.11 10.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.993 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.464 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 30.1 t70 -75.93 164.97 56.91 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.724 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.593 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 24.2 Cg_exo -28.72 178.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.534 1 C-N-CA 125.65 4.233 . . . . 0.0 115.111 168.626 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.593 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 4.5 Cg_exo -22.51 115.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 124.384 3.389 . . . . 0.0 115.036 -149.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.43 ' CB ' HG22 ' A' ' 39' ' ' VAL . 36.3 m-85 -60.89 107.86 0.77 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.603 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.697 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.4 ptpt -152.28 153.79 34.43 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.0 111.55 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 36' ' ' MET . 71.4 t -131.13 133.09 63.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.858 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -115.98 115.71 26.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.125 0.266 . . . . 0.0 110.407 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.77 172.09 13.16 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.274 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.6 t -120.89 146.87 46.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.78 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.41 -162.49 14.34 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.287 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -141.53 -18.34 0.78 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.419 ' HB3' ' HG3' ' B' ' 218' ' ' ALY . . . -136.8 134.7 37.29 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.567 -175.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.503 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -75.54 169.27 54.75 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.378 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -168.48 154.97 7.22 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.406 ' HB ' ' OE1' ' B' ' 219' ' ' GLN . 23.4 mm -65.6 122.55 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.561 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.6 tt -113.6 104.95 55.27 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.548 -178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.1 108.02 1.25 Allowed 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 123.197 2.598 . . . . 0.0 111.881 173.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -98.79 124.86 52.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.676 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.59 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 72.8 mt-10 -113.67 119.91 39.06 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.419 0.628 . . . . 0.0 110.075 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.414 HG11 HD13 ' A' ' 14' ' ' LEU . 60.7 t -102.98 123.34 56.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.432 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.441 ' CD2' ' HB3' ' A' ' 100' ' ' LYS . 25.7 m-85 -99.25 155.45 17.49 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.86 0.838 . . . . 0.0 111.138 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.445 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.6 m-85 -125.67 156.9 38.55 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.998 -176.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.09 92.02 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.237 0.541 . . . . 0.0 111.346 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -158.42 -178.19 7.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.678 172.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.677 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -114.38 6.09 15.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.652 0.263 . . . . 0.0 111.383 -177.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 6.3 mm-40 -102.07 -152.76 0.45 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.851 -168.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.618 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 13.4 mm-40 -31.56 159.63 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.98 1.312 . . . . 0.0 113.317 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.4 Cg_exo -28.63 125.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 124.716 3.611 . . . . 0.0 114.19 -162.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -72.59 -1.76 17.31 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.226 -170.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 91' ' ' TYR . 4.2 pttt -155.56 171.23 20.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.484 0.659 . . . . 0.0 111.012 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.572 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.5 m -133.11 154.55 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.207 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -123.03 117.02 24.5 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.019 0.438 . . . . 0.0 111.07 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.4 m-85 -108.76 116.99 33.03 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.741 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -81.58 109.99 16.54 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.437 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 68.5 t80 -122.35 137.17 54.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.725 -174.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.486 ' OD2' ' HB3' ' A' ' 108' ' ' PHE . 30.6 t70 -86.95 110.64 20.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.575 HD11 HG11 ' A' ' 37' ' ' VAL . 1.7 mp -83.61 91.41 7.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.554 ' HB2' ' HD2' ' B' ' 214' ' ' LYS . 15.6 p90 -98.59 154.72 17.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.105 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 22.8 mt -133.3 137.89 46.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -176.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.592 ' HD1' HG23 ' A' ' 117' ' ' VAL . 2.6 p-80 -67.86 172.12 5.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 173.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.1 155.56 32.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.565 0.698 . . . . 0.0 111.338 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.782 ' HA ' HG21 ' A' ' 22' ' ' VAL . 15.2 tt0 -56.22 101.17 0.05 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.22 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.814 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 120.89 2.44 11.31 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.913 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -109.47 140.23 21.9 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -56.84 152.46 42.62 Favored 'Trans proline' 0 C--N 1.363 1.306 0 C-N-CA 122.297 1.998 . . . . 0.0 114.367 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 17.6 Cg_exo -36.14 158.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.176 1 C-N-CA 126.064 4.509 . . . . 0.0 116.619 177.369 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.592 HG23 ' HD1' ' A' ' 110' ' ' HIS . 48.6 t -121.06 141.49 41.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.0 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -141.91 96.69 3.01 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.443 ' O ' HD23 ' A' ' 120' ' ' LEU . 55.3 t-80 -115.67 136.0 53.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.731 -177.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 119' ' ' HIS . 7.5 mt -117.57 151.07 37.91 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.776 0.672 . . . . 0.0 110.295 177.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 18.0 ttm180 -140.36 148.01 40.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 42.4 t -132.51 125.86 31.58 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -121.61 134.01 55.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.715 -177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.71 129.43 35.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.198 0.523 . . . . 0.0 111.652 -175.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.845 ' HB2' HG23 ' A' ' 12' ' ' VAL . 6.4 mt -95.1 131.54 40.98 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.9 m -122.91 122.71 39.26 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.014 -0.674 . . . . 0.0 110.82 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -118.11 105.7 12.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.515 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.26 119.78 23.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.436 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.86 64.36 4.0 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.07 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -83.5 170.24 11.82 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.506 2.137 . . . . 0.0 111.155 172.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.7 p -70.24 142.81 52.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -57.0 -41.43 78.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.611 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -56.09 -33.03 64.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.79 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.705 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.8 t80 -75.41 -40.48 57.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.64 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.7 ttm180 -55.3 -45.89 76.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -53.05 -42.19 65.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.251 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 45.6 mtpt -71.68 -38.96 70.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 41.5 mt -68.11 -31.55 71.23 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.911 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 56.0 mt -80.52 -28.95 37.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.966 0.413 . . . . 0.0 110.917 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -78.72 -27.39 44.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.589 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.981 174.492 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 112.052 -0.419 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.96 36.71 12.66 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.013 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 214' ' ' LYS . . . . . 0.554 ' HD2' ' HB2' ' A' ' 108' ' ' PHE . 46.4 pttt -139.95 -175.8 4.36 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.483 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -58.49 158.29 15.51 Favored Pre-proline 0 C--O 1.236 0.377 0 O-C-N 123.36 0.412 . . . . 0.0 111.489 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 7.5 Cg_endo -50.94 168.71 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.285 2.657 . . . . 0.0 112.974 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 8.7 tpp180 -132.5 136.95 47.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.8 -177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 218' ' ' ALY . . . . . 0.419 ' HG3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 219' ' ' GLN . . . . . 0.406 ' OE1' ' HB ' ' A' ' 85' ' ' ILE . 6.8 tt0 -152.5 114.02 4.3 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 92.4 mt 60.57 29.45 19.02 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.684 0.615 . . . . 0.0 109.474 -171.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -68.24 110.1 3.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.142 -175.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.3 m -101.65 -31.87 10.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.552 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -94.03 -63.33 1.2 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.74 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.644 -0.693 . . . . 0.0 110.897 -178.267 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.4 t -84.27 132.18 34.66 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -110.68 62.17 0.61 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.904 0.383 . . . . 0.0 110.531 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 55.0 ttm -72.17 -33.24 67.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.287 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -107.2 152.07 24.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.424 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.6 m -78.83 93.89 5.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 176.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.529 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 67.9 m -59.29 109.24 0.83 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.209 0.528 . . . . 0.0 111.093 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.9 t -127.65 125.79 40.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.46 132.75 53.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.998 0.428 . . . . 0.0 111.268 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.1 t -99.92 139.06 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 1.7 mp0 -125.09 119.67 29.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.271 0.558 . . . . 0.0 110.366 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.875 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.45 164.4 4.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.767 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 42' ' ' PRO . 92.1 mttt -132.92 125.93 30.97 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.373 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.48 HD13 HG11 ' A' ' 90' ' ' VAL . 90.8 mt -115.48 142.38 46.78 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.276 0.56 . . . . 0.0 110.372 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 7.0 tt0 -109.07 128.5 55.03 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.014 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.543 HD12 HG12 ' A' ' 39' ' ' VAL . 1.6 mm? -109.14 122.19 46.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -143.5 170.59 25.53 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.649 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -165.42 152.53 10.5 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.745 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.674 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 62.6 mtp180 -117.48 140.7 49.26 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.979 171.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -135.98 123.83 22.62 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.572 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 14.3 tt0 -121.4 144.76 48.49 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.556 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.915 HG11 ' H ' ' A' ' 113' ' ' GLY . 9.8 p -99.03 153.49 4.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -105.03 152.06 23.2 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.261 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.9 mmtm -68.2 -20.82 64.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.396 0.617 . . . . 0.0 109.737 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -140.79 111.09 6.75 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.646 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.2 Cg_exo -47.81 155.27 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.176 2.584 . . . . 0.0 112.423 173.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.438 HG22 ' HB2' ' A' ' 31' ' ' PHE . 9.1 t -75.11 -169.7 0.99 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.865 -172.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 m -61.81 -24.61 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -107.05 11.36 29.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.324 1.059 . . . . 0.0 109.327 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.74 33.1 47.9 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.538 172.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.438 ' HB2' HG22 ' A' ' 27' ' ' THR . 19.4 m-30 -90.38 127.93 36.33 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.591 HG22 ' HG3' ' A' ' 26' ' ' PRO . 60.3 p -85.48 -29.87 23.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.34 -169.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.457 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.8 m80 -118.87 144.43 46.39 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -172.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -115.41 119.94 37.92 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 171.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -122.78 150.86 42.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.212 0.529 . . . . 0.0 111.031 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.72 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 50.4 ttp -129.11 116.48 19.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.428 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.2 m -99.14 149.77 5.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.299 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.643 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.6 OUTLIER -151.61 156.26 40.09 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.263 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.1 m -123.73 135.22 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.899 169.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -134.95 175.78 9.26 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.002 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.463 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -90.14 -178.61 44.46 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.14 173.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HB3' ' HB2' ' A' ' 13' ' ' LYS . 37.4 Cg_endo -76.63 111.87 3.34 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.147 1.898 . . . . 0.0 112.458 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 57.7 67.12 1.0 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.882 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.6 m80 72.87 -7.27 1.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.0 m -67.49 126.71 30.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.373 0.13 . . . . 0.0 110.848 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -69.03 126.68 30.57 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.637 HD12 HG21 ' A' ' 51' ' ' VAL . 1.1 pt -94.87 -3.74 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.763 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -63.36 -1.28 1.07 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.22 -0.446 . . . . 0.0 112.201 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -79.16 -33.6 43.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.416 ' CE2' HG22 ' A' ' 47' ' ' ILE . 54.0 p90 -117.65 -18.15 9.75 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.565 175.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.637 HG21 HD12 ' A' ' 47' ' ' ILE . 84.0 t -91.4 130.87 39.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.747 0.308 . . . . 0.0 110.369 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 7.8 tp10 -102.39 -63.36 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.144 0.497 . . . . 0.0 110.506 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -131.12 162.07 30.71 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 95.0 t -133.72 155.78 40.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 169.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.598 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.4 p -141.75 134.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.529 0.68 . . . . 0.0 111.402 -174.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.428 ' CD2' HG12 ' A' ' 88' ' ' ILE . 22.3 m-85 -115.88 107.27 14.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.131 -0.941 . . . . 0.0 108.646 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -79.44 90.74 5.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.229 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.449 HD11 HG11 ' A' ' 76' ' ' VAL . 19.9 mt -78.2 -176.85 4.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.888 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.79 143.96 43.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.15 -21.54 63.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.091 -175.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t -69.13 -17.04 63.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.888 0.375 . . . . 0.0 110.548 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -85.13 139.53 36.69 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.85 117.55 4.29 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.277 1.985 . . . . 0.0 111.271 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 57.37 80.19 0.3 Allowed Pre-proline 0 C--O 1.225 -0.231 0 O-C-N 123.672 0.607 . . . . 0.0 110.505 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.15 -20.79 48.12 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.884 2.389 . . . . 0.0 113.465 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -97.45 108.68 21.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.942 0.401 . . . . 0.0 110.915 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 19.7 mmt85 -111.38 104.87 13.36 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.017 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 5.4 m -90.63 135.92 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 169.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.0 m -112.87 116.46 30.06 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -101.38 -28.58 12.51 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.545 0.688 . . . . 0.0 110.245 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.571 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 3.1 m-20 -75.52 -177.17 0.66 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.927 -175.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.639 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 13.3 Cg_exo -45.0 -168.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.963 3.109 . . . . 0.0 113.936 165.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.639 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 2.6 Cg_endo -28.52 114.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.512 2.808 . . . . 0.0 114.563 -152.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 50.8 m-85 -62.17 96.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.287 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.72 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 17.3 ptpt -143.2 148.77 37.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.491 0.662 . . . . 0.0 112.727 -177.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 36' ' ' MET . 79.3 t -123.66 133.26 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.416 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -117.55 103.21 9.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' A' ' 67' ' ' ARG . 1.7 tp10 -136.27 169.7 17.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.741 0.305 . . . . 0.0 110.765 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 8.3 t -123.69 144.91 49.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.173 -176.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.23 -174.13 27.54 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -130.38 2.14 4.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.298 0.549 . . . . 0.0 112.016 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.549 ' HB3' ' HE3' ' B' ' 218' ' ' ALY . . . -160.17 130.91 5.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.744 0.307 . . . . 0.0 110.77 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -71.33 173.96 42.28 Favored Glycine 0 C--O 1.237 0.326 0 CA-C-N 115.604 -0.726 . . . . 0.0 113.381 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -173.1 157.09 3.39 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.87 0.468 . . . . 0.0 110.218 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 106' ' ' ASP . 12.9 mm -62.66 124.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.204 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.508 HD22 HG13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -108.66 106.2 58.3 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.98 112.7 3.47 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.807 2.338 . . . . 0.0 111.671 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.508 HG13 HD22 ' A' ' 86' ' ' LEU . 5.3 mt -108.15 125.74 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.633 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.598 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.2 mt-10 -107.93 122.12 46.17 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.388 0.613 . . . . 0.0 110.327 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 14' ' ' LEU . 75.8 t -101.11 116.63 45.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.285 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -88.74 139.3 30.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.815 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.1 m-85 -113.21 146.24 39.63 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.923 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -89.75 94.4 9.82 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.664 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -156.32 156.35 33.82 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.754 -170.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -107.8 -7.78 16.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.345 1.069 . . . . 0.0 109.515 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.15 -151.22 0.4 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.516 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.457 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 8.0 mm-40 -27.07 154.52 0.01 OUTLIER Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 4.2 Cg_exo -31.29 126.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.214 1 C-N-CA 125.529 4.153 . . . . 0.0 115.133 -168.238 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.85 14.46 11.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.932 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -161.91 142.76 10.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.349 0.595 . . . . 0.0 111.224 -176.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.513 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -129.23 156.48 41.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.761 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -128.77 107.55 9.75 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.466 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.513 ' CZ ' HG21 ' A' ' 101' ' ' VAL . 20.5 m-85 -100.27 137.89 38.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -94.73 122.51 37.41 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.377 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -133.26 130.76 39.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.324 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.465 ' HA ' HD13 ' A' ' 85' ' ' ILE . 17.4 t70 -84.47 107.0 16.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -175.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.467 HD11 ' CG1' ' A' ' 37' ' ' VAL . 1.5 mp -85.07 103.46 14.1 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.43 ' HB3' ' NH2' ' B' ' 217' ' ' ARG . 50.4 p90 -118.48 157.13 27.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.004 0.43 . . . . 0.0 110.352 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 mt -127.7 162.45 26.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.473 ' C ' ' HB2' ' B' ' 215' ' ' ALA . 36.0 m170 -94.62 164.07 13.12 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' B' ' 215' ' ' ALA . 1.3 mm? -51.99 147.07 7.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.958 0.409 . . . . 0.0 111.896 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.77 ' HA ' HG21 ' A' ' 22' ' ' VAL . 29.2 tt0 -61.89 100.86 0.17 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.846 177.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.915 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 109.31 28.26 4.43 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.525 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.02 159.37 65.1 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 119.024 -0.513 . . . . 0.0 110.539 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -32.67 175.19 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 124.984 3.79 . . . . 0.0 115.879 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -97.35 165.07 0.91 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 124.022 3.148 . . . . 0.0 111.876 -172.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 9.2 t -113.99 102.29 13.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.624 -177.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -118.23 100.99 7.87 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -127.47 127.67 44.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.215 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.4 mt -107.38 150.78 26.35 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.494 174.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.638 ' HD3' ' N ' ' A' ' 122' ' ' CYS . 0.0 OUTLIER -148.14 140.44 24.27 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -174.387 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.638 ' N ' ' HD3' ' A' ' 121' ' ' ARG . 49.7 t -131.57 130.23 41.97 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.829 -175.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -121.48 141.12 51.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.089 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -104.47 132.16 51.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.174 0.512 . . . . 0.0 111.37 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.875 ' HB2' HG23 ' A' ' 12' ' ' VAL . 6.9 mt -99.36 116.11 30.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.169 175.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 35.4 m -112.14 115.2 28.47 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.557 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -114.53 109.45 18.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.901 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.71 120.35 24.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.901 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.529 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 78.1 m-20 58.04 63.59 4.35 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.654 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -85.14 165.65 11.2 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.835 2.356 . . . . 0.0 111.496 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.4 p -67.47 145.08 55.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 175.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.12 -43.76 70.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 136' ' ' ARG . 3.1 t70 -59.71 -30.77 69.03 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.746 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.698 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 11.0 t80 -76.01 -39.84 54.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.634 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 29.1 ttm180 -55.12 -46.03 75.56 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 121.236 0.541 . . . . 0.0 109.583 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 46.3 ttt180 -51.21 -44.01 61.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.495 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -71.75 -39.91 69.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.6 mt -69.3 -29.57 67.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.857 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 40.5 mt -80.31 -41.17 25.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.047 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -68.28 -30.19 69.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.337 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.583 176.964 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 213' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 110' ' ' HIS . . . 139.44 66.97 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.596 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -76.22 131.06 39.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.004 0.431 . . . . 0.0 110.533 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 215' ' ' ALA . . . . . 0.516 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -83.14 171.29 11.96 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.662 -176.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 216' ' ' PRO . . . . . 0.516 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 0.1 OUTLIER -34.59 152.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.263 3.309 . . . . 0.0 114.749 168.767 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' A' ' 108' ' ' PHE . 17.1 ttm180 -150.14 132.63 15.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.024 -178.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 218' ' ' ALY . . . . . 0.549 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -77.75 68.78 3.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.656 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 31.5 mt -116.75 135.14 54.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.111 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -153.75 -68.52 0.14 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.15 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.9 t -162.13 157.81 23.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.015 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 70.02 -62.52 0.42 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.887 0.742 . . . . 0.0 111.344 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.162 179.118 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.563 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.8 m 55.95 61.01 2.95 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.258 0.551 . . . . 0.0 111.042 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -78.85 -26.44 44.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.949 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.8 mmt -70.74 -52.41 20.98 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 52.07 69.97 0.61 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.99 175.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.4 m -65.22 131.58 46.89 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -50.13 109.16 0.27 Allowed 'General case' 0 C--O 1.232 0.166 0 O-C-N 123.759 0.662 . . . . 0.0 111.761 -171.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.2 t -154.89 101.42 2.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.709 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.87 129.32 55.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.923 0.392 . . . . 0.0 110.557 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.9 t -101.87 137.25 30.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.5 mt-30 -117.2 120.53 38.54 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.037 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.838 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.49 167.84 3.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.711 175.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.664 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 43.7 mtpt -133.39 139.68 46.92 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.46 HD13 HG11 ' A' ' 90' ' ' VAL . 96.8 mt -126.99 151.9 47.95 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 175.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.684 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 41.1 tt0 -114.26 120.82 41.73 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.314 -174.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.636 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.1 mm? -108.67 115.32 29.87 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -144.88 169.64 26.6 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.011 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -163.11 155.78 18.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.164 0.507 . . . . 0.0 110.917 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 20.8 mtp180 -118.93 153.44 34.59 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.677 175.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -149.44 128.17 12.48 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.804 175.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -129.23 164.1 24.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.822 HG11 ' H ' ' A' ' 113' ' ' GLY . 1.8 p -103.44 163.47 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.2 mtp180 -112.51 135.13 53.59 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.61 -11.38 58.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.495 0.664 . . . . 0.0 110.457 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -135.9 103.29 9.97 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.833 170.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.531 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.2 Cg_exo -47.06 155.29 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.183 2.589 . . . . 0.0 112.211 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 t -76.71 -172.32 2.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -171.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 m -61.97 -30.43 48.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.495 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.83 -7.3 59.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.181 0.515 . . . . 0.0 110.38 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.65 32.42 33.7 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.206 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -98.54 138.49 35.67 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.531 HG22 ' HG3' ' A' ' 26' ' ' PRO . 26.5 p -86.77 -30.33 21.66 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -169.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.522 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.9 m80 -112.55 146.15 39.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -170.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -117.47 118.97 33.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -121.95 148.11 45.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.009 0.433 . . . . 0.0 111.111 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.645 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 41.1 ttp -125.75 122.04 35.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.526 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.9 m -103.23 153.05 5.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.072 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -154.26 154.52 33.57 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -126.71 129.5 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.844 169.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -134.91 -178.5 5.11 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.887 0.375 . . . . 0.0 111.067 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.44 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -92.37 166.85 29.68 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 173.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.664 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 41.0 Cg_endo -62.31 111.73 1.37 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 123.199 2.599 . . . . 0.0 112.727 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 58.02 67.84 0.91 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.784 172.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 75.47 -12.07 1.02 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.979 0.512 . . . . 0.0 112.353 172.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.1 m -62.37 122.94 16.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.799 0.333 . . . . 0.0 111.081 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -69.59 125.22 26.07 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.104 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.612 HD12 HG21 ' A' ' 51' ' ' VAL . 2.4 pt -96.07 -1.87 10.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -56.35 -16.45 5.64 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.942 0.401 . . . . 0.0 111.394 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -73.42 -43.85 59.56 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.617 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.475 ' CE2' HG22 ' A' ' 47' ' ' ILE . 49.5 p90 -106.07 -20.02 13.54 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.865 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.612 HG21 HD12 ' A' ' 47' ' ' ILE . 76.3 t -91.53 131.33 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.208 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.582 ' HB2' ' HG3' ' A' ' 93' ' ' LYS . 26.2 tt0 -103.46 -62.72 1.26 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.693 0.759 . . . . 0.0 110.327 -173.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 45.2 mtpt -131.73 161.16 33.5 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.578 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 93.2 t -134.8 153.5 34.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.573 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.3 p -139.36 132.71 37.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.635 0.731 . . . . 0.0 111.157 -175.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.48 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 27.0 m-85 -113.28 105.45 13.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.51 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -79.04 94.26 5.27 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.468 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.582 ' CD2' HD11 ' A' ' 86' ' ' LEU . 11.3 mt -73.34 179.74 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.04 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.51 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 4.1 t-80 -81.98 146.96 29.46 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -57.24 -21.68 35.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.669 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 t -64.71 -22.48 66.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.095 0.474 . . . . 0.0 110.581 174.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -90.48 129.12 46.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.567 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.65 138.31 44.99 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.152 1.901 . . . . 0.0 110.699 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 58.45 67.32 2.18 Favored Pre-proline 0 C--O 1.223 -0.302 0 O-C-N 123.447 0.467 . . . . 0.0 109.983 -174.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.91 -22.01 56.47 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.689 2.259 . . . . 0.0 113.79 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -93.92 109.97 21.66 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.061 0.458 . . . . 0.0 110.44 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 21.8 mmt85 -113.05 100.97 9.02 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.771 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.5 m -92.74 138.17 20.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 171.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.45 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 25.9 t -118.53 111.53 18.73 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -92.59 -26.93 17.65 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.926 0.869 . . . . 0.0 109.261 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.576 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -84.58 179.68 1.81 Allowed Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.946 -171.535 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.62 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 22.8 Cg_exo -28.28 -179.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.535 1 C-N-CA 126.125 4.55 . . . . 0.0 115.896 163.058 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.62 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.6 Cg_endo -29.24 115.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 124.318 3.345 . . . . 0.0 115.04 -153.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 42.3 m-85 -62.7 98.19 0.12 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.153 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.645 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.1 ptpt -145.27 151.26 38.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.275 0.559 . . . . 0.0 111.905 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 36' ' ' MET . 73.7 t -128.12 131.65 69.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.431 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.48 108.16 14.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.926 0.393 . . . . 0.0 110.009 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.34 174.01 10.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.424 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 8.1 t -122.99 146.89 47.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.217 -176.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.74 -168.24 27.61 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.221 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -138.31 -10.7 1.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.76 123.16 9.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.153 0.501 . . . . 0.0 110.938 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.71 175.03 13.17 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.001 -1.0 . . . . 0.0 114.471 -177.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' A' ' 59' ' ' HIS . 21.8 p90 -174.24 155.59 2.43 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.218 -0.491 . . . . 0.0 110.288 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 106' ' ' ASP . 19.8 mm -63.58 128.32 25.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.369 171.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.582 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.8 tt -120.03 105.84 41.99 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 121.025 0.44 . . . . 0.0 110.123 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.74 113.48 2.99 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 123.322 2.681 . . . . 0.0 112.327 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 mt -103.76 124.36 58.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.337 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.3 mt-10 -107.93 127.47 53.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.117 0.485 . . . . 0.0 110.289 175.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.46 HG11 HD13 ' A' ' 14' ' ' LEU . 70.0 t -107.3 120.8 59.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.741 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 86.7 m-85 -90.77 145.48 24.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.386 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.428 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 19.8 m-85 -126.04 161.42 27.61 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.933 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.582 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -101.6 94.22 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 117.986 0.357 . . . . 0.0 110.615 177.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -158.54 175.41 13.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.964 170.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.463 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -114.37 6.24 15.98 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 177.241 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -98.6 -153.08 0.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -176.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -30.85 150.17 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.963 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -37.57 120.8 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.677 3.585 . . . . 0.0 113.777 -169.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.43 ' N ' ' HD3' ' A' ' 99' ' ' ARG . 0.3 OUTLIER -89.77 20.34 4.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.871 -175.35 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -143.24 137.77 29.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.176 0.513 . . . . 0.0 110.16 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.32 155.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.517 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -125.41 117.35 23.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.118 0.485 . . . . 0.0 111.08 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.636 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.2 m-85 -108.1 119.6 39.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.966 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -80.91 105.82 12.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.35 0.595 . . . . 0.0 109.905 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -118.18 133.84 55.54 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.371 -175.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.402 ' HA ' HD13 ' A' ' 85' ' ' ILE . 31.8 t70 -87.55 111.82 21.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.039 -175.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.522 HD11 HG11 ' A' ' 37' ' ' VAL . 1.9 mp -88.76 101.54 14.11 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -113.21 155.33 25.23 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.515 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.7 mt -128.52 155.09 45.42 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -100.23 162.13 13.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 118.36 0.527 . . . . 0.0 110.175 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -52.12 141.61 18.16 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.524 ' HA ' HG21 ' A' ' 22' ' ' VAL . 5.0 tt0 -52.22 121.68 7.29 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.446 176.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.822 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 123.38 -49.74 0.88 Allowed Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.311 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -144.53 74.57 15.23 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 117.23 0.515 . . . . 0.0 112.119 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.517 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 35.7 Cg_endo -107.67 107.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 122.839 2.359 . . . . 0.0 113.506 174.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -99.39 98.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.353 2.702 . . . . 0.0 111.393 168.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 44.1 t -122.16 111.4 30.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.97 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -144.88 96.51 2.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.427 ' O ' HD23 ' A' ' 120' ' ' LEU . 27.5 t-80 -122.27 134.09 54.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.215 -174.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 119' ' ' HIS . 8.3 mt -117.78 153.9 32.66 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.452 0.47 . . . . 0.0 111.205 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.478 ' HD2' HD23 ' A' ' 16' ' ' LEU . 20.8 ttm180 -145.17 151.14 37.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.474 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 48.9 t -136.37 122.23 19.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -120.32 142.14 49.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.673 0.273 . . . . 0.0 111.089 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.422 ' HD3' ' HB3' ' A' ' 11' ' ' GLN . 22.1 ttmt -92.22 138.69 31.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.202 0.525 . . . . 0.0 111.641 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.838 ' HB2' HG23 ' A' ' 12' ' ' VAL . 5.9 mt -105.49 118.76 37.38 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.0 m -111.95 123.09 49.51 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.151 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -118.97 110.0 16.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.881 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -81.66 128.12 33.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.507 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 49.89 60.66 14.94 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.422 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.29 173.6 9.7 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.521 2.147 . . . . 0.0 111.626 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 p -67.58 136.92 55.23 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 174.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -56.5 -34.14 66.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.566 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 9.3 m-20 -62.76 -32.56 73.73 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.686 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.4 t80 -76.53 -40.45 49.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.572 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 50.3 ttp180 -55.75 -41.66 74.27 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 43.7 ttm180 -58.09 -36.3 72.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.06 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 37.8 mtpt -72.3 -40.38 67.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.89 0.376 . . . . 0.0 110.246 176.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 26.0 mt -71.15 -25.34 62.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.948 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 30.4 mt -89.8 -23.61 21.67 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.834 0.35 . . . . 0.0 110.783 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.02 -23.96 38.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.876 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.265 176.145 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -96.32 -48.33 2.22 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.006 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -84.7 142.57 29.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.95 0.405 . . . . 0.0 110.54 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.81 163.16 38.11 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.727 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.54 171.18 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.444 2.096 . . . . 0.0 112.602 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 30.6 mtp85 -133.4 139.31 46.69 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -141.64 -45.59 0.36 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.89 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.49 115.92 26.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.567 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -82.99 110.9 18.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.651 175.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 25.4 m -72.33 84.07 1.07 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.433 0.635 . . . . 0.0 111.067 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -131.66 0.15 3.95 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.827 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.615 -177.124 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 m -87.96 98.14 11.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.79 0.328 . . . . 0.0 110.458 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -140.2 8.42 2.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.821 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 96.6 mmm 61.59 -164.11 0.25 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.65 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.41 30.88 20.14 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.223 0.535 . . . . 0.0 110.907 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -139.87 86.02 2.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.288 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.4 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 25.1 m -59.48 111.01 1.24 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.537 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.54 ' O ' ' HD2' ' A' ' 130' ' ' PRO . 3.4 p -88.47 108.39 19.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.955 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.75 124.88 39.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.065 0.46 . . . . 0.0 111.753 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 t -101.7 139.75 22.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 5.2 mp0 -127.38 131.41 50.35 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -176.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.829 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -116.12 171.05 5.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.947 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -133.4 131.66 40.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.775 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.05 144.18 43.06 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.744 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 36.7 tt0 -109.68 123.26 49.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.036 -175.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.611 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.0 mm? -106.53 110.21 22.35 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.426 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -136.78 170.22 23.53 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.433 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -164.95 151.8 10.72 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.149 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.0 mtp180 -113.54 145.62 40.95 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.524 173.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -136.92 118.77 15.16 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.92 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -111.62 154.04 25.46 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.733 HG21 ' HA ' ' A' ' 112' ' ' GLU . 3.1 p -103.88 161.91 4.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 3.7 mtp180 -112.19 141.01 46.4 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -68.18 -20.26 64.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.571 0.7 . . . . 0.0 109.143 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -131.1 104.24 15.23 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.365 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HG3' HG22 ' A' ' 32' ' ' THR . 88.3 Cg_exo -47.63 154.42 1.82 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.27 2.647 . . . . 0.0 112.988 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.432 HG22 ' HB2' ' A' ' 31' ' ' PHE . 9.0 t -73.96 -170.65 0.95 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.077 -171.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 m -54.1 -33.48 24.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -104.24 5.96 35.14 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.162 0.982 . . . . 0.0 109.447 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.7 25.45 20.44 Favored Glycine 0 CA--C 1.503 -0.717 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.151 169.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.432 ' HB2' HG22 ' A' ' 27' ' ' THR . 21.9 m-30 -94.36 140.32 29.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.873 0.845 . . . . 0.0 111.11 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.52 HG22 ' HG3' ' A' ' 26' ' ' PRO . 44.8 p -94.41 -23.85 17.59 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.857 -162.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.509 ' O ' ' HA ' ' A' ' 79' ' ' SER . 69.9 m80 -118.22 146.55 44.17 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -170.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.532 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 4.0 m-20 -126.98 123.73 37.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.483 170.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.412 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 54.1 p-90 -125.15 153.39 43.11 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.921 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.675 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 44.8 ttp -129.61 120.65 25.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.273 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.9 m -100.46 151.19 5.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -151.69 152.74 33.19 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.5 m -124.35 127.65 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.19 171.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -127.18 -179.48 4.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.021 0.439 . . . . 0.0 111.22 -176.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.539 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -94.68 -173.13 38.03 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.042 172.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -65.18 110.33 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.039 1.826 . . . . 0.0 111.753 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 15.4 mm-40 51.09 65.31 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.325 177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' A' ' 43' ' ' GLU . 75.4 t60 76.59 -10.39 1.33 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 171.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.6 m -60.24 127.09 30.07 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -66.04 126.6 29.12 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 120.863 0.363 . . . . 0.0 110.336 -178.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.666 HD12 HG21 ' A' ' 51' ' ' VAL . 1.1 pt -94.97 -4.05 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.76 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -65.78 0.59 1.67 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.866 0.365 . . . . 0.0 111.866 -176.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -76.86 -36.01 57.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.467 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 55.3 p90 -116.91 -17.15 10.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.52 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.666 HG21 HD12 ' A' ' 47' ' ' ILE . 98.1 t -91.35 130.32 40.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.86 0.362 . . . . 0.0 110.259 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.464 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 9.6 tp10 -99.38 -62.49 1.23 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.263 0.554 . . . . 0.0 110.169 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 43.1 mtpt -132.26 163.69 28.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.481 HG21 HG21 ' A' ' 39' ' ' VAL . 94.4 t -134.52 157.38 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 168.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.543 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.2 p -142.03 128.97 19.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.62 0.724 . . . . 0.0 111.166 -175.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.477 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 25.8 m-85 -110.86 104.57 13.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.581 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -78.31 92.5 4.53 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.815 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.635 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.5 mt -71.81 -178.67 2.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.89 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -76.18 142.08 41.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.17 -17.2 39.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -61.31 -28.54 69.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.36 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -82.09 131.82 55.41 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.088 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.93 124.74 15.05 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.183 1.922 . . . . 0.0 110.931 171.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 60.7 70.28 0.99 Allowed Pre-proline 0 N--CA 1.466 0.362 0 O-C-N 123.578 0.549 . . . . 0.0 110.406 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.75 -23.6 35.62 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.666 2.244 . . . . 0.0 113.781 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -90.45 105.25 17.69 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.309 0.576 . . . . 0.0 110.333 -174.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -105.54 86.92 2.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.078 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.3 m -69.27 138.22 22.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.211 0.529 . . . . 0.0 110.066 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.75 103.19 7.96 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -94.84 -23.73 17.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.054 0.931 . . . . 0.0 109.307 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.592 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 4.1 t70 -75.8 173.49 7.06 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.826 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.659 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.3 Cg_exo -32.91 -175.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.675 1 C-N-CA 125.457 4.105 . . . . 0.0 114.732 163.202 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.9 Cg_endo -28.01 115.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 124.299 3.332 . . . . 0.0 114.508 -158.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 42.7 m-85 -61.49 107.13 0.74 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.009 -175.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.675 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 17.3 ptpt -152.13 150.46 29.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.379 0.609 . . . . 0.0 112.066 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.5 t -128.57 132.55 67.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.629 177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -121.11 106.31 11.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.455 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.29 169.14 18.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.035 0.445 . . . . 0.0 111.463 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 0.8 OUTLIER -114.91 137.05 52.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.861 -178.087 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -143.68 -178.1 19.16 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -129.76 -2.39 4.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.685 0.278 . . . . 0.0 110.97 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -163.55 142.27 7.98 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.398 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.46 179.72 39.63 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.425 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -178.11 157.03 1.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.605 0.362 . . . . 0.0 110.293 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.3 mm -63.02 128.49 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.057 171.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.635 HD11 ' CD2' ' A' ' 58' ' ' LEU . 5.7 tt -120.29 105.2 42.26 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-O 121.04 0.448 . . . . 0.0 110.224 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.34 110.66 2.3 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 123.312 2.675 . . . . 0.0 112.316 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.427 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.9 mt -102.3 123.75 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.29 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.6 mt-10 -109.27 126.62 53.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.042 0.449 . . . . 0.0 109.939 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 53.0 t -104.5 122.09 57.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.149 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 73.0 m-85 -89.64 136.82 32.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.018 -178.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.444 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.5 m-85 -114.77 156.36 25.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.077 178.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.464 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -104.47 91.67 3.99 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.26 0.552 . . . . 0.0 111.347 -178.683 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -158.51 179.75 8.84 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.909 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.597 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -113.19 4.19 16.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 110.915 176.608 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 44.9 mm-40 -99.34 -152.07 0.4 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.155 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.439 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 51.3 mm-40 -25.63 148.18 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -34.49 120.68 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 125.085 3.857 . . . . 0.0 113.873 -170.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.93 19.24 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.419 -174.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 11.8 ptpt -151.39 144.38 24.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.205 0.526 . . . . 0.0 110.432 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.94 154.71 30.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.63 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -120.81 118.96 31.35 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.939 0.399 . . . . 0.0 110.811 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.611 ' CD2' HD21 ' A' ' 16' ' ' LEU . 24.1 m-85 -112.54 117.08 31.35 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.712 174.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.98 105.93 14.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.626 0.727 . . . . 0.0 109.791 177.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -115.99 127.52 55.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.212 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -81.48 109.89 16.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.605 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.523 HD11 HG11 ' A' ' 37' ' ' VAL . 1.4 mp -83.87 91.16 7.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.442 . . . . 0.0 109.81 176.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -96.46 154.02 17.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.279 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.2 mt -127.91 162.3 27.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.677 ' CD2' ' HA ' ' A' ' 116' ' ' PRO . 23.8 p80 -96.52 166.97 11.43 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.792 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.11 150.59 47.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.954 0.407 . . . . 0.0 111.261 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.733 ' HA ' HG21 ' A' ' 22' ' ' VAL . 5.1 tt0 -61.82 104.3 0.43 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.469 173.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.33 24.43 6.81 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.211 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -132.04 146.53 62.09 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -43.75 139.67 5.12 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 122.703 2.269 . . . . 0.0 114.112 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.677 ' HA ' ' CD2' ' A' ' 110' ' ' HIS . 22.0 Cg_endo -61.39 174.56 1.98 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.232 3.288 . . . . 0.0 114.176 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 48.6 t -116.42 133.12 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.398 -173.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -144.5 97.65 3.07 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -124.44 137.12 54.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.254 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.2 mt -115.74 153.48 31.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.74 0.65 . . . . 0.0 110.097 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 20.2 ttt180 -142.64 136.38 29.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 75.0 m -115.25 113.65 24.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.867 0.365 . . . . 0.0 111.052 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -110.73 134.89 52.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.878 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -96.48 125.9 41.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.261 0.553 . . . . 0.0 111.836 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.829 ' HB2' HG23 ' A' ' 12' ' ' VAL . 12.6 mt -90.21 120.42 31.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 171.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.2 m -112.84 119.9 39.59 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.694 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.49 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 30.6 m-85 -118.25 109.23 16.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.154 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.34 116.84 20.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.191 0.519 . . . . 0.0 111.153 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 4.4 t30 52.75 61.78 11.04 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.501 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 96.5 Cg_endo -77.73 169.23 21.13 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.353 2.036 . . . . 0.0 111.489 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' A' ' 134' ' ' PHE . 6.6 p -59.62 141.25 55.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -57.82 -36.09 71.77 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.366 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.89 -34.5 74.75 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.676 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.0 t80 -73.94 -40.12 63.29 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.615 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 19.9 ttm180 -55.08 -44.62 75.02 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.591 173.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -55.49 -38.59 69.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.106 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -72.05 -39.74 68.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.984 0.421 . . . . 0.0 110.413 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 34.0 mt -72.62 -26.07 61.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.223 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.8 mt -85.6 -25.4 26.71 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.894 0.378 . . . . 0.0 110.689 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -80.74 -27.72 36.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.149 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.536 176.453 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -126.97 158.07 20.82 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.2 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 66.7 mttm 66.27 94.93 0.06 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.107 0.563 . . . . 0.0 111.549 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.01 156.76 65.88 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.427 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.53 168.64 3.82 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.13 1.887 . . . . 0.0 111.674 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -149.27 152.26 35.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.372 0.606 . . . . 0.0 111.592 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -86.68 -40.03 15.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.161 0.505 . . . . 0.0 110.081 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 32.7 tp -145.25 52.05 1.2 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.485 -0.78 . . . . 0.0 108.929 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.26 106.41 18.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.82 -177.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 19.2 m -115.93 -37.46 3.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.295 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -120.88 41.28 3.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.182 0.515 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.134 178.231 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 t 55.87 48.35 18.23 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.357 0.599 . . . . 0.0 110.966 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -102.45 146.34 28.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.193 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.0 mtt 59.19 40.4 21.67 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.422 0.629 . . . . 0.0 110.027 -176.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.53 89.91 6.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.874 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 p -66.43 134.03 51.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.576 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.0 m -72.66 115.15 11.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.827 0.346 . . . . 0.0 110.202 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.5 p -129.45 116.89 19.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.368 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.87 138.72 49.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.657 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.496 HG23 ' HG3' ' A' ' 130' ' ' PRO . 10.2 t -104.93 143.34 16.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 2.8 mp0 -127.35 127.67 44.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.743 0.306 . . . . 0.0 110.362 -176.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.826 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -112.13 171.92 3.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.224 178.278 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 99.6 mttt -137.41 138.06 39.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.695 0.284 . . . . 0.0 110.53 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.404 HD22 HD13 ' A' ' 47' ' ' ILE . 85.4 mt -121.4 142.02 50.41 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.53 175.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 121' ' ' ARG . 3.0 tm-20 -107.8 128.09 54.29 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.046 -175.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.612 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -111.24 107.64 17.01 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.81 168.4 23.95 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.612 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -162.88 152.17 15.21 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.485 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.649 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -122.46 121.06 35.72 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.371 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.411 ' O ' ' HE1' ' A' ' 114' ' ' HIS . . . -115.61 117.4 30.2 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.283 -176.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -111.09 158.9 18.33 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.786 HG11 ' H ' ' A' ' 113' ' ' GLY . 5.0 p -103.79 156.41 5.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 23' ' ' ARG . 3.0 mtp180 -104.66 140.74 37.6 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -63.39 -22.22 66.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.612 0.72 . . . . 0.0 109.342 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -140.93 107.91 6.35 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.483 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.523 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.8 Cg_exo -49.23 156.88 2.2 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.301 2.667 . . . . 0.0 112.816 174.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -79.36 -173.5 3.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.658 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -42.43 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 122.625 0.37 . . . . 0.0 111.349 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -75.32 2.2 11.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.079 0.466 . . . . 0.0 111.144 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.61 29.33 65.81 Favored Glycine 0 CA--C 1.507 -0.466 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.64 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -86.8 129.43 34.88 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.523 HG22 ' HG3' ' A' ' 26' ' ' PRO . 59.9 p -91.51 -20.12 22.06 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.105 -168.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.0 m80 -122.12 145.85 47.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -172.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -121.81 123.81 42.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -126.22 143.31 51.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.196 0.522 . . . . 0.0 110.96 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.595 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 45.5 ttp -120.27 117.29 27.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.515 174.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 9.9 m -98.96 153.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.342 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.4 p90 -153.63 153.98 33.34 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -124.73 131.12 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.322 168.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.67 175.02 14.61 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.861 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.509 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -81.88 -176.44 51.15 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.296 -168.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 11.8 Cg_exo -63.01 112.19 1.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.981 2.454 . . . . 0.0 111.702 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 52.02 52.58 14.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.671 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.0 t60 80.3 -3.47 1.91 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.701 171.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.481 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 49.9 m -58.58 123.42 16.22 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -58.11 127.12 30.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.652 0.263 . . . . 0.0 111.078 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.56 HD12 HG21 ' A' ' 51' ' ' VAL . 5.6 pt -97.7 -1.98 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -66.51 -4.49 8.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.815 0.34 . . . . 0.0 111.003 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -71.35 -34.38 70.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.755 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -120.68 -17.5 7.99 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.555 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 47' ' ' ILE . 91.4 t -89.75 128.48 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.921 0.391 . . . . 0.0 110.487 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.87 -62.38 1.27 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.366 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -145.66 153.56 41.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 55' ' ' VAL . 91.5 t -128.0 158.16 39.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.914 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.637 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.7 p -142.11 134.13 26.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.14 0.495 . . . . 0.0 111.246 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 22.7 m-85 -115.86 107.29 14.83 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -77.94 94.33 4.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.925 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.599 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.4 mt -75.29 -177.7 3.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.845 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.505 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 68.7 t60 -73.97 138.89 44.46 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -54.97 -24.55 24.5 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.022 -170.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 t -69.3 -19.17 63.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.188 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 21.0 m-85 -77.95 139.6 61.71 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.7 0.286 . . . . 0.0 110.994 -176.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.35 119.9 6.81 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.066 2.51 . . . . 0.0 111.11 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 59.45 67.39 1.87 Allowed Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.45 -170.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.15 -20.25 50.06 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.591 2.194 . . . . 0.0 113.006 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -95.66 102.26 14.04 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.143 0.497 . . . . 0.0 110.488 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -98.75 94.23 6.51 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.516 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -79.52 135.21 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 172.176 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 m -127.95 114.56 17.3 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -106.66 -24.53 12.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.674 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.626 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 5.9 p-10 -68.51 -174.87 0.22 Allowed Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.397 1.079 . . . . 0.0 111.347 -175.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.631 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 4.2 Cg_exo -40.61 -167.63 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 124.231 3.287 . . . . 0.0 114.552 167.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.657 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 Cg_endo -39.68 124.49 1.33 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.626 2.217 . . . . 0.0 113.097 -155.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 46.7 m-85 -62.5 95.75 0.07 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.187 -175.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.657 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 4.8 ptpt -141.4 145.88 35.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.453 0.644 . . . . 0.0 112.251 -176.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 36' ' ' MET . 92.7 t -125.33 131.29 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.827 177.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -115.43 110.55 19.49 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -133.62 170.18 15.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.067 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.0 t -121.96 142.72 50.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.708 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.62 -168.5 21.71 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.125 -0.559 . . . . 0.0 111.892 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -135.8 -11.92 2.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.178 0.489 . . . . 0.0 111.651 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.423 ' HB3' ' HE3' ' B' ' 218' ' ' ALY . . . -145.63 132.73 20.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.914 0.388 . . . . 0.0 110.567 -175.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.67 171.5 51.79 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.14 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -169.51 155.38 6.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 106' ' ' ASP . 23.3 mm -63.21 126.45 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.982 172.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.599 HD11 ' CD2' ' A' ' 58' ' ' LEU . 5.6 tt -117.74 104.29 49.43 Favored Pre-proline 0 N--CA 1.444 -0.727 0 CA-C-O 121.22 0.533 . . . . 0.0 110.378 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.543 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 24.7 Cg_exo -65.47 108.48 1.21 Allowed 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 123.85 3.034 . . . . 0.0 112.384 172.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -101.49 124.47 55.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.26 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.637 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.5 mt-10 -108.17 127.49 53.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.095 0.474 . . . . 0.0 109.867 175.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.7 t -108.0 119.83 58.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.69 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.528 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 96.8 m-85 -93.24 138.55 31.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.583 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.416 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.9 m-85 -112.25 149.5 32.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.206 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.48 92.25 9.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.372 0.606 . . . . 0.0 109.946 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.539 ' HB3' ' HG3' ' A' ' 99' ' ' ARG . 50.9 t30 -158.13 156.69 31.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.668 -174.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -113.33 8.56 18.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.288 0.566 . . . . 0.0 111.013 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.515 ' HB2' HD21 ' A' ' 94' ' ' ASN . 0.4 OUTLIER -100.59 -152.29 0.42 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.236 -175.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.508 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 16.9 mm-40 -33.39 155.04 0.04 OUTLIER Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.133 0.973 . . . . 0.0 112.892 173.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 1.3 Cg_endo -37.88 122.44 0.51 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 124.566 3.511 . . . . 0.0 114.055 -168.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.539 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -95.62 20.18 10.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.412 -174.291 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.75 137.6 26.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.272 0.558 . . . . 0.0 111.01 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.0 OUTLIER -125.93 156.79 36.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.576 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.543 ' HE ' ' HB3' ' A' ' 87' ' ' PRO . 29.3 ttt180 -131.26 115.77 16.74 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.417 0.627 . . . . 0.0 110.8 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.612 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.8 m-85 -107.53 114.31 28.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.048 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.75 102.97 5.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.317 0.579 . . . . 0.0 109.636 176.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -114.08 127.29 55.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.287 0.565 . . . . 0.0 110.662 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.421 ' HA ' HD13 ' A' ' 85' ' ' ILE . 11.8 t70 -80.4 104.47 10.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.931 -177.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.529 HD11 HG11 ' A' ' 37' ' ' VAL . 1.8 mp -82.8 109.34 16.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 174.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.481 ' CE1' HG11 ' A' ' 117' ' ' VAL . 54.4 p90 -124.64 160.55 28.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.444 0.64 . . . . 0.0 111.054 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.3 mt -135.76 156.57 48.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.603 ' HB2' ' CG ' ' A' ' 114' ' ' HIS . 55.3 m170 -101.6 171.23 7.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.58 173.2 3.53 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.55 0.614 . . . . 0.0 112.262 -174.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.732 ' HA ' HG21 ' A' ' 22' ' ' VAL . 12.8 mt-10 -61.3 131.62 50.92 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.963 0.411 . . . . 0.0 110.888 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.786 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 96.2 2.95 60.42 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.659 -177.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.603 ' CG ' ' HB2' ' A' ' 110' ' ' HIS . 10.3 p80 -78.77 149.57 74.43 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-O 119.832 -0.128 . . . . 0.0 110.896 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.06 137.46 37.56 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.335 1.357 . . . . 0.0 111.087 162.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -41.2 148.71 0.23 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.749 3.633 . . . . 0.0 114.905 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 30.1 t -100.22 125.25 54.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.668 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -133.48 97.77 4.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.964 0.411 . . . . 0.0 110.12 -173.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -125.22 130.37 51.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.774 -173.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.3 mt -118.45 140.74 49.39 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.548 0.53 . . . . 0.0 110.397 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 22.2 ttm180 -131.37 132.34 44.35 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 120.519 0.199 . . . . 0.0 111.203 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 57.3 m -110.13 110.62 21.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.938 0.399 . . . . 0.0 110.708 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 22.5 mm-40 -97.65 159.52 14.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.578 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -120.28 133.59 55.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.213 0.53 . . . . 0.0 111.337 -177.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.826 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.8 mt -107.44 120.4 42.08 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.15 175.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.3 m -110.89 123.18 49.61 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.658 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -120.31 102.42 8.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.893 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -78.98 125.34 29.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.459 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 56.88 63.0 5.63 Favored Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.871 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.496 ' HG3' HG23 ' A' ' 10' ' ' VAL . 71.6 Cg_endo -81.89 165.37 17.57 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.47 2.114 . . . . 0.0 111.675 177.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.45 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 13.4 p -68.1 143.21 55.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 174.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -57.79 -42.24 83.74 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.23 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -63.11 -25.93 68.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.622 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.612 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.3 t80 -73.43 -38.23 65.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.61 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 35.2 ttm180 -56.1 -45.57 79.41 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 173.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -55.06 -38.08 67.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.622 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.503 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 46.5 mtpt -72.35 -41.52 66.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.758 0.313 . . . . 0.0 110.763 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.0 mt -70.65 -32.87 70.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.065 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 50.8 mt -74.97 -33.89 61.95 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -73.97 -28.66 61.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.493 175.776 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . 79.37 -113.16 3.6 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.322 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -164.08 137.91 5.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.97 150.28 97.84 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.69 173.76 3.41 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.402 2.068 . . . . 0.0 112.453 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -145.67 137.18 25.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.961 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 218' ' ' ALY . . . . . 0.423 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -111.16 73.33 0.81 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.019 0.437 . . . . 0.0 110.698 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.36 77.25 3.4 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.346 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 58.07 67.51 0.94 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.56 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 5.8 t -84.24 -17.7 38.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.793 0.33 . . . . 0.0 110.734 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.31 95.2 9.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.079 0.466 . . . . 0.0 110.112 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.382 -0.818 . . . . 0.0 110.278 179.568 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.664 0.269 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.491 HG23 ' HG3' ' A' ' 130' ' ' PRO . 6.6 t -105.28 142.07 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.98 124.13 41.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.869 0.366 . . . . 0.0 110.454 -177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.834 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -113.73 178.79 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.184 178.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 122' ' ' CYS . 16.2 tttp -145.51 135.8 23.98 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.94 151.95 39.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 41.7 tt0 -117.47 124.38 48.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.4 -176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -107.14 118.06 35.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.96 169.9 27.96 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.899 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -164.12 146.21 8.99 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.94 0.4 . . . . 0.0 110.43 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -117.48 134.96 54.27 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 173.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -122.94 117.17 24.91 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.933 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -110.54 150.5 28.84 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.703 HG21 ' HA ' ' A' ' 112' ' ' GLU . 1.8 p -103.62 161.6 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.1 mtp180 -110.33 146.86 35.0 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -76.12 -14.26 60.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 109.049 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -141.31 103.97 6.04 Favored Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.047 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.564 ' HG3' HG22 ' A' ' 32' ' ' THR . 82.0 Cg_exo -47.72 156.04 1.34 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.375 2.717 . . . . 0.0 113.049 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -77.7 -170.4 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.379 -173.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 m -61.68 -31.24 50.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.892 0.377 . . . . 0.0 111.297 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -86.43 3.38 44.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.742 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.97 29.38 69.15 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.391 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -89.56 133.93 34.37 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.564 HG22 ' HG3' ' A' ' 26' ' ' PRO . 36.6 p -90.07 -24.22 21.21 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.323 -171.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.469 ' O ' ' HA ' ' A' ' 79' ' ' SER . 63.3 m80 -118.7 150.04 40.41 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -170.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -129.6 119.54 23.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.411 ' HH2' HD22 ' A' ' 58' ' ' LEU . 42.9 p-90 -121.13 146.34 46.85 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.039 0.447 . . . . 0.0 110.676 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.576 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 24.2 ttp -122.85 109.82 14.65 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.482 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.595 HG11 HD11 ' A' ' 107' ' ' LEU . 11.8 m -94.52 150.05 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.463 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.506 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 0.3 OUTLIER -151.8 156.03 39.4 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 7.8 m -122.05 124.95 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.632 168.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 40' ' ' ARG . 3.1 mmp_? -126.63 178.12 6.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.098 -173.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.55 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -96.87 177.93 33.17 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.308 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.605 ' HD2' ' OG ' ' A' ' 45' ' ' SER . 13.0 Cg_exo -63.18 113.8 2.2 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.406 2.071 . . . . 0.0 111.27 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 61.3 46.04 8.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.253 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 65.37 16.4 10.51 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.605 ' OG ' ' HD2' ' A' ' 42' ' ' PRO . 60.6 p -67.87 139.88 56.52 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -68.89 125.29 26.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.55 HG23 ' HA3' ' A' ' 41' ' ' GLY . 3.4 pt -96.74 -0.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -172.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.68 -4.65 4.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -76.07 -34.9 59.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.554 0.216 . . . . 0.0 110.85 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.422 ' CE2' HG22 ' A' ' 47' ' ' ILE . 51.0 p90 -115.71 -17.65 11.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.297 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.539 HG21 HD12 ' A' ' 47' ' ' ILE . 86.8 t -91.92 122.7 43.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.213 0.53 . . . . 0.0 110.095 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 5.7 tp10 -89.21 -58.01 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.592 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 15.4 tttt -152.45 152.72 32.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.743 -175.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 95.4 t -130.82 156.9 43.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.3 p -140.67 138.04 35.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.179 0.514 . . . . 0.0 111.105 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 17.6 m-85 -120.41 110.7 16.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.5 94.35 7.45 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.86 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.549 ' CD2' HD11 ' A' ' 86' ' ' LEU . 9.0 mt -79.38 -177.15 5.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.759 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -80.27 145.38 32.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -56.88 -20.18 21.7 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.38 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 m -67.2 -21.73 65.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.117 0.484 . . . . 0.0 110.829 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -81.81 135.39 48.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.89 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.4 117.96 4.76 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.342 2.028 . . . . 0.0 110.812 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 60.5 80.87 0.25 Allowed Pre-proline 0 C--O 1.226 -0.182 0 O-C-N 123.665 0.603 . . . . 0.0 110.114 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.93 -22.71 64.37 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.615 2.21 . . . . 0.0 113.216 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HE2' ' CG1' ' A' ' 68' ' ' VAL . 78.6 tttt -100.6 109.54 21.63 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.194 0.521 . . . . 0.0 110.855 -176.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 22.5 mmt85 -108.64 104.72 14.08 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.69 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 2.8 m -97.25 136.67 27.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.7 m -120.5 110.76 16.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.024 0.44 . . . . 0.0 110.09 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -99.69 -25.04 14.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.562 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.555 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 8.1 t70 -66.87 173.06 2.76 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.351 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.659 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 60.1 Cg_exo -30.22 -167.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.953 1 C-N-CA 125.322 4.014 . . . . 0.0 115.365 159.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.3 Cg_endo -32.19 121.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 123.408 2.739 . . . . 0.0 114.761 -154.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 31.8 m-85 -65.9 91.73 0.15 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.622 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 0.4 OUTLIER -148.73 148.16 29.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.541 0.686 . . . . 0.0 112.043 -178.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 36' ' ' MET . 94.2 t -118.92 129.23 75.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.239 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -117.18 101.6 8.59 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.42 170.55 15.32 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 -174.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 7.4 t -120.87 144.68 48.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.972 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.52 -161.98 12.9 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -138.32 -14.91 1.29 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.335 0.567 . . . . 0.0 112.341 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.25 146.46 35.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.91 0.386 . . . . 0.0 111.158 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.431 ' O ' ' HD2' ' B' ' 217' ' ' ARG . . . -86.08 170.15 42.95 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.52 -0.764 . . . . 0.0 113.045 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -170.58 159.71 6.89 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 122.566 0.346 . . . . 0.0 110.252 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.447 HG12 HH22 ' B' ' 217' ' ' ARG . 14.8 mm -68.24 119.48 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.549 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.8 tt -112.94 105.04 55.98 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.617 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.15 120.6 7.3 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 122.823 2.349 . . . . 0.0 112.299 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.5 mt -108.48 129.47 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.318 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.54 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.7 mt-10 -114.58 122.24 45.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.143 0.497 . . . . 0.0 110.086 176.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.6 t -102.69 123.22 55.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.804 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 93.9 m-85 -95.33 138.94 32.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.641 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -113.13 161.04 17.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -108.09 91.6 3.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.467 0.651 . . . . 0.0 110.543 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.515 ' OD1' ' HB2' ' A' ' 96' ' ' GLU . 15.8 t-20 -159.57 167.7 27.9 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.842 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.588 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -113.58 9.07 17.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.515 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 3.1 mp0 -99.6 -152.95 0.43 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 14.3 mm-40 -32.43 152.37 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.192 0.997 . . . . 0.0 113.027 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.8 Cg_endo -44.21 117.74 1.43 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.136 3.224 . . . . 0.0 113.499 -168.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -87.45 20.76 2.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.133 -172.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.2 139.16 48.24 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.395 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.531 HG21 ' CE2' ' A' ' 103' ' ' PHE . 1.6 m -116.91 156.97 18.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.951 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -130.04 107.04 9.04 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.929 0.395 . . . . 0.0 110.32 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.672 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.5 m-85 -108.18 119.96 40.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.345 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -84.26 114.72 22.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.08 0.467 . . . . 0.0 109.81 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -126.31 133.8 51.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.661 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.3 115.98 26.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.802 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.595 HD11 HG11 ' A' ' 37' ' ' VAL . 2.5 mp -88.82 95.05 10.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -104.92 154.99 19.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.529 . . . . 0.0 111.57 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 mt -137.42 163.63 30.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.986 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.572 ' HD2' ' O ' ' A' ' 111' ' ' LEU . 17.9 p-80 -99.77 167.74 10.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.54 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.572 ' O ' ' HD2' ' A' ' 110' ' ' HIS . 1.0 OUTLIER -68.18 147.04 52.81 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 173.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.703 ' HA ' HG21 ' A' ' 22' ' ' VAL . 4.5 tt0 . . . . . 0 CA--C 1.533 0.307 0 C-N-CA 122.796 0.438 . . . . 0.0 110.349 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 58.0 t . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -138.0 96.71 3.26 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -122.12 125.78 46.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.852 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.1 mt -113.26 150.52 32.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.858 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.7 ttt180 -144.93 142.71 30.08 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 60.9 m -128.88 116.13 18.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.895 0.378 . . . . 0.0 111.193 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -111.64 135.12 52.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.311 -176.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -90.83 136.38 33.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.198 0.523 . . . . 0.0 111.562 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.834 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.0 mt -106.87 124.69 49.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 20.2 m -120.55 124.15 44.64 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.209 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -120.86 112.82 19.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.585 -176.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -85.57 127.9 34.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.007 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 56.75 58.16 8.47 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.493 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HG3' HG23 ' A' ' 10' ' ' VAL . 95.5 Cg_endo -84.51 166.13 12.17 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.455 2.104 . . . . 0.0 111.694 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.1 p -73.21 145.09 46.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.766 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -54.34 -42.37 70.14 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.507 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.511 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.1 p-10 -57.22 -33.04 67.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.651 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 11.0 t80 -75.73 -40.16 56.03 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.621 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 37.2 ttm180 -56.96 -45.29 82.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -56.43 -34.76 67.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.34 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 36.2 mtpt -75.2 -41.33 58.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.812 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.1 mt -69.33 -27.06 65.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 44.0 mt -83.99 -35.69 23.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.318 . . . . 0.0 110.937 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -70.59 -30.49 67.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.732 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.547 -0.74 . . . . 0.0 110.373 176.711 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.492 ' HA ' HD22 ' A' ' 111' ' ' LEU . . . . . . . . 0 C--O 1.235 0.314 0 N-CA-C 111.121 0.045 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . 0.44 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 10.5 Cg_endo -53.7 165.59 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.562 2.175 . . . . 0.0 112.472 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.447 HH22 HG12 ' A' ' 85' ' ' ILE . 6.2 tpt180 . . . . . 0 C--N 1.319 -0.742 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.86 -173.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.413 HG23 ' HG3' ' A' ' 130' ' ' PRO . 9.6 t -100.17 138.85 23.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 6.4 mp0 -125.7 119.86 29.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.936 0.398 . . . . 0.0 110.443 -174.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.808 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.56 -179.74 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.888 178.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 36.0 ttpt -151.31 123.28 8.13 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.849 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.443 ' HG ' HD11 ' A' ' 125' ' ' LEU . 84.8 mt -106.66 145.57 31.81 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.313 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 3.5 tt0 -105.01 126.55 52.19 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.144 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.657 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -112.54 114.52 27.21 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -140.9 171.05 24.28 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.842 -1.171 . . . . 0.0 111.728 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -162.97 146.01 10.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.512 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -118.81 132.03 56.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.709 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.631 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -130.56 131.35 44.98 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.468 0.651 . . . . 0.0 111.271 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 3.8 tt0 -129.6 155.08 46.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.229 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.665 HG21 ' HA ' ' A' ' 112' ' ' GLU . 2.8 p -101.85 153.45 5.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 23' ' ' ARG . 1.1 mtp180 -102.57 135.48 44.12 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 20.3 tptt -75.75 -5.54 46.25 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.613 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -133.87 99.78 13.68 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.079 168.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.483 ' HG3' HG22 ' A' ' 32' ' ' THR . 83.1 Cg_exo -50.98 156.57 4.69 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.02 2.48 . . . . 0.0 111.868 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 31' ' ' PHE . 10.2 t -78.79 -172.67 3.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.091 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 m -60.09 -31.66 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.928 0.394 . . . . 0.0 111.237 -174.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -86.73 4.29 41.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.11 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.42 32.5 68.13 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.253 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.459 ' HB2' HG22 ' A' ' 27' ' ' THR . 17.7 m-30 -90.72 127.19 36.23 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.483 HG22 ' HG3' ' A' ' 26' ' ' PRO . 36.1 p -87.52 -29.91 20.98 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -170.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 79' ' ' SER . 67.1 m80 -115.47 142.29 46.91 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -112.27 123.83 51.12 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.445 ' CZ2' ' HB3' ' A' ' 78' ' ' GLU . 54.2 p-90 -127.6 147.27 50.35 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.135 0.493 . . . . 0.0 110.889 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.638 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 51.7 ttp -123.6 122.64 38.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.459 174.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.57 ' CG2' ' HB ' ' A' ' 76' ' ' VAL . 10.2 m -102.5 152.21 5.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.588 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -153.27 152.04 30.71 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.951 -0.7 . . . . 0.0 112.812 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.0 m -122.76 125.99 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.703 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -134.65 -178.92 5.29 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.221 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.502 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -94.02 -173.84 39.22 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 175.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 1.4 Cg_endo -81.57 111.37 2.3 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.235 1.957 . . . . 0.0 112.693 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 58.7 70.18 0.67 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 71.74 -11.12 0.77 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.26 0.624 . . . . 0.0 112.344 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.5 ' HB3' ' OXT' ' A' ' 141' ' ' ALA . 19.9 m -66.92 120.67 13.98 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -69.86 127.16 31.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 120.881 0.372 . . . . 0.0 110.271 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.556 HD12 HG21 ' A' ' 51' ' ' VAL . 1.2 pt -90.5 -3.47 10.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.569 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -65.74 -0.87 2.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.891 0.377 . . . . 0.0 111.552 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -74.29 -39.87 62.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.221 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.407 ' CE2' HG22 ' A' ' 47' ' ' ILE . 53.5 p90 -113.61 -20.27 11.28 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.94 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.556 HG21 HD12 ' A' ' 47' ' ' ILE . 52.5 t -93.38 135.77 27.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.781 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 93' ' ' LYS . 8.4 tp10 -111.91 -60.87 1.79 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.172 0.511 . . . . 0.0 110.711 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.665 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 6.7 tttm -138.24 146.92 43.16 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.253 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 98.1 t -127.01 159.21 37.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.566 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.8 p -141.85 136.2 30.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.299 0.571 . . . . 0.0 111.574 -174.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.483 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 22.0 m-85 -119.06 105.6 11.58 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -77.53 87.92 3.86 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.015 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.5 mt -71.38 -176.46 1.52 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.825 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -76.32 140.29 41.41 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -59.39 -19.55 47.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.021 -174.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -58.94 -27.27 65.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.743 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -85.47 131.64 47.24 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.084 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.95 121.5 10.12 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.668 2.246 . . . . 0.0 111.554 175.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 64' ' ' ARG . 16.5 mtm180 55.79 67.24 3.06 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.512 -176.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.36 -17.46 60.18 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.189 2.592 . . . . 0.0 113.52 -172.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -86.23 101.62 13.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.141 0.496 . . . . 0.0 110.228 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 22.0 mmt180 -98.42 107.83 20.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.68 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -99.05 136.19 31.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.1 m -120.6 113.56 20.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.295 0.569 . . . . 0.0 110.316 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -102.75 -24.55 13.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.614 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.527 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 13.8 t70 -68.0 170.12 8.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.623 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.639 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.2 Cg_exo -32.71 -178.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.568 1 C-N-CA 125.346 4.031 . . . . 0.0 114.865 164.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.639 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.7 Cg_endo -28.29 119.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 124.292 3.328 . . . . 0.0 113.942 -157.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.588 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 51.2 m-85 -60.1 98.66 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.59 -171.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.638 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 10.7 ptpt -140.18 150.42 44.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.438 0.637 . . . . 0.0 112.171 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 36' ' ' MET . 81.1 t -126.87 130.83 71.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.604 175.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.81 109.88 18.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.835 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 35' ' ' TRP . 1.9 tp10 -135.31 174.45 10.59 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -177.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.3 t -128.45 143.8 51.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.2 -170.62 26.09 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.884 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -130.36 -11.42 4.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.263 0.531 . . . . 0.0 112.066 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -148.84 139.3 22.55 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.434 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.518 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -75.5 176.45 50.37 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.355 -0.838 . . . . 0.0 113.361 -176.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -172.41 158.29 4.28 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.2 mm -65.44 126.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.329 . . . . 0.0 110.522 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.512 HD22 HG13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -111.23 104.64 56.4 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.86 111.14 2.96 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.708 2.272 . . . . 0.0 111.826 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.512 HG13 HD22 ' A' ' 86' ' ' LEU . 4.9 mt -104.43 125.69 59.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.43 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.566 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 54.4 mt-10 -111.45 123.64 50.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.171 0.51 . . . . 0.0 110.039 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 72.4 t -103.79 122.42 56.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.112 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.665 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 75.7 m-85 -94.63 132.42 39.38 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 112.005 -176.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.499 ' HE1' HG22 ' A' ' 51' ' ' VAL . 18.9 m-85 -114.38 164.07 14.44 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.079 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.462 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -107.9 100.48 9.84 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 122.327 -0.233 . . . . 0.0 111.479 175.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -158.28 178.18 10.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.742 171.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.52 -1.11 15.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.756 -178.338 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -100.62 -153.12 0.44 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.092 -176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -29.56 152.74 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.395 1.078 . . . . 0.0 113.907 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -32.89 122.46 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 125.03 3.82 . . . . 0.0 114.2 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.9 19.5 2.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.697 -176.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -150.09 144.56 25.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.276 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.13 157.21 28.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 102' ' ' ARG . 11.6 ttt180 -129.08 108.69 10.58 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.8 m-85 -104.66 120.44 41.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.189 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.83 111.61 19.36 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -124.94 127.28 46.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.317 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -78.82 121.81 25.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.952 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.528 HD11 ' CG1' ' A' ' 37' ' ' VAL . 1.5 mp -94.53 91.66 6.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.538 ' CE2' HG13 ' A' ' 117' ' ' VAL . 37.8 p90 -100.11 160.14 14.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.04 0.448 . . . . 0.0 110.845 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.9 mt -134.26 155.9 49.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.406 ' O ' ' NE2' ' A' ' 33' ' ' HIS . 1.4 m-70 -101.05 175.53 5.57 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 122.329 -0.232 . . . . 0.0 111.043 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.89 139.01 58.24 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.665 ' HA ' HG21 ' A' ' 22' ' ' VAL . 1.5 tm-20 . . . . . 0 N--CA 1.466 0.331 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.898 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.631 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 4.7 t . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.665 0.269 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -141.93 97.98 3.24 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -122.45 130.75 53.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.04 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.8 mt -114.83 155.58 26.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.379 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 23.2 ttm180 -144.9 145.45 31.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 61.3 m -127.56 110.37 12.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.02 0.438 . . . . 0.0 110.768 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.438 ' HG3' HD23 ' A' ' 16' ' ' LEU . 2.5 mm-40 -107.21 125.84 51.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.27 -174.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -81.9 135.49 35.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.194 0.521 . . . . 0.0 111.431 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.808 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.2 mt -103.38 114.8 29.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.4 m -107.15 115.64 30.53 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.989 0.423 . . . . 0.0 110.902 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -115.39 106.22 13.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.036 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -81.6 118.52 22.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.82 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 62.43 67.51 1.17 Allowed Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.147 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.413 ' HG3' HG23 ' A' ' 10' ' ' VAL . 60.7 Cg_endo -89.81 175.47 3.07 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.093 2.528 . . . . 0.0 111.881 174.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.3 p -84.31 147.05 27.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.41 -42.15 63.81 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.173 0.442 . . . . 0.0 112.147 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 6.4 p-10 -56.36 -32.02 64.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.796 0.332 . . . . 0.0 110.29 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.708 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.8 t80 -76.96 -42.74 37.86 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.677 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 38.0 ttm180 -54.74 -46.27 74.27 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -52.4 -42.8 64.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.381 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 36.1 mtpt -73.31 -38.98 65.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.853 0.358 . . . . 0.0 110.896 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 36.7 mt -70.02 -26.26 63.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.986 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.2 mt -83.58 -32.84 25.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 110.923 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -75.77 -26.38 57.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.308 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.5 ' OXT' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.466 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.444 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.236 0.351 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . 0.444 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 5.0 Cg_endo -48.82 161.55 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.687 2.258 . . . . 0.0 112.551 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.518 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 5.1 tpp180 . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.05 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.475 HG23 ' HG3' ' A' ' 130' ' ' PRO . 3.2 t -105.28 138.23 31.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -124.96 127.4 46.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -176.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.826 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -115.17 164.65 11.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.273 178.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 37.8 mttp -129.23 131.51 47.08 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.411 HD13 HG11 ' A' ' 90' ' ' VAL . 90.4 mt -115.1 140.23 49.24 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.248 0.547 . . . . 0.0 109.786 174.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.5 tt0 -106.33 121.34 44.02 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.873 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.581 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -106.01 112.17 25.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.423 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -137.32 166.59 24.96 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.656 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -163.53 149.69 11.72 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.163 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.9 mtt180 -115.21 140.76 48.81 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.694 174.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.652 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -126.84 120.71 29.91 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.511 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -114.18 148.3 37.52 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 112' ' ' GLU . 2.4 p -103.39 161.21 4.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 171.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 23' ' ' ARG . 3.0 mtp180 -116.15 134.67 54.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -68.92 -12.85 62.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.434 0.635 . . . . 0.0 109.679 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -134.89 102.17 11.27 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.162 171.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.518 ' HG3' HG22 ' A' ' 32' ' ' THR . 98.4 Cg_exo -49.28 154.79 3.58 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.021 2.48 . . . . 0.0 112.054 175.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -78.23 -174.06 3.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.852 -170.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.523 HG22 ' OE1' ' A' ' 29' ' ' GLU . 1.9 m -66.31 -30.83 51.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.207 0.527 . . . . 0.0 110.48 -175.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.523 ' OE1' HG22 ' A' ' 28' ' ' VAL . 3.0 mp0 -76.24 -6.65 52.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.471 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.08 34.29 38.07 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.478 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -102.56 136.54 42.2 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.518 HG22 ' HG3' ' A' ' 26' ' ' PRO . 47.4 p -92.78 -24.12 18.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.422 -169.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.435 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.0 m80 -121.11 144.63 48.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -171.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -119.15 125.45 49.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.1 p-90 -126.49 147.32 49.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.036 0.446 . . . . 0.0 110.834 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.57 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.2 ttp -125.53 115.24 19.9 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.759 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.578 HG11 HD11 ' A' ' 107' ' ' LEU . 14.2 m -97.32 150.0 4.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.817 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.2 p90 -150.98 155.8 39.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.3 m -126.05 129.03 72.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.343 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 40' ' ' ARG . 10.1 mmm180 -135.42 -176.9 4.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.332 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.496 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -89.38 -163.57 39.46 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.642 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 3.9 Cg_exo -71.91 109.85 2.77 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.17 1.913 . . . . 0.0 111.64 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 44' ' ' HIS . 28.9 mt-10 52.29 68.66 0.78 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.342 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 22.2 m170 75.51 -6.76 1.91 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.455 0.702 . . . . 0.0 112.764 172.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.555 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 72.5 m -61.2 136.05 57.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.467 0.175 . . . . 0.0 111.311 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -73.44 126.68 30.74 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.598 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.5 pt -97.27 -4.61 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -64.0 -0.43 1.13 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -77.66 -34.98 52.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.521 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.479 ' CE2' HG22 ' A' ' 47' ' ' ILE . 50.0 p90 -121.05 -16.88 7.94 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.727 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.598 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 77.8 t -94.26 126.02 46.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 9.5 tp10 -96.63 -57.88 2.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.444 0.64 . . . . 0.0 111.026 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 24.6 tttt -145.7 150.74 36.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.286 -175.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 88.9 t -131.28 158.1 43.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.435 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.597 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.2 p -141.71 138.42 31.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.266 0.555 . . . . 0.0 111.287 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 18.1 m-85 -120.95 110.35 16.18 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -82.53 95.88 7.87 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.957 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.4 mt -78.17 -178.8 5.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.815 0.34 . . . . 0.0 110.151 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.45 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 18.9 t60 -85.43 151.2 24.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 1.6 mp0 -51.87 -28.33 15.7 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.797 -169.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 t -79.0 -6.2 55.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.867 0.365 . . . . 0.0 111.273 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -90.36 134.89 30.33 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.57 136.48 30.95 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.282 1.988 . . . . 0.0 109.727 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 61.64 73.8 0.55 Allowed Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -172.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.47 -18.73 60.41 Favored 'Trans proline' 0 C--O 1.223 -0.233 0 C-N-CA 121.887 1.725 . . . . 0.0 112.656 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -110.37 106.76 16.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.678 0.275 . . . . 0.0 110.598 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.3 mmt85 -104.41 100.0 9.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.769 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -89.54 137.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.564 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 36.0 t -128.1 116.81 20.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.096 0.474 . . . . 0.0 110.116 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -106.55 -27.26 10.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.124 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.665 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -71.42 -177.3 0.46 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.571 -175.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.665 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 13.5 Cg_exo -31.17 178.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 125.17 3.913 . . . . 0.0 114.862 163.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.63 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.8 Cg_exo -26.32 121.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 124.797 3.665 . . . . 0.0 114.972 -157.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.564 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 34.2 m-85 -62.21 91.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.958 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.39 151.64 39.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.611 0.719 . . . . 0.0 112.676 179.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 36' ' ' MET . 93.8 t -123.47 129.14 74.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.631 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -114.38 112.99 23.93 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.35 173.31 11.61 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.839 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 3.2 t -121.11 145.93 47.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.139 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.16 -157.96 9.48 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -144.51 -17.48 0.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.82 140.75 31.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.999 0.428 . . . . 0.0 111.116 -176.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.89 169.81 55.03 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.773 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 59' ' ' HIS . 11.6 p90 -169.93 158.09 7.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.767 0.427 . . . . 0.0 110.059 -176.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.5 mm -67.18 126.14 26.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.609 0.243 . . . . 0.0 110.596 172.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.532 HD22 HG13 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -111.78 104.96 56.54 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.77 112.99 3.23 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.781 2.321 . . . . 0.0 112.088 171.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.532 HG13 HD22 ' A' ' 86' ' ' LEU . 6.3 mt -106.6 128.79 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.309 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.597 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 45.9 mt-10 -112.81 123.59 50.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.22 0.534 . . . . 0.0 109.964 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.411 HG11 HD13 ' A' ' 14' ' ' LEU . 57.5 t -104.84 118.88 52.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.747 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.588 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 89.3 m-85 -90.79 139.81 30.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.157 0.503 . . . . 0.0 111.245 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.418 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.0 m-85 -113.07 165.1 12.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.573 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -118.58 93.95 4.29 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.995 0.426 . . . . 0.0 112.001 -177.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.524 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 0.7 OUTLIER -160.48 -172.53 3.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.031 174.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 20.7 tptp -110.35 0.4 17.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.472 0.653 . . . . 0.0 111.23 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.409 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 6.5 mp0 -100.08 -155.71 0.52 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 -171.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.409 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 13.2 mm-40 -32.5 149.48 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.419 1.088 . . . . 0.0 113.536 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -30.22 125.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 125.205 3.936 . . . . 0.0 115.076 -164.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.524 ' HD3' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -82.01 18.96 1.21 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.83 -178.536 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -154.45 140.28 18.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.198 0.523 . . . . 0.0 110.941 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -120.31 157.35 22.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -128.25 107.64 9.94 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.657 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.581 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.6 m-85 -103.07 123.94 47.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.217 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -88.13 101.23 13.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.357 0.598 . . . . 0.0 110.147 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -110.18 132.27 54.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.769 -175.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.16 118.37 21.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.06 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.578 HD11 HG11 ' A' ' 37' ' ' VAL . 1.2 mp -95.2 91.29 6.22 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 175.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -102.22 156.88 17.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.219 0.533 . . . . 0.0 111.278 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 mt -134.47 163.9 28.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.2 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.479 ' CD2' ' H ' ' A' ' 110' ' ' HIS . 8.4 p80 -99.67 164.16 12.18 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.22 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.46 153.78 26.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.939 0.399 . . . . 0.0 111.145 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.713 ' HA ' HG21 ' A' ' 22' ' ' VAL . 8.7 tt0 . . . . . 0 CA--C 1.532 0.265 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.308 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 69.0 t . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 120.503 0.192 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.449 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.93 96.58 2.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -119.9 129.84 54.55 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.163 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.7 mt -108.11 149.34 28.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.547 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 15.6 ttt180 -140.73 137.93 33.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 85.8 m -120.09 116.58 25.97 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.157 0.504 . . . . 0.0 111.214 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 9.8 mm-40 -105.98 158.93 16.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.309 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -124.98 123.88 40.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.148 0.499 . . . . 0.0 111.387 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.826 ' HB2' HG23 ' A' ' 12' ' ' VAL . 5.9 mt -98.31 122.04 40.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.797 176.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.0 m -113.84 122.4 46.93 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.922 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -120.9 107.66 12.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.447 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -83.24 124.32 30.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.125 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 51.72 67.71 3.89 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.337 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.475 ' HG3' HG23 ' A' ' 10' ' ' VAL . 83.4 Cg_endo -86.57 -179.27 2.97 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.947 2.431 . . . . 0.0 112.003 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 69.6 p -79.12 140.37 37.83 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -58.81 -33.19 70.09 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.2 p-10 -65.31 -30.97 71.88 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.631 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 18.7 t80 -74.3 -42.32 59.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.587 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.6 ttm180 -54.19 -45.51 72.17 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.929 173.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -55.23 -39.45 69.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.333 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 40.8 mtpt -69.95 -39.97 75.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.93 0.395 . . . . 0.0 110.421 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 41.7 mt -69.53 -31.77 70.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.72 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.6 mt -80.91 -31.39 35.13 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.188 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -76.99 -26.71 54.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.134 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.358 175.419 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.236 0.358 0 N-CA-C 110.888 -0.041 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 10.0 Cg_endo -51.9 176.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.974 2.449 . . . . 0.0 112.96 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.717 -172.582 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.943 0.402 . . . . 0.0 111.861 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.421 HG23 ' HG3' ' A' ' 130' ' ' PRO . 4.3 t -109.7 140.32 29.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 172.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 4.5 mp0 -128.57 118.75 23.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.874 0.369 . . . . 0.0 110.168 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.874 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -107.03 170.21 2.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.174 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HE3' ' HB3' ' A' ' 42' ' ' PRO . 54.9 mtmt -137.07 133.86 35.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.739 0.304 . . . . 0.0 110.467 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.3 mt -114.66 142.16 46.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.002 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.1 tt0 -103.48 123.48 46.98 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.712 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.651 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.1 mm? -110.56 113.32 25.85 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -142.19 175.52 22.7 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.896 -1.145 . . . . 0.0 111.981 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -167.1 151.67 7.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.06 0.457 . . . . 0.0 110.859 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 80.9 mtt180 -116.5 151.84 35.3 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.946 171.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -144.28 134.4 24.18 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.419 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -132.6 160.73 35.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.214 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' A' ' 112' ' ' GLU . 1.8 p -103.75 161.11 4.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 170.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.476 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 5.5 mtp85 -104.81 143.09 33.61 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -66.37 -19.05 65.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.59 0.709 . . . . 0.0 109.254 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -134.13 106.37 11.34 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.294 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.562 ' HG3' HG22 ' A' ' 32' ' ' THR . 99.0 Cg_exo -50.39 163.76 0.61 Allowed 'Trans proline' 0 N--CA 1.474 0.372 0 C-N-CA 123.109 2.539 . . . . 0.0 112.475 174.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 31' ' ' PHE . 8.9 t -82.88 -175.7 5.94 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.468 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.05 -30.96 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.782 0.325 . . . . 0.0 111.309 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -82.78 -0.28 47.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.037 0.446 . . . . 0.0 110.701 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.81 33.96 49.7 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.476 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.404 ' HB2' HG22 ' A' ' 27' ' ' THR . 20.3 m-30 -95.57 130.71 42.34 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 176.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.562 HG22 ' HG3' ' A' ' 26' ' ' PRO . 28.8 p -90.34 -30.98 17.1 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -170.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.458 ' O ' ' HA ' ' A' ' 79' ' ' SER . 62.7 m80 -112.19 146.21 38.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -170.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.476 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 6.1 m-20 -124.14 121.27 34.69 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.481 ' HH2' HD22 ' A' ' 58' ' ' LEU . 49.2 p-90 -122.52 150.22 42.85 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.645 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 46.0 ttp -125.59 118.06 24.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.612 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.9 m -100.02 150.15 5.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.263 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -151.13 154.69 37.43 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.6 m -124.15 127.97 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.833 170.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -132.08 -179.11 5.22 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.316 -174.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.5 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -97.11 -176.15 34.76 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.26 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.468 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 12.0 Cg_exo -68.8 111.7 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.768 2.312 . . . . 0.0 112.234 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 58.19 54.2 6.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.624 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 71.22 1.53 3.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.58 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 141' ' ' ALA . 49.7 m -63.11 128.23 34.89 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -68.96 128.22 35.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.042 0.449 . . . . 0.0 110.35 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.581 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.4 pt -94.66 -1.49 10.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.376 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -59.66 -3.69 0.53 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.534 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 93.2 m-70 -82.27 -31.98 29.82 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.143 -0.348 . . . . 0.0 111.471 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.461 ' CE1' HG22 ' A' ' 47' ' ' ILE . 54.2 p90 -119.66 -20.03 7.84 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.413 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.581 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 65.8 t -90.54 131.32 38.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 9.0 tp10 -102.62 -60.24 1.57 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.434 0.635 . . . . 0.0 110.262 -176.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 20.6 tttt -144.61 149.95 36.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.135 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.452 HG21 HG21 ' A' ' 39' ' ' VAL . 94.6 t -128.55 157.69 41.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.58 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 9.1 p -141.41 133.39 28.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.299 0.571 . . . . 0.0 111.054 -174.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.474 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 30.5 m-85 -117.02 109.04 16.48 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -80.62 91.93 5.9 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.915 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.54 ' CD2' HD11 ' A' ' 86' ' ' LEU . 11.0 mt -73.93 -176.96 2.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.999 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -77.34 147.53 36.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -56.14 -19.35 13.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.931 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.05 -24.99 65.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.108 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -81.65 137.56 47.67 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.645 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.73 118.03 5.14 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.462 2.108 . . . . 0.0 111.326 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 58.19 68.38 1.85 Allowed Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.521 0.513 . . . . 0.0 110.431 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.54 -18.48 63.73 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.845 2.363 . . . . 0.0 113.391 -174.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -88.94 101.25 13.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.185 0.517 . . . . 0.0 110.13 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 18.7 mmt180 -97.71 98.35 9.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.345 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -83.49 136.34 22.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.599 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.8 m -131.41 109.01 10.01 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -106.18 -24.24 12.38 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.63 0.728 . . . . 0.0 110.336 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.678 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 2.7 t70 -70.41 179.9 0.77 Allowed Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.319 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.678 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 16.6 Cg_exo -31.13 178.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 125.245 3.963 . . . . 0.0 114.489 163.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.605 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.3 Cg_endo -29.64 124.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 124.332 3.355 . . . . 0.0 114.442 -154.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 36.7 m-85 -61.87 93.94 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.901 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -146.14 145.53 30.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.264 0.554 . . . . 0.0 111.889 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.0 t -125.19 131.6 72.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.059 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -115.97 110.37 18.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.752 0.311 . . . . 0.0 110.196 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -130.18 165.44 22.34 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.933 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 2.1 m -116.12 129.65 56.43 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.979 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.42 -160.7 9.17 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -136.37 -20.04 1.42 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.291 0.546 . . . . 0.0 111.451 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.7 142.99 36.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.853 0.359 . . . . 0.0 110.974 -174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -78.88 174.55 55.25 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.58 -177.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -173.13 159.41 3.89 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.963 0.505 . . . . 0.0 110.131 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 106' ' ' ASP . 14.3 mm -68.07 125.5 25.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 172.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.54 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.1 tt -117.72 105.55 47.59 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.994 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.99 114.07 3.25 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 123.227 2.618 . . . . 0.0 112.231 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.438 HG12 ' CD2' ' A' ' 56' ' ' PHE . 5.0 mt -104.6 126.37 59.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.09 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.58 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.2 mt-10 -112.53 124.34 52.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.238 0.542 . . . . 0.0 110.124 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.7 t -103.72 120.44 53.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.772 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.59 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 74.5 m-85 -90.06 139.1 30.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.967 0.413 . . . . 0.0 110.346 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.435 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.7 m-85 -111.36 146.32 37.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.8 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -84.2 93.93 8.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.428 ' CG ' ' H ' ' A' ' 96' ' ' GLU . 62.4 t30 -155.98 159.33 39.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.372 0.606 . . . . 0.0 112.124 -171.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.76 -4.0 14.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.734 175.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.527 ' HG2' ' CG2' ' A' ' 131' ' ' THR . 0.4 OUTLIER -100.29 -153.92 0.46 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.42 -177.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 20.6 mm-40 -27.07 150.19 0.02 OUTLIER Pre-proline 0 N--CA 1.48 1.03 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 3.0 Cg_exo -32.5 126.43 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.189 1 C-N-CA 125.316 4.011 . . . . 0.0 114.465 -167.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -85.7 19.5 2.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.246 -176.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.52 143.45 22.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.286 0.565 . . . . 0.0 111.159 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -126.93 154.79 37.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -121.18 121.85 38.7 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.001 0.429 . . . . 0.0 111.073 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.651 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.9 m-85 -113.86 117.7 32.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.923 174.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.61 111.89 15.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.188 0.518 . . . . 0.0 109.761 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -121.4 136.17 54.99 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.553 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.44 ' HA ' HD13 ' A' ' 85' ' ' ILE . 11.7 t70 -89.35 110.6 21.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.62 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.504 HD11 HG11 ' A' ' 37' ' ' VAL . 1.5 mp -89.36 97.63 11.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.745 0.307 . . . . 0.0 110.199 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -104.33 155.65 18.58 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.014 0.435 . . . . 0.0 110.769 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.2 mt -130.76 152.46 50.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -101.82 168.82 9.19 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.875 -0.515 . . . . 0.0 111.191 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -53.61 134.81 41.25 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -172.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.579 ' HA ' HG21 ' A' ' 22' ' ' VAL . 35.5 tt0 . . . . . 0 C--O 1.232 0.168 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.221 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 37.5 t . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.721 0.296 . . . . 0.0 111.719 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.491 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -145.9 108.26 4.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.557 174.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.478 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.8 t-80 -127.22 135.25 50.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.657 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 119' ' ' HIS . 8.1 mt -118.03 147.36 43.31 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.497 0.498 . . . . 0.0 110.326 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.3 ttm180 -137.04 148.74 47.0 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.437 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 61.6 m -130.7 120.23 23.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.598 0.237 . . . . 0.0 110.39 175.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -118.47 143.63 46.57 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -100.94 136.54 40.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.259 0.552 . . . . 0.0 112.055 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.874 ' HB2' HG23 ' A' ' 12' ' ' VAL . 4.9 mt -104.42 115.2 29.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.814 174.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 34.4 m -105.13 116.77 32.52 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.062 0.458 . . . . 0.0 110.687 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -113.83 106.44 14.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.049 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -78.79 118.14 20.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.398 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.2 t30 52.14 63.03 9.69 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.397 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.421 ' HG3' HG23 ' A' ' 10' ' ' VAL . 88.5 Cg_endo -80.25 -179.24 5.07 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.771 2.314 . . . . 0.0 112.395 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.527 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 3.5 p -72.75 139.74 47.32 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 173.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -56.95 -39.42 74.51 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.534 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 6.9 p-10 -63.33 -28.66 70.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.666 0.27 . . . . 0.0 110.343 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.635 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 14.8 t80 -75.57 -42.16 52.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.628 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 44.5 ttm105 -53.36 -45.97 69.39 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.099 0.476 . . . . 0.0 109.816 173.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -52.93 -41.12 64.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.381 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 38.8 mtpt -72.36 -39.6 67.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.618 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.9 mt -68.58 -30.59 69.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.909 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 36.1 mt -80.67 -35.68 33.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.163 -177.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -75.28 -30.09 60.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.78 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.749 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.235 0.34 0 CA-C-O 119.817 -0.135 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . 0.46 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 9.4 Cg_endo -51.87 162.97 1.52 Allowed 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 122.407 2.071 . . . . 0.0 112.063 174.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 26.8 ttt180 . . . . . 0 C--N 1.319 -0.727 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.663 -177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 120.754 0.311 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.44 HG23 ' HG3' ' A' ' 130' ' ' PRO . 5.1 t -104.2 141.25 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 4.7 mp0 -128.76 130.26 46.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.899 0.38 . . . . 0.0 110.177 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.832 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -116.32 165.65 11.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.252 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 67.1 mttm -128.5 133.67 48.52 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.37 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.451 HD22 HD13 ' A' ' 47' ' ' ILE . 82.2 mt -115.6 141.19 48.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.722 175.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.9 tt0 -104.33 129.98 52.18 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.862 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.628 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -114.99 112.44 22.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -138.09 170.1 23.94 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.956 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -164.2 151.63 12.06 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.881 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 67.8 mtt180 -116.87 143.09 46.1 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.727 174.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -139.21 131.26 27.95 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.532 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -133.94 163.69 28.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.898 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.609 HG21 ' HA ' ' A' ' 112' ' ' GLU . 1.9 p -103.37 158.27 4.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 32' ' ' THR . 3.7 mtp180 -102.76 142.92 33.1 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -70.53 -13.36 62.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.663 0.744 . . . . 0.0 109.434 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -142.96 104.63 5.23 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.052 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.6 Cg_exo -47.81 152.91 2.71 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.059 2.506 . . . . 0.0 112.243 174.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.405 HG22 ' HB2' ' A' ' 31' ' ' PHE . 8.8 t -76.42 -170.08 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -171.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 m -62.42 -32.86 56.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.762 0.315 . . . . 0.0 111.729 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -82.18 -4.1 56.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.254 0.55 . . . . 0.0 110.438 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.99 31.46 43.22 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.413 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.405 ' HB2' HG22 ' A' ' 27' ' ' THR . 19.0 m-30 -90.3 131.67 35.97 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.55 HG22 ' HG3' ' A' ' 26' ' ' PRO . 75.7 p -90.27 -29.49 18.11 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -168.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.2 m80 -112.55 146.08 39.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -171.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -117.78 121.08 39.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -124.83 147.55 48.68 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.068 0.461 . . . . 0.0 110.788 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.624 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 47.3 ttp -124.24 116.91 23.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.662 176.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.4 m -98.43 150.68 4.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.443 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -151.1 151.16 31.58 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.294 0.569 . . . . 0.0 112.36 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -122.55 138.46 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.334 169.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -155.88 -176.97 6.23 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.514 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -90.41 -170.92 43.85 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.514 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 3.2 Cg_exo -74.46 110.1 3.03 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.103 1.869 . . . . 0.0 112.366 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 49.8 77.07 0.12 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.508 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 76.62 -11.7 1.14 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.791 0.436 . . . . 0.0 112.134 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.538 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 50.6 m -68.36 123.26 20.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.719 0.295 . . . . 0.0 110.452 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -76.5 129.18 36.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.029 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.581 HD12 HG21 ' A' ' 51' ' ' VAL . 4.8 pt -95.46 -1.68 10.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.418 ' HG2' ' OH ' ' A' ' 74' ' ' TYR . 96.2 mt-30 -69.85 -0.79 7.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.9 0.381 . . . . 0.0 111.384 -175.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -71.46 -39.53 70.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.22 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -113.57 -17.61 12.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.394 -0.523 . . . . 0.0 111.593 176.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.581 HG21 HD12 ' A' ' 47' ' ' ILE . 91.5 t -91.29 130.45 40.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.828 0.346 . . . . 0.0 110.215 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.494 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 8.0 tp10 -99.13 -55.99 2.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.182 0.515 . . . . 0.0 110.46 -175.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.561 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -148.79 156.88 42.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 55' ' ' VAL . 90.2 t -131.92 156.93 42.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.8 p -142.55 133.99 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.318 0.58 . . . . 0.0 110.979 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 29.6 m-85 -116.06 104.32 11.45 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -78.33 92.43 4.54 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.981 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.5 mt -75.36 -177.79 3.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 151.78 22.9 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.56 -175.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 1.6 mp0 -55.64 -21.95 20.34 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.727 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.0 t -65.84 -24.58 66.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 110.614 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -82.62 135.22 46.46 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.332 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.45 120.36 7.87 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.233 1.955 . . . . 0.0 110.537 172.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 60.68 81.57 0.24 Allowed Pre-proline 0 N--CA 1.464 0.23 0 O-C-N 123.502 0.501 . . . . 0.0 110.379 -173.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -61.0 -25.31 81.32 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.584 2.189 . . . . 0.0 113.747 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HE3' ' CG1' ' A' ' 68' ' ' VAL . 23.5 ttpt -98.32 107.24 19.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.058 0.456 . . . . 0.0 111.1 -172.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -106.1 100.9 10.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.892 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.44 ' CG1' ' HE3' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -87.63 137.8 20.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.8 m -125.34 114.09 18.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -104.3 -28.21 11.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.43 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.483 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 26.7 t70 -73.58 171.06 11.68 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.135 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.583 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 72.7 Cg_exo -26.0 -174.1 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.676 1 C-N-CA 126.016 4.477 . . . . 0.0 116.062 164.127 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.583 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 6.5 Cg_endo -33.3 120.37 0.11 Allowed 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.375 2.717 . . . . 0.0 114.139 -149.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.556 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 38.8 m-85 -62.74 93.35 0.05 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.212 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -143.71 144.82 32.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.342 0.591 . . . . 0.0 112.039 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.5 t -120.35 131.8 71.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.595 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.18 105.99 13.21 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -131.51 173.2 11.34 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.508 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.0 t -125.03 144.74 50.25 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.724 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.84 -170.66 29.07 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -133.08 -12.26 2.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.411 0.606 . . . . 0.0 111.645 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.41 145.1 32.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.661 0.267 . . . . 0.0 110.589 -177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.552 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -83.63 178.03 52.48 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.782 -0.644 . . . . 0.0 113.266 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -178.15 157.81 1.13 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.064 0.546 . . . . 0.0 110.168 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 106' ' ' ASP . 21.1 mm -62.67 125.47 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.661 171.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.569 HD22 HG13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -107.93 105.01 55.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -68.36 105.33 1.22 Allowed 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 123.013 2.475 . . . . 0.0 111.625 170.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.569 HG13 HD22 ' A' ' 86' ' ' LEU . 5.8 mt -100.87 123.73 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.237 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.9 mt-10 -109.67 123.62 49.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.286 0.565 . . . . 0.0 110.039 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -103.04 117.21 48.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.619 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.561 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 83.8 m-85 -87.89 141.23 28.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.086 0.469 . . . . 0.0 110.778 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.451 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.3 m-85 -114.12 153.82 28.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.884 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.494 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -95.77 94.13 7.49 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.55 HD21 ' HB2' ' A' ' 96' ' ' GLU . 58.3 t30 -155.37 158.46 38.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.933 -170.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.2 ptpp? -107.85 -6.95 16.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.718 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.55 ' HB2' HD21 ' A' ' 94' ' ' ASN . 23.7 mm-40 -101.29 -150.73 0.4 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.822 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.462 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 15.3 mm-40 -25.27 149.04 0.02 OUTLIER Pre-proline 0 N--CA 1.479 1.006 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -31.45 126.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 1 C-N-CA 125.41 4.074 . . . . 0.0 114.717 -170.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.58 19.52 1.97 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.823 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.73 142.12 20.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 110.537 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -124.63 155.63 32.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 174.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -124.19 119.11 28.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.144 0.497 . . . . 0.0 111.163 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.628 ' CD2' HD21 ' A' ' 16' ' ' LEU . 24.0 m-85 -111.58 115.77 29.72 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.906 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.79 101.82 7.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.37 0.605 . . . . 0.0 109.773 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -115.58 134.82 54.69 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.646 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.411 ' HA ' HD13 ' A' ' 85' ' ' ILE . 12.6 t70 -86.52 118.17 25.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.684 -176.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.501 HD11 ' CG1' ' A' ' 37' ' ' VAL . 1.4 mp -93.96 91.45 6.9 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.512 ' CE1' HG13 ' A' ' 117' ' ' VAL . 50.4 p90 -99.32 157.03 16.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.043 0.449 . . . . 0.0 110.832 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.5 mt -133.68 158.57 42.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -102.13 174.48 5.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.244 -0.285 . . . . 0.0 110.364 172.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.24 160.98 31.18 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.609 ' HA ' HG21 ' A' ' 22' ' ' VAL . 5.4 mp0 . . . . . 0 N--CA 1.471 0.61 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.377 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 4.9 t . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.796 0.332 . . . . 0.0 111.59 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.469 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.16 97.13 3.0 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.465 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.9 t-80 -119.55 134.34 55.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.777 -176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 119' ' ' HIS . 9.8 mt -117.91 145.76 44.42 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.681 0.613 . . . . 0.0 110.016 176.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.653 ' HD3' ' OE2' ' A' ' 123' ' ' GLU . 11.3 ttm180 -132.96 148.46 52.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.482 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 84.6 m -123.32 116.13 22.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.332 0.587 . . . . 0.0 111.059 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.653 ' OE2' ' HD3' ' A' ' 121' ' ' ARG . 64.3 mm-40 -98.43 162.45 13.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.383 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -125.48 128.35 47.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.413 0.625 . . . . 0.0 111.115 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.832 ' HB2' HG23 ' A' ' 12' ' ' VAL . 8.3 mt -100.34 115.37 29.81 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.962 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 20.9 m -109.14 122.71 47.89 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.005 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -120.42 100.61 7.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.046 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -73.42 116.36 13.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.653 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.0 t30 58.26 74.76 0.59 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.452 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.44 ' HG3' HG23 ' A' ' 10' ' ' VAL . 82.2 Cg_endo -97.48 -178.54 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.23 2.62 . . . . 0.0 112.817 -174.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.456 ' CG2' ' HG3' ' A' ' 96' ' ' GLU . 5.9 p -71.66 144.54 49.35 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -57.36 -45.97 83.84 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.92 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -57.93 -28.94 64.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.613 0.244 . . . . 0.0 110.918 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.667 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.2 t80 -73.12 -47.01 47.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.656 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.3 ttm105 -52.18 -48.3 65.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.264 0.554 . . . . 0.0 109.924 174.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -54.83 -34.52 62.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.778 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.5 mtmt -81.52 -37.68 27.46 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.514 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.8 mt -66.19 -28.9 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.7 mt -80.42 -37.98 31.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.434 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.448 ' NZ ' ' HB2' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -70.76 -30.39 66.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.877 -176.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.913 178.975 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.432 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.234 0.252 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . 0.432 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 19.8 Cg_endo -58.49 170.01 2.74 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.434 2.089 . . . . 0.0 112.239 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 17.9 ttm180 . . . . . 0 C--N 1.321 -0.642 0 CA-C-O 120.979 0.418 . . . . 0.0 110.831 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.469 HG23 ' HG3' ' A' ' 130' ' ' PRO . 6.3 t -104.83 144.17 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -132.29 114.86 14.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.849 0.357 . . . . 0.0 110.292 -173.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.903 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -105.85 166.04 3.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.343 -179.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -129.23 126.01 38.18 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.148 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.421 HD22 HD13 ' A' ' 47' ' ' ILE . 79.0 mt -103.62 142.78 33.72 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.662 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 28.1 tt0 -107.94 125.5 51.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.302 -173.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.529 ' CD1' HG12 ' A' ' 39' ' ' VAL . 2.2 mm? -107.79 117.54 34.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 173.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -139.88 165.33 25.94 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.396 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -162.87 149.03 12.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.077 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 34.8 mtp180 -121.62 128.17 51.63 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.61 117.46 29.45 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.377 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -110.13 141.67 42.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.455 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' A' ' 112' ' ' GLU . 5.7 p -102.95 146.08 11.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mtp85 -97.0 142.93 28.35 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -72.32 -13.92 61.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.489 0.661 . . . . 0.0 109.335 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 26' ' ' PRO . 13.7 tmtt? -138.8 100.49 8.12 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.89 176.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HG3' HG22 ' A' ' 32' ' ' THR . 80.7 Cg_exo -50.78 160.31 1.88 Allowed 'Trans proline' 0 N--CA 1.478 0.577 0 C-N-CA 123.612 2.874 . . . . 0.0 113.359 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.4 t -79.65 -174.41 4.3 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.836 -175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.446 ' H ' HG13 ' A' ' 28' ' ' VAL . 1.2 m -62.32 -32.59 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.849 0.357 . . . . 0.0 111.163 -174.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -79.78 -6.45 57.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.11 0.481 . . . . 0.0 110.513 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.6 33.26 38.98 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.268 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -93.46 130.88 39.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.565 HG22 ' HG3' ' A' ' 26' ' ' PRO . 45.9 p -92.04 -21.56 20.42 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.251 -170.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.459 ' HE1' ' OE1' ' A' ' 112' ' ' GLU . 54.9 m80 -118.84 147.24 44.15 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -171.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -123.3 117.28 24.9 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.412 ' HH2' HD22 ' A' ' 58' ' ' LEU . 49.3 p-90 -121.3 147.93 45.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.105 0.479 . . . . 0.0 111.263 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.622 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 52.2 ttp -125.33 119.38 28.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.514 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.5 m -101.93 148.97 6.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.471 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 2.1 p90 -149.5 153.28 36.99 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.8 m -123.58 135.86 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.636 170.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HD2' ' OE2' ' A' ' 15' ' ' GLU . 8.3 ptp85 -152.56 -176.74 5.85 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.483 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -90.75 -173.57 44.19 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.453 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.525 ' HD2' ' OG ' ' A' ' 45' ' ' SER . 5.1 Cg_exo -74.21 125.7 9.93 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.169 2.579 . . . . 0.0 111.354 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 61.99 47.67 5.69 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.544 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 37.1 m80 64.23 18.36 11.24 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.525 ' OG ' ' HD2' ' A' ' 42' ' ' PRO . 22.9 p -71.05 153.64 42.42 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 122.131 -0.356 . . . . 0.0 110.137 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.35 125.5 30.45 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.585 HD12 HG21 ' A' ' 51' ' ' VAL . 4.6 pt -96.58 -1.52 10.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.575 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 32.8 tt0 -70.48 -4.52 23.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.575 0.702 . . . . 0.0 109.736 -174.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.427 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 93.8 m-70 -66.1 -39.41 89.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.304 173.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -116.07 -19.39 10.33 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.133 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.585 HG21 HD12 ' A' ' 47' ' ' ILE . 96.7 t -88.8 131.32 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.229 0.537 . . . . 0.0 109.939 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.96 -59.85 1.68 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.367 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 16.2 tttt -149.53 149.78 31.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.811 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 93.9 t -128.92 157.41 41.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -177.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.579 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 8.7 p -142.53 135.1 26.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.383 0.611 . . . . 0.0 111.169 -174.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 25.1 m-85 -117.78 108.3 15.2 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -81.31 93.58 6.58 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.123 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.584 ' CD2' HD11 ' A' ' 86' ' ' LEU . 9.9 mt -74.16 -177.82 3.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 73.2 t60 -80.93 137.48 36.13 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.5 -20.49 20.58 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.5 t -64.57 -18.14 64.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.866 0.365 . . . . 0.0 110.902 173.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 44.0 m-85 -83.27 144.14 46.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.13 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 62' ' ' PHE . 15.9 Cg_exo -68.71 118.69 5.82 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.425 2.083 . . . . 0.0 110.851 173.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.401 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 26.2 mmm180 63.54 73.17 0.5 Allowed Pre-proline 0 N--CA 1.465 0.279 0 O-C-N 123.543 0.527 . . . . 0.0 110.007 -176.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.24 -22.71 66.65 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.793 2.329 . . . . 0.0 113.406 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -97.35 103.29 15.21 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 120.974 0.416 . . . . 0.0 110.421 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.401 ' HD3' ' O ' ' A' ' 64' ' ' ARG . 15.7 mmm-85 -105.15 102.23 11.73 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.321 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.6 m -95.26 138.27 21.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.5 m -125.13 119.63 29.11 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -106.74 -28.71 10.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.59 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.727 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 37.4 m-20 -72.13 -172.31 0.22 Allowed Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.531 1.132 . . . . 0.0 111.768 -174.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.727 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 72.4 Cg_exo -39.89 -172.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.858 0 C-N-CA 123.492 2.794 . . . . 0.0 114.084 165.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.651 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.7 Cg_endo -33.83 123.42 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 123.857 3.038 . . . . 0.0 114.442 -154.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 36.9 m-85 -63.21 92.07 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.187 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -142.79 145.41 33.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.183 0.516 . . . . 0.0 111.866 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 36' ' ' MET . 75.1 t -118.55 133.73 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.42 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.469 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 5.7 mm-40 -112.15 107.36 16.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.975 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.25 169.47 17.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.122 0.487 . . . . 0.0 111.039 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.2 t -126.94 143.24 51.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.888 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.76 -161.68 13.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.746 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -137.69 -14.86 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.292 0.546 . . . . 0.0 112.174 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.27 148.05 35.77 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.023 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.541 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -84.99 179.43 51.08 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.619 -0.719 . . . . 0.0 113.182 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -178.96 155.52 0.76 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.935 0.494 . . . . 0.0 109.911 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 106' ' ' ASP . 23.0 mm -62.72 127.1 22.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.242 171.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.584 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.7 tt -120.09 104.82 43.27 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-O 121.129 0.49 . . . . 0.0 110.106 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.19 112.2 2.24 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.399 2.732 . . . . 0.0 112.721 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.406 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.9 mt -103.64 124.26 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.183 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.579 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 50.9 mt-10 -109.62 124.67 51.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.152 0.501 . . . . 0.0 109.903 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.1 t -105.26 119.2 54.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.841 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 88.9 m-85 -91.19 138.82 31.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.015 0.436 . . . . 0.0 110.863 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.5 m-85 -112.14 154.65 25.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.735 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.3 95.14 7.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.623 HD21 ' HB2' ' A' ' 96' ' ' GLU . 61.0 t30 -155.33 164.38 38.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.808 -172.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -112.86 -4.6 13.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.615 178.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.623 ' HB2' HD21 ' A' ' 94' ' ' ASN . 17.4 mm-40 -100.93 -153.47 0.45 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.067 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 20.3 mm-40 -29.89 153.23 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 124.621 1.168 . . . . 0.0 114.071 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 6.2 Cg_exo -32.72 124.86 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.125 1 C-N-CA 125.356 4.037 . . . . 0.0 114.876 -167.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.473 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -88.2 19.58 3.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.392 -177.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -152.37 140.41 20.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.235 0.54 . . . . 0.0 110.887 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.1 m -125.75 156.41 35.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.72 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -122.92 121.8 37.05 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.011 0.434 . . . . 0.0 111.201 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CZ ' HG21 ' A' ' 101' ' ' VAL . 23.6 m-85 -112.83 110.75 21.05 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.707 173.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -82.21 99.03 9.04 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -108.32 138.97 43.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.159 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.418 ' HA ' HD13 ' A' ' 85' ' ' ILE . 12.4 t70 -81.83 113.66 19.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.96 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.562 HD11 HG11 ' A' ' 37' ' ' VAL . 1.8 mp -90.01 104.99 17.51 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.402 ' CE2' HG11 ' A' ' 117' ' ' VAL . 12.4 p90 -116.01 154.95 28.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.91 0.386 . . . . 0.0 110.661 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.9 mt -135.48 162.59 32.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.647 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.485 ' CD2' ' H ' ' A' ' 110' ' ' HIS . 7.7 p80 -100.49 171.82 7.5 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.418 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' B' ' 215' ' ' ALA . 1.0 OUTLIER -74.42 168.85 18.89 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.834 0.349 . . . . 0.0 111.129 177.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.71 ' HA ' HG21 ' A' ' 22' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.468 0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.52 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 31.6 t . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -139.01 98.22 3.48 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -125.0 132.59 53.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.41 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.4 mt -111.43 156.45 21.62 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.866 0.729 . . . . 0.0 109.103 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 16.3 ttt180 -147.47 143.71 28.08 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.31 -0.244 . . . . 0.0 110.719 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 24.8 p -118.98 116.88 27.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.217 0.532 . . . . 0.0 111.064 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -111.92 132.84 54.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.951 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -97.81 131.56 44.2 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.164 0.506 . . . . 0.0 111.742 -172.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.903 ' HB2' HG23 ' A' ' 12' ' ' VAL . 7.4 mt -99.34 118.1 35.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.2 m -106.26 120.48 41.97 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.175 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -117.59 99.33 6.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.895 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -71.72 117.42 13.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.958 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.4 t30 55.94 78.35 0.38 Allowed Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.873 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.469 ' HG3' HG23 ' A' ' 10' ' ' VAL . 95.6 Cg_endo -97.64 -178.22 0.31 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.003 2.469 . . . . 0.0 112.13 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.0 p -74.1 142.25 45.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 171.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.435 ' OE2' ' HD2' ' A' ' 135' ' ' ARG . 4.0 tp10 -56.51 -38.25 71.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.019 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.659 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 15.6 m-20 -59.98 -35.29 74.69 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.625 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.6 t80 -72.54 -40.66 66.55 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.685 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 30.9 ttm180 -55.85 -45.62 78.39 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -59.13 -34.69 72.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.955 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.659 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 40.4 mtpt -71.32 -43.56 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.2 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 37.3 mt -68.63 -34.33 75.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.767 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 43.4 mt -74.1 -33.81 63.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.928 0.394 . . . . 0.0 110.836 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -76.57 -27.02 55.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.538 -175.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.84 178.32 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.429 ' HA ' HD22 ' A' ' 111' ' ' LEU . . . . . . . . 0 C--O 1.235 0.331 0 N-CA-C 111.482 0.178 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.31 -177.3 0.12 Allowed 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.547 2.164 . . . . 0.0 113.23 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 18.4 ttm180 . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.71 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 t -99.97 139.8 20.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.0 mp0 -125.67 120.41 30.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.04 0.447 . . . . 0.0 110.046 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.867 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.68 161.85 5.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.974 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' CE ' ' HB3' ' A' ' 42' ' ' PRO . 47.5 mtmt -128.57 128.62 44.6 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.364 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.401 HD13 HG11 ' A' ' 90' ' ' VAL . 82.5 mt -111.79 140.64 46.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.103 0.478 . . . . 0.0 109.715 174.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.609 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.7 tt0 -104.68 122.35 45.49 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.929 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.657 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.4 mm? -108.67 117.92 35.43 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.23 -179.85 24.52 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.21 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -169.43 154.45 5.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -122.1 136.27 54.9 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -133.62 126.62 31.28 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.358 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.416 ' NE2' ' HB2' ' A' ' 34' ' ' ASP . 0.6 OUTLIER -130.13 158.26 40.17 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.149 178.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.563 HG21 ' HA ' ' A' ' 112' ' ' GLU . 1.7 p -101.85 160.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.601 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 6.3 ptm180 -111.95 142.27 44.56 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -70.08 -8.85 52.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.532 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -144.55 100.89 4.71 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.584 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HG3' HG22 ' A' ' 32' ' ' THR . 86.7 Cg_exo -50.06 155.04 4.76 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.144 2.563 . . . . 0.0 111.87 175.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.435 HG22 ' HB2' ' A' ' 31' ' ' PHE . 8.8 t -78.26 -175.47 4.19 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.062 -171.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.419 ' H ' HG13 ' A' ' 28' ' ' VAL . 2.1 m -57.52 -33.09 43.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 122.634 0.373 . . . . 0.0 111.838 -175.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -86.6 0.42 54.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.086 0.469 . . . . 0.0 110.73 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.04 33.18 41.78 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.899 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.435 ' HB2' HG22 ' A' ' 27' ' ' THR . 16.3 m-30 -92.07 133.17 35.99 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.563 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 58.7 p -96.7 -27.76 14.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -168.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 79' ' ' SER . 66.9 m80 -118.42 140.77 49.35 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -172.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.601 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 17.3 m-20 -115.39 116.02 27.55 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -119.38 151.51 38.37 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.006 0.432 . . . . 0.0 110.893 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.626 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 57.0 ttp -127.43 120.9 29.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.43 174.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.8 m -100.84 152.16 5.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.212 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -153.08 154.14 34.26 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 10.2 m -120.82 126.15 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.671 168.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 15' ' ' GLU . 14.1 mmm180 -128.62 176.52 7.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 -172.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.553 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -97.78 -177.4 33.76 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.571 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 8.1 Cg_exo -69.8 111.01 2.7 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.505 2.137 . . . . 0.0 112.323 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 53.56 61.66 3.01 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.525 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 76.55 -7.43 1.84 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.29 0.636 . . . . 0.0 112.366 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.4 m -69.44 128.6 37.12 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.29 -0.256 . . . . 0.0 111.046 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -65.22 129.59 40.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 110.653 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.58 HD12 HG21 ' A' ' 51' ' ' VAL . 4.2 pt -95.78 -1.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -61.22 -15.72 37.4 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.111 0.482 . . . . 0.0 110.906 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -63.64 -37.13 86.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.209 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.415 ' CE2' HG22 ' A' ' 47' ' ' ILE . 53.9 p90 -117.9 -16.63 9.9 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.408 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.58 HG21 HD12 ' A' ' 47' ' ' ILE . 95.4 t -89.56 129.71 40.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.131 0.491 . . . . 0.0 110.199 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -97.45 -66.0 0.93 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.417 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.645 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -144.45 151.18 38.83 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 55' ' ' VAL . 95.1 t -124.2 159.52 29.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 O-C-N 122.104 -0.372 . . . . 0.0 110.198 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.561 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.4 p -143.18 137.53 26.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.073 0.464 . . . . 0.0 111.016 -174.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.525 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 17.1 m-85 -120.8 111.22 17.3 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -84.42 95.23 8.71 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.941 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.549 ' CD2' HD11 ' A' ' 86' ' ' LEU . 8.1 mt -73.48 -177.59 2.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -81.21 146.64 30.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -56.4 -19.26 14.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.413 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 m -69.59 -20.56 63.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.085 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -83.34 144.41 46.49 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.582 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.63 118.24 5.45 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.586 2.191 . . . . 0.0 110.65 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 61.06 78.5 0.31 Allowed Pre-proline 0 C--O 1.225 -0.192 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.181 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.65 -24.03 77.48 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.847 2.364 . . . . 0.0 113.732 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -97.44 109.14 21.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.969 -0.457 . . . . 0.0 110.881 -174.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 21.6 mmt85 -108.01 105.55 15.37 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.136 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.55 142.2 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 175.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 43.4 t -131.81 114.65 14.96 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -106.75 -24.82 11.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.242 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.538 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 24.7 t70 -68.97 171.63 6.16 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.564 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 82.6 Cg_exo -29.2 -170.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.557 1.652 1 C-N-CA 125.478 4.119 . . . . 0.0 115.466 164.032 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.642 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 Cg_endo -36.17 121.7 0.26 Allowed 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 122.808 2.339 . . . . 0.0 113.887 -151.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 39.5 m-85 -62.17 91.44 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.059 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.642 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 4.6 ptpt -139.16 146.92 41.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.261 0.553 . . . . 0.0 111.877 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.0 t -123.71 131.82 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.804 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.77 113.54 24.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.25 172.85 12.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.222 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.3 t -126.67 141.3 51.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.495 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.61 -171.44 23.59 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.41 ' O ' ' HB2' ' B' ' 216' ' ' PRO . 45.5 p90 -131.47 -1.92 3.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.592 0.696 . . . . 0.0 112.195 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' B' ' 217' ' ' ARG . . . -152.68 129.92 11.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.902 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.517 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -72.31 175.29 43.16 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.348 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -175.96 158.95 2.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.669 0.388 . . . . 0.0 110.275 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 85' ' ' ILE . 12.1 mm -65.58 124.86 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.409 171.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.549 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.9 tt -118.24 105.87 45.95 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.05 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.08 118.64 5.8 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.918 2.412 . . . . 0.0 112.212 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.0 mt -107.61 125.0 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.068 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.561 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 55.0 mt-10 -111.44 118.3 35.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.268 0.556 . . . . 0.0 109.924 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.401 HG11 HD13 ' A' ' 14' ' ' LEU . 64.6 t -100.42 119.18 48.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.825 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.645 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 82.5 m-85 -92.24 138.81 31.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.039 0.447 . . . . 0.0 110.815 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -112.53 150.84 30.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.19 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.67 95.13 10.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.577 HD21 ' HB2' ' A' ' 96' ' ' GLU . 62.6 t30 -154.2 155.34 35.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 0.0 112.152 -169.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.87 -1.94 15.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.131 174.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.577 ' HB2' HD21 ' A' ' 94' ' ' ASN . 32.7 mm-40 -100.29 -152.22 0.42 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.792 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -31.36 154.06 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -30.92 125.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.161 1 C-N-CA 125.37 4.047 . . . . 0.0 114.51 -169.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.66 17.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.899 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.62 149.08 26.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.142 0.496 . . . . 0.0 111.035 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.511 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.3 m -123.1 157.78 28.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.724 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -128.12 106.96 9.42 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.695 0.283 . . . . 0.0 110.35 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.4 m-85 -106.57 121.37 44.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.001 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.31 114.58 23.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -123.93 138.39 54.48 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.349 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.5 119.71 30.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.555 HD11 HG11 ' A' ' 37' ' ' VAL . 2.0 mp -93.11 91.7 7.44 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CE2' HG13 ' A' ' 117' ' ' VAL . 27.0 p90 -100.28 153.51 19.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.963 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.5 mt -129.39 154.15 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.427 ' ND1' HG22 ' A' ' 117' ' ' VAL . 27.9 m170 -103.15 170.39 7.99 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.124 -0.36 . . . . 0.0 111.107 174.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.48 141.2 57.85 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.563 ' HA ' HG21 ' A' ' 22' ' ' VAL . 8.9 mt-10 . . . . . 0 N--CA 1.474 0.765 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.896 175.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 4.7 t . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 120.826 0.346 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -144.04 121.87 11.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.423 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.2 t-80 -144.47 131.81 20.79 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.255 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 119' ' ' HIS . 7.2 mt -116.28 147.4 41.55 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.707 0.629 . . . . 0.0 109.862 175.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 20.3 ttm180 -136.19 146.02 46.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 84.2 m -128.73 114.48 16.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.022 0.439 . . . . 0.0 110.703 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -109.79 142.7 40.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.006 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -102.74 129.29 49.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.494 0.664 . . . . 0.0 111.845 -172.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.867 ' HB2' HG23 ' A' ' 12' ' ' VAL . 6.5 mt -96.77 120.24 36.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.548 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.8 m -111.22 121.62 45.75 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.623 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -118.83 110.68 17.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.311 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -76.07 117.58 17.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.334 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.3 t30 48.03 64.66 8.21 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.92 177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.41 176.28 10.17 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.367 2.044 . . . . 0.0 111.899 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.4 p -72.75 144.71 47.5 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.442 ' HG3' ' NH1' ' A' ' 135' ' ' ARG . 29.5 tt0 -56.01 -44.17 78.43 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.502 -0.479 . . . . 0.0 112.032 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -56.9 -32.37 65.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.651 0.262 . . . . 0.0 110.449 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.669 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.8 t80 -76.73 -41.28 45.65 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.628 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.9 ttm180 -54.93 -44.44 74.27 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -57.1 -40.14 76.4 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.311 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 50.2 mtpt -71.19 -40.95 70.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.85 0.357 . . . . 0.0 110.858 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 45.9 mt -69.28 -33.77 73.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.3 mt -76.61 -31.24 57.3 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.826 0.346 . . . . 0.0 110.783 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -75.02 -27.51 60.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.167 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 119.151 -0.452 . . . . 0.0 110.119 175.093 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.233 0.228 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 0.3 OUTLIER -36.18 145.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.622 2.882 . . . . 0.0 114.381 175.048 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 15.2 ttm180 . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.2 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 120.764 0.316 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 t -99.71 139.37 21.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.86 118.03 25.42 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.024 0.44 . . . . 0.0 110.101 -174.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.839 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.14 176.48 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.838 -178.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 57.6 mttt -143.67 138.72 29.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.097 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.433 ' CD2' HG21 ' A' ' 47' ' ' ILE . 86.8 mt -126.25 147.5 49.67 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 175.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.1 tt0 -105.01 127.95 53.09 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.225 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.68 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -112.98 120.7 42.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -145.65 175.93 24.92 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.926 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -167.91 150.41 5.65 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.152 0.501 . . . . 0.0 109.886 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.506 ' HG2' ' OD1' ' A' ' 118' ' ' ASN . 68.5 mtp180 -122.27 145.4 48.26 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.365 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.738 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -132.82 129.01 37.95 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.643 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.428 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 14.8 tt0 -126.09 147.95 49.47 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.223 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 112' ' ' GLU . 1.0 OUTLIER -103.05 156.3 5.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 170.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.746 ' NH2' ' HA ' ' A' ' 26' ' ' PRO . 17.6 mtm-85 -111.88 150.93 29.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -76.56 -6.26 51.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -136.95 106.14 8.85 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.746 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 71.5 Cg_exo -52.95 144.5 44.92 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.059 1.84 . . . . 0.0 112.272 175.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.43 ' N ' ' NH2' ' A' ' 23' ' ' ARG . 4.2 t -85.77 -175.28 5.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.745 -168.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.4 m -57.2 -33.69 43.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -171.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -87.93 -0.26 56.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.718 0.294 . . . . 0.0 111.496 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.72 35.02 23.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.407 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -101.68 145.0 29.7 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.424 HG22 ' HG3' ' A' ' 26' ' ' PRO . 30.3 p -104.36 -33.86 8.49 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.1 m80 -110.02 145.28 37.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -170.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.464 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -122.95 116.52 23.73 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.417 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 50.8 p-90 -118.16 155.1 31.05 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.702 -175.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.644 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 48.3 ttp -130.86 121.07 24.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.574 175.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 9.2 m -100.82 152.03 5.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.05 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -153.72 151.73 29.96 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.597 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -121.88 124.78 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.246 168.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.442 ' HA ' ' NE ' ' A' ' 40' ' ' ARG . 2.6 mmp_? -133.43 168.71 18.12 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.975 0.417 . . . . 0.0 110.985 -173.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.449 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -85.46 118.22 4.74 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 173.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 45' ' ' SER . 40.3 Cg_endo -74.64 151.69 41.75 Favored 'Trans proline' 0 C--N 1.326 -0.647 0 C-N-CA 122.854 2.369 . . . . 0.0 113.01 -176.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 61.86 54.47 2.85 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.994 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 66.2 1.06 1.85 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.297 0.639 . . . . 0.0 112.241 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 12.9 m -76.53 139.43 40.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.0 111.541 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -103.06 124.95 49.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.574 HD12 HG21 ' A' ' 51' ' ' VAL . 19.9 pt -95.7 -2.37 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -169.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -68.74 -11.5 60.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.472 0.653 . . . . 0.0 110.175 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.51 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 95.6 m-70 -68.87 -40.98 78.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.122 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -110.05 -14.54 14.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.753 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.574 HG21 HD12 ' A' ' 47' ' ' ILE . 96.4 t -92.59 129.37 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.995 0.426 . . . . 0.0 110.351 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -95.33 -58.43 2.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.377 0.608 . . . . 0.0 110.615 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -152.57 155.7 37.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.578 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 77.5 t -129.51 156.93 42.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 13.4 p -141.54 137.29 32.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.132 0.492 . . . . 0.0 111.042 -174.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.468 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 30.9 m-85 -119.07 108.3 14.55 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -79.63 95.59 5.95 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.05 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.582 ' CD2' HD11 ' A' ' 86' ' ' LEU . 10.6 mt -81.86 -178.07 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -87.85 152.08 22.37 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 1.7 mp0 -59.67 -15.45 19.5 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.079 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -67.33 -18.89 65.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.348 0.594 . . . . 0.0 110.373 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.01 142.23 24.27 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.432 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.21 129.98 21.64 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.373 2.049 . . . . 0.0 110.384 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 61.01 76.62 0.4 Allowed Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 123.45 0.469 . . . . 0.0 109.864 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.95 -18.17 62.72 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.467 2.111 . . . . 0.0 113.312 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -110.42 107.22 16.83 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 122.06 -0.4 . . . . 0.0 110.653 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.6 mmt85 -105.74 108.0 19.29 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.415 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.8 m -97.74 138.85 21.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.3 m -123.2 113.19 18.61 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.995 0.426 . . . . 0.0 109.988 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -105.86 -25.54 12.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.625 0.726 . . . . 0.0 110.259 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.74 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 14.4 m-20 -75.05 -172.03 0.25 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.882 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.74 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 78.0 Cg_exo -38.42 -179.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.415 2.744 . . . . 0.0 114.027 166.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.63 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -30.48 125.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 124.622 3.548 . . . . 0.0 114.985 -153.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 31.5 m-85 -61.69 92.84 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.735 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.585 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 13.4 ptpt -147.71 144.7 28.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.235 0.541 . . . . 0.0 111.817 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.8 t -122.17 131.89 72.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.99 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -119.32 107.65 13.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.941 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.57 170.58 15.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.996 0.427 . . . . 0.0 110.828 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 5.8 t -117.92 143.88 45.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.371 -176.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.99 -162.43 11.97 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -137.38 -16.41 1.38 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.276 0.538 . . . . 0.0 111.38 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.94 143.51 32.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.671 0.272 . . . . 0.0 110.462 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -81.46 -177.86 52.03 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.128 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -176.8 157.6 1.53 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.087 0.555 . . . . 0.0 109.901 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.0 mm -63.41 120.17 9.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 172.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.582 HD11 ' CD2' ' A' ' 58' ' ' LEU . 5.9 tt -114.34 105.47 53.86 Favored Pre-proline 0 N--CA 1.444 -0.738 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.6 114.22 3.77 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.03 2.487 . . . . 0.0 112.231 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.468 HG12 ' CE2' ' A' ' 56' ' ' PHE . 3.7 mp -101.16 130.37 50.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.037 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.5 mt-10 -111.9 124.5 52.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.064 0.459 . . . . 0.0 110.149 174.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.8 t -103.29 117.84 49.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.71 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.537 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 89.5 m-85 -88.63 141.55 28.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.51 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.434 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 26.4 m-85 -115.43 154.39 29.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.702 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.22 93.22 7.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.578 HD21 ' HB2' ' A' ' 96' ' ' GLU . 60.9 t30 -155.65 162.37 40.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.286 0.565 . . . . 0.0 112.076 -172.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.721 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -113.15 4.06 16.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.861 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.578 ' HB2' HD21 ' A' ' 94' ' ' ASN . 40.4 mm-40 -100.67 -155.57 0.52 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.153 -176.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.656 ' HB2' ' HD2' ' A' ' 98' ' ' PRO . 10.9 pt-20 -44.32 159.32 0.25 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.591 0.756 . . . . 0.0 111.853 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 97' ' ' GLU . 4.3 Cg_exo -31.36 128.33 0.08 OUTLIER 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 125.064 3.843 . . . . 0.0 115.189 -162.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.57 19.54 3.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.972 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.515 ' HE2' ' CE2' ' A' ' 91' ' ' TYR . 1.9 ptpt -149.04 143.86 26.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.939 0.399 . . . . 0.0 110.288 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -128.51 154.4 39.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.236 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -120.78 117.13 26.65 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.073 0.464 . . . . 0.0 110.836 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.68 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.1 m-85 -109.04 109.94 21.09 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.573 175.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.4 115.41 13.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.361 0.6 . . . . 0.0 109.699 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.45 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 66.4 t80 -129.93 127.72 40.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.542 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.88 111.46 18.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.847 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.504 HD11 HG11 ' A' ' 37' ' ' VAL . 2.0 mp -84.61 105.26 15.29 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -113.85 157.27 22.55 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.311 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.1 mt -131.0 154.81 47.77 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -101.64 169.72 8.65 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.394 174.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -55.98 134.64 52.46 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.558 ' HA ' HG21 ' A' ' 22' ' ' VAL . 3.5 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.455 173.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.738 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 38.4 t . . . . . 0 CA--C 1.519 -0.218 0 CA-C-O 120.651 0.263 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.506 ' OD1' ' HG2' ' A' ' 19' ' ' ARG . 63.4 t30 -145.57 114.62 6.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.643 175.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.466 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.5 t-80 -137.4 134.46 35.93 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.241 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.3 mt -119.19 151.1 38.93 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.612 0.57 . . . . 0.0 110.326 177.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.504 ' HG2' ' N ' ' A' ' 122' ' ' CYS . 21.9 ttm180 -142.58 153.76 43.81 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 176.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.504 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 85.7 m -137.73 122.97 19.32 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 9.6 mt-10 -119.5 155.37 32.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.473 0.178 . . . . 0.0 110.644 -177.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -107.96 138.6 43.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.617 0.722 . . . . 0.0 112.412 -172.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.839 ' HB2' HG23 ' A' ' 12' ' ' VAL . 6.8 mt -109.52 123.44 49.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.683 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.6 m -114.1 122.15 45.99 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.185 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.483 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 28.6 m-85 -118.45 109.39 16.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.112 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.79 120.67 24.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.22 0.533 . . . . 0.0 111.433 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 53.36 60.78 11.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.116 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 127' ' ' PHE . 71.6 Cg_endo -76.11 167.7 25.48 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.143 1.895 . . . . 0.0 110.755 174.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 72.2 p -70.36 141.16 52.26 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.419 ' HG3' ' NH1' ' A' ' 135' ' ' ARG . 20.6 tt0 -52.43 -43.05 64.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -173.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.558 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 8.9 p-10 -59.21 -29.65 67.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.848 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.605 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 8.1 t80 -75.27 -39.64 59.56 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.621 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 36.2 ttm180 -54.66 -45.28 73.81 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -56.23 -35.08 66.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.591 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 38.5 mtpt -74.8 -42.25 58.43 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.256 -0.277 . . . . 0.0 110.423 176.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.0 mt -68.93 -32.92 72.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 -177.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 37.5 mt -78.37 -33.1 49.16 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.773 0.32 . . . . 0.0 110.785 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -73.27 -26.77 61.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.481 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.953 179.07 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.237 0.406 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . 0.513 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 6.9 Cg_endo -49.42 167.22 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.701 2.267 . . . . 0.0 113.021 175.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.496 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 6.5 tpp180 . . . . . 0 C--N 1.321 -0.67 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.448 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.381 0 CA-C-O 120.91 0.386 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.74 141.38 17.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.3 mp0 -124.08 135.16 53.37 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.029 0.442 . . . . 0.0 110.106 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.838 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -111.87 173.51 2.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.632 174.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 122' ' ' CYS . 47.3 tttt -142.37 119.16 11.15 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.4 mt -107.35 142.31 37.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.203 0.525 . . . . 0.0 110.023 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.6 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.4 tm-20 -111.91 120.53 42.25 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.612 -176.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.604 HD12 HG12 ' A' ' 39' ' ' VAL . 1.4 mm? -103.19 112.47 25.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -135.67 169.52 23.47 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.565 -1.303 . . . . 0.0 111.485 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -164.01 151.43 12.24 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.976 -0.689 . . . . 0.0 111.337 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 21.0 mtp180 -114.98 150.63 35.49 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.327 173.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -145.06 126.79 15.25 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.767 176.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -121.35 151.24 40.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.756 HG21 ' HA ' ' A' ' 112' ' ' GLU . 4.5 p -101.77 153.92 5.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.569 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 3.0 mtp180 -107.38 140.02 40.96 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -68.46 -16.06 63.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.756 0.788 . . . . 0.0 109.623 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -136.23 105.55 9.43 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.969 172.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.507 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.0 Cg_exo -49.9 156.3 3.49 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.844 2.363 . . . . 0.0 112.004 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -75.85 -173.92 2.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.838 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.42 -32.88 49.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.773 0.32 . . . . 0.0 111.45 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -84.39 -0.63 53.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.085 0.469 . . . . 0.0 110.742 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.41 32.14 52.4 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.638 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -92.03 130.91 37.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.507 HG22 ' HG3' ' A' ' 26' ' ' PRO . 77.3 p -89.35 -29.97 18.73 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.445 -169.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.404 ' O ' ' HA ' ' A' ' 79' ' ' SER . 69.6 m80 -116.17 143.1 45.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -172.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.569 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -121.07 121.45 37.93 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -123.94 151.37 43.66 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.558 -174.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.66 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 56.0 ttp -127.33 116.59 20.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.705 175.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 8.7 m -98.2 151.98 4.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.38 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.563 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.0 OUTLIER -153.44 156.08 37.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 178.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.604 HG12 HD12 ' A' ' 16' ' ' LEU . 4.4 m -126.31 128.32 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.19 171.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -134.99 -177.07 4.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.023 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.488 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -93.53 -171.8 39.49 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.005 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 9.1 Cg_exo -67.41 111.76 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.562 2.175 . . . . 0.0 111.167 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 58.96 57.17 3.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.06 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 71.6 m80 67.83 9.36 7.06 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.489 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 71.5 m -67.47 138.04 56.3 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 122.432 -0.168 . . . . 0.0 110.902 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -70.3 126.15 28.82 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.922 0.391 . . . . 0.0 110.02 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.603 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.6 pt -97.32 -4.3 9.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -173.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.04 1.84 0.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -79.34 -33.39 43.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.505 0.193 . . . . 0.0 110.723 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.478 ' CE1' HG22 ' A' ' 47' ' ' ILE . 52.8 p90 -119.79 -20.78 7.48 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.211 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.603 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 91.7 t -89.36 130.29 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.48 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 10.3 tp10 -99.23 -63.07 1.16 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.204 0.526 . . . . 0.0 110.313 -176.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -144.06 152.84 41.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.045 178.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 97.5 t -127.04 159.06 37.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.208 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.571 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 13.0 p -141.74 137.33 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.131 0.491 . . . . 0.0 111.209 -176.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 23.6 m-85 -118.19 108.77 15.56 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -79.49 94.08 5.53 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.976 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.607 ' CD2' HD11 ' A' ' 86' ' ' LEU . 11.3 mt -78.67 -178.2 5.79 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 144.35 47.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.186 0.517 . . . . 0.0 109.811 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.23 -23.69 62.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.792 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.5 t -77.06 -13.35 59.97 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.751 0.31 . . . . 0.0 110.992 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -81.26 140.1 48.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.497 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.26 123.41 13.56 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.471 2.114 . . . . 0.0 110.798 172.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 57.87 77.58 0.4 Allowed Pre-proline 0 N--CA 1.454 -0.253 0 O-C-N 123.876 0.735 . . . . 0.0 110.733 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.12 -22.24 73.86 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.493 2.129 . . . . 0.0 113.094 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -106.29 105.84 16.07 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 120.858 0.361 . . . . 0.0 110.704 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.1 mmt85 -104.65 108.48 19.96 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.491 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 2.8 m -97.69 136.51 28.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.1 m -120.3 113.61 20.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.038 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -104.78 -23.04 13.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.041 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.56 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -70.39 -174.87 0.26 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.319 -175.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.649 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 48.4 Cg_exo -42.37 -179.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.542 2.828 . . . . 0.0 113.474 169.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.649 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 4.2 Cg_exo -28.4 122.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.451 3.434 . . . . 0.0 114.17 -159.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.563 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 40.7 m-85 -60.31 100.21 0.09 Allowed 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.276 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.66 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.2 ptpt -148.03 147.8 29.99 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.581 0.705 . . . . 0.0 112.501 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 36' ' ' MET . 83.8 t -122.91 132.28 71.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.428 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -117.45 106.6 13.36 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.438 ' CD ' HH22 ' A' ' 67' ' ' ARG . 1.8 tp10 -133.71 175.95 8.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.515 -175.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 8.2 t -128.04 145.87 50.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.201 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.21 -163.62 14.55 Favored Glycine 0 N--CA 1.453 -0.167 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.22 -12.57 2.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.693 0.746 . . . . 0.0 112.018 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -150.58 134.29 16.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.97 0.414 . . . . 0.0 111.119 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.47 167.16 44.59 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.201 -0.909 . . . . 0.0 114.144 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -166.53 154.84 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.017 -0.591 . . . . 0.0 109.964 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.91 124.51 16.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 110.375 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.607 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -118.34 104.92 47.27 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.671 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.31 119.53 6.43 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.058 2.505 . . . . 0.0 112.22 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.423 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.5 mt -109.13 129.31 64.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.179 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.571 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.8 mt-10 -110.39 126.31 54.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 0.0 110.044 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 80.2 t -106.08 121.65 58.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.564 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 96.6 m-85 -95.69 135.27 37.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.438 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.9 m-85 -109.55 156.44 20.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.342 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.48 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -98.48 93.08 5.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.004 0.43 . . . . 0.0 110.782 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.48 HD21 ' HB2' ' A' ' 96' ' ' GLU . 61.8 t30 -158.61 167.96 28.18 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.201 -0.312 . . . . 0.0 111.146 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.591 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -113.59 4.57 16.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.02 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.554 ' HG2' ' CG2' ' A' ' 131' ' ' THR . 0.0 OUTLIER -101.16 -153.16 0.45 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.479 -175.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.583 ' HB2' ' HD2' ' A' ' 98' ' ' PRO . 13.9 pt-20 -39.84 155.16 0.17 Allowed Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.781 0.832 . . . . 0.0 112.027 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 97' ' ' GLU . 2.2 Cg_endo -35.87 123.07 0.27 Allowed 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 124.896 3.73 . . . . 0.0 114.511 -165.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.429 ' N ' ' HD3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -93.63 21.02 6.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.067 -177.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.05 138.93 30.28 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.093 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.507 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.2 m -128.38 155.83 40.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.674 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.98 120.03 26.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CZ ' HG21 ' A' ' 101' ' ' VAL . 21.1 m-85 -110.48 132.72 53.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.659 0.266 . . . . 0.0 110.638 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -91.55 105.88 18.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.502 0.668 . . . . 0.0 109.573 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -116.66 135.78 53.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.573 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -87.8 114.51 24.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.993 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.549 HD11 HG11 ' A' ' 37' ' ' VAL . 1.7 mp -90.42 91.34 8.42 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -102.37 155.01 18.53 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.072 0.463 . . . . 0.0 110.977 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt -129.14 163.31 25.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -91.69 174.35 7.4 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.285 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.48 149.47 42.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.167 0.508 . . . . 0.0 111.554 177.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.756 ' HA ' HG21 ' A' ' 22' ' ' VAL . 18.7 tt0 . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.107 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 22.3 t . . . . . 0 CA--C 1.521 -0.153 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.482 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -145.35 97.85 3.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -126.23 131.56 51.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.545 -174.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.8 mt -107.39 146.54 31.51 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.698 0.623 . . . . 0.0 109.835 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -139.96 129.01 23.59 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.455 ' N ' ' HD3' ' A' ' 121' ' ' ARG . 67.2 m -120.07 123.91 44.56 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -172.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -122.43 145.49 48.24 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.727 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -100.61 129.14 46.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.22 0.533 . . . . 0.0 111.797 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.838 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.5 mt -94.63 119.44 33.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.688 172.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.5 m -109.51 123.53 49.56 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.894 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.485 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 31.3 m-85 -120.07 108.3 14.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.894 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -78.73 118.2 20.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.508 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.7 t30 50.02 64.55 8.24 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.676 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 127' ' ' PHE . 74.3 Cg_endo -74.68 178.06 7.64 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.402 2.068 . . . . 0.0 111.673 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.554 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 10.8 p -72.19 142.94 49.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.58 -37.93 76.83 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.067 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -63.85 -29.37 70.57 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.653 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 9.6 t80 -73.85 -42.05 61.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.639 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.1 ttm180 -54.3 -46.05 72.69 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.766 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -54.61 -38.26 66.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.441 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 44.3 mtpt -73.93 -40.19 63.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.799 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.7 mt -67.87 -32.57 73.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 40.5 mt -79.71 -32.28 41.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.316 . . . . 0.0 111.099 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -75.89 -25.74 56.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.306 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.216 174.859 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.484 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.236 0.384 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . 0.484 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 10.5 Cg_endo -54.54 157.97 11.14 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.038 1.825 . . . . 0.0 111.437 175.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 . . . . . 0 C--N 1.321 -0.641 0 CA-C-O 120.91 0.386 . . . . 0.0 110.387 179.647 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 121.095 0.474 . . . . 0.0 111.581 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 t -100.01 143.88 13.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.83 127.59 29.17 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.391 0.615 . . . . 0.0 110.955 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.794 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.02 176.81 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.942 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.582 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 95.3 mttt -138.64 137.63 37.09 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.408 ' HG ' HD11 ' A' ' 125' ' ' LEU . 88.8 mt -122.45 142.05 50.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.076 0.465 . . . . 0.0 109.812 173.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.2 tt0 -104.34 124.65 49.58 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.999 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.643 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -110.85 114.17 27.3 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -140.09 174.86 22.23 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.618 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 36' ' ' MET . 2.0 p-80 -166.17 153.05 9.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.212 0.529 . . . . 0.0 110.195 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 38.4 mtp180 -120.8 134.59 55.28 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.438 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -129.89 119.87 23.99 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.492 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -117.89 145.84 44.34 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.757 HG21 ' HA ' ' A' ' 112' ' ' GLU . 5.0 p -99.07 154.79 4.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 32' ' ' THR . 2.4 mtp180 -107.61 147.89 30.04 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -76.54 -12.44 60.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.764 0.792 . . . . 0.0 109.502 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -142.5 104.97 5.45 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.032 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.437 ' HG3' HG22 ' A' ' 32' ' ' THR . 78.7 Cg_exo -47.25 157.86 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.489 2.793 . . . . 0.0 113.46 177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -76.97 -173.04 2.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.898 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.482 HG22 ' OE1' ' A' ' 29' ' ' GLU . 2.1 m -66.52 -28.8 44.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.96 0.409 . . . . 0.0 110.898 -174.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.482 ' OE1' HG22 ' A' ' 28' ' ' VAL . 1.9 mp0 -78.49 -8.12 58.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 110.227 175.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.01 32.99 37.92 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.2 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -98.94 140.8 32.56 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.437 HG22 ' HG3' ' A' ' 26' ' ' PRO . 38.0 p -89.25 -27.26 20.72 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -169.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -118.85 142.59 47.59 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -172.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -116.09 119.48 35.98 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 172.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 78' ' ' GLU . 48.8 p-90 -121.35 150.96 40.68 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.093 0.473 . . . . 0.0 111.13 -178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 53.4 ttp -126.34 120.6 30.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.679 175.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.4 m -101.19 150.1 6.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.225 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.635 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.2 p90 -151.46 152.41 32.99 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.5 m -124.03 127.24 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.001 170.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -136.8 -176.74 4.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . -91.82 169.63 32.67 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 175.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 15.0 Cg_endo -53.39 113.96 1.54 Allowed 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 123.776 2.984 . . . . 0.0 112.657 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 56.32 51.26 11.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.419 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 69.12 11.95 8.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.482 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.478 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 66.8 m -62.27 126.83 28.7 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 171.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.54 ' OD1' ' HB2' ' A' ' 48' ' ' GLN . 6.5 t-20 -68.7 125.49 26.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.095 -175.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.626 HD12 HG21 ' A' ' 51' ' ' VAL . 1.5 pt -96.78 -2.37 10.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -174.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.54 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 11.1 mt-30 -61.82 -3.95 1.34 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -77.56 -37.85 49.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.401 0.143 . . . . 0.0 110.871 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.443 ' CE2' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -115.23 -18.61 11.07 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.547 176.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.626 HG21 HD12 ' A' ' 47' ' ' ILE . 84.2 t -90.48 130.15 40.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 8.4 tp10 -98.83 -58.58 1.91 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.315 0.579 . . . . 0.0 110.355 -176.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -149.02 153.76 38.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.048 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 55' ' ' VAL . 66.9 t -129.12 159.09 41.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.229 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.592 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.2 p -143.1 135.1 24.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.219 0.533 . . . . 0.0 111.363 -175.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.527 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 27.6 m-85 -116.7 111.66 20.11 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.16 93.15 7.0 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.414 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.608 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.6 mt -76.87 -176.91 4.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.426 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.507 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 36.8 t60 -66.86 138.69 57.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.063 0.459 . . . . 0.0 109.802 -177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -56.3 -25.68 49.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.4 t -75.52 -18.31 59.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.451 0.167 . . . . 0.0 111.438 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 59' ' ' HIS . 3.3 m-85 -75.09 134.91 73.91 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -60.99 117.56 4.34 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.714 2.276 . . . . 0.0 111.437 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 59.02 70.51 1.13 Allowed Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.503 -171.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.73 -17.45 59.12 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.733 2.288 . . . . 0.0 111.866 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -91.88 102.33 14.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.165 -177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.0 mmt180 -97.91 104.68 16.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.781 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.05 136.14 24.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.218 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 79.6 m -126.12 115.42 19.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.953 0.406 . . . . 0.0 109.923 175.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -106.69 -24.77 12.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.605 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.726 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 6.0 p-10 -75.71 -174.71 0.41 Allowed Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.329 -175.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.726 ' HD2' ' HB2' ' A' ' 71' ' ' ASP . 71.7 Cg_exo -39.11 -172.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.01 3.14 . . . . 0.0 114.548 167.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.648 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 8.5 Cg_endo -35.55 122.92 0.24 Allowed 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.399 2.733 . . . . 0.0 113.662 -152.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 44.2 m-85 -61.93 91.2 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.21 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 5.4 ptpt -139.37 146.4 40.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 0.0 112.034 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.7 t -120.96 132.29 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.345 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.54 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 5.3 mm-40 -108.56 106.04 15.93 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.246 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 35' ' ' TRP . 1.5 tp10 -134.79 171.06 14.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.709 0.29 . . . . 0.0 110.412 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -131.91 144.4 50.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.856 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.5 -170.34 27.18 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -126.72 -11.63 6.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.289 0.544 . . . . 0.0 111.771 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' B' ' 217' ' ' ARG . . . -147.83 141.49 25.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.961 0.41 . . . . 0.0 111.565 -176.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.11 164.49 51.41 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.099 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -163.31 156.37 18.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.458 HD13 ' HA ' ' A' ' 106' ' ' ASP . 21.9 mm -64.37 126.07 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 110.211 173.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.608 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.0 tt -120.39 104.46 42.99 Favored Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.232 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.9 116.56 4.2 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.296 2.664 . . . . 0.0 112.536 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.417 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.8 mt -107.76 127.45 63.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.175 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.592 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.5 mt-10 -110.11 126.88 54.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.1 0.476 . . . . 0.0 110.01 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.3 t -106.49 119.97 56.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.744 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 88.5 m-85 -92.53 135.84 33.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.822 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.427 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.1 m-85 -109.93 148.21 32.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.308 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.413 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -87.52 94.6 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.519 HD21 ' HB3' ' A' ' 96' ' ' GLU . 58.9 t30 -155.66 155.4 33.15 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.273 -172.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.52 -2.51 18.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.693 0.758 . . . . 0.0 109.466 171.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.519 ' HB3' HD21 ' A' ' 94' ' ' ASN . 2.1 tp10 -101.55 -152.01 0.43 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.218 -174.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.445 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 8.2 mm-40 -29.42 150.33 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.195 0.998 . . . . 0.0 113.548 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.0 Cg_exo -32.2 126.54 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.05 1 C-N-CA 125.415 4.077 . . . . 0.0 115.011 -168.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.476 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -89.64 19.03 4.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.304 -177.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.9 140.07 16.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.361 0.6 . . . . 0.0 111.552 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.2 m -130.47 155.36 41.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.008 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -123.44 120.33 32.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.978 0.418 . . . . 0.0 111.25 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.643 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.5 m-85 -112.44 116.6 30.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.446 174.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -85.93 105.98 16.79 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.457 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 61.8 t80 -112.34 137.2 50.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.911 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.458 ' HA ' HD13 ' A' ' 85' ' ' ILE . 38.2 t70 -86.36 103.52 15.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.308 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.499 HD11 HG11 ' A' ' 37' ' ' VAL . 2.5 mp -82.21 115.82 21.47 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -131.15 160.74 33.87 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.534 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.9 mt -136.18 163.26 30.78 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -175.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -100.84 172.81 6.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.99 152.25 24.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.846 0.355 . . . . 0.0 111.677 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.757 ' HA ' HG21 ' A' ' 22' ' ' VAL . 10.4 tt0 . . . . . 0 C--O 1.233 0.207 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.926 175.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 16.7 t . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.398 0.142 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -144.15 97.45 3.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.5 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.5 t-80 -120.82 137.68 54.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.764 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.5 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.0 mt -120.48 146.95 45.75 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.478 0.487 . . . . 0.0 110.436 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.3 ttm180 -138.93 149.99 45.41 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.448 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 71.6 m -133.7 121.13 21.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 175.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -116.62 133.79 55.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 110.358 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -84.7 141.44 30.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.544 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.794 ' HB2' HG23 ' A' ' 12' ' ' VAL . 5.3 mt -111.35 110.47 20.95 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.2 m -107.09 120.02 40.95 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.822 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.547 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 25.8 m-85 -116.78 109.98 17.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.787 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -79.0 116.91 19.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.976 0.417 . . . . 0.0 110.576 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.6 t30 56.7 61.67 6.79 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.211 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 127' ' ' PHE . 72.0 Cg_endo -75.74 169.86 21.38 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.306 2.004 . . . . 0.0 111.039 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.3 p -74.84 144.66 43.34 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -53.35 -43.09 67.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -172.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -55.73 -34.18 64.91 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.883 0.373 . . . . 0.0 110.421 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.682 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 7.8 t80 -75.95 -40.9 53.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.592 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.6 ttm180 -54.79 -43.92 73.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.564 0.697 . . . . 0.0 109.386 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.23 -36.49 75.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.216 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -73.97 -40.66 62.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.749 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.0 mt -66.81 -37.08 83.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.02 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.1 mt -75.33 -34.08 61.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.04 0.447 . . . . 0.0 110.577 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -72.32 -26.43 61.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.956 -175.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.352 -0.833 . . . . 0.0 110.541 175.986 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.583 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.234 0.282 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . 0.583 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 29.2 Cg_endo -62.58 169.25 8.66 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 121.788 1.659 . . . . 0.0 111.49 176.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.458 ' HA ' ' HB1' ' A' ' 82' ' ' ALA . 33.1 mtp180 . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 121.159 0.504 . . . . 0.0 110.883 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.375 0 CA-C-O 120.725 0.298 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.56 138.52 41.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.418 ' HB3' ' HD2' ' A' ' 124' ' ' LYS . 8.9 mt-30 -114.39 138.77 50.13 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.806 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -132.71 125.77 53.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.441 177.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -99.81 130.23 45.99 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.639 -0.663 . . . . 0.0 111.279 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD13 HG11 ' A' ' 90' ' ' VAL . 96.3 mt -108.98 142.38 39.72 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.848 176.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.68 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.0 tt0 -104.15 126.42 51.25 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.195 -174.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.612 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -114.55 122.64 47.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -152.1 172.74 31.37 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.239 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -165.7 152.38 9.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.044 0.449 . . . . 0.0 110.138 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -117.03 152.04 35.48 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -141.96 133.29 26.47 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.532 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -129.79 164.74 23.4 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.823 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' A' ' 112' ' ' GLU . 2.4 p -104.24 161.01 4.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 168.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.499 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 4.3 mtp85 -105.52 140.54 38.45 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -67.05 -17.87 65.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.73 0.776 . . . . 0.0 109.477 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -136.76 107.31 9.04 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.893 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.528 ' HG3' HG22 ' A' ' 32' ' ' THR . 64.7 Cg_exo -45.89 156.3 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.277 2.651 . . . . 0.0 113.176 177.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 29' ' ' GLU . 11.3 t -75.99 -169.92 1.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.634 -171.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.54 -27.4 42.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 122.874 0.47 . . . . 0.0 111.532 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.483 ' H ' HG23 ' A' ' 27' ' ' THR . 20.7 mm-40 -86.6 -12.06 49.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.408 0.623 . . . . 0.0 109.856 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.85 19.96 38.46 Favored Glycine 0 CA--C 1.503 -0.7 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.575 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -91.25 145.18 24.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.663 -0.768 . . . . 0.0 110.827 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.528 HG22 ' HG3' ' A' ' 26' ' ' PRO . 44.6 p -94.0 -28.72 15.61 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.4 -164.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.407 ' NE2' ' O ' ' A' ' 110' ' ' HIS . 59.9 m80 -108.64 153.69 23.06 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -169.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 1.1 m-20 -131.95 133.35 44.41 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.409 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 56.7 p-90 -139.19 149.82 44.85 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.046 0.451 . . . . 0.0 111.488 -177.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.654 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 47.7 ttp -125.85 120.91 31.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.887 174.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.5 m -99.92 152.73 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.315 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.3 p90 -150.94 153.16 34.72 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.4 m -127.09 128.54 70.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.244 170.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -135.28 -176.12 4.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.949 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.476 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -91.12 -169.06 42.11 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.269 177.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 4.9 Cg_exo -72.82 112.16 3.43 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.665 2.244 . . . . 0.0 111.617 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 59.55 60.68 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.536 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 67.0 m80 71.16 -3.0 2.18 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 66.6 m -60.06 134.15 56.78 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.479 0.181 . . . . 0.0 111.299 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -69.96 126.42 29.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.659 HD12 HG21 ' A' ' 51' ' ' VAL . 1.5 pt -96.66 -4.84 9.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -174.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -68.89 6.21 0.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.851 0.357 . . . . 0.0 111.782 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -80.12 -33.57 38.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.546 172.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.4 ' CE1' HG22 ' A' ' 47' ' ' ILE . 54.4 p90 -119.39 -18.75 8.46 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.301 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.659 HG21 HD12 ' A' ' 47' ' ' ILE . 91.4 t -88.68 131.25 36.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -98.06 -52.01 3.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 0.0 110.366 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -156.97 158.56 36.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.67 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 55' ' ' VAL . 93.9 t -132.29 158.11 43.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.586 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.6 p -141.92 135.39 29.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.225 0.535 . . . . 0.0 111.085 -175.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.512 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 29.3 m-85 -117.59 108.37 15.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.73 92.57 4.81 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.161 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.621 ' CD2' HD11 ' A' ' 86' ' ' LEU . 10.7 mt -76.9 -178.42 4.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -79.01 144.02 35.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.07 -19.76 21.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.832 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -66.58 -21.95 66.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.111 0.481 . . . . 0.0 110.997 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -84.14 132.89 46.54 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.528 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.82 122.43 10.98 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.41 2.074 . . . . 0.0 111.1 172.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 59.96 69.3 1.25 Allowed Pre-proline 0 CA--C 1.531 0.232 0 O-C-N 123.738 0.649 . . . . 0.0 110.476 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.81 -22.4 49.49 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.636 2.224 . . . . 0.0 113.157 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -93.33 98.47 11.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.247 0.546 . . . . 0.0 110.202 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 13.2 mmt180 -94.36 96.69 9.7 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.446 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -86.35 136.66 22.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 172.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.0 m -124.86 111.6 15.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.03 0.443 . . . . 0.0 109.925 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -100.73 -27.51 13.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.681 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.503 ' OD1' ' HD2' ' A' ' 72' ' ' PRO . 28.4 t70 -69.63 168.63 15.99 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.712 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.61 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 42.4 Cg_exo -26.35 -168.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.864 1 C-N-CA 126.12 4.547 . . . . 0.0 116.277 161.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.61 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 10.3 Cg_endo -37.18 120.2 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.981 2.454 . . . . 0.0 113.976 -151.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 35.3 m-85 -62.45 98.37 0.11 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.935 -177.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 11.9 ptpt -149.52 146.23 27.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.468 0.651 . . . . 0.0 112.103 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.9 t -126.5 131.22 71.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.011 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -117.0 111.34 19.43 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -132.7 171.54 13.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.33 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 5.0 t -116.4 146.41 42.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.18 172.06 28.52 Favored Glycine 0 CA--C 1.507 -0.434 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.802 -173.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -130.41 -4.17 4.3 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.962 0.41 . . . . 0.0 110.215 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' B' ' 217' ' ' ARG . . . -164.1 137.19 5.18 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.222 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.49 -174.47 28.72 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 116.187 -0.46 . . . . 0.0 114.19 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.0 p90 179.96 158.02 0.71 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.858 0.463 . . . . 0.0 110.462 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.83 129.26 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.621 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.3 tt -120.85 104.76 41.48 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-O 121.109 0.48 . . . . 0.0 110.154 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.82 114.37 3.12 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 123.25 2.634 . . . . 0.0 112.196 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -104.43 124.58 59.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.065 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.586 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.0 mt-10 -108.52 127.09 53.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.164 0.507 . . . . 0.0 110.008 175.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.452 HG11 HD13 ' A' ' 14' ' ' LEU . 57.0 t -106.73 117.98 53.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.622 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 81.0 m-85 -90.32 139.33 30.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.809 -178.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.448 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.0 m-85 -114.94 151.66 33.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.197 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.5 95.48 9.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.614 HD21 ' HB2' ' A' ' 96' ' ' GLU . 56.6 t30 -155.5 160.9 40.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.222 0.534 . . . . 0.0 111.595 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.66 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.6 OUTLIER -112.37 -1.42 15.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.778 178.132 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.614 ' HB2' HD21 ' A' ' 94' ' ' ASN . 18.4 mm-40 -102.02 -154.19 0.48 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.787 -175.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 97' ' ' GLU . 2.4 mp0 -26.79 152.5 0.01 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.938 1.295 . . . . 0.0 114.082 172.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 3.2 Cg_exo -31.66 125.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.197 1 C-N-CA 125.399 4.066 . . . . 0.0 114.756 -169.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.26 19.72 3.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.998 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -153.49 146.47 24.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.188 0.518 . . . . 0.0 110.934 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -128.7 155.87 40.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.025 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -120.89 121.29 37.75 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.841 0.353 . . . . 0.0 111.064 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.612 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.4 m-85 -113.79 112.21 23.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.649 173.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.31 105.97 11.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -115.57 137.25 52.26 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.672 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -85.86 114.25 22.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.894 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.532 HD11 HG11 ' A' ' 37' ' ' VAL . 2.0 mp -92.89 103.86 16.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -115.59 158.9 21.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.064 0.459 . . . . 0.0 110.28 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.1 mt -130.75 158.11 41.0 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.407 ' O ' ' NE2' ' A' ' 33' ' ' HIS . 2.8 m-70 -101.82 173.86 6.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.297 0.498 . . . . 0.0 110.648 173.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -62.4 136.8 58.08 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -173.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.487 ' HA ' HG21 ' A' ' 22' ' ' VAL . 6.5 tt0 . . . . . 0 C--N 1.34 0.193 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.844 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 39.5 t . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.961 0.41 . . . . 0.0 111.619 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.471 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -135.79 98.37 3.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -121.8 142.78 49.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.178 -176.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.456 HD11 ' CG ' ' A' ' 15' ' ' GLU . 16.6 tp -136.99 159.38 42.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.163 0.506 . . . . 0.0 111.57 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.502 ' HD2' HD23 ' A' ' 16' ' ' LEU . 19.7 ttm180 -152.98 149.23 27.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.321 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.414 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 69.5 m -138.7 118.25 12.98 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 174.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -114.7 146.06 41.34 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 11' ' ' GLN . 38.6 ttpt -103.52 127.48 50.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.416 0.627 . . . . 0.0 112.398 -174.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.806 ' HB2' HG23 ' A' ' 12' ' ' VAL . 7.7 mt -86.43 149.53 24.93 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.3 m -140.97 121.89 14.5 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.144 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -115.93 114.85 25.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.232 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -84.76 120.85 26.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.315 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 50.5 65.49 6.73 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.766 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.35 -178.76 4.2 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.764 2.309 . . . . 0.0 112.074 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 74.4 p -74.97 137.15 41.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -61.19 -29.15 69.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -67.57 -28.3 67.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.646 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.8 t80 -75.07 -42.96 55.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.409 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.66 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.3 ttm180 -54.45 -43.69 71.85 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.755 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -55.87 -39.79 72.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.156 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 51.0 mtpt -71.09 -39.76 71.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.811 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 33.9 mt -69.61 -26.68 64.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.73 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 41.6 mt -86.19 -28.88 23.62 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.054 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -77.22 -31.15 55.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.261 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.828 178.487 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.409 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 110.715 -0.105 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 14.0 Cg_endo -58.97 172.27 1.73 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.221 1.947 . . . . 0.0 112.129 173.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.507 ' HA ' ' HB1' ' A' ' 82' ' ' ALA . 11.8 ptp180 . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.28 0.562 . . . . 0.0 111.577 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 121.054 0.454 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 t -101.72 140.72 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.1 mp0 -125.78 120.66 31.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.087 0.47 . . . . 0.0 110.224 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.857 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -108.52 177.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.686 179.007 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 98.7 mttt -142.58 136.42 29.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.579 0.228 . . . . 0.0 110.74 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.437 ' HG ' HD11 ' A' ' 125' ' ' LEU . 79.4 mt -119.68 142.56 48.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 109.945 174.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.609 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.8 tt0 -102.87 123.08 45.84 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.058 -176.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.645 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -109.78 113.68 26.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 174.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -142.67 173.8 23.8 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.849 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -164.01 151.93 12.7 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.007 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 70.6 mtt180 -116.82 140.92 48.87 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.748 171.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.0 125.51 29.87 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.282 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -119.5 155.07 32.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.718 HG21 ' HA ' ' A' ' 112' ' ' GLU . 4.9 p -103.93 159.3 5.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.452 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 2.2 mtp180 -108.84 147.43 32.12 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -72.13 -18.39 61.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.651 0.738 . . . . 0.0 109.28 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -139.89 103.81 6.87 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.412 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.533 ' HG3' HG22 ' A' ' 32' ' ' THR . 70.2 Cg_exo -47.2 156.61 0.81 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.533 2.822 . . . . 0.0 112.736 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.422 HG22 ' HB2' ' A' ' 31' ' ' PHE . 10.2 t -77.23 -174.52 3.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.665 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.49 HG22 ' OE1' ' A' ' 29' ' ' GLU . 1.1 m -64.15 -27.81 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.106 0.479 . . . . 0.0 110.827 -175.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.49 ' OE1' HG22 ' A' ' 28' ' ' VAL . 2.3 mp0 -80.18 -2.06 43.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.382 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.26 31.22 63.92 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.365 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.422 ' HB2' HG22 ' A' ' 27' ' ' THR . 21.6 m-30 -93.64 131.55 38.84 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.533 HG22 ' HG3' ' A' ' 26' ' ' PRO . 62.1 p -89.69 -20.32 23.77 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.426 -168.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.413 ' NE2' ' O ' ' A' ' 110' ' ' HIS . 66.0 m80 -124.07 148.33 47.18 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -172.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.452 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 7.4 m-20 -123.82 123.79 41.24 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 170.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -123.8 154.24 39.85 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.29 0.567 . . . . 0.0 111.192 -176.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.643 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 15.1 tmm? -128.96 136.71 50.73 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.062 174.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.3 m -121.67 149.43 24.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.387 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.663 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.6 OUTLIER -149.32 157.25 43.18 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.2 m -123.91 126.38 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.662 167.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -135.39 -176.28 4.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.734 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . -93.19 179.15 39.18 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.427 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.413 ' HB3' ' HB2' ' A' ' 13' ' ' LYS . 33.8 Cg_endo -73.97 112.67 3.6 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.337 2.025 . . . . 0.0 111.879 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 61.71 47.86 5.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.079 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 67.88 6.97 5.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.715 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.489 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 48.6 m -63.26 122.53 16.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -60.83 125.01 22.14 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.93 0.395 . . . . 0.0 110.528 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.584 HD12 HG21 ' A' ' 51' ' ' VAL . 1.7 pt -95.3 -2.2 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.738 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -59.23 -12.85 5.99 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.306 0.574 . . . . 0.0 110.672 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -67.8 -45.0 76.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.959 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.416 ' CE2' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -111.83 -18.37 12.72 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.309 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.584 HG21 HD12 ' A' ' 47' ' ' ILE . 59.3 t -92.58 137.02 23.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.964 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.555 ' HB2' ' HG3' ' A' ' 93' ' ' LYS . 10.5 tp10 -113.98 -63.18 1.49 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.271 0.557 . . . . 0.0 110.915 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 24.9 tttt -136.73 149.55 47.92 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.129 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 99.0 t -131.13 156.94 43.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.601 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.9 p -140.62 134.9 34.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.374 0.606 . . . . 0.0 111.601 -175.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.496 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 16.1 m-85 -117.33 111.26 19.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -81.75 97.88 8.17 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.043 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.625 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.3 mt -80.77 -177.82 6.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.877 0.37 . . . . 0.0 110.631 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 143.2 45.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -60.04 -23.29 63.61 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.1 t -70.68 -22.15 62.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.998 0.427 . . . . 0.0 110.867 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 17.8 m-85 -75.39 141.48 73.52 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.731 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 62' ' ' PHE . 23.4 Cg_exo -64.77 128.55 21.23 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.395 2.063 . . . . 0.0 110.318 171.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.519 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 52.9 mtm180 58.11 74.92 0.58 Allowed Pre-proline 0 C--N 1.331 -0.226 0 O-C-N 123.618 0.574 . . . . 0.0 110.246 -175.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.1 -24.38 52.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.509 2.139 . . . . 0.0 113.065 -178.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -101.52 104.62 15.53 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.14 0.495 . . . . 0.0 110.183 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.519 ' HD3' ' O ' ' A' ' 64' ' ' ARG . 9.4 mmm-85 -103.1 104.13 14.26 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.492 -177.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -98.59 137.63 25.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.8 m -118.1 120.22 37.12 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -103.16 -29.83 11.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.613 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.578 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 6.2 m-20 -81.03 -178.31 1.14 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.101 -175.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 0.9 OUTLIER -41.34 -166.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 124.277 3.318 . . . . 0.0 114.231 165.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.564 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 3.3 Cg_endo -29.82 118.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 123.291 2.661 . . . . 0.0 113.883 -147.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.663 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 54.2 m-85 -64.56 88.75 0.06 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.848 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 13.9 ptpt -136.92 142.9 42.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.409 0.623 . . . . 0.0 112.418 -174.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.6 t -119.56 136.56 56.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.618 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -124.21 107.01 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.35 172.84 12.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.402 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.4 t -123.15 146.03 48.11 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.674 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.38 23.72 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -130.27 -18.35 3.27 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.503 0.652 . . . . 0.0 111.903 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.75 145.09 32.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.001 0.429 . . . . 0.0 111.178 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.73 172.5 51.97 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.673 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -168.71 158.9 9.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 122.905 0.482 . . . . 0.0 110.064 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 mm -66.76 121.08 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.188 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.625 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.6 tt -116.46 108.25 45.67 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.406 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -79.9 121.26 4.47 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.799 2.333 . . . . 0.0 112.056 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.475 HG12 ' CE2' ' A' ' 56' ' ' PHE . 3.9 mp -105.53 133.59 49.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.323 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.9 mt-10 -113.37 121.32 43.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.202 0.525 . . . . 0.0 110.217 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.426 HG13 HG22 ' A' ' 54' ' ' VAL . 84.0 t -101.54 122.56 53.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.115 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.565 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 87.3 m-85 -91.12 138.57 31.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.548 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.461 ' HE1' HG22 ' A' ' 51' ' ' VAL . 21.3 m-85 -119.91 162.32 19.37 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.16 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.555 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -105.16 97.24 7.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 121.159 -0.217 . . . . 0.0 111.353 176.282 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -155.63 168.86 25.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.298 0.57 . . . . 0.0 112.272 173.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.591 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -103.97 9.28 36.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.484 174.596 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.4 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 35.9 mm-40 -101.01 -154.65 0.49 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.442 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.475 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 22.6 mm-40 -35.95 157.36 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.63 0 C-N-CA 124.24 1.016 . . . . 0.0 113.266 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 7.3 Cg_exo -31.88 125.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 124.713 3.609 . . . . 0.0 114.302 -172.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.45 20.06 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.841 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -152.13 140.76 20.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.919 178.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.2 m -115.91 156.79 16.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -128.39 107.88 10.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.873 0.368 . . . . 0.0 110.487 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.2 m-85 -105.67 120.96 43.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.202 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -82.59 117.15 22.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -126.6 136.18 52.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.242 0.544 . . . . 0.0 110.875 -176.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.38 112.79 21.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.951 -178.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.569 HD11 HG11 ' A' ' 37' ' ' VAL . 1.2 mp -91.04 94.64 9.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -104.03 155.85 18.34 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.087 0.47 . . . . 0.0 111.054 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.5 mt -129.36 162.5 27.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.247 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.524 ' CD2' ' H ' ' A' ' 110' ' ' HIS . 5.7 p80 -100.18 173.09 6.79 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.285 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -73.57 161.03 30.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.997 0.427 . . . . 0.0 111.635 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.718 ' HA ' HG21 ' A' ' 22' ' ' VAL . 14.7 mt-10 . . . . . 0 C--O 1.232 0.176 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.304 173.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 67.4 t . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.407 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.47 96.43 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.421 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.3 t-80 -116.3 132.49 56.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.46 -177.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 119' ' ' HIS . 9.5 mt -117.04 141.82 47.76 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.51 0.506 . . . . 0.0 110.327 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 18.3 ttm180 -131.2 148.41 52.7 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.434 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 59.1 m -133.84 117.0 16.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 6.1 mt-10 -113.34 137.45 51.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.842 0.354 . . . . 0.0 111.085 -175.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -89.45 126.56 35.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.822 -175.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.857 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.2 mt -92.69 115.38 28.05 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 23.7 m -110.66 114.74 28.35 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.911 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -115.64 109.41 17.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.547 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -76.02 117.77 18.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.129 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.5 t30 54.46 67.32 3.45 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.267 176.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.96 -179.37 5.05 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.56 2.173 . . . . 0.0 111.359 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.2 p -77.52 145.7 36.82 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 173.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -54.42 -40.54 68.38 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.795 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.1 p-10 -59.81 -32.44 70.64 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.593 0.235 . . . . 0.0 110.662 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.676 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 4.7 t80 -73.78 -41.11 62.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.621 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 45.2 ttm105 -54.72 -43.61 72.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.609 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -57.33 -37.43 72.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.31 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 32.7 mtpt -73.94 -42.42 60.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.839 0.352 . . . . 0.0 110.3 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 33.0 mt -69.73 -30.99 68.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.219 -176.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 27.3 mt -79.64 -32.8 41.7 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.778 0.323 . . . . 0.0 110.684 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.62 -30.27 64.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.565 -176.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.757 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.237 0.441 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 6.9 Cg_endo -51.09 168.62 0.23 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.12 1.88 . . . . 0.0 112.465 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 . . . . . 0 C--N 1.321 -0.653 0 CA-C-O 120.923 0.392 . . . . 0.0 111.123 -174.288 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.117 0.484 . . . . 0.0 111.434 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.21 142.38 21.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.08 124.99 38.38 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.262 -178.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.885 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -109.28 168.72 3.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.4 175.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.93 126.56 27.13 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.571 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.412 HD13 HG11 ' A' ' 90' ' ' VAL . 82.2 mt -105.99 142.2 36.1 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.991 177.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.639 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.5 tt0 -102.82 125.0 49.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.05 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.681 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -112.54 113.96 26.38 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -144.91 175.86 24.3 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.849 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -165.88 155.11 11.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.183 0.516 . . . . 0.0 111.164 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 26.7 mtp180 -116.55 152.18 34.66 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.745 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.58 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -147.56 125.82 12.25 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.839 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -125.48 141.99 51.75 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.782 HG21 ' HA ' ' A' ' 112' ' ' GLU . 7.5 p -100.73 152.4 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.771 ' HD2' ' O ' ' A' ' 25' ' ' LYS . 5.9 ptt180 -116.7 138.65 51.3 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -68.02 -17.36 64.39 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.562 0.696 . . . . 0.0 109.473 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.771 ' O ' ' HD2' ' A' ' 23' ' ' ARG . 44.7 tttm -117.49 99.05 52.37 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.483 170.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HG3' HG22 ' A' ' 32' ' ' THR . 50.3 Cg_exo -58.11 159.52 18.37 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.104 1.869 . . . . 0.0 110.915 171.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 t -81.68 -172.77 4.05 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.741 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.413 ' H ' HG13 ' A' ' 28' ' ' VAL . 1.7 m -59.0 -29.82 42.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.208 0.528 . . . . 0.0 111.492 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -85.47 -0.22 54.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.32 30.53 62.49 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.162 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -89.45 125.55 35.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.445 HG22 ' HG3' ' A' ' 26' ' ' PRO . 40.4 p -86.6 -27.51 23.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.471 -171.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 79' ' ' SER . 68.6 m80 -118.1 142.27 47.6 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -171.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -115.05 119.96 38.21 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 173.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -122.65 154.95 37.34 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.149 0.499 . . . . 0.0 111.32 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.645 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 52.4 ttp -133.21 119.92 20.48 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.571 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.0 m -100.53 152.31 4.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.285 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.597 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -152.46 155.5 37.62 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.539 -0.464 . . . . 0.0 112.234 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.6 m -128.11 127.17 67.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.132 170.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.475 HH11 ' HB3' ' A' ' 73' ' ' PRO . 9.9 mmm180 -132.49 -177.14 4.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.332 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.456 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -89.75 -167.55 42.49 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.649 174.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 2.9 Cg_exo -73.86 111.53 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.278 1.985 . . . . 0.0 111.697 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 60.78 61.28 1.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.662 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 72.91 -5.54 1.88 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.364 0.666 . . . . 0.0 112.527 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 58.7 m -59.31 133.07 55.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.551 0.215 . . . . 0.0 110.916 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -71.24 126.09 28.7 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.023 0.44 . . . . 0.0 110.318 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.609 HD12 HG21 ' A' ' 51' ' ' VAL . 1.4 pt -96.35 -2.73 10.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.485 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -57.86 -13.91 5.18 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.219 0.533 . . . . 0.0 111.285 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -69.88 -41.42 74.8 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.493 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.469 ' CE2' HG22 ' A' ' 47' ' ' ILE . 52.8 p90 -114.67 -14.39 12.04 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.883 -0.51 . . . . 0.0 111.543 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.609 HG21 HD12 ' A' ' 47' ' ' ILE . 90.0 t -94.31 125.86 46.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -92.44 -62.71 1.34 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.517 -176.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.706 ' HD2' ' CD1' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -145.86 151.1 37.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 98.1 t -125.28 160.93 30.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.594 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.6 p -142.32 137.81 29.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.192 0.52 . . . . 0.0 111.124 -176.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.512 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 26.7 m-85 -119.5 110.78 17.31 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -83.27 92.94 7.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.488 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.606 ' CD2' HD11 ' A' ' 86' ' ' LEU . 11.4 mt -78.54 177.73 8.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.986 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.89 144.32 49.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -58.87 -25.37 63.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.835 -170.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.8 t -72.75 -19.23 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.992 0.425 . . . . 0.0 110.592 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -75.23 135.31 73.13 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.23 118.65 5.49 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.436 2.091 . . . . 0.0 111.135 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 62.29 79.06 0.28 Allowed Pre-proline 0 CA--C 1.53 0.195 0 O-C-N 123.638 0.586 . . . . 0.0 110.203 -176.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.32 -21.16 66.02 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.803 2.336 . . . . 0.0 113.454 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -105.96 108.79 20.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.944 0.402 . . . . 0.0 110.694 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 24.2 mmt85 -106.64 98.37 8.05 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.035 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -84.29 136.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.391 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.9 m -125.7 112.04 15.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.862 0.363 . . . . 0.0 110.267 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -106.93 -21.65 12.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.31 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.667 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 3.1 t70 -65.37 -177.64 0.25 Allowed Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.537 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.667 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 16.7 Cg_exo -33.02 -175.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.542 0 C-N-CA 125.031 3.821 . . . . 0.0 114.285 160.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.649 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.6 Cg_endo -34.81 126.69 0.22 Allowed 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 123.657 2.905 . . . . 0.0 114.044 -160.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 33.0 m-85 -61.8 94.06 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.793 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 3.9 ptpt -144.15 146.29 32.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.225 0.536 . . . . 0.0 111.717 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 36' ' ' MET . 71.7 t -124.87 132.53 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.871 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.97 111.87 21.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.23 172.39 12.75 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.168 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 9.6 t -123.1 149.39 44.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.83 -175.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.82 -169.65 22.47 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -132.18 -10.93 3.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.146 0.473 . . . . 0.0 111.339 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' B' ' 217' ' ' ARG . . . -151.27 140.35 21.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.635 0.255 . . . . 0.0 110.47 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.61 179.22 49.35 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.771 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -173.94 156.28 2.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.677 0.275 . . . . 0.0 110.721 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 85' ' ' ILE . 14.2 mm -64.95 121.27 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.136 172.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.606 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -114.67 104.94 54.04 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.636 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.39 117.07 4.83 Favored 'Trans proline' 0 C--O 1.239 0.559 0 C-N-CA 123.05 2.5 . . . . 0.0 112.019 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 mt -106.81 126.17 62.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.21 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.594 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 46.3 mt-10 -110.57 122.64 48.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.367 0.603 . . . . 0.0 110.181 176.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.412 HG11 HD13 ' A' ' 14' ' ' LEU . 54.4 t -104.4 119.39 53.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.282 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.706 ' CD1' ' HD2' ' A' ' 53' ' ' LYS . 28.2 m-85 -94.8 156.14 16.51 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.424 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.7 m-85 -126.86 157.51 39.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.018 -177.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -105.76 93.65 4.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.252 0.548 . . . . 0.0 111.622 -178.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.568 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 62.0 t30 -160.24 -176.6 5.73 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 5.6 tmtt? -109.88 -5.04 15.63 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.245 0.545 . . . . 0.0 111.248 177.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.436 ' HB2' ' ND2' ' A' ' 94' ' ' ASN . 16.1 mm-40 -96.47 -155.41 0.48 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.852 -168.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 11.2 mm-40 -28.97 151.15 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 124.833 1.253 . . . . 0.0 113.902 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -30.62 124.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 125.087 3.858 . . . . 0.0 114.713 -165.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -75.26 12.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.5 -177.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.546 ' HE2' ' CE2' ' A' ' 91' ' ' TYR . 2.5 ptpt -150.03 147.67 28.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.318 0.58 . . . . 0.0 111.342 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.52 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -123.55 155.24 29.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 174.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -128.53 106.82 9.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.76 0.314 . . . . 0.0 110.336 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.681 ' CD2' HD21 ' A' ' 16' ' ' LEU . 22.9 m-85 -103.09 121.19 42.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.304 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -84.31 112.64 20.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -124.79 138.34 54.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.377 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.401 ' HA ' HD13 ' A' ' 85' ' ' ILE . 24.6 t70 -90.86 120.15 31.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.919 0.39 . . . . 0.0 110.959 -177.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.516 HD11 HG11 ' A' ' 37' ' ' VAL . 2.1 mp -93.76 91.75 7.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.009 175.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -101.03 157.74 16.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.207 0.527 . . . . 0.0 110.654 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.8 mt -129.76 163.78 25.46 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' B' ' 215' ' ' ALA . 38.7 m170 -94.18 174.83 6.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 172.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -67.52 165.16 17.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.009 0.433 . . . . 0.0 111.634 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.782 ' HA ' HG21 ' A' ' 22' ' ' VAL . 16.9 tt0 . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.748 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 22.5 t . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.443 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.66 96.39 2.86 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.431 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.2 t-80 -118.98 134.97 54.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.618 -177.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 119' ' ' HIS . 8.4 mt -116.58 152.59 33.84 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.514 0.509 . . . . 0.0 110.575 177.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 19.8 ttm180 -143.58 149.63 37.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 173.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.482 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 61.4 m -134.12 120.71 20.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -115.81 138.11 51.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.695 0.283 . . . . 0.0 110.437 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -90.48 129.91 36.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.474 0.654 . . . . 0.0 112.185 -174.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.885 ' HB2' HG23 ' A' ' 12' ' ' VAL . 11.1 mt -95.16 117.49 30.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.386 171.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.7 m -109.06 122.66 47.75 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.667 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -120.42 104.45 10.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.675 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -85.67 120.74 27.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.706 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 59.02 61.96 4.39 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.201 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -87.4 173.82 5.35 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.116 2.544 . . . . 0.0 112.013 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 134' ' ' PHE . 11.7 p -69.26 140.46 54.47 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -58.28 -37.08 74.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -63.36 -29.67 70.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.62 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.6 t80 -73.02 -43.4 62.15 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.665 ' O ' HD13 ' A' ' 139' ' ' LEU . 50.0 ttp180 -52.79 -52.58 56.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.809 175.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -55.09 -36.32 65.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.934 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -71.08 -39.2 72.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.624 -0.43 . . . . 0.0 109.84 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.6 mt -65.55 -19.11 65.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.706 0.765 . . . . 0.0 109.839 175.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.665 HD13 ' O ' ' A' ' 135' ' ' ARG . 6.4 mp -89.56 -26.36 20.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.962 -177.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -90.5 -19.14 24.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.203 0.525 . . . . 0.0 110.631 -174.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.18 174.384 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 110' ' ' HIS . . . . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . 0.427 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 34.5 Cg_exo -59.86 175.22 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.676 1.584 . . . . 0.0 112.71 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.4 ' HA ' ' HB1' ' A' ' 82' ' ' ALA . 11.3 ptp180 . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.332 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 121.182 0.515 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.8 t -103.13 142.58 16.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -121.95 127.31 50.21 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.806 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -112.08 172.18 3.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.927 177.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 97.0 mttt -135.83 131.84 35.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.565 0.221 . . . . 0.0 110.611 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.422 ' HG ' HD11 ' A' ' 125' ' ' LEU . 83.5 mt -116.52 142.04 47.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.239 0.543 . . . . 0.0 109.954 175.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.611 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.5 tt0 -105.13 125.12 50.64 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.939 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.582 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.5 mm? -108.57 122.22 46.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -143.85 167.61 26.68 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.984 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -163.72 154.15 15.57 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.379 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 53.4 mtp180 -121.15 144.87 48.34 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.866 172.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.68 118.29 24.47 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.785 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.95 137.05 50.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.678 HG21 ' HA ' ' A' ' 112' ' ' GLU . 3.3 p -103.5 137.87 30.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.4 mtp180 -92.81 139.96 30.0 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -175.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -68.14 -15.29 63.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.427 0.632 . . . . 0.0 109.729 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -139.03 102.35 7.55 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.427 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HG3' HG22 ' A' ' 32' ' ' THR . 90.8 Cg_exo -50.19 158.0 2.68 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.076 2.517 . . . . 0.0 112.169 175.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.8 t -78.22 -175.67 4.27 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.407 -174.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.423 ' H ' HG13 ' A' ' 28' ' ' VAL . 1.3 m -63.04 -31.05 51.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.092 0.472 . . . . 0.0 110.894 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -77.98 -6.7 55.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.447 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.37 33.41 39.52 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.401 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -94.7 129.7 41.49 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.557 HG22 ' HG3' ' A' ' 26' ' ' PRO . 38.9 p -91.9 -25.66 18.82 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.43 -168.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 79' ' ' SER . 56.5 m80 -117.28 140.53 49.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -113.86 112.15 22.88 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.406 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 54.7 p-90 -118.44 148.84 42.16 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.082 0.468 . . . . 0.0 111.127 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.648 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 57.8 ttp -129.37 122.64 29.88 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.802 175.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.7 m -102.59 151.29 6.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.369 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -152.15 152.87 32.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.2 m -124.02 127.14 73.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.271 171.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 73' ' ' PRO . 2.5 mmp_? -135.62 -176.58 4.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.705 -176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.489 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -91.54 -171.73 42.57 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.661 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 30.7 Cg_endo -75.7 113.68 3.79 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.515 2.143 . . . . 0.0 112.173 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 58.98 52.45 6.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.384 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.6 t60 74.38 -3.82 2.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.825 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 63.9 m -59.04 128.74 38.75 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 176.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -72.25 127.06 31.38 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.779 0.324 . . . . 0.0 110.844 -174.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.553 HD12 HG21 ' A' ' 51' ' ' VAL . 5.9 pt -96.42 -1.96 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -61.31 -14.66 28.56 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.383 0.611 . . . . 0.0 110.928 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.463 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 88.1 m-70 -65.7 -39.22 91.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.709 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -114.61 -16.01 11.91 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.464 176.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.553 HG21 HD12 ' A' ' 47' ' ' ILE . 99.3 t -91.79 129.09 43.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.084 0.469 . . . . 0.0 110.23 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -97.1 -63.92 1.09 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.335 0.588 . . . . 0.0 110.409 -175.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 6.6 ptmm? -141.1 157.54 45.16 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 91.7 t -130.04 158.33 42.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 67' ' ' ARG . 9.7 p -142.31 134.75 26.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.341 0.591 . . . . 0.0 111.214 -174.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 29.6 m-85 -117.78 105.5 12.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -77.05 90.86 3.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.872 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.581 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.9 mt -71.01 -177.77 1.75 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.825 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.79 139.77 43.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -176.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -56.53 -23.53 40.51 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -171.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.8 t -71.72 -16.31 62.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.069 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -79.51 141.01 56.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.13 116.84 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.097 1.865 . . . . 0.0 111.327 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 58.41 66.59 2.51 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.552 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.4 -18.74 66.01 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.223 2.615 . . . . 0.0 113.466 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -87.48 100.79 13.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.991 0.424 . . . . 0.0 110.534 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.0 mmt180 -100.13 110.81 23.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.826 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -100.64 136.01 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.7 m -114.37 118.24 33.32 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -105.09 -25.72 12.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.534 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.601 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 9.5 p-10 -76.5 -175.08 0.45 Allowed Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.382 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 1.5 Cg_exo -41.97 -166.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.231 3.288 . . . . 0.0 114.203 164.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.624 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 6.9 Cg_endo -34.89 120.02 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.005 2.47 . . . . 0.0 113.602 -151.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 47.5 m-85 -62.35 94.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.043 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 12.2 ptpt -142.28 145.9 34.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.279 0.561 . . . . 0.0 112.201 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 36' ' ' MET . 79.6 t -121.28 132.61 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.462 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.421 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 7.0 mm-40 -112.06 112.49 24.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.982 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -137.42 169.87 17.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.197 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 3.5 t -126.75 141.9 51.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.14 -169.27 24.17 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.281 -0.485 . . . . 0.0 111.953 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -132.84 -11.41 3.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.253 0.527 . . . . 0.0 111.973 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.41 136.99 20.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.18 -172.99 47.18 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.208 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -178.87 159.53 1.05 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.362 0.265 . . . . 0.0 110.485 -173.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.3 mm -63.9 123.43 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.581 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.1 tt -117.76 104.88 48.59 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-O 121.138 0.494 . . . . 0.0 109.995 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.54 112.98 3.0 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.336 2.691 . . . . 0.0 112.357 173.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 56' ' ' PHE . 3.8 mt -102.33 123.52 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.283 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.8 mt-10 -109.48 124.46 51.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.179 0.514 . . . . 0.0 110.198 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.4 t -103.36 118.76 50.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.907 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.587 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 69.9 m-85 -91.05 134.75 34.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.512 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.45 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 25.6 m-85 -110.11 152.07 26.46 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.047 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.58 94.19 9.77 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.418 ' HB3' ' HG3' ' A' ' 99' ' ' ARG . 64.0 t30 -154.61 158.65 40.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.875 -172.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -111.42 -9.68 14.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.909 0.862 . . . . 0.0 110.006 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 35.6 mm-40 -99.05 -151.77 0.39 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.47 -174.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 22.2 mm-40 -27.16 152.11 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.5 Cg_exo -31.1 126.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 1 C-N-CA 125.522 4.148 . . . . 0.0 115.262 -167.202 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.418 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -89.0 18.97 4.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.647 -179.182 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.422 ' HZ3' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -154.65 143.01 20.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.247 0.546 . . . . 0.0 110.874 -178.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -128.43 155.76 40.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.345 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -125.47 115.64 20.55 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.173 0.511 . . . . 0.0 111.118 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.582 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.8 m-85 -107.98 108.18 19.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.678 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -72.11 113.29 8.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.281 0.562 . . . . 0.0 109.659 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.5 ' CD1' ' HD2' ' A' ' 121' ' ' ARG . 31.8 t80 -124.47 129.22 50.25 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.707 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -85.15 106.85 16.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.605 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.529 HD11 HG11 ' A' ' 37' ' ' VAL . 1.6 mp -82.1 106.07 13.71 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.489 ' CE2' HG11 ' A' ' 117' ' ' VAL . 56.0 p90 -117.63 161.5 19.55 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.221 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.4 mt -135.05 162.98 30.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.636 -171.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.516 ' HD2' ' O ' ' A' ' 111' ' ' LEU . 6.9 p-80 -93.17 166.85 12.13 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 177.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.516 ' O ' ' HD2' ' A' ' 110' ' ' HIS . 2.1 mm? -68.01 146.83 53.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.701 0.286 . . . . 0.0 111.124 177.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.678 ' HA ' HG21 ' A' ' 22' ' ' VAL . 23.7 tt0 . . . . . 0 CA--C 1.531 0.226 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.888 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 26.7 t . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.443 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -143.62 98.15 3.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.525 ' O ' HD23 ' A' ' 120' ' ' LEU . 55.0 t-80 -119.4 134.62 55.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.755 -176.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.3 mt -123.17 142.17 51.19 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 123.682 0.614 . . . . 0.0 110.558 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.581 ' HD3' ' HB2' ' A' ' 16' ' ' LEU . 17.9 mtp180 -119.41 146.76 45.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 22.0 p -117.46 101.43 8.38 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 165.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.9 mm-40 -97.56 154.52 17.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.461 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -108.66 135.68 49.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.223 0.535 . . . . 0.0 111.906 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.806 ' HB2' HG23 ' A' ' 12' ' ' VAL . 11.0 mt -106.64 120.77 42.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 171.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.4 m -115.36 123.1 47.83 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.964 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -120.26 104.85 10.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.036 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.24 124.87 30.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.063 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 63.25 61.25 1.88 Allowed Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.769 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.7 170.05 5.43 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.788 2.325 . . . . 0.0 111.574 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 134' ' ' PHE . 12.3 p -71.43 144.86 49.6 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -56.71 -43.38 80.51 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.473 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.574 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 5.0 p-10 -59.68 -27.98 66.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.671 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.681 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 7.1 t80 -73.12 -41.72 63.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.659 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 34.8 ttm-85 -51.74 -47.35 64.08 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.569 0.699 . . . . 0.0 109.638 172.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.3 ttm180 -58.54 -37.43 75.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.543 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 39.0 mtpt -70.82 -41.32 71.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.838 0.352 . . . . 0.0 110.102 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 36.2 mt -69.12 -33.83 74.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.863 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 57.9 mt -75.22 -37.58 61.03 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.075 0.464 . . . . 0.0 110.606 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp -70.22 -28.38 65.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.452 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.74 -0.648 . . . . 0.0 110.376 175.085 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.093 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.19 172.02 4.58 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 121.783 1.655 . . . . 0.0 112.429 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 120.918 0.39 . . . . 0.0 110.732 178.482 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 120.878 0.37 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.433 HG23 ' HG3' ' A' ' 130' ' ' PRO . 4.6 t -113.12 141.24 29.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.0 115.51 18.62 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.897 0.38 . . . . 0.0 110.287 -175.54 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.9 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -105.87 177.02 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.951 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.677 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 99.5 mttt -141.59 149.64 41.0 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.476 HD13 HG11 ' A' ' 90' ' ' VAL . 91.4 mt -129.02 143.37 50.85 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.71 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.3 tt0 -102.36 122.61 44.61 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.843 -175.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.679 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -110.84 116.25 30.92 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 175.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.77 179.87 25.24 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.293 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -169.73 150.37 3.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.932 0.396 . . . . 0.0 110.531 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.63 139.7 49.87 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -129.3 126.65 39.49 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.999 0.428 . . . . 0.0 111.085 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -129.66 151.36 50.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.692 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.591 HG21 ' HA ' ' A' ' 112' ' ' GLU . 1.3 p -101.7 158.02 4.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 mtp180 -105.91 142.94 34.76 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -70.51 -14.71 62.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.583 0.706 . . . . 0.0 109.209 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -138.23 103.45 8.02 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.043 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.532 ' HG3' HG22 ' A' ' 32' ' ' THR . 72.7 Cg_exo -47.47 160.1 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.335 2.69 . . . . 0.0 112.764 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.9 t -78.85 -177.88 5.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.605 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -41.67 78.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.81 0.338 . . . . 0.0 111.271 -176.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -71.11 -7.95 50.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.9 0.381 . . . . 0.0 111.399 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.3 33.14 26.59 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.617 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -95.77 132.3 41.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.532 HG22 ' HG3' ' A' ' 26' ' ' PRO . 69.4 p -90.83 -29.68 17.42 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -169.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 79' ' ' SER . 65.4 m80 -112.88 143.85 43.44 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -172.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.519 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -122.15 118.47 28.74 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 172.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.413 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 49.2 p-90 -121.87 151.5 40.6 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.791 -175.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.593 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 50.0 ttp -127.21 119.81 27.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.777 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 76' ' ' VAL . 9.9 m -98.84 154.8 3.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.148 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -155.3 156.14 34.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.1 m -125.07 127.58 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.784 169.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 mmm-85 -131.76 177.9 7.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.883 0.373 . . . . 0.0 110.912 -175.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.491 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -92.7 162.7 26.72 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.553 177.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.677 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 18.4 Cg_endo -57.25 114.11 1.79 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.229 2.619 . . . . 0.0 112.3 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 59.17 57.74 3.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.898 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 71.91 1.33 3.87 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.645 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 77.8 p -63.52 132.07 50.1 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.012 -0.43 . . . . 0.0 109.845 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -75.93 126.04 30.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.537 HD12 HG21 ' A' ' 51' ' ' VAL . 6.1 pt -96.74 -1.22 10.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -171.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -63.24 -8.62 8.73 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -74.24 -36.87 63.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.072 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.439 ' CE2' HG22 ' A' ' 47' ' ' ILE . 52.3 p90 -114.07 -14.35 12.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.46 175.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.537 HG21 HD12 ' A' ' 47' ' ' ILE . 97.6 t -98.82 122.06 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 122.888 0.475 . . . . 0.0 110.145 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.619 ' CG ' ' HB3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -91.67 -44.31 9.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.194 0.521 . . . . 0.0 110.072 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -158.99 158.68 33.7 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.314 -174.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 96.6 t -137.21 157.05 34.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.953 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.616 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.8 p -142.18 136.52 29.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.344 0.592 . . . . 0.0 111.497 -175.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 19.8 m-85 -119.22 109.96 16.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -81.63 94.62 6.97 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.396 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.611 ' CD2' HD11 ' A' ' 86' ' ' LEU . 13.3 mt -77.16 -177.34 4.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.748 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.59 144.02 53.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.189 0.519 . . . . 0.0 109.697 -178.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -60.7 -24.24 65.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.004 -169.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.1 t -78.17 -8.67 58.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.614 0.245 . . . . 0.0 111.186 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -85.53 135.22 38.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -62.28 121.52 9.56 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.725 2.283 . . . . 0.0 110.901 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 61.36 72.1 0.71 Allowed Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.024 -173.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.88 -20.58 58.12 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.496 2.13 . . . . 0.0 112.296 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.564 ' HE3' ' CG1' ' A' ' 68' ' ' VAL . 24.9 ttpt -93.23 104.46 16.63 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.929 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 7.3 mmm180 -103.79 102.32 12.15 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.259 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.564 ' CG1' ' HE3' ' A' ' 66' ' ' LYS . 2.2 m -99.03 138.29 23.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.8 m -125.06 119.54 28.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -107.13 -23.81 12.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.509 0.671 . . . . 0.0 110.547 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.728 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 3.8 p-10 -74.26 -172.62 0.26 Allowed Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.188 -175.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.728 ' HD2' ' HB2' ' A' ' 71' ' ' ASP . 75.1 Cg_exo -40.85 -170.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 124.181 3.254 . . . . 0.0 114.598 168.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.651 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 7.9 Cg_endo -36.32 122.41 0.29 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.509 2.806 . . . . 0.0 113.842 -155.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.484 ' CB ' HG22 ' A' ' 39' ' ' VAL . 41.0 m-85 -62.55 97.34 0.09 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.01 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 12.4 ptpt -146.37 144.36 29.7 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.461 0.648 . . . . 0.0 112.129 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.1 t -121.89 131.69 72.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.833 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -114.74 114.0 25.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.89 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.31 173.02 12.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.143 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 7.6 t -126.64 144.77 50.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.715 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.09 -171.76 29.73 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -130.06 -8.07 4.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.197 0.498 . . . . 0.0 111.331 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.87 144.32 28.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.927 0.394 . . . . 0.0 111.235 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -82.99 173.97 52.52 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.029 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -172.67 158.58 4.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.732 0.413 . . . . 0.0 110.041 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 106' ' ' ASP . 16.1 mm -65.49 124.56 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.21 171.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.611 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -117.61 105.3 48.26 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.886 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.65 118.49 5.71 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 123.109 2.54 . . . . 0.0 112.652 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.464 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.2 mt -108.1 126.09 64.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.369 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.616 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 43.6 mt-10 -109.52 123.57 49.62 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.088 0.471 . . . . 0.0 110.081 176.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.476 HG11 HD13 ' A' ' 14' ' ' LEU . 75.6 t -103.33 125.22 57.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.715 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 76.8 m-85 -96.39 132.11 42.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.84 -177.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.406 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 19.9 m-85 -110.62 165.07 12.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.835 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.619 ' HB3' ' CG ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -116.05 95.31 5.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.208 0.528 . . . . 0.0 111.863 -178.068 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.611 ' OD1' ' HB2' ' A' ' 96' ' ' GLU . 9.1 t-20 -157.91 177.49 11.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.272 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.598 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.49 -0.83 15.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.917 0.865 . . . . 0.0 110.811 178.206 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.611 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -96.47 -152.93 0.39 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.508 -173.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -31.33 150.94 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -37.09 120.1 0.28 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 124.911 3.741 . . . . 0.0 114.013 -168.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.72 20.31 3.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.889 -175.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.43 138.86 26.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.312 0.577 . . . . 0.0 110.574 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.527 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.3 m -122.38 155.25 27.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -129.24 106.07 8.58 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.192 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.679 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.3 m-85 -102.38 111.63 24.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.028 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -76.23 117.62 18.11 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -127.58 142.03 51.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.256 -175.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.403 ' HA ' HD13 ' A' ' 85' ' ' ILE . 11.6 t70 -92.05 118.48 30.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.064 -175.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.478 HD11 HG11 ' A' ' 37' ' ' VAL . 2.0 mp -97.09 96.22 8.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 175.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -105.08 156.44 18.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.984 0.421 . . . . 0.0 111.28 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 mt -132.44 152.86 51.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -101.53 174.21 6.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.382 0.537 . . . . 0.0 110.374 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.07 158.47 28.36 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -172.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.591 ' HA ' HG21 ' A' ' 22' ' ' VAL . 6.2 mp0 . . . . . 0 N--CA 1.477 0.899 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.093 -177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.735 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 43.5 t . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.694 0.283 . . . . 0.0 111.453 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -145.04 97.23 2.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.455 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.0 t-80 -123.65 134.14 53.81 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.104 -0.239 . . . . 0.0 111.23 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 119' ' ' HIS . 7.1 mt -117.03 153.74 32.17 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.757 0.661 . . . . 0.0 110.108 175.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 19.9 ttm180 -142.24 147.86 37.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 173.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.411 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 81.1 m -130.81 118.85 21.41 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 6.2 mt-10 -112.93 136.57 52.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.29 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -91.41 134.92 34.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.457 0.646 . . . . 0.0 111.639 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.9 ' HB2' HG23 ' A' ' 12' ' ' VAL . 5.5 mt -104.67 113.91 27.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.777 173.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.9 m -103.52 123.85 47.68 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.132 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -120.75 105.28 10.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.458 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.32 119.9 23.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.131 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 54.24 64.37 6.42 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.871 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.433 ' HG3' HG23 ' A' ' 10' ' ' VAL . 91.9 Cg_endo -80.05 177.89 7.8 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.3 2.0 . . . . 0.0 111.297 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.408 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 5.6 p -76.86 141.99 40.39 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -56.49 -43.1 79.34 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.298 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 8.0 p-10 -59.65 -29.5 68.08 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.564 -0.161 . . . . 0.0 110.564 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.664 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 14.6 t80 -74.7 -40.84 61.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.606 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 43.8 ttm105 -56.02 -44.91 79.15 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.682 174.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -57.4 -37.0 72.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.019 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 44.3 mtpt -72.13 -38.96 69.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.702 0.287 . . . . 0.0 110.682 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.3 mt -69.84 -30.98 68.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.578 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 33.0 mt -82.84 -31.13 28.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.918 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -73.61 -31.13 63.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.02 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.198 176.909 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.236 0.372 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 49.5 Cg_exo -55.87 165.53 3.67 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.528 1.485 . . . . 0.0 112.138 177.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 22.4 ttm180 . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 121.167 0.508 . . . . 0.0 111.41 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 121.037 0.446 . . . . 0.0 111.443 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.3 142.98 19.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -122.46 131.78 54.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.919 0.39 . . . . 0.0 110.203 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.845 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -114.79 165.77 9.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.622 176.385 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.602 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . 97.2 mttt -135.31 127.35 29.73 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.659 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.414 HD13 HG11 ' A' ' 90' ' ' VAL . 89.4 mt -113.19 142.66 45.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.196 0.522 . . . . 0.0 110.248 177.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.668 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.9 tt0 -104.49 126.08 51.25 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.758 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.657 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -112.43 113.71 26.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -145.64 176.64 24.52 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 119.699 -1.239 . . . . 0.0 111.756 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -166.29 156.03 11.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.993 0.425 . . . . 0.0 110.622 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 62.4 mtt180 -117.17 139.47 50.72 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 172.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -130.06 123.53 30.7 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.599 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -117.76 144.19 45.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.777 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.782 HG21 ' HA ' ' A' ' 112' ' ' GLU . 2.6 p -104.3 152.97 6.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 170.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.558 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -108.52 139.99 42.48 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -65.73 -20.51 66.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.606 0.717 . . . . 0.0 109.229 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -131.36 101.36 16.12 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.974 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.553 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.7 Cg_exo -48.63 158.7 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.52 2.813 . . . . 0.0 113.172 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.1 t -80.15 -173.04 3.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.211 -172.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -58.33 -36.98 60.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.0 0.52 . . . . 0.0 111.836 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -83.14 -1.34 52.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 110.704 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 34.09 37.87 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.962 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -98.16 134.95 40.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.553 HG22 ' HG3' ' A' ' 26' ' ' PRO . 25.6 p -88.4 -27.22 21.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.111 -171.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.426 ' CD2' ' HB3' ' A' ' 109' ' ' LEU . 64.5 m80 -115.69 145.19 42.97 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -171.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.558 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 5.8 m-20 -123.23 125.63 45.44 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.417 ' HH2' HD22 ' A' ' 58' ' ' LEU . 55.7 p-90 -128.28 149.85 50.31 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.097 0.475 . . . . 0.0 111.002 -176.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.697 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 45.2 ttp -128.16 122.37 31.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.354 174.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 6.2 m -101.42 153.96 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.327 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -153.36 153.74 33.15 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.199 -0.6 . . . . 0.0 112.553 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 10.6 m -124.79 130.83 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.044 171.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.463 ' HB2' ' HB3' ' A' ' 15' ' ' GLU . 2.7 mmt85 -129.5 -177.09 4.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.958 0.408 . . . . 0.0 111.381 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.502 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -94.0 -164.17 36.37 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.229 174.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 2.7 Cg_exo -72.86 111.88 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.617 2.212 . . . . 0.0 111.369 177.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 57.18 56.52 5.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.578 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.1 m80 67.51 5.22 4.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.82 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 70.8 m -64.93 129.3 39.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.45 ' OD1' ' HB2' ' A' ' 48' ' ' GLN . 8.4 t-20 -59.96 127.08 30.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.595 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.621 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.5 pt -96.72 -3.89 10.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.45 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 1.5 mp0 -60.14 -6.27 1.36 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -73.0 -37.88 66.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.939 177.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.496 ' CE1' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -118.24 -21.09 8.31 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.353 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.621 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 96.6 t -87.06 130.52 36.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -99.64 -54.78 2.83 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.21 0.529 . . . . 0.0 110.526 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.89 142.14 16.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.177 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 55' ' ' VAL . 90.2 t -117.55 160.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.937 -175.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.59 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.8 p -144.16 135.52 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.165 0.507 . . . . 0.0 111.145 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.526 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 30.9 m-85 -118.15 109.91 16.97 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -83.26 92.89 7.58 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.833 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.561 ' CD2' HD11 ' A' ' 86' ' ' LEU . 9.8 mt -71.51 -177.39 1.83 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 79.1 t60 -76.15 142.81 41.48 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.808 -0.757 . . . . 0.0 108.999 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 1.8 mp0 -54.52 -20.67 8.25 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.028 -171.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t -82.97 -5.87 59.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.672 0.272 . . . . 0.0 111.026 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.475 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 62.0 m-85 -82.35 148.46 59.28 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.88 117.91 5.23 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.613 2.209 . . . . 0.0 110.917 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 52.56 73.52 0.93 Allowed Pre-proline 0 C--O 1.226 -0.15 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.076 -174.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.46 -20.55 64.27 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.892 2.394 . . . . 0.0 113.56 -174.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -90.29 105.53 17.87 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.207 0.527 . . . . 0.0 110.457 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -106.73 89.26 2.96 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.281 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -71.6 139.64 19.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.149 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.4 m -126.91 114.26 17.63 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 175.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -107.35 -28.11 10.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.993 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.464 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 30.1 t70 -75.93 164.97 56.91 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.724 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.593 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 24.2 Cg_exo -28.72 178.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.534 1 C-N-CA 125.65 4.233 . . . . 0.0 115.111 168.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.593 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 4.5 Cg_exo -22.51 115.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 124.384 3.389 . . . . 0.0 115.036 -149.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.43 ' CB ' HG22 ' A' ' 39' ' ' VAL . 36.3 m-85 -60.89 107.86 0.77 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.603 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.697 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.4 ptpt -152.28 153.79 34.43 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.0 111.55 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 36' ' ' MET . 71.4 t -131.13 133.09 63.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.858 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -115.98 115.71 26.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.125 0.266 . . . . 0.0 110.407 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.77 172.09 13.16 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.274 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.6 t -120.89 146.87 46.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.78 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.41 -162.49 14.34 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.287 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -141.53 -18.34 0.78 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.8 134.7 37.29 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.567 -175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.503 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -75.54 169.27 54.75 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.378 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -168.48 154.97 7.22 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.4 mm -65.6 122.55 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.561 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.6 tt -113.6 104.95 55.27 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.548 -178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.1 108.02 1.25 Allowed 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 123.197 2.598 . . . . 0.0 111.881 173.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -98.79 124.86 52.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.676 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.59 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 72.8 mt-10 -113.67 119.91 39.06 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.419 0.628 . . . . 0.0 110.075 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.414 HG11 HD13 ' A' ' 14' ' ' LEU . 60.7 t -102.98 123.34 56.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.432 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.441 ' CD2' ' HB3' ' A' ' 100' ' ' LYS . 25.7 m-85 -99.25 155.45 17.49 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.86 0.838 . . . . 0.0 111.138 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.445 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.6 m-85 -125.67 156.9 38.55 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.998 -176.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.09 92.02 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.237 0.541 . . . . 0.0 111.346 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -158.42 -178.19 7.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.678 172.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.677 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -114.38 6.09 15.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.652 0.263 . . . . 0.0 111.383 -177.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 6.3 mm-40 -102.07 -152.76 0.45 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.851 -168.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.618 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 13.4 mm-40 -31.56 159.63 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.98 1.312 . . . . 0.0 113.317 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.4 Cg_exo -28.63 125.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 124.716 3.611 . . . . 0.0 114.19 -162.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -72.59 -1.76 17.31 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.226 -170.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 91' ' ' TYR . 4.2 pttt -155.56 171.23 20.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.484 0.659 . . . . 0.0 111.012 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.572 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.5 m -133.11 154.55 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.207 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -123.03 117.02 24.5 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.019 0.438 . . . . 0.0 111.07 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.4 m-85 -108.76 116.99 33.03 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.741 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -81.58 109.99 16.54 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.437 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 68.5 t80 -122.35 137.17 54.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.725 -174.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.486 ' OD2' ' HB3' ' A' ' 108' ' ' PHE . 30.6 t70 -86.95 110.64 20.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.575 HD11 HG11 ' A' ' 37' ' ' VAL . 1.7 mp -83.61 91.41 7.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.502 ' CE2' HG11 ' A' ' 117' ' ' VAL . 15.6 p90 -98.59 154.72 17.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.105 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 22.8 mt -133.3 137.89 46.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -176.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.592 ' HD1' HG23 ' A' ' 117' ' ' VAL . 2.6 p-80 -67.86 172.12 5.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 173.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.1 155.56 32.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.565 0.698 . . . . 0.0 111.338 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.782 ' HA ' HG21 ' A' ' 22' ' ' VAL . 15.2 tt0 . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.22 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.592 HG23 ' HD1' ' A' ' 110' ' ' HIS . 48.6 t . . . . . 0 N--CA 1.45 -0.43 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.91 96.69 3.01 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.443 ' O ' HD23 ' A' ' 120' ' ' LEU . 55.3 t-80 -115.67 136.0 53.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.731 -177.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 119' ' ' HIS . 7.5 mt -117.57 151.07 37.91 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.776 0.672 . . . . 0.0 110.295 177.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 18.0 ttm180 -140.36 148.01 40.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 42.4 t -132.51 125.86 31.58 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -121.61 134.01 55.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.715 -177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.71 129.43 35.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.198 0.523 . . . . 0.0 111.652 -175.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.845 ' HB2' HG23 ' A' ' 12' ' ' VAL . 6.4 mt -95.1 131.54 40.98 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.9 m -122.91 122.71 39.26 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.014 -0.674 . . . . 0.0 110.82 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -118.11 105.7 12.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.515 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.26 119.78 23.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.436 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.86 64.36 4.0 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.07 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -83.5 170.24 11.82 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.506 2.137 . . . . 0.0 111.155 172.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.7 p -70.24 142.81 52.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -57.0 -41.43 78.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.611 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -56.09 -33.03 64.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.79 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.705 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.8 t80 -75.41 -40.48 57.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.64 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.7 ttm180 -55.3 -45.89 76.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -53.05 -42.19 65.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.251 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 45.6 mtpt -71.68 -38.96 70.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 41.5 mt -68.11 -31.55 71.23 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.911 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 56.0 mt -80.52 -28.95 37.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.966 0.413 . . . . 0.0 110.917 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -78.72 -27.39 44.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.589 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.981 174.492 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.483 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.236 0.377 0 N-CA-C 111.489 0.181 . . . . 0.0 111.489 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 7.5 Cg_endo -50.94 168.71 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.285 2.657 . . . . 0.0 112.974 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 8.7 tpp180 . . . . . 0 C--N 1.32 -0.708 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.8 -177.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.55 0 CA-C-O 120.998 0.428 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.1 t -99.92 139.06 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 1.7 mp0 -125.09 119.67 29.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.271 0.558 . . . . 0.0 110.366 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.875 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.45 164.4 4.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.767 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 42' ' ' PRO . 92.1 mttt -132.92 125.93 30.97 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.373 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.48 HD13 HG11 ' A' ' 90' ' ' VAL . 90.8 mt -115.48 142.38 46.78 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.276 0.56 . . . . 0.0 110.372 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 7.0 tt0 -109.07 128.5 55.03 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.014 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.543 HD12 HG12 ' A' ' 39' ' ' VAL . 1.6 mm? -109.14 122.19 46.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -143.5 170.59 25.53 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.649 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -165.42 152.53 10.5 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.745 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.674 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 62.6 mtp180 -117.48 140.7 49.26 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.979 171.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -135.98 123.83 22.62 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.572 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 14.3 tt0 -121.4 144.76 48.49 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.556 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.77 HG21 ' HA ' ' A' ' 112' ' ' GLU . 9.8 p -99.03 153.49 4.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -105.03 152.06 23.2 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.261 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.9 mmtm -68.2 -20.82 64.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.396 0.617 . . . . 0.0 109.737 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -140.79 111.09 6.75 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.646 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.2 Cg_exo -47.81 155.27 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.176 2.584 . . . . 0.0 112.423 173.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.438 HG22 ' HB2' ' A' ' 31' ' ' PHE . 9.1 t -75.11 -169.7 0.99 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.865 -172.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 m -61.81 -24.61 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -107.05 11.36 29.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.324 1.059 . . . . 0.0 109.327 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.74 33.1 47.9 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.538 172.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.438 ' HB2' HG22 ' A' ' 27' ' ' THR . 19.4 m-30 -90.38 127.93 36.33 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.591 HG22 ' HG3' ' A' ' 26' ' ' PRO . 60.3 p -85.48 -29.87 23.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.34 -169.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.457 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.8 m80 -118.87 144.43 46.39 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -172.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -115.41 119.94 37.92 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 171.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -122.78 150.86 42.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.212 0.529 . . . . 0.0 111.031 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.72 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 50.4 ttp -129.11 116.48 19.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.428 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.2 m -99.14 149.77 5.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.299 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.643 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.6 OUTLIER -151.61 156.26 40.09 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.263 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.1 m -123.73 135.22 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.899 169.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -134.95 175.78 9.26 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.002 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.463 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -90.14 -178.61 44.46 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.14 173.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HB3' ' HB2' ' A' ' 13' ' ' LYS . 37.4 Cg_endo -76.63 111.87 3.34 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.147 1.898 . . . . 0.0 112.458 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 57.7 67.12 1.0 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.882 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.6 m80 72.87 -7.27 1.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.0 m -67.49 126.71 30.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.373 0.13 . . . . 0.0 110.848 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -69.03 126.68 30.57 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.637 HD12 HG21 ' A' ' 51' ' ' VAL . 1.1 pt -94.87 -3.74 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.763 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -63.36 -1.28 1.07 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.22 -0.446 . . . . 0.0 112.201 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -79.16 -33.6 43.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.416 ' CE2' HG22 ' A' ' 47' ' ' ILE . 54.0 p90 -117.65 -18.15 9.75 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.565 175.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.637 HG21 HD12 ' A' ' 47' ' ' ILE . 84.0 t -91.4 130.87 39.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.747 0.308 . . . . 0.0 110.369 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 7.8 tp10 -102.39 -63.36 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.144 0.497 . . . . 0.0 110.506 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -131.12 162.07 30.71 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 95.0 t -133.72 155.78 40.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 169.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.598 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.4 p -141.75 134.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.529 0.68 . . . . 0.0 111.402 -174.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.428 ' CD2' HG12 ' A' ' 88' ' ' ILE . 22.3 m-85 -115.88 107.27 14.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.131 -0.941 . . . . 0.0 108.646 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -79.44 90.74 5.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.229 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.449 HD11 HG11 ' A' ' 76' ' ' VAL . 19.9 mt -78.2 -176.85 4.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.888 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.79 143.96 43.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.15 -21.54 63.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.091 -175.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t -69.13 -17.04 63.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.888 0.375 . . . . 0.0 110.548 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -85.13 139.53 36.69 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.85 117.55 4.29 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.277 1.985 . . . . 0.0 111.271 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 57.37 80.19 0.3 Allowed Pre-proline 0 C--O 1.225 -0.231 0 O-C-N 123.672 0.607 . . . . 0.0 110.505 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.15 -20.79 48.12 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.884 2.389 . . . . 0.0 113.465 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -97.45 108.68 21.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.942 0.401 . . . . 0.0 110.915 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 19.7 mmt85 -111.38 104.87 13.36 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.017 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 5.4 m -90.63 135.92 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 169.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.0 m -112.87 116.46 30.06 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -101.38 -28.58 12.51 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.545 0.688 . . . . 0.0 110.245 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.571 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 3.1 m-20 -75.52 -177.17 0.66 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.927 -175.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.639 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 13.3 Cg_exo -45.0 -168.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.963 3.109 . . . . 0.0 113.936 165.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.639 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 2.6 Cg_endo -28.52 114.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.512 2.808 . . . . 0.0 114.563 -152.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 50.8 m-85 -62.17 96.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.287 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.72 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 17.3 ptpt -143.2 148.77 37.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.491 0.662 . . . . 0.0 112.727 -177.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 36' ' ' MET . 79.3 t -123.66 133.26 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.416 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -117.55 103.21 9.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' A' ' 67' ' ' ARG . 1.7 tp10 -136.27 169.7 17.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.741 0.305 . . . . 0.0 110.765 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 8.3 t -123.69 144.91 49.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.173 -176.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.23 -174.13 27.54 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -130.38 2.14 4.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.298 0.549 . . . . 0.0 112.016 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -160.17 130.91 5.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.744 0.307 . . . . 0.0 110.77 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -71.33 173.96 42.28 Favored Glycine 0 C--O 1.237 0.326 0 CA-C-N 115.604 -0.726 . . . . 0.0 113.381 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -173.1 157.09 3.39 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.87 0.468 . . . . 0.0 110.218 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 106' ' ' ASP . 12.9 mm -62.66 124.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.204 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.508 HD22 HG13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -108.66 106.2 58.3 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.98 112.7 3.47 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.807 2.338 . . . . 0.0 111.671 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.508 HG13 HD22 ' A' ' 86' ' ' LEU . 5.3 mt -108.15 125.74 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.633 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.598 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.2 mt-10 -107.93 122.12 46.17 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.388 0.613 . . . . 0.0 110.327 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 14' ' ' LEU . 75.8 t -101.11 116.63 45.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.285 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -88.74 139.3 30.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.815 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.1 m-85 -113.21 146.24 39.63 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.923 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -89.75 94.4 9.82 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -156.32 156.35 33.82 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.754 -170.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -107.8 -7.78 16.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.345 1.069 . . . . 0.0 109.515 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.15 -151.22 0.4 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.516 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.457 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 8.0 mm-40 -27.07 154.52 0.01 OUTLIER Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 4.2 Cg_exo -31.29 126.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.214 1 C-N-CA 125.529 4.153 . . . . 0.0 115.133 -168.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.85 14.46 11.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.932 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -161.91 142.76 10.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.349 0.595 . . . . 0.0 111.224 -176.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.513 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -129.23 156.48 41.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -128.77 107.55 9.75 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.466 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.513 ' CZ ' HG21 ' A' ' 101' ' ' VAL . 20.5 m-85 -100.27 137.89 38.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -94.73 122.51 37.41 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.377 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -133.26 130.76 39.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.324 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.465 ' HA ' HD13 ' A' ' 85' ' ' ILE . 17.4 t70 -84.47 107.0 16.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -175.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.467 HD11 ' CG1' ' A' ' 37' ' ' VAL . 1.5 mp -85.07 103.46 14.1 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.43 ' HB3' ' NH2' ' B' ' 217' ' ' ARG . 50.4 p90 -118.48 157.13 27.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.004 0.43 . . . . 0.0 110.352 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 mt -127.7 162.45 26.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.473 ' C ' ' HB2' ' B' ' 215' ' ' ALA . 36.0 m170 -94.62 164.07 13.12 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' B' ' 215' ' ' ALA . 1.3 mm? -51.99 147.07 7.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.958 0.409 . . . . 0.0 111.896 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.77 ' HA ' HG21 ' A' ' 22' ' ' VAL . 29.2 tt0 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.846 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 9.2 t . . . . . 0 CA--C 1.519 -0.227 0 CA-C-O 120.554 0.216 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.432 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -118.23 100.99 7.87 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -127.47 127.67 44.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.215 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.4 mt -107.38 150.78 26.35 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.494 174.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.638 ' HD3' ' N ' ' A' ' 122' ' ' CYS . 0.0 OUTLIER -148.14 140.44 24.27 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -174.387 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.638 ' N ' ' HD3' ' A' ' 121' ' ' ARG . 49.7 t -131.57 130.23 41.97 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.829 -175.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -121.48 141.12 51.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.089 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -104.47 132.16 51.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.174 0.512 . . . . 0.0 111.37 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.875 ' HB2' HG23 ' A' ' 12' ' ' VAL . 6.9 mt -99.36 116.11 30.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.169 175.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 35.4 m -112.14 115.2 28.47 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.557 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -114.53 109.45 18.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.901 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.71 120.35 24.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.901 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 58.04 63.59 4.35 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.654 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -85.14 165.65 11.2 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.835 2.356 . . . . 0.0 111.496 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.4 p -67.47 145.08 55.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 175.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.12 -43.76 70.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 136' ' ' ARG . 3.1 t70 -59.71 -30.77 69.03 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.746 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.698 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 11.0 t80 -76.01 -39.84 54.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.634 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 29.1 ttm180 -55.12 -46.03 75.56 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 121.236 0.541 . . . . 0.0 109.583 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 46.3 ttt180 -51.21 -44.01 61.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.495 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -71.75 -39.91 69.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.6 mt -69.3 -29.57 67.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.857 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 40.5 mt -80.31 -41.17 25.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.047 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -68.28 -30.19 69.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.337 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.583 176.964 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . 0.516 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . . . . . . 0 C--O 1.237 0.433 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . 0.516 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 0.1 OUTLIER -34.59 152.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.263 3.309 . . . . 0.0 114.749 168.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' A' ' 108' ' ' PHE . 17.1 ttm180 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.024 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 120.923 0.392 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.9 t -101.87 137.25 30.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.5 mt-30 -117.2 120.53 38.54 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.037 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.838 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.49 167.84 3.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.711 175.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.664 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 43.7 mtpt -133.39 139.68 46.92 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.46 HD13 HG11 ' A' ' 90' ' ' VAL . 96.8 mt -126.99 151.9 47.95 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 175.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.684 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 41.1 tt0 -114.26 120.82 41.73 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.314 -174.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.636 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.1 mm? -108.67 115.32 29.87 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -144.88 169.64 26.6 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.011 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -163.11 155.78 18.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.164 0.507 . . . . 0.0 110.917 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 20.8 mtp180 -118.93 153.44 34.59 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.677 175.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -149.44 128.17 12.48 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.804 175.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -129.23 164.1 24.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.524 HG21 ' HA ' ' A' ' 112' ' ' GLU . 1.8 p -103.44 163.47 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.2 mtp180 -112.51 135.13 53.59 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.61 -11.38 58.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.495 0.664 . . . . 0.0 110.457 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -135.9 103.29 9.97 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.833 170.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.531 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.2 Cg_exo -47.06 155.29 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.183 2.589 . . . . 0.0 112.211 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 t -76.71 -172.32 2.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -171.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 m -61.97 -30.43 48.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.495 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.83 -7.3 59.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.181 0.515 . . . . 0.0 110.38 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.65 32.42 33.7 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.206 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -98.54 138.49 35.67 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.531 HG22 ' HG3' ' A' ' 26' ' ' PRO . 26.5 p -86.77 -30.33 21.66 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -169.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.522 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.9 m80 -112.55 146.15 39.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -170.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -117.47 118.97 33.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -121.95 148.11 45.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.009 0.433 . . . . 0.0 111.111 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.645 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 41.1 ttp -125.75 122.04 35.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.526 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.9 m -103.23 153.05 5.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.072 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -154.26 154.52 33.57 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -126.71 129.5 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.844 169.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -134.91 -178.5 5.11 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.887 0.375 . . . . 0.0 111.067 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.44 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -92.37 166.85 29.68 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 173.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.664 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 41.0 Cg_endo -62.31 111.73 1.37 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 123.199 2.599 . . . . 0.0 112.727 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 58.02 67.84 0.91 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.784 172.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 75.47 -12.07 1.02 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.979 0.512 . . . . 0.0 112.353 172.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.1 m -62.37 122.94 16.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.799 0.333 . . . . 0.0 111.081 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.59 125.22 26.07 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.104 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.612 HD12 HG21 ' A' ' 51' ' ' VAL . 2.4 pt -96.07 -1.87 10.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -56.35 -16.45 5.64 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.942 0.401 . . . . 0.0 111.394 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -73.42 -43.85 59.56 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.617 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.475 ' CE2' HG22 ' A' ' 47' ' ' ILE . 49.5 p90 -106.07 -20.02 13.54 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.865 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.612 HG21 HD12 ' A' ' 47' ' ' ILE . 76.3 t -91.53 131.33 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.208 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.582 ' HB2' ' HG3' ' A' ' 93' ' ' LYS . 26.2 tt0 -103.46 -62.72 1.26 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.693 0.759 . . . . 0.0 110.327 -173.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 45.2 mtpt -131.73 161.16 33.5 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.578 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 93.2 t -134.8 153.5 34.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.573 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.3 p -139.36 132.71 37.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.635 0.731 . . . . 0.0 111.157 -175.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.48 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 27.0 m-85 -113.28 105.45 13.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.51 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -79.04 94.26 5.27 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.468 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.582 ' CD2' HD11 ' A' ' 86' ' ' LEU . 11.3 mt -73.34 179.74 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.04 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.51 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 22.9 t60 -81.98 146.96 29.46 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -57.24 -21.68 35.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.669 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 t -64.71 -22.48 66.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.095 0.474 . . . . 0.0 110.581 174.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -90.48 129.12 46.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.567 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.65 138.31 44.99 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.152 1.901 . . . . 0.0 110.699 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 58.45 67.32 2.18 Favored Pre-proline 0 C--O 1.223 -0.302 0 O-C-N 123.447 0.467 . . . . 0.0 109.983 -174.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.91 -22.01 56.47 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.689 2.259 . . . . 0.0 113.79 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -93.92 109.97 21.66 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.061 0.458 . . . . 0.0 110.44 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 21.8 mmt85 -113.05 100.97 9.02 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.771 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.5 m -92.74 138.17 20.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 171.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.45 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 25.9 t -118.53 111.53 18.73 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -92.59 -26.93 17.65 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.926 0.869 . . . . 0.0 109.261 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.576 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -84.58 179.68 1.81 Allowed Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.946 -171.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.62 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 22.8 Cg_exo -28.28 -179.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.535 1 C-N-CA 126.125 4.55 . . . . 0.0 115.896 163.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.62 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.6 Cg_endo -29.24 115.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 124.318 3.345 . . . . 0.0 115.04 -153.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 42.3 m-85 -62.7 98.19 0.12 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.153 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.645 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.1 ptpt -145.27 151.26 38.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.275 0.559 . . . . 0.0 111.905 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 36' ' ' MET . 73.7 t -128.12 131.65 69.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.431 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.48 108.16 14.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.926 0.393 . . . . 0.0 110.009 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.34 174.01 10.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.424 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 8.1 t -122.99 146.89 47.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.217 -176.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.74 -168.24 27.61 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.221 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -138.31 -10.7 1.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.76 123.16 9.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.153 0.501 . . . . 0.0 110.938 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.71 175.03 13.17 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.001 -1.0 . . . . 0.0 114.471 -177.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' A' ' 59' ' ' HIS . 21.8 p90 -174.24 155.59 2.43 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.218 -0.491 . . . . 0.0 110.288 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 106' ' ' ASP . 19.8 mm -63.58 128.32 25.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.369 171.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.582 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.8 tt -120.03 105.84 41.99 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 121.025 0.44 . . . . 0.0 110.123 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.74 113.48 2.99 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 123.322 2.681 . . . . 0.0 112.327 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 mt -103.76 124.36 58.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.337 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.3 mt-10 -107.93 127.47 53.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.117 0.485 . . . . 0.0 110.289 175.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.46 HG11 HD13 ' A' ' 14' ' ' LEU . 70.0 t -107.3 120.8 59.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.741 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 86.7 m-85 -90.77 145.48 24.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.386 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.428 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 19.8 m-85 -126.04 161.42 27.61 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.933 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.582 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -101.6 94.22 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 117.986 0.357 . . . . 0.0 110.615 177.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -158.54 175.41 13.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.964 170.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.463 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -114.37 6.24 15.98 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 177.241 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -98.6 -153.08 0.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -176.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -30.85 150.17 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.963 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -37.57 120.8 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.677 3.585 . . . . 0.0 113.777 -169.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.43 ' N ' ' HD3' ' A' ' 99' ' ' ARG . 0.3 OUTLIER -89.77 20.34 4.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.871 -175.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -143.24 137.77 29.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.176 0.513 . . . . 0.0 110.16 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.32 155.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -125.41 117.35 23.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.118 0.485 . . . . 0.0 111.08 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.636 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.2 m-85 -108.1 119.6 39.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.966 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -80.91 105.82 12.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.35 0.595 . . . . 0.0 109.905 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -118.18 133.84 55.54 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.371 -175.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.402 ' HA ' HD13 ' A' ' 85' ' ' ILE . 31.8 t70 -87.55 111.82 21.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.039 -175.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.522 HD11 HG11 ' A' ' 37' ' ' VAL . 1.9 mp -88.76 101.54 14.11 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -113.21 155.33 25.23 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.515 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.7 mt -128.52 155.09 45.42 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -100.23 162.13 13.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 118.36 0.527 . . . . 0.0 110.175 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -52.12 141.61 18.16 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.524 ' HA ' HG21 ' A' ' 22' ' ' VAL . 5.0 tt0 . . . . . 0 C--O 1.231 0.085 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.446 176.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 44.1 t . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.947 0.403 . . . . 0.0 111.97 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.414 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.88 96.51 2.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.427 ' O ' HD23 ' A' ' 120' ' ' LEU . 27.5 t-80 -122.27 134.09 54.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.215 -174.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 119' ' ' HIS . 8.3 mt -117.78 153.9 32.66 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.452 0.47 . . . . 0.0 111.205 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.478 ' HD2' HD23 ' A' ' 16' ' ' LEU . 20.8 ttm180 -145.17 151.14 37.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.474 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 48.9 t -136.37 122.23 19.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -120.32 142.14 49.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.673 0.273 . . . . 0.0 111.089 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.422 ' HD3' ' HB3' ' A' ' 11' ' ' GLN . 22.1 ttmt -92.22 138.69 31.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.202 0.525 . . . . 0.0 111.641 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.838 ' HB2' HG23 ' A' ' 12' ' ' VAL . 5.9 mt -105.49 118.76 37.38 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.0 m -111.95 123.09 49.51 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.151 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -118.97 110.0 16.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.881 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -81.66 128.12 33.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.507 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 49.89 60.66 14.94 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.422 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.29 173.6 9.7 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.521 2.147 . . . . 0.0 111.626 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 p -67.58 136.92 55.23 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 174.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -56.5 -34.14 66.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.566 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 9.3 m-20 -62.76 -32.56 73.73 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.686 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.4 t80 -76.53 -40.45 49.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.572 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 50.3 ttp180 -55.75 -41.66 74.27 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 43.7 ttm180 -58.09 -36.3 72.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.06 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 37.8 mtpt -72.3 -40.38 67.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.89 0.376 . . . . 0.0 110.246 176.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 26.0 mt -71.15 -25.34 62.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.948 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 30.4 mt -89.8 -23.61 21.67 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.834 0.35 . . . . 0.0 110.783 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.02 -23.96 38.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.876 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.265 176.145 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.307 0 N-CA-C 110.727 -0.101 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.54 171.18 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.444 2.096 . . . . 0.0 112.602 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 30.6 mtp85 . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 177.652 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.065 0.46 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 t -101.7 139.75 22.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 5.2 mp0 -127.38 131.41 50.35 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -176.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.829 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -116.12 171.05 5.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.947 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -133.4 131.66 40.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.775 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.05 144.18 43.06 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.744 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 36.7 tt0 -109.68 123.26 49.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.036 -175.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.611 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.0 mm? -106.53 110.21 22.35 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.426 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -136.78 170.22 23.53 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.433 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -164.95 151.8 10.72 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.149 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.0 mtp180 -113.54 145.62 40.95 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.524 173.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -136.92 118.77 15.16 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.92 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -111.62 154.04 25.46 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.733 HG21 ' HA ' ' A' ' 112' ' ' GLU . 3.1 p -103.88 161.91 4.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 3.7 mtp180 -112.19 141.01 46.4 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -68.18 -20.26 64.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.571 0.7 . . . . 0.0 109.143 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -131.1 104.24 15.23 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.365 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HG3' HG22 ' A' ' 32' ' ' THR . 88.3 Cg_exo -47.63 154.42 1.82 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.27 2.647 . . . . 0.0 112.988 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.432 HG22 ' HB2' ' A' ' 31' ' ' PHE . 9.0 t -73.96 -170.65 0.95 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.077 -171.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 m -54.1 -33.48 24.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -104.24 5.96 35.14 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.162 0.982 . . . . 0.0 109.447 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.7 25.45 20.44 Favored Glycine 0 CA--C 1.503 -0.717 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.151 169.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.432 ' HB2' HG22 ' A' ' 27' ' ' THR . 21.9 m-30 -94.36 140.32 29.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.873 0.845 . . . . 0.0 111.11 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.52 HG22 ' HG3' ' A' ' 26' ' ' PRO . 44.8 p -94.41 -23.85 17.59 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.857 -162.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.509 ' O ' ' HA ' ' A' ' 79' ' ' SER . 69.9 m80 -118.22 146.55 44.17 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -170.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.532 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 4.0 m-20 -126.98 123.73 37.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.483 170.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.412 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 54.1 p-90 -125.15 153.39 43.11 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.921 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.675 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 44.8 ttp -129.61 120.65 25.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.273 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.9 m -100.46 151.19 5.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -151.69 152.74 33.19 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.5 m -124.35 127.65 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.19 171.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -127.18 -179.48 4.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.021 0.439 . . . . 0.0 111.22 -176.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.539 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -94.68 -173.13 38.03 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.042 172.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -65.18 110.33 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.039 1.826 . . . . 0.0 111.753 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 15.4 mm-40 51.09 65.31 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.325 177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' A' ' 43' ' ' GLU . 75.4 t60 76.59 -10.39 1.33 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 171.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.6 m -60.24 127.09 30.07 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -66.04 126.6 29.12 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 120.863 0.363 . . . . 0.0 110.336 -178.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.666 HD12 HG21 ' A' ' 51' ' ' VAL . 1.1 pt -94.97 -4.05 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.76 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -65.78 0.59 1.67 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.866 0.365 . . . . 0.0 111.866 -176.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -76.86 -36.01 57.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.467 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 55.3 p90 -116.91 -17.15 10.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.52 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.666 HG21 HD12 ' A' ' 47' ' ' ILE . 98.1 t -91.35 130.32 40.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.86 0.362 . . . . 0.0 110.259 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.464 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 9.6 tp10 -99.38 -62.49 1.23 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.263 0.554 . . . . 0.0 110.169 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 43.1 mtpt -132.26 163.69 28.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.481 HG21 HG21 ' A' ' 39' ' ' VAL . 94.4 t -134.52 157.38 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 168.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.543 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.2 p -142.03 128.97 19.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.62 0.724 . . . . 0.0 111.166 -175.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.477 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 25.8 m-85 -110.86 104.57 13.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.581 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -78.31 92.5 4.53 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.815 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.635 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.5 mt -71.81 -178.67 2.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.89 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -76.18 142.08 41.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.17 -17.2 39.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -61.31 -28.54 69.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.36 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -82.09 131.82 55.41 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.088 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.93 124.74 15.05 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.183 1.922 . . . . 0.0 110.931 171.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 60.7 70.28 0.99 Allowed Pre-proline 0 N--CA 1.466 0.362 0 O-C-N 123.578 0.549 . . . . 0.0 110.406 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.75 -23.6 35.62 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.666 2.244 . . . . 0.0 113.781 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -90.45 105.25 17.69 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.309 0.576 . . . . 0.0 110.333 -174.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -105.54 86.92 2.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.078 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.3 m -69.27 138.22 22.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.211 0.529 . . . . 0.0 110.066 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.75 103.19 7.96 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -94.84 -23.73 17.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.054 0.931 . . . . 0.0 109.307 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.592 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 4.1 t70 -75.8 173.49 7.06 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.826 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.659 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.3 Cg_exo -32.91 -175.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.675 1 C-N-CA 125.457 4.105 . . . . 0.0 114.732 163.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.9 Cg_endo -28.01 115.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 124.299 3.332 . . . . 0.0 114.508 -158.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 42.7 m-85 -61.49 107.13 0.74 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.009 -175.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.675 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 17.3 ptpt -152.13 150.46 29.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.379 0.609 . . . . 0.0 112.066 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.5 t -128.57 132.55 67.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.629 177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -121.11 106.31 11.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.455 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.29 169.14 18.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.035 0.445 . . . . 0.0 111.463 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 0.8 OUTLIER -114.91 137.05 52.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.861 -178.087 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -143.68 -178.1 19.16 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -129.76 -2.39 4.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.685 0.278 . . . . 0.0 110.97 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -163.55 142.27 7.98 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.398 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.46 179.72 39.63 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.425 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -178.11 157.03 1.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.605 0.362 . . . . 0.0 110.293 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.3 mm -63.02 128.49 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.057 171.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.635 HD11 ' CD2' ' A' ' 58' ' ' LEU . 5.7 tt -120.29 105.2 42.26 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-O 121.04 0.448 . . . . 0.0 110.224 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.34 110.66 2.3 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 123.312 2.675 . . . . 0.0 112.316 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.427 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.9 mt -102.3 123.75 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.29 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.6 mt-10 -109.27 126.62 53.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.042 0.449 . . . . 0.0 109.939 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 53.0 t -104.5 122.09 57.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.149 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 73.0 m-85 -89.64 136.82 32.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.018 -178.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.444 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.5 m-85 -114.77 156.36 25.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.077 178.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.464 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -104.47 91.67 3.99 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.26 0.552 . . . . 0.0 111.347 -178.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -158.51 179.75 8.84 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.909 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.597 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -113.19 4.19 16.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 110.915 176.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 44.9 mm-40 -99.34 -152.07 0.4 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.155 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.439 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 51.3 mm-40 -25.63 148.18 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -34.49 120.68 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 125.085 3.857 . . . . 0.0 113.873 -170.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.93 19.24 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.419 -174.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 11.8 ptpt -151.39 144.38 24.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.205 0.526 . . . . 0.0 110.432 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.94 154.71 30.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -120.81 118.96 31.35 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.939 0.399 . . . . 0.0 110.811 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.611 ' CD2' HD21 ' A' ' 16' ' ' LEU . 24.1 m-85 -112.54 117.08 31.35 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.712 174.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.98 105.93 14.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.626 0.727 . . . . 0.0 109.791 177.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -115.99 127.52 55.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.212 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -81.48 109.89 16.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.605 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.523 HD11 HG11 ' A' ' 37' ' ' VAL . 1.4 mp -83.87 91.16 7.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.442 . . . . 0.0 109.81 176.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -96.46 154.02 17.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.279 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.2 mt -127.91 162.3 27.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.428 ' O ' ' NE2' ' A' ' 33' ' ' HIS . 23.8 p80 -96.52 166.97 11.43 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.792 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.11 150.59 47.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.954 0.407 . . . . 0.0 111.261 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.733 ' HA ' HG21 ' A' ' 22' ' ' VAL . 5.1 tt0 . . . . . 0 C--O 1.232 0.144 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.469 173.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 48.6 t . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.5 97.65 3.07 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -124.44 137.12 54.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.254 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.2 mt -115.74 153.48 31.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.74 0.65 . . . . 0.0 110.097 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 20.2 ttt180 -142.64 136.38 29.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 75.0 m -115.25 113.65 24.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.867 0.365 . . . . 0.0 111.052 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -110.73 134.89 52.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.878 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -96.48 125.9 41.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.261 0.553 . . . . 0.0 111.836 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.829 ' HB2' HG23 ' A' ' 12' ' ' VAL . 12.6 mt -90.21 120.42 31.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 171.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.2 m -112.84 119.9 39.59 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.694 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.49 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 30.6 m-85 -118.25 109.23 16.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.154 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.34 116.84 20.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.191 0.519 . . . . 0.0 111.153 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.4 t30 52.75 61.78 11.04 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.501 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 127' ' ' PHE . 96.5 Cg_endo -77.73 169.23 21.13 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.353 2.036 . . . . 0.0 111.489 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' A' ' 134' ' ' PHE . 6.6 p -59.62 141.25 55.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -57.82 -36.09 71.77 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.366 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.89 -34.5 74.75 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.676 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.0 t80 -73.94 -40.12 63.29 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.615 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 19.9 ttm180 -55.08 -44.62 75.02 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.591 173.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -55.49 -38.59 69.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.106 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -72.05 -39.74 68.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.984 0.421 . . . . 0.0 110.413 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 34.0 mt -72.62 -26.07 61.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.223 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.8 mt -85.6 -25.4 26.71 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.894 0.378 . . . . 0.0 110.689 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -80.74 -27.72 36.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.149 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.536 176.453 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.53 168.64 3.82 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.13 1.887 . . . . 0.0 111.674 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 . . . . . 0 C--N 1.323 -0.553 0 CA-C-O 121.372 0.606 . . . . 0.0 111.592 -178.432 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.822 0.344 . . . . 0.0 111.657 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.496 HG23 ' HG3' ' A' ' 130' ' ' PRO . 10.2 t -104.93 143.34 16.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -127.35 127.67 44.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.743 0.306 . . . . 0.0 110.362 -176.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.826 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -112.13 171.92 3.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.224 178.278 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 99.6 mttt -137.41 138.06 39.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.695 0.284 . . . . 0.0 110.53 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.404 HD22 HD13 ' A' ' 47' ' ' ILE . 85.4 mt -121.4 142.02 50.41 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.53 175.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 121' ' ' ARG . 3.0 tm-20 -107.8 128.09 54.29 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.046 -175.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.612 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -111.24 107.64 17.01 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.81 168.4 23.95 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.612 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -162.88 152.17 15.21 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.485 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.649 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -122.46 121.06 35.72 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.61 117.4 30.2 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.283 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -111.09 158.9 18.33 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.732 HG21 ' HA ' ' A' ' 112' ' ' GLU . 5.0 p -103.79 156.41 5.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 23' ' ' ARG . 3.0 mtp180 -104.66 140.74 37.6 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -63.39 -22.22 66.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.612 0.72 . . . . 0.0 109.342 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -140.93 107.91 6.35 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.483 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.523 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.8 Cg_exo -49.23 156.88 2.2 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.301 2.667 . . . . 0.0 112.816 174.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -79.36 -173.5 3.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.658 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -42.43 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 122.625 0.37 . . . . 0.0 111.349 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -75.32 2.2 11.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.079 0.466 . . . . 0.0 111.144 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.61 29.33 65.81 Favored Glycine 0 CA--C 1.507 -0.466 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.64 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -86.8 129.43 34.88 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.523 HG22 ' HG3' ' A' ' 26' ' ' PRO . 59.9 p -91.51 -20.12 22.06 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.105 -168.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.0 m80 -122.12 145.85 47.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -172.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -121.81 123.81 42.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -126.22 143.31 51.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.196 0.522 . . . . 0.0 110.96 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.595 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 45.5 ttp -120.27 117.29 27.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.515 174.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 9.9 m -98.96 153.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.342 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.4 p90 -153.63 153.98 33.34 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -124.73 131.12 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.322 168.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.67 175.02 14.61 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.861 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.509 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -81.88 -176.44 51.15 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.296 -168.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 11.8 Cg_exo -63.01 112.19 1.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.981 2.454 . . . . 0.0 111.702 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 52.02 52.58 14.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.671 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.0 t60 80.3 -3.47 1.91 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.701 171.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.481 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 49.9 m -58.58 123.42 16.22 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -58.11 127.12 30.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.652 0.263 . . . . 0.0 111.078 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.56 HD12 HG21 ' A' ' 51' ' ' VAL . 5.6 pt -97.7 -1.98 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -66.51 -4.49 8.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.815 0.34 . . . . 0.0 111.003 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -71.35 -34.38 70.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.755 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -120.68 -17.5 7.99 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.555 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 47' ' ' ILE . 91.4 t -89.75 128.48 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.921 0.391 . . . . 0.0 110.487 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.87 -62.38 1.27 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.366 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -145.66 153.56 41.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 55' ' ' VAL . 91.5 t -128.0 158.16 39.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.914 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.637 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.7 p -142.11 134.13 26.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.14 0.495 . . . . 0.0 111.246 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 22.7 m-85 -115.86 107.29 14.83 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -77.94 94.33 4.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.925 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.599 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.4 mt -75.29 -177.7 3.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.845 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.505 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 68.7 t60 -73.97 138.89 44.46 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -54.97 -24.55 24.5 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.022 -170.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 t -69.3 -19.17 63.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.188 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 21.0 m-85 -77.95 139.6 61.71 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.7 0.286 . . . . 0.0 110.994 -176.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.35 119.9 6.81 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.066 2.51 . . . . 0.0 111.11 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 59.45 67.39 1.87 Allowed Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.45 -170.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.15 -20.25 50.06 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.591 2.194 . . . . 0.0 113.006 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -95.66 102.26 14.04 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.143 0.497 . . . . 0.0 110.488 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -98.75 94.23 6.51 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.516 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -79.52 135.21 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 172.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 m -127.95 114.56 17.3 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -106.66 -24.53 12.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.674 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.626 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 5.9 p-10 -68.51 -174.87 0.22 Allowed Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.397 1.079 . . . . 0.0 111.347 -175.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.631 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 4.2 Cg_exo -40.61 -167.63 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 124.231 3.287 . . . . 0.0 114.552 167.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.657 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 Cg_endo -39.68 124.49 1.33 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.626 2.217 . . . . 0.0 113.097 -155.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 46.7 m-85 -62.5 95.75 0.07 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.187 -175.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.657 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 4.8 ptpt -141.4 145.88 35.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.453 0.644 . . . . 0.0 112.251 -176.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 36' ' ' MET . 92.7 t -125.33 131.29 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.827 177.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -115.43 110.55 19.49 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -133.62 170.18 15.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.067 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.0 t -121.96 142.72 50.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.708 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.62 -168.5 21.71 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.125 -0.559 . . . . 0.0 111.892 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -135.8 -11.92 2.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.178 0.489 . . . . 0.0 111.651 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.63 132.73 20.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.914 0.388 . . . . 0.0 110.567 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.67 171.5 51.79 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.14 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -169.51 155.38 6.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 106' ' ' ASP . 23.3 mm -63.21 126.45 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.982 172.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.599 HD11 ' CD2' ' A' ' 58' ' ' LEU . 5.6 tt -117.74 104.29 49.43 Favored Pre-proline 0 N--CA 1.444 -0.727 0 CA-C-O 121.22 0.533 . . . . 0.0 110.378 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.543 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 24.7 Cg_exo -65.47 108.48 1.21 Allowed 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 123.85 3.034 . . . . 0.0 112.384 172.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -101.49 124.47 55.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.26 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.637 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.5 mt-10 -108.17 127.49 53.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.095 0.474 . . . . 0.0 109.867 175.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.7 t -108.0 119.83 58.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.69 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.528 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 96.8 m-85 -93.24 138.55 31.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.583 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.416 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.9 m-85 -112.25 149.5 32.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.206 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.48 92.25 9.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.372 0.606 . . . . 0.0 109.946 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.539 ' HB3' ' HG3' ' A' ' 99' ' ' ARG . 50.9 t30 -158.13 156.69 31.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.668 -174.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -113.33 8.56 18.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.288 0.566 . . . . 0.0 111.013 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.515 ' HB2' HD21 ' A' ' 94' ' ' ASN . 0.4 OUTLIER -100.59 -152.29 0.42 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.236 -175.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.508 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 16.9 mm-40 -33.39 155.04 0.04 OUTLIER Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.133 0.973 . . . . 0.0 112.892 173.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 1.3 Cg_endo -37.88 122.44 0.51 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 124.566 3.511 . . . . 0.0 114.055 -168.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.539 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -95.62 20.18 10.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.412 -174.291 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.75 137.6 26.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.272 0.558 . . . . 0.0 111.01 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.0 OUTLIER -125.93 156.79 36.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.576 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.543 ' HE ' ' HB3' ' A' ' 87' ' ' PRO . 29.3 ttt180 -131.26 115.77 16.74 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.417 0.627 . . . . 0.0 110.8 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.612 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.8 m-85 -107.53 114.31 28.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.048 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.75 102.97 5.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.317 0.579 . . . . 0.0 109.636 176.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -114.08 127.29 55.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.287 0.565 . . . . 0.0 110.662 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.421 ' HA ' HD13 ' A' ' 85' ' ' ILE . 11.8 t70 -80.4 104.47 10.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.931 -177.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.529 HD11 HG11 ' A' ' 37' ' ' VAL . 1.8 mp -82.8 109.34 16.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 174.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.481 ' CE1' HG11 ' A' ' 117' ' ' VAL . 54.4 p90 -124.64 160.55 28.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.444 0.64 . . . . 0.0 111.054 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.3 mt -135.76 156.57 48.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.418 ' O ' ' NE2' ' A' ' 33' ' ' HIS . 55.3 m170 -101.6 171.23 7.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.58 173.2 3.53 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.55 0.614 . . . . 0.0 112.262 -174.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.732 ' HA ' HG21 ' A' ' 22' ' ' VAL . 12.8 mt-10 . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 120.963 0.411 . . . . 0.0 110.888 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 30.1 t . . . . . 0 CA--C 1.513 -0.449 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -133.48 97.77 4.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.964 0.411 . . . . 0.0 110.12 -173.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -125.22 130.37 51.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.774 -173.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.3 mt -118.45 140.74 49.39 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.548 0.53 . . . . 0.0 110.397 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 22.2 ttm180 -131.37 132.34 44.35 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 120.519 0.199 . . . . 0.0 111.203 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 57.3 m -110.13 110.62 21.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.938 0.399 . . . . 0.0 110.708 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 22.5 mm-40 -97.65 159.52 14.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.578 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -120.28 133.59 55.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.213 0.53 . . . . 0.0 111.337 -177.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.826 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.8 mt -107.44 120.4 42.08 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.15 175.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.3 m -110.89 123.18 49.61 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.658 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -120.31 102.42 8.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.893 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -78.98 125.34 29.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.459 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 56.88 63.0 5.63 Favored Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.871 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.496 ' HG3' HG23 ' A' ' 10' ' ' VAL . 71.6 Cg_endo -81.89 165.37 17.57 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.47 2.114 . . . . 0.0 111.675 177.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.45 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 13.4 p -68.1 143.21 55.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 174.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -57.79 -42.24 83.74 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.23 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -63.11 -25.93 68.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.622 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.612 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.3 t80 -73.43 -38.23 65.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.61 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 35.2 ttm180 -56.1 -45.57 79.41 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 173.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -55.06 -38.08 67.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.622 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.503 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 46.5 mtpt -72.35 -41.52 66.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.758 0.313 . . . . 0.0 110.763 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.0 mt -70.65 -32.87 70.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.065 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 50.8 mt -74.97 -33.89 61.95 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -73.97 -28.66 61.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.493 175.776 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.37 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.69 173.76 3.41 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.402 2.068 . . . . 0.0 112.453 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.961 -178.702 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' HA2' ' SD ' ' A' ' 4' ' ' MET . . . . . . . . 0 N--CA 1.483 1.798 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -63.07 110.11 1.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.749 0.309 . . . . 0.0 111.024 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.1 t60 62.07 22.75 13.33 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.774 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.491 ' SD ' ' HA2' ' A' ' 1' ' ' GLY . 68.3 mtt -93.87 -23.82 17.97 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.008 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.35 156.09 17.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.626 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.8 t -78.54 76.79 5.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.372 0.606 . . . . 0.0 109.751 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.6 m -126.06 133.63 51.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.907 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.9 m -96.12 113.51 25.12 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.12 139.2 48.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.664 0.269 . . . . 0.0 111.387 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.491 HG23 ' HG3' ' A' ' 130' ' ' PRO . 6.6 t -105.28 142.07 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.98 124.13 41.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.869 0.366 . . . . 0.0 110.454 -177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.834 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -113.73 178.79 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.184 178.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 122' ' ' CYS . 16.2 tttp -145.51 135.8 23.98 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.94 151.95 39.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 41.7 tt0 -117.47 124.38 48.64 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.4 -176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -107.14 118.06 35.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 174.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -146.96 169.9 27.96 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.899 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -164.12 146.21 8.99 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 120.94 0.4 . . . . 0.0 110.43 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -117.48 134.96 54.27 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 173.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -122.94 117.17 24.91 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.933 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -110.54 150.5 28.84 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.703 HG21 ' HA ' ' A' ' 112' ' ' GLU . 1.8 p -103.62 161.6 4.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.1 mtp180 -110.33 146.86 35.0 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -76.12 -14.26 60.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 109.049 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -141.31 103.97 6.04 Favored Pre-proline 0 N--CA 1.447 -0.617 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.047 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.564 ' HG3' HG22 ' A' ' 32' ' ' THR . 82.0 Cg_exo -47.72 156.04 1.34 Allowed 'Trans proline' 0 CA--C 1.532 0.391 0 C-N-CA 123.375 2.717 . . . . 0.0 113.049 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -77.7 -170.4 1.83 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.379 -173.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 m -61.68 -31.24 50.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.892 0.377 . . . . 0.0 111.297 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -86.43 3.38 44.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.742 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.97 29.38 69.15 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.391 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -89.56 133.93 34.37 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.564 HG22 ' HG3' ' A' ' 26' ' ' PRO . 36.6 p -90.07 -24.22 21.21 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.323 -171.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.469 ' O ' ' HA ' ' A' ' 79' ' ' SER . 63.3 m80 -118.7 150.04 40.41 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -170.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -129.6 119.54 23.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.411 ' HH2' HD22 ' A' ' 58' ' ' LEU . 42.9 p-90 -121.13 146.34 46.85 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.039 0.447 . . . . 0.0 110.676 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.576 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 24.2 ttp -122.85 109.82 14.65 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.482 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.595 HG11 HD11 ' A' ' 107' ' ' LEU . 11.8 m -94.52 150.05 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.463 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.506 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 0.3 OUTLIER -151.8 156.03 39.4 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.313 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 7.8 m -122.05 124.95 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.632 168.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 40' ' ' ARG . 3.1 mmp_? -126.63 178.12 6.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.098 -173.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.55 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -96.87 177.93 33.17 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.308 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.605 ' HD2' ' OG ' ' A' ' 45' ' ' SER . 13.0 Cg_exo -63.18 113.8 2.2 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.406 2.071 . . . . 0.0 111.27 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 61.3 46.04 8.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.253 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 65.37 16.4 10.51 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.605 ' OG ' ' HD2' ' A' ' 42' ' ' PRO . 60.6 p -67.87 139.88 56.52 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 174.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -68.89 125.29 26.16 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.55 HG23 ' HA3' ' A' ' 41' ' ' GLY . 3.4 pt -96.74 -0.88 10.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -172.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.68 -4.65 4.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -76.07 -34.9 59.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.554 0.216 . . . . 0.0 110.85 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.422 ' CE2' HG22 ' A' ' 47' ' ' ILE . 51.0 p90 -115.71 -17.65 11.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.297 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.539 HG21 HD12 ' A' ' 47' ' ' ILE . 86.8 t -91.92 122.7 43.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.213 0.53 . . . . 0.0 110.095 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 5.7 tp10 -89.21 -58.01 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.592 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 15.4 tttt -152.45 152.72 32.32 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.743 -175.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 95.4 t -130.82 156.9 43.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.3 p -140.67 138.04 35.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.179 0.514 . . . . 0.0 111.105 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 17.6 m-85 -120.41 110.7 16.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.5 94.35 7.45 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.86 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.549 ' CD2' HD11 ' A' ' 86' ' ' LEU . 9.0 mt -79.38 -177.15 5.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.759 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -80.27 145.38 32.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -56.88 -20.18 21.7 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.38 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 m -67.2 -21.73 65.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.117 0.484 . . . . 0.0 110.829 176.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -81.81 135.39 48.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.89 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -58.4 117.96 4.76 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.342 2.028 . . . . 0.0 110.812 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 60.5 80.87 0.25 Allowed Pre-proline 0 C--O 1.226 -0.182 0 O-C-N 123.665 0.603 . . . . 0.0 110.114 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.93 -22.71 64.37 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.615 2.21 . . . . 0.0 113.216 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.477 ' HE2' ' CG1' ' A' ' 68' ' ' VAL . 78.6 tttt -100.6 109.54 21.63 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.194 0.521 . . . . 0.0 110.855 -176.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 22.5 mmt85 -108.64 104.72 14.08 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.69 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 2.8 m -97.25 136.67 27.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 172.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.7 m -120.5 110.76 16.86 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.024 0.44 . . . . 0.0 110.09 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -99.69 -25.04 14.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.562 176.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.555 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 8.1 t70 -66.87 173.06 2.76 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.351 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.659 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 60.1 Cg_exo -30.22 -167.06 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.953 1 C-N-CA 125.322 4.014 . . . . 0.0 115.365 159.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.3 Cg_endo -32.19 121.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 123.408 2.739 . . . . 0.0 114.761 -154.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 31.8 m-85 -65.9 91.73 0.15 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.622 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 0.4 OUTLIER -148.73 148.16 29.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.541 0.686 . . . . 0.0 112.043 -178.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 36' ' ' MET . 94.2 t -118.92 129.23 75.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.239 176.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -117.18 101.6 8.59 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.42 170.55 15.32 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.983 -174.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 7.4 t -120.87 144.68 48.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.972 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.52 -161.98 12.9 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -138.32 -14.91 1.29 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.335 0.567 . . . . 0.0 112.341 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.446 ' HB3' ' HE3' ' B' ' 218' ' ' ALY . . . -142.25 146.46 35.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.91 0.386 . . . . 0.0 111.158 -175.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.431 ' O ' ' HD2' ' B' ' 217' ' ' ARG . . . -86.08 170.15 42.95 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.52 -0.764 . . . . 0.0 113.045 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -170.58 159.71 6.89 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 122.566 0.346 . . . . 0.0 110.252 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.447 HG12 HH22 ' B' ' 217' ' ' ARG . 14.8 mm -68.24 119.48 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.549 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.8 tt -112.94 105.04 55.98 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.617 -178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.15 120.6 7.3 Favored 'Trans proline' 0 C--O 1.239 0.541 0 C-N-CA 122.823 2.349 . . . . 0.0 112.299 175.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.5 mt -108.48 129.47 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.318 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.54 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.7 mt-10 -114.58 122.24 45.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.143 0.497 . . . . 0.0 110.086 176.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.6 t -102.69 123.22 55.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.804 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 93.9 m-85 -95.33 138.94 32.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.641 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -113.13 161.04 17.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.527 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -108.09 91.6 3.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.467 0.651 . . . . 0.0 110.543 -179.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.515 ' OD1' ' HB2' ' A' ' 96' ' ' GLU . 15.8 t-20 -159.57 167.7 27.9 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.842 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.588 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -113.58 9.07 17.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.515 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 3.1 mp0 -99.6 -152.95 0.43 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 14.3 mm-40 -32.43 152.37 0.04 OUTLIER Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 124.192 0.997 . . . . 0.0 113.027 174.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.8 Cg_endo -44.21 117.74 1.43 Allowed 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.136 3.224 . . . . 0.0 113.499 -168.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 97' ' ' GLU . 0.1 OUTLIER -87.45 20.76 2.73 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.133 -172.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.2 139.16 48.24 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.395 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.531 HG21 ' CE2' ' A' ' 103' ' ' PHE . 1.6 m -116.91 156.97 18.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.951 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -130.04 107.04 9.04 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.929 0.395 . . . . 0.0 110.32 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.672 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.5 m-85 -108.18 119.96 40.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.345 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -84.26 114.72 22.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.08 0.467 . . . . 0.0 109.81 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -126.31 133.8 51.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.661 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -88.3 115.98 26.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.802 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.595 HD11 HG11 ' A' ' 37' ' ' VAL . 2.5 mp -88.82 95.05 10.14 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 176.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -104.92 154.99 19.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.212 0.529 . . . . 0.0 111.57 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 mt -137.42 163.63 30.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.986 -173.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.725 ' CE1' ' HA ' ' A' ' 116' ' ' PRO . 17.9 p-80 -99.77 167.74 10.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.54 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.572 ' O ' ' HD2' ' A' ' 110' ' ' HIS . 1.0 OUTLIER -68.18 147.04 52.81 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 173.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.703 ' HA ' HG21 ' A' ' 22' ' ' VAL . 4.5 tt0 -54.75 100.81 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.796 0.438 . . . . 0.0 110.349 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.63 30.4 4.34 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.838 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -135.63 153.14 77.32 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.057 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -27.64 127.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 124.155 3.237 . . . . 0.0 114.95 173.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.725 ' HA ' ' CE1' ' A' ' 110' ' ' HIS . 39.6 Cg_endo -66.98 -179.11 1.56 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.775 2.984 . . . . 0.0 112.489 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 58.0 t -122.03 126.92 75.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.488 -172.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -138.0 96.71 3.26 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -122.12 125.78 46.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.852 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.1 mt -113.26 150.52 32.32 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.858 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.508 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.7 ttt180 -144.93 142.71 30.08 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 60.9 m -128.88 116.13 18.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.895 0.378 . . . . 0.0 111.193 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -111.64 135.12 52.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.311 -176.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -90.83 136.38 33.1 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.198 0.523 . . . . 0.0 111.562 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.834 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.0 mt -106.87 124.69 49.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 172.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 20.2 m -120.55 124.15 44.64 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.209 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -120.86 112.82 19.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.585 -176.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -85.57 127.9 34.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.007 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 56.75 58.16 8.47 Favored Pre-proline 0 N--CA 1.47 0.535 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.493 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HG3' HG23 ' A' ' 10' ' ' VAL . 95.5 Cg_endo -84.51 166.13 12.17 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.455 2.104 . . . . 0.0 111.694 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.1 p -73.21 145.09 46.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.766 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -54.34 -42.37 70.14 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.507 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.511 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.1 p-10 -57.22 -33.04 67.12 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.651 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 11.0 t80 -75.73 -40.16 56.03 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.621 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 37.2 ttm180 -56.96 -45.29 82.95 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -56.43 -34.76 67.12 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.34 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.511 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 36.2 mtpt -75.2 -41.33 58.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.812 176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.1 mt -69.33 -27.06 65.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 44.0 mt -83.99 -35.69 23.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.318 . . . . 0.0 110.937 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -70.59 -30.49 67.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.732 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.547 -0.74 . . . . 0.0 110.373 176.711 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -149.74 80.71 0.2 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.082 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -149.77 -168.62 3.16 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.492 ' HA ' HD22 ' A' ' 111' ' ' LEU . . . -59.42 160.23 13.98 Favored Pre-proline 0 C--O 1.235 0.314 0 O-C-N 123.083 0.239 . . . . 0.0 111.121 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.44 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 10.5 Cg_endo -53.7 165.59 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.562 2.175 . . . . 0.0 112.472 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.447 HH22 HG12 ' A' ' 85' ' ' ILE . 6.2 tpt180 -143.11 128.68 19.12 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.86 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . 0.446 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.533 ' OE1' ' HA ' ' B' ' 222' ' ' THR . 8.6 pt20 -62.56 153.09 33.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.507 -176.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.43 HD22 ' N ' ' B' ' 220' ' ' LEU . 3.0 mm? -76.99 -29.02 55.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.398 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.409 ' HB1' ' HB3' ' B' ' 224' ' ' ALA . . . -139.17 116.24 11.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.931 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.533 ' HA ' ' OE1' ' B' ' 219' ' ' GLN . 25.6 m -71.6 106.38 4.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.442 -175.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt 58.6 43.26 19.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.687 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . 0.409 ' HB3' ' HB1' ' B' ' 221' ' ' ALA . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.978 -0.534 . . . . 0.0 110.222 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 m -80.6 124.7 29.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.898 0.38 . . . . 0.0 110.485 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -85.72 38.84 0.77 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.303 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.6 ttm -83.34 -24.56 32.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.965 0.412 . . . . 0.0 110.144 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.22 -53.19 11.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.199 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.6 p -86.22 76.76 9.68 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 t -107.26 110.02 21.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.307 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.6 t -158.16 117.17 3.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.87 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.66 128.19 56.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.852 0.358 . . . . 0.0 111.447 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.413 HG23 ' HG3' ' A' ' 130' ' ' PRO . 9.6 t -100.17 138.85 23.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 6.4 mp0 -125.7 119.86 29.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.936 0.398 . . . . 0.0 110.443 -174.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.808 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.56 -179.74 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.888 178.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 36.0 ttpt -151.31 123.28 8.13 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.849 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.443 ' HG ' HD11 ' A' ' 125' ' ' LEU . 84.8 mt -106.66 145.57 31.81 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.313 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 3.5 tt0 -105.01 126.55 52.19 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.144 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.657 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -112.54 114.52 27.21 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -140.9 171.05 24.28 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.842 -1.171 . . . . 0.0 111.728 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -162.97 146.01 10.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.512 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -118.81 132.03 56.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.709 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.631 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -130.56 131.35 44.98 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.468 0.651 . . . . 0.0 111.271 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 3.8 tt0 -129.6 155.08 46.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.904 -1.498 . . . . 0.0 108.229 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.899 HG11 ' H ' ' A' ' 113' ' ' GLY . 2.8 p -101.85 153.45 5.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 23' ' ' ARG . 1.1 mtp180 -102.57 135.48 44.12 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.462 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 20.3 tptt -75.75 -5.54 46.25 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.613 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -133.87 99.78 13.68 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.079 168.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.483 ' HG3' HG22 ' A' ' 32' ' ' THR . 83.1 Cg_exo -50.98 156.57 4.69 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 123.02 2.48 . . . . 0.0 111.868 175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 31' ' ' PHE . 10.2 t -78.79 -172.67 3.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.091 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.4 m -60.09 -31.66 48.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.928 0.394 . . . . 0.0 111.237 -174.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -86.73 4.29 41.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.11 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.42 32.5 68.13 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.171 -0.538 . . . . 0.0 112.253 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.459 ' HB2' HG22 ' A' ' 27' ' ' THR . 17.7 m-30 -90.72 127.19 36.23 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.483 HG22 ' HG3' ' A' ' 26' ' ' PRO . 36.1 p -87.52 -29.91 20.98 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -170.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 79' ' ' SER . 67.1 m80 -115.47 142.29 46.91 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -112.27 123.83 51.12 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.445 ' CZ2' ' HB3' ' A' ' 78' ' ' GLU . 54.2 p-90 -127.6 147.27 50.35 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.135 0.493 . . . . 0.0 110.889 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.638 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 51.7 ttp -123.6 122.64 38.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.459 174.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.57 ' CG2' ' HB ' ' A' ' 76' ' ' VAL . 10.2 m -102.5 152.21 5.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.588 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -153.27 152.04 30.71 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.951 -0.7 . . . . 0.0 112.812 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.0 m -122.76 125.99 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.703 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -134.65 -178.92 5.29 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.221 -174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.502 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -94.02 -173.84 39.22 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 175.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 1.4 Cg_endo -81.57 111.37 2.3 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.235 1.957 . . . . 0.0 112.693 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 58.7 70.18 0.67 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 71.74 -11.12 0.77 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.26 0.624 . . . . 0.0 112.344 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.5 ' HB3' ' OXT' ' A' ' 141' ' ' ALA . 19.9 m -66.92 120.67 13.98 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -69.86 127.16 31.92 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 120.881 0.372 . . . . 0.0 110.271 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.556 HD12 HG21 ' A' ' 51' ' ' VAL . 1.2 pt -90.5 -3.47 10.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.569 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -65.74 -0.87 2.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.891 0.377 . . . . 0.0 111.552 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -74.29 -39.87 62.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.221 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.407 ' CE2' HG22 ' A' ' 47' ' ' ILE . 53.5 p90 -113.61 -20.27 11.28 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.94 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.556 HG21 HD12 ' A' ' 47' ' ' ILE . 52.5 t -93.38 135.77 27.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.781 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 93' ' ' LYS . 8.4 tp10 -111.91 -60.87 1.79 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.172 0.511 . . . . 0.0 110.711 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.665 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 6.7 tttm -138.24 146.92 43.16 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.253 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 98.1 t -127.01 159.21 37.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.566 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.8 p -141.85 136.2 30.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.299 0.571 . . . . 0.0 111.574 -174.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.483 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 22.0 m-85 -119.06 105.6 11.58 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -77.53 87.92 3.86 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.015 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.5 mt -71.38 -176.46 1.52 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.825 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -76.32 140.29 41.41 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -59.39 -19.55 47.92 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.021 -174.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -58.94 -27.27 65.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.743 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -85.47 131.64 47.24 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.084 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.95 121.5 10.12 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.668 2.246 . . . . 0.0 111.554 175.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 64' ' ' ARG . 16.5 mtm180 55.79 67.24 3.06 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.512 -176.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.36 -17.46 60.18 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.189 2.592 . . . . 0.0 113.52 -172.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -86.23 101.62 13.2 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.141 0.496 . . . . 0.0 110.228 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 22.0 mmt180 -98.42 107.83 20.39 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.68 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -99.05 136.19 31.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.1 m -120.6 113.56 20.43 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.295 0.569 . . . . 0.0 110.316 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -102.75 -24.55 13.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.614 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.527 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 13.8 t70 -68.0 170.12 8.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.623 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.639 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.2 Cg_exo -32.71 -178.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.568 1 C-N-CA 125.346 4.031 . . . . 0.0 114.865 164.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.639 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.7 Cg_endo -28.29 119.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 124.292 3.328 . . . . 0.0 113.942 -157.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.588 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 51.2 m-85 -60.1 98.66 0.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.59 -171.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.638 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 10.7 ptpt -140.18 150.42 44.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.438 0.637 . . . . 0.0 112.171 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 36' ' ' MET . 81.1 t -126.87 130.83 71.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.604 175.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -114.81 109.88 18.84 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.835 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.445 ' HB3' ' CZ2' ' A' ' 35' ' ' TRP . 1.9 tp10 -135.31 174.45 10.59 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -177.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.3 t -128.45 143.8 51.04 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.2 -170.62 26.09 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.884 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -130.36 -11.42 4.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.263 0.531 . . . . 0.0 112.066 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.515 ' HB3' ' HE3' ' B' ' 218' ' ' ALY . . . -148.84 139.3 22.55 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.434 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.518 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -75.5 176.45 50.37 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.355 -0.838 . . . . 0.0 113.361 -176.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -172.41 158.29 4.28 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.44 HG12 HD21 ' B' ' 220' ' ' LEU . 23.2 mm -65.44 126.27 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.329 . . . . 0.0 110.522 173.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.512 HD22 HG13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -111.23 104.64 56.4 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.86 111.14 2.96 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.708 2.272 . . . . 0.0 111.826 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.512 HG13 HD22 ' A' ' 86' ' ' LEU . 4.9 mt -104.43 125.69 59.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.43 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.566 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 54.4 mt-10 -111.45 123.64 50.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.171 0.51 . . . . 0.0 110.039 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 72.4 t -103.79 122.42 56.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.112 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.665 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 75.7 m-85 -94.63 132.42 39.38 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 112.005 -176.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.499 ' HE1' HG22 ' A' ' 51' ' ' VAL . 18.9 m-85 -114.38 164.07 14.44 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.079 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.462 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -107.9 100.48 9.84 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 122.327 -0.233 . . . . 0.0 111.479 175.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -158.28 178.18 10.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.742 171.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.52 -1.11 15.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.756 -178.338 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -100.62 -153.12 0.44 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.092 -176.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -29.56 152.74 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.395 1.078 . . . . 0.0 113.907 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -32.89 122.46 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 125.03 3.82 . . . . 0.0 114.2 -171.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.9 19.5 2.09 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.697 -176.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -150.09 144.56 25.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.276 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.13 157.21 28.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 102' ' ' ARG . 11.6 ttt180 -129.08 108.69 10.58 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.8 m-85 -104.66 120.44 41.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.189 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -83.83 111.61 19.36 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -124.94 127.28 46.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.317 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -78.82 121.81 25.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.952 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.528 HD11 ' CG1' ' A' ' 37' ' ' VAL . 1.5 mp -94.53 91.66 6.71 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 175.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.538 ' CE2' HG13 ' A' ' 117' ' ' VAL . 37.8 p90 -100.11 160.14 14.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.04 0.448 . . . . 0.0 110.845 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.9 mt -134.26 155.9 49.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.406 ' O ' ' NE2' ' A' ' 33' ' ' HIS . 1.4 m-70 -101.05 175.53 5.57 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 122.329 -0.232 . . . . 0.0 111.043 176.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -65.89 139.01 58.24 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.665 ' HA ' HG21 ' A' ' 22' ' ' VAL . 1.5 tm-20 -50.74 117.9 2.77 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.898 173.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.899 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 122.68 -50.23 0.85 Allowed Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.633 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -144.22 75.43 15.4 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 117.293 0.546 . . . . 0.0 110.615 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.563 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 60.8 Cg_endo -108.35 109.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 123.185 2.59 . . . . 0.0 114.004 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -98.25 97.88 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.264 0 C-N-CA 122.31 2.007 . . . . 0.0 111.016 166.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.631 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 4.7 t -119.17 102.54 13.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.9 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -141.93 97.98 3.24 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -122.45 130.75 53.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.04 -175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.8 mt -114.83 155.58 26.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.379 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 23.2 ttm180 -144.9 145.45 31.58 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 175.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 61.3 m -127.56 110.37 12.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.02 0.438 . . . . 0.0 110.768 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.438 ' HG3' HD23 ' A' ' 16' ' ' LEU . 2.5 mm-40 -107.21 125.84 51.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.27 -174.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -81.9 135.49 35.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.194 0.521 . . . . 0.0 111.431 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.808 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.2 mt -103.38 114.8 29.36 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 171.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.4 m -107.15 115.64 30.53 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.989 0.423 . . . . 0.0 110.902 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -115.39 106.22 13.74 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.036 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -81.6 118.52 22.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.82 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 62.43 67.51 1.17 Allowed Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.147 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.413 ' HG3' HG23 ' A' ' 10' ' ' VAL . 60.7 Cg_endo -89.81 175.47 3.07 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.093 2.528 . . . . 0.0 111.881 174.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.3 p -84.31 147.05 27.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -52.41 -42.15 63.81 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.173 0.442 . . . . 0.0 112.147 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 6.4 p-10 -56.36 -32.02 64.35 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.796 0.332 . . . . 0.0 110.29 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.708 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.8 t80 -76.96 -42.74 37.86 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.677 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 38.0 ttm180 -54.74 -46.27 74.27 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -52.4 -42.8 64.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.381 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 36.1 mtpt -73.31 -38.98 65.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.853 0.358 . . . . 0.0 110.896 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 36.7 mt -70.02 -26.26 63.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.986 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.2 mt -83.58 -32.84 25.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.785 0.326 . . . . 0.0 110.923 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.0 ttpt -75.77 -26.38 57.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.308 -176.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.5 ' OXT' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.778 -0.63 . . . . 0.0 110.466 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 112.069 -0.413 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -109.74 -30.6 3.44 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.137 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -83.65 123.84 30.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.76 0.314 . . . . 0.0 110.645 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.444 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -67.5 164.33 39.3 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.296 177.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.444 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 5.0 Cg_endo -48.82 161.55 0.48 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.687 2.258 . . . . 0.0 112.551 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.518 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 5.1 tpp180 -142.04 129.87 21.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.05 -174.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . 0.515 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' B' ' 218' ' ' ALY . 61.1 tt0 71.51 -56.8 0.63 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.753 0.658 . . . . 0.0 111.048 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.44 HD21 HG12 ' A' ' 85' ' ' ILE . 6.4 mp -92.26 113.59 25.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.851 0.357 . . . . 0.0 110.435 178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.84 -67.26 0.82 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.9 m 54.98 44.0 28.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.312 0.577 . . . . 0.0 111.26 174.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.41 -1.09 31.46 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.465 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.21 179.551 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.1 m -81.01 -23.14 38.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.967 0.413 . . . . 0.0 110.482 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -92.98 78.82 4.63 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.3 mtp -87.99 15.38 7.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.715 -175.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.61 -14.72 62.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.279 0.561 . . . . 0.0 109.962 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.3 m -97.87 136.09 38.68 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.926 176.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.7 m -66.38 110.23 3.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.566 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.1 p -86.67 112.57 21.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.18 0.514 . . . . 0.0 110.809 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.47 135.34 53.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.269 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.475 HG23 ' HG3' ' A' ' 130' ' ' PRO . 3.2 t -105.28 138.23 31.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -124.96 127.4 46.98 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -176.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.826 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -115.17 164.65 11.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.273 178.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 37.8 mttp -129.23 131.51 47.08 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.411 HD13 HG11 ' A' ' 90' ' ' VAL . 90.4 mt -115.1 140.23 49.24 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.248 0.547 . . . . 0.0 109.786 174.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.597 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.5 tt0 -106.33 121.34 44.02 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.873 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.581 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -106.01 112.17 25.11 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 173.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.423 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -137.32 166.59 24.96 Favored Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.656 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -163.53 149.69 11.72 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.163 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.9 mtt180 -115.21 140.76 48.81 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.694 174.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.652 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -126.84 120.71 29.91 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.511 176.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -114.18 148.3 37.52 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 112' ' ' GLU . 2.4 p -103.39 161.21 4.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 171.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 23' ' ' ARG . 3.0 mtp180 -116.15 134.67 54.67 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -68.92 -12.85 62.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.434 0.635 . . . . 0.0 109.679 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -134.89 102.17 11.27 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.162 171.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.518 ' HG3' HG22 ' A' ' 32' ' ' THR . 98.4 Cg_exo -49.28 154.79 3.58 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.021 2.48 . . . . 0.0 112.054 175.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -78.23 -174.06 3.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.852 -170.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.523 HG22 ' OE1' ' A' ' 29' ' ' GLU . 1.9 m -66.31 -30.83 51.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.207 0.527 . . . . 0.0 110.48 -175.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.523 ' OE1' HG22 ' A' ' 28' ' ' VAL . 3.0 mp0 -76.24 -6.65 52.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.471 176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.08 34.29 38.07 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.478 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -102.56 136.54 42.2 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.518 HG22 ' HG3' ' A' ' 26' ' ' PRO . 47.4 p -92.78 -24.12 18.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.422 -169.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.435 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.0 m80 -121.11 144.63 48.46 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -171.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -119.15 125.45 49.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.1 p-90 -126.49 147.32 49.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.036 0.446 . . . . 0.0 110.834 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.57 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 37.2 ttp -125.53 115.24 19.9 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.759 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.578 HG11 HD11 ' A' ' 107' ' ' LEU . 14.2 m -97.32 150.0 4.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.817 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.2 p90 -150.98 155.8 39.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.3 m -126.05 129.03 72.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.343 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 40' ' ' ARG . 10.1 mmm180 -135.42 -176.9 4.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.332 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.496 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -89.38 -163.57 39.46 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.642 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.555 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 3.9 Cg_exo -71.91 109.85 2.77 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.17 1.913 . . . . 0.0 111.64 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 44' ' ' HIS . 28.9 mt-10 52.29 68.66 0.78 Allowed 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.342 177.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 22.2 m170 75.51 -6.76 1.91 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.455 0.702 . . . . 0.0 112.764 172.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.555 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 72.5 m -61.2 136.05 57.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.467 0.175 . . . . 0.0 111.311 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -73.44 126.68 30.74 Favored 'General case' 0 C--O 1.231 0.079 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.598 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.5 pt -97.27 -4.61 9.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -64.0 -0.43 1.13 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -77.66 -34.98 52.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.521 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.479 ' CE2' HG22 ' A' ' 47' ' ' ILE . 50.0 p90 -121.05 -16.88 7.94 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.727 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.598 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 77.8 t -94.26 126.02 46.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 9.5 tp10 -96.63 -57.88 2.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.444 0.64 . . . . 0.0 111.026 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 24.6 tttt -145.7 150.74 36.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.286 -175.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 88.9 t -131.28 158.1 43.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.435 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.597 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.2 p -141.71 138.42 31.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.266 0.555 . . . . 0.0 111.287 -175.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 18.1 m-85 -120.95 110.35 16.18 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -82.53 95.88 7.87 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.957 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.4 mt -78.17 -178.8 5.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.815 0.34 . . . . 0.0 110.151 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.45 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 18.9 t60 -85.43 151.2 24.17 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -175.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 1.6 mp0 -51.87 -28.33 15.7 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.619 -1.173 . . . . 0.0 113.797 -169.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.0 t -79.0 -6.2 55.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.867 0.365 . . . . 0.0 111.273 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -90.36 134.89 30.33 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.57 136.48 30.95 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.282 1.988 . . . . 0.0 109.727 175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 61.64 73.8 0.55 Allowed Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -172.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.47 -18.73 60.41 Favored 'Trans proline' 0 C--O 1.223 -0.233 0 C-N-CA 121.887 1.725 . . . . 0.0 112.656 -176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -110.37 106.76 16.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 120.678 0.275 . . . . 0.0 110.598 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.3 mmt85 -104.41 100.0 9.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.769 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -89.54 137.96 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.564 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 36.0 t -128.1 116.81 20.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.096 0.474 . . . . 0.0 110.116 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.2 mttp -106.55 -27.26 10.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.124 175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.665 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -71.42 -177.3 0.46 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.571 -175.166 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.665 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 13.5 Cg_exo -31.17 178.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 125.17 3.913 . . . . 0.0 114.862 163.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.63 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.8 Cg_exo -26.32 121.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.366 1.492 0 C-N-CA 124.797 3.665 . . . . 0.0 114.972 -157.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.564 ' HA ' ' SG ' ' A' ' 69' ' ' CYS . 34.2 m-85 -62.21 91.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.958 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -144.39 151.64 39.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.611 0.719 . . . . 0.0 112.676 179.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 36' ' ' MET . 93.8 t -123.47 129.14 74.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.282 -1.326 . . . . 0.0 109.631 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -114.38 112.99 23.93 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.35 173.31 11.61 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.839 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 3.2 t -121.11 145.93 47.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.139 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.16 -157.96 9.48 Favored Glycine 0 N--CA 1.453 -0.196 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -144.51 -17.48 0.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.82 140.75 31.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.999 0.428 . . . . 0.0 111.116 -176.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.89 169.81 55.03 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.276 -0.875 . . . . 0.0 113.773 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 59' ' ' HIS . 11.6 p90 -169.93 158.09 7.04 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.767 0.427 . . . . 0.0 110.059 -176.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.5 mm -67.18 126.14 26.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 120.609 0.243 . . . . 0.0 110.596 172.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.532 HD22 HG13 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -111.78 104.96 56.54 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.77 112.99 3.23 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.781 2.321 . . . . 0.0 112.088 171.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.532 HG13 HD22 ' A' ' 86' ' ' LEU . 6.3 mt -106.6 128.79 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.309 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.597 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 45.9 mt-10 -112.81 123.59 50.66 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.22 0.534 . . . . 0.0 109.964 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.411 HG11 HD13 ' A' ' 14' ' ' LEU . 57.5 t -104.84 118.88 52.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.747 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.588 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 89.3 m-85 -90.79 139.81 30.39 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.157 0.503 . . . . 0.0 111.245 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.418 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.0 m-85 -113.07 165.1 12.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.573 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -118.58 93.95 4.29 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.995 0.426 . . . . 0.0 112.001 -177.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.524 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 0.7 OUTLIER -160.48 -172.53 3.58 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.031 174.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 20.7 tptp -110.35 0.4 17.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.472 0.653 . . . . 0.0 111.23 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.409 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 6.5 mp0 -100.08 -155.71 0.52 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.145 -171.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.409 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 13.2 mm-40 -32.5 149.48 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.419 1.088 . . . . 0.0 113.536 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -30.22 125.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 125.205 3.936 . . . . 0.0 115.076 -164.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.524 ' HD3' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -82.01 18.96 1.21 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.83 -178.536 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -154.45 140.28 18.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.198 0.523 . . . . 0.0 110.941 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -120.31 157.35 22.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -128.25 107.64 9.94 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.657 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.581 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.6 m-85 -103.07 123.94 47.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.217 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -88.13 101.23 13.61 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.357 0.598 . . . . 0.0 110.147 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -110.18 132.27 54.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.769 -175.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.16 118.37 21.79 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.06 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.578 HD11 HG11 ' A' ' 37' ' ' VAL . 1.2 mp -95.2 91.29 6.22 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 175.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -102.22 156.88 17.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.219 0.533 . . . . 0.0 111.278 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 mt -134.47 163.9 28.65 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.2 -175.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.806 ' CD2' ' HA ' ' A' ' 116' ' ' PRO . 8.4 p80 -99.67 164.16 12.18 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.22 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.46 153.78 26.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.939 0.399 . . . . 0.0 111.145 174.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.713 ' HA ' HG21 ' A' ' 22' ' ' VAL . 8.7 tt0 -63.37 98.93 0.17 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.308 175.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.0 28.91 6.67 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.843 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.485 ' CG ' ' HD2' ' A' ' 115' ' ' PRO . 51.7 t-80 -136.23 148.72 65.56 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-O 118.348 -0.834 . . . . 0.0 108.788 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 114' ' ' HIS . 1.1 Cg_exo -24.49 113.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 124.684 3.589 . . . . 0.0 115.194 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.806 ' HA ' ' CD2' ' A' ' 110' ' ' HIS . 50.3 Cg_exo -55.48 -179.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 124.047 3.164 . . . . 0.0 114.51 175.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 69.0 t -122.47 130.17 74.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.992 -172.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.449 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.93 96.58 2.88 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 172.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -119.9 129.84 54.55 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.163 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.7 mt -108.11 149.34 28.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.547 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 15.6 ttt180 -140.73 137.93 33.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 85.8 m -120.09 116.58 25.97 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.157 0.504 . . . . 0.0 111.214 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 9.8 mm-40 -105.98 158.93 16.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.309 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -124.98 123.88 40.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.148 0.499 . . . . 0.0 111.387 -174.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.826 ' HB2' HG23 ' A' ' 12' ' ' VAL . 5.9 mt -98.31 122.04 40.99 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.797 176.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 9.0 m -113.84 122.4 46.93 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.922 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -120.9 107.66 12.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.447 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -83.24 124.32 30.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.125 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 51.72 67.71 3.89 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.337 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.475 ' HG3' HG23 ' A' ' 10' ' ' VAL . 83.4 Cg_endo -86.57 -179.27 2.97 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.947 2.431 . . . . 0.0 112.003 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 69.6 p -79.12 140.37 37.83 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -58.81 -33.19 70.09 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -174.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.2 p-10 -65.31 -30.97 71.88 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.631 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 18.7 t80 -74.3 -42.32 59.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.587 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.6 ttm180 -54.19 -45.51 72.17 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.929 173.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -55.23 -39.45 69.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.333 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 40.8 mtpt -69.95 -39.97 75.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.93 0.395 . . . . 0.0 110.421 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 41.7 mt -69.53 -31.77 70.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.72 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.6 mt -80.91 -31.39 35.13 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.188 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -76.99 -26.71 54.2 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.134 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.358 175.419 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 112.101 -0.4 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.55 -86.2 1.52 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.047 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -74.79 127.25 32.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.041 0.448 . . . . 0.0 110.836 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -63.6 165.37 12.14 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.888 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 10.0 Cg_endo -51.9 176.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.974 2.449 . . . . 0.0 112.96 175.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -142.87 143.77 32.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.717 -172.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -137.25 -52.1 0.66 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.269 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 26.5 tp 58.77 62.43 1.91 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.62 0.724 . . . . 0.0 110.648 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -82.51 74.48 9.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.739 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 11.3 t -143.17 17.44 1.91 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.77 0.795 . . . . 0.0 109.711 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -109.99 38.74 2.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.439 -176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.147 179.335 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -85.4 112.9 21.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.879 0.371 . . . . 0.0 110.105 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -141.33 30.04 1.77 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.182 0.515 . . . . 0.0 110.639 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -76.48 -13.86 60.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.521 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.84 -9.55 51.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.58 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.4 t -92.06 92.43 8.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.186 0.517 . . . . 0.0 109.957 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 m -82.49 109.25 16.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.91 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 56.5 m -93.79 110.63 22.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.902 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.82 140.84 32.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.943 0.402 . . . . 0.0 111.861 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.421 HG23 ' HG3' ' A' ' 130' ' ' PRO . 4.3 t -109.7 140.32 29.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 172.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 4.5 mp0 -128.57 118.75 23.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 120.874 0.369 . . . . 0.0 110.168 -175.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.874 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -107.03 170.21 2.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.174 179.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HE3' ' HB3' ' A' ' 42' ' ' PRO . 54.9 mtmt -137.07 133.86 35.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.739 0.304 . . . . 0.0 110.467 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.3 mt -114.66 142.16 46.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.002 175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.1 tt0 -103.48 123.48 46.98 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.712 -176.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.651 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.1 mm? -110.56 113.32 25.85 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -142.19 175.52 22.7 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.896 -1.145 . . . . 0.0 111.981 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -167.1 151.67 7.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.06 0.457 . . . . 0.0 110.859 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 80.9 mtt180 -116.5 151.84 35.3 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.946 171.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -144.28 134.4 24.18 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.419 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -132.6 160.73 35.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.214 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.947 HG11 ' H ' ' A' ' 113' ' ' GLY . 1.8 p -103.75 161.11 4.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 170.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.476 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 5.5 mtp85 -104.81 143.09 33.61 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -66.37 -19.05 65.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.59 0.709 . . . . 0.0 109.254 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -134.13 106.37 11.34 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.294 174.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.562 ' HG3' HG22 ' A' ' 32' ' ' THR . 99.0 Cg_exo -50.39 163.76 0.61 Allowed 'Trans proline' 0 N--CA 1.474 0.372 0 C-N-CA 123.109 2.539 . . . . 0.0 112.475 174.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 31' ' ' PHE . 8.9 t -82.88 -175.7 5.94 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.468 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.05 -30.96 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 120.782 0.325 . . . . 0.0 111.309 -173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -82.78 -0.28 47.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.037 0.446 . . . . 0.0 110.701 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.81 33.96 49.7 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.476 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.404 ' HB2' HG22 ' A' ' 27' ' ' THR . 20.3 m-30 -95.57 130.71 42.34 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 176.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.562 HG22 ' HG3' ' A' ' 26' ' ' PRO . 28.8 p -90.34 -30.98 17.1 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -170.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.458 ' O ' ' HA ' ' A' ' 79' ' ' SER . 62.7 m80 -112.19 146.21 38.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -170.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.476 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 6.1 m-20 -124.14 121.27 34.69 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 172.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.481 ' HH2' HD22 ' A' ' 58' ' ' LEU . 49.2 p-90 -122.52 150.22 42.85 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.645 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 46.0 ttp -125.59 118.06 24.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.612 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.9 m -100.02 150.15 5.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.263 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -151.13 154.69 37.43 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.6 m -124.15 127.97 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.833 170.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -132.08 -179.11 5.22 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.316 -174.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.5 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -97.11 -176.15 34.76 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.26 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.468 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 12.0 Cg_exo -68.8 111.7 2.69 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.768 2.312 . . . . 0.0 112.234 -179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 58.19 54.2 6.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.624 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 71.22 1.53 3.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.58 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 141' ' ' ALA . 49.7 m -63.11 128.23 34.89 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -68.96 128.22 35.92 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.042 0.449 . . . . 0.0 110.35 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.581 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.4 pt -94.66 -1.49 10.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.376 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -59.66 -3.69 0.53 Allowed 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.534 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 93.2 m-70 -82.27 -31.98 29.82 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.143 -0.348 . . . . 0.0 111.471 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.461 ' CE1' HG22 ' A' ' 47' ' ' ILE . 54.2 p90 -119.66 -20.03 7.84 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.413 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.581 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 65.8 t -90.54 131.32 38.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 9.0 tp10 -102.62 -60.24 1.57 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.434 0.635 . . . . 0.0 110.262 -176.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.59 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 20.6 tttt -144.61 149.95 36.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.135 -176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG21 HG21 ' A' ' 39' ' ' VAL . 94.6 t -128.55 157.69 41.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.58 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 9.1 p -141.41 133.39 28.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.299 0.571 . . . . 0.0 111.054 -174.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.474 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 30.5 m-85 -117.02 109.04 16.48 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -80.62 91.93 5.9 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.915 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.54 ' CD2' HD11 ' A' ' 86' ' ' LEU . 11.0 mt -73.93 -176.96 2.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.999 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -77.34 147.53 36.11 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -56.14 -19.35 13.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.931 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.05 -24.99 65.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.108 176.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -81.65 137.56 47.67 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.645 -175.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.73 118.03 5.14 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.462 2.108 . . . . 0.0 111.326 175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.1 mtp180 58.19 68.38 1.85 Allowed Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 123.521 0.513 . . . . 0.0 110.431 -173.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.54 -18.48 63.73 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.845 2.363 . . . . 0.0 113.391 -174.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -88.94 101.25 13.88 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 121.185 0.517 . . . . 0.0 110.13 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 18.7 mmt180 -97.71 98.35 9.79 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.345 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -83.49 136.34 22.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.599 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.8 m -131.41 109.01 10.01 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -106.18 -24.24 12.38 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.63 0.728 . . . . 0.0 110.336 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.678 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 2.7 t70 -70.41 179.9 0.77 Allowed Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.319 -177.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.678 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 16.6 Cg_exo -31.13 178.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.335 0 C-N-CA 125.245 3.963 . . . . 0.0 114.489 163.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.605 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.3 Cg_endo -29.64 124.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 124.332 3.355 . . . . 0.0 114.442 -154.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 36.7 m-85 -61.87 93.94 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.901 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -146.14 145.53 30.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.264 0.554 . . . . 0.0 111.889 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.0 t -125.19 131.6 72.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.059 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -115.97 110.37 18.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.752 0.311 . . . . 0.0 110.196 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -130.18 165.44 22.34 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.933 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 2.1 m -116.12 129.65 56.43 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.979 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.42 -160.7 9.17 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -136.37 -20.04 1.42 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.291 0.546 . . . . 0.0 111.451 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.481 ' HB3' ' HE3' ' B' ' 218' ' ' ALY . . . -139.7 142.99 36.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.853 0.359 . . . . 0.0 110.974 -174.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -78.88 174.55 55.25 Favored Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.58 -177.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -173.13 159.41 3.89 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.963 0.505 . . . . 0.0 110.131 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 106' ' ' ASP . 14.3 mm -68.07 125.5 25.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 172.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.54 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.1 tt -117.72 105.55 47.59 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.994 -177.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.99 114.07 3.25 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 123.227 2.618 . . . . 0.0 112.231 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.438 HG12 ' CD2' ' A' ' 56' ' ' PHE . 5.0 mt -104.6 126.37 59.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.09 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.58 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.2 mt-10 -112.53 124.34 52.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.238 0.542 . . . . 0.0 110.124 176.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.7 t -103.72 120.44 53.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.772 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.59 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 74.5 m-85 -90.06 139.1 30.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.967 0.413 . . . . 0.0 110.346 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.435 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.7 m-85 -111.36 146.32 37.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.8 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.1 OUTLIER -84.2 93.93 8.28 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.428 ' CG ' ' H ' ' A' ' 96' ' ' GLU . 62.4 t30 -155.98 159.33 39.12 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.372 0.606 . . . . 0.0 112.124 -171.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.504 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.76 -4.0 14.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.734 175.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.527 ' HG2' ' CG2' ' A' ' 131' ' ' THR . 0.4 OUTLIER -100.29 -153.92 0.46 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.42 -177.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 20.6 mm-40 -27.07 150.19 0.02 OUTLIER Pre-proline 0 N--CA 1.48 1.03 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 3.0 Cg_exo -32.5 126.43 0.11 Allowed 'Trans proline' 0 C--N 1.361 1.189 1 C-N-CA 125.316 4.011 . . . . 0.0 114.465 -167.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -85.7 19.5 2.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.246 -176.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.52 143.45 22.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.286 0.565 . . . . 0.0 111.159 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -126.93 154.79 37.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 174.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 24.3 ttt180 -121.18 121.85 38.7 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.001 0.429 . . . . 0.0 111.073 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.651 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.9 m-85 -113.86 117.7 32.17 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.923 174.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -78.61 111.89 15.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.188 0.518 . . . . 0.0 109.761 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -121.4 136.17 54.99 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.553 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.44 ' HA ' HD13 ' A' ' 85' ' ' ILE . 11.7 t70 -89.35 110.6 21.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.62 -176.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.504 HD11 HG11 ' A' ' 37' ' ' VAL . 1.5 mp -89.36 97.63 11.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.745 0.307 . . . . 0.0 110.199 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -104.33 155.65 18.58 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.014 0.435 . . . . 0.0 110.769 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.2 mt -130.76 152.46 50.08 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -101.82 168.82 9.19 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.875 -0.515 . . . . 0.0 111.191 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -53.61 134.81 41.25 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -172.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.579 ' HA ' HG21 ' A' ' 22' ' ' VAL . 35.5 tt0 -49.48 118.43 2.75 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.221 172.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.947 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 123.75 -50.38 0.85 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.458 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -144.77 74.44 14.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 117.46 0.63 . . . . 0.0 111.791 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.495 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 58.1 Cg_endo -108.99 109.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.983 2.456 . . . . 0.0 113.864 176.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -98.17 97.54 0.07 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.967 2.445 . . . . 0.0 111.093 168.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 37.5 t -117.14 112.19 38.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.719 -177.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.491 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -145.9 108.26 4.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.557 174.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.478 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.8 t-80 -127.22 135.25 50.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.657 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 119' ' ' HIS . 8.1 mt -118.03 147.36 43.31 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.497 0.498 . . . . 0.0 110.326 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.3 ttm180 -137.04 148.74 47.0 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.437 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 61.6 m -130.7 120.23 23.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.598 0.237 . . . . 0.0 110.39 175.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -118.47 143.63 46.57 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -100.94 136.54 40.62 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.259 0.552 . . . . 0.0 112.055 -173.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.874 ' HB2' HG23 ' A' ' 12' ' ' VAL . 4.9 mt -104.42 115.2 29.96 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.814 174.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 34.4 m -105.13 116.77 32.52 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.062 0.458 . . . . 0.0 110.687 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -113.83 106.44 14.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.049 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -78.79 118.14 20.57 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.398 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 4.2 t30 52.14 63.03 9.69 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.397 177.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.421 ' HG3' HG23 ' A' ' 10' ' ' VAL . 88.5 Cg_endo -80.25 -179.24 5.07 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.771 2.314 . . . . 0.0 112.395 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.527 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 3.5 p -72.75 139.74 47.32 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 173.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -56.95 -39.42 74.51 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.534 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 6.9 p-10 -63.33 -28.66 70.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.666 0.27 . . . . 0.0 110.343 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.635 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 14.8 t80 -75.57 -42.16 52.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.628 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 44.5 ttm105 -53.36 -45.97 69.39 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.099 0.476 . . . . 0.0 109.816 173.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -52.93 -41.12 64.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.381 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 38.8 mtpt -72.36 -39.6 67.95 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.618 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.635 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.9 mt -68.58 -30.59 69.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.909 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 36.1 mt -80.67 -35.68 33.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.163 -177.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -75.28 -30.09 60.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.78 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.749 177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.42 0 N-CA-C 111.769 -0.532 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . 99.85 -50.48 1.12 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.908 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -85.83 129.15 34.91 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.775 0.321 . . . . 0.0 110.158 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -67.26 164.81 33.35 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.852 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.46 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 9.4 Cg_endo -51.87 162.97 1.52 Allowed 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 122.407 2.071 . . . . 0.0 112.063 174.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 26.8 ttt180 -142.03 144.02 33.42 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.663 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . 0.481 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -84.52 46.45 1.24 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.46 0.648 . . . . 0.0 110.182 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 54.4 tp -76.74 79.4 3.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.659 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -161.35 97.74 1.12 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.753 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 6.2 p -59.98 114.27 2.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.864 -177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -131.76 45.22 2.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.675 0.75 . . . . 0.0 109.058 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.887 -178.722 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -78.46 127.09 31.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -94.48 75.65 3.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.171 0.51 . . . . 0.0 110.147 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.9 tpt -99.04 -17.14 18.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.092 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.21 -32.61 66.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.696 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.1 p -91.76 76.81 5.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.158 0.504 . . . . 0.0 110.165 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.638 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 13.0 m -78.61 130.17 35.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.65 -176.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 40.6 t -153.53 125.38 7.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.282 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.68 130.45 51.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.754 0.311 . . . . 0.0 111.276 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.44 HG23 ' HG3' ' A' ' 130' ' ' PRO . 5.1 t -104.2 141.25 20.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 4.7 mp0 -128.76 130.26 46.81 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.899 0.38 . . . . 0.0 110.177 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.832 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -116.32 165.65 11.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.252 178.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 67.1 mttm -128.5 133.67 48.52 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.37 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.451 HD22 HD13 ' A' ' 47' ' ' ILE . 82.2 mt -115.6 141.19 48.39 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.722 175.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.9 tt0 -104.33 129.98 52.18 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.862 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.628 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -114.99 112.44 22.68 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 173.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -138.09 170.1 23.94 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.956 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -164.2 151.63 12.06 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.881 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 67.8 mtt180 -116.87 143.09 46.1 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.727 174.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -139.21 131.26 27.95 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.532 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -133.94 163.69 28.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.898 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.88 HG11 ' H ' ' A' ' 113' ' ' GLY . 1.9 p -103.37 158.27 4.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 172.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 32' ' ' THR . 3.7 mtp180 -102.76 142.92 33.1 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 176.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -70.53 -13.36 62.08 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.663 0.744 . . . . 0.0 109.434 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -142.96 104.63 5.23 Favored Pre-proline 0 N--CA 1.446 -0.654 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.052 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.6 Cg_exo -47.81 152.91 2.71 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.059 2.506 . . . . 0.0 112.243 174.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.405 HG22 ' HB2' ' A' ' 31' ' ' PHE . 8.8 t -76.42 -170.08 1.39 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -171.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 m -62.42 -32.86 56.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.762 0.315 . . . . 0.0 111.729 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -82.18 -4.1 56.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.254 0.55 . . . . 0.0 110.438 177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.99 31.46 43.22 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.413 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.405 ' HB2' HG22 ' A' ' 27' ' ' THR . 19.0 m-30 -90.3 131.67 35.97 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.55 HG22 ' HG3' ' A' ' 26' ' ' PRO . 75.7 p -90.27 -29.49 18.11 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -168.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.2 m80 -112.55 146.08 39.16 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -171.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -117.78 121.08 39.85 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -124.83 147.55 48.68 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.068 0.461 . . . . 0.0 110.788 -179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.624 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 47.3 ttp -124.24 116.91 23.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.662 176.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.4 m -98.43 150.68 4.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.443 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -151.1 151.16 31.58 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.294 0.569 . . . . 0.0 112.36 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -122.55 138.46 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.334 169.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -155.88 -176.97 6.23 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.514 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -90.41 -170.92 43.85 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.514 -177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 3.2 Cg_exo -74.46 110.1 3.03 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.103 1.869 . . . . 0.0 112.366 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 49.8 77.07 0.12 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.508 174.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 76.62 -11.7 1.14 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.791 0.436 . . . . 0.0 112.134 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.538 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 50.6 m -68.36 123.26 20.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.719 0.295 . . . . 0.0 110.452 177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -76.5 129.18 36.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.029 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.581 HD12 HG21 ' A' ' 51' ' ' VAL . 4.8 pt -95.46 -1.68 10.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.418 ' HG2' ' OH ' ' A' ' 74' ' ' TYR . 96.2 mt-30 -69.85 -0.79 7.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.9 0.381 . . . . 0.0 111.384 -175.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -71.46 -39.53 70.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.22 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -113.57 -17.61 12.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 120.394 -0.523 . . . . 0.0 111.593 176.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.581 HG21 HD12 ' A' ' 47' ' ' ILE . 91.5 t -91.29 130.45 40.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.828 0.346 . . . . 0.0 110.215 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.494 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 8.0 tp10 -99.13 -55.99 2.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.182 0.515 . . . . 0.0 110.46 -175.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.561 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -148.79 156.88 42.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 55' ' ' VAL . 90.2 t -131.92 156.93 42.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.8 p -142.55 133.99 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.318 0.58 . . . . 0.0 110.979 -173.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.489 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 29.6 m-85 -116.06 104.32 11.45 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -78.33 92.43 4.54 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.981 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.5 mt -75.36 -177.79 3.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 151.78 22.9 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.56 -175.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.445 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 1.6 mp0 -55.64 -21.95 20.34 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.727 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.0 t -65.84 -24.58 66.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.025 0.44 . . . . 0.0 110.614 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -82.62 135.22 46.46 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.332 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.45 120.36 7.87 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.233 1.955 . . . . 0.0 110.537 172.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 60.68 81.57 0.24 Allowed Pre-proline 0 N--CA 1.464 0.23 0 O-C-N 123.502 0.501 . . . . 0.0 110.379 -173.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -61.0 -25.31 81.32 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.584 2.189 . . . . 0.0 113.747 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HE3' ' CG1' ' A' ' 68' ' ' VAL . 23.5 ttpt -98.32 107.24 19.66 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.058 0.456 . . . . 0.0 111.1 -172.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -106.1 100.9 10.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.892 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.44 ' CG1' ' HE3' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -87.63 137.8 20.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 173.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.8 m -125.34 114.09 18.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -104.3 -28.21 11.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.43 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.483 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 26.7 t70 -73.58 171.06 11.68 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.135 -178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.583 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 72.7 Cg_exo -26.0 -174.1 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.676 1 C-N-CA 126.016 4.477 . . . . 0.0 116.062 164.127 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.583 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 6.5 Cg_endo -33.3 120.37 0.11 Allowed 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 123.375 2.717 . . . . 0.0 114.139 -149.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.556 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 38.8 m-85 -62.74 93.35 0.05 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.212 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -143.71 144.82 32.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.342 0.591 . . . . 0.0 112.039 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.5 t -120.35 131.8 71.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.595 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.18 105.99 13.21 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -131.51 173.2 11.34 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.508 -174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.0 t -125.03 144.74 50.25 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.724 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.84 -170.66 29.07 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -133.08 -12.26 2.86 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 117.411 0.606 . . . . 0.0 111.645 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.443 ' HB3' ' HG3' ' B' ' 218' ' ' ALY . . . -143.41 145.1 32.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.661 0.267 . . . . 0.0 110.589 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.552 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -83.63 178.03 52.48 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.782 -0.644 . . . . 0.0 113.266 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -178.15 157.81 1.13 Allowed 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.064 0.546 . . . . 0.0 110.168 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 106' ' ' ASP . 21.1 mm -62.67 125.47 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.661 171.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.569 HD22 HG13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -107.93 105.01 55.36 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -68.36 105.33 1.22 Allowed 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 123.013 2.475 . . . . 0.0 111.625 170.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.569 HG13 HD22 ' A' ' 86' ' ' LEU . 5.8 mt -100.87 123.73 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.237 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.9 mt-10 -109.67 123.62 49.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.286 0.565 . . . . 0.0 110.039 176.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -103.04 117.21 48.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.619 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.561 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 83.8 m-85 -87.89 141.23 28.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.086 0.469 . . . . 0.0 110.778 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.451 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.3 m-85 -114.12 153.82 28.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.884 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.494 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -95.77 94.13 7.49 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.55 HD21 ' HB2' ' A' ' 96' ' ' GLU . 58.3 t30 -155.37 158.46 38.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.933 -170.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.2 ptpp? -107.85 -6.95 16.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.718 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.55 ' HB2' HD21 ' A' ' 94' ' ' ASN . 23.7 mm-40 -101.29 -150.73 0.4 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.822 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.462 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 15.3 mm-40 -25.27 149.04 0.02 OUTLIER Pre-proline 0 N--CA 1.479 1.006 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -31.45 126.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 1 C-N-CA 125.41 4.074 . . . . 0.0 114.717 -170.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.58 19.52 1.97 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.823 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.73 142.12 20.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.159 0.504 . . . . 0.0 110.537 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -124.63 155.63 32.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 174.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -124.19 119.11 28.43 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.144 0.497 . . . . 0.0 111.163 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.628 ' CD2' HD21 ' A' ' 16' ' ' LEU . 24.0 m-85 -111.58 115.77 29.72 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.906 176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.79 101.82 7.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.37 0.605 . . . . 0.0 109.773 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -115.58 134.82 54.69 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.646 -175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.411 ' HA ' HD13 ' A' ' 85' ' ' ILE . 12.6 t70 -86.52 118.17 25.76 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.684 -176.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.501 HD11 ' CG1' ' A' ' 37' ' ' VAL . 1.4 mp -93.96 91.45 6.9 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.512 ' CE1' HG13 ' A' ' 117' ' ' VAL . 50.4 p90 -99.32 157.03 16.68 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.043 0.449 . . . . 0.0 110.832 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.5 mt -133.68 158.57 42.93 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -102.13 174.48 5.91 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 122.244 -0.285 . . . . 0.0 110.364 172.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.661 HD23 ' HG3' ' B' ' 214' ' ' LYS . 3.0 mm? -70.24 160.98 31.18 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.609 ' HA ' HG21 ' A' ' 22' ' ' VAL . 5.4 mp0 -58.72 123.11 15.27 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.377 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.88 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 115.66 -45.04 1.35 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.262 -0.971 . . . . 0.0 112.843 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -140.98 74.58 25.5 Favored Pre-proline 0 N--CA 1.464 0.228 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.505 -175.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.562 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 71.9 Cg_endo -113.0 107.28 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.789 2.326 . . . . 0.0 113.448 172.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -99.66 96.78 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 123.034 2.489 . . . . 0.0 110.922 165.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 4.9 t -123.09 109.41 23.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.59 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.469 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.16 97.13 3.0 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.465 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.9 t-80 -119.55 134.34 55.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.777 -176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 119' ' ' HIS . 9.8 mt -117.91 145.76 44.42 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.681 0.613 . . . . 0.0 110.016 176.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.653 ' HD3' ' OE2' ' A' ' 123' ' ' GLU . 11.3 ttm180 -132.96 148.46 52.27 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.482 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 84.6 m -123.32 116.13 22.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.332 0.587 . . . . 0.0 111.059 175.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.653 ' OE2' ' HD3' ' A' ' 121' ' ' ARG . 64.3 mm-40 -98.43 162.45 13.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.383 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -125.48 128.35 47.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.413 0.625 . . . . 0.0 111.115 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.832 ' HB2' HG23 ' A' ' 12' ' ' VAL . 8.3 mt -100.34 115.37 29.81 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.962 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 20.9 m -109.14 122.71 47.89 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.005 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -120.42 100.61 7.26 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.046 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -73.42 116.36 13.89 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.653 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.638 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 5.0 t30 58.26 74.76 0.59 Allowed Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.452 175.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 8' ' ' CYS . 82.2 Cg_endo -97.48 -178.54 0.33 Allowed 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.23 2.62 . . . . 0.0 112.817 -174.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.456 ' CG2' ' HG3' ' A' ' 96' ' ' GLU . 5.9 p -71.66 144.54 49.35 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -57.36 -45.97 83.84 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.92 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -57.93 -28.94 64.73 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.613 0.244 . . . . 0.0 110.918 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.667 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.2 t80 -73.12 -47.01 47.88 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.656 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.3 ttm105 -52.18 -48.3 65.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.264 0.554 . . . . 0.0 109.924 174.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -54.83 -34.52 62.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.778 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.5 mtmt -81.52 -37.68 27.46 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.514 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.8 mt -66.19 -28.9 69.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.825 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.7 mt -80.42 -37.98 31.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.434 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.448 ' NZ ' ' HB2' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -70.76 -30.39 66.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.877 -176.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.756 -0.64 . . . . 0.0 110.913 178.975 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.27 79.2 0.92 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.28 -0.486 . . . . 0.0 112.586 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . 0.661 ' HG3' HD23 ' A' ' 111' ' ' LEU . 23.2 tptm -82.22 -42.6 18.72 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.958 0.409 . . . . 0.0 109.915 177.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.432 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -68.59 159.62 80.69 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.966 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.432 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 19.8 Cg_endo -58.49 170.01 2.74 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.434 2.089 . . . . 0.0 112.239 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 17.9 ttm180 -142.8 135.95 28.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.979 0.418 . . . . 0.0 110.831 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . 0.443 ' HG3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -91.46 -31.39 16.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.854 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 18.4 tp -159.33 47.39 0.29 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.628 0.727 . . . . 0.0 109.814 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -70.38 -11.64 61.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.324 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 16.7 m -64.06 -25.91 68.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.909 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -96.01 19.64 11.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.579 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.093 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.173 179.85 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -67.75 -29.8 69.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.856 0.36 . . . . 0.0 111.51 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -76.49 -34.24 58.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.092 0.473 . . . . 0.0 110.034 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.5 tpp -71.39 -50.68 29.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.204 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.5 114.4 11.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.804 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.8 t -100.0 138.81 36.55 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.435 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 53.8 m -71.27 108.52 4.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.905 0.383 . . . . 0.0 110.156 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 61.8 m -97.95 116.24 29.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.713 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -99.8 134.06 43.26 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -171.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.469 HG23 ' HG3' ' A' ' 130' ' ' PRO . 6.3 t -104.83 144.17 15.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -132.29 114.86 14.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.849 0.357 . . . . 0.0 110.292 -173.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.903 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -105.85 166.04 3.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.343 -179.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -129.23 126.01 38.18 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.148 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.421 HD22 HD13 ' A' ' 47' ' ' ILE . 79.0 mt -103.62 142.78 33.72 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.662 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 28.1 tt0 -107.94 125.5 51.58 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.302 -173.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.529 ' CD1' HG12 ' A' ' 39' ' ' VAL . 2.2 mm? -107.79 117.54 34.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 173.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -139.88 165.33 25.94 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.091 -1.052 . . . . 0.0 111.396 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -162.87 149.03 12.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.077 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 34.8 mtp180 -121.62 128.17 51.63 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -117.61 117.46 29.45 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.377 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -110.13 141.67 42.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.455 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' A' ' 112' ' ' GLU . 5.7 p -102.95 146.08 11.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 170.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.7 mtp85 -97.0 142.93 28.35 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -72.32 -13.92 61.61 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.489 0.661 . . . . 0.0 109.335 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 26' ' ' PRO . 13.7 tmtt? -138.8 100.49 8.12 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.89 176.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.565 ' HG3' HG22 ' A' ' 32' ' ' THR . 80.7 Cg_exo -50.78 160.31 1.88 Allowed 'Trans proline' 0 N--CA 1.478 0.577 0 C-N-CA 123.612 2.874 . . . . 0.0 113.359 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.4 t -79.65 -174.41 4.3 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.836 -175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.446 ' H ' HG13 ' A' ' 28' ' ' VAL . 1.2 m -62.32 -32.59 55.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.849 0.357 . . . . 0.0 111.163 -174.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -79.78 -6.45 57.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.11 0.481 . . . . 0.0 110.513 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.6 33.26 38.98 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.268 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -93.46 130.88 39.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.565 HG22 ' HG3' ' A' ' 26' ' ' PRO . 45.9 p -92.04 -21.56 20.42 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.251 -170.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.459 ' HE1' ' OE1' ' A' ' 112' ' ' GLU . 54.9 m80 -118.84 147.24 44.15 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -171.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -123.3 117.28 24.9 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 169.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.412 ' HH2' HD22 ' A' ' 58' ' ' LEU . 49.3 p-90 -121.3 147.93 45.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.105 0.479 . . . . 0.0 111.263 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.622 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 52.2 ttp -125.33 119.38 28.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.514 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.5 m -101.93 148.97 6.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.471 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.56 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 2.1 p90 -149.5 153.28 36.99 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.8 m -123.58 135.86 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.636 170.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.436 ' HD2' ' OE2' ' A' ' 15' ' ' GLU . 8.3 ptp85 -152.56 -176.74 5.85 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.483 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -90.75 -173.57 44.19 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.453 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.525 ' HD2' ' OG ' ' A' ' 45' ' ' SER . 5.1 Cg_exo -74.21 125.7 9.93 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.169 2.579 . . . . 0.0 111.354 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 61.99 47.67 5.69 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.544 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 37.1 m80 64.23 18.36 11.24 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.525 ' OG ' ' HD2' ' A' ' 42' ' ' PRO . 22.9 p -71.05 153.64 42.42 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 122.131 -0.356 . . . . 0.0 110.137 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -81.35 125.5 30.45 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.585 HD12 HG21 ' A' ' 51' ' ' VAL . 4.6 pt -96.58 -1.52 10.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.575 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 32.8 tt0 -70.48 -4.52 23.14 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.575 0.702 . . . . 0.0 109.736 -174.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.427 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 93.8 m-70 -66.1 -39.41 89.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.304 173.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -116.07 -19.39 10.33 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.133 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.585 HG21 HD12 ' A' ' 47' ' ' ILE . 96.7 t -88.8 131.32 36.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.229 0.537 . . . . 0.0 109.939 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.96 -59.85 1.68 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.367 -175.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 16.2 tttt -149.53 149.78 31.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.811 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 93.9 t -128.92 157.41 41.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -177.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.579 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 8.7 p -142.53 135.1 26.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.383 0.611 . . . . 0.0 111.169 -174.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 25.1 m-85 -117.78 108.3 15.2 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -81.31 93.58 6.58 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.123 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.584 ' CD2' HD11 ' A' ' 86' ' ' LEU . 9.9 mt -74.16 -177.82 3.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 73.2 t60 -80.93 137.48 36.13 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.5 -20.49 20.58 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -172.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.5 t -64.57 -18.14 64.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.866 0.365 . . . . 0.0 110.902 173.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 44.0 m-85 -83.27 144.14 46.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.13 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 62' ' ' PHE . 15.9 Cg_exo -68.71 118.69 5.82 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.425 2.083 . . . . 0.0 110.851 173.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.401 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 26.2 mmm180 63.54 73.17 0.5 Allowed Pre-proline 0 N--CA 1.465 0.279 0 O-C-N 123.543 0.527 . . . . 0.0 110.007 -176.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.24 -22.71 66.65 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.793 2.329 . . . . 0.0 113.406 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -97.35 103.29 15.21 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 120.974 0.416 . . . . 0.0 110.421 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.401 ' HD3' ' O ' ' A' ' 64' ' ' ARG . 15.7 mmm-85 -105.15 102.23 11.73 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.321 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.6 m -95.26 138.27 21.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.5 m -125.13 119.63 29.11 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -106.74 -28.71 10.0 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.59 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.727 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 37.4 m-20 -72.13 -172.31 0.22 Allowed Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.531 1.132 . . . . 0.0 111.768 -174.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.727 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 72.4 Cg_exo -39.89 -172.2 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.858 0 C-N-CA 123.492 2.794 . . . . 0.0 114.084 165.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.651 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.7 Cg_endo -33.83 123.42 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 123.857 3.038 . . . . 0.0 114.442 -154.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 36.9 m-85 -63.21 92.07 0.05 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.187 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 12.2 ptpt -142.79 145.41 33.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.183 0.516 . . . . 0.0 111.866 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 36' ' ' MET . 75.1 t -118.55 133.73 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.42 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.469 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 5.7 mm-40 -112.15 107.36 16.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.975 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.25 169.47 17.73 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.122 0.487 . . . . 0.0 111.039 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.2 t -126.94 143.24 51.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.888 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.76 -161.68 13.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.746 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -137.69 -14.86 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.292 0.546 . . . . 0.0 112.174 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.444 ' HB3' ' HG3' ' B' ' 218' ' ' ALY . . . -143.27 148.05 35.77 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.023 -176.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.541 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -84.99 179.43 51.08 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.619 -0.719 . . . . 0.0 113.182 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -178.96 155.52 0.76 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 122.935 0.494 . . . . 0.0 109.911 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 106' ' ' ASP . 23.0 mm -62.72 127.1 22.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.242 171.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.584 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.7 tt -120.09 104.82 43.27 Favored Pre-proline 0 N--CA 1.448 -0.571 0 CA-C-O 121.129 0.49 . . . . 0.0 110.106 -177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.19 112.2 2.24 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 123.399 2.732 . . . . 0.0 112.721 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.406 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.9 mt -103.64 124.26 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.183 177.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.579 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 50.9 mt-10 -109.62 124.67 51.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.152 0.501 . . . . 0.0 109.903 176.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.1 t -105.26 119.2 54.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.841 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 88.9 m-85 -91.19 138.82 31.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.015 0.436 . . . . 0.0 110.863 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.5 m-85 -112.14 154.65 25.17 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.735 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.3 95.14 7.5 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.623 HD21 ' HB2' ' A' ' 96' ' ' GLU . 61.0 t30 -155.33 164.38 38.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.808 -172.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.559 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -112.86 -4.6 13.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.615 178.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.623 ' HB2' HD21 ' A' ' 94' ' ' ASN . 17.4 mm-40 -100.93 -153.47 0.45 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.067 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 20.3 mm-40 -29.89 153.23 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.935 0 C-N-CA 124.621 1.168 . . . . 0.0 114.071 176.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 6.2 Cg_exo -32.72 124.86 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.125 1 C-N-CA 125.356 4.037 . . . . 0.0 114.876 -167.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.473 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -88.2 19.58 3.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.392 -177.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -152.37 140.41 20.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.235 0.54 . . . . 0.0 110.887 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.1 m -125.75 156.41 35.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.72 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -122.92 121.8 37.05 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.011 0.434 . . . . 0.0 111.201 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CZ ' HG21 ' A' ' 101' ' ' VAL . 23.6 m-85 -112.83 110.75 21.05 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.707 173.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -82.21 99.03 9.04 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -108.32 138.97 43.71 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.159 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.418 ' HA ' HD13 ' A' ' 85' ' ' ILE . 12.4 t70 -81.83 113.66 19.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.96 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.562 HD11 HG11 ' A' ' 37' ' ' VAL . 1.8 mp -90.01 104.99 17.51 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.402 ' CE2' HG11 ' A' ' 117' ' ' VAL . 12.4 p90 -116.01 154.95 28.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.91 0.386 . . . . 0.0 110.661 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.9 mt -135.48 162.59 32.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.647 -173.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.685 ' CD2' ' HA ' ' A' ' 116' ' ' PRO . 7.7 p80 -100.49 171.82 7.5 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.418 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' B' ' 215' ' ' ALA . 1.0 OUTLIER -74.42 168.85 18.89 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.834 0.349 . . . . 0.0 111.129 177.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.71 ' HA ' HG21 ' A' ' 22' ' ' VAL . 0.8 OUTLIER -67.23 120.3 13.56 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.52 178.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.682 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 85.73 16.89 62.77 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.925 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -115.76 152.4 47.33 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-O 118.709 -0.662 . . . . 0.0 110.024 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -28.28 124.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.364 1.373 0 C-N-CA 124.288 3.325 . . . . 0.0 114.631 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.685 ' HA ' ' CD2' ' A' ' 110' ' ' HIS . 24.6 Cg_exo -62.98 -178.77 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.236 2.624 . . . . 0.0 112.936 174.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 31.6 t -122.42 130.73 74.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.064 -176.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -139.01 98.22 3.48 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -125.0 132.59 53.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.41 -175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.4 mt -111.43 156.45 21.62 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.866 0.729 . . . . 0.0 109.103 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 16.3 ttt180 -147.47 143.71 28.08 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.31 -0.244 . . . . 0.0 110.719 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 24.8 p -118.98 116.88 27.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.217 0.532 . . . . 0.0 111.064 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -111.92 132.84 54.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.951 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -97.81 131.56 44.2 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.164 0.506 . . . . 0.0 111.742 -172.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.903 ' HB2' HG23 ' A' ' 12' ' ' VAL . 7.4 mt -99.34 118.1 35.24 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.2 m -106.26 120.48 41.97 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.175 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -117.59 99.33 6.9 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.895 -176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -71.72 117.42 13.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.958 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.435 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 5.4 t30 55.94 78.35 0.38 Allowed Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.873 174.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.587 ' HD3' ' O ' ' A' ' 8' ' ' CYS . 95.6 Cg_endo -97.64 -178.22 0.31 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.003 2.469 . . . . 0.0 112.13 -177.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.0 p -74.1 142.25 45.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 171.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.435 ' OE2' ' HD2' ' A' ' 135' ' ' ARG . 4.0 tp10 -56.51 -38.25 71.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.019 177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.659 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 15.6 m-20 -59.98 -35.29 74.69 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 178.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.625 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.6 t80 -72.54 -40.66 66.55 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.685 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 30.9 ttm180 -55.85 -45.62 78.39 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -59.13 -34.69 72.35 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.955 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.659 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 40.4 mtpt -71.32 -43.56 66.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.2 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 37.3 mt -68.63 -34.33 75.55 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.767 -177.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 43.4 mt -74.1 -33.81 63.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.928 0.394 . . . . 0.0 110.836 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -76.57 -27.02 55.7 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.538 -175.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.84 178.32 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.879 -0.488 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -77.99 68.68 2.8 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.606 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -80.04 -35.76 36.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.695 0.283 . . . . 0.0 110.791 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.429 ' HA ' HD22 ' A' ' 111' ' ' LEU . . . -71.78 161.31 79.36 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.482 -174.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.31 -177.3 0.12 Allowed 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.547 2.164 . . . . 0.0 113.23 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 18.4 ttm180 -150.18 138.92 20.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.71 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . 0.444 ' HG3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -93.7 122.37 36.08 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 8.2 tt -74.91 100.15 4.02 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.079 0.466 . . . . 0.0 110.217 -175.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -97.77 -59.49 1.76 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.54 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 16.5 m 51.38 55.29 9.67 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.725 0.774 . . . . 0.0 110.637 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -82.93 -34.21 26.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.353 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.975 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.018 175.554 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 N-CA-C 112.129 -0.388 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -87.61 141.51 28.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.875 0.369 . . . . 0.0 110.487 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -118.63 141.78 48.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.1 tmm? -76.81 84.3 3.4 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 56.72 -90.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.898 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.6 t -118.67 145.68 45.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.3 m -59.02 110.1 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 129' ' ' ASN . 13.6 p -90.11 127.7 36.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.565 -171.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.5 129.36 46.44 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.992 175.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 t -99.97 139.8 20.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.0 mp0 -125.67 120.41 30.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.04 0.447 . . . . 0.0 110.046 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.867 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.68 161.85 5.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.974 179.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' CE ' ' HB3' ' A' ' 42' ' ' PRO . 47.5 mtmt -128.57 128.62 44.6 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.364 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.401 HD13 HG11 ' A' ' 90' ' ' VAL . 82.5 mt -111.79 140.64 46.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.103 0.478 . . . . 0.0 109.715 174.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.609 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.7 tt0 -104.68 122.35 45.49 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.929 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.657 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.4 mm? -108.67 117.92 35.43 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 175.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.23 -179.85 24.52 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.21 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -169.43 154.45 5.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -122.1 136.27 54.9 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -133.62 126.62 31.28 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 119.828 -0.749 . . . . 0.0 111.358 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.416 ' NE2' ' HB2' ' A' ' 34' ' ' ASP . 0.6 OUTLIER -130.13 158.26 40.17 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.149 178.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.83 HG11 ' H ' ' A' ' 113' ' ' GLY . 1.7 p -101.85 160.57 3.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.601 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 6.3 ptm180 -111.95 142.27 44.56 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.4 tptp -70.08 -8.85 52.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.532 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -144.55 100.89 4.71 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.584 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.425 ' HG3' HG22 ' A' ' 32' ' ' THR . 86.7 Cg_exo -50.06 155.04 4.76 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.144 2.563 . . . . 0.0 111.87 175.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.435 HG22 ' HB2' ' A' ' 31' ' ' PHE . 8.8 t -78.26 -175.47 4.19 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.062 -171.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.419 ' H ' HG13 ' A' ' 28' ' ' VAL . 2.1 m -57.52 -33.09 43.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 122.634 0.373 . . . . 0.0 111.838 -175.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -86.6 0.42 54.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.086 0.469 . . . . 0.0 110.73 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.04 33.18 41.78 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.899 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.435 ' HB2' HG22 ' A' ' 27' ' ' THR . 16.3 m-30 -92.07 133.17 35.99 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.563 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 58.7 p -96.7 -27.76 14.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -168.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 79' ' ' SER . 66.9 m80 -118.42 140.77 49.35 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -172.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.601 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 17.3 m-20 -115.39 116.02 27.55 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -119.38 151.51 38.37 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 121.006 0.432 . . . . 0.0 110.893 -177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.626 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 57.0 ttp -127.43 120.9 29.46 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.43 174.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.8 m -100.84 152.16 5.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.212 179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.592 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -153.08 154.14 34.26 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 10.2 m -120.82 126.15 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.671 168.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 15' ' ' GLU . 14.1 mmm180 -128.62 176.52 7.72 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.804 -172.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.553 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -97.78 -177.4 33.76 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.571 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HB3' ' CE ' ' A' ' 13' ' ' LYS . 8.1 Cg_exo -69.8 111.01 2.7 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.505 2.137 . . . . 0.0 112.323 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 53.56 61.66 3.01 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.525 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 76.55 -7.43 1.84 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.29 0.636 . . . . 0.0 112.366 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.4 m -69.44 128.6 37.12 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.29 -0.256 . . . . 0.0 111.046 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -65.22 129.59 40.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 110.653 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.58 HD12 HG21 ' A' ' 51' ' ' VAL . 4.2 pt -95.78 -1.84 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -61.22 -15.72 37.4 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.111 0.482 . . . . 0.0 110.906 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -63.64 -37.13 86.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.209 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.415 ' CE2' HG22 ' A' ' 47' ' ' ILE . 53.9 p90 -117.9 -16.63 9.9 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.408 176.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.58 HG21 HD12 ' A' ' 47' ' ' ILE . 95.4 t -89.56 129.71 40.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.131 0.491 . . . . 0.0 110.199 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -97.45 -66.0 0.93 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.417 -174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.645 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -144.45 151.18 38.83 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 55' ' ' VAL . 95.1 t -124.2 159.52 29.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 O-C-N 122.104 -0.372 . . . . 0.0 110.198 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.561 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.4 p -143.18 137.53 26.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.073 0.464 . . . . 0.0 111.016 -174.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.525 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 17.1 m-85 -120.8 111.22 17.3 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -84.42 95.23 8.71 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.941 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.549 ' CD2' HD11 ' A' ' 86' ' ' LEU . 8.1 mt -73.48 -177.59 2.7 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -81.21 146.64 30.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -56.4 -19.26 14.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.413 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 m -69.59 -20.56 63.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.085 176.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -83.34 144.41 46.49 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.582 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.63 118.24 5.45 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.586 2.191 . . . . 0.0 110.65 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 61.06 78.5 0.31 Allowed Pre-proline 0 C--O 1.225 -0.192 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.181 -176.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.65 -24.03 77.48 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.847 2.364 . . . . 0.0 113.732 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.6 ttpt -97.44 109.14 21.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 121.969 -0.457 . . . . 0.0 110.881 -174.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 21.6 mmt85 -108.01 105.55 15.37 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.136 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.55 142.2 13.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 175.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 43.4 t -131.81 114.65 14.96 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -106.75 -24.82 11.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.242 176.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.538 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 24.7 t70 -68.97 171.63 6.16 Favored Pre-proline 0 CA--C 1.544 0.75 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.564 178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 82.6 Cg_exo -29.2 -170.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.557 1.652 1 C-N-CA 125.478 4.119 . . . . 0.0 115.466 164.032 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.642 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 Cg_endo -36.17 121.7 0.26 Allowed 'Trans proline' 0 C--N 1.368 1.576 0 C-N-CA 122.808 2.339 . . . . 0.0 113.887 -151.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 39.5 m-85 -62.17 91.44 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.059 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.642 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 4.6 ptpt -139.16 146.92 41.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.261 0.553 . . . . 0.0 111.877 -177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 36' ' ' MET . 72.0 t -123.71 131.82 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.804 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -114.77 113.54 24.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.25 172.85 12.15 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.222 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.3 t -126.67 141.3 51.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.495 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.61 -171.44 23.59 Favored Glycine 0 N--CA 1.453 -0.231 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.41 ' O ' ' HB2' ' B' ' 216' ' ' PRO . 45.5 p90 -131.47 -1.92 3.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.592 0.696 . . . . 0.0 112.195 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.582 ' HB3' ' HG3' ' B' ' 218' ' ' ALY . . . -152.68 129.92 11.24 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.902 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.517 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -72.31 175.29 43.16 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.496 -0.774 . . . . 0.0 113.348 -178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -175.96 158.95 2.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.669 0.388 . . . . 0.0 110.275 -176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 85' ' ' ILE . 12.1 mm -65.58 124.86 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.409 171.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.549 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.9 tt -118.24 105.87 45.95 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.05 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.08 118.64 5.8 Favored 'Trans proline' 0 C--O 1.239 0.549 0 C-N-CA 122.918 2.412 . . . . 0.0 112.212 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.0 mt -107.61 125.0 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.068 178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.561 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 55.0 mt-10 -111.44 118.3 35.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.268 0.556 . . . . 0.0 109.924 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.401 HG11 HD13 ' A' ' 14' ' ' LEU . 64.6 t -100.42 119.18 48.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.825 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.645 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 82.5 m-85 -92.24 138.81 31.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.039 0.447 . . . . 0.0 110.815 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -112.53 150.84 30.73 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.19 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.67 95.13 10.12 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.577 HD21 ' HB2' ' A' ' 96' ' ' GLU . 62.6 t30 -154.2 155.34 35.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.211 0.529 . . . . 0.0 112.152 -169.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.87 -1.94 15.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.131 174.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.577 ' HB2' HD21 ' A' ' 94' ' ' ASN . 32.7 mm-40 -100.29 -152.22 0.42 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.792 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -31.36 154.06 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -30.92 125.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.161 1 C-N-CA 125.37 4.047 . . . . 0.0 114.51 -169.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.66 17.73 1.74 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.899 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.62 149.08 26.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.142 0.496 . . . . 0.0 111.035 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.511 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.3 m -123.1 157.78 28.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.724 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -128.12 106.96 9.42 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.695 0.283 . . . . 0.0 110.35 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.4 m-85 -106.57 121.37 44.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.001 177.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -86.31 114.58 23.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 175.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -123.93 138.39 54.48 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.349 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -89.5 119.71 30.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.555 HD11 HG11 ' A' ' 37' ' ' VAL . 2.0 mp -93.11 91.7 7.44 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CE2' HG13 ' A' ' 117' ' ' VAL . 27.0 p90 -100.28 153.51 19.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.963 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.5 mt -129.39 154.15 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.427 ' ND1' HG22 ' A' ' 117' ' ' VAL . 27.9 m170 -103.15 170.39 7.99 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 122.124 -0.36 . . . . 0.0 111.107 174.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -61.48 141.2 57.85 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.563 ' HA ' HG21 ' A' ' 22' ' ' VAL . 8.9 mt-10 -50.77 123.06 8.25 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.896 175.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.83 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 119.47 -50.12 0.83 Allowed Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.845 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -144.48 74.26 15.39 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.629 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.461 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 72.1 Cg_endo -111.07 108.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 123.119 2.546 . . . . 0.0 113.368 174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -97.91 97.95 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.927 2.418 . . . . 0.0 110.605 167.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 4.7 t -116.34 109.58 28.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.075 -178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -144.04 121.87 11.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.423 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.2 t-80 -144.47 131.81 20.79 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.255 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 119' ' ' HIS . 7.2 mt -116.28 147.4 41.55 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.707 0.629 . . . . 0.0 109.862 175.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 20.3 ttm180 -136.19 146.02 46.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 84.2 m -128.73 114.48 16.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.022 0.439 . . . . 0.0 110.703 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -109.79 142.7 40.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.006 -178.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -102.74 129.29 49.33 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.494 0.664 . . . . 0.0 111.845 -172.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.867 ' HB2' HG23 ' A' ' 12' ' ' VAL . 6.5 mt -96.77 120.24 36.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.548 173.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.8 m -111.22 121.62 45.75 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.623 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -118.83 110.68 17.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.311 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -76.07 117.58 17.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.334 -176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 5.3 t30 48.03 64.66 8.21 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.92 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.41 176.28 10.17 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.367 2.044 . . . . 0.0 111.899 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 80.4 p -72.75 144.71 47.5 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.442 ' HG3' ' NH1' ' A' ' 135' ' ' ARG . 29.5 tt0 -56.01 -44.17 78.43 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.502 -0.479 . . . . 0.0 112.032 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -56.9 -32.37 65.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.651 0.262 . . . . 0.0 110.449 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.669 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.8 t80 -76.73 -41.28 45.65 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.628 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.9 ttm180 -54.93 -44.44 74.27 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 173.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -57.1 -40.14 76.4 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.311 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 50.2 mtpt -71.19 -40.95 70.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.85 0.357 . . . . 0.0 110.858 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 45.9 mt -69.28 -33.77 73.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.87 -178.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.628 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.3 mt -76.61 -31.24 57.3 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 120.826 0.346 . . . . 0.0 110.783 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -75.02 -27.51 60.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.167 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 119.151 -0.452 . . . . 0.0 110.119 175.093 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.712 0 N-CA-C 112.163 -0.375 . . . . 0.0 112.163 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -77.28 -49.69 7.25 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.87 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -86.46 128.93 35.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.7 0.286 . . . . 0.0 110.56 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -77.09 165.5 51.71 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.909 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.478 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 0.3 OUTLIER -36.18 145.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.622 2.882 . . . . 0.0 114.381 175.048 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 15.2 ttm180 -151.63 127.94 10.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.2 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . 0.582 ' HG3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -83.44 35.36 0.5 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.678 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' B' ' 218' ' ' ALY . 3.5 mm? -118.64 151.09 38.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.865 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -81.34 69.78 8.05 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.009 0.433 . . . . 0.0 110.872 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 6.0 t -70.82 133.78 46.8 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.641 178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -81.82 111.06 17.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.283 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.439 -0.791 . . . . 0.0 110.339 178.097 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 112.061 -0.416 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 38.8 m -131.32 62.34 1.62 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.834 0.349 . . . . 0.0 110.236 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 2' ' ' SER . 36.0 m-70 71.93 -55.3 0.67 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.67 0.788 . . . . 0.0 111.947 -178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.8 ptm -162.25 126.05 3.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.819 0.342 . . . . 0.0 110.345 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -157.27 -67.22 0.1 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.126 0.488 . . . . 0.0 110.338 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.0 p -88.82 163.55 15.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.858 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.582 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 67.3 m -73.73 108.4 6.54 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.144 0.497 . . . . 0.0 110.903 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.529 ' O ' ' HD2' ' A' ' 130' ' ' PRO . 51.2 t -104.99 104.87 14.7 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.325 176.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.93 126.58 50.15 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.009 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 t -99.71 139.37 21.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.86 118.03 25.42 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.024 0.44 . . . . 0.0 110.101 -174.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.839 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.14 176.48 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.838 -178.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 57.6 mttt -143.67 138.72 29.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.097 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.433 ' CD2' HG21 ' A' ' 47' ' ' ILE . 86.8 mt -126.25 147.5 49.67 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 175.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.1 tt0 -105.01 127.95 53.09 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.225 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.68 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -112.98 120.7 42.28 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -145.65 175.93 24.92 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 119.667 -1.254 . . . . 0.0 111.926 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -167.91 150.41 5.65 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.152 0.501 . . . . 0.0 109.886 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.506 ' HG2' ' OD1' ' A' ' 118' ' ' ASN . 68.5 mtp180 -122.27 145.4 48.26 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.365 176.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.738 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -132.82 129.01 37.95 Favored 'General case' 0 C--N 1.314 -0.962 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.643 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.428 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 14.8 tt0 -126.09 147.95 49.47 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.223 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.783 HG11 ' H ' ' A' ' 113' ' ' GLY . 1.0 OUTLIER -103.05 156.3 5.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 170.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.746 ' NH2' ' HA ' ' A' ' 26' ' ' PRO . 17.6 mtm-85 -111.88 150.93 29.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -76.56 -6.26 51.16 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -136.95 106.14 8.85 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.746 ' HA ' ' NH2' ' A' ' 23' ' ' ARG . 71.5 Cg_exo -52.95 144.5 44.92 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.059 1.84 . . . . 0.0 112.272 175.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.43 ' N ' ' NH2' ' A' ' 23' ' ' ARG . 4.2 t -85.77 -175.28 5.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.745 -168.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.4 m -57.2 -33.69 43.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -171.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -87.93 -0.26 56.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.718 0.294 . . . . 0.0 111.496 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.72 35.02 23.44 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.407 175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -101.68 145.0 29.7 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.424 HG22 ' HG3' ' A' ' 26' ' ' PRO . 30.3 p -104.36 -33.86 8.49 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.1 m80 -110.02 145.28 37.28 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -170.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.464 ' OD1' ' HD3' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -122.95 116.52 23.73 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.417 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 50.8 p-90 -118.16 155.1 31.05 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.702 -175.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.644 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 48.3 ttp -130.86 121.07 24.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.574 175.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 9.2 m -100.82 152.03 5.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.05 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -153.72 151.73 29.96 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.597 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -121.88 124.78 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.246 168.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.442 ' HA ' ' NE ' ' A' ' 40' ' ' ARG . 2.6 mmp_? -133.43 168.71 18.12 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 120.975 0.417 . . . . 0.0 110.985 -173.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.449 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -85.46 118.22 4.74 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 173.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 45' ' ' SER . 40.3 Cg_endo -74.64 151.69 41.75 Favored 'Trans proline' 0 C--N 1.326 -0.647 0 C-N-CA 122.854 2.369 . . . . 0.0 113.01 -176.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 61.86 54.47 2.85 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.994 175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 66.2 1.06 1.85 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.297 0.639 . . . . 0.0 112.241 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' PRO . 12.9 m -76.53 139.43 40.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.0 111.541 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -103.06 124.95 49.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.574 HD12 HG21 ' A' ' 51' ' ' VAL . 19.9 pt -95.7 -2.37 10.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -169.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -68.74 -11.5 60.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.472 0.653 . . . . 0.0 110.175 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.51 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 95.6 m-70 -68.87 -40.98 78.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.122 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -110.05 -14.54 14.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.753 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.574 HG21 HD12 ' A' ' 47' ' ' ILE . 96.4 t -92.59 129.37 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.995 0.426 . . . . 0.0 110.351 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -95.33 -58.43 2.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.377 0.608 . . . . 0.0 110.615 -175.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -152.57 155.7 37.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.578 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 77.5 t -129.51 156.93 42.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 13.4 p -141.54 137.29 32.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.132 0.492 . . . . 0.0 111.042 -174.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.468 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 30.9 m-85 -119.07 108.3 14.55 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -79.63 95.59 5.95 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.05 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.582 ' CD2' HD11 ' A' ' 86' ' ' LEU . 10.6 mt -81.86 -178.07 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -87.85 152.08 22.37 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 1.7 mp0 -59.67 -15.45 19.5 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.079 -176.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -67.33 -18.89 65.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.348 0.594 . . . . 0.0 110.373 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.01 142.23 24.27 Favored Pre-proline 0 N--CA 1.449 -0.484 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.432 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.21 129.98 21.64 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.373 2.049 . . . . 0.0 110.384 171.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 61.01 76.62 0.4 Allowed Pre-proline 0 CA--C 1.531 0.233 0 O-C-N 123.45 0.469 . . . . 0.0 109.864 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.95 -18.17 62.72 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.467 2.111 . . . . 0.0 113.312 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -110.42 107.22 16.83 Favored 'General case' 0 N--CA 1.439 -1.003 0 O-C-N 122.06 -0.4 . . . . 0.0 110.653 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.6 mmt85 -105.74 108.0 19.29 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.415 178.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.8 m -97.74 138.85 21.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 174.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.3 m -123.2 113.19 18.61 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.995 0.426 . . . . 0.0 109.988 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -105.86 -25.54 12.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.625 0.726 . . . . 0.0 110.259 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.74 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 14.4 m-20 -75.05 -172.03 0.25 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.882 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.74 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 78.0 Cg_exo -38.42 -179.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 123.415 2.744 . . . . 0.0 114.027 166.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.63 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -30.48 125.98 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 124.622 3.548 . . . . 0.0 114.985 -153.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 31.5 m-85 -61.69 92.84 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.735 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.585 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 13.4 ptpt -147.71 144.7 28.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.235 0.541 . . . . 0.0 111.817 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.8 t -122.17 131.89 72.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.99 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -119.32 107.65 13.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.941 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.57 170.58 15.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.996 0.427 . . . . 0.0 110.828 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 5.8 t -117.92 143.88 45.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.371 -176.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.99 -162.43 11.97 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -137.38 -16.41 1.38 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.276 0.538 . . . . 0.0 111.38 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.431 ' HB3' ' HG3' ' B' ' 218' ' ' ALY . . . -142.94 143.51 32.02 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.671 0.272 . . . . 0.0 110.462 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -81.46 -177.86 52.03 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.715 -0.675 . . . . 0.0 113.128 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -176.8 157.6 1.53 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.087 0.555 . . . . 0.0 109.901 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.0 mm -63.41 120.17 9.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 172.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.582 HD11 ' CD2' ' A' ' 58' ' ' LEU . 5.9 tt -114.34 105.47 53.86 Favored Pre-proline 0 N--CA 1.444 -0.738 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.6 114.22 3.77 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.03 2.487 . . . . 0.0 112.231 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.468 HG12 ' CE2' ' A' ' 56' ' ' PHE . 3.7 mp -101.16 130.37 50.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.037 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.5 mt-10 -111.9 124.5 52.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.064 0.459 . . . . 0.0 110.149 174.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.8 t -103.29 117.84 49.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.71 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.537 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 89.5 m-85 -88.63 141.55 28.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.51 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.434 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 26.4 m-85 -115.43 154.39 29.35 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.702 177.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.22 93.22 7.64 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.578 HD21 ' HB2' ' A' ' 96' ' ' GLU . 60.9 t30 -155.65 162.37 40.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.286 0.565 . . . . 0.0 112.076 -172.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.721 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.2 OUTLIER -113.15 4.06 16.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.861 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.578 ' HB2' HD21 ' A' ' 94' ' ' ASN . 40.4 mm-40 -100.67 -155.57 0.52 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.153 -176.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.656 ' HB2' ' HD2' ' A' ' 98' ' ' PRO . 10.9 pt-20 -44.32 159.32 0.25 Allowed Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.591 0.756 . . . . 0.0 111.853 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 97' ' ' GLU . 4.3 Cg_exo -31.36 128.33 0.08 OUTLIER 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 125.064 3.843 . . . . 0.0 115.189 -162.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.57 19.54 3.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.972 -177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.515 ' HE2' ' CE2' ' A' ' 91' ' ' TYR . 1.9 ptpt -149.04 143.86 26.35 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.939 0.399 . . . . 0.0 110.288 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -128.51 154.4 39.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.236 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -120.78 117.13 26.65 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.073 0.464 . . . . 0.0 110.836 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.68 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.1 m-85 -109.04 109.94 21.09 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.573 175.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -74.4 115.41 13.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.361 0.6 . . . . 0.0 109.699 177.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.45 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 66.4 t80 -129.93 127.72 40.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.542 -174.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.88 111.46 18.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.847 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.504 HD11 HG11 ' A' ' 37' ' ' VAL . 2.0 mp -84.61 105.26 15.29 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -113.85 157.27 22.55 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.114 -0.635 . . . . 0.0 110.311 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.1 mt -131.0 154.81 47.77 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.412 ' HB2' ' CB ' ' A' ' 115' ' ' PRO . 29.5 m170 -101.64 169.72 8.65 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.394 174.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -55.98 134.64 52.46 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -173.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.558 ' HA ' HG21 ' A' ' 22' ' ' VAL . 3.5 tt0 -49.67 124.8 10.27 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.455 173.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.783 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 122.76 -52.19 0.77 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.127 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -146.58 73.59 12.69 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 117.501 0.65 . . . . 0.0 111.753 174.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.516 ' CG ' ' HB ' ' A' ' 22' ' ' VAL . 74.2 Cg_endo -107.46 108.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.857 2.371 . . . . 0.0 113.508 174.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -98.12 98.73 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.032 2.488 . . . . 0.0 111.033 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.738 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 38.4 t -115.05 117.61 56.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.245 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.506 ' OD1' ' HG2' ' A' ' 19' ' ' ARG . 63.4 t30 -145.57 114.62 6.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.643 175.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.466 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.5 t-80 -137.4 134.46 35.93 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.241 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.3 mt -119.19 151.1 38.93 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.612 0.57 . . . . 0.0 110.326 177.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.504 ' HG2' ' N ' ' A' ' 122' ' ' CYS . 21.9 ttm180 -142.58 153.76 43.81 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 176.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.504 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 85.7 m -137.73 122.97 19.32 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 9.6 mt-10 -119.5 155.37 32.26 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.473 0.178 . . . . 0.0 110.644 -177.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -107.96 138.6 43.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.617 0.722 . . . . 0.0 112.412 -172.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.839 ' HB2' HG23 ' A' ' 12' ' ' VAL . 6.8 mt -109.52 123.44 49.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.683 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.6 m -114.1 122.15 45.99 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.185 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.483 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 28.6 m-85 -118.45 109.39 16.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.112 -178.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.79 120.67 24.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.22 0.533 . . . . 0.0 111.433 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.582 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 65.1 m-80 53.36 60.78 11.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.116 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 71.6 Cg_endo -76.11 167.7 25.48 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.143 1.895 . . . . 0.0 110.755 174.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 72.2 p -70.36 141.16 52.26 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.419 ' HG3' ' NH1' ' A' ' 135' ' ' ARG . 20.6 tt0 -52.43 -43.05 64.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -173.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.558 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 8.9 p-10 -59.21 -29.65 67.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.848 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.605 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 8.1 t80 -75.27 -39.64 59.56 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.621 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 36.2 ttm180 -54.66 -45.28 73.81 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -56.23 -35.08 66.95 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.591 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 38.5 mtpt -74.8 -42.25 58.43 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.256 -0.277 . . . . 0.0 110.423 176.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.0 mt -68.93 -32.92 72.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 -177.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 37.5 mt -78.37 -33.1 49.16 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.773 0.32 . . . . 0.0 110.785 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -73.27 -26.77 61.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.481 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.953 179.07 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -104.82 -40.39 2.16 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.114 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -74.84 127.1 32.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.795 0.331 . . . . 0.0 110.795 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -69.17 166.31 30.21 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.208 177.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.513 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 6.9 Cg_endo -49.42 167.22 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.701 2.267 . . . . 0.0 113.021 175.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.496 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 6.5 tpp180 -144.63 121.03 10.97 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.448 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . 0.431 ' HG3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -82.75 67.69 8.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.61 0.719 . . . . 0.0 109.921 -177.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 86.0 mt -94.88 106.36 18.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.101 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -110.01 84.15 1.88 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.218 0.532 . . . . 0.0 110.167 177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 19.5 m -77.85 91.43 4.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.933 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -131.09 -63.96 0.83 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.149 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.417 -0.802 . . . . 0.0 110.443 -179.961 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 112.074 -0.411 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -98.83 34.83 1.98 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.881 0.372 . . . . 0.0 111.235 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -145.28 76.57 1.49 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.294 0.569 . . . . 0.0 110.502 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.6 mtm -74.67 74.24 2.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.765 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.08 74.82 1.54 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.754 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 p -60.54 124.21 19.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.045 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.742 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 48.4 m -87.88 108.85 19.37 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.463 ' O ' ' HD2' ' A' ' 130' ' ' PRO . 58.8 m -116.33 126.21 53.2 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.988 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.64 123.73 41.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.91 0.386 . . . . 0.0 111.504 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.74 141.38 17.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.3 mp0 -124.08 135.16 53.37 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.029 0.442 . . . . 0.0 110.106 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.838 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -111.87 173.51 2.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.632 174.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 122' ' ' CYS . 47.3 tttt -142.37 119.16 11.15 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -175.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.4 mt -107.35 142.31 37.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.203 0.525 . . . . 0.0 110.023 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.6 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.4 tm-20 -111.91 120.53 42.25 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.612 -176.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.604 HD12 HG12 ' A' ' 39' ' ' VAL . 1.4 mm? -103.19 112.47 25.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -135.67 169.52 23.47 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 119.565 -1.303 . . . . 0.0 111.485 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -164.01 151.43 12.24 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.976 -0.689 . . . . 0.0 111.337 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 21.0 mtp180 -114.98 150.63 35.49 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.327 173.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -145.06 126.79 15.25 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.767 176.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -121.35 151.24 40.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.855 HG11 ' H ' ' A' ' 113' ' ' GLY . 4.5 p -101.77 153.92 5.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 171.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.569 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 3.0 mtp180 -107.38 140.02 40.96 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -68.46 -16.06 63.76 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.756 0.788 . . . . 0.0 109.623 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -136.23 105.55 9.43 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.969 172.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.507 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.0 Cg_exo -49.9 156.3 3.49 Favored 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.844 2.363 . . . . 0.0 112.004 174.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.1 t -75.85 -173.92 2.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.838 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.42 -32.88 49.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.773 0.32 . . . . 0.0 111.45 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -84.39 -0.63 53.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.085 0.469 . . . . 0.0 110.742 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.41 32.14 52.4 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.638 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -92.03 130.91 37.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.507 HG22 ' HG3' ' A' ' 26' ' ' PRO . 77.3 p -89.35 -29.97 18.73 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.445 -169.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.404 ' O ' ' HA ' ' A' ' 79' ' ' SER . 69.6 m80 -116.17 143.1 45.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -172.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.569 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 0.6 OUTLIER -121.07 121.45 37.93 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 173.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -123.94 151.37 43.66 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.558 -174.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.66 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 56.0 ttp -127.33 116.59 20.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.705 175.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 8.7 m -98.2 151.98 4.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.38 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.563 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.0 OUTLIER -153.44 156.08 37.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 178.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.604 HG12 HD12 ' A' ' 16' ' ' LEU . 4.4 m -126.31 128.32 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.19 171.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -134.99 -177.07 4.47 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.023 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.488 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -93.53 -171.8 39.49 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.005 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 9.1 Cg_exo -67.41 111.76 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.562 2.175 . . . . 0.0 111.167 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 58.96 57.17 3.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.06 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 71.6 m80 67.83 9.36 7.06 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.489 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 71.5 m -67.47 138.04 56.3 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 122.432 -0.168 . . . . 0.0 110.902 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -70.3 126.15 28.82 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.922 0.391 . . . . 0.0 110.02 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.603 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.6 pt -97.32 -4.3 9.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -173.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -65.04 1.84 0.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -79.34 -33.39 43.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.505 0.193 . . . . 0.0 110.723 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.478 ' CE1' HG22 ' A' ' 47' ' ' ILE . 52.8 p90 -119.79 -20.78 7.48 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.211 174.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.603 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 91.7 t -89.36 130.29 38.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.48 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 10.3 tp10 -99.23 -63.07 1.16 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.204 0.526 . . . . 0.0 110.313 -176.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -144.06 152.84 41.52 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.045 178.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 97.5 t -127.04 159.06 37.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.208 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.571 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 13.0 p -141.74 137.33 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.131 0.491 . . . . 0.0 111.209 -176.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 23.6 m-85 -118.19 108.77 15.56 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -79.49 94.08 5.53 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.976 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.607 ' CD2' HD11 ' A' ' 86' ' ' LEU . 11.3 mt -78.67 -178.2 5.79 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.11 144.35 47.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.186 0.517 . . . . 0.0 109.811 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -59.23 -23.69 62.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.792 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.5 t -77.06 -13.35 59.97 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.751 0.31 . . . . 0.0 110.992 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -81.26 140.1 48.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.497 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -58.26 123.41 13.56 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 122.471 2.114 . . . . 0.0 110.798 172.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 57.87 77.58 0.4 Allowed Pre-proline 0 N--CA 1.454 -0.253 0 O-C-N 123.876 0.735 . . . . 0.0 110.733 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.12 -22.24 73.86 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.493 2.129 . . . . 0.0 113.094 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -106.29 105.84 16.07 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-O 120.858 0.361 . . . . 0.0 110.704 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.1 mmt85 -104.65 108.48 19.96 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.491 178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 2.8 m -97.69 136.51 28.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.1 m -120.3 113.61 20.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.038 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -104.78 -23.04 13.09 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.041 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.56 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -70.39 -174.87 0.26 Allowed Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.319 -175.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.649 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 48.4 Cg_exo -42.37 -179.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 123.542 2.828 . . . . 0.0 113.474 169.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.649 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 4.2 Cg_exo -28.4 122.41 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.451 3.434 . . . . 0.0 114.17 -159.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.563 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 40.7 m-85 -60.31 100.21 0.09 Allowed 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.276 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.66 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.2 ptpt -148.03 147.8 29.99 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.581 0.705 . . . . 0.0 112.501 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 36' ' ' MET . 83.8 t -122.91 132.28 71.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 114.378 -1.283 . . . . 0.0 109.428 177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -117.45 106.6 13.36 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.438 ' CD ' HH22 ' A' ' 67' ' ' ARG . 1.8 tp10 -133.71 175.95 8.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.515 -175.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 8.2 t -128.04 145.87 50.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.201 -178.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.21 -163.62 14.55 Favored Glycine 0 N--CA 1.453 -0.167 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.22 -12.57 2.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.693 0.746 . . . . 0.0 112.018 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.455 ' HB3' ' HE3' ' B' ' 218' ' ' ALY . . . -150.58 134.29 16.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.97 0.414 . . . . 0.0 111.119 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.47 167.16 44.59 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.201 -0.909 . . . . 0.0 114.144 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -166.53 154.84 10.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.017 -0.591 . . . . 0.0 109.964 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.0 mm -61.91 124.51 16.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.775 0.321 . . . . 0.0 110.375 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.607 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -118.34 104.92 47.27 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.671 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.31 119.53 6.43 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.058 2.505 . . . . 0.0 112.22 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.423 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.5 mt -109.13 129.31 64.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.179 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.571 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.8 mt-10 -110.39 126.31 54.15 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 0.0 110.044 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 80.2 t -106.08 121.65 58.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.564 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 96.6 m-85 -95.69 135.27 37.6 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.684 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.438 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.9 m-85 -109.55 156.44 20.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.342 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.48 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -98.48 93.08 5.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.004 0.43 . . . . 0.0 110.782 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.48 HD21 ' HB2' ' A' ' 96' ' ' GLU . 61.8 t30 -158.61 167.96 28.18 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.201 -0.312 . . . . 0.0 111.146 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.591 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.4 OUTLIER -113.59 4.57 16.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.02 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.554 ' HG2' ' CG2' ' A' ' 131' ' ' THR . 0.0 OUTLIER -101.16 -153.16 0.45 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.479 -175.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.583 ' HB2' ' HD2' ' A' ' 98' ' ' PRO . 13.9 pt-20 -39.84 155.16 0.17 Allowed Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 123.781 0.832 . . . . 0.0 112.027 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.583 ' HD2' ' HB2' ' A' ' 97' ' ' GLU . 2.2 Cg_endo -35.87 123.07 0.27 Allowed 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 124.896 3.73 . . . . 0.0 114.511 -165.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.429 ' N ' ' HD3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -93.63 21.02 6.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.067 -177.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -143.05 138.93 30.28 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.093 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.507 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.2 m -128.38 155.83 40.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.674 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.98 120.03 26.72 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.507 ' CZ ' HG21 ' A' ' 101' ' ' VAL . 21.1 m-85 -110.48 132.72 53.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.659 0.266 . . . . 0.0 110.638 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -91.55 105.88 18.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.502 0.668 . . . . 0.0 109.573 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -116.66 135.78 53.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.573 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -87.8 114.51 24.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.993 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.549 HD11 HG11 ' A' ' 37' ' ' VAL . 1.7 mp -90.42 91.34 8.42 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 175.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -102.37 155.01 18.53 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.072 0.463 . . . . 0.0 110.977 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 mt -129.14 163.31 25.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -91.69 174.35 7.4 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.285 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.48 149.47 42.71 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.167 0.508 . . . . 0.0 111.554 177.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.756 ' HA ' HG21 ' A' ' 22' ' ' VAL . 18.7 tt0 -65.12 102.24 0.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.107 176.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.855 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 108.51 23.38 6.61 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.36 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.517 ' CG ' ' HD2' ' A' ' 115' ' ' PRO . 48.4 t60 -128.55 154.76 79.53 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 118.639 -0.695 . . . . 0.0 109.134 -176.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 114' ' ' HIS . 7.0 Cg_exo -31.03 171.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.516 0 C-N-CA 125.042 3.828 . . . . 0.0 116.038 171.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -98.16 169.97 0.68 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 124.4 3.4 . . . . 0.0 112.41 -169.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 22.3 t -115.99 131.17 69.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.482 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -145.35 97.85 3.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -126.23 131.56 51.92 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.545 -174.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.8 mt -107.39 146.54 31.51 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 123.698 0.623 . . . . 0.0 109.835 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 0.0 OUTLIER -139.96 129.01 23.59 Favored 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -177.246 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.455 ' N ' ' HD3' ' A' ' 121' ' ' ARG . 67.2 m -120.07 123.91 44.56 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -172.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -122.43 145.49 48.24 Favored 'General case' 0 C--O 1.23 0.054 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.727 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -100.61 129.14 46.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.22 0.533 . . . . 0.0 111.797 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.838 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.5 mt -94.63 119.44 33.28 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.688 172.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.5 m -109.51 123.53 49.56 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.894 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.485 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 31.3 m-85 -120.07 108.3 14.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.894 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -78.73 118.2 20.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.508 -177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.742 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 6.7 t30 50.02 64.55 8.24 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.676 -178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 127' ' ' PHE . 74.3 Cg_endo -74.68 178.06 7.64 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.402 2.068 . . . . 0.0 111.673 177.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.554 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 10.8 p -72.19 142.94 49.04 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 174.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.58 -37.93 76.83 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.067 -177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -63.85 -29.37 70.57 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.653 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 9.6 t80 -73.85 -42.05 61.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.639 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.1 ttm180 -54.3 -46.05 72.69 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.766 173.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -54.61 -38.26 66.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.441 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 44.3 mtpt -73.93 -40.19 63.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.799 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.7 mt -67.87 -32.57 73.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 40.5 mt -79.71 -32.28 41.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.763 0.316 . . . . 0.0 111.099 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -75.89 -25.74 56.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.306 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.216 174.859 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.725 0 N-CA-C 111.807 -0.517 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -82.7 107.43 2.85 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.287 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm 62.92 -154.16 0.34 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 122.737 0.415 . . . . 0.0 110.198 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.484 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -63.56 164.72 14.3 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.109 173.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.484 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 10.5 Cg_endo -54.54 157.97 11.14 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.038 1.825 . . . . 0.0 111.437 175.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -128.41 160.77 31.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.91 0.386 . . . . 0.0 110.387 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . 0.455 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -77.94 -42.42 33.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.092 0.473 . . . . 0.0 109.858 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 90.3 mt -101.42 95.0 6.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.785 177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' B' ' 224' ' ' ALA . . . 64.92 89.81 0.09 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.728 0.643 . . . . 0.0 111.731 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 32.8 m -64.7 110.61 2.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.589 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 61.48 27.63 17.13 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.458 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . 0.415 ' HA ' ' HB1' ' B' ' 221' ' ' ALA . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.518 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m 58.0 42.79 22.13 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.258 0.552 . . . . 0.0 110.619 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -75.25 120.81 21.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.879 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -99.21 -24.46 14.85 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.385 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 64.35 -78.04 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.044 0.84 . . . . 0.0 111.78 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.6 t -140.04 124.97 18.44 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.489 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 16.9 m -103.01 108.91 20.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.84 0.352 . . . . 0.0 110.445 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.645 ' O ' ' HD2' ' A' ' 130' ' ' PRO . 42.7 t -92.24 111.63 23.26 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.96 118.37 35.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.095 0.474 . . . . 0.0 111.581 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 t -100.01 143.88 13.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -135.83 127.59 29.17 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.391 0.615 . . . . 0.0 110.955 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.794 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.02 176.81 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.942 -177.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.582 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 95.3 mttt -138.64 137.63 37.09 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.408 ' HG ' HD11 ' A' ' 125' ' ' LEU . 88.8 mt -122.45 142.05 50.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.076 0.465 . . . . 0.0 109.812 173.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.2 tt0 -104.34 124.65 49.58 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.999 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.643 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -110.85 114.17 27.3 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -140.09 174.86 22.23 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.618 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 36' ' ' MET . 2.0 p-80 -166.17 153.05 9.53 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.212 0.529 . . . . 0.0 110.195 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 38.4 mtp180 -120.8 134.59 55.28 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.438 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -129.89 119.87 23.99 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.492 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -117.89 145.84 44.34 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.757 HG21 ' HA ' ' A' ' 112' ' ' GLU . 5.0 p -99.07 154.79 4.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 32' ' ' THR . 2.4 mtp180 -107.61 147.89 30.04 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -76.54 -12.44 60.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.764 0.792 . . . . 0.0 109.502 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -142.5 104.97 5.45 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.032 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.437 ' HG3' HG22 ' A' ' 32' ' ' THR . 78.7 Cg_exo -47.25 157.86 0.63 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.489 2.793 . . . . 0.0 113.46 177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -76.97 -173.04 2.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.898 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.482 HG22 ' OE1' ' A' ' 29' ' ' GLU . 2.1 m -66.52 -28.8 44.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.96 0.409 . . . . 0.0 110.898 -174.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.482 ' OE1' HG22 ' A' ' 28' ' ' VAL . 1.9 mp0 -78.49 -8.12 58.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.124 0.488 . . . . 0.0 110.227 175.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.01 32.99 37.92 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.2 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -98.94 140.8 32.56 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.437 HG22 ' HG3' ' A' ' 26' ' ' PRO . 38.0 p -89.25 -27.26 20.72 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -169.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -118.85 142.59 47.59 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -172.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -116.09 119.48 35.98 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 172.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 78' ' ' GLU . 48.8 p-90 -121.35 150.96 40.68 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.093 0.473 . . . . 0.0 111.13 -178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 53.4 ttp -126.34 120.6 30.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.679 175.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.4 m -101.19 150.1 6.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.225 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.635 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.2 p90 -151.46 152.41 32.99 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.5 m -124.03 127.24 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.001 170.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -136.8 -176.74 4.46 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 -176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . -91.82 169.63 32.67 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 175.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 15.0 Cg_endo -53.39 113.96 1.54 Allowed 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 123.776 2.984 . . . . 0.0 112.657 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 56.32 51.26 11.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.419 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 69.12 11.95 8.39 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.482 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.478 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 66.8 m -62.27 126.83 28.7 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 171.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.54 ' OD1' ' HB2' ' A' ' 48' ' ' GLN . 6.5 t-20 -68.7 125.49 26.71 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.095 -175.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.626 HD12 HG21 ' A' ' 51' ' ' VAL . 1.5 pt -96.78 -2.37 10.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -174.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.54 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 11.1 mt-30 -61.82 -3.95 1.34 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -77.56 -37.85 49.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.401 0.143 . . . . 0.0 110.871 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.443 ' CE2' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -115.23 -18.61 11.07 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.547 176.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.626 HG21 HD12 ' A' ' 47' ' ' ILE . 84.2 t -90.48 130.15 40.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.413 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 8.4 tp10 -98.83 -58.58 1.91 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.315 0.579 . . . . 0.0 110.355 -176.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -149.02 153.76 38.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.048 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 55' ' ' VAL . 66.9 t -129.12 159.09 41.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.229 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.592 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.2 p -143.1 135.1 24.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.219 0.533 . . . . 0.0 111.363 -175.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.527 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 27.6 m-85 -116.7 111.66 20.11 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -82.16 93.15 7.0 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.414 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.608 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.6 mt -76.87 -176.91 4.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.426 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.507 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 36.8 t60 -66.86 138.69 57.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.063 0.459 . . . . 0.0 109.802 -177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 58.0 mm-40 -56.3 -25.68 49.36 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -169.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.4 t -75.52 -18.31 59.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.451 0.167 . . . . 0.0 111.438 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 59' ' ' HIS . 3.3 m-85 -75.09 134.91 73.91 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -60.99 117.56 4.34 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.714 2.276 . . . . 0.0 111.437 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 59.02 70.51 1.13 Allowed Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.503 -171.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.73 -17.45 59.12 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.733 2.288 . . . . 0.0 111.866 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -91.88 102.33 14.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.165 -177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.0 mmt180 -97.91 104.68 16.73 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.781 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.05 136.14 24.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.218 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 79.6 m -126.12 115.42 19.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.953 0.406 . . . . 0.0 109.923 175.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -106.69 -24.77 12.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.605 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.726 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 6.0 p-10 -75.71 -174.71 0.41 Allowed Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.329 -175.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.726 ' HD2' ' HB2' ' A' ' 71' ' ' ASP . 71.7 Cg_exo -39.11 -172.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 124.01 3.14 . . . . 0.0 114.548 167.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.648 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 8.5 Cg_endo -35.55 122.92 0.24 Allowed 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.399 2.733 . . . . 0.0 113.662 -152.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.635 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 44.2 m-85 -61.93 91.2 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.21 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 5.4 ptpt -139.37 146.4 40.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.256 0.551 . . . . 0.0 112.034 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.7 t -120.96 132.29 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.345 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.54 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 5.3 mm-40 -108.56 106.04 15.93 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.246 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 35' ' ' TRP . 1.5 tp10 -134.79 171.06 14.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.709 0.29 . . . . 0.0 110.412 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -131.91 144.4 50.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.856 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.5 -170.34 27.18 Favored Glycine 0 CA--C 1.517 0.184 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -126.72 -11.63 6.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.289 0.544 . . . . 0.0 111.771 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' B' ' 217' ' ' ARG . . . -147.83 141.49 25.57 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.961 0.41 . . . . 0.0 111.565 -176.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.11 164.49 51.41 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.452 -0.794 . . . . 0.0 113.099 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -163.31 156.37 18.92 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -177.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.458 HD13 ' HA ' ' A' ' 106' ' ' ASP . 21.9 mm -64.37 126.07 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 110.211 173.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.608 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.0 tt -120.39 104.46 42.99 Favored Pre-proline 0 N--CA 1.444 -0.749 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.232 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.9 116.56 4.2 Favored 'Trans proline' 0 C--O 1.235 0.359 0 C-N-CA 123.296 2.664 . . . . 0.0 112.536 172.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.417 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.8 mt -107.76 127.45 63.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.175 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.592 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.5 mt-10 -110.11 126.88 54.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.1 0.476 . . . . 0.0 110.01 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.3 t -106.49 119.97 56.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.744 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 88.5 m-85 -92.53 135.84 33.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.822 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.427 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.1 m-85 -109.93 148.21 32.02 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.308 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.413 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -87.52 94.6 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.519 HD21 ' HB3' ' A' ' 96' ' ' GLU . 58.9 t30 -155.66 155.4 33.15 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.273 -172.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.52 -2.51 18.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.693 0.758 . . . . 0.0 109.466 171.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.519 ' HB3' HD21 ' A' ' 94' ' ' ASN . 2.1 tp10 -101.55 -152.01 0.43 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.218 -174.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.445 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 8.2 mm-40 -29.42 150.33 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 124.195 0.998 . . . . 0.0 113.548 177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.0 Cg_exo -32.2 126.54 0.1 OUTLIER 'Trans proline' 0 C--N 1.358 1.05 1 C-N-CA 125.415 4.077 . . . . 0.0 115.011 -168.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.476 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -89.64 19.03 4.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.304 -177.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.9 140.07 16.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.361 0.6 . . . . 0.0 111.552 -177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.2 m -130.47 155.36 41.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.008 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -123.44 120.33 32.64 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.978 0.418 . . . . 0.0 111.25 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.643 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.5 m-85 -112.44 116.6 30.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.446 174.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -85.93 105.98 16.79 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.457 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 61.8 t80 -112.34 137.2 50.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.911 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.458 ' HA ' HD13 ' A' ' 85' ' ' ILE . 38.2 t70 -86.36 103.52 15.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.308 -176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.499 HD11 HG11 ' A' ' 37' ' ' VAL . 2.5 mp -82.21 115.82 21.47 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 174.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.499 ' HB2' ' HA3' ' B' ' 213' ' ' GLY . 50.0 p90 -131.15 160.74 33.87 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.534 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.9 mt -136.18 163.26 30.78 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -175.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -100.84 172.81 6.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 172.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.99 152.25 24.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.846 0.355 . . . . 0.0 111.677 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.757 ' HA ' HG21 ' A' ' 22' ' ' VAL . 10.4 tt0 -64.2 106.3 1.06 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.926 175.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.51 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 108.05 23.01 6.92 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 -175.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.449 ' HB3' ' HD2' ' A' ' 115' ' ' PRO . 21.9 m-70 -133.89 163.57 50.19 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 114' ' ' HIS . 1.3 Cg_endo -43.37 162.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.074 3.183 . . . . 0.0 114.392 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -89.53 -179.27 1.9 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.947 3.098 . . . . 0.0 111.288 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 16.7 t -126.82 134.15 66.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.671 -175.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -144.15 97.45 3.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.5 ' O ' HD23 ' A' ' 120' ' ' LEU . 59.5 t-80 -120.82 137.68 54.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.764 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.5 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.0 mt -120.48 146.95 45.75 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.478 0.487 . . . . 0.0 110.436 178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 21.3 ttm180 -138.93 149.99 45.41 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.448 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 71.6 m -133.7 121.13 21.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 175.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -116.62 133.79 55.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 110.358 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -84.7 141.44 30.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.544 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.794 ' HB2' HG23 ' A' ' 12' ' ' VAL . 5.3 mt -111.35 110.47 20.95 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.2 m -107.09 120.02 40.95 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.822 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.547 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 25.8 m-85 -116.78 109.98 17.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.787 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -79.0 116.91 19.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.976 0.417 . . . . 0.0 110.576 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 4.6 t30 56.7 61.67 6.79 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.211 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 72.0 Cg_endo -75.74 169.86 21.38 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.306 2.004 . . . . 0.0 111.039 171.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 67.3 p -74.84 144.66 43.34 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -53.35 -43.09 67.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -172.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -55.73 -34.18 64.91 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.883 0.373 . . . . 0.0 110.421 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.682 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 7.8 t80 -75.95 -40.9 53.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.592 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.6 ttm180 -54.79 -43.92 73.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.564 0.697 . . . . 0.0 109.386 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.23 -36.49 75.55 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.216 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -73.97 -40.66 62.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.749 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.0 mt -66.81 -37.08 83.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.02 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 42.1 mt -75.33 -34.08 61.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.04 0.447 . . . . 0.0 110.577 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -72.32 -26.43 61.94 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.956 -175.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.352 -0.833 . . . . 0.0 110.541 175.986 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.916 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 108' ' ' PHE . . . 109.21 176.54 21.42 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.856 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -128.43 36.88 4.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.826 0.346 . . . . 0.0 110.117 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.583 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -135.28 169.06 14.74 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.583 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 29.2 Cg_endo -62.58 169.25 8.66 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 121.788 1.659 . . . . 0.0 111.49 176.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.458 ' HA ' ' HB1' ' A' ' 82' ' ' ALA . 33.1 mtp180 -138.66 157.3 46.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.159 0.504 . . . . 0.0 110.883 178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -82.87 154.53 24.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.858 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 35.6 tp -81.66 62.47 5.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.311 0.576 . . . . 0.0 109.501 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -79.85 -37.71 34.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.062 -176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 30.9 m 65.54 93.57 0.07 Allowed 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.532 0.52 . . . . 0.0 111.533 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -69.82 129.38 39.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.193 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 O-C-N 123.849 0.718 . . . . 0.0 111.221 179.01 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 111.621 -0.592 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -80.48 -33.11 36.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.733 0.266 . . . . 0.0 111.178 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -88.12 -41.35 13.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.116 0.484 . . . . 0.0 109.911 177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.3 mtt -118.26 98.42 6.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.948 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.36 143.4 26.75 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.42 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 p -76.12 91.72 3.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.434 177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.434 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 15.6 t -80.85 109.69 15.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.184 -177.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 60.1 m -131.44 141.35 49.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.537 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.11 151.01 31.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.56 138.52 41.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.418 ' HB3' ' HD2' ' A' ' 124' ' ' LYS . 8.9 mt-30 -114.39 138.77 50.13 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.806 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -132.71 125.77 53.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.441 177.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -99.81 130.23 45.99 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.639 -0.663 . . . . 0.0 111.279 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD13 HG11 ' A' ' 90' ' ' VAL . 96.3 mt -108.98 142.38 39.72 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.848 176.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.68 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.0 tt0 -104.15 126.42 51.25 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.195 -174.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.612 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -114.55 122.64 47.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -152.1 172.74 31.37 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.239 177.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -165.7 152.38 9.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.044 0.449 . . . . 0.0 110.138 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -117.03 152.04 35.48 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -141.96 133.29 26.47 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.532 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -129.79 164.74 23.4 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.823 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.845 HG11 ' H ' ' A' ' 113' ' ' GLY . 2.4 p -104.24 161.01 4.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 168.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.499 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 4.3 mtp85 -105.52 140.54 38.45 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -67.05 -17.87 65.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.73 0.776 . . . . 0.0 109.477 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -136.76 107.31 9.04 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.893 175.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.528 ' HG3' HG22 ' A' ' 32' ' ' THR . 64.7 Cg_exo -45.89 156.3 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.277 2.651 . . . . 0.0 113.176 177.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 29' ' ' GLU . 11.3 t -75.99 -169.92 1.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.634 -171.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.54 -27.4 42.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 122.874 0.47 . . . . 0.0 111.532 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' H ' HG23 ' A' ' 27' ' ' THR . 20.7 mm-40 -86.6 -12.06 49.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.408 0.623 . . . . 0.0 109.856 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.85 19.96 38.46 Favored Glycine 0 CA--C 1.503 -0.7 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.575 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -91.25 145.18 24.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.663 -0.768 . . . . 0.0 110.827 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.528 HG22 ' HG3' ' A' ' 26' ' ' PRO . 44.6 p -94.0 -28.72 15.61 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.4 -164.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.407 ' NE2' ' O ' ' A' ' 110' ' ' HIS . 59.9 m80 -108.64 153.69 23.06 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -169.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 1.1 m-20 -131.95 133.35 44.41 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.409 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 56.7 p-90 -139.19 149.82 44.85 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.046 0.451 . . . . 0.0 111.488 -177.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.654 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 47.7 ttp -125.85 120.91 31.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.887 174.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.5 m -99.92 152.73 4.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.315 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.3 p90 -150.94 153.16 34.72 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.68 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.4 m -127.09 128.54 70.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.244 170.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -135.28 -176.12 4.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.949 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.476 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -91.12 -169.06 42.11 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.269 177.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 4.9 Cg_exo -72.82 112.16 3.43 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.665 2.244 . . . . 0.0 111.617 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 59.55 60.68 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.536 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 67.0 m80 71.16 -3.0 2.18 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 66.6 m -60.06 134.15 56.78 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.479 0.181 . . . . 0.0 111.299 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -69.96 126.42 29.64 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.659 HD12 HG21 ' A' ' 51' ' ' VAL . 1.5 pt -96.66 -4.84 9.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -174.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -68.89 6.21 0.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.851 0.357 . . . . 0.0 111.782 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -80.12 -33.57 38.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.546 172.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.4 ' CE1' HG22 ' A' ' 47' ' ' ILE . 54.4 p90 -119.39 -18.75 8.46 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.301 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.659 HG21 HD12 ' A' ' 47' ' ' ILE . 91.4 t -88.68 131.25 36.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -98.06 -52.01 3.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 0.0 110.366 -175.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -156.97 158.56 36.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.214 -0.903 . . . . 0.0 108.67 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 55' ' ' VAL . 93.9 t -132.29 158.11 43.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.586 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.6 p -141.92 135.39 29.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.225 0.535 . . . . 0.0 111.085 -175.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.512 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 29.3 m-85 -117.59 108.37 15.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -78.73 92.57 4.81 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.161 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.621 ' CD2' HD11 ' A' ' 86' ' ' LEU . 10.7 mt -76.9 -178.42 4.89 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -79.01 144.02 35.1 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.07 -19.76 21.15 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.832 -174.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -66.58 -21.95 66.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.111 0.481 . . . . 0.0 110.997 176.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -84.14 132.89 46.54 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.528 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.82 122.43 10.98 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.41 2.074 . . . . 0.0 111.1 172.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 59.96 69.3 1.25 Allowed Pre-proline 0 CA--C 1.531 0.232 0 O-C-N 123.738 0.649 . . . . 0.0 110.476 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.81 -22.4 49.49 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.636 2.224 . . . . 0.0 113.157 -175.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -93.33 98.47 11.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.247 0.546 . . . . 0.0 110.202 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 13.2 mmt180 -94.36 96.69 9.7 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.446 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -86.35 136.66 22.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 172.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.0 m -124.86 111.6 15.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.03 0.443 . . . . 0.0 109.925 176.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -100.73 -27.51 13.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.681 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.503 ' OD1' ' HD2' ' A' ' 72' ' ' PRO . 28.4 t70 -69.63 168.63 15.99 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.712 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.61 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 42.4 Cg_exo -26.35 -168.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.864 1 C-N-CA 126.12 4.547 . . . . 0.0 116.277 161.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.61 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 10.3 Cg_endo -37.18 120.2 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.981 2.454 . . . . 0.0 113.976 -151.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 35.3 m-85 -62.45 98.37 0.11 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.935 -177.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 11.9 ptpt -149.52 146.23 27.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.468 0.651 . . . . 0.0 112.103 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.9 t -126.5 131.22 71.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.011 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -117.0 111.34 19.43 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -132.7 171.54 13.72 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.33 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 5.0 t -116.4 146.41 42.52 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.18 172.06 28.52 Favored Glycine 0 CA--C 1.507 -0.434 0 C-N-CA 121.204 -0.522 . . . . 0.0 112.802 -173.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -130.41 -4.17 4.3 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.962 0.41 . . . . 0.0 110.215 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' B' ' 217' ' ' ARG . . . -164.1 137.19 5.18 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.222 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.49 -174.47 28.72 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 116.187 -0.46 . . . . 0.0 114.19 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.0 p90 179.96 158.02 0.71 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.858 0.463 . . . . 0.0 110.462 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.6 mm -65.83 129.26 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.621 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.3 tt -120.85 104.76 41.48 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-O 121.109 0.48 . . . . 0.0 110.154 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.82 114.37 3.12 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 123.25 2.634 . . . . 0.0 112.196 172.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -104.43 124.58 59.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.065 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.586 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.0 mt-10 -108.52 127.09 53.62 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.164 0.507 . . . . 0.0 110.008 175.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.452 HG11 HD13 ' A' ' 14' ' ' LEU . 57.0 t -106.73 117.98 53.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.622 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 81.0 m-85 -90.32 139.33 30.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.809 -178.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.448 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.0 m-85 -114.94 151.66 33.68 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.197 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.5 95.48 9.98 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.614 HD21 ' HB2' ' A' ' 96' ' ' GLU . 56.6 t30 -155.5 160.9 40.94 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.222 0.534 . . . . 0.0 111.595 -173.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.66 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.6 OUTLIER -112.37 -1.42 15.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.778 178.132 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.614 ' HB2' HD21 ' A' ' 94' ' ' ASN . 18.4 mm-40 -102.02 -154.19 0.48 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.787 -175.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 97' ' ' GLU . 2.4 mp0 -26.79 152.5 0.01 OUTLIER Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.938 1.295 . . . . 0.0 114.082 172.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 3.2 Cg_exo -31.66 125.11 0.09 OUTLIER 'Trans proline' 0 C--N 1.361 1.197 1 C-N-CA 125.399 4.066 . . . . 0.0 114.756 -169.206 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.26 19.72 3.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.998 -177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -153.49 146.47 24.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.188 0.518 . . . . 0.0 110.934 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.9 OUTLIER -128.7 155.87 40.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.025 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -120.89 121.29 37.75 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.841 0.353 . . . . 0.0 111.064 176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.612 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.4 m-85 -113.79 112.21 23.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.649 173.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.31 105.97 11.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -115.57 137.25 52.26 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.672 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -85.86 114.25 22.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.894 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.532 HD11 HG11 ' A' ' 37' ' ' VAL . 2.0 mp -92.89 103.86 16.15 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 174.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -115.59 158.9 21.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.064 0.459 . . . . 0.0 110.28 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.1 mt -130.75 158.11 41.0 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.407 ' O ' ' NE2' ' A' ' 33' ' ' HIS . 2.8 m-70 -101.82 173.86 6.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.297 0.498 . . . . 0.0 110.648 173.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -62.4 136.8 58.08 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -173.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.487 ' HA ' HG21 ' A' ' 22' ' ' VAL . 6.5 tt0 -51.4 122.81 8.47 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.844 177.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.845 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 122.8 -50.66 0.83 Allowed Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.963 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -145.19 74.7 14.17 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 117.183 0.491 . . . . 0.0 110.605 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.514 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 39.6 Cg_endo -107.06 108.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 123.131 2.554 . . . . 0.0 113.263 176.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -98.27 97.52 0.07 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 123.0 2.467 . . . . 0.0 111.068 170.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 39.5 t -116.93 107.5 22.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.619 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.471 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -135.79 98.37 3.89 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 174.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -121.8 142.78 49.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.178 -176.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.456 HD11 ' CG ' ' A' ' 15' ' ' GLU . 16.6 tp -136.99 159.38 42.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.163 0.506 . . . . 0.0 111.57 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.502 ' HD2' HD23 ' A' ' 16' ' ' LEU . 19.7 ttm180 -152.98 149.23 27.98 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.321 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.414 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 69.5 m -138.7 118.25 12.98 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 174.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -114.7 146.06 41.34 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 11' ' ' GLN . 38.6 ttpt -103.52 127.48 50.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.416 0.627 . . . . 0.0 112.398 -174.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.806 ' HB2' HG23 ' A' ' 12' ' ' VAL . 7.7 mt -86.43 149.53 24.93 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 169.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 7.3 m -140.97 121.89 14.5 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.144 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -115.93 114.85 25.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.232 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -84.76 120.85 26.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.315 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 55.1 m-80 50.5 65.49 6.73 Favored Pre-proline 0 N--CA 1.467 0.409 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.766 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -82.35 -178.76 4.2 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.764 2.309 . . . . 0.0 112.074 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 74.4 p -74.97 137.15 41.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 170.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -61.19 -29.15 69.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -67.57 -28.3 67.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.646 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.8 t80 -75.07 -42.96 55.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.409 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.66 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 39.3 ttm180 -54.45 -43.69 71.85 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.755 173.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -55.87 -39.79 72.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.156 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 51.0 mtpt -71.09 -39.76 71.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.811 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 33.9 mt -69.61 -26.68 64.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.73 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 41.6 mt -86.19 -28.88 23.62 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.054 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -77.22 -31.15 55.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.261 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.828 178.487 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.84 -93.0 1.72 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.844 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -80.63 141.33 35.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.015 0.436 . . . . 0.0 110.411 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.409 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -75.17 162.91 71.23 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.715 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.409 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 14.0 Cg_endo -58.97 172.27 1.73 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.221 1.947 . . . . 0.0 112.129 173.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.507 ' HA ' ' HB1' ' A' ' 82' ' ' ALA . 11.8 ptp180 -152.74 153.68 33.71 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.28 0.562 . . . . 0.0 111.577 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -136.66 26.7 3.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.747 -173.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 51.2 tp -106.96 89.28 2.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.316 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -94.16 16.19 15.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.83 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 30.0 m 75.29 -61.08 0.49 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.926 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 57.01 64.73 1.56 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.346 0.593 . . . . 0.0 110.728 -175.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.146 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.687 177.89 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t 59.23 76.16 0.37 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.37 0.605 . . . . 0.0 110.336 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -153.89 -172.13 4.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.977 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.5 tpp 61.86 80.05 0.24 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.804 0.69 . . . . 0.0 110.914 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.48 148.8 35.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.375 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.0 p -79.27 76.49 5.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.109 0.481 . . . . 0.0 110.559 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.404 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 25.2 t -73.87 109.41 7.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.379 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.9 m -105.33 114.89 29.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.692 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.9 131.21 43.9 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.054 0.454 . . . . 0.0 111.974 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 t -101.72 140.72 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.1 mp0 -125.78 120.66 31.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.087 0.47 . . . . 0.0 110.224 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.857 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -108.52 177.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.686 179.007 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 98.7 mttt -142.58 136.42 29.2 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.579 0.228 . . . . 0.0 110.74 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.437 ' HG ' HD11 ' A' ' 125' ' ' LEU . 79.4 mt -119.68 142.56 48.37 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 0.0 109.945 174.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.609 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.8 tt0 -102.87 123.08 45.84 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.058 -176.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.645 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.3 mm? -109.78 113.68 26.63 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 174.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -142.67 173.8 23.8 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.849 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -164.01 151.93 12.7 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.007 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 70.6 mtt180 -116.82 140.92 48.87 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.748 171.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.0 125.51 29.87 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.282 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -119.5 155.07 32.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.718 HG21 ' HA ' ' A' ' 112' ' ' GLU . 4.9 p -103.93 159.3 5.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.452 ' HD2' ' OD2' ' A' ' 34' ' ' ASP . 2.2 mtp180 -108.84 147.43 32.12 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -72.13 -18.39 61.9 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.651 0.738 . . . . 0.0 109.28 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -139.89 103.81 6.87 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.412 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.533 ' HG3' HG22 ' A' ' 32' ' ' THR . 70.2 Cg_exo -47.2 156.61 0.81 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.533 2.822 . . . . 0.0 112.736 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.422 HG22 ' HB2' ' A' ' 31' ' ' PHE . 10.2 t -77.23 -174.52 3.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.665 -172.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.49 HG22 ' OE1' ' A' ' 29' ' ' GLU . 1.1 m -64.15 -27.81 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.106 0.479 . . . . 0.0 110.827 -175.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.49 ' OE1' HG22 ' A' ' 28' ' ' VAL . 2.3 mp0 -80.18 -2.06 43.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.382 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.26 31.22 63.92 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.365 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.422 ' HB2' HG22 ' A' ' 27' ' ' THR . 21.6 m-30 -93.64 131.55 38.84 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.533 HG22 ' HG3' ' A' ' 26' ' ' PRO . 62.1 p -89.69 -20.32 23.77 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.426 -168.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.413 ' NE2' ' O ' ' A' ' 110' ' ' HIS . 66.0 m80 -124.07 148.33 47.18 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -172.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.452 ' OD2' ' HD2' ' A' ' 23' ' ' ARG . 7.4 m-20 -123.82 123.79 41.24 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 170.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -123.8 154.24 39.85 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.29 0.567 . . . . 0.0 111.192 -176.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.643 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 15.1 tmm? -128.96 136.71 50.73 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.062 174.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.3 m -121.67 149.43 24.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.387 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.663 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.6 OUTLIER -149.32 157.25 43.18 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.2 m -123.91 126.38 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.662 167.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -135.39 -176.28 4.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.734 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . -93.19 179.15 39.18 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.427 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.413 ' HB3' ' HB2' ' A' ' 13' ' ' LYS . 33.8 Cg_endo -73.97 112.67 3.6 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.337 2.025 . . . . 0.0 111.879 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 61.71 47.86 5.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.079 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 67.88 6.97 5.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.715 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.489 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 48.6 m -63.26 122.53 16.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -60.83 125.01 22.14 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.93 0.395 . . . . 0.0 110.528 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.584 HD12 HG21 ' A' ' 51' ' ' VAL . 1.7 pt -95.3 -2.2 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.738 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -59.23 -12.85 5.99 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.306 0.574 . . . . 0.0 110.672 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -67.8 -45.0 76.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.959 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.416 ' CE2' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -111.83 -18.37 12.72 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.309 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.584 HG21 HD12 ' A' ' 47' ' ' ILE . 59.3 t -92.58 137.02 23.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.964 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.555 ' HB2' ' HG3' ' A' ' 93' ' ' LYS . 10.5 tp10 -113.98 -63.18 1.49 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.271 0.557 . . . . 0.0 110.915 -176.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 24.9 tttt -136.73 149.55 47.92 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.129 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 99.0 t -131.13 156.94 43.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.601 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.9 p -140.62 134.9 34.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.374 0.606 . . . . 0.0 111.601 -175.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.496 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 16.1 m-85 -117.33 111.26 19.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -81.75 97.88 8.17 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.043 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.625 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.3 mt -80.77 -177.82 6.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.877 0.37 . . . . 0.0 110.631 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 143.2 45.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -60.04 -23.29 63.61 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -171.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.1 t -70.68 -22.15 62.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.998 0.427 . . . . 0.0 110.867 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 17.8 m-85 -75.39 141.48 73.52 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.731 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 62' ' ' PHE . 23.4 Cg_exo -64.77 128.55 21.23 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.395 2.063 . . . . 0.0 110.318 171.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.519 ' O ' ' HD3' ' A' ' 67' ' ' ARG . 52.9 mtm180 58.11 74.92 0.58 Allowed Pre-proline 0 C--N 1.331 -0.226 0 O-C-N 123.618 0.574 . . . . 0.0 110.246 -175.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.1 -24.38 52.12 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.509 2.139 . . . . 0.0 113.065 -178.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -101.52 104.62 15.53 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 121.14 0.495 . . . . 0.0 110.183 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.519 ' HD3' ' O ' ' A' ' 64' ' ' ARG . 9.4 mmm-85 -103.1 104.13 14.26 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.492 -177.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -98.59 137.63 25.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 83.8 m -118.1 120.22 37.12 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -103.16 -29.83 11.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.613 -177.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.578 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 6.2 m-20 -81.03 -178.31 1.14 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.101 -175.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 71' ' ' ASP . 0.9 OUTLIER -41.34 -166.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 124.277 3.318 . . . . 0.0 114.231 165.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.564 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 3.3 Cg_endo -29.82 118.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 123.291 2.661 . . . . 0.0 113.883 -147.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.663 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 54.2 m-85 -64.56 88.75 0.06 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.848 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 13.9 ptpt -136.92 142.9 42.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.409 0.623 . . . . 0.0 112.418 -174.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.6 t -119.56 136.56 56.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.618 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -124.21 107.01 10.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.35 172.84 12.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.402 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.4 t -123.15 146.03 48.11 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.674 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.87 -166.38 23.72 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -130.27 -18.35 3.27 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.503 0.652 . . . . 0.0 111.903 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.438 ' HB3' ' HG3' ' B' ' 218' ' ' ALY . . . -142.75 145.09 32.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.001 0.429 . . . . 0.0 111.178 -174.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.73 172.5 51.97 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.673 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -168.71 158.9 9.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 122.905 0.482 . . . . 0.0 110.064 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 mm -66.76 121.08 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 110.188 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.625 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.6 tt -116.46 108.25 45.67 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.406 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -79.9 121.26 4.47 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 122.799 2.333 . . . . 0.0 112.056 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.475 HG12 ' CE2' ' A' ' 56' ' ' PHE . 3.9 mp -105.53 133.59 49.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.323 178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.9 mt-10 -113.37 121.32 43.99 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.202 0.525 . . . . 0.0 110.217 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.426 HG13 HG22 ' A' ' 54' ' ' VAL . 84.0 t -101.54 122.56 53.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.115 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.565 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 87.3 m-85 -91.12 138.57 31.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.548 -178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.461 ' HE1' HG22 ' A' ' 51' ' ' VAL . 21.3 m-85 -119.91 162.32 19.37 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.16 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.555 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -105.16 97.24 7.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 121.159 -0.217 . . . . 0.0 111.353 176.282 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -155.63 168.86 25.79 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.298 0.57 . . . . 0.0 112.272 173.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.591 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -103.97 9.28 36.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.484 174.596 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.4 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 35.9 mm-40 -101.01 -154.65 0.49 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.442 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.475 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 22.6 mm-40 -35.95 157.36 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.63 0 C-N-CA 124.24 1.016 . . . . 0.0 113.266 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 7.3 Cg_exo -31.88 125.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 124.713 3.609 . . . . 0.0 114.302 -172.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.45 20.06 0.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.841 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -152.13 140.76 20.8 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.919 178.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.2 m -115.91 156.79 16.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -128.39 107.88 10.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.873 0.368 . . . . 0.0 110.487 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.2 m-85 -105.67 120.96 43.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.202 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -82.59 117.15 22.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -126.6 136.18 52.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.242 0.544 . . . . 0.0 110.875 -176.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.38 112.79 21.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.951 -178.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.569 HD11 HG11 ' A' ' 37' ' ' VAL . 1.2 mp -91.04 94.64 9.71 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 176.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -104.03 155.85 18.34 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.087 0.47 . . . . 0.0 111.054 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 30.5 mt -129.36 162.5 27.86 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.247 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.6 ' NE2' ' HA ' ' A' ' 116' ' ' PRO . 5.7 p80 -100.18 173.09 6.79 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.285 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -73.57 161.03 30.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.997 0.427 . . . . 0.0 111.635 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.718 ' HA ' HG21 ' A' ' 22' ' ' VAL . 14.7 mt-10 -64.99 125.53 25.17 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.304 173.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.498 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 83.08 21.29 59.29 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.432 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.456 ' CG ' ' HD2' ' A' ' 115' ' ' PRO . 57.4 t60 -121.31 147.58 47.52 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 176.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 114' ' ' HIS . 10.9 Cg_endo -55.28 136.58 74.12 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.278 1.985 . . . . 0.0 113.292 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.6 ' HA ' ' NE2' ' A' ' 110' ' ' HIS . 49.5 Cg_exo -44.73 177.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 124.932 3.755 . . . . 0.0 116.204 175.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 67.4 t -124.16 139.38 50.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.936 -173.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.407 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.47 96.43 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.421 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.3 t-80 -116.3 132.49 56.65 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.46 -177.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 119' ' ' HIS . 9.5 mt -117.04 141.82 47.76 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 123.51 0.506 . . . . 0.0 110.327 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 18.3 ttm180 -131.2 148.41 52.7 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.434 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 59.1 m -133.84 117.0 16.34 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 6.1 mt-10 -113.34 137.45 51.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.842 0.354 . . . . 0.0 111.085 -175.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 ttmt -89.45 126.56 35.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.822 -175.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.857 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.2 mt -92.69 115.38 28.05 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 23.7 m -110.66 114.74 28.35 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.911 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -115.64 109.41 17.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.547 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -76.02 117.77 18.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.129 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.404 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 5.5 t30 54.46 67.32 3.45 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.267 176.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.96 -179.37 5.05 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.56 2.173 . . . . 0.0 111.359 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.2 p -77.52 145.7 36.82 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 173.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -54.42 -40.54 68.38 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.795 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 3.1 p-10 -59.81 -32.44 70.64 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.593 0.235 . . . . 0.0 110.662 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.676 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 4.7 t80 -73.78 -41.11 62.89 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.621 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 45.2 ttm105 -54.72 -43.61 72.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.609 173.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -57.33 -37.43 72.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.31 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 32.7 mtpt -73.94 -42.42 60.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.839 0.352 . . . . 0.0 110.3 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 33.0 mt -69.73 -30.99 68.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.219 -176.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 27.3 mt -79.64 -32.8 41.7 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.778 0.323 . . . . 0.0 110.684 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.62 -30.27 64.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.565 -176.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 45' ' ' SER . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.437 -0.792 . . . . 0.0 110.757 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.808 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' B' ' 214' ' ' LYS . . . -99.51 147.22 18.25 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.586 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' B' ' 213' ' ' GLY . 92.4 mttt 70.2 119.66 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.634 0.731 . . . . 0.0 112.091 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -72.27 171.05 10.54 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.612 172.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 6.9 Cg_endo -51.09 168.62 0.23 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.12 1.88 . . . . 0.0 112.465 175.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -145.01 141.65 29.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.923 0.392 . . . . 0.0 111.123 -174.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . 0.438 ' HG3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -59.41 151.61 23.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.446 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.758 ' H ' HD23 ' B' ' 220' ' ' LEU . 1.5 pt? -83.81 52.22 2.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.574 0.702 . . . . 0.0 110.217 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -140.18 149.67 43.25 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.148 -177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 15.1 t -107.6 149.57 27.89 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -135.24 147.64 49.34 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.299 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.858 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.417 172.208 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.522 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 t -122.69 -3.29 8.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.627 0.214 . . . . 0.0 110.807 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -70.96 -59.55 2.73 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.0 ttm -100.99 -34.74 9.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.706 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 53.83 56.59 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.544 0.528 . . . . 0.0 110.474 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.2 p -66.08 113.31 4.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.648 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.417 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 63.4 m -73.59 109.11 6.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.971 0.415 . . . . 0.0 110.081 177.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.5 p -88.53 111.96 22.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.514 177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.27 132.27 55.04 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.117 0.484 . . . . 0.0 111.434 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.21 142.38 21.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.08 124.99 38.38 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.262 -178.077 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.885 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -109.28 168.72 3.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.4 175.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.93 126.56 27.13 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.571 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.412 HD13 HG11 ' A' ' 90' ' ' VAL . 82.2 mt -105.99 142.2 36.1 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.991 177.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.639 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.5 tt0 -102.82 125.0 49.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.05 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.681 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -112.54 113.96 26.38 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -144.91 175.86 24.3 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.096 -1.05 . . . . 0.0 111.849 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -165.88 155.11 11.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.183 0.516 . . . . 0.0 111.164 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 26.7 mtp180 -116.55 152.18 34.66 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.745 174.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.58 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -147.56 125.82 12.25 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.839 177.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -125.48 141.99 51.75 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.818 HG11 ' H ' ' A' ' 113' ' ' GLY . 7.5 p -100.73 152.4 4.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.771 ' HD2' ' O ' ' A' ' 25' ' ' LYS . 5.9 ptt180 -116.7 138.65 51.3 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -68.02 -17.36 64.39 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.562 0.696 . . . . 0.0 109.473 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.771 ' O ' ' HD2' ' A' ' 23' ' ' ARG . 44.7 tttm -117.49 99.05 52.37 Favored Pre-proline 0 N--CA 1.443 -0.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.483 170.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HG3' HG22 ' A' ' 32' ' ' THR . 50.3 Cg_exo -58.11 159.52 18.37 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.104 1.869 . . . . 0.0 110.915 171.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.6 t -81.68 -172.77 4.05 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.741 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.413 ' H ' HG13 ' A' ' 28' ' ' VAL . 1.7 m -59.0 -29.82 42.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.208 0.528 . . . . 0.0 111.492 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -85.47 -0.22 54.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.32 30.53 62.49 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.162 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -89.45 125.55 35.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.445 HG22 ' HG3' ' A' ' 26' ' ' PRO . 40.4 p -86.6 -27.51 23.83 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.471 -171.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.432 ' O ' ' HA ' ' A' ' 79' ' ' SER . 68.6 m80 -118.1 142.27 47.6 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -171.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -115.05 119.96 38.21 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 173.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -122.65 154.95 37.34 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.149 0.499 . . . . 0.0 111.32 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.645 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 52.4 ttp -133.21 119.92 20.48 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.571 176.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 10.0 m -100.53 152.31 4.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.285 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.597 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -152.46 155.5 37.62 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.539 -0.464 . . . . 0.0 112.234 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.6 m -128.11 127.17 67.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.132 170.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.475 HH11 ' HB3' ' A' ' 73' ' ' PRO . 9.9 mmm180 -132.49 -177.14 4.34 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.332 -177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.456 ' CA ' HG23 ' A' ' 47' ' ' ILE . . . -89.75 -167.55 42.49 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.649 174.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 2.9 Cg_exo -73.86 111.53 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.278 1.985 . . . . 0.0 111.697 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 60.78 61.28 1.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.662 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 72.91 -5.54 1.88 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.364 0.666 . . . . 0.0 112.527 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.473 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 58.7 m -59.31 133.07 55.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.551 0.215 . . . . 0.0 110.916 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -71.24 126.09 28.7 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.023 0.44 . . . . 0.0 110.318 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.609 HD12 HG21 ' A' ' 51' ' ' VAL . 1.4 pt -96.35 -2.73 10.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.485 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -57.86 -13.91 5.18 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.219 0.533 . . . . 0.0 111.285 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -69.88 -41.42 74.8 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.493 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.469 ' CE2' HG22 ' A' ' 47' ' ' ILE . 52.8 p90 -114.67 -14.39 12.04 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.883 -0.51 . . . . 0.0 111.543 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.609 HG21 HD12 ' A' ' 47' ' ' ILE . 90.0 t -94.31 125.86 46.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -92.44 -62.71 1.34 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.517 -176.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.706 ' HD2' ' CD1' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -145.86 151.1 37.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 98.1 t -125.28 160.93 30.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.594 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.6 p -142.32 137.81 29.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.192 0.52 . . . . 0.0 111.124 -176.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.512 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 26.7 m-85 -119.5 110.78 17.31 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -83.27 92.94 7.6 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.488 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.606 ' CD2' HD11 ' A' ' 86' ' ' LEU . 11.4 mt -78.54 177.73 8.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.986 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.89 144.32 49.05 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -58.87 -25.37 63.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.243 -0.889 . . . . 0.0 112.835 -170.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.8 t -72.75 -19.23 61.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.992 0.425 . . . . 0.0 110.592 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -75.23 135.31 73.13 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.23 118.65 5.49 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.436 2.091 . . . . 0.0 111.135 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 62.29 79.06 0.28 Allowed Pre-proline 0 CA--C 1.53 0.195 0 O-C-N 123.638 0.586 . . . . 0.0 110.203 -176.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.32 -21.16 66.02 Favored 'Trans proline' 0 CA--C 1.531 0.333 0 C-N-CA 122.803 2.336 . . . . 0.0 113.454 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -105.96 108.79 20.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 120.944 0.402 . . . . 0.0 110.694 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 24.2 mmt85 -106.64 98.37 8.05 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.035 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -84.29 136.87 21.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 172.391 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.9 m -125.7 112.04 15.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.862 0.363 . . . . 0.0 110.267 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -106.93 -21.65 12.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.31 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.667 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 3.1 t70 -65.37 -177.64 0.25 Allowed Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 114.237 -1.347 . . . . 0.0 110.537 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.667 ' HD2' ' CG ' ' A' ' 71' ' ' ASP . 16.7 Cg_exo -33.02 -175.55 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.542 0 C-N-CA 125.031 3.821 . . . . 0.0 114.285 160.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.649 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 5.6 Cg_endo -34.81 126.69 0.22 Allowed 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 123.657 2.905 . . . . 0.0 114.044 -160.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 33.0 m-85 -61.8 94.06 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.793 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 3.9 ptpt -144.15 146.29 32.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.225 0.536 . . . . 0.0 111.717 -178.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 36' ' ' MET . 71.7 t -124.87 132.53 71.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.871 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.97 111.87 21.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.23 172.39 12.75 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.168 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 9.6 t -123.1 149.39 44.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.83 -175.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.82 -169.65 22.47 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 48.2 p90 -132.18 -10.93 3.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 117.146 0.473 . . . . 0.0 111.339 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' B' ' 217' ' ' ARG . . . -151.27 140.35 21.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.635 0.255 . . . . 0.0 110.47 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.61 179.22 49.35 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.771 -175.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -173.94 156.28 2.73 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.677 0.275 . . . . 0.0 110.721 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 85' ' ' ILE . 14.2 mm -64.95 121.27 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.136 172.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.606 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -114.67 104.94 54.04 Favored Pre-proline 0 N--CA 1.442 -0.84 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.636 -178.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.39 117.07 4.83 Favored 'Trans proline' 0 C--O 1.239 0.559 0 C-N-CA 123.05 2.5 . . . . 0.0 112.019 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 mt -106.81 126.17 62.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.21 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.594 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 46.3 mt-10 -110.57 122.64 48.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.367 0.603 . . . . 0.0 110.181 176.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.412 HG11 HD13 ' A' ' 14' ' ' LEU . 54.4 t -104.4 119.39 53.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.282 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.706 ' CD1' ' HD2' ' A' ' 53' ' ' LYS . 28.2 m-85 -94.8 156.14 16.51 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.424 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.7 m-85 -126.86 157.51 39.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.018 -177.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.535 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -105.76 93.65 4.76 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.252 0.548 . . . . 0.0 111.622 -178.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.568 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 62.0 t30 -160.24 -176.6 5.73 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.926 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 5.6 tmtt? -109.88 -5.04 15.63 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.245 0.545 . . . . 0.0 111.248 177.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.436 ' HB2' ' ND2' ' A' ' 94' ' ' ASN . 16.1 mm-40 -96.47 -155.41 0.48 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.852 -168.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 11.2 mm-40 -28.97 151.15 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 124.833 1.253 . . . . 0.0 113.902 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -30.62 124.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 125.087 3.858 . . . . 0.0 114.713 -165.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -75.26 12.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.5 -177.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.546 ' HE2' ' CE2' ' A' ' 91' ' ' TYR . 2.5 ptpt -150.03 147.67 28.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.318 0.58 . . . . 0.0 111.342 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.52 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -123.55 155.24 29.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 174.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -128.53 106.82 9.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.76 0.314 . . . . 0.0 110.336 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.681 ' CD2' HD21 ' A' ' 16' ' ' LEU . 22.9 m-85 -103.09 121.19 42.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.304 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -84.31 112.64 20.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 175.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -124.79 138.34 54.28 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.377 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.401 ' HA ' HD13 ' A' ' 85' ' ' ILE . 24.6 t70 -90.86 120.15 31.65 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.919 0.39 . . . . 0.0 110.959 -177.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.516 HD11 HG11 ' A' ' 37' ' ' VAL . 2.1 mp -93.76 91.75 7.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.009 175.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -101.03 157.74 16.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.207 0.527 . . . . 0.0 110.654 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.8 mt -129.76 163.78 25.46 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' B' ' 215' ' ' ALA . 38.7 m170 -94.18 174.83 6.95 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 172.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -67.52 165.16 17.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.009 0.433 . . . . 0.0 111.634 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.782 ' HA ' HG21 ' A' ' 22' ' ' VAL . 16.9 tt0 -75.26 103.65 5.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.748 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.818 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 106.61 17.81 11.69 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -175.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.503 ' CD2' ' HD2' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -114.27 162.54 22.68 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 118.963 -0.541 . . . . 0.0 109.651 -177.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.503 ' HD2' ' CD2' ' A' ' 114' ' ' HIS . 1.6 Cg_endo -44.68 177.75 0.0 OUTLIER 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 123.869 3.046 . . . . 0.0 114.005 174.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -97.04 166.83 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.83 3.02 . . . . 0.0 111.776 -171.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 22.5 t -113.61 126.45 71.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.443 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.66 96.39 2.86 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.431 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.2 t-80 -118.98 134.97 54.85 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.618 -177.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 119' ' ' HIS . 8.4 mt -116.58 152.59 33.84 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.514 0.509 . . . . 0.0 110.575 177.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 19.8 ttm180 -143.58 149.63 37.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 173.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.482 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 61.4 m -134.12 120.71 20.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -115.81 138.11 51.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.695 0.283 . . . . 0.0 110.437 -177.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -90.48 129.91 36.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.474 0.654 . . . . 0.0 112.185 -174.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.885 ' HB2' HG23 ' A' ' 12' ' ' VAL . 11.1 mt -95.16 117.49 30.32 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.386 171.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.7 m -109.06 122.66 47.75 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.667 -178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -120.42 104.45 10.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.675 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -85.67 120.74 27.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.706 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.417 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 83.6 m-20 59.02 61.96 4.39 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.201 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -87.4 173.82 5.35 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.116 2.544 . . . . 0.0 112.013 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.425 ' OG1' ' HB2' ' A' ' 134' ' ' PHE . 11.7 p -69.26 140.46 54.47 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -58.28 -37.08 74.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -63.36 -29.67 70.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.529 -0.174 . . . . 0.0 110.529 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.62 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.6 t80 -73.02 -43.4 62.15 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.665 ' O ' HD13 ' A' ' 139' ' ' LEU . 50.0 ttp180 -52.79 -52.58 56.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.809 175.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -55.09 -36.32 65.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.934 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -71.08 -39.2 72.31 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 120.624 -0.43 . . . . 0.0 109.84 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.6 mt -65.55 -19.11 65.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.706 0.765 . . . . 0.0 109.839 175.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.665 HD13 ' O ' ' A' ' 135' ' ' ARG . 6.4 mp -89.56 -26.36 20.88 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.962 -177.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt -90.5 -19.14 24.17 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.203 0.525 . . . . 0.0 110.631 -174.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.18 174.384 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -84.02 55.23 5.0 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.558 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -158.01 138.92 13.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.179 0.514 . . . . 0.0 110.7 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 110' ' ' HIS . . . -82.52 170.65 14.02 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.351 -0.841 . . . . 0.0 109.773 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.427 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 34.5 Cg_exo -59.86 175.22 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.676 1.584 . . . . 0.0 112.71 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.4 ' HA ' ' HB1' ' A' ' 82' ' ' ALA . 11.3 ptp180 -150.03 158.59 44.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.332 177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -107.09 74.99 1.01 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.85 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 10.1 mp -97.6 -15.64 20.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.772 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -144.81 83.78 1.71 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.665 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 32.5 m -87.62 111.66 21.49 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.005 -176.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -83.16 80.85 8.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.841 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.758 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.322 179.156 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.0 m -73.45 -11.03 60.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.351 . . . . 0.0 111.458 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -73.99 -28.79 61.64 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 15.4 tpt -95.55 -42.03 8.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.171 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.7 97.41 7.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.605 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.6 t -71.55 138.85 49.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.002 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.429 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 8.5 t -79.97 138.57 37.1 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.516 -176.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.4 t -162.12 133.57 5.29 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.56 136.81 52.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.182 0.515 . . . . 0.0 112.302 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.8 t -103.13 142.58 16.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 174.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -121.95 127.31 50.21 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.806 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -112.08 172.18 3.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.927 177.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 97.0 mttt -135.83 131.84 35.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.565 0.221 . . . . 0.0 110.611 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.422 ' HG ' HD11 ' A' ' 125' ' ' LEU . 83.5 mt -116.52 142.04 47.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.239 0.543 . . . . 0.0 109.954 175.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.611 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 2.5 tt0 -105.13 125.12 50.64 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.939 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.582 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.5 mm? -108.57 122.22 46.63 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -143.85 167.61 26.68 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.984 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -163.72 154.15 15.57 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.379 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 53.4 mtp180 -121.15 144.87 48.34 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.866 172.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.68 118.29 24.47 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.501 -0.879 . . . . 0.0 111.785 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.95 137.05 50.48 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -177.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.678 HG21 ' HA ' ' A' ' 112' ' ' GLU . 3.3 p -103.5 137.87 30.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.4 mtp180 -92.81 139.96 30.0 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -175.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -68.14 -15.29 63.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.427 0.632 . . . . 0.0 109.729 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -139.03 102.35 7.55 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.427 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HG3' HG22 ' A' ' 32' ' ' THR . 90.8 Cg_exo -50.19 158.0 2.68 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 123.076 2.517 . . . . 0.0 112.169 175.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.8 t -78.22 -175.67 4.27 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.407 -174.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.423 ' H ' HG13 ' A' ' 28' ' ' VAL . 1.3 m -63.04 -31.05 51.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.092 0.472 . . . . 0.0 110.894 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -77.98 -6.7 55.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.447 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.37 33.41 39.52 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.401 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -94.7 129.7 41.49 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.557 HG22 ' HG3' ' A' ' 26' ' ' PRO . 38.9 p -91.9 -25.66 18.82 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.43 -168.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 79' ' ' SER . 56.5 m80 -117.28 140.53 49.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -113.86 112.15 22.88 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.406 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 54.7 p-90 -118.44 148.84 42.16 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.082 0.468 . . . . 0.0 111.127 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.648 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 57.8 ttp -129.37 122.64 29.88 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.162 -0.927 . . . . 0.0 109.802 175.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.7 m -102.59 151.29 6.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.369 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -152.15 152.87 32.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.2 m -124.02 127.14 73.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.271 171.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.509 ' CZ ' ' HA ' ' A' ' 73' ' ' PRO . 2.5 mmp_? -135.62 -176.58 4.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.705 -176.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.489 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -91.54 -171.73 42.57 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.661 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 30.7 Cg_endo -75.7 113.68 3.79 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.515 2.143 . . . . 0.0 112.173 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 58.98 52.45 6.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.384 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 32.6 t60 74.38 -3.82 2.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.825 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 63.9 m -59.04 128.74 38.75 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 176.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -72.25 127.06 31.38 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.779 0.324 . . . . 0.0 110.844 -174.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.553 HD12 HG21 ' A' ' 51' ' ' VAL . 5.9 pt -96.42 -1.96 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -61.31 -14.66 28.56 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.383 0.611 . . . . 0.0 110.928 -175.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.463 ' O ' ' HE2' ' A' ' 137' ' ' LYS . 88.1 m-70 -65.7 -39.22 91.01 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.709 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -114.61 -16.01 11.91 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.464 176.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.553 HG21 HD12 ' A' ' 47' ' ' ILE . 99.3 t -91.79 129.09 43.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.084 0.469 . . . . 0.0 110.23 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -97.1 -63.92 1.09 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.335 0.588 . . . . 0.0 110.409 -175.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 6.6 ptmm? -141.1 157.54 45.16 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 91.7 t -130.04 158.33 42.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 67' ' ' ARG . 9.7 p -142.31 134.75 26.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.341 0.591 . . . . 0.0 111.214 -174.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 29.6 m-85 -117.78 105.5 12.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -77.05 90.86 3.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.872 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.581 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.9 mt -71.01 -177.77 1.75 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.825 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.79 139.77 43.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -176.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -56.53 -23.53 40.51 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -171.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.8 t -71.72 -16.31 62.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.069 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -79.51 141.01 56.08 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.13 116.84 4.23 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.097 1.865 . . . . 0.0 111.327 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 58.41 66.59 2.51 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.552 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.4 -18.74 66.01 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.223 2.615 . . . . 0.0 113.466 -172.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -87.48 100.79 13.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.991 0.424 . . . . 0.0 110.534 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 23.0 mmt180 -100.13 110.81 23.09 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.826 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.7 m -100.64 136.01 34.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.7 m -114.37 118.24 33.32 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -105.09 -25.72 12.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.534 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.601 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 9.5 p-10 -76.5 -175.08 0.45 Allowed Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.382 -175.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 1.5 Cg_exo -41.97 -166.38 0.0 OUTLIER 'Trans proline' 0 CA--C 1.552 1.4 0 C-N-CA 124.231 3.288 . . . . 0.0 114.203 164.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.624 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 6.9 Cg_endo -34.89 120.02 0.15 Allowed 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.005 2.47 . . . . 0.0 113.602 -151.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.57 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 47.5 m-85 -62.35 94.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.043 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 12.2 ptpt -142.28 145.9 34.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.279 0.561 . . . . 0.0 112.201 -178.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.648 ' O ' ' HA ' ' A' ' 36' ' ' MET . 79.6 t -121.28 132.61 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.462 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.421 ' OE1' ' HB2' ' A' ' 36' ' ' MET . 7.0 mm-40 -112.06 112.49 24.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.982 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -137.42 169.87 17.05 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.197 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 3.5 t -126.75 141.9 51.7 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.14 -169.27 24.17 Favored Glycine 0 CA--C 1.518 0.275 0 C-N-CA 121.281 -0.485 . . . . 0.0 111.953 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -132.84 -11.41 3.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.253 0.527 . . . . 0.0 111.973 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.41 136.99 20.2 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.18 -172.99 47.18 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.208 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -178.87 159.53 1.05 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.362 0.265 . . . . 0.0 110.485 -173.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.3 mm -63.9 123.43 16.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.581 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.1 tt -117.76 104.88 48.59 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-O 121.138 0.494 . . . . 0.0 109.995 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.54 112.98 3.0 Favored 'Trans proline' 0 C--O 1.237 0.45 0 C-N-CA 123.336 2.691 . . . . 0.0 112.357 173.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 56' ' ' PHE . 3.8 mt -102.33 123.52 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.283 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.8 mt-10 -109.48 124.46 51.1 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.179 0.514 . . . . 0.0 110.198 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.4 t -103.36 118.76 50.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.907 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.587 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 69.9 m-85 -91.05 134.75 34.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.512 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.45 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 25.6 m-85 -110.11 152.07 26.46 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.047 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.58 94.19 9.77 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 177.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.418 ' HB3' ' HG3' ' A' ' 99' ' ' ARG . 64.0 t30 -154.61 158.65 40.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.875 -172.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -111.42 -9.68 14.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.909 0.862 . . . . 0.0 110.006 176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 35.6 mm-40 -99.05 -151.77 0.39 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.47 -174.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 22.2 mm-40 -27.16 152.11 0.02 OUTLIER Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.5 Cg_exo -31.1 126.62 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 1 C-N-CA 125.522 4.148 . . . . 0.0 115.262 -167.202 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.418 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -89.0 18.97 4.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.647 -179.182 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.422 ' HZ3' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -154.65 143.01 20.49 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.247 0.546 . . . . 0.0 110.874 -178.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -128.43 155.76 40.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.345 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -125.47 115.64 20.55 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.173 0.511 . . . . 0.0 111.118 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.582 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.8 m-85 -107.98 108.18 19.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.678 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -72.11 113.29 8.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.281 0.562 . . . . 0.0 109.659 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.5 ' CD1' ' HD2' ' A' ' 121' ' ' ARG . 31.8 t80 -124.47 129.22 50.25 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.707 -175.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -85.15 106.85 16.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.605 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.529 HD11 HG11 ' A' ' 37' ' ' VAL . 1.6 mp -82.1 106.07 13.71 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 177.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.489 ' CE2' HG11 ' A' ' 117' ' ' VAL . 56.0 p90 -117.63 161.5 19.55 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.221 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.4 mt -135.05 162.98 30.93 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.636 -171.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.735 ' CE1' ' HA ' ' A' ' 116' ' ' PRO . 6.9 p-80 -93.17 166.85 12.13 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 177.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.516 ' O ' ' HD2' ' A' ' 110' ' ' HIS . 2.1 mm? -68.01 146.83 53.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.701 0.286 . . . . 0.0 111.124 177.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.678 ' HA ' HG21 ' A' ' 22' ' ' VAL . 23.7 tt0 -57.42 101.25 0.06 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.888 176.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.504 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 118.71 18.58 4.75 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.685 -177.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.458 ' CG ' ' HD2' ' A' ' 115' ' ' PRO . 63.9 t60 -129.8 150.02 74.66 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.458 ' HD2' ' CG ' ' A' ' 114' ' ' HIS . 13.9 Cg_endo -56.63 166.06 4.05 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 122.253 1.969 . . . . 0.0 112.727 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.735 ' HA ' ' CE1' ' A' ' 110' ' ' HIS . 4.7 Cg_exo -77.4 -179.52 5.51 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 123.647 2.898 . . . . 0.0 114.142 -168.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 26.7 t -119.53 137.96 51.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.231 -1.349 . . . . 0.0 109.029 -177.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.443 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -143.62 98.15 3.19 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.525 ' O ' HD23 ' A' ' 120' ' ' LEU . 55.0 t-80 -119.4 134.62 55.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.755 -176.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 119' ' ' HIS . 10.3 mt -123.17 142.17 51.19 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 123.682 0.614 . . . . 0.0 110.558 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.581 ' HD3' ' HB2' ' A' ' 16' ' ' LEU . 17.9 mtp180 -119.41 146.76 45.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 22.0 p -117.46 101.43 8.38 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 165.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 33.9 mm-40 -97.56 154.52 17.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.461 -177.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -108.66 135.68 49.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.223 0.535 . . . . 0.0 111.906 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.806 ' HB2' HG23 ' A' ' 12' ' ' VAL . 11.0 mt -106.64 120.77 42.84 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 171.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 19.4 m -115.36 123.1 47.83 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.964 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -120.26 104.85 10.39 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.036 -175.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.24 124.87 30.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.063 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 78.7 m-20 63.25 61.25 1.88 Allowed Pre-proline 0 N--CA 1.466 0.366 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.769 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -88.7 170.05 5.43 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.788 2.325 . . . . 0.0 111.574 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 134' ' ' PHE . 12.3 p -71.43 144.86 49.6 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -56.71 -43.38 80.51 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.473 -177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.574 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 5.0 p-10 -59.68 -27.98 66.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.671 178.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.681 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 7.1 t80 -73.12 -41.72 63.69 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.659 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 34.8 ttm-85 -51.74 -47.35 64.08 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.569 0.699 . . . . 0.0 109.638 172.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 46.3 ttm180 -58.54 -37.43 75.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.543 -178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 39.0 mtpt -70.82 -41.32 71.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.838 0.352 . . . . 0.0 110.102 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 36.2 mt -69.12 -33.83 74.09 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.863 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.659 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 57.9 mt -75.22 -37.58 61.03 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.075 0.464 . . . . 0.0 110.606 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.9 ttpp -70.22 -28.38 65.22 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.452 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.74 -0.648 . . . . 0.0 110.376 175.085 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -94.54 -0.39 64.82 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.447 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.83 -78.48 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.184 0.594 . . . . 0.0 111.619 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -75.9 162.98 69.8 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.19 172.02 4.58 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 121.783 1.655 . . . . 0.0 112.429 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -146.34 157.11 43.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.918 0.39 . . . . 0.0 110.732 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -137.55 118.65 14.43 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.647 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' B' ' 220' ' ' LEU . 0.3 OUTLIER 53.39 66.46 1.23 Allowed 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.95 0.781 . . . . 0.0 110.013 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.77 144.49 28.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.583 -178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 2.6 m -80.06 64.36 4.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.33 0.586 . . . . 0.0 110.571 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -86.02 53.82 2.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.781 -178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.397 -179.298 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 p -76.26 -30.07 57.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.852 0.358 . . . . 0.0 111.07 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -86.05 123.05 30.93 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.004 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.8 ptp -131.48 50.48 2.23 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.506 0.669 . . . . 0.0 110.158 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.89 64.74 5.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.989 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.2 t -67.9 84.75 0.22 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.302 0.573 . . . . 0.0 109.823 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.4 m -72.6 109.15 6.04 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.318 -174.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.3 m -110.89 110.94 21.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.09 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.31 146.01 33.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.878 0.37 . . . . 0.0 111.126 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.433 HG23 ' HG3' ' A' ' 130' ' ' PRO . 4.6 t -113.12 141.24 29.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 173.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -128.0 115.51 18.62 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.897 0.38 . . . . 0.0 110.287 -175.54 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.9 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -105.87 177.02 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.951 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.677 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 99.5 mttt -141.59 149.64 41.0 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.476 HD13 HG11 ' A' ' 90' ' ' VAL . 91.4 mt -129.02 143.37 50.85 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 172.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.71 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 5.3 tt0 -102.36 122.61 44.61 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.843 -175.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.679 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -110.84 116.25 30.92 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 175.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -148.77 179.87 25.24 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.293 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -169.73 150.37 3.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.932 0.396 . . . . 0.0 110.531 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.63 139.7 49.87 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -129.3 126.65 39.49 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.999 0.428 . . . . 0.0 111.085 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -129.66 151.36 50.35 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.692 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.611 HG11 ' H ' ' A' ' 113' ' ' GLY . 1.3 p -101.7 158.02 4.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 2.4 mtp180 -105.91 142.94 34.76 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 177.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 44.4 tptt -70.51 -14.71 62.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.583 0.706 . . . . 0.0 109.209 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -138.23 103.45 8.02 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.043 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.532 ' HG3' HG22 ' A' ' 32' ' ' THR . 72.7 Cg_exo -47.47 160.1 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.335 2.69 . . . . 0.0 112.764 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.9 t -78.85 -177.88 5.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.605 -174.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -41.67 78.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.81 0.338 . . . . 0.0 111.271 -176.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -71.11 -7.95 50.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.9 0.381 . . . . 0.0 111.399 177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.3 33.14 26.59 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.617 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -95.77 132.3 41.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.532 HG22 ' HG3' ' A' ' 26' ' ' PRO . 69.4 p -90.83 -29.68 17.42 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -169.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 79' ' ' SER . 65.4 m80 -112.88 143.85 43.44 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -172.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.519 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -122.15 118.47 28.74 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 172.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.413 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 49.2 p-90 -121.87 151.5 40.6 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.791 -175.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.593 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 50.0 ttp -127.21 119.81 27.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.777 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 76' ' ' VAL . 9.9 m -98.84 154.8 3.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.148 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -155.3 156.14 34.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 179.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 6.1 m -125.07 127.58 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.784 169.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.0 mmm-85 -131.76 177.9 7.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.883 0.373 . . . . 0.0 110.912 -175.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.491 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -92.7 162.7 26.72 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.553 177.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.677 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 18.4 Cg_endo -57.25 114.11 1.79 Allowed 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.229 2.619 . . . . 0.0 112.3 177.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 59.17 57.74 3.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.898 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 71.91 1.33 3.87 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.645 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 77.8 p -63.52 132.07 50.1 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.012 -0.43 . . . . 0.0 109.845 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -75.93 126.04 30.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.537 HD12 HG21 ' A' ' 51' ' ' VAL . 6.1 pt -96.74 -1.22 10.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -171.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -63.24 -8.62 8.73 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -74.24 -36.87 63.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.072 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.439 ' CE2' HG22 ' A' ' 47' ' ' ILE . 52.3 p90 -114.07 -14.35 12.38 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.46 175.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.537 HG21 HD12 ' A' ' 47' ' ' ILE . 97.6 t -98.82 122.06 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 122.888 0.475 . . . . 0.0 110.145 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.619 ' CG ' ' HB3' ' A' ' 93' ' ' LYS . 0.6 OUTLIER -91.67 -44.31 9.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.194 0.521 . . . . 0.0 110.072 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -158.99 158.68 33.7 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.314 -174.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 96.6 t -137.21 157.05 34.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.953 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.616 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 11.8 p -142.18 136.52 29.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.344 0.592 . . . . 0.0 111.497 -175.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 19.8 m-85 -119.22 109.96 16.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -81.63 94.62 6.97 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.396 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.611 ' CD2' HD11 ' A' ' 86' ' ' LEU . 13.3 mt -77.16 -177.34 4.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.748 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.59 144.02 53.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.189 0.519 . . . . 0.0 109.697 -178.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -60.7 -24.24 65.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.209 -0.905 . . . . 0.0 113.004 -169.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.1 t -78.17 -8.67 58.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.614 0.245 . . . . 0.0 111.186 -177.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -85.53 135.22 38.72 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -62.28 121.52 9.56 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.725 2.283 . . . . 0.0 110.901 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 61.36 72.1 0.71 Allowed Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.024 -173.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.88 -20.58 58.12 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.496 2.13 . . . . 0.0 112.296 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.564 ' HE3' ' CG1' ' A' ' 68' ' ' VAL . 24.9 ttpt -93.23 104.46 16.63 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.929 -178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 7.3 mmm180 -103.79 102.32 12.15 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.259 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.564 ' CG1' ' HE3' ' A' ' 66' ' ' LYS . 2.2 m -99.03 138.29 23.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.8 m -125.06 119.54 28.94 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -107.13 -23.81 12.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.509 0.671 . . . . 0.0 110.547 177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.728 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 3.8 p-10 -74.26 -172.62 0.26 Allowed Pre-proline 0 CA--C 1.547 0.86 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.188 -175.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.728 ' HD2' ' HB2' ' A' ' 71' ' ' ASP . 75.1 Cg_exo -40.85 -170.28 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 124.181 3.254 . . . . 0.0 114.598 168.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.651 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 7.9 Cg_endo -36.32 122.41 0.29 Allowed 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.509 2.806 . . . . 0.0 113.842 -155.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.484 ' CB ' HG22 ' A' ' 39' ' ' VAL . 41.0 m-85 -62.55 97.34 0.09 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.01 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 12.4 ptpt -146.37 144.36 29.7 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.461 0.648 . . . . 0.0 112.129 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 36' ' ' MET . 69.1 t -121.89 131.69 72.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.833 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -114.74 114.0 25.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.89 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.31 173.02 12.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.143 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 7.6 t -126.64 144.77 50.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.715 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.09 -171.76 29.73 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 111.574 -0.611 . . . . 0.0 111.574 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -130.06 -8.07 4.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.197 0.498 . . . . 0.0 111.331 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.532 ' HB3' ' HE3' ' B' ' 218' ' ' ALY . . . -147.87 144.32 28.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.927 0.394 . . . . 0.0 111.235 -176.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -82.99 173.97 52.52 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.029 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -172.67 158.58 4.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 122.732 0.413 . . . . 0.0 110.041 -178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 106' ' ' ASP . 16.1 mm -65.49 124.56 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.21 171.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.611 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.4 tt -117.61 105.3 48.26 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.886 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.65 118.49 5.71 Favored 'Trans proline' 0 C--O 1.238 0.48 0 C-N-CA 123.109 2.54 . . . . 0.0 112.652 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.464 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.2 mt -108.1 126.09 64.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.369 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.616 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 43.6 mt-10 -109.52 123.57 49.62 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.088 0.471 . . . . 0.0 110.081 176.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.476 HG11 HD13 ' A' ' 14' ' ' LEU . 75.6 t -103.33 125.22 57.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.715 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 76.8 m-85 -96.39 132.11 42.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.84 -177.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.406 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 19.9 m-85 -110.62 165.07 12.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.835 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.619 ' HB3' ' CG ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -116.05 95.31 5.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.208 0.528 . . . . 0.0 111.863 -178.068 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.611 ' OD1' ' HB2' ' A' ' 96' ' ' GLU . 9.1 t-20 -157.91 177.49 11.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.272 176.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.598 ' HG2' ' O ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -112.49 -0.83 15.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.917 0.865 . . . . 0.0 110.811 178.206 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.611 ' HB2' ' OD1' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -96.47 -152.93 0.39 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.508 -173.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -31.33 150.94 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.916 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -37.09 120.1 0.28 Allowed 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 124.911 3.741 . . . . 0.0 114.013 -168.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.72 20.31 3.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.889 -175.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.43 138.86 26.49 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.312 0.577 . . . . 0.0 110.574 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.527 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.3 m -122.38 155.25 27.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -129.24 106.07 8.58 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.192 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.679 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.3 m-85 -102.38 111.63 24.0 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.028 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -76.23 117.62 18.11 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -127.58 142.03 51.48 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.256 -175.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.403 ' HA ' HD13 ' A' ' 85' ' ' ILE . 11.6 t70 -92.05 118.48 30.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.064 -175.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.478 HD11 HG11 ' A' ' 37' ' ' VAL . 2.0 mp -97.09 96.22 8.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 175.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -105.08 156.44 18.07 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.984 0.421 . . . . 0.0 111.28 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 mt -132.44 152.86 51.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 115' ' ' PRO . 7.7 m-70 -101.53 174.21 6.07 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.382 0.537 . . . . 0.0 110.374 173.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -66.07 158.47 28.36 Favored 'General case' 0 C--O 1.243 0.761 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -172.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.591 ' HA ' HG21 ' A' ' 22' ' ' VAL . 6.2 mp0 -54.93 154.25 5.48 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.093 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.611 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 85.12 -50.55 4.4 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.079 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -145.14 75.86 13.76 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-N 117.892 0.846 . . . . 0.0 112.356 -174.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.592 ' CG ' ' HB ' ' A' ' 22' ' ' VAL . 57.6 Cg_endo -110.16 107.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.583 0 C-N-CA 122.836 2.357 . . . . 0.0 112.136 167.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -98.01 96.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.561 2.174 . . . . 0.0 111.053 171.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.735 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 43.5 t -117.86 115.2 47.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.156 -0.617 . . . . 0.0 111.453 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -145.04 97.23 2.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.455 ' O ' HD23 ' A' ' 120' ' ' LEU . 58.0 t-80 -123.65 134.14 53.81 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.104 -0.239 . . . . 0.0 111.23 -176.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 119' ' ' HIS . 7.1 mt -117.03 153.74 32.17 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 123.757 0.661 . . . . 0.0 110.108 175.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 19.9 ttm180 -142.24 147.86 37.17 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 173.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.411 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 81.1 m -130.81 118.85 21.41 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 6.2 mt-10 -112.93 136.57 52.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.29 -177.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -91.41 134.92 34.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.457 0.646 . . . . 0.0 111.639 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.9 ' HB2' HG23 ' A' ' 12' ' ' VAL . 5.5 mt -104.67 113.91 27.79 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.777 173.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 24.9 m -103.52 123.85 47.68 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.132 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -120.75 105.28 10.59 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.458 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.32 119.9 23.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.131 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 54.24 64.37 6.42 Favored Pre-proline 0 N--CA 1.467 0.417 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.871 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.433 ' HG3' HG23 ' A' ' 10' ' ' VAL . 91.9 Cg_endo -80.05 177.89 7.8 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.3 2.0 . . . . 0.0 111.297 175.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.408 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 5.6 p -76.86 141.99 40.39 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -56.49 -43.1 79.34 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.298 -173.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 8.0 p-10 -59.65 -29.5 68.08 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.564 -0.161 . . . . 0.0 110.564 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.664 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 14.6 t80 -74.7 -40.84 61.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.606 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 43.8 ttm105 -56.02 -44.91 79.15 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.682 174.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -57.4 -37.0 72.03 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.019 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 44.3 mtpt -72.13 -38.96 69.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.702 0.287 . . . . 0.0 110.682 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.3 mt -69.84 -30.98 68.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.578 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 33.0 mt -82.84 -31.13 28.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.918 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -73.61 -31.13 63.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.02 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.198 176.909 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -96.5 -82.08 1.61 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.281 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -115.86 166.53 11.86 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.205 0.526 . . . . 0.0 111.367 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -71.09 170.79 10.2 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.655 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 49.5 Cg_exo -55.87 165.53 3.67 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.528 1.485 . . . . 0.0 112.138 177.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' A' ' 83' ' ' GLY . 22.4 ttm180 -140.44 136.74 33.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.167 0.508 . . . . 0.0 111.41 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . 0.532 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -61.0 160.06 10.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.033 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 9.9 mp -77.46 80.96 3.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.837 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -68.46 104.54 1.94 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.576 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 20.0 p -100.73 139.67 36.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.741 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -113.04 5.0 16.97 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.738 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.564 -0.731 . . . . 0.0 110.229 177.136 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 112.336 -0.306 . . . . 0.0 112.336 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 t 60.39 77.71 0.31 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.094 0.473 . . . . 0.0 110.603 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.9 m80 67.41 30.31 6.96 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.116 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 52.9 ttm -88.68 127.56 35.58 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 176.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.25 165.3 0.26 Allowed 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.825 0.703 . . . . 0.0 110.638 -175.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.8 t -140.28 140.17 35.66 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.7 m -68.96 108.28 3.44 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.925 0.393 . . . . 0.0 110.056 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.1 t -119.91 112.52 19.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.748 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.58 134.72 53.96 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.037 0.446 . . . . 0.0 111.443 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.3 142.98 19.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -122.46 131.78 54.03 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.919 0.39 . . . . 0.0 110.203 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.845 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -114.79 165.77 9.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.622 176.385 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.602 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . 97.2 mttt -135.31 127.35 29.73 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.659 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.414 HD13 HG11 ' A' ' 90' ' ' VAL . 89.4 mt -113.19 142.66 45.53 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.196 0.522 . . . . 0.0 110.248 177.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.668 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 4.9 tt0 -104.49 126.08 51.25 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.758 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.657 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -112.43 113.71 26.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 173.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -145.64 176.64 24.52 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 119.699 -1.239 . . . . 0.0 111.756 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -166.29 156.03 11.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.993 0.425 . . . . 0.0 110.622 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 62.4 mtt180 -117.17 139.47 50.72 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 172.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 116' ' ' PRO . . . -130.06 123.53 30.7 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.553 -0.859 . . . . 0.0 111.599 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -117.76 144.19 45.54 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.777 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.814 HG11 ' H ' ' A' ' 113' ' ' GLY . 2.6 p -104.3 152.97 6.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 170.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.558 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -108.52 139.99 42.48 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -65.73 -20.51 66.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.606 0.717 . . . . 0.0 109.229 176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -131.36 101.36 16.12 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.974 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.553 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.7 Cg_exo -48.63 158.7 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.52 2.813 . . . . 0.0 113.172 177.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.1 t -80.15 -173.04 3.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.211 -172.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.7 m -58.33 -36.98 60.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 123.0 0.52 . . . . 0.0 111.836 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -83.14 -1.34 52.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.148 0.499 . . . . 0.0 110.704 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 34.09 37.87 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.962 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -98.16 134.95 40.52 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.553 HG22 ' HG3' ' A' ' 26' ' ' PRO . 25.6 p -88.4 -27.22 21.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.111 -171.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.426 ' CD2' ' HB3' ' A' ' 109' ' ' LEU . 64.5 m80 -115.69 145.19 42.97 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -171.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.558 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 5.8 m-20 -123.23 125.63 45.44 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 169.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.417 ' HH2' HD22 ' A' ' 58' ' ' LEU . 55.7 p-90 -128.28 149.85 50.31 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.097 0.475 . . . . 0.0 111.002 -176.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.697 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 45.2 ttp -128.16 122.37 31.77 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.354 174.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 6.2 m -101.42 153.96 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.327 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.4 OUTLIER -153.36 153.74 33.15 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.199 -0.6 . . . . 0.0 112.553 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.668 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 10.6 m -124.79 130.83 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.044 171.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.463 ' HB2' ' HB3' ' A' ' 15' ' ' GLU . 2.7 mmt85 -129.5 -177.09 4.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.958 0.408 . . . . 0.0 111.381 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.502 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -94.0 -164.17 36.37 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.229 174.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 2.7 Cg_exo -72.86 111.88 3.37 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.617 2.212 . . . . 0.0 111.369 177.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 57.18 56.52 5.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.578 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.1 m80 67.51 5.22 4.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.82 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 70.8 m -64.93 129.3 39.23 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.45 ' OD1' ' HB2' ' A' ' 48' ' ' GLN . 8.4 t-20 -59.96 127.08 30.14 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.595 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.621 ' HB ' ' CG2' ' A' ' 51' ' ' VAL . 1.5 pt -96.72 -3.89 10.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.45 ' HB2' ' OD1' ' A' ' 46' ' ' ASN . 1.5 mp0 -60.14 -6.27 1.36 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -73.0 -37.88 66.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.191 -0.203 . . . . 0.0 110.939 177.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.496 ' CE1' HG22 ' A' ' 47' ' ' ILE . 52.4 p90 -118.24 -21.09 8.31 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.353 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.621 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 96.6 t -87.06 130.52 36.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -99.64 -54.78 2.83 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.21 0.529 . . . . 0.0 110.526 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.89 142.14 16.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.177 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 55' ' ' VAL . 90.2 t -117.55 160.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.937 -175.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.59 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 14.8 p -144.16 135.52 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.165 0.507 . . . . 0.0 111.145 -176.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.526 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 30.9 m-85 -118.15 109.91 16.97 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -83.26 92.89 7.58 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.833 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.561 ' CD2' HD11 ' A' ' 86' ' ' LEU . 9.8 mt -71.51 -177.39 1.83 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.475 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 79.1 t60 -76.15 142.81 41.48 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.808 -0.757 . . . . 0.0 108.999 -176.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 1.8 mp0 -54.52 -20.67 8.25 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.028 -171.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.0 t -82.97 -5.87 59.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.672 0.272 . . . . 0.0 111.026 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.475 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 62.0 m-85 -82.35 148.46 59.28 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.88 117.91 5.23 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.613 2.209 . . . . 0.0 110.917 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.7 mtm180 52.56 73.52 0.93 Allowed Pre-proline 0 C--O 1.226 -0.15 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.076 -174.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.46 -20.55 64.27 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.892 2.394 . . . . 0.0 113.56 -174.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -90.29 105.53 17.87 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 121.207 0.527 . . . . 0.0 110.457 -177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -106.73 89.26 2.96 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.281 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -71.6 139.64 19.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 172.149 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.4 m -126.91 114.26 17.63 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 175.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -107.35 -28.11 10.07 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.993 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.464 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 30.1 t70 -75.93 164.97 56.91 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.724 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.593 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 24.2 Cg_exo -28.72 178.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.534 1 C-N-CA 125.65 4.233 . . . . 0.0 115.111 168.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.593 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 4.5 Cg_exo -22.51 115.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 124.384 3.389 . . . . 0.0 115.036 -149.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.43 ' CB ' HG22 ' A' ' 39' ' ' VAL . 36.3 m-85 -60.89 107.86 0.77 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.603 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.697 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.4 ptpt -152.28 153.79 34.43 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.016 0.436 . . . . 0.0 111.55 -178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 36' ' ' MET . 71.4 t -131.13 133.09 63.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.858 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -115.98 115.71 26.63 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 123.125 0.266 . . . . 0.0 110.407 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.77 172.09 13.16 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.274 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.6 t -120.89 146.87 46.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.78 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.41 -162.49 14.34 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.287 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -141.53 -18.34 0.78 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.419 ' HB3' ' HG3' ' B' ' 218' ' ' ALY . . . -136.8 134.7 37.29 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.567 -175.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.503 ' O ' ' HD3' ' B' ' 217' ' ' ARG . . . -75.54 169.27 54.75 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.378 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -168.48 154.97 7.22 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.406 ' HB ' ' OE1' ' B' ' 219' ' ' GLN . 23.4 mm -65.6 122.55 16.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 172.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.561 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.6 tt -113.6 104.95 55.27 Favored Pre-proline 0 N--CA 1.442 -0.873 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.548 -178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -66.1 108.02 1.25 Allowed 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 123.197 2.598 . . . . 0.0 111.881 173.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -98.79 124.86 52.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.676 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.59 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 72.8 mt-10 -113.67 119.91 39.06 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.419 0.628 . . . . 0.0 110.075 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.414 HG11 HD13 ' A' ' 14' ' ' LEU . 60.7 t -102.98 123.34 56.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.432 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.441 ' CD2' ' HB3' ' A' ' 100' ' ' LYS . 25.7 m-85 -99.25 155.45 17.49 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.86 0.838 . . . . 0.0 111.138 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.445 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.6 m-85 -125.67 156.9 38.55 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.245 -1.343 . . . . 0.0 109.998 -176.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.09 92.02 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.237 0.541 . . . . 0.0 111.346 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -158.42 -178.19 7.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.678 172.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.677 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -114.38 6.09 15.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.652 0.263 . . . . 0.0 111.383 -177.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 6.3 mm-40 -102.07 -152.76 0.45 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.851 -168.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.618 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 13.4 mm-40 -31.56 159.63 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 124.98 1.312 . . . . 0.0 113.317 175.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 5.4 Cg_exo -28.63 125.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.369 1.615 0 C-N-CA 124.716 3.611 . . . . 0.0 114.19 -162.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 -72.59 -1.76 17.31 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.226 -170.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 91' ' ' TYR . 4.2 pttt -155.56 171.23 20.3 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.484 0.659 . . . . 0.0 111.012 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.572 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 1.5 m -133.11 154.55 39.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.757 -1.111 . . . . 0.0 109.207 178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -123.03 117.02 24.5 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.019 0.438 . . . . 0.0 111.07 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.657 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.4 m-85 -108.76 116.99 33.03 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.741 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -81.58 109.99 16.54 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.437 ' HD1' ' CZ ' ' A' ' 121' ' ' ARG . 68.5 t80 -122.35 137.17 54.95 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.725 -174.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.486 ' OD2' ' HB3' ' A' ' 108' ' ' PHE . 30.6 t70 -86.95 110.64 20.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.575 HD11 HG11 ' A' ' 37' ' ' VAL . 1.7 mp -83.61 91.41 7.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 173.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.554 ' HB2' ' HD2' ' B' ' 214' ' ' LYS . 15.6 p90 -98.59 154.72 17.72 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.105 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 22.8 mt -133.3 137.89 46.18 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -176.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.592 ' HD1' HG23 ' A' ' 117' ' ' VAL . 2.6 p-80 -67.86 172.12 5.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 173.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.1 155.56 32.33 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.565 0.698 . . . . 0.0 111.338 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.782 ' HA ' HG21 ' A' ' 22' ' ' VAL . 15.2 tt0 -56.22 101.17 0.05 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.124 -1.398 . . . . 0.0 110.22 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.814 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 120.89 2.44 11.31 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.913 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -109.47 140.23 21.9 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -56.84 152.46 42.62 Favored 'Trans proline' 0 C--N 1.363 1.306 0 C-N-CA 122.297 1.998 . . . . 0.0 114.367 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 20' ' ' ALA . 17.6 Cg_exo -36.14 158.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.176 1 C-N-CA 126.064 4.509 . . . . 0.0 116.619 177.369 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.592 HG23 ' HD1' ' A' ' 110' ' ' HIS . 48.6 t -121.06 141.49 41.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.0 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.91 96.69 3.01 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.443 ' O ' HD23 ' A' ' 120' ' ' LEU . 55.3 t-80 -115.67 136.0 53.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.731 -177.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 119' ' ' HIS . 7.5 mt -117.57 151.07 37.91 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.776 0.672 . . . . 0.0 110.295 177.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 18.0 ttm180 -140.36 148.01 40.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 173.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 42.4 t -132.51 125.86 31.58 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -121.61 134.01 55.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.715 -177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.71 129.43 35.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.198 0.523 . . . . 0.0 111.652 -175.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.845 ' HB2' HG23 ' A' ' 12' ' ' VAL . 6.4 mt -95.1 131.54 40.98 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 8.9 m -122.91 122.71 39.26 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.014 -0.674 . . . . 0.0 110.82 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -118.11 105.7 12.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.515 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.26 119.78 23.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.436 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.86 64.36 4.0 Favored Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.07 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -83.5 170.24 11.82 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.506 2.137 . . . . 0.0 111.155 172.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.7 p -70.24 142.81 52.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 174.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -57.0 -41.43 78.43 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.611 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -56.09 -33.03 64.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.79 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.705 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.8 t80 -75.41 -40.48 57.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.64 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 28.7 ttm180 -55.3 -45.89 76.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -53.05 -42.19 65.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.251 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 45.6 mtpt -71.68 -38.96 70.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.975 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 41.5 mt -68.11 -31.55 71.23 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.911 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 56.0 mt -80.52 -28.95 37.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.966 0.413 . . . . 0.0 110.917 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.1 ttpt -78.72 -27.39 44.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.589 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.981 174.492 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 112.052 -0.419 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.96 36.71 12.66 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.013 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . 0.554 ' HD2' ' HB2' ' A' ' 108' ' ' PHE . 46.4 pttt -139.95 -175.8 4.36 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.635 -0.135 . . . . 0.0 110.635 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.483 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -58.49 158.29 15.51 Favored Pre-proline 0 C--O 1.236 0.377 0 O-C-N 123.36 0.412 . . . . 0.0 111.489 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 7.5 Cg_endo -50.94 168.71 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.285 2.657 . . . . 0.0 112.974 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 83' ' ' GLY . 8.7 tpp180 -132.5 136.95 47.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.8 -177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . 0.419 ' HG3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . 0.406 ' OE1' ' HB ' ' A' ' 85' ' ' ILE . 6.8 tt0 -152.5 114.02 4.3 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 92.4 mt 60.57 29.45 19.02 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.684 0.615 . . . . 0.0 109.474 -171.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -68.24 110.1 3.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.142 -175.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.3 m -101.65 -31.87 10.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.552 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -94.03 -63.33 1.2 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.74 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.644 -0.693 . . . . 0.0 110.897 -178.267 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.4 t -84.27 132.18 34.66 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -110.68 62.17 0.61 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.904 0.383 . . . . 0.0 110.531 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 55.0 ttm -72.17 -33.24 67.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.287 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -107.2 152.07 24.58 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.424 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.6 m -78.83 93.89 5.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 176.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.529 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 67.9 m -59.29 109.24 0.83 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.209 0.528 . . . . 0.0 111.093 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.9 t -127.65 125.79 40.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.46 132.75 53.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.998 0.428 . . . . 0.0 111.268 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.1 t -99.92 139.06 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 175.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 1.7 mp0 -125.09 119.67 29.29 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.271 0.558 . . . . 0.0 110.366 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.875 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.45 164.4 4.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.767 179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 42' ' ' PRO . 92.1 mttt -132.92 125.93 30.97 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.373 -176.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.48 HD13 HG11 ' A' ' 90' ' ' VAL . 90.8 mt -115.48 142.38 46.78 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.276 0.56 . . . . 0.0 110.372 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 7.0 tt0 -109.07 128.5 55.03 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.014 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.543 HD12 HG12 ' A' ' 39' ' ' VAL . 1.6 mm? -109.14 122.19 46.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.465 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -143.5 170.59 25.53 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 119.514 -1.327 . . . . 0.0 111.649 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -165.42 152.53 10.5 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.745 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.674 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 62.6 mtp180 -117.48 140.7 49.26 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.979 171.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -135.98 123.83 22.62 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.572 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 22' ' ' VAL . 14.3 tt0 -121.4 144.76 48.49 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.556 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.915 HG11 ' H ' ' A' ' 113' ' ' GLY . 9.8 p -99.03 153.49 4.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 172.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 23' ' ' ARG . 0.9 OUTLIER -105.03 152.06 23.2 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.261 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 49.9 mmtm -68.2 -20.82 64.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.396 0.617 . . . . 0.0 109.737 176.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -140.79 111.09 6.75 Favored Pre-proline 0 N--CA 1.446 -0.633 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.646 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.2 Cg_exo -47.81 155.27 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.176 2.584 . . . . 0.0 112.423 173.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.438 HG22 ' HB2' ' A' ' 31' ' ' PHE . 9.1 t -75.11 -169.7 0.99 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.865 -172.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 m -61.81 -24.61 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -107.05 11.36 29.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.324 1.059 . . . . 0.0 109.327 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.74 33.1 47.9 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.538 172.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.438 ' HB2' HG22 ' A' ' 27' ' ' THR . 19.4 m-30 -90.38 127.93 36.33 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.591 HG22 ' HG3' ' A' ' 26' ' ' PRO . 60.3 p -85.48 -29.87 23.93 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.34 -169.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.457 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.8 m80 -118.87 144.43 46.39 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -172.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -115.41 119.94 37.92 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 171.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -122.78 150.86 42.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.212 0.529 . . . . 0.0 111.031 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.72 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 50.4 ttp -129.11 116.48 19.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.428 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 11.2 m -99.14 149.77 5.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.299 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.643 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.6 OUTLIER -151.61 156.26 40.09 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.263 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.1 m -123.73 135.22 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.899 169.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -134.95 175.78 9.26 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.002 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.463 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -90.14 -178.61 44.46 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.14 173.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HB3' ' HB2' ' A' ' 13' ' ' LYS . 37.4 Cg_endo -76.63 111.87 3.34 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.147 1.898 . . . . 0.0 112.458 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 57.7 67.12 1.0 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.882 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 63.6 m80 72.87 -7.27 1.5 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.0 m -67.49 126.71 30.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.373 0.13 . . . . 0.0 110.848 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -69.03 126.68 30.57 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.637 HD12 HG21 ' A' ' 51' ' ' VAL . 1.1 pt -94.87 -3.74 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.763 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -63.36 -1.28 1.07 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.22 -0.446 . . . . 0.0 112.201 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -79.16 -33.6 43.93 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.416 ' CE2' HG22 ' A' ' 47' ' ' ILE . 54.0 p90 -117.65 -18.15 9.75 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.565 175.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.637 HG21 HD12 ' A' ' 47' ' ' ILE . 84.0 t -91.4 130.87 39.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.747 0.308 . . . . 0.0 110.369 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 93' ' ' LYS . 7.8 tp10 -102.39 -63.36 1.16 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.144 0.497 . . . . 0.0 110.506 -176.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.1 mtpp -131.12 162.07 30.71 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 95.0 t -133.72 155.78 40.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 169.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.598 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 10.4 p -141.75 134.99 29.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.529 0.68 . . . . 0.0 111.402 -174.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.428 ' CD2' HG12 ' A' ' 88' ' ' ILE . 22.3 m-85 -115.88 107.27 14.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.131 -0.941 . . . . 0.0 108.646 -179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -79.44 90.74 5.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.229 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.449 HD11 HG11 ' A' ' 76' ' ' VAL . 19.9 mt -78.2 -176.85 4.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.888 -177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.79 143.96 43.75 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.15 -21.54 63.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.091 -175.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t -69.13 -17.04 63.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.888 0.375 . . . . 0.0 110.548 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -85.13 139.53 36.69 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.85 117.55 4.29 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.277 1.985 . . . . 0.0 111.271 176.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 57.37 80.19 0.3 Allowed Pre-proline 0 C--O 1.225 -0.231 0 O-C-N 123.672 0.607 . . . . 0.0 110.505 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.15 -20.79 48.12 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.884 2.389 . . . . 0.0 113.465 -177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -97.45 108.68 21.45 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.942 0.401 . . . . 0.0 110.915 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 19.7 mmt85 -111.38 104.87 13.36 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.017 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 5.4 m -90.63 135.92 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 169.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.0 m -112.87 116.46 30.06 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -101.38 -28.58 12.51 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.545 0.688 . . . . 0.0 110.245 -177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.571 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 3.1 m-20 -75.52 -177.17 0.66 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.927 -175.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.639 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 13.3 Cg_exo -45.0 -168.52 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.963 3.109 . . . . 0.0 113.936 165.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.639 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 2.6 Cg_endo -28.52 114.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.512 2.808 . . . . 0.0 114.563 -152.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.643 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 50.8 m-85 -62.17 96.92 0.08 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.287 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.72 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 17.3 ptpt -143.2 148.77 37.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.491 0.662 . . . . 0.0 112.727 -177.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 36' ' ' MET . 79.3 t -123.66 133.26 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.416 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -117.55 103.21 9.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' A' ' 67' ' ' ARG . 1.7 tp10 -136.27 169.7 17.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.741 0.305 . . . . 0.0 110.765 -174.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 8.3 t -123.69 144.91 49.36 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.173 -176.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.23 -174.13 27.54 Favored Glycine 0 C--N 1.332 0.336 0 N-CA-C 111.735 -0.546 . . . . 0.0 111.735 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -130.38 2.14 4.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.298 0.549 . . . . 0.0 112.016 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.549 ' HB3' ' HE3' ' B' ' 218' ' ' ALY . . . -160.17 130.91 5.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.744 0.307 . . . . 0.0 110.77 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' B' ' 217' ' ' ARG . . . -71.33 173.96 42.28 Favored Glycine 0 C--O 1.237 0.326 0 CA-C-N 115.604 -0.726 . . . . 0.0 113.381 -178.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -173.1 157.09 3.39 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.87 0.468 . . . . 0.0 110.218 -176.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 106' ' ' ASP . 12.9 mm -62.66 124.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.204 172.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.508 HD22 HG13 ' A' ' 88' ' ' ILE . 0.8 OUTLIER -108.66 106.2 58.3 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.98 112.7 3.47 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.807 2.338 . . . . 0.0 111.671 172.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.508 HG13 HD22 ' A' ' 86' ' ' LEU . 5.3 mt -108.15 125.74 64.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.633 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.598 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 44.2 mt-10 -107.93 122.12 46.17 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.388 0.613 . . . . 0.0 110.327 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 14' ' ' LEU . 75.8 t -101.11 116.63 45.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.285 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -88.74 139.3 30.61 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.815 -178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.441 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 22.1 m-85 -113.21 146.24 39.63 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.923 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -89.75 94.4 9.82 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -156.32 156.35 33.82 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.754 -170.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -107.8 -7.78 16.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 122.345 1.069 . . . . 0.0 109.515 172.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.15 -151.22 0.4 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.516 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.457 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 8.0 mm-40 -27.07 154.52 0.01 OUTLIER Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 174.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 4.2 Cg_exo -31.29 126.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.214 1 C-N-CA 125.529 4.153 . . . . 0.0 115.133 -168.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.85 14.46 11.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.932 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -161.91 142.76 10.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.349 0.595 . . . . 0.0 111.224 -176.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.513 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -129.23 156.48 41.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -128.77 107.55 9.75 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.466 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.513 ' CZ ' HG21 ' A' ' 101' ' ' VAL . 20.5 m-85 -100.27 137.89 38.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -94.73 122.51 37.41 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.377 173.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -133.26 130.76 39.41 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.324 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.465 ' HA ' HD13 ' A' ' 85' ' ' ILE . 17.4 t70 -84.47 107.0 16.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.146 -175.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.467 HD11 ' CG1' ' A' ' 37' ' ' VAL . 1.5 mp -85.07 103.46 14.1 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.43 ' HB3' ' NH2' ' B' ' 217' ' ' ARG . 50.4 p90 -118.48 157.13 27.83 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.004 0.43 . . . . 0.0 110.352 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 mt -127.7 162.45 26.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.473 ' C ' ' HB2' ' B' ' 215' ' ' ALA . 36.0 m170 -94.62 164.07 13.12 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 175.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' B' ' 215' ' ' ALA . 1.3 mm? -51.99 147.07 7.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.958 0.409 . . . . 0.0 111.896 176.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.77 ' HA ' HG21 ' A' ' 22' ' ' VAL . 29.2 tt0 -61.89 100.86 0.17 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.846 177.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.915 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 109.31 28.26 4.43 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.525 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.02 159.37 65.1 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 119.024 -0.513 . . . . 0.0 110.539 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -32.67 175.19 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 124.984 3.79 . . . . 0.0 115.879 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -97.35 165.07 0.91 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 124.022 3.148 . . . . 0.0 111.876 -172.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 9.2 t -113.99 102.29 13.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.624 -177.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.432 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -118.23 100.99 7.87 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -127.47 127.67 44.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.215 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.4 mt -107.38 150.78 26.35 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.494 174.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.638 ' HD3' ' N ' ' A' ' 122' ' ' CYS . 0.0 OUTLIER -148.14 140.44 24.27 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -174.387 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.638 ' N ' ' HD3' ' A' ' 121' ' ' ARG . 49.7 t -131.57 130.23 41.97 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.829 -175.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -121.48 141.12 51.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.089 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -104.47 132.16 51.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.174 0.512 . . . . 0.0 111.37 -175.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.875 ' HB2' HG23 ' A' ' 12' ' ' VAL . 6.9 mt -99.36 116.11 30.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.169 175.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 35.4 m -112.14 115.2 28.47 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.557 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -114.53 109.45 18.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.901 -176.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -80.71 120.35 24.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.901 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.529 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 78.1 m-20 58.04 63.59 4.35 Favored Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.654 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -85.14 165.65 11.2 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.835 2.356 . . . . 0.0 111.496 173.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.4 p -67.47 145.08 55.34 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 175.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -54.12 -43.76 70.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 136' ' ' ARG . 3.1 t70 -59.71 -30.77 69.03 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.746 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.698 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 11.0 t80 -76.01 -39.84 54.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.634 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 29.1 ttm180 -55.12 -46.03 75.56 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-O 121.236 0.541 . . . . 0.0 109.583 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.402 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 46.3 ttt180 -51.21 -44.01 61.52 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.495 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -71.75 -39.91 69.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.135 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 35.6 mt -69.3 -29.57 67.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.857 -178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 40.5 mt -80.31 -41.17 25.37 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.047 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -68.28 -30.19 69.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.337 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.583 176.964 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.761 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 110' ' ' HIS . . . 139.44 66.97 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.596 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -76.22 131.06 39.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.004 0.431 . . . . 0.0 110.533 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . 0.516 ' HB1' ' HD2' ' B' ' 216' ' ' PRO . . . -83.14 171.29 11.96 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.662 -176.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . 0.516 ' HD2' ' HB1' ' B' ' 215' ' ' ALA . 0.1 OUTLIER -34.59 152.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.263 3.309 . . . . 0.0 114.749 168.767 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' A' ' 108' ' ' PHE . 17.1 ttm180 -150.14 132.63 15.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.024 -178.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . 0.549 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -77.75 68.78 3.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.656 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 31.5 mt -116.75 135.14 54.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.111 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -153.75 -68.52 0.14 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.15 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.9 t -162.13 157.81 23.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.015 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 70.02 -62.52 0.42 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.887 0.742 . . . . 0.0 111.344 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.428 -0.796 . . . . 0.0 110.162 179.118 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.563 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.8 m 55.95 61.01 2.95 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.258 0.551 . . . . 0.0 111.042 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.0 t60 -78.85 -26.44 44.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.949 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.8 mmt -70.74 -52.41 20.98 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 52.07 69.97 0.61 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.99 175.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.4 m -65.22 131.58 46.89 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.6 m -50.13 109.16 0.27 Allowed 'General case' 0 C--O 1.232 0.166 0 O-C-N 123.759 0.662 . . . . 0.0 111.761 -171.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.2 t -154.89 101.42 2.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.709 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.87 129.32 55.09 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.923 0.392 . . . . 0.0 110.557 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.9 t -101.87 137.25 30.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 3.5 mt-30 -117.2 120.53 38.54 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.037 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.838 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -106.49 167.84 3.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.711 175.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.664 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 43.7 mtpt -133.39 139.68 46.92 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.46 HD13 HG11 ' A' ' 90' ' ' VAL . 96.8 mt -126.99 151.9 47.95 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 175.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.684 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 41.1 tt0 -114.26 120.82 41.73 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.314 -174.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.636 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.1 mm? -108.67 115.32 29.87 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -144.88 169.64 26.6 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.011 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -163.11 155.78 18.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.164 0.507 . . . . 0.0 110.917 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 20.8 mtp180 -118.93 153.44 34.59 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.677 175.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.599 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -149.44 128.17 12.48 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.804 175.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -129.23 164.1 24.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.822 HG11 ' H ' ' A' ' 113' ' ' GLY . 1.8 p -103.44 163.47 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 172.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 32' ' ' THR . 1.2 mtp180 -112.51 135.13 53.59 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -67.61 -11.38 58.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.495 0.664 . . . . 0.0 110.457 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -135.9 103.29 9.97 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-N 115.019 -0.991 . . . . 0.0 108.833 170.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.531 ' HG3' HG22 ' A' ' 32' ' ' THR . 76.2 Cg_exo -47.06 155.29 0.96 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.183 2.589 . . . . 0.0 112.211 175.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.2 t -76.71 -172.32 2.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -171.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 m -61.97 -30.43 48.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.495 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.83 -7.3 59.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.181 0.515 . . . . 0.0 110.38 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.65 32.42 33.7 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.206 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -98.54 138.49 35.67 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.531 HG22 ' HG3' ' A' ' 26' ' ' PRO . 26.5 p -86.77 -30.33 21.66 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -169.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.522 ' O ' ' HA ' ' A' ' 79' ' ' SER . 64.9 m80 -112.55 146.15 39.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -170.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -117.47 118.97 33.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -121.95 148.11 45.19 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.009 0.433 . . . . 0.0 111.111 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.645 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 41.1 ttp -125.75 122.04 35.1 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.526 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.9 m -103.23 153.05 5.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.072 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.9 p90 -154.26 154.52 33.57 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.684 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -126.71 129.5 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.844 169.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -134.91 -178.5 5.11 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.887 0.375 . . . . 0.0 111.067 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.44 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -92.37 166.85 29.68 Favored Glycine 0 N--CA 1.44 -1.097 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 173.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.664 ' HD3' ' O ' ' A' ' 13' ' ' LYS . 41.0 Cg_endo -62.31 111.73 1.37 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 123.199 2.599 . . . . 0.0 112.727 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 58.02 67.84 0.91 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.784 172.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 75.47 -12.07 1.02 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.979 0.512 . . . . 0.0 112.353 172.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.1 m -62.37 122.94 16.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.799 0.333 . . . . 0.0 111.081 -178.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.59 125.22 26.07 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.104 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.612 HD12 HG21 ' A' ' 51' ' ' VAL . 2.4 pt -96.07 -1.87 10.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -56.35 -16.45 5.64 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.942 0.401 . . . . 0.0 111.394 -176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -73.42 -43.85 59.56 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.617 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.475 ' CE2' HG22 ' A' ' 47' ' ' ILE . 49.5 p90 -106.07 -20.02 13.54 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.865 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.612 HG21 HD12 ' A' ' 47' ' ' ILE . 76.3 t -91.53 131.33 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.208 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.582 ' HB2' ' HG3' ' A' ' 93' ' ' LYS . 26.2 tt0 -103.46 -62.72 1.26 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.693 0.759 . . . . 0.0 110.327 -173.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 45.2 mtpt -131.73 161.16 33.5 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.578 174.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 93.2 t -134.8 153.5 34.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 169.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.573 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.3 p -139.36 132.71 37.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.635 0.731 . . . . 0.0 111.157 -175.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.48 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 27.0 m-85 -113.28 105.45 13.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.51 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -79.04 94.26 5.27 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.468 177.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.582 ' CD2' HD11 ' A' ' 86' ' ' LEU . 11.3 mt -73.34 179.74 3.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.04 -178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.51 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 22.9 t60 -81.98 146.96 29.46 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -175.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -57.24 -21.68 35.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.669 -175.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.2 t -64.71 -22.48 66.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.095 0.474 . . . . 0.0 110.581 174.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -90.48 129.12 46.26 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.567 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.65 138.31 44.99 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.152 1.901 . . . . 0.0 110.699 174.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 58.45 67.32 2.18 Favored Pre-proline 0 C--O 1.223 -0.302 0 O-C-N 123.447 0.467 . . . . 0.0 109.983 -174.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.91 -22.01 56.47 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.689 2.259 . . . . 0.0 113.79 -174.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 53.0 tttp -93.92 109.97 21.66 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 121.061 0.458 . . . . 0.0 110.44 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 21.8 mmt85 -113.05 100.97 9.02 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.771 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.563 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 3.5 m -92.74 138.17 20.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 171.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.45 ' SG ' ' HA ' ' A' ' 74' ' ' TYR . 25.9 t -118.53 111.53 18.73 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -92.59 -26.93 17.65 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.926 0.869 . . . . 0.0 109.261 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.576 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -84.58 179.68 1.81 Allowed Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.946 -171.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.62 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 22.8 Cg_exo -28.28 -179.08 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.535 1 C-N-CA 126.125 4.55 . . . . 0.0 115.896 163.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.62 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.6 Cg_endo -29.24 115.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 124.318 3.345 . . . . 0.0 115.04 -153.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 42.3 m-85 -62.7 98.19 0.12 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.153 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.645 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 16.1 ptpt -145.27 151.26 38.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.275 0.559 . . . . 0.0 111.905 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 36' ' ' MET . 73.7 t -128.12 131.65 69.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.431 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.48 108.16 14.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.926 0.393 . . . . 0.0 110.009 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.34 174.01 10.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.424 -176.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 8.1 t -122.99 146.89 47.22 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.217 -176.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.74 -168.24 27.61 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.221 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -138.31 -10.7 1.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.76 123.16 9.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.153 0.501 . . . . 0.0 110.938 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.71 175.03 13.17 Favored Glycine 0 CA--C 1.52 0.396 0 CA-C-N 115.001 -1.0 . . . . 0.0 114.471 -177.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' A' ' 59' ' ' HIS . 21.8 p90 -174.24 155.59 2.43 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.218 -0.491 . . . . 0.0 110.288 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 106' ' ' ASP . 19.8 mm -63.58 128.32 25.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.669 -0.242 . . . . 0.0 110.369 171.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.582 HD11 ' CD2' ' A' ' 58' ' ' LEU . 6.8 tt -120.03 105.84 41.99 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 121.025 0.44 . . . . 0.0 110.123 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.74 113.48 2.99 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 123.322 2.681 . . . . 0.0 112.327 173.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 mt -103.76 124.36 58.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.337 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 45.3 mt-10 -107.93 127.47 53.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.117 0.485 . . . . 0.0 110.289 175.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.46 HG11 HD13 ' A' ' 14' ' ' LEU . 70.0 t -107.3 120.8 59.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.741 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 86.7 m-85 -90.77 145.48 24.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.386 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.428 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 19.8 m-85 -126.04 161.42 27.61 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.933 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.582 ' HG3' ' HB2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -101.6 94.22 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 117.986 0.357 . . . . 0.0 110.615 177.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -158.54 175.41 13.71 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.964 170.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.463 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -114.37 6.24 15.98 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 177.241 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -98.6 -153.08 0.42 Allowed 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -176.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -30.85 150.17 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.963 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -37.57 120.8 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 124.677 3.585 . . . . 0.0 113.777 -169.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.43 ' N ' ' HD3' ' A' ' 99' ' ' ARG . 0.3 OUTLIER -89.77 20.34 4.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.871 -175.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -143.24 137.77 29.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.176 0.513 . . . . 0.0 110.16 174.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.32 155.07 29.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -125.41 117.35 23.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.118 0.485 . . . . 0.0 111.08 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.636 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.2 m-85 -108.1 119.6 39.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.966 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -80.91 105.82 12.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.35 0.595 . . . . 0.0 109.905 177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -118.18 133.84 55.54 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.371 -175.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.402 ' HA ' HD13 ' A' ' 85' ' ' ILE . 31.8 t70 -87.55 111.82 21.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.039 -175.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.522 HD11 HG11 ' A' ' 37' ' ' VAL . 1.9 mp -88.76 101.54 14.11 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 175.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -113.21 155.33 25.23 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.515 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 14.7 mt -128.52 155.09 45.42 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -100.23 162.13 13.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 118.36 0.527 . . . . 0.0 110.175 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -52.12 141.61 18.16 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.524 ' HA ' HG21 ' A' ' 22' ' ' VAL . 5.0 tt0 -52.22 121.68 7.29 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.446 176.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.822 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 123.38 -49.74 0.88 Allowed Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.311 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -144.53 74.57 15.23 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 117.23 0.515 . . . . 0.0 112.119 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.517 ' HG3' ' HB ' ' A' ' 22' ' ' VAL . 35.7 Cg_endo -107.67 107.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.378 0 C-N-CA 122.839 2.359 . . . . 0.0 113.506 174.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -99.39 98.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.353 2.702 . . . . 0.0 111.393 168.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 44.1 t -122.16 111.4 30.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.97 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.414 HD22 ' C ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -144.88 96.51 2.87 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 174.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.427 ' O ' HD23 ' A' ' 120' ' ' LEU . 27.5 t-80 -122.27 134.09 54.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.215 -174.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 119' ' ' HIS . 8.3 mt -117.78 153.9 32.66 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.452 0.47 . . . . 0.0 111.205 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.478 ' HD2' HD23 ' A' ' 16' ' ' LEU . 20.8 ttm180 -145.17 151.14 37.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.474 ' N ' ' HG2' ' A' ' 121' ' ' ARG . 48.9 t -136.37 122.23 19.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -120.32 142.14 49.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.673 0.273 . . . . 0.0 111.089 -176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.422 ' HD3' ' HB3' ' A' ' 11' ' ' GLN . 22.1 ttmt -92.22 138.69 31.32 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 121.202 0.525 . . . . 0.0 111.641 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.838 ' HB2' HG23 ' A' ' 12' ' ' VAL . 5.9 mt -105.49 118.76 37.38 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 169.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 18.0 m -111.95 123.09 49.51 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.151 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -118.97 110.0 16.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.881 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -81.66 128.12 33.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.507 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 49.89 60.66 14.94 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.422 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.29 173.6 9.7 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.521 2.147 . . . . 0.0 111.626 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.6 p -67.58 136.92 55.23 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 174.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -56.5 -34.14 66.69 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.566 178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 9.3 m-20 -62.76 -32.56 73.73 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.686 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.4 t80 -76.53 -40.45 49.91 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.572 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 50.3 ttp180 -55.75 -41.66 74.27 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 173.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 43.7 ttm180 -58.09 -36.3 72.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.06 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 133' ' ' ASP . 37.8 mtpt -72.3 -40.38 67.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.89 0.376 . . . . 0.0 110.246 176.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 26.0 mt -71.15 -25.34 62.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.948 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.572 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 30.4 mt -89.8 -23.61 21.67 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.834 0.35 . . . . 0.0 110.783 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.02 -23.96 38.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.876 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.265 176.145 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -96.32 -48.33 2.22 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.006 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -84.7 142.57 29.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.95 0.405 . . . . 0.0 110.54 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.81 163.16 38.11 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.727 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.54 171.18 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.444 2.096 . . . . 0.0 112.602 174.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 30.6 mtp85 -133.4 139.31 46.69 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -141.64 -45.59 0.36 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.89 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -88.49 115.92 26.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.567 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -82.99 110.9 18.36 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.651 175.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 25.4 m -72.33 84.07 1.07 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.433 0.635 . . . . 0.0 111.067 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -131.66 0.15 3.95 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.827 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.615 -177.124 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 m -87.96 98.14 11.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.79 0.328 . . . . 0.0 110.458 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -140.2 8.42 2.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.821 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 96.6 mmm 61.59 -164.11 0.25 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.65 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.41 30.88 20.14 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.223 0.535 . . . . 0.0 110.907 -178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -139.87 86.02 2.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.288 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.4 ' HA ' ' OD1' ' A' ' 129' ' ' ASN . 25.1 m -59.48 111.01 1.24 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.537 -175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.54 ' O ' ' HD2' ' A' ' 130' ' ' PRO . 3.4 p -88.47 108.39 19.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.955 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.75 124.88 39.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.065 0.46 . . . . 0.0 111.753 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 t -101.7 139.75 22.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 5.2 mp0 -127.38 131.41 50.35 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -176.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.829 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -116.12 171.05 5.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.947 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -133.4 131.66 40.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.771 -0.371 . . . . 0.0 110.775 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.05 144.18 43.06 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.744 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 36.7 tt0 -109.68 123.26 49.19 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.036 -175.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.611 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.0 mm? -106.53 110.21 22.35 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 174.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.426 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -136.78 170.22 23.53 Favored Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 119.895 -1.145 . . . . 0.0 111.433 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -164.95 151.8 10.72 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.149 178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 29.0 mtp180 -113.54 145.62 40.95 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.524 173.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . . . -136.92 118.77 15.16 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.474 -0.89 . . . . 0.0 111.92 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -111.62 154.04 25.46 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.733 HG21 ' HA ' ' A' ' 112' ' ' GLU . 3.1 p -103.88 161.91 4.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HD2' ' OD1' ' A' ' 34' ' ' ASP . 3.7 mtp180 -112.19 141.01 46.4 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.6 tptt -68.18 -20.26 64.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.571 0.7 . . . . 0.0 109.143 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -131.1 104.24 15.23 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.365 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.52 ' HG3' HG22 ' A' ' 32' ' ' THR . 88.3 Cg_exo -47.63 154.42 1.82 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.27 2.647 . . . . 0.0 112.988 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.432 HG22 ' HB2' ' A' ' 31' ' ' PHE . 9.0 t -73.96 -170.65 0.95 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.077 -171.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 m -54.1 -33.48 24.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -172.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -104.24 5.96 35.14 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 122.162 0.982 . . . . 0.0 109.447 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.7 25.45 20.44 Favored Glycine 0 CA--C 1.503 -0.717 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.151 169.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.432 ' HB2' HG22 ' A' ' 27' ' ' THR . 21.9 m-30 -94.36 140.32 29.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.873 0.845 . . . . 0.0 111.11 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.52 HG22 ' HG3' ' A' ' 26' ' ' PRO . 44.8 p -94.41 -23.85 17.59 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.837 -1.529 . . . . 0.0 112.857 -162.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.509 ' O ' ' HA ' ' A' ' 79' ' ' SER . 69.9 m80 -118.22 146.55 44.17 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -170.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.532 ' OD1' ' HD2' ' A' ' 23' ' ' ARG . 4.0 m-20 -126.98 123.73 37.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.483 170.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.412 ' HZ3' HG22 ' A' ' 37' ' ' VAL . 54.1 p-90 -125.15 153.39 43.11 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.921 -175.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.675 ' SD ' ' HD3' ' A' ' 75' ' ' LYS . 44.8 ttp -129.61 120.65 25.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.273 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 7.9 m -100.46 151.19 5.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -151.69 152.74 33.19 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 5.5 m -124.35 127.65 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.19 171.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 44.3 mtm180 -127.18 -179.48 4.89 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.021 0.439 . . . . 0.0 111.22 -176.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.539 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -94.68 -173.13 38.03 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.042 172.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -65.18 110.33 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.039 1.826 . . . . 0.0 111.753 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 44' ' ' HIS . 15.4 mm-40 51.09 65.31 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.325 177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' A' ' 43' ' ' GLU . 75.4 t60 76.59 -10.39 1.33 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 171.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.6 m -60.24 127.09 30.07 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -66.04 126.6 29.12 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 120.863 0.363 . . . . 0.0 110.336 -178.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.666 HD12 HG21 ' A' ' 51' ' ' VAL . 1.1 pt -94.97 -4.05 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.76 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -65.78 0.59 1.67 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.866 0.365 . . . . 0.0 111.866 -176.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -76.86 -36.01 57.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.467 174.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CZ ' HG22 ' A' ' 47' ' ' ILE . 55.3 p90 -116.91 -17.15 10.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.52 175.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.666 HG21 HD12 ' A' ' 47' ' ' ILE . 98.1 t -91.35 130.32 40.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.86 0.362 . . . . 0.0 110.259 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.464 ' CD ' ' HE3' ' A' ' 93' ' ' LYS . 9.6 tp10 -99.38 -62.49 1.23 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.263 0.554 . . . . 0.0 110.169 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 43.1 mtpt -132.26 163.69 28.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.481 HG21 HG21 ' A' ' 39' ' ' VAL . 94.4 t -134.52 157.38 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 168.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.543 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.2 p -142.03 128.97 19.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.62 0.724 . . . . 0.0 111.166 -175.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.477 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 25.8 m-85 -110.86 104.57 13.2 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.581 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -78.31 92.5 4.53 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.815 177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.635 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.5 mt -71.81 -178.67 2.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.89 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -76.18 142.08 41.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -60.17 -17.2 39.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.585 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -61.31 -28.54 69.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.36 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -82.09 131.82 55.41 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.088 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.93 124.74 15.05 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.183 1.922 . . . . 0.0 110.931 171.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 60.7 70.28 0.99 Allowed Pre-proline 0 N--CA 1.466 0.362 0 O-C-N 123.578 0.549 . . . . 0.0 110.406 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.75 -23.6 35.62 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.666 2.244 . . . . 0.0 113.781 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -90.45 105.25 17.69 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.309 0.576 . . . . 0.0 110.333 -174.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -105.54 86.92 2.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.078 -175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.3 m -69.27 138.22 22.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.211 0.529 . . . . 0.0 110.066 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.75 103.19 7.96 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -94.84 -23.73 17.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.054 0.931 . . . . 0.0 109.307 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.592 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 4.1 t70 -75.8 173.49 7.06 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 113.816 -1.538 . . . . 0.0 110.826 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.659 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 17.3 Cg_exo -32.91 -175.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.675 1 C-N-CA 125.457 4.105 . . . . 0.0 114.732 163.202 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' A' ' 72' ' ' PRO . 1.9 Cg_endo -28.01 115.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 124.299 3.332 . . . . 0.0 114.508 -158.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 42.7 m-85 -61.49 107.13 0.74 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.341 -1.3 . . . . 0.0 111.009 -175.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.675 ' HD3' ' SD ' ' A' ' 36' ' ' MET . 17.3 ptpt -152.13 150.46 29.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.379 0.609 . . . . 0.0 112.066 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 36' ' ' MET . 77.5 t -128.57 132.55 67.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.629 177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -121.11 106.31 11.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.455 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -137.29 169.14 18.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.035 0.445 . . . . 0.0 111.463 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 0.8 OUTLIER -114.91 137.05 52.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.861 -178.087 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -143.68 -178.1 19.16 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -129.76 -2.39 4.75 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.685 0.278 . . . . 0.0 110.97 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -163.55 142.27 7.98 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.398 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.46 179.72 39.63 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 115.933 -0.576 . . . . 0.0 113.425 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -178.11 157.03 1.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 122.605 0.362 . . . . 0.0 110.293 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.3 mm -63.02 128.49 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.057 171.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.635 HD11 ' CD2' ' A' ' 58' ' ' LEU . 5.7 tt -120.29 105.2 42.26 Favored Pre-proline 0 N--CA 1.444 -0.728 0 CA-C-O 121.04 0.448 . . . . 0.0 110.224 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -68.34 110.66 2.3 Favored 'Trans proline' 0 C--O 1.239 0.545 0 C-N-CA 123.312 2.675 . . . . 0.0 112.316 174.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.427 HG12 ' CD2' ' A' ' 56' ' ' PHE . 4.9 mt -102.3 123.75 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.29 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 44.6 mt-10 -109.27 126.62 53.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.042 0.449 . . . . 0.0 109.939 175.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 53.0 t -104.5 122.09 57.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.149 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 73.0 m-85 -89.64 136.82 32.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.018 -178.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.444 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 23.5 m-85 -114.77 156.36 25.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.077 178.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.464 ' HE3' ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -104.47 91.67 3.99 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.26 0.552 . . . . 0.0 111.347 -178.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -158.51 179.75 8.84 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.909 173.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.597 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -113.19 4.19 16.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 110.915 176.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HB3' ' H ' ' A' ' 97' ' ' GLU . 44.9 mm-40 -99.34 -152.07 0.4 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.155 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.439 ' H ' ' HB3' ' A' ' 96' ' ' GLU . 51.3 mm-40 -25.63 148.18 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -34.49 120.68 0.14 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 125.085 3.857 . . . . 0.0 113.873 -170.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.93 19.24 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.419 -174.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 11.8 ptpt -151.39 144.38 24.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.205 0.526 . . . . 0.0 110.432 175.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 0.8 OUTLIER -123.94 154.71 30.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -120.81 118.96 31.35 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.939 0.399 . . . . 0.0 110.811 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.611 ' CD2' HD21 ' A' ' 16' ' ' LEU . 24.1 m-85 -112.54 117.08 31.35 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.712 174.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.98 105.93 14.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.626 0.727 . . . . 0.0 109.791 177.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -115.99 127.52 55.0 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.212 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -81.48 109.89 16.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.605 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.523 HD11 HG11 ' A' ' 37' ' ' VAL . 1.4 mp -83.87 91.16 7.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.442 . . . . 0.0 109.81 176.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -96.46 154.02 17.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.279 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.2 mt -127.91 162.3 27.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.677 ' CD2' ' HA ' ' A' ' 116' ' ' PRO . 23.8 p80 -96.52 166.97 11.43 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.792 177.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.11 150.59 47.88 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.954 0.407 . . . . 0.0 111.261 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.733 ' HA ' HG21 ' A' ' 22' ' ' VAL . 5.1 tt0 -61.82 104.3 0.43 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.469 173.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.33 24.43 6.81 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.211 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -132.04 146.53 62.09 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -43.75 139.67 5.12 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 122.703 2.269 . . . . 0.0 114.112 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.677 ' HA ' ' CD2' ' A' ' 110' ' ' HIS . 22.0 Cg_endo -61.39 174.56 1.98 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.232 3.288 . . . . 0.0 114.176 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 20' ' ' ALA . 48.6 t -116.42 133.12 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.398 -173.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.5 97.65 3.07 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -124.44 137.12 54.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.254 -174.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 25.2 mt -115.74 153.48 31.32 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.74 0.65 . . . . 0.0 110.097 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 20.2 ttt180 -142.64 136.38 29.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 177.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 75.0 m -115.25 113.65 24.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.867 0.365 . . . . 0.0 111.052 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -110.73 134.89 52.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.878 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -96.48 125.9 41.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.261 0.553 . . . . 0.0 111.836 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.829 ' HB2' HG23 ' A' ' 12' ' ' VAL . 12.6 mt -90.21 120.42 31.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 171.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 26.2 m -112.84 119.9 39.59 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.694 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.49 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 30.6 m-85 -118.25 109.23 16.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.154 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.34 116.84 20.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.191 0.519 . . . . 0.0 111.153 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' A' ' 7' ' ' SER . 4.4 t30 52.75 61.78 11.04 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.501 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 96.5 Cg_endo -77.73 169.23 21.13 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.353 2.036 . . . . 0.0 111.489 176.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' A' ' 134' ' ' PHE . 6.6 p -59.62 141.25 55.38 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -57.82 -36.09 71.77 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.366 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.89 -34.5 74.75 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.676 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 6.0 t80 -73.94 -40.12 63.29 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.615 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 19.9 ttm180 -55.08 -44.62 75.02 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.591 173.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -55.49 -38.59 69.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.106 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -72.05 -39.74 68.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.984 0.421 . . . . 0.0 110.413 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 34.0 mt -72.62 -26.07 61.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.223 -178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 48.8 mt -85.6 -25.4 26.71 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.894 0.378 . . . . 0.0 110.689 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -80.74 -27.72 36.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.149 -177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 CA-C-O 118.442 -0.789 . . . . 0.0 110.536 176.453 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -126.97 158.07 20.82 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.2 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 66.7 mttm 66.27 94.93 0.06 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.107 0.563 . . . . 0.0 111.549 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.01 156.76 65.88 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.427 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.53 168.64 3.82 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.13 1.887 . . . . 0.0 111.674 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -149.27 152.26 35.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.372 0.606 . . . . 0.0 111.592 -178.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -86.68 -40.03 15.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.161 0.505 . . . . 0.0 110.081 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 32.7 tp -145.25 52.05 1.2 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.485 -0.78 . . . . 0.0 108.929 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -99.26 106.41 18.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.82 -177.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 19.2 m -115.93 -37.46 3.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.295 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -120.88 41.28 3.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.182 0.515 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.134 178.231 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.681 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 t 55.87 48.35 18.23 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.357 0.599 . . . . 0.0 110.966 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -102.45 146.34 28.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.193 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 65.0 mtt 59.19 40.4 21.67 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.422 0.629 . . . . 0.0 110.027 -176.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.53 89.91 6.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.874 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 p -66.43 134.03 51.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.576 178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.0 m -72.66 115.15 11.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.827 0.346 . . . . 0.0 110.202 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.5 p -129.45 116.89 19.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.368 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.87 138.72 49.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.657 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.496 HG23 ' HG3' ' A' ' 130' ' ' PRO . 10.2 t -104.93 143.34 16.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -127.35 127.67 44.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.743 0.306 . . . . 0.0 110.362 -176.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.826 HG23 ' HB2' ' A' ' 125' ' ' LEU . 0.1 OUTLIER -112.13 171.92 3.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.224 178.278 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 123' ' ' GLU . 99.6 mttt -137.41 138.06 39.46 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.695 0.284 . . . . 0.0 110.53 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.404 HD22 HD13 ' A' ' 47' ' ' ILE . 85.4 mt -121.4 142.02 50.41 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.53 175.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 121' ' ' ARG . 3.0 tm-20 -107.8 128.09 54.29 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.046 -175.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.612 HD21 ' CD2' ' A' ' 103' ' ' PHE . 2.2 mm? -111.24 107.64 17.01 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -135.81 168.4 23.95 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.612 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -162.88 152.17 15.21 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.485 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.649 ' HA ' ' O ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -122.46 121.06 35.72 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.411 ' O ' ' HE1' ' A' ' 114' ' ' HIS . . . -115.61 117.4 30.2 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.283 -176.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -111.09 158.9 18.33 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.786 HG11 ' H ' ' A' ' 113' ' ' GLY . 5.0 p -103.79 156.41 5.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 23' ' ' ARG . 3.0 mtp180 -104.66 140.74 37.6 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -63.39 -22.22 66.75 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.612 0.72 . . . . 0.0 109.342 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -140.93 107.91 6.35 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.483 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.523 ' HG3' HG22 ' A' ' 32' ' ' THR . 93.8 Cg_exo -49.23 156.88 2.2 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.301 2.667 . . . . 0.0 112.816 174.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.0 t -79.36 -173.5 3.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.658 -175.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -57.23 -42.43 79.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 122.625 0.37 . . . . 0.0 111.349 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -75.32 2.2 11.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.079 0.466 . . . . 0.0 111.144 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.61 29.33 65.81 Favored Glycine 0 CA--C 1.507 -0.466 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.64 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -86.8 129.43 34.88 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.523 HG22 ' HG3' ' A' ' 26' ' ' PRO . 59.9 p -91.51 -20.12 22.06 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.105 -168.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.441 ' O ' ' HA ' ' A' ' 79' ' ' SER . 60.0 m80 -122.12 145.85 47.77 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -172.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -121.81 123.81 42.67 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 172.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -126.22 143.31 51.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.196 0.522 . . . . 0.0 110.96 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.595 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 45.5 ttp -120.27 117.29 27.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.515 174.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 9.9 m -98.96 153.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.342 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 74' ' ' TYR . 1.4 p90 -153.63 153.98 33.34 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.7 m -124.73 131.12 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.322 168.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.67 175.02 14.61 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.861 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.509 ' HA3' HG23 ' A' ' 47' ' ' ILE . . . -81.88 -176.44 51.15 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.296 -168.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 45' ' ' SER . 11.8 Cg_exo -63.01 112.19 1.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.981 2.454 . . . . 0.0 111.702 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 52.02 52.58 14.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.671 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.0 t60 80.3 -3.47 1.91 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.701 171.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.481 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 49.9 m -58.58 123.42 16.22 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -58.11 127.12 30.48 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.652 0.263 . . . . 0.0 111.078 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.56 HD12 HG21 ' A' ' 51' ' ' VAL . 5.6 pt -97.7 -1.98 10.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -66.51 -4.49 8.56 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.815 0.34 . . . . 0.0 111.003 -177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -71.35 -34.38 70.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.755 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -120.68 -17.5 7.99 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.555 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.56 HG21 HD12 ' A' ' 47' ' ' ILE . 91.4 t -89.75 128.48 41.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 120.921 0.391 . . . . 0.0 110.487 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -96.87 -62.38 1.27 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.366 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -145.66 153.56 41.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 55' ' ' VAL . 91.5 t -128.0 158.16 39.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.914 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.637 ' CG1' ' HB2' ' A' ' 89' ' ' GLU . 7.7 p -142.11 134.13 26.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.14 0.495 . . . . 0.0 111.246 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.503 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 22.7 m-85 -115.86 107.29 14.83 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -77.94 94.33 4.57 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.925 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.599 ' CD2' HD11 ' A' ' 86' ' ' LEU . 12.4 mt -75.29 -177.7 3.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.845 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.505 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . 68.7 t60 -73.97 138.89 44.46 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -175.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 -54.97 -24.55 24.5 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.022 -170.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.7 t -69.3 -19.17 63.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.188 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 59' ' ' HIS . 21.0 m-85 -77.95 139.6 61.71 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.7 0.286 . . . . 0.0 110.994 -176.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.35 119.9 6.81 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.066 2.51 . . . . 0.0 111.11 173.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 59.45 67.39 1.87 Allowed Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.45 -170.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.15 -20.25 50.06 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.591 2.194 . . . . 0.0 113.006 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -95.66 102.26 14.04 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.143 0.497 . . . . 0.0 110.488 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -98.75 94.23 6.51 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.516 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 54' ' ' VAL . 0.8 OUTLIER -79.52 135.21 26.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 172.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 m -127.95 114.56 17.3 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mttt -106.66 -24.53 12.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.674 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.626 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 5.9 p-10 -68.51 -174.87 0.22 Allowed Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.397 1.079 . . . . 0.0 111.347 -175.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.631 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 4.2 Cg_exo -40.61 -167.63 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.508 0 C-N-CA 124.231 3.287 . . . . 0.0 114.552 167.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.657 ' O ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 Cg_endo -39.68 124.49 1.33 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.626 2.217 . . . . 0.0 113.097 -155.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 46.7 m-85 -62.5 95.75 0.07 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.187 -175.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.657 ' HG2' ' O ' ' A' ' 73' ' ' PRO . 4.8 ptpt -141.4 145.88 35.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.453 0.644 . . . . 0.0 112.251 -176.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 36' ' ' MET . 92.7 t -125.33 131.29 72.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.827 177.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -115.43 110.55 19.49 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -133.62 170.18 15.92 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.067 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 33' ' ' HIS . 4.0 t -121.96 142.72 50.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.708 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.62 -168.5 21.71 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 121.125 -0.559 . . . . 0.0 111.892 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -135.8 -11.92 2.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.178 0.489 . . . . 0.0 111.651 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.423 ' HB3' ' HE3' ' B' ' 218' ' ' ALY . . . -145.63 132.73 20.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.914 0.388 . . . . 0.0 110.567 -175.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -73.67 171.5 51.79 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.623 -0.717 . . . . 0.0 113.14 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -169.51 155.38 6.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 106' ' ' ASP . 23.3 mm -63.21 126.45 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.982 172.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.599 HD11 ' CD2' ' A' ' 58' ' ' LEU . 5.6 tt -117.74 104.29 49.43 Favored Pre-proline 0 N--CA 1.444 -0.727 0 CA-C-O 121.22 0.533 . . . . 0.0 110.378 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.543 ' HB3' ' HE ' ' A' ' 102' ' ' ARG . 24.7 Cg_exo -65.47 108.48 1.21 Allowed 'Trans proline' 0 C--O 1.239 0.526 0 C-N-CA 123.85 3.034 . . . . 0.0 112.384 172.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.4 mt -101.49 124.47 55.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.26 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.637 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 48.5 mt-10 -108.17 127.49 53.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.095 0.474 . . . . 0.0 109.867 175.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.7 t -108.0 119.83 58.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.69 178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.528 ' HB2' ' O ' ' A' ' 53' ' ' LYS . 96.8 m-85 -93.24 138.55 31.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.583 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.416 ' CE2' ' CG1' ' A' ' 101' ' ' VAL . 24.9 m-85 -112.25 149.5 32.24 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.206 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.48 92.25 9.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.372 0.606 . . . . 0.0 109.946 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.539 ' HB3' ' HG3' ' A' ' 99' ' ' ARG . 50.9 t30 -158.13 156.69 31.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.668 -174.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -113.33 8.56 18.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.288 0.566 . . . . 0.0 111.013 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.515 ' HB2' HD21 ' A' ' 94' ' ' ASN . 0.4 OUTLIER -100.59 -152.29 0.42 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.236 -175.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.508 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 16.9 mm-40 -33.39 155.04 0.04 OUTLIER Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.133 0.973 . . . . 0.0 112.892 173.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 97' ' ' GLU . 1.3 Cg_endo -37.88 122.44 0.51 Allowed 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 124.566 3.511 . . . . 0.0 114.055 -168.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.539 ' HG3' ' HB3' ' A' ' 94' ' ' ASN . 0.2 OUTLIER -95.62 20.18 10.04 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.412 -174.291 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.75 137.6 26.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.272 0.558 . . . . 0.0 111.01 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 1.0 OUTLIER -125.93 156.79 36.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.576 -178.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.543 ' HE ' ' HB3' ' A' ' 87' ' ' PRO . 29.3 ttt180 -131.26 115.77 16.74 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.417 0.627 . . . . 0.0 110.8 177.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.612 ' CD2' HD21 ' A' ' 16' ' ' LEU . 23.8 m-85 -107.53 114.31 28.21 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.048 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.75 102.97 5.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.317 0.579 . . . . 0.0 109.636 176.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -114.08 127.29 55.86 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.287 0.565 . . . . 0.0 110.662 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.421 ' HA ' HD13 ' A' ' 85' ' ' ILE . 11.8 t70 -80.4 104.47 10.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.931 -177.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.529 HD11 HG11 ' A' ' 37' ' ' VAL . 1.8 mp -82.8 109.34 16.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 174.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.481 ' CE1' HG11 ' A' ' 117' ' ' VAL . 54.4 p90 -124.64 160.55 28.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.444 0.64 . . . . 0.0 111.054 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 6.3 mt -135.76 156.57 48.6 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.603 ' HB2' ' CG ' ' A' ' 114' ' ' HIS . 55.3 m170 -101.6 171.23 7.68 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 170.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.58 173.2 3.53 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.55 0.614 . . . . 0.0 112.262 -174.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.732 ' HA ' HG21 ' A' ' 22' ' ' VAL . 12.8 mt-10 -61.3 131.62 50.92 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.963 0.411 . . . . 0.0 110.888 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.786 ' H ' HG11 ' A' ' 22' ' ' VAL . . . 96.2 2.95 60.42 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.659 -177.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.603 ' CG ' ' HB2' ' A' ' 110' ' ' HIS . 10.3 p80 -78.77 149.57 74.43 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-O 119.832 -0.128 . . . . 0.0 110.896 -177.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.06 137.46 37.56 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.335 1.357 . . . . 0.0 111.087 162.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -41.2 148.71 0.23 Allowed 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 124.749 3.633 . . . . 0.0 114.905 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 19' ' ' ARG . 30.1 t -100.22 125.25 54.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.668 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -133.48 97.77 4.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.964 0.411 . . . . 0.0 110.12 -173.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -125.22 130.37 51.96 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.774 -173.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.3 mt -118.45 140.74 49.39 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.548 0.53 . . . . 0.0 110.397 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 22.2 ttm180 -131.37 132.34 44.35 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 120.519 0.199 . . . . 0.0 111.203 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 57.3 m -110.13 110.62 21.55 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.938 0.399 . . . . 0.0 110.708 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 22.5 mm-40 -97.65 159.52 14.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.578 179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -120.28 133.59 55.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.213 0.53 . . . . 0.0 111.337 -177.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.826 ' HB2' HG23 ' A' ' 12' ' ' VAL . 9.8 mt -107.44 120.4 42.08 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.15 175.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 21.3 m -110.89 123.18 49.61 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.658 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -120.31 102.42 8.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.893 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -78.98 125.34 29.25 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.459 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 56.88 63.0 5.63 Favored Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.871 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.496 ' HG3' HG23 ' A' ' 10' ' ' VAL . 71.6 Cg_endo -81.89 165.37 17.57 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.47 2.114 . . . . 0.0 111.675 177.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.45 ' CG2' ' HG2' ' A' ' 96' ' ' GLU . 13.4 p -68.1 143.21 55.54 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 174.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -57.79 -42.24 83.74 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.23 -175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -63.11 -25.93 68.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.768 0.318 . . . . 0.0 110.622 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.612 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 15.3 t80 -73.43 -38.23 65.59 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.61 ' O ' ' HG ' ' A' ' 139' ' ' LEU . 35.2 ttm180 -56.1 -45.57 79.41 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 173.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -55.06 -38.08 67.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.622 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.503 ' HD3' ' HA ' ' A' ' 134' ' ' PHE . 46.5 mtpt -72.35 -41.52 66.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.758 0.313 . . . . 0.0 110.763 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 134' ' ' PHE . 40.0 mt -70.65 -32.87 70.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.065 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 135' ' ' ARG . 50.8 mt -74.97 -33.89 61.95 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.907 0.384 . . . . 0.0 110.839 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -73.97 -28.66 61.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.903 -0.57 . . . . 0.0 110.493 175.776 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . 79.37 -113.16 3.6 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.322 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -164.08 137.91 5.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.97 150.28 97.84 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.69 173.76 3.41 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.402 2.068 . . . . 0.0 112.453 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -145.67 137.18 25.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.961 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' ALY . . . . . 0.423 ' HE3' ' HB3' ' A' ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -111.16 73.33 0.81 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.019 0.437 . . . . 0.0 110.698 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -95.36 77.25 3.4 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.346 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 58.07 67.51 0.94 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.56 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 5.8 t -84.24 -17.7 38.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.793 0.33 . . . . 0.0 110.734 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.31 95.2 9.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.079 0.466 . . . . 0.0 110.112 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.382 -0.818 . . . . 0.0 110.278 179.568 . . . . . . . . 0 0 . 1 stop_ save_